,trialid,source_register,date_registration,date_enrollement,retrospective_registration,recruitment_status,phase,study_type,countries,public_title,target_enrollment,web_address
0,NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,True,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),500,https://clinicaltrials.gov/show/NCT04246242
1,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49599
2,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49596
3,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49612
4,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49607
5,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",300,http://www.chictr.org.cn/showproj.aspx?proj=49486
6,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",520,http://www.chictr.org.cn/showproj.aspx?proj=49514
7,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",180,http://www.chictr.org.cn/showproj.aspx?proj=49543
8,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",20,http://www.chictr.org.cn/showproj.aspx?proj=49532
9,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49533
10,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49530
11,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,400,http://www.chictr.org.cn/showproj.aspx?proj=49306
12,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,80,http://www.chictr.org.cn/showproj.aspx?proj=49490
13,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=49387
14,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),72,http://www.chictr.org.cn/showproj.aspx?proj=49425
15,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49355
16,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49161
17,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49453
18,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49348
19,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=49452
20,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),600,http://www.chictr.org.cn/showproj.aspx?proj=49422
21,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",160,http://www.chictr.org.cn/showproj.aspx?proj=49380
22,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=49342
23,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49415
24,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",60,http://www.chictr.org.cn/showproj.aspx?proj=49131
25,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",188,http://www.chictr.org.cn/showproj.aspx?proj=49409
26,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",408,http://www.chictr.org.cn/showproj.aspx?proj=49408
27,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),238,http://www.chictr.org.cn/showproj.aspx?proj=49222
28,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49287
29,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",90,http://www.chictr.org.cn/showproj.aspx?proj=49297
30,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",112,http://www.chictr.org.cn/showproj.aspx?proj=49263
31,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",440,http://www.chictr.org.cn/showproj.aspx?proj=49283
32,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49086
33,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",192,http://www.chictr.org.cn/showproj.aspx?proj=49187
34,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,40,http://www.chictr.org.cn/showproj.aspx?proj=49215
35,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),380,http://www.chictr.org.cn/showproj.aspx?proj=49165
36,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",205,http://www.chictr.org.cn/showproj.aspx?proj=49145
37,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),63,http://www.chictr.org.cn/showproj.aspx?proj=49146
38,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49075
39,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,600,http://www.chictr.org.cn/showproj.aspx?proj=48985
40,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,400,http://www.chictr.org.cn/showproj.aspx?proj=48988
41,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=49042
42,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",1000,http://www.chictr.org.cn/showproj.aspx?proj=49080
43,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=48880
44,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,200,http://www.chictr.org.cn/showproj.aspx?proj=48792
45,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",30,http://www.chictr.org.cn/showproj.aspx?proj=49015
46,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",30,http://www.chictr.org.cn/showproj.aspx?proj=49013
47,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=48968
48,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=48992
49,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",328,http://www.chictr.org.cn/showproj.aspx?proj=48991
50,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",140,http://www.chictr.org.cn/showproj.aspx?proj=48860
51,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",100,http://www.chictr.org.cn/showproj.aspx?proj=48861
52,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",90,http://www.chictr.org.cn/showproj.aspx?proj=48971
53,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=48931
54,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,200,http://www.chictr.org.cn/showproj.aspx?proj=48965
55,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=48919
56,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48927
57,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,100,http://www.chictr.org.cn/showproj.aspx?proj=48930
58,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,100,http://www.chictr.org.cn/showproj.aspx?proj=48929
59,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=48904
60,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48911
61,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48884
62,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,120,http://www.chictr.org.cn/showproj.aspx?proj=48827
63,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),72,http://www.chictr.org.cn/showproj.aspx?proj=48881
64,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),45,http://www.chictr.org.cn/showproj.aspx?proj=48907
65,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,42,http://www.chictr.org.cn/showproj.aspx?proj=48886
66,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=48824
67,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=48768
68,IRCT20190809044488N1,IRCT,2020-01-13,2019-09-07,True,Recruiting,Phase 3,Interventional,Iran,"Effects of using Forced Hot air system on physiological parameters, waking time and arterial blood gases in patients undergoing coronary artery bypass grafting surgery",102,http://en.irct.ir/trial/41571
69,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50025
70,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50059
71,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,60,http://www.chictr.org.cn/showproj.aspx?proj=49229
72,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),16,http://www.chictr.org.cn/showproj.aspx?proj=50017
73,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=49567
74,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",20,http://www.chictr.org.cn/showproj.aspx?proj=49696
75,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49947
76,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50004
77,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),130,http://www.chictr.org.cn/showproj.aspx?proj=50005
78,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49594
79,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",348,http://www.chictr.org.cn/showproj.aspx?proj=49762
80,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),16,http://www.chictr.org.cn/showproj.aspx?proj=49901
81,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988
82,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),180,http://www.chictr.org.cn/showproj.aspx?proj=49747
83,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49932
84,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,400,http://www.chictr.org.cn/showproj.aspx?proj=49910
85,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49889
86,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49902
87,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,180,http://www.chictr.org.cn/showproj.aspx?proj=49952
88,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",200,http://www.chictr.org.cn/showproj.aspx?proj=49831
89,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49869
90,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=49861
91,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",300,http://www.chictr.org.cn/showproj.aspx?proj=49866
92,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=49891
93,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=49544
94,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",132,http://www.chictr.org.cn/showproj.aspx?proj=49647
95,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),828,http://www.chictr.org.cn/showproj.aspx?proj=49703
96,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49824
97,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=49852
98,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49812
99,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49799
100,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49718
101,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49777
102,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49619
103,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49737
104,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),480,http://www.chictr.org.cn/showproj.aspx?proj=49770
105,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49738
106,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",240,http://www.chictr.org.cn/showproj.aspx?proj=49723
107,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",50,http://www.chictr.org.cn/showproj.aspx?proj=49748
108,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49717
109,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=49510
110,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,200,http://www.chictr.org.cn/showproj.aspx?proj=49309
111,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49574
112,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49674
113,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=49720
114,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=49218
115,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),186,http://www.chictr.org.cn/showproj.aspx?proj=49702
116,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",300,http://www.chictr.org.cn/showproj.aspx?proj=49321
117,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49664
118,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,100,http://www.chictr.org.cn/showproj.aspx?proj=49639
119,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49618
120,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",300,http://www.chictr.org.cn/showproj.aspx?proj=49402
121,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",68,http://www.chictr.org.cn/showproj.aspx?proj=49534
122,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",320,http://www.chictr.org.cn/showproj.aspx?proj=49428
123,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49138
124,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49220
125,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),78,http://www.chictr.org.cn/showproj.aspx?proj=49317
126,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=50380
127,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50273
128,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,80,http://www.chictr.org.cn/showproj.aspx?proj=50268
129,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",30,http://www.chictr.org.cn/showproj.aspx?proj=50174
130,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,60,http://www.chictr.org.cn/showproj.aspx?proj=50286
131,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50341
132,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",340,http://www.chictr.org.cn/showproj.aspx?proj=50173
133,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=50323
134,ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,False,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",292,http://www.chictr.org.cn/showproj.aspx?proj=48801
135,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50231
136,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,300,http://www.chictr.org.cn/showproj.aspx?proj=50247
137,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50248
138,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=49691
139,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),26,http://www.chictr.org.cn/showproj.aspx?proj=49963
140,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,20,http://www.chictr.org.cn/showproj.aspx?proj=50130
141,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",60,http://www.chictr.org.cn/showproj.aspx?proj=49887
142,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,300,http://www.chictr.org.cn/showproj.aspx?proj=50089
143,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),186,http://www.chictr.org.cn/showproj.aspx?proj=49945
144,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50110
145,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50115
146,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),120,http://www.chictr.org.cn/showproj.aspx?proj=50107
147,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=49883
148,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49914
149,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49797
150,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,450,http://www.chictr.org.cn/showproj.aspx?proj=49796
151,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",72,http://www.chictr.org.cn/showproj.aspx?proj=49666
152,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=49592
153,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=49536
154,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=49482
155,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",120,http://www.chictr.org.cn/showproj.aspx?proj=49301
156,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",108,http://www.chictr.org.cn/showproj.aspx?proj=48782
157,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,48,http://www.chictr.org.cn/showproj.aspx?proj=48777
158,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,30,http://www.chictr.org.cn/showproj.aspx?proj=50727
159,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50690
160,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658
161,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,100,http://www.chictr.org.cn/showproj.aspx?proj=49790
162,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=50586
163,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,60,http://www.chictr.org.cn/showproj.aspx?proj=49632
164,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50487
165,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",10,http://www.chictr.org.cn/showproj.aspx?proj=50507
166,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=50263
167,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=50453
168,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",328,http://www.chictr.org.cn/showproj.aspx?proj=50470
169,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50450
170,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),19,http://www.chictr.org.cn/showproj.aspx?proj=50458
171,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),19,http://www.chictr.org.cn/showproj.aspx?proj=50452
172,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49753
173,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),394,http://www.chictr.org.cn/showproj.aspx?proj=50421
174,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),96,http://www.chictr.org.cn/showproj.aspx?proj=50082
175,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,60,http://www.chictr.org.cn/showproj.aspx?proj=50378
176,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49435
177,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=49081
178,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",70,http://www.chictr.org.cn/showproj.aspx?proj=49088
179,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=48775
180,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=49014
181,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=48684
182,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50462
183,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),24,http://www.chictr.org.cn/showproj.aspx?proj=51028
184,ChiCTR2000030894,ChiCTR,2020-03-16,2020-03-01,True,Recruiting,Phase 4,Interventional,China,"Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",150,http://www.chictr.org.cn/showproj.aspx?proj=51126
185,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,40,http://www.chictr.org.cn/showproj.aspx?proj=51118
186,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50662
187,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51090
188,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51081
189,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,81,http://www.chictr.org.cn/showproj.aspx?proj=51086
190,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=51072
191,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,300,http://www.chictr.org.cn/showproj.aspx?proj=51054
192,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=51050
193,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),800,http://www.chictr.org.cn/showproj.aspx?proj=51044
194,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986
195,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,128,http://www.chictr.org.cn/showproj.aspx?proj=51018
196,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50973
197,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50934
198,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,20,http://www.chictr.org.cn/showproj.aspx?proj=50956
199,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),70,http://www.chictr.org.cn/showproj.aspx?proj=49284
200,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50941
201,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50910
202,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,120,http://www.chictr.org.cn/showproj.aspx?proj=50793
203,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50843
204,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=50251
205,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,50,http://www.chictr.org.cn/showproj.aspx?proj=50537
206,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=50795
207,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,60,http://www.chictr.org.cn/showproj.aspx?proj=50786
208,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,240,http://www.chictr.org.cn/showproj.aspx?proj=50763
209,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50693
210,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",300,http://www.chictr.org.cn/showproj.aspx?proj=50126
211,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50455
212,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50057
213,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=51404
214,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=51416
215,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=51148
216,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=51136
217,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,320,http://www.chictr.org.cn/showproj.aspx?proj=50984
218,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,60,http://www.chictr.org.cn/showproj.aspx?proj=51349
219,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,76,http://www.chictr.org.cn/showproj.aspx?proj=51331
220,ChiCTR2000030987,ChiCTR,2020-03-20,2020-03-05,True,Recruiting,Phase 2/Phase 3,Interventional,China,A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51329
221,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=51265
222,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50199
223,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=51059
224,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,108,http://www.chictr.org.cn/showproj.aspx?proj=51184
225,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=50696
226,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",30,http://www.chictr.org.cn/showproj.aspx?proj=51141
227,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",100,http://www.chictr.org.cn/showproj.aspx?proj=50476
228,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),108,http://www.chictr.org.cn/showproj.aspx?proj=51154
229,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,40,http://www.chictr.org.cn/showproj.aspx?proj=50660
230,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusâ€“infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",240,http://www.chictr.org.cn/showproj.aspx?proj=50137
231,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",360,http://www.chictr.org.cn/showproj.aspx?proj=49524
232,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49074
233,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",480,http://www.chictr.org.cn/showproj.aspx?proj=49065
234,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",90,http://www.chictr.org.cn/showproj.aspx?proj=48809
235,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-05-03,False,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25
236,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,60,http://www.chictr.org.cn/showproj.aspx?proj=51425
237,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,20,http://www.chictr.org.cn/showproj.aspx?proj=51647
238,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,110,http://www.chictr.org.cn/showproj.aspx?proj=51455
239,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=51194
240,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",300,http://www.chictr.org.cn/showproj.aspx?proj=49420
241,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),28,http://www.chictr.org.cn/showproj.aspx?proj=51030
242,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,90,http://www.chictr.org.cn/showproj.aspx?proj=51112
243,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),204,http://www.chictr.org.cn/showproj.aspx?proj=51317
244,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),76,http://www.chictr.org.cn/showproj.aspx?proj=51061
245,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",144,http://www.chictr.org.cn/showproj.aspx?proj=51240
246,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),2840,http://www.chictr.org.cn/showproj.aspx?proj=51100
247,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=51139
248,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50778
249,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,204,http://www.chictr.org.cn/showproj.aspx?proj=50202
250,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50066
251,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49840
252,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-GuÃ©rin,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69
253,EUCTR2020-001023-14-GB,EU Clinical Trials Register,2020-03-17,2020-03-17,False,Authorised,Phase 2,Interventional,United Kingdom,a trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14
254,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),192,http://www.chictr.org.cn/showproj.aspx?proj=51119
255,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50474
256,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51684
257,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51911
258,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),36,http://www.chictr.org.cn/showproj.aspx?proj=51904
259,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),56,http://www.chictr.org.cn/showproj.aspx?proj=51693
260,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",80,http://www.chictr.org.cn/showproj.aspx?proj=51859
261,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,200,http://www.chictr.org.cn/showproj.aspx?proj=49254
262,EUCTR2020-000936-23-FR,EU Clinical Trials Register,2020-03-09,2020-09-03,False,Authorised,Phase 3,Interventional,"United Kingdom, Belgium, Netherlands, Luxembourg, Spain, France, Germany","Multi-centre, adaptive, randomized trial of the safety and efficacy of treatments of COVID-19 in hospitalized adults - DisCoVeRy",3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23
263,EUCTR2020-001386-37-IT,EU Clinical Trials Register,2020-04-02,2020-03-27,True,Authorised,Phase 2,Interventional,Italy,Efficacy of Tocilizumab - COVID-19,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001386-37
264,ACTRN12620000443998,ANZCTR,2020-04-06,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,58,https://anzctr.org.au/ACTRN12620000443998.aspx
265,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=52216
266,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",500,http://www.chictr.org.cn/showproj.aspx?proj=52006
267,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),105,http://www.chictr.org.cn/showproj.aspx?proj=52165
268,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50613
269,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,120,http://www.chictr.org.cn/showproj.aspx?proj=50928
270,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-10-04,False,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23
271,EUCTR2020-001188-96-FR,EU Clinical Trials Register,2020-03-24,2020-07-04,False,Authorised,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 infection (COVID-19) in exposed healthcare workers: a randomized double-blind placebo-controlled clinical trial,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001188-96
272,EUCTR2020-001373-70-FR,EU Clinical Trials Register,2020-03-29,2020-01-04,True,Authorised,"Human pharmacology (Phase I): 
Therapeutic exploratory (Phase II): yes
Therapeutic confirmatory - (Phase III): 
Therapeutic use (Phase IV): no
",Interventional,France,"Study comparing the efficacy of a chloroquine analog (GNS561), anti PD-1 (nivolumab) and anti-interleukine-6 receptor (tocilizumab) versus standard of care in advanced or metastatic cancer patients with SARS-CoV-2 (COVID-19) infection",273,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001373-70
273,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-08-04,False,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11
274,EUCTR2020-001457-43-FR,EU Clinical Trials Register,2020-04-02,2020-10-04,False,Authorised,Phase 3,Interventional,France,Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43
275,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-02-04,True,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19
276,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11
277,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-01-04,True,Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21
278,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-10-04,False,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33
279,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69
280,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-03-04,True,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37
281,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-06-04,False,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31
282,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-07-04,False,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33
283,EUCTR2020-001039-29-GR,EU Clinical Trials Register,2020-03-31,2020-01-04,True,Authorised,Phase 2,Interventional,Greece,MANAGEMENT OF NOVEL SARS CORONAVIRUS,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001039-29
284,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,10,https://clinicaltrials.gov/show/NCT04337216
285,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,1450,https://clinicaltrials.gov/show/NCT04343677
286,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group EasybreatheÂ® snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,100,https://anzctr.org.au/ACTRN12620000472976.aspx
287,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of NasodineÂ® Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,20,https://anzctr.org.au/ACTRN12620000470998.aspx
288,ACTRN12620000480987,ANZCTR,2020-04-16,2020-01-06,True,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),507,https://anzctr.org.au/ACTRN12620000480987.aspx
289,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=52477
290,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),8,http://www.chictr.org.cn/showproj.aspx?proj=52483
291,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),45,http://www.chictr.org.cn/showproj.aspx?proj=52142
292,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414
293,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=52106
294,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=49631
295,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",240,http://www.chictr.org.cn/showproj.aspx?proj=48889
296,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",240,http://www.chictr.org.cn/showproj.aspx?proj=48898
297,EUCTR2020-001303-16-FR,EU Clinical Trials Register,2020-03-29,2020-11-04,False,Authorised,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Hospitalized Patients with VIDOC-19 : A Randomized, Multi-Centre, Adaptive, Blinded Study",1600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001303-16
298,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18
299,EUCTR2020-001160-28-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28
300,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11
301,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74
302,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31
303,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12
304,EUCTR2020-001587-29-ES,EU Clinical Trials Register,2020-04-13,2020-08-04,False,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,714,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29
305,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12
306,EUCTR2020-001331-26-GB,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Authorised,Phase 3,Interventional,United Kingdom,Preventative Drug Treatment for COVID-19 Infectious Disease,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001331-26
307,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34
308,EUCTR2020-001682-36-ES,EU Clinical Trials Register,2020-04-14,2020-04-13,True,Authorised,Phase 2,Interventional,Spain,Treatment of COVID-19 with allogeneic mesenchymal cells (MSVÂ®).,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36
309,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25
310,EUCTR2020-001448-24-GB,EU Clinical Trials Register,2020-04-17,2020-04-15,True,Authorised,Phase 3,Interventional,"Ghana, South Africa, United Kingdom, India, Nigeria",Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24
311,EUCTR2020-001570-30-FR,EU Clinical Trials Register,2020-04-06,2020-09-04,False,Authorised,Phase 3,Interventional,France,ICAR (IgIV in Covid-related ARds),126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001570-30
312,EUCTR2020-001254-22-BE,EU Clinical Trials Register,2020-03-24,2020-03-24,False,Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22
313,IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,45,http://en.irct.ir/trial/46424
314,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,50,http://en.irct.ir/trial/46536
315,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,30,http://en.irct.ir/trial/46538
316,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon ÃŸ in treatment  of COVID-19,30,http://en.irct.ir/trial/46545
317,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,150,http://en.irct.ir/trial/46554
318,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),20,http://en.irct.ir/trial/46561
319,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,50,http://en.irct.ir/trial/46567
320,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,40,http://en.irct.ir/trial/46573
321,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,125,http://en.irct.ir/trial/46576
322,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,310,http://en.irct.ir/trial/46603
323,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,62,http://en.irct.ir/trial/46609
324,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,10,http://en.irct.ir/trial/46623
325,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,30,http://en.irct.ir/trial/46624
326,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,60,http://en.irct.ir/trial/46629
327,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,60,http://en.irct.ir/trial/46637
328,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,40,http://en.irct.ir/trial/46665
329,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,10,http://en.irct.ir/trial/46668
330,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,374,http://en.irct.ir/trial/46678
331,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,40,http://en.irct.ir/trial/46681
332,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,200,http://en.irct.ir/trial/46690
333,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,200,http://en.irct.ir/trial/46693
334,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/46697
335,IRCT20200324046852N1,IRCT,2020-04-05,2020-04-01,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of efficacy of oral Levamisole and  Formoterol+Budesonide inhaler with standard treatment of Corona infection.,30,http://en.irct.ir/trial/46706
336,IRCT20200324046851N1,IRCT,2020-04-03,2020-03-29,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of nano curcumin supplementation on the reduction of inflammation and mortality in patients with coronavirus 2019 admitted to ICU ward of imam Reza hospital in Tabriz,86,http://en.irct.ir/trial/46712
337,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,30,http://en.irct.ir/trial/46720
338,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,60,http://en.irct.ir/trial/46736
339,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,200,http://en.irct.ir/trial/46759
340,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,80,http://en.irct.ir/trial/46775
341,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,40,http://en.irct.ir/trial/46786
342,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,5,http://en.irct.ir/trial/46789
343,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,60,http://en.irct.ir/trial/46803
344,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,60,http://en.irct.ir/trial/46804
345,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",105,http://en.irct.ir/trial/46810
346,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,100,http://en.irct.ir/trial/46824
347,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,10,http://en.irct.ir/trial/46837
348,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,60,http://en.irct.ir/trial/46838
349,ACTRN12620000492954,ANZCTR,2020-04-20,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,20,https://anzctr.org.au/ACTRN12620000492954.aspx
350,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",34,https://anzctr.org.au/ACTRN12620000482965.aspx
351,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",120,http://www.chictr.org.cn/showproj.aspx?proj=52958
352,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",200,http://www.chictr.org.cn/showproj.aspx?proj=52942
353,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,186,http://www.chictr.org.cn/showproj.aspx?proj=52972
354,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",120,http://www.chictr.org.cn/showproj.aspx?proj=52692
355,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,242,http://www.chictr.org.cn/showproj.aspx?proj=52867
356,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=52916
357,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",350,http://www.chictr.org.cn/showproj.aspx?proj=52824
358,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",200,http://www.chictr.org.cn/showproj.aspx?proj=52699
359,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,200,http://www.chictr.org.cn/showproj.aspx?proj=52781
360,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",200,http://www.chictr.org.cn/showproj.aspx?proj=52662
361,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-09-04,False,Authorised,Phase 4,Interventional,"China, United States, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30
362,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14
363,EUCTR2020-001366-11-IT,EU Clinical Trials Register,2020-04-20,2020-09-04,False,Authorised,Phase 3,Interventional,"Argentina, South Africa, Indonesia, Peru, Canada, Italy, Thailand, Spain, Brazil, Norway, Iran, Germany, Switzerland",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11
364,EUCTR2020-001255-40-ES,EU Clinical Trials Register,2020-04-20,2020-04-16,True,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40
365,EUCTR2020-001531-27-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Authorised,Phase 2,Interventional,Spain,Clinical trial of Sarilumab in adults hospitalized with COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001531-27
366,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42
367,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-03-04,True,Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41
368,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,100,http://www.chictr.org.cn/showproj.aspx?proj=53190
369,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394
370,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=53048
371,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,140,http://www.chictr.org.cn/showproj.aspx?proj=53050
372,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=52506
373,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=51437
374,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13
375,EUCTR2020-001823-15-FR,EU Clinical Trials Register,2020-04-15,2020-04-28,False,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15
376,EUCTR2020-001678-31-FR,EU Clinical Trials Register,2020-04-17,2020-04-28,False,Authorised,Phase 3,Interventional,France,"Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and GuÃ©rin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers.â€
COVID-BCG",1120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001678-31
377,EUCTR2020-001364-29-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Authorised,Phase 1/Phase 2,Interventional,Spain,"Study with stem cells from allogenic adipose tissue, in patients with coronavirus severe pneumonia",26,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001364-29
378,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20
379,EUCTR2020-000982-18-NO,EU Clinical Trials Register,2020-03-24,2020-03-26,False,Authorised,Phase 3,Interventional,Norway,A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19).,443,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18
380,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),2000,https://anzctr.org.au/ACTRN12620000524998.aspx
381,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",342,http://www.chictr.org.cn/showproj.aspx?proj=53368
382,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,60,http://www.chictr.org.cn/showproj.aspx?proj=53458
383,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=53322
384,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,12,http://www.chictr.org.cn/showproj.aspx?proj=53389
385,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=52671
386,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-06-05,False,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42
387,EUCTR2020-001766-11-FR,EU Clinical Trials Register,2020-04-15,2020-04-29,False,Authorised,Phase 2,Interventional,France,Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001766-11
388,EUCTR2020-001370-30-GB,EU Clinical Trials Register,2020-04-15,2020-04-28,False,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30
389,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21
390,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27
391,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-04-05,True,Authorised,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome â€“ 1,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66
392,EUCTR2020-001909-22-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,Authorised,Phase 3,Interventional,France,EFFICACY OF INTRAVENOUS ALMITRINE IN REDUCING THE NEED FOR MECHANICAL VENTILATION IN PATIENTS WITH HYPOXEMIC ACUTE RESPIRATORY FAILURE DUE TO COVID-19-RELATED PNEUMONIA:  A RANDOMIZED CONTROLLED DOUBLE-BLIND STUDYFROM THE SKIP-ICU CONSORTIUM,212,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001909-22
393,EUCTR2020-001449-38-GB,EU Clinical Trials Register,2020-04-17,2020-04-29,False,Authorised,Phase 3,Interventional,United Kingdom,A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38
394,EUCTR2020-001786-36-GB,EU Clinical Trials Register,2020-04-15,2020-06-05,False,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, Italy, United States, Spain, France",Study of investigational medicinal product of CYT107 in patients with COVID-19 infection who have low number of lymphocytes in their blood (ILIAD 7 trial),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36
395,EUCTR2020-001721-31-GB,EU Clinical Trials Register,2020-04-27,2020-01-05,True,Authorised,Phase 2,Interventional,United Kingdom,Sinus-Wash Pilot Study,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001721-31
396,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-06-05,False,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28
397,EUCTR2020-001882-36-GR,EU Clinical Trials Register,2020-04-30,2020-07-05,False,Authorised,Phase 2,Interventional,Greece,CLARITHROMYCIN IN COVID-19,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001882-36
398,EUCTR2020-001206-35-AT,EU Clinical Trials Register,2020-03-26,2020-04-14,False,Authorised,Phase 4,Interventional,Austria,Discontinuation of ACE inhibitors in patients with COVID-19 infection,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35
399,EUCTR2020-001696-32-ES,EU Clinical Trials Register,2020-05-08,2020-08-05,False,Authorised,Phase 2,Interventional,Spain,Efficacy and safety study of IVIG in hospitalized subjects with COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001696-32
400,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",30,https://clinicaltrials.gov/show/NCT04380948
401,ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,False,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,25,http://www.chictr.org.cn/showproj.aspx?proj=53790
402,ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,True,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",200,http://www.chictr.org.cn/showproj.aspx?proj=53274
403,ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,True,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,240,http://www.chictr.org.cn/showproj.aspx?proj=53658
404,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,True,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136
405,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,False,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",100,http://www.chictr.org.cn/showproj.aspx?proj=49224
406,ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,False,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",400,http://www.chictr.org.cn/showproj.aspx?proj=49051
407,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,40,http://en.irct.ir/trial/46533
408,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,85,http://en.irct.ir/trial/46550
409,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,80,http://en.irct.ir/trial/46551
410,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,100,http://en.irct.ir/trial/46639
411,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,120,http://en.irct.ir/trial/46660
412,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,62,http://en.irct.ir/trial/46713
413,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,60,http://en.irct.ir/trial/46715
414,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,100,http://en.irct.ir/trial/46731
415,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,70,http://en.irct.ir/trial/46741
416,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,120,http://en.irct.ir/trial/46762
417,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,68,http://en.irct.ir/trial/46782
418,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with â€œSofosbuvir standard of care therapeutic regimenVelpatasvirâ€ to â€œstandard of caretherapeutic regimenâ€ in patients with COVID-19,80,http://en.irct.ir/trial/46790
419,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,50,http://en.irct.ir/trial/46811
420,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,40,http://en.irct.ir/trial/46814
421,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,100,http://en.irct.ir/trial/46849
422,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/46850
423,IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,True,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with â€œSofosbuvir-Daclatasvirâ€, â€œLithiumâ€,and â€œTrifluoprazineâ€ to â€œstandard of care in three groups of patients with COVID-19",80,http://en.irct.ir/trial/46853
424,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,40,http://en.irct.ir/trial/46868
425,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",110,http://en.irct.ir/trial/46879
426,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,48,http://en.irct.ir/trial/46885
427,IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,False,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,50,http://en.irct.ir/trial/46887
428,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,40,http://en.irct.ir/trial/46893
429,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,60,http://en.irct.ir/trial/46903
430,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,60,http://en.irct.ir/trial/46907
431,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),130,http://en.irct.ir/trial/46913
432,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,60,http://en.irct.ir/trial/46926
433,IRCT20200405046953N1,IRCT,2020-04-06,2020-04-08,False,Recruiting,Phase 3,Interventional,Iran,Comparison of therapies for COVID-19,3000,http://en.irct.ir/trial/46930
434,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,12,http://en.irct.ir/trial/46931
435,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,500,http://en.irct.ir/trial/46932
436,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",40,http://en.irct.ir/trial/46940
437,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,84,http://en.irct.ir/trial/46942
438,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,60,http://en.irct.ir/trial/46946
439,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,40,http://en.irct.ir/trial/46958
440,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,15,http://en.irct.ir/trial/46961
441,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,906,http://en.irct.ir/trial/46968
442,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,60,http://en.irct.ir/trial/46969
443,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,60,http://en.irct.ir/trial/46973
444,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,140,http://en.irct.ir/trial/46974
445,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,40,http://en.irct.ir/trial/46977
446,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,40,http://en.irct.ir/trial/46978
447,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,70,http://en.irct.ir/trial/47006
448,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,30,http://en.irct.ir/trial/47013
449,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,100,http://en.irct.ir/trial/47014
450,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,10,http://en.irct.ir/trial/47015
451,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,60,http://en.irct.ir/trial/47018
452,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,10,http://en.irct.ir/trial/47021
453,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,100,http://en.irct.ir/trial/47022
454,IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,False,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,50,http://en.irct.ir/trial/47034
455,IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,True,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,101,http://en.irct.ir/trial/47052
456,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,60,http://en.irct.ir/trial/47061
457,IRCT20200217046526N2,IRCT,2020-04-13,2020-04-05,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,60,http://en.irct.ir/trial/47073
458,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,110,http://en.irct.ir/trial/47078
459,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,200,http://en.irct.ir/trial/47087
460,IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,40,http://en.irct.ir/trial/47088
461,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,1000,http://en.irct.ir/trial/47090
462,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,82,http://en.irct.ir/trial/47099
463,IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,30,http://en.irct.ir/trial/47115
464,IRCT20170207032444N3,IRCT,2020-04-17,2020-04-15,True,Recruiting,Phase 3,Interventional,Iran,Thalidomide in COVID19,60,http://en.irct.ir/trial/47119
465,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,60,http://en.irct.ir/trial/47139
466,IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,False,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,40,http://en.irct.ir/trial/47141
467,IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,60,http://en.irct.ir/trial/47142
468,IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,76,http://en.irct.ir/trial/47146
469,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,80,http://en.irct.ir/trial/47149
470,IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,True,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,60,http://en.irct.ir/trial/47152
471,IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,True,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,20,http://en.irct.ir/trial/47156
472,IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,True,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",60,http://en.irct.ir/trial/47160
473,IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,False,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,50,http://en.irct.ir/trial/47169
474,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,15,http://en.irct.ir/trial/47212
475,IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,True,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,20,http://en.irct.ir/trial/47219
476,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,100,http://en.irct.ir/trial/47234
477,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,110,http://en.irct.ir/trial/47244
478,IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,True,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,66,http://en.irct.ir/trial/47251
479,IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,70,http://en.irct.ir/trial/47264
480,IRCT20200419047128N1,IRCT,2020-04-22,2020-05-04,False,Recruiting,Phase 3,Interventional,Iran,Tranilast in COVID19,60,http://en.irct.ir/trial/47265
481,IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,True,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,10,http://en.irct.ir/trial/47266
482,IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",80,http://en.irct.ir/trial/47268
483,IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,6,http://en.irct.ir/trial/47275
484,IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,70,http://en.irct.ir/trial/47300
485,IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,True,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,100,http://en.irct.ir/trial/47318
486,IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,84,http://en.irct.ir/trial/47334
487,IRCT20190618043923N4,IRCT,2020-05-04,2020-04-25,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Ozone Autohemotherapy in Covid19,20,http://en.irct.ir/trial/47363
488,IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,False,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,86,http://en.irct.ir/trial/47387
489,IRCT20200419047128N2,IRCT,2020-04-24,2020-04-29,False,Not Recruiting,Phase 3,Interventional,Iran,Quercetin in COVID19,60,http://en.irct.ir/trial/47396
490,IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,True,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",80,http://en.irct.ir/trial/47401
491,IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),60,http://en.irct.ir/trial/47437
492,IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,40,http://en.irct.ir/trial/47468
493,IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,False,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),80,http://en.irct.ir/trial/47475
494,IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,False,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,46,http://en.irct.ir/trial/47495
495,IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,False,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,100,http://en.irct.ir/trial/47501
496,IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,30,http://en.irct.ir/trial/47508
497,IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),80,http://en.irct.ir/trial/47516
498,IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,60,http://en.irct.ir/trial/47520
499,IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,48,http://en.irct.ir/trial/47572
500,IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,False,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47576
501,IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,False,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47577
502,IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,False,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",40,http://en.irct.ir/trial/47578
503,IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,60,http://en.irct.ir/trial/47594
504,IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,120,http://en.irct.ir/trial/47629
505,IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,True,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,152,http://en.irct.ir/trial/47639
506,IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,True,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,50,http://en.irct.ir/trial/47641
507,IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,False,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,40,http://en.irct.ir/trial/47682
508,IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,68,http://en.irct.ir/trial/47684
509,IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,False,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,88,http://en.irct.ir/trial/47934
510,IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,124,http://en.irct.ir/trial/47953
511,IRCT20200509047366N1,IRCT,2020-05-12,2020-05-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Radiotherapy in COVID-19,5,http://en.irct.ir/trial/48020
512,IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,False,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",81,http://en.irct.ir/trial/48043
513,KCT0005003,CRIS,2020-05-11,2020-05-25,False,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635
514,JPRN-jRCT2031190264,JPRN,2020-03-24,2020-03-26,False,Not Recruiting,Phase 3,Interventional,"United States, Japan, South Korea","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",100,https://jrct.niph.go.jp/latest-detail/jRCT2031190264
515,JPRN-UMIN000040286,JPRN,2020-05-11,2020-05-12,False,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966
516,JPRN-UMIN000040401,JPRN,2020-05-15,2020-05-15,False,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104
517,ISRCTN85216856,ISRCTN,2020-05-11,2020-10-05,False,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,200,http://isrctn.com/ISRCTN85216856
518,ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,True,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=53925
519,ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,True,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=53529
520,ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,True,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,6,http://www.chictr.org.cn/showproj.aspx?proj=53859
521,ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,False,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,160,http://www.chictr.org.cn/showproj.aspx?proj=53840
522,EUCTR2020-001805-21-GB,EU Clinical Trials Register,2020-05-07,2020-05-15,False,Authorised,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in treatment of Novel Coronavirus (COVID-19),120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21
523,EUCTR2020-001886-35-GB,EU Clinical Trials Register,2020-05-11,2020-05-15,False,Authorised,Phase 2,Interventional,United Kingdom,A Clinical Trial of Nebulized Bovactant (Alveofact Â®) for the Treatment of Moderate to Severe COVID-19,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001886-35
524,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38
525,NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,300,https://clinicaltrials.gov/show/NCT04404634
526,ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,False,Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,300,http://www.chictr.org.cn/showproj.aspx?proj=54482
527,ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,True,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,30,http://www.chictr.org.cn/showproj.aspx?proj=54408
528,ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,True,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,24,http://www.chictr.org.cn/showproj.aspx?proj=54346
529,ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,True,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=54321
530,ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,True,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,104,http://www.chictr.org.cn/showproj.aspx?proj=54326
531,ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,True,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=54176
532,ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,150,http://www.chictr.org.cn/showproj.aspx?proj=49590
533,ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,True,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,120,http://www.chictr.org.cn/showproj.aspx?proj=54185
534,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773
535,ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,True,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,300,http://isrctn.com/ISRCTN15254871
536,EUCTR2020-001573-78-FR,EU Clinical Trials Register,2020-04-14,2020-06-05,False,Authorised,Phase 2,Interventional,"France, United States",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78
537,EUCTR2020-001754-21-FR,EU Clinical Trials Register,2020-04-17,2020-05-19,False,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21
538,EUCTR2020-001963-10-FR,EU Clinical Trials Register,2020-04-20,2020-12-05,False,Authorised,Phase 3,Interventional,France,"Interleukin-1 (IL-1) and Interferon gamma (IFNg) inhibition during COVID 19 inflammation: Randomized, controlled study assessing efficacy and safety of Anakinra and Ruxolitinib",54,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001963-10
539,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98
540,EUCTR2020-001497-30-FR,EU Clinical Trials Register,2020-04-28,2020-12-05,False,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",ravulizumab for the treatment of patients with Coronavirus Disease 2019,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30
541,EUCTR2020-001684-89-GB,EU Clinical Trials Register,2020-04-17,2020-05-05,False,Authorised,Phase 2,Interventional,United Kingdom,"A clinical trial to gather information on the safety and effectiveness of drugs in patients with the COVID-19 infection, that could be used in larger trials.",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001684-89
542,EUCTR2020-001296-33-DK,EU Clinical Trials Register,2020-04-03,2020-06-05,False,Authorised,Phase 2,Interventional,Denmark,"Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure â€“ a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial",80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001296-33
543,EUCTR2020-001759-42-GB,EU Clinical Trials Register,2020-05-13,2020-05-20,False,Authorised,Phase 2,Interventional,"Chile, Argentina, Sweden, South Africa, United Kingdom, Belgium, Netherlands, Canada, United States, Mexico, Spain, Brazil, Japan, Poland, France",Investigating otilimab in patients with severe coronavirus related lung disease.,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001759-42
544,ACTRN12620000635965,ANZCTR,2020-05-29,2020-05-06,True,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",50,https://anzctr.org.au/ACTRN12620000635965.aspx
545,ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,False,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=54707
546,ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,True,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,9,http://www.chictr.org.cn/showproj.aspx?proj=54278
547,EUCTR2020-001597-30-GB,EU Clinical Trials Register,2020-04-09,2020-05-29,False,Authorised,Phase 2,Interventional,"Italy, Ireland, United States, United Kingdom",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30
548,EUCTR2020-002111-22-PL,EU Clinical Trials Register,2020-04-29,2020-06-26,False,Authorised,Phase 3,Interventional,Poland,Study evaluating the impact of BCG vaccination on the incidence and course of SARS-CoV-2 infection among health care workers in Poland during the COVID-19 pandemic,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002111-22
549,EUCTR2020-001849-39-SE,EU Clinical Trials Register,2020-04-28,2020-05-18,False,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39
550,EUCTR2020-001951-42-PL,EU Clinical Trials Register,2020-04-29,2020-08-05,False,Authorised,Phase 3,Interventional,"Spain, Canada, Italy, Poland",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42
551,ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,True,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=55097
552,EUCTR2020-001571-32-FR,EU Clinical Trials Register,2020-04-07,2020-04-15,False,Authorised,Phase 2,Interventional,France,Low dose of IL-2 In Acute respiratory DistrEss syndrome related to COVID-19,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001571-32
553,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85
554,EUCTR2020-001411-25-GB,EU Clinical Trials Register,2020-04-06,2020-04-24,False,Authorised,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, United States, Israel, Spain, Italy, Austria, France, India, Germany, Malaysia",Low Dose Oral Selinexor in Patients with Severe COVID-19 Infection,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25
555,EUCTR2020-001937-11-GB,EU Clinical Trials Register,2020-06-08,2020-04-30,True,Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11
556,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),70,http://en.irct.ir/trial/46463
557,IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,True,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,94,http://en.irct.ir/trial/46519
558,IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,80,http://en.irct.ir/trial/46718
559,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,70,http://en.irct.ir/trial/46721
560,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,70,http://en.irct.ir/trial/46728
561,IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,False,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,100,http://en.irct.ir/trial/46732
562,IRCT20200401046909N1,IRCT,2020-04-09,2020-04-15,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the  efficacy of oral 25-hydroxyvitamin D3 on COVID-19,260,http://en.irct.ir/trial/46875
563,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,68,http://en.irct.ir/trial/46904
564,IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,True,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,30,http://en.irct.ir/trial/46963
565,IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,True,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,60,http://en.irct.ir/trial/46975
566,IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,True,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,60,http://en.irct.ir/trial/46983
567,IRCT20200401046909N2,IRCT,2020-04-11,2020-04-14,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19,540,http://en.irct.ir/trial/47010
568,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,6,http://en.irct.ir/trial/47030
569,IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,150,http://en.irct.ir/trial/47044
570,IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,60,http://en.irct.ir/trial/47062
571,IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,True,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,74,http://en.irct.ir/trial/47091
572,IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,False,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,30,http://en.irct.ir/trial/47188
573,IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,True,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,30,http://en.irct.ir/trial/47197
574,IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,100,http://en.irct.ir/trial/47200
575,IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,True,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,100,http://en.irct.ir/trial/47209
576,IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,False,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,500,http://en.irct.ir/trial/47279
577,IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,False,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",62,http://en.irct.ir/trial/47335
578,IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,True,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,60,http://en.irct.ir/trial/47504
579,IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,50,http://en.irct.ir/trial/47559
580,IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,True,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,40,http://en.irct.ir/trial/47609
581,IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,False,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,40,http://en.irct.ir/trial/47645
582,IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,True,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,68,http://en.irct.ir/trial/47665
583,IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,30,http://en.irct.ir/trial/47666
584,IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,10,http://en.irct.ir/trial/47692
585,IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,True,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,300,http://en.irct.ir/trial/47704
586,IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,100,http://en.irct.ir/trial/47707
587,IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,120,http://en.irct.ir/trial/47722
588,IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,False,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,10,http://en.irct.ir/trial/47735
589,IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,80,http://en.irct.ir/trial/47935
590,IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,90,http://en.irct.ir/trial/47964
591,IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,True,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,60,http://en.irct.ir/trial/47974
592,IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,True,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",60,http://en.irct.ir/trial/47979
593,IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,False,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,130000,http://en.irct.ir/trial/47989
594,IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,60,http://en.irct.ir/trial/47990
595,IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,60,http://en.irct.ir/trial/48001
596,IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,True,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,100,http://en.irct.ir/trial/48018
597,IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,80,http://en.irct.ir/trial/48019
598,IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,100,http://en.irct.ir/trial/48024
599,IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,False,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,92,http://en.irct.ir/trial/48039
600,IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,False,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,40,http://en.irct.ir/trial/48058
601,IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,True,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,72,http://en.irct.ir/trial/48061
602,IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,False,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,100,http://en.irct.ir/trial/48066
603,IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,True,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,40,http://en.irct.ir/trial/48096
604,IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,True,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,30,http://en.irct.ir/trial/48102
605,IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,84,http://en.irct.ir/trial/48114
606,IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,True,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",60,http://en.irct.ir/trial/48116
607,IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,60,http://en.irct.ir/trial/48126
608,IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,True,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,50,http://en.irct.ir/trial/48141
609,IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,48,http://en.irct.ir/trial/48153
610,IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,50,http://en.irct.ir/trial/48176
611,IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,True,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,15,http://en.irct.ir/trial/48185
612,IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,20,http://en.irct.ir/trial/48187
613,IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,False,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,50,http://en.irct.ir/trial/48213
614,IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,True,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,70,http://en.irct.ir/trial/48218
615,IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,False,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,108,http://en.irct.ir/trial/48226
616,IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,True,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,60,http://en.irct.ir/trial/48262
617,IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,False,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,80,http://en.irct.ir/trial/48289
618,IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,False,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,60,http://en.irct.ir/trial/48292
619,IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,30,http://en.irct.ir/trial/48312
620,IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,76,http://en.irct.ir/trial/48329
621,IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,False,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,74,http://en.irct.ir/trial/48403
622,IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",60,http://en.irct.ir/trial/48444
623,IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,50,http://en.irct.ir/trial/48495
624,IRCT20160118026097N3,IRCT,2020-05-31,2020-03-20,True,Recruiting,Phase 3,Interventional,Iran,The effect of interferon on the treatment of covid19 patients,60,http://en.irct.ir/trial/48517
625,IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,True,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,60,http://en.irct.ir/trial/48534
626,IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,False,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,80,http://en.irct.ir/trial/48644
627,IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,False,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,30,http://en.irct.ir/trial/48702
628,IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,False,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",60,http://en.irct.ir/trial/48749
629,KCT0005105,CRIS,2020-06-10,2020-04-08,True,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults with Mild COVID-19,141,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795
630,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-01-04,True,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227
631,JPRN-jRCTs032200044,JPRN,2020-06-03,2020-03-06,True,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044
632,JPRN-UMIN000040341,JPRN,2020-05-09,2020-05-09,False,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023
633,JPRN-UMIN000040407,JPRN,2020-05-15,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108
634,JPRN-UMIN000040479,JPRN,2020-05-22,2020-05-22,False,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202
635,JPRN-UMIN000040694,JPRN,2020-06-09,2020-06-10,False,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448
636,ACTRN12620000500954,ANZCTR,2020-04-22,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,20,https://anzctr.org.au/ACTRN12620000500954.aspx
637,ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,False,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,40,https://anzctr.org.au/ACTRN12620000676910.aspx
638,ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,False,Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,100,http://isrctn.com/ISRCTN94091479
639,ISRCTN33578935,ISRCTN,2020-06-02,2020-01-06,True,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,64,http://isrctn.com/ISRCTN33578935
640,ISRCTN21363594,ISRCTN,2020-05-18,2020-01-05,True,Recruiting,Not Applicable,Interventional,"United Arab Emirates, Oman, Saudi Arabia",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),80,http://isrctn.com/ISRCTN21363594
641,ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,True,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures â€“ an online survey,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291
642,EUCTR2020-001636-95-GB,EU Clinical Trials Register,2020-05-04,2020-05-20,False,Authorised,Phase 2,Interventional,United Kingdom,Does subcutaneously(SC) administered of anakinra achieve good penetration in blood and result in reduce inflammation in patients with SARS-CoV-19?,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95
643,EUCTR2020-001481-11-DE,EU Clinical Trials Register,2020-04-16,2020-04-22,False,Authorised,Phase 2,Interventional,Germany,Treatment with Ruxolitinib in Covid-19 patients with severe symptoms,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001481-11
644,EUCTR2020-001889-10-GB,EU Clinical Trials Register,2020-05-15,2020-02-06,True,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10
645,EUCTR2020-002120-37-GB,EU Clinical Trials Register,2020-06-08,2020-06-16,False,Authorised,Phase 2/Phase 3,Interventional,"United Kingdom, Netherlands, United States, Italy, Spain, France, Germany","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37
646,EUCTR2020-001497-30-GB,EU Clinical Trials Register,2020-04-27,2020-07-05,False,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",ravulizumab for the treatment of patients with Coronavirus Disease 2019,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30
647,ACTRN12620000688987,ANZCTR,2020-06-19,2020-02-06,True,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShieldÂ® N-95 masks
",80,https://anzctr.org.au/ACTRN12620000688987.aspx
648,ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,False,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),340,http://www.chictr.org.cn/showproj.aspx?proj=55154
649,ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,False,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",168,http://www.chictr.org.cn/showproj.aspx?proj=55524
650,ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,True,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,25,http://www.chictr.org.cn/showproj.aspx?proj=55582
651,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",120,http://www.chictr.org.cn/showproj.aspx?proj=49104
652,EUCTR2020-001767-86-IE,EU Clinical Trials Register,2020-04-15,2020-06-25,False,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86
653,EUCTR2020-002060-31-CZ,EU Clinical Trials Register,2020-05-26,2020-06-22,False,Authorised,Phase 3,Interventional,Czech Republic,An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002060-31
654,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-06-05,False,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71
655,EUCTR2020-001435-27-FR,EU Clinical Trials Register,2020-04-01,2020-10-04,False,Authorised,Phase 3,Interventional,France,"Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety
of several experimental treatments to reduce the risk of hospitalization or death
(COVERAGE trial)",845,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001435-27
656,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,Not Recruiting,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 Ã  risque dâ€™aggravation secondaire : Ã©tude prospective multicentrique randomisÃ©e en double aveugle,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33
657,EUCTR2020-001258-23-IT,EU Clinical Trials Register,2020-04-20,2020-04-20,False,Authorised,Phase 2,Interventional,Italy,COLCHICINE TO COUNTERACT INFLAMMATORY RESPONSE IN COVID-19 PNEUMONIA,310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001258-23
658,EUCTR2020-002230-32-GB,EU Clinical Trials Register,2020-06-11,2020-06-23,False,Authorised,Phase 2,Interventional,United Kingdom,Investigating potential new therapies for COVID-19.,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002230-32
659,EUCTR2020-002448-21-GR,EU Clinical Trials Register,2020-05-20,2020-05-26,False,Authorised,Phase 4,Interventional,Greece,BCG VACCINATION TO PREVENT COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002448-21
660,EUCTR2020-001740-26-GB,EU Clinical Trials Register,2020-04-24,2020-05-05,False,Authorised,Phase 2,Interventional,United Kingdom,A study of an antibiotic called Azithromycin for those who come to hospital with COVID-19 symptoms who are not admitted to hospital (otherwise known as Ambulatory COVID-19) â€“ ATOMIC2,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26
661,EUCTR2020-001366-11-IE,EU Clinical Trials Register,2020-04-17,2020-05-15,False,Authorised,Phase 4,Interventional,"Australia, Ireland, Portugal, Canada, Norway, Italy, Spain, Latvia, France, India, Lithuania, Romania",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11
662,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with coronavirus disease-2019 (COVID-19) referring to Sina and Imam-Khomeini Hospitals in 2020,60,http://en.irct.ir/trial/46531
663,IRCT20200416047099N2,IRCT,2020-07-04,2020-06-21,True,Recruiting,Phase 2,Interventional,Iran,Plasma exchange in COVID-19 patients,10,http://en.irct.ir/trial/47357
664,IRCT20200428047229N1,IRCT,2020-06-27,2020-03-29,True,Recruiting,Phase 3,Interventional,Iran,Effect of Medical Beer on COVID-19,60,http://en.irct.ir/trial/47530
665,IRCT20200428047232N1,IRCT,2020-07-05,2020-05-09,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of Thalidomide in Covid 19 pneumonia,60,http://en.irct.ir/trial/47637
666,IRCT20200504047298N2,IRCT,2020-06-15,2020-07-10,False,Recruiting,Phase 3,Interventional,Iran,Effect of Opuntia Cactus extract in patients with Covid-19,48,http://en.irct.ir/trial/47675
667,IRCT20171105037262N4,IRCT,2020-06-18,2020-04-29,True,Recruiting,Phase 3,Interventional,Iran,Adalimumab effect on COVID-19,100,http://en.irct.ir/trial/47696
668,IRCT20200508047345N1,IRCT,2020-06-14,2020-06-21,False,Not Recruiting,Not Applicable,Interventional,Iran,Combined effects of Extracts on  Covid-19,100,http://en.irct.ir/trial/47987
669,IRCT20200511047396N1,IRCT,2020-05-16,2020-06-30,False,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients,50,http://en.irct.ir/trial/48048
670,IRCT20180425039414N3,IRCT,2020-06-17,2020-04-20,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19),80,http://en.irct.ir/trial/48083
671,IRCT20200510047385N1,IRCT,2020-07-07,2020-06-30,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of SVF and exosome in covid-19 patients with acute respiratory distress syndrome,60,http://en.irct.ir/trial/48099
672,IRCT20200513047426N1,IRCT,2020-06-27,2020-06-21,True,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of oral hydroxy-chloroquine in close contacts of COVID-19 patients,500,http://en.irct.ir/trial/48236
673,IRCT20110726007117N11,IRCT,2020-07-05,2020-06-21,True,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D supplementation in novel corona virus 2019,210,http://en.irct.ir/trial/48287
674,IRCT20200112046089N1,IRCT,2020-06-25,2020-06-14,True,Recruiting,Phase 3,Interventional,Iran,Resveratrol in COVID19,50,http://en.irct.ir/trial/48330
675,IRCT20200330046899N1,IRCT,2020-06-17,2020-04-20,True,Recruiting,Phase 3,Interventional,Iran,Effectiveness of herbal capsule in  COVID-19,50,http://en.irct.ir/trial/48365
676,IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,True,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,100,http://en.irct.ir/trial/48493
677,IRCT20200317046797N6,IRCT,2020-06-18,2020-06-21,False,Recruiting,Phase 3,Interventional,Iran,Edaravone in COVID-19,30,http://en.irct.ir/trial/48500
678,IRCT20200504047298N1,IRCT,2020-06-14,2020-06-14,False,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atazanavir/Ritonavirin treatment of COViD-19,100,http://en.irct.ir/trial/48640
679,IRCT20200505047305N1,IRCT,2020-06-30,2020-06-06,True,Recruiting,Not Applicable,Interventional,Iran,Grief counseling in family members of the COVID-19 victims,120,http://en.irct.ir/trial/48683
680,IRCT20150107020592N29,IRCT,2020-06-21,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Blood Purification Techniques on  COVID-19 Pneumonia,12,http://en.irct.ir/trial/48695
681,IRCT20200607047675N1,IRCT,2020-06-15,2020-06-19,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19),100,http://en.irct.ir/trial/48700
682,IRCT20200608047686N1,IRCT,2020-06-30,2020-05-31,True,Not Recruiting,Phase 2,Interventional,Iran,The role of metronidazole in COVID-19,30,http://en.irct.ir/trial/48717
683,IRCT20150107020592N26,IRCT,2020-06-15,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS),20,http://en.irct.ir/trial/48746
684,IRCT20200609047707N1,IRCT,2020-06-24,2020-07-09,False,Recruiting,Phase 3,Interventional,Iran,Effective of Elman tablet on COVID-19 infection severity,90,http://en.irct.ir/trial/48764
685,IRCT20200611047735N1,IRCT,2020-06-19,2020-07-05,False,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of nano micelles containing curcumin (Sina Ccurcumin) as a therapeutic supplement in patients with COVID-19,40,http://en.irct.ir/trial/48843
686,IRCT20150107020592N27,IRCT,2020-06-15,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of pentaglobin in the treatment of critically ill patients with COVID-19,60,http://en.irct.ir/trial/48907
687,IRCT20200515047456N1,IRCT,2020-06-28,2020-06-17,True,Recruiting,Phase 3,Interventional,Iran,The role of anticoagulant and thrombolitic in treatment of COVID patients,15,http://en.irct.ir/trial/48929
688,IRCT20200611047727N1,IRCT,2020-06-24,2020-07-22,False,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of Inspiratory muscle training in patients with COVID-19,40,http://en.irct.ir/trial/48941
689,IRCT20150107020592N28,IRCT,2020-06-18,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of borage based solutions in cytokine's levels in covid-19 ARDS patients,50,http://en.irct.ir/trial/48972
690,IRCT20150107020592N30,IRCT,2020-07-10,2020-03-20,True,Recruiting,Phase 3,Interventional,Iran,Prophylactic  Favipiravir  for Healthcare Workers in COVID-19 Pandemic,30,http://en.irct.ir/trial/48992
691,IRCT20150725023332N3,IRCT,2020-06-27,2020-04-20,True,Recruiting,Phase 3,Interventional,Iran,The effect of Bromelain and Montelukast  in Covid-19 patients,60,http://en.irct.ir/trial/49112
692,IRCT20180712040446N2,IRCT,2020-07-01,2020-06-30,True,Recruiting,Phase 3,Interventional,Iran,Investigating the effect of  sweet almond on symptoms of COVID 19,60,http://en.irct.ir/trial/49120
693,IRCT20190121042444N3,IRCT,2020-07-04,2020-02-20,True,Recruiting,Phase 3,Interventional,Iran,Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients,78,http://en.irct.ir/trial/49132
694,IRCT20111224008507N3,IRCT,2020-06-27,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in the treatment of coronavirus infection,60,http://en.irct.ir/trial/49174
695,IRCT20180519039711N6,IRCT,2020-06-29,2020-07-19,False,Not Recruiting,Not Applicable,Interventional,Iran,Effect of mandala staining on anxiety in patients with COVID-19,60,http://en.irct.ir/trial/49186
696,IRCT20200426047206N2,IRCT,2020-07-06,2020-07-22,False,Not Recruiting,Phase 3,Interventional,Iran,The efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia,30,http://en.irct.ir/trial/49385
697,EUCTR2020-001413-20-ES,EU Clinical Trials Register,2020-04-13,2020-07-04,False,Not Recruiting,Phase 2,Interventional,Spain,Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001413-20
698,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-02-04,True,Not Recruiting,Phase 2/Phase 3,Interventional,"Denmark, Hungary, United Kingdom, Czech Republic, France, Germany",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29
699,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-03-04,True,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55
700,EUCTR2020-001750-22-GB,EU Clinical Trials Register,2020-07-07,2020-09-07,False,Authorised,Phase 2,Interventional,United Kingdom,Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS),186,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001750-22
701,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,100,https://jrct.niph.go.jp/latest-detail/jRCTs031190226
702,JPRN-jRCTs041200025,JPRN,2020-07-01,2020-01-07,True,Recruiting,Phase 2,Interventional,Japan,Phase II trial of combination therapy with favipiravir and corticosteroids for COVID-19,69,https://jrct.niph.go.jp/latest-detail/jRCTs041200025
703,JPRN-UMIN000040733,JPRN,2020-06-22,2020-06-22,False,Not Recruiting,Not Applicable,Interventional,Japan,A study on the prevalence of infection in dental institutions by measuring the antibody titer to COVID-19 of the staff members of Kanagawa Dental College Medical Center,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461
704,JPRN-UMIN000040838,JPRN,2020-07-01,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,Japan,A seroprevalence study of COVID-19 in IBD patients,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628
705,NCT04471662,ClinicalTrials.gov,2020-07-13,2020-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients,50,https://clinicaltrials.gov/show/NCT04471662
706,ACTRN12620000740998,ANZCTR,2020-07-16,2020-07-16,False,Not Recruiting,Not Applicable,Interventional,Australia,A Study of Lying Face Down to Help Improve Oxygen Levels of Adults Not Needing Ventilators in Intensive Care with COVID-19,20,https://anzctr.org.au/ACTRN12620000740998.aspx
707,ACTRN12620000731998,ANZCTR,2020-07-13,2020-01-09,True,Not Recruiting,Phase 1,Interventional,Australia,Will treating the overwhelming patient response with medications affect COVID-19 mortality?,36,https://anzctr.org.au/ACTRN12620000731998.aspx
708,ACTRN12620000737932,ANZCTR,2020-07-14,2020-05-22,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Nasal washout and gargling for healthcare staff in Care Homes during the COVID-19 pandemic: The Good-NIGHT COVID pilot study,300,https://anzctr.org.au/ACTRN12620000737932.aspx
709,ChiCTR2000034795,ChiCTR,2020-07-19,2020-01-28,True,Not Recruiting,Not Applicable,Interventional,China,The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial,42,http://www.chictr.org.cn/showproj.aspx?proj=56756
710,ChiCTR2000034794,ChiCTR,2020-07-19,2020-05-01,True,Recruiting,Not Applicable,Interventional,China,"Sancai granule improves lung and kidney function for patient with novel coronavirus pneumonia (COVID-19) in the recovery period: a randomized, parallel controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=56771
711,EUCTR2020-001504-42-FR,EU Clinical Trials Register,2020-04-20,2020-07-15,False,Authorised,Phase 2,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42
712,EUCTR2020-001747-21-PT,EU Clinical Trials Register,2020-05-22,2020-06-07,False,Authorised,Phase 4,Interventional,Portugal,Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19),160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001747-21
713,EUCTR2020-002106-68-GB,EU Clinical Trials Register,2020-07-07,2020-07-16,False,Authorised,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early antivirals,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68
714,EUCTR2020-001808-42-ES,EU Clinical Trials Register,2020-07-10,2020-06-17,True,Authorised,Phase 2,Interventional,Spain,"PHASE II CLINICAL TRIAL, SINGLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TO EXPLORE THE EFFECTIVENESS AND SAFETY OF MELATONIN  IN PATIENTS WITH COVID-19 ENTERED INTO THE INTENSIVE CARE UNIT",18,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001808-42
715,EUCTR2020-002193-27-ES,EU Clinical Trials Register,2020-07-14,2020-06-15,True,Authorised,Phase 2,Interventional,Spain,"Double-blind, randomized, controlled, clinical trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19",20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002193-27
716,EUCTR2020-001445-39-ES,EU Clinical Trials Register,2020-04-03,2020-03-31,True,Not Recruiting,Phase 2,Interventional,Spain,CLINICAL TRIAL TO EVALUATE METHYLPREDNISOLONE PULSES AND TACROLIMUS IN HOSPITALIZED PATIENTS WITH SEVERE PNEUMONIA SECONDARY TO COVID-19 (TACROVID),84,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001445-39
717,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Not Recruiting,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37
718,EUCTR2020-001707-16-ES,EU Clinical Trials Register,2020-07-22,2020-06-25,True,Authorised,Phase 3,Interventional,Spain,"PHASE III RANDOMIZED, UNICENTRIC OPEN, CONTROLLED CLINICAL TRIAL TO DEMONSTRATE THE EFFECTIVENESS OF TOCILIZUMAB AGAINST SYSTEMIC CORTICOTHERAPY IN PATIENTS ENTERED BY COVID-19 WITH BILATERAL PNEUMONIA AND BAD EVOLUTION",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001707-16
719,EUCTR2020-001890-56-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Authorised,Phase 4,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of gammaglobulins in COVID-19 treatment,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001890-56
720,EUCTR2020-001794-77-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Authorised,Phase 2,Interventional,Spain,Randomised clinical trial to test if silibinin administration can prevent the respiratory failure secondary to the COVID19 lung infection in oncologic patients.,92,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001794-77
721,EUCTR2020-001929-31-ES,EU Clinical Trials Register,2020-07-22,2020-06-16,True,Authorised,Phase 4,Interventional,Spain,Controlled trial on the usefulness of pioglitazone treatment in patients with type 2 diabetes mellitus and COVID-19.,76,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001929-31
722,EUCTR2020-002186-34-ES,EU Clinical Trials Register,2020-07-22,2020-03-06,True,Authorised,Phase 4,Interventional,Spain,Efficacy of the early use of corticotherapy in CoV-2 infection to prevent the progression of acute respiratory distress syndrome (ARDS),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002186-34
723,EUCTR2020-002310-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,Authorised,Phase 2,Interventional,Spain,â€œMADRID-COVIDâ€,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002310-41
724,EUCTR2020-002166-13-ES,EU Clinical Trials Register,2020-07-22,2020-09-07,False,Authorised,Phase 2,Interventional,Spain,Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients with SARS-CoV-2 (COVID-19) Infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002166-13
725,EUCTR2020-002449-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,Authorised,Phase 3,Interventional,Spain,"Pilot trial on early treatment with hydroxychloroquine in patients with
COVID-19 who do not have hospital admission at diagnosis.",340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41
726,EUCTR2020-001904-41-GB,EU Clinical Trials Register,2020-04-30,2020-05-20,False,Authorised,Phase 2,Interventional,United Kingdom,A study comparing favipiravir versus standard of care management as an early treatment arm in COVID-19 patients,302,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001904-41
727,EUCTR2020-002668-29-GB,EU Clinical Trials Register,2020-06-10,2020-06-25,False,Authorised,Phase 2,Interventional,United Kingdom,plasma exchange in severe COVID-19 infection,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29
728,EUCTR2020-002632-75-GB,EU Clinical Trials Register,2020-06-01,2020-08-07,False,Authorised,Phase 2,Interventional,United Kingdom,"Trial to be conducted in more sites, with drug known to both patient and Investigator, in which patients will be assigned randomly to receive the drug or not in order to assess the efficacy and tolerability of the drug (porcine surfactant, CurosurfÂ®) in hospitalized patients with SARS-COV-19 (COVID-19 INFECTION) acute respiratory distress syndrome",85,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002632-75
729,ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,False,No Status Given,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,160,https://anzctr.org.au/ACTRN12620000588998.aspx
730,ACTRN12620000566932,ANZCTR,2020-05-14,2020-05-10,True,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,400,https://anzctr.org.au/ACTRN12620000566932.aspx
731,ACTRN12620000674932,ANZCTR,2020-06-12,2020-07-13,False,Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.",120,https://anzctr.org.au/ACTRN12620000674932.aspx
732,ISRCTN14326006,ISRCTN,2020-04-14,2020-04-13,True,Recruiting,Phase 3,Interventional,Canada,Does taking hydroxychloroquine before and during exposure to patients protect frontline healthcare workers from coronavirus?,988,http://isrctn.com/ISRCTN14326006
733,EUCTR2020-002494-10-GB,EU Clinical Trials Register,2020-06-08,2020-07-17,False,Authorised,Phase 4,Interventional,United Kingdom,PERSONAL-COVIDBP,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10
734,EUCTR2020-002476-13-GB,EU Clinical Trials Register,2020-06-29,2020-07-24,False,Authorised,Phase 2,Interventional,United Kingdom,A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19.,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13
735,EUCTR2020-002952-18-GB,EU Clinical Trials Register,2020-07-09,2020-07-21,False,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,DEFEAT-COVID Study,178,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002952-18
736,ACTRN12620000787987,ANZCTR,2020-08-04,2020-09-30,False,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Anxiety and Depression Arising from COVID-19-Related Financial Stress,206,https://anzctr.org.au/ACTRN12620000787987.aspx
737,ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,True,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",40,http://www.chictr.org.cn/showproj.aspx?proj=52103
738,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=49918
739,ISRCTN17072692,ISRCTN,2020-06-04,2020-06-16,False,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,320,http://isrctn.com/ISRCTN17072692
740,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-12-04,False,Not Recruiting,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21
741,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,Not Recruiting,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30
742,EUCTR2020-002574-27-FR,EU Clinical Trials Register,2020-06-15,2020-07-08,False,Authorised,Phase 1/Phase 2,Interventional,France,A study to evaluate the safety and efficacy of XAV-19 in patients with COVID-19 induced moderate pneumonia,368,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002574-27
743,JPRN-UMIN000041160,JPRN,2020-08-01,2020-08-27,False,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study,42,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000
744,ACTRN12620000786998,ANZCTR,2020-08-04,2020-08-24,False,Not Recruiting,Not Applicable,Interventional,New Zealand,A Digital Companion for Loneliness During the COVID-19 Pandemic: A Feasibility Study,30,https://anzctr.org.au/ACTRN12620000786998.aspx
745,ACTRN12620000795998,ANZCTR,2020-08-07,2020-05-31,True,Not Recruiting,Not Applicable,Interventional,Bangladesh,COVID-19 Health and wellbeing Trial in Bangladesh,2402,https://anzctr.org.au/ACTRN12620000795998.aspx
746,ACTRN12620000811909,ANZCTR,2020-08-13,2020-09-30,False,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Mood Training Program on Anxiety and Depression Arising from COVID-19-Related Stress,240,https://anzctr.org.au/ACTRN12620000811909.aspx
747,ChiCTR2000035691,ChiCTR,2020-08-16,2020-08-20,False,Not Recruiting,Phase 1,Prevention,China,"A randomized, double-blind, placebo-controlled phase I clinical trial for evaluation of the safety and tolerability of recombinant novel coronavirus vaccines (CHO cells) in healthy people aged 60 years and above",50,http://www.chictr.org.cn/showproj.aspx?proj=58207
748,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),288,http://www.chictr.org.cn/showproj.aspx?proj=53003
749,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,No Status Given,Not Applicable,Interventional,China,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,110,http://www.chictr.org.cn/showproj.aspx?proj=49502
750,ISRCTN60069084,ISRCTN,2020-07-19,2020-01-09,True,Recruiting,Phase 3/Phase 4,Interventional,"Oman, Saudi Arabia",Effect of N-acetylcysteine on COVID-19 treatment,1180,http://isrctn.com/ISRCTN60069084
751,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,100,http://en.irct.ir/trial/46897
752,IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,False,Not Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,125,http://en.irct.ir/trial/47012
753,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,60,http://en.irct.ir/trial/47016
754,IRCT20200414047076N1,IRCT,2020-08-01,2020-04-18,True,Recruiting,Not Applicable,Interventional,Iran,Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers,160,http://en.irct.ir/trial/47286
755,IRCT20170922036314N4,IRCT,2020-06-22,2020-07-10,False,Recruiting,Not Applicable,Interventional,Iran,"The effects of self-care cellphone application on stress, anxiety and depression among admitted patients with COVID-19",112,http://en.irct.ir/trial/47383
756,IRCT20200503047281N1,IRCT,2020-07-25,2020-09-22,False,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of Convalescent Plasma Therapy for COVID-19 Patients,40,http://en.irct.ir/trial/47632
757,IRCT20200505047318N1,IRCT,2020-08-06,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of finasterid on COVID-19 treatment,80,http://en.irct.ir/trial/48007
758,IRCT20110907007511N4,IRCT,2020-07-25,2020-05-16,True,Recruiting,Phase 3,Interventional,Iran,Effect of Lavender syrup on COVID-19,30,http://en.irct.ir/trial/48013
759,IRCT20200511047399N1,IRCT,2020-07-23,2020-02-20,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of omega-3 on diabetic patients with Covid-19,30,http://en.irct.ir/trial/48045
760,IRCT20200522047545N1,IRCT,2020-08-05,2020-07-31,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19",200,http://en.irct.ir/trial/48351
761,IRCT20200522047542N1,IRCT,2020-08-04,2020-07-18,True,Recruiting,Phase 1,Interventional,Iran,Effect of Corton on olfactory dysfunction in COVID-19 patients,70,http://en.irct.ir/trial/48379
762,IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,True,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,100,http://en.irct.ir/trial/48394
763,IRCT20200525047570N1,IRCT,2020-07-30,2020-07-31,False,Not Recruiting,Phase 2,Interventional,Iran,"A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine storm",60,http://en.irct.ir/trial/48583
764,IRCT20200607047682N1,IRCT,2020-07-27,2020-06-09,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial of Annual SZ drug in Covid-19,60,http://en.irct.ir/trial/48727
765,IRCT20190602043787N3,IRCT,2020-07-20,2020-07-22,False,Recruiting,Phase 3,Interventional,Iran,Ivermectin effect in the treatment of patients with covid-19,40,http://en.irct.ir/trial/49180
766,IRCT20190624043993N3,IRCT,2020-07-23,2020-08-22,False,Not Recruiting,Phase 3,Interventional,Iran,The evaluation of isotretinoineffects on treatment of COVID-19 infections,50,http://en.irct.ir/trial/49257
767,IRCT20190624043993N2,IRCT,2020-07-12,2020-08-22,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of ivermectin effects on Covid-19,50,http://en.irct.ir/trial/49280
768,IRCT20200105046009N4,IRCT,2020-07-18,2020-06-30,True,Recruiting,Phase 3,Interventional,Iran,management of the  pulmonary diseases based on Persian medicine in patients infected with COVID-19,80,http://en.irct.ir/trial/49365
769,IRCT20200506047323N3,IRCT,2020-07-22,2020-07-25,False,Recruiting,Phase 3,Interventional,Iran,The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19,60,http://en.irct.ir/trial/49463
770,IRCT20200705048013N1,IRCT,2020-07-19,2020-02-20,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of Pentoxifylline in patients with Covid-19,150,http://en.irct.ir/trial/49525
771,IRCT20190406043175N3,IRCT,2020-07-12,2020-08-22,False,Not Recruiting,Not Applicable,Interventional,Iran,The effect of diet based on traditional medicine on COVID-19,80,http://en.irct.ir/trial/49530
772,IRCT20170117032025N7,IRCT,2020-07-12,2020-07-11,True,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Mouthwashes in Early Reducing the mouth Viral Load Among COVID-19 Patients,60,http://en.irct.ir/trial/49534
773,IRCT20190415043279N6,IRCT,2020-07-24,2020-07-10,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Afsantin on COVID 19,80,http://en.irct.ir/trial/49544
774,IRCT20200426047206N3,IRCT,2020-07-21,2020-07-22,False,Recruiting,Phase 3,Interventional,Iran,The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19,48,http://en.irct.ir/trial/49579
775,IRCT20200408046990N3,IRCT,2020-07-16,2020-07-21,False,Recruiting,Phase 2,Interventional,Iran,"Evaluation of atorvastatin tablet as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem Hospital, Mashhad",40,http://en.irct.ir/trial/49629
776,IRCT20151227025726N20,IRCT,2020-07-26,2020-07-09,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients,80,http://en.irct.ir/trial/49638
777,IRCT20101020004976N6,IRCT,2020-07-18,2020-05-14,True,Recruiting,Phase 3,Interventional,Iran,The effect of  LactocareÂ® synbiotic on the prevention of COVID-19 infection in the staff of emergency department,80,http://en.irct.ir/trial/49670
778,IRCT20180513039641N2,IRCT,2020-07-27,2020-07-26,True,Recruiting,Phase 3,Interventional,Iran,Determination of dandelion capsule on patient with Covid-19 virus,80,http://en.irct.ir/trial/49803
779,IRCT20200506047323N4,IRCT,2020-08-01,2020-08-10,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Desferal in COVID-19,60,http://en.irct.ir/trial/49881
780,IRCT20200723048178N1,IRCT,2020-07-28,2020-07-28,False,Recruiting,Not Applicable,Interventional,Pakistan,nimesulide in COVID-19 infection,60,http://en.irct.ir/trial/49901
781,IRCT20160131026298N4,IRCT,2020-08-04,2020-04-20,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individuals,60,http://en.irct.ir/trial/49925
782,KCT0005307,CRIS,2020-08-11,2020-09-30,False,Recruiting,Phase 2,Interventional,South Korea,AN OPEN LABEL PHYSICIAN INITIATED 28 DAY PHASE 2A STUDY OF IFENPRODIL ON LUNG FUNCTION IN CONFIRMED COVID-19 INFECTED PATIENTS WITH SEVERE PNEUMONIA,40,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062
783,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-09-04,False,Not Recruiting,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13
784,EUCTR2020-001739-28-BE,EU Clinical Trials Register,2020-04-10,2020-05-20,False,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28
785,ACTRN12620000840987,ANZCTR,2020-08-26,2020-05-05,True,Recruiting,Phase 1,Interventional,Australia,Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia,10,https://anzctr.org.au/ACTRN12620000840987.aspx
786,ACTRN12620000843954,ANZCTR,2020-08-26,2020-01-09,True,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. Arm 1 : Prevention in patients not infected with COVID-19.",1914,https://anzctr.org.au/ACTRN12620000843954.aspx
787,ACTRN12620000842965,ANZCTR,2020-08-26,2020-01-09,True,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 2 : Post-exposure prevention in patients recently exposed to COVID-19",170,https://anzctr.org.au/ACTRN12620000842965.aspx
788,ACTRN12620000841976,ANZCTR,2020-08-26,2020-01-09,True,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 3: treatment among cancer patients with moderate COVID-19 infection.",126,https://anzctr.org.au/ACTRN12620000841976.aspx
789,ACTRN12620000844943,ANZCTR,2020-08-26,2020-01-09,True,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer
Arm 4: treatment among cancer patients with severe COVID-19 infection.",72,https://anzctr.org.au/ACTRN12620000844943.aspx
790,ChiCTR2000035633,ChiCTR,2020-08-15,2020-11-13,False,Not Recruiting,Not Applicable,Interventional,China,"Clinical study of safety, tolerance, and pharmacokinetics of nebulizer (INF-K + anti-inflammatory factor TFF2) in healthy volunteers and exploration of PK/PD fitting modeling in clinical trials of Novel Coronavirus Pneumonia (COVID-19) patients",32,http://www.chictr.org.cn/showproj.aspx?proj=57741
791,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",160,http://www.chictr.org.cn/showproj.aspx?proj=52679
792,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,False,Not Recruiting,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41
793,EUCTR2020-001888-90-DK,EU Clinical Trials Register,2020-04-16,2020-04-30,False,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for healthcare workers against COVID-19,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001888-90
794,ACTRN12620000876998,ANZCTR,2020-09-03,2020-08-14,True,Recruiting,Not Applicable,Interventional,Australia,The Building Educatorsâ€™ Skills in Adolescent Mental Health (BEAM) study: A cluster randomised-controlled trial of an adolescent mental health training program for secondary school Educators,234,https://anzctr.org.au/ACTRN12620000876998.aspx
795,ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,100,http://isrctn.com/ISRCTN99248812
796,EUCTR2020-002394-94-BE,EU Clinical Trials Register,2020-06-04,2020-06-22,False,Authorised,Phase 2,Interventional,Belgium,"Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild or
moderate corona virus disease (COVID-19)",6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002394-94
797,EUCTR2020-001644-25-DE,EU Clinical Trials Register,2020-05-08,2020-10-06,False,Authorised,Phase 2,Interventional,"Chile, Argentina, Sweden, Russian Federation, South Africa, Peru, Italy, Mexico, Spain, Turkey, Brazil, Japan, France, Germany","A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19",177,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25
798,EUCTR2020-001673-75-GB,EU Clinical Trials Register,2020-06-04,2020-02-07,True,Authorised,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Belgium, Italy, Brazil, Spain, Mexico, France, Germany","Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress.

",1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75
799,KCT0005344,CRIS,2020-08-24,2020-06-18,True,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,60,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17363
800,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,Not Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238
801,JPRN-JapicCTI-205416,JPRN,2020-08-19,2020-01-09,True,Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19),6,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416
802,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-02-03,True,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120
803,JPRN-UMIN000040837,JPRN,2020-06-24,2020-05-27,True,Not Recruiting,Not Applicable,Interventional,Japan,A Randomized Controlled trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression in the Covid-19 Pandemic,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623
804,IRCT20200402046917N1,IRCT,2020-08-31,2020-08-22,True,Recruiting,Not Applicable,Interventional,Iran,therapeutic effect of Rosa Damascena extract in treatment of COVID-19,20,http://en.irct.ir/trial/46938
805,IRCT20170128032241N3,IRCT,2020-08-17,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,Evaluation the Efficacy of CURCUDEN 35 in Patients with COVID-19,20,http://en.irct.ir/trial/47031
806,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Not Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,64,http://en.irct.ir/trial/47058
807,IRCT20200418047119N1,IRCT,2020-09-01,2020-08-31,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of curcumin in treatment of respiratory syndrome of corona,42,http://en.irct.ir/trial/47231
808,IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,True,Not Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,90,http://en.irct.ir/trial/47319
809,IRCT20200514047445N1,IRCT,2020-08-10,2020-08-05,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in improving patients with covid -19,60,http://en.irct.ir/trial/48275
810,IRCT20190131042569N5,IRCT,2020-08-23,2020-06-29,True,Recruiting,Phase 3,Interventional,Iran,The effect of nebulizing Peppermint extract and Rose extract on percentage of blood oxygen saturation in patients with COVID-19,60,http://en.irct.ir/trial/48311
811,IRCT20200527047581N1,IRCT,2020-08-23,2020-06-05,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of  oral health care and mouth rinse in treatment of Covid-19,200,http://en.irct.ir/trial/48447
812,IRCT20200616047792N1,IRCT,2020-08-03,2020-08-18,False,Recruiting,Not Applicable,Interventional,Iran,A study of therapeutic effect of blood ozone therapy of severe Covid-19 patients,60,http://en.irct.ir/trial/48978
813,IRCT20200616047799N1,IRCT,2020-08-23,2020-06-30,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Photobiomodulation anti-inflammatory effect in COVID-19,40,http://en.irct.ir/trial/49012
814,IRCT20090304001739N3,IRCT,2020-09-01,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of slow release mucoadhesive paste ofâ€ MUCODENTOL â€œ in oral vestibule on symptoms of COVID-19 disease  in hospital staff,1600,http://en.irct.ir/trial/49065
815,IRCT20200623047897N1,IRCT,2020-08-16,2020-05-21,True,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of N-acetylcysteine in patients with COVID-19,60,http://en.irct.ir/trial/49277
816,IRCT20200630047962N1,IRCT,2020-08-21,2020-08-07,True,Recruiting,Not Applicable,Interventional,Iran,The effect of progressive muscle relaxation on covid-19 anxiety in pregnant women,126,http://en.irct.ir/trial/49309
817,IRCT20200705048011N1,IRCT,2020-08-16,2020-08-22,False,Recruiting,Not Applicable,Interventional,Iran,Garlic and cinnamon on the treatment of patients with corona,45,http://en.irct.ir/trial/49481
818,IRCT20190312043030N2,IRCT,2020-08-19,2020-06-29,True,Recruiting,Phase 3,Interventional,Iran,"The effect of selenium, vitamin C and methylprednisolone combination on mortality and morbidity of Covid-19 patients.",40,http://en.irct.ir/trial/49508
819,IRCT20170716035126N4,IRCT,2020-08-26,2020-07-10,True,Not Recruiting,Phase 3,Interventional,Iran,The efficacy of methylprednisolone mini pulse on the treatment of COVID-19 patients admitted to intensive care unit,60,http://en.irct.ir/trial/49519
820,IRCT20200711048076N1,IRCT,2020-09-05,2020-05-21,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of mucodentol on covid-19 symptoms,600,http://en.irct.ir/trial/49555
821,IRCT20200509047364N2,IRCT,2020-08-17,2020-06-21,True,Recruiting,Phase 3,Interventional,Iran,Famotidine and COVID-19,20,http://en.irct.ir/trial/49657
822,IRCT20200718048129N1,IRCT,2020-08-11,2020-08-22,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Hydroxychloroquine and Clarithromycin in dyspnea and caugh caused by COVID-19 in recovery phase,45,http://en.irct.ir/trial/49729
823,IRCT20200725048199N1,IRCT,2020-08-11,2020-08-10,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Shalomin on the treatment and improvement of symptoms in patients with Covid 19,146,http://en.irct.ir/trial/49853
824,IRCT20160808029264N9,IRCT,2020-08-15,2020-09-20,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of chest physiotherapy in COVID-19 patients with respiratory infection,44,http://en.irct.ir/trial/49890
825,IRCT20190831044653N5,IRCT,2020-08-24,2020-08-20,True,Recruiting,Phase 2,Interventional,Iran,?The effect of Atorvastatin therapy in COVID-19,160,http://en.irct.ir/trial/49893
826,IRCT20200730048253N1,IRCT,2020-08-08,2020-08-22,False,Recruiting,Phase 3,Interventional,Iran,Evaluating the effectiveness of intravenous ozonized saline in COVID-19 disease,60,http://en.irct.ir/trial/50031
827,IRCT20091012002582N22,IRCT,2020-08-08,2020-08-22,False,Recruiting,Phase 3,Interventional,Iran,Effect of hemoperfusion on short term outcome of critical ill COVID-19,160,http://en.irct.ir/trial/50079
828,IRCT20101219005416N3,IRCT,2020-08-26,2020-08-10,True,Recruiting,Not Applicable,Interventional,Iran,Effect of traditional medicine protocol included Astraglus gossypinus  with  Ferula assa capsule on improvement of  COVID-19 outpatients symptoms,120,http://en.irct.ir/trial/50101
829,IRCT20200806048318N1,IRCT,2020-08-20,2020-09-22,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal tea on improving respiratory symptoms in patients with Covid-19,80,http://en.irct.ir/trial/50227
830,IRCT20200506047323N5,IRCT,2020-08-14,2020-08-22,False,Recruiting,Phase 3,Interventional,Iran,Melatonin in COVID-19,60,http://en.irct.ir/trial/50239
831,IRCT20090701002113N2,IRCT,2020-08-25,2020-08-15,True,Recruiting,Phase 3,Interventional,Iran,Methylene Blue in COVID-19,260,http://en.irct.ir/trial/50275
832,IRCT20180922041089N4,IRCT,2020-08-23,2020-04-19,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of oral Ivermectin on patients with COVID-19,130,http://en.irct.ir/trial/50305
833,IRCT20161108030776N3,IRCT,2020-08-26,2020-09-05,False,Recruiting,Not Applicable,Interventional,Iran,Effect of donkey milk on the new corona virus infection,110,http://en.irct.ir/trial/50341
834,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-23,False,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,1,https://anzctr.org.au/ACTRN12620000477921.aspx
835,ACTRN12620000454976,ANZCTR,2020-04-08,2020-02-07,True,Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,160,https://anzctr.org.au/ACTRN12620000454976.aspx
836,ACTRN12620000517976,ANZCTR,2020-04-27,2020-09-07,False,Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),206,https://anzctr.org.au/ACTRN12620000517976.aspx
837,ACTRN12620000580976,ANZCTR,2020-05-19,2020-10-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (â€œTROCARâ€),150,https://anzctr.org.au/ACTRN12620000580976.aspx
838,ACTRN12620000698976,ANZCTR,2020-06-23,2020-10-06,False,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,40,https://anzctr.org.au/ACTRN12620000698976.aspx
839,ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,False,No Status Given,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus Calmetteâ€“GuÃ©rin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",3468,https://anzctr.org.au/ACTRN12620000707965.aspx
840,ACTRN12620000817943,ANZCTR,2020-08-14,2020-08-22,False,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of COVID-19 Vaccine in Healthy Adults",280,https://anzctr.org.au/ACTRN12620000817943.aspx
841,ACTRN12620000860965,ANZCTR,2020-08-28,2020-01-09,True,Not Recruiting,Not Applicable,Interventional,Australia,A research study to determine the effect of a smartphone application (app) on management of patients with heart failure in isolation due to COVID-19,400,https://anzctr.org.au/ACTRN12620000860965.aspx
842,ChiCTR2000034825,ChiCTR,2020-07-21,2020-07-20,True,Not Recruiting,Phase 1,Interventional,China,A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China,144,http://www.chictr.org.cn/showproj.aspx?proj=56834
843,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51940
844,EUCTR2020-002503-19-GB,EU Clinical Trials Register,2020-07-30,2020-11-09,False,Authorised,Phase 3,Interventional,"Spain, Netherlands, Australia, United Kingdom",Tuberculosis vaccination to Reduce the impact of Coronavirus infection in healthcare workers following contact of Coronavirus,7244,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002503-19
845,ACTRN12620000571976,ANZCTR,2020-05-15,2020-04-06,True,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",75,https://anzctr.org.au/ACTRN12620000571976.aspx
846,ISRCTN44152751,ISRCTN,2020-05-04,2020-11-05,False,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,116750,http://isrctn.com/ISRCTN44152751
847,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364
848,EUCTR2020-002314-40-AT,EU Clinical Trials Register,2020-07-15,2020-09-14,False,Authorised,Phase 2,Interventional,Austria,A Pilot study to investigate the cardiac effect and pharmacokinetics of potential combination treatments for COVID-19,16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002314-40
849,EUCTR2020-001860-27-GB,EU Clinical Trials Register,2020-04-17,2020-12-05,False,Authorised,Phase 1/Phase 2,Interventional,United Kingdom,AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment. A randomised Phase I/II study to determine the safety and effectiveness of multiple drugs for the treatment of COVID-19,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001860-27
850,EUCTR2020-001466-11-GR,EU Clinical Trials Register,2020-04-14,2020-04-15,False,Authorised,Phase 2,Interventional,Greece,Prevention of severe respiratory failure in Covid-19,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11
851,EUCTR2020-001643-13-GB,EU Clinical Trials Register,2020-04-29,2020-05-15,False,Authorised,Phase 3,Interventional,United Kingdom,A randomised double-blind placebo-controlled trial of Brensocatib (INS1007) in patients with severe COVID-19,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001643-13
852,ISRCTN51232965,ISRCTN,2020-09-14,2020-07-13,True,Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants",216,http://isrctn.com/ISRCTN51232965
853,ISRCTN10378358,ISRCTN,2020-07-08,2020-01-11,True,Recruiting,Not Applicable,Interventional,United Kingdom,"Reducing the risk of COVID-19 spread in hospitals, by stopping droplets from spreading",400,http://isrctn.com/ISRCTN10378358
854,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,No Status Given,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",20,http://www.chictr.org.cn/showproj.aspx?proj=50254
855,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Not Recruiting,Not Applicable,Interventional,China,Withdraw       Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,30,http://www.chictr.org.cn/showproj.aspx?proj=41760
856,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Not Recruiting,Not Applicable,Interventional,China,Withdraw           Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,30,http://www.chictr.org.cn/showproj.aspx?proj=49062
857,EUCTR2020-001281-11-FR,EU Clinical Trials Register,2020-03-26,2020-03-30,False,Not Recruiting,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11
858,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35
859,EUCTR2020-001634-36-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Authorised,Phase 2,Interventional,Spain,Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection.,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36
860,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64
861,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66
862,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22
863,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39
864,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39
865,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86
866,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29
867,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30
868,EUCTR2020-001376-15-DE,EU Clinical Trials Register,2020-04-06,2020-05-13,False,Not Recruiting,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15
869,EUCTR2020-002728-35-HU,EU Clinical Trials Register,2020-08-13,2020-09-17,False,Authorised,Phase 3,Interventional,Hungary,Clinical trial of Favipiravir treatment of patients with COVID-19,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002728-35
870,EUCTR2020-001640-26-GB,EU Clinical Trials Register,2020-04-09,2020-04-17,False,Authorised,Phase 2,Interventional,United Kingdom,A clinical trial of nebulised recombinant tissue plasminogen activator (rtPA) in patients with COVID-19 Acute Respiratory Distress Syndrome to decrease the duration of ventilatory support and mortality: A pilot study (the PACA trial),36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001640-26
871,EUCTR2020-003470-47-NL,EU Clinical Trials Register,2020-09-26,2020-08-27,True,Authorised,Phase 4,Interventional,Netherlands,Investigation IN VULNERABLE ELDERLY to evaluate the reduction of respiratory infections during the coronapandemie by training of the immuunsystem through a BCG vaccination,5200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003470-47
872,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36
873,ACTRN12620000834954,ANZCTR,2020-08-24,2020-09-16,False,Not Recruiting,Phase 1,Interventional,Australia,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants",24,https://anzctr.org.au/ACTRN12620000834954.aspx
874,JPRN-UMIN000041458,JPRN,2020-10-01,2020-07-01,True,Not Recruiting,Not Applicable,Interventional,Japan,Research on the maintenance and improvement of physical and mental functions of elderly people under the self-restraint caused by COVID-19 by using a remote system to connect their homes,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327
875,EUCTR2020-001367-88-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Not Recruiting,Phase 3,Interventional,Denmark,Efficacy and safety of novel treatment options for adults with COVID-19 pneumonia,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001367-88
876,EUCTR2020-001395-15-DK,EU Clinical Trials Register,2020-03-30,2020-06-04,False,Not Recruiting,Phase 3,Interventional,Denmark,Low dose hydrocortisone in patients with COVID-19 and severe oxygen deficiency â€“ the COVID STEROID trial,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001395-15
877,EUCTR2020-002542-16-GB,EU Clinical Trials Register,2020-09-17,2020-09-30,False,Authorised,Phase 3,Interventional,"Denmark, Argentina, Portugal, Greece, United Kingdom, Belgium, Peru, Thailand, United States, Spain, Israel, Mexico, Japan, Poland, France, Germany, Nigeria",Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC),500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002542-16
878,EUCTR2020-001807-18-GB,EU Clinical Trials Register,2020-04-29,2020-05-18,False,Authorised,Phase 2,Interventional,"Argentina, Moldova, Republic of, South Africa, United Kingdom, Ukraine, United States, Brazil, Finland, Poland, Romania",TD-0903 for acute lung injury associated with COVID-19,222,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001807-18
879,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-21,False,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13
880,EUCTR2020-002110-41-GB,EU Clinical Trials Register,2020-05-29,2020-06-18,False,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,A clinical study in a community setting to see whether use of camostat reduces the worsening of COVID-19.,389,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002110-41
881,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Not Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,30,http://en.irct.ir/trial/46564
882,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,324,http://en.irct.ir/trial/46783
883,IRCT20190810044500N7,IRCT,2020-09-19,2020-04-08,True,Recruiting,Phase 2,Interventional,Iran,Evaluation of Levamisole efficacy in treatment of Covid-19,50,http://en.irct.ir/trial/46826
884,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Not Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",60,http://en.irct.ir/trial/46828
885,IRCT20190717044241N2,IRCT,2020-04-22,2020-04-20,True,Recruiting,Phase 1,Interventional,Iran,Cell therapy in patients with COVID-19,5,http://en.irct.ir/trial/47110
886,IRCT20081019001369N7,IRCT,2020-09-27,2020-10-22,False,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate against COVID-19,30,http://en.irct.ir/trial/47441
887,IRCT20200504047295N1,IRCT,2020-09-16,2020-08-10,True,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of Shallomin syrup on patients affected by COVID-19,90,http://en.irct.ir/trial/47661
888,IRCT20160118026097N4,IRCT,2020-09-13,2020-03-29,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of dexamethasone in the treatment of high-risk covid19 patients,60,http://en.irct.ir/trial/48310
889,IRCT20160118026097N5,IRCT,2020-09-19,2020-03-29,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of plasmapheresis in the treatment of high-risk covid patients in Qom province,60,http://en.irct.ir/trial/48401
890,IRCT20190226042851N1,IRCT,2020-10-05,2020-08-22,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of nano-based inhalation solution to relieve shortness of breath in COVID-19 patients,40,http://en.irct.ir/trial/48462
891,IRCT20180624040213N2,IRCT,2020-09-14,2020-07-21,True,Recruiting,Phase 3,Interventional,Iran,Montelukast in COVID-19,114,http://en.irct.ir/trial/49420
892,IRCT20200504047298N3,IRCT,2020-09-09,2020-08-22,True,Recruiting,Phase 3,Interventional,Iran,Effect of Diphenhydramine Compound in Covid-19,120,http://en.irct.ir/trial/49696
893,IRCT20191228045924N1,IRCT,2020-09-20,2020-04-19,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of methylene blue on treatment of COVID-19 patients,80,http://en.irct.ir/trial/49767
894,IRCT20200802048266N1,IRCT,2020-09-22,2020-11-19,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of MMR vaccine in preventing Covid disease 19,323,http://en.irct.ir/trial/50035
895,IRCT20131112015390N5,IRCT,2020-09-26,2020-05-21,True,Not Recruiting,Not Applicable,Interventional,Iran,"Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19",110,http://en.irct.ir/trial/50268
896,IRCT20200317046797N7,IRCT,2020-09-14,2020-04-20,True,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease,3500,http://en.irct.ir/trial/50556
897,IRCT20200831048568N1,IRCT,2020-09-11,2020-09-10,True,Recruiting,Phase 3,Interventional,Iran,Efficacy of sofosbuvir and daclatasvir in ambulatory patients with coronavirus disease,2000,http://en.irct.ir/trial/50601
898,IRCT20181203041832N1,IRCT,2020-10-05,2020-09-22,True,Recruiting,Not Applicable,Interventional,Iran,The effectiveness of online mindfulness training on mental health and quality of work life of nurses fighting on the frontlines against COVID-19,36,http://en.irct.ir/trial/50750
899,IRCT20200902048598N1,IRCT,2020-09-28,2020-09-22,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of education in the prevention of covid-19,200,http://en.irct.ir/trial/50796
900,IRCT20140911019125N8,IRCT,2020-09-26,2020-09-10,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of corona disease,120,http://en.irct.ir/trial/50848
901,IRCT20200913048701N1,IRCT,2020-09-22,2020-09-22,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of effects of eucalyptus tablets on the process of covid 19 disease,50,http://en.irct.ir/trial/50912
902,IRCT20200907048644N1,IRCT,2020-10-04,2020-09-22,True,Recruiting,Phase 1,Interventional,Iran,Celecoxib effects on  COVID-19 patients,60,http://en.irct.ir/trial/50932
903,IRCT20200913048708N1,IRCT,2020-10-01,2020-10-31,False,Not Recruiting,Phase 2,Interventional,Iran,Efficacy and safety of Chlorpromazine  in the treatment of COVID-19 patients,60,http://en.irct.ir/trial/50959
904,IRCT20131115015405N4,IRCT,2020-10-03,2020-07-22,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of fluvoxamine on cytokine in COVID-19 patients,40,http://en.irct.ir/trial/50977
905,IRCT20131125015536N13,IRCT,2020-10-03,2020-05-21,True,Recruiting,Not Applicable,Interventional,Iran,Assessment of the effect of nanocurcumin supplement in patients with COVID-19,48,http://en.irct.ir/trial/51310
906,IRCT20201001048893N1,IRCT,2020-10-03,2020-03-10,True,Not Recruiting,Not Applicable,Interventional,Iran,Effect of Online Psycho-educational Interventions on Psychological Health of Patients with COVID-19,50,http://en.irct.ir/trial/51328
907,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Not Recruiting,Not Applicable,Interventional,China,Canceled by the investigator                                       Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=44213
908,EUCTR2020-001610-38-DK,EU Clinical Trials Register,2020-04-07,2020-09-16,False,Authorised,Phase 4,Interventional,Denmark,Irbesartan and Oseltamivir treatment of COVID-19 infection.,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001610-38
909,EUCTR2020-001498-63-GB,EU Clinical Trials Register,2020-06-09,2020-01-10,True,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, United States, Brazil, France","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63
910,ISRCTN18428598,ISRCTN,2020-10-08,2020-01-01,True,Recruiting,Not Applicable,Interventional,United Kingdom,Does the Flexible Phonics programme lead to improved reading outcomes for children in Reception when taught in addition to existing phonics programmes/practice?,2875,http://isrctn.com/ISRCTN18428598
911,ISRCTN43900695,ISRCTN,2020-04-08,2020-08-17,False,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,60,http://isrctn.com/ISRCTN43900695
912,EUCTR2020-004928-42-HU,EU Clinical Trials Register,2020-10-12,2020-12-10,False,Authorised,Phase 3,Interventional,Hungary,Clinical trail of remdesivir in Covid-19 patinets,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004928-42
913,EUCTR2020-001473-79-GB,EU Clinical Trials Register,2020-04-24,2020-07-05,False,Authorised,Phase 3,Interventional,"Spain, Italy, United States, United Kingdom",Dapagliflozin in Respiratory failure in patients with COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001473-79
914,EUCTR2020-002211-21-GB,EU Clinical Trials Register,2020-07-07,2020-07-31,False,Authorised,Phase 2,Interventional,United Kingdom,A Phase II clinical trial to assess how safe and how effective AZD1656 is in treating COVID-19 in diabetic patients compared to placebo.,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002211-21
915,EUCTR2020-001803-17-GB,EU Clinical Trials Register,2020-06-05,2020-07-14,False,Authorised,Phase 2/Phase 3,Interventional,"Spain, Italy, United States, United Kingdom",Phase 2/3 study of Remdesivir in patients from birth to <18 years old with COVID-19,52,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001803-17
916,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,1000,http://isrctn.com/ISRCTN14966673
917,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Not Recruiting,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38
918,EUCTR2020-001455-40-GR,EU Clinical Trials Register,2020-04-01,2020-01-04,True,Not Recruiting,Phase 2,Interventional,Greece,A study using colchicine for preventing the complications from Covid-19,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001455-40
919,EUCTR2020-002295-13-FR,EU Clinical Trials Register,2020-05-22,2020-10-15,False,Authorised,Phase 2,Interventional,France,"Evaluation of the efficacy, safety and tolerability of alisporivir for the treatment of hospitalised patients with infections due to SARS-CoV-2 (COVID-19). 
",100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002295-13
920,EUCTR2020-001734-36-FR,EU Clinical Trials Register,2020-04-15,2020-04-20,False,Not Recruiting,Phase 3,Interventional,France,Efficacy and safety of ANAkinra during Adult Â« COVID-19 Â» with Aggravating respiratory symptoms: a multicenter open-label controlled randomized trial,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001734-36
921,EUCTR2020-001867-94-FR,EU Clinical Trials Register,2020-04-20,2020-10-15,False,Authorised,Phase 3,Interventional,France,Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectÃ©s par le SARS-CoV2 (COVID-19) non hospitalisÃ©s,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001867-94
922,EUCTR2020-001745-40-IT,EU Clinical Trials Register,2020-06-24,2020-04-23,True,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40
923,EUCTR2020-001732-10-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10
924,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,No Status Given,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,70,https://anzctr.org.au/ACTRN12620000457943.aspx
925,ACTRN12620000557932,ANZCTR,2020-05-11,2020-07-09,False,Recruiting,Not Applicable,Interventional,"Turkey, Australia","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",200,https://anzctr.org.au/ACTRN12620000557932.aspx
926,ISRCTN13447477,ISRCTN,2020-05-22,2020-04-11,True,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,22,http://isrctn.com/ISRCTN13447477
927,EUCTR2020-003486-19-GB,EU Clinical Trials Register,2020-08-14,2020-08-10,True,Authorised,Phase 2,Interventional,United Kingdom,SFX-01 treatment for Acute Respiratory Infections (STAR-Covid19),300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19
928,EUCTR2020-001162-12-FR,EU Clinical Trials Register,2020-03-20,2020-03-26,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Canada, Italy, Israel, Spain, Japan, France, Germany",Sarilumab COVID-19,460,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12
929,EUCTR2020-003689-37-FR,EU Clinical Trials Register,2020-10-01,2020-10-27,False,Authorised,Phase 2,Interventional,France,"REmimazolam infusion in the context of Hypnotic Shortage in the Critical care Unit during the pandemic of COVID-19. The non-randomized, non-controlled, pilot, open, mono-centric REHSCU study.",30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003689-37
930,EUCTR2020-002677-95-IT,EU Clinical Trials Register,2020-08-10,2020-08-25,False,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, United Kingdom, United States, Brazil, Mexico, Italy",A clinical trial using opaganib in adult patients hospitalised with severe pneumonia due to COVID-19,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002677-95
931,EUCTR2020-001662-11-DE,EU Clinical Trials Register,2020-04-15,2020-05-05,False,Not Recruiting,Phase 3,Interventional,"United Kingdom, United States, Italy, Spain, France, Germany","Phase 3 randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of ruxolitinib in patients with COVID-19 associated cytokine storm (RUXCOVID)",402,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11
932,EUCTR2020-001689-12-GR,EU Clinical Trials Register,2020-10-19,2020-10-23,False,Authorised,Phase 3,Interventional,"South Africa, Greece, United Kingdom, Canada, United States, Brazil, Spain",COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),6000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12
933,EUCTR2020-004123-16-GB,EU Clinical Trials Register,2020-09-11,2020-09-23,False,Authorised,Phase 3,Interventional,United Kingdom,Study to evaluate the efficacy and safety of a SARS-CoV-2 rS vaccine with Matrix-M1â„¢ Adjuvant in Adult Participants 18-84 Years of Age in the United Kingdom,15000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004123-16
934,JPRN-UMIN000042034,JPRN,2020-10-07,2020-09-09,True,Not Recruiting,Not Applicable,Interventional,Japan,About preventive measures against covid-19 infection in sports,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574
935,ISRCTN13455972,ISRCTN,2020-08-04,2020-04-08,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of coronavirus self-isolation interventions,10000,http://isrctn.com/ISRCTN13455972
936,ChiCTR2000038740,ChiCTR,2020-09-30,2020-08-01,True,Not Recruiting,Not Applicable,Interventional,China,Study on Traditional Chinese Medicine Intervention Program for the Sequela of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=62250
937,ChiCTR2000037782,ChiCTR,2020-09-01,2020-09-01,False,Not Recruiting,Phase 1,Interventional,China,A Phase I Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),60,http://www.chictr.org.cn/showproj.aspx?proj=55421
938,ChiCTR2000037524,ChiCTR,2020-08-29,2020-08-29,False,Not Recruiting,Not Applicable,Interventional,China,Effects of an online mindfulness-based intervention on quality of life and psychological symptoms in novel coronavirus pneumonia (COVID-19) patients in China: a randomized controlled trial,1600,http://www.chictr.org.cn/showproj.aspx?proj=60034
939,ChiCTR2000037518,ChiCTR,2020-08-28,2020-08-28,False,Not Recruiting,Phase 1,Interventional,China,"Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)",168,http://www.chictr.org.cn/showproj.aspx?proj=60581
940,ChiCTR2000036871,ChiCTR,2020-08-25,2020-09-01,False,Not Recruiting,Phase 4,Interventional,Pakistan,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.",300,http://www.chictr.org.cn/showproj.aspx?proj=55984
941,ChiCTR2000036333,ChiCTR,2020-08-22,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,China,Using Mindfulness to Reduce Anxiety and Depression of Patient with Fever Undergoing Screening in an Isolation Ward During novel coronavirus pneumonia (COVID-19) pandemic,51,http://www.chictr.org.cn/showproj.aspx?proj=57115
942,IRCT20100623004251N13,IRCT,2020-04-04,2019-10-23,True,Not Recruiting,Not Applicable,Interventional,Iran,Comparison of the Effect of Types of Orthosis and Back School Program on Physical Fitness and Respiratory Capacity of Elderly with Thoracic Kyphosis,60,http://en.irct.ir/trial/42393
943,IRCT20200324046850N5,IRCT,2020-04-04,2020-10-17,False,Recruiting,Phase 2,Interventional,Iran,Effectiveness of vitamin C on the improvement process of patients with COVID-19,400,http://en.irct.ir/trial/46751
944,IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,True,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,357,http://en.irct.ir/trial/47163
945,IRCT20200328046885N1,IRCT,2020-10-12,2020-07-19,True,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the effectiveness of two treatment regimens in patients with COVID-19,300,http://en.irct.ir/trial/47565
946,IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,True,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,120,http://en.irct.ir/trial/48049
947,IRCT20200531047619N1,IRCT,2020-10-18,2020-08-21,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tofacitinib in covid-19 patients,10,http://en.irct.ir/trial/48766
948,IRCT20200802048267N1,IRCT,2020-10-20,2020-08-22,True,Recruiting,Phase 2,Interventional,Iran,Propolis supplementation AND Coronavirus,80,http://en.irct.ir/trial/50162
949,IRCT20200816048422N1,IRCT,2020-10-16,2020-06-25,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19),70,http://en.irct.ir/trial/50363
950,IRCT20150808023559N23,IRCT,2020-10-11,2020-09-20,True,Recruiting,Phase 2,Interventional,Iran,Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19,100,http://en.irct.ir/trial/50405
951,IRCT20200825048514N1,IRCT,2020-10-10,2020-05-04,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of ÃŸ-interferon and methylprednisolone in COVID-19,60,http://en.irct.ir/trial/50543
952,IRCT20200328046886N2,IRCT,2020-10-12,2020-08-22,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19,120,http://en.irct.ir/trial/50980
953,IRCT20080901001165N63,IRCT,2020-10-22,2020-07-22,True,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Myrtus nasal spray in controlling the symptoms of patients with mild  COVID-19,100,http://en.irct.ir/trial/51157
954,IRCT20100228003449N31,IRCT,2020-10-08,2020-09-26,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Corticosteroids in COVID-19,119,http://en.irct.ir/trial/51163
955,IRCT20200923048815N1,IRCT,2020-10-15,2020-10-22,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of synbiotic on inflammatory markers and clinical manifestations in patients with C0VID-19,80,http://en.irct.ir/trial/51166
956,IRCT20200922048804N1,IRCT,2020-10-06,2020-08-05,True,Not Recruiting,Not Applicable,Interventional,Iran,Melatonin in COVID-19,20,http://en.irct.ir/trial/51177
957,IRCT20200404046937N5,IRCT,2020-10-14,2020-09-27,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of remdesivir in COVID-19,50,http://en.irct.ir/trial/51178
958,IRCT20200928048867N1,IRCT,2020-10-22,2020-10-01,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors,10,http://en.irct.ir/trial/51319
959,IRCT20201003048904N1,IRCT,2020-10-11,2020-10-11,False,Recruiting,Not Applicable,Interventional,Iran,Effect of Blood Transfusion in Covid-19,40,http://en.irct.ir/trial/51364
960,IRCT20201003048905N1,IRCT,2020-10-07,2020-05-23,True,Not Recruiting,Not Applicable,Interventional,Iran,Effect of spiritual care based on Ghalbe Salim on anxiety related to COVID-19 (corona phobia),14,http://en.irct.ir/trial/51394
961,IRCT20201004048922N1,IRCT,2020-10-10,2020-10-11,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial,75,http://en.irct.ir/trial/51443
962,IRCT20201005048936N1,IRCT,2020-10-26,2020-10-31,False,Recruiting,Phase 3,Interventional,Iran,The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19,126,http://en.irct.ir/trial/51499
963,IRCT20181208041886N1,IRCT,2020-10-18,2020-10-22,False,Recruiting,Not Applicable,Interventional,Iran,Levamizole in treatment of COVID19.,60,http://en.irct.ir/trial/51501
964,IRCT20200128046294N3,IRCT,2020-10-22,2020-10-24,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Safety of Sofosbuvir /Daclatasvir in outpatients with COVID-19,50,http://en.irct.ir/trial/51585
965,IRCT20200930048892N1,IRCT,2020-10-18,2020-10-20,False,Recruiting,Not Applicable,Interventional,Iran,evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients,70,http://en.irct.ir/trial/51595
966,EUCTR2020-001275-32-DK,EU Clinical Trials Register,2020-03-24,2020-03-04,True,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001275-32
967,EUCTR2020-002122-82-DE,EU Clinical Trials Register,2020-05-07,2020-12-06,False,Authorised,Phase 2,Interventional,Germany,Clinical study for the Evaluation of efficacy and safety of a Treatment with Plasma gained from patients who recovered from COVID-19 infection and given to patients who are currently suffering from a severe COVID-19 infection,58,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002122-82
968,ISRCTN25647404,ISRCTN,2020-11-09,2020-09-20,True,Recruiting,Not Applicable,Interventional,United Kingdom,Measurement of the effect of mouthwash against COVID-19,104,http://isrctn.com/ISRCTN25647404
969,ISRCTN11188345,ISRCTN,2020-05-15,2020-07-05,False,Recruiting,Phase 4,Interventional,United Kingdom,A therapeutic study in pre-ICU patients admitted with coronavirus using repurposed drugs,375,http://isrctn.com/ISRCTN11188345
970,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14
971,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69
972,EUCTR2020-001827-15-ES,EU Clinical Trials Register,2020-05-05,2020-04-30,True,Authorised,Phase 3,Interventional,Spain,"EARLY TREATMENT OF PNEUMONIA COVID-19 WITH GLUCOCORTICOIDS.
RANDOMIZED CONTROLLED CLINICAL TRIAL",72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001827-15
973,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Authorised,Phase 3,Interventional,Spain,Ensayo clÃ­nico aleatorizado para investigar la eficacia de la administraciÃ³n anticipada de la colchicina en pacientes mayores de 70 aÃ±os y de alto riesgo en tener complicaciones pulmonares como neumonÃ­a asociada al coronavirus.,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16
974,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66
975,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37
976,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29
977,EUCTR2020-001953-36-ES,EU Clinical Trials Register,2020-05-08,2020-08-05,False,Authorised,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Patients with Coronavirus Disease (COVID-19),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001953-36
978,EUCTR2020-001512-26-DE,EU Clinical Trials Register,2020-04-01,2020-04-22,False,Not Recruiting,Phase 2,Interventional,Germany,Hydroxychloroquine for the treatment of mild COVID-19 disease,2700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001512-26
979,EUCTR2020-001903-17-ES,EU Clinical Trials Register,2020-05-15,2020-10-06,False,Authorised,Phase 3,Interventional,Spain,Effects of Tocilizumab  and its combination with Vitamin D to treat the increased defensive response in COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001903-17
980,EUCTR2020-002114-40-FR,EU Clinical Trials Register,2020-06-17,2020-07-30,False,Authorised,Phase 3,Interventional,France,Nintedanib for the treatment of pulmonary fibrosis induced by Covid-19,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002114-40
981,EUCTR2020-001852-16-NL,EU Clinical Trials Register,2020-07-14,2020-07-14,False,Authorised,Phase 2,Interventional,Netherlands,Iodine treatment Coronavirus infection,224,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001852-16
982,EUCTR2020-002056-20-FR,EU Clinical Trials Register,2020-06-15,2020-10-14,False,Authorised,Phase 2,Interventional,France,"X06 to rescue acute respiratory distress syndrome 
during Covid-19 pneumonia  : FX-COVID
",50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002056-20
983,EUCTR2020-004144-28-GB,EU Clinical Trials Register,2020-10-15,2020-10-23,False,Authorised,Phase 2,Interventional,United Kingdom,PROphylaxis for paTiEnts at risk of COVID-19 infecTion - PROTECT,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004144-28
984,EUCTR2020-002497-27-CZ,EU Clinical Trials Register,2020-10-22,2020-10-27,False,Authorised,Phase 4,Interventional,Czech Republic,"A randomized, open-label, phase IV monocentric study evaluating the clinical effect of oral immunomodulatory therapy with IMUNORÂ® in patients with moderate COVID-19 disease",30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002497-27
985,EUCTR2020-001736-95-GB,EU Clinical Trials Register,2020-04-23,2020-04-28,False,Authorised,Phase 2,Interventional,United Kingdom,A Phase 2 Study for the Treatment of COVID 19 in Hospitalised Patients,1800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95
986,EUCTR2020-002293-28-SE,EU Clinical Trials Register,2020-05-13,2020-05-29,False,Authorised,Phase 2,Interventional,Sweden,"Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.

A single-blind, randomized, placebo-controlled feasibility study.",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002293-28
987,EUCTR2020-001072-15-GB,EU Clinical Trials Register,2020-03-19,2020-03-26,False,Authorised,Phase 2,Interventional,United Kingdom,"A phase I/II to determine efficacy, safety and immunogenicity of a candidate COVID-19 vaccine",1112,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001072-15
988,EUCTR2020-002225-29-FR,EU Clinical Trials Register,2020-04-30,2020-12-11,False,Authorised,Phase 2,Interventional,France,Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections.,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002225-29
989,ISRCTN16842454,ISRCTN,2020-11-10,2020-05-19,True,Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and safety of plasma convalescent therapy in patients with COVID-19,5,http://isrctn.com/ISRCTN16842454
990,EUCTR2020-001467-82-NL,EU Clinical Trials Register,2020-04-28,2020-10-23,False,Authorised,Phase 2,Interventional,Netherlands,Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001467-82
991,EUCTR2020-004743-83-GB,EU Clinical Trials Register,2020-10-26,2020-09-11,True,Authorised,Phase 3,Interventional,"Moldova, Republic of, Russian Federation, United Kingdom, Canada, Turkey, Poland, France, Romania, Belgium, Germany, Argentina, South Africa, Netherlands, Ukraine, Italy, Mexico, Brazil, Chile, Peru, Portugal, Colombia, United States, Israel, Serbia, Spain, India",A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004743-83
992,EUCTR2020-004356-16-GB,EU Clinical Trials Register,2020-10-12,2020-11-18,False,Authorised,Phase 3,Interventional,"United Kingdom, Belgium, United States, Spain, France","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection",5000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004356-16
993,ISRCTN68675756,ISRCTN,2020-07-01,2020-10-02,False,Not Recruiting,Not Applicable,Interventional,China,Psychological intervention to improve the mental health of patients with COVID-19,93,http://isrctn.com/ISRCTN68675756
994,EUCTR2020-001553-48-FR,EU Clinical Trials Register,2020-04-03,2020-04-13,False,Not Recruiting,Phase 2,Interventional,France,CorticoÃ¯des au cours de la pneumonie virale Covid-19 liÃ©e Ã  lâ€™infection par le SARS-Cov-2,304,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001553-48
995,EUCTR2020-001357-52-ES,EU Clinical Trials Register,2020-05-14,2020-05-13,True,Authorised,Phase 4,Interventional,Spain,Effect of the administration of Hydroxychloroquine as prevention of COVID-19 infection in patients with biological treatment or with JAK inhibitors,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001357-52
996,EUCTR2020-001319-26-ES,EU Clinical Trials Register,2020-05-14,2020-05-14,False,Authorised,Phase 3,Interventional,Spain,Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive.,1080,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001319-26
997,EUCTR2020-001995-13-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13
998,EUCTR2020-002274-28-ES,EU Clinical Trials Register,2020-05-21,2020-05-19,True,Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28
999,EUCTR2020-001704-42-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42
1000,EUCTR2020-002287-31-ES,EU Clinical Trials Register,2020-05-25,2020-05-22,True,Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31
1001,EUCTR2020-002037-15-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15
1002,EUCTR2020-001960-28-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28
1003,EUCTR2020-001841-38-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38
1004,EUCTR2020-002456-21-NL,EU Clinical Trials Register,2020-05-26,2020-05-28,False,Not Recruiting,Phase 4,Interventional,Netherlands,Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002456-21
1005,EUCTR2020-001605-23-ES,EU Clinical Trials Register,2020-05-31,2020-05-29,True,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23
1006,EUCTR2020-002312-43-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43
1007,EUCTR2020-001671-32-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32
1008,EUCTR2020-002009-25-CZ,EU Clinical Trials Register,2020-06-04,2020-01-10,True,Authorised,Phase 2,Interventional,Czech Republic,The efficacy and safety of Eftilagimod Alpha Treatment in COVID-19 disease (EAT COVID trial),104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002009-25
1009,EUCTR2020-001971-33-ES,EU Clinical Trials Register,2020-07-22,2020-02-06,True,Authorised,Phase 3,Interventional,Spain,"Pragmatic study ""CORIVER"": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID19)",45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001971-33
1010,EUCTR2020-002567-57-GB,EU Clinical Trials Register,2020-10-22,2020-11-23,False,Authorised,Phase 4,Interventional,United Kingdom,To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support.,112,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002567-57
1011,EUCTR2020-004682-39-CZ,EU Clinical Trials Register,2020-11-13,2020-11-16,False,Authorised,Phase 4,Interventional,Czech Republic,"Pilot, open-label, monocentric study evaluating safety and clinical effect of application of NORMOSANGÂ® in patients with COVID-19 disease",8,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004682-39
1012,EUCTR2020-001689-12-GB,EU Clinical Trials Register,2020-10-15,2020-11-20,False,Authorised,Phase 3,Interventional,"South Africa, Greece, United Kingdom, Canada, United States, Brazil, Spain",COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),6000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12
1013,EUCTR2020-001113-21-GB,EU Clinical Trials Register,2020-03-19,2020-03-17,True,Authorised,Phase 2/Phase 3,Interventional,"Nepal, Vietnam, Indonesia, United Kingdom",RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY),20000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001113-21
1014,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88
1015,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,64,http://en.irct.ir/trial/46733
1016,IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",80,http://en.irct.ir/trial/47019
1017,IRCT20200415047080N2,IRCT,2020-11-07,2020-04-04,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of TAC cocktail in critically ill patients with Covid 19 induced pneumonia,30,http://en.irct.ir/trial/47186
1018,IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,False,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus (COVID-19),100,http://en.irct.ir/trial/47529
1019,IRCT20200415047080N1,IRCT,2020-11-02,2020-09-22,True,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Tissue plasminogen activator (TPA) for treatment of ARDS induced by Covid-19,30,http://en.irct.ir/trial/47982
1020,IRCT20200608047686N2,IRCT,2020-11-19,2020-10-17,True,Recruiting,Phase 2,Interventional,Iran,The role of hemoperfusion in COVID-19,40,http://en.irct.ir/trial/48933
1021,IRCT20151227025726N24,IRCT,2020-11-25,2020-07-10,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of bromhexine administration in COVID-19,100,http://en.irct.ir/trial/49043
1022,IRCT20200624047908N1,IRCT,2020-07-05,2020-07-13,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of sofosbuvir/daclatasvir  in COVID-19 patients,1000,http://en.irct.ir/trial/49198
1023,IRCT20150623022884N3,IRCT,2020-11-18,2020-04-08,True,Not Recruiting,Phase 2,Interventional,Iran,MAB98 for treatment of Covid-19,120,http://en.irct.ir/trial/49249
1024,IRCT20130428013151N2,IRCT,2020-10-28,2020-04-25,True,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of mucodentol on people with coronavirus,200,http://en.irct.ir/trial/49356
1025,IRCT20200506047323N6,IRCT,2020-11-17,2020-11-15,True,Recruiting,Phase 3,Interventional,Iran,Effect of Ivermectin in treatment of COVID-19,120,http://en.irct.ir/trial/49501
1026,IRCT20160131026298N6,IRCT,2020-09-08,2020-11-05,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Nigel-7 capsule and black seed mixture on corona,80,http://en.irct.ir/trial/50246
1027,IRCT20160919029870N3,IRCT,2020-11-24,2020-03-20,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of selenium in patients with Covid-19,80,http://en.irct.ir/trial/50425
1028,IRCT20200711048077N1,IRCT,2020-11-16,2020-11-21,False,Recruiting,Not Applicable,Interventional,Iran,Evaluation of respiratory Tele-rehabilitation in patient with COVID-19,60,http://en.irct.ir/trial/50721
1029,IRCT20200408046987N2,IRCT,2020-11-07,2020-10-16,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19,150,http://en.irct.ir/trial/51007
1030,IRCT20200921048786N1,IRCT,2020-11-11,2020-09-22,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of interferon beta-1b in the treatment of COVID-19,82,http://en.irct.ir/trial/51086
1031,IRCT20151227025726N23,IRCT,2020-11-10,2020-08-06,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19,60,http://en.irct.ir/trial/51473
1032,IRCT20181030041504N1,IRCT,2020-11-08,2020-10-07,True,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation of the combined effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19",100,http://en.irct.ir/trial/51482
1033,IRCT20200428047229N3,IRCT,2020-11-25,2020-09-08,True,Recruiting,Phase 3,Interventional,Iran,Effect of cupping on respiratory symptoms of COVID-19,72,http://en.irct.ir/trial/51516
1034,IRCT20201012049010N1,IRCT,2020-11-12,2020-07-22,True,Not Recruiting,Not Applicable,Interventional,Iran,The effect of balloon-blowing on dyspnea and oxygenation in non-critical adult covid-19 patients.,90,http://en.irct.ir/trial/51591
1035,IRCT20200426047206N4,IRCT,2020-11-01,2020-10-22,True,Recruiting,Phase 3,Interventional,Iran,Effect of Melatonin in treatment of COVID-19,60,http://en.irct.ir/trial/51687
1036,IRCT20150825023753N17,IRCT,2020-11-01,2020-04-13,True,Not Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital,18,http://en.irct.ir/trial/51709
1037,IRCT20201015049030N1,IRCT,2020-11-07,2020-09-11,True,Recruiting,Phase 2,Interventional,Iran,Effect of  Dexamethasone on treatment of COVID-19,200,http://en.irct.ir/trial/51736
1038,IRCT20201020049088N1,IRCT,2020-11-15,2020-11-05,True,Recruiting,Not Applicable,Interventional,Iran,The effects of aromatherapy on the anxiety and sleep quality of the patients with COVID-19,60,http://en.irct.ir/trial/51748
1039,IRCT20201016049048N1,IRCT,2020-11-04,2020-11-07,False,Recruiting,Not Applicable,Interventional,Iran,Effect of Iranian Borage on the management of Covid-19 symptoms,60,http://en.irct.ir/trial/51767
1040,IRCT20201015049036N1,IRCT,2020-11-27,2020-09-12,True,Not Recruiting,Phase 2,Interventional,Iran,Efficacy of Date Palm Leaf Extract (Phoenix dactylifera) in Patients with COVID-19 Hospitalized in Ganjavian Hospital in Dezful,100,http://en.irct.ir/trial/51772
1041,IRCT20181208041886N2,IRCT,2020-10-29,2020-11-21,False,Recruiting,Not Applicable,Interventional,Iran,Aftogel and COVID-19 PCR test,60,http://en.irct.ir/trial/51774
1042,IRCT20200720048139N1,IRCT,2020-11-09,2020-11-21,False,Recruiting,Phase 2,Interventional,Iran,Investigating effect of Spirulina dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units,138,http://en.irct.ir/trial/51784
1043,IRCT20200927048848N2,IRCT,2020-11-04,2020-10-31,True,Recruiting,Phase 3,Interventional,Iran,squalene and COVID-19,15,http://en.irct.ir/trial/51922
1044,IRCT20170809035597N2,IRCT,2020-11-16,2020-08-17,True,Not Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of  pentoxifylline in treatment and recovery of patients with COVID-19,86,http://en.irct.ir/trial/51927
1045,IRCT20191211045691N2,IRCT,2020-11-02,2020-09-14,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Doxycycline in combination with standard treatment in Covid-19 patients,60,http://en.irct.ir/trial/51951
1046,IRCT20190713044192N2,IRCT,2020-11-21,2020-11-21,False,Recruiting,Not Applicable,Interventional,Iran,The effect of the online child birth preparation classes on pregnant women during COVID_19  pandemic,100,http://en.irct.ir/trial/52153
1047,IRCT20170315033086N7,IRCT,2020-11-12,2020-11-21,False,Recruiting,Phase 2,Interventional,Iran,An Investigation of the impact of Faramir on the clinical symptoms in patients with COVID-19,128,http://en.irct.ir/trial/52223
1048,IRCT20190804044429N4,IRCT,2020-11-25,2020-11-10,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,pentoxifyliine in COVID-19,60,http://en.irct.ir/trial/52284
1049,ACTRN12620000788976,ANZCTR,2020-08-05,2021-04-01,False,Recruiting,Phase 1,Interventional,Australia,Safety and efficacy of intranasal delivery of BromAcÂ® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients,40,https://anzctr.org.au/ACTRN12620000788976.aspx
1050,ISRCTN93382525,ISRCTN,2020-08-03,2020-12-10,False,Recruiting,Not Applicable,Interventional,United Kingdom,STAR (Study of Trauma And Recovery): a trial of trauma-focused psychological therapy for psychosis,300,http://isrctn.com/ISRCTN93382525
1051,ISRCTN14241621,ISRCTN,2020-07-21,2020-03-30,True,Recruiting,Phase 2,Interventional,United Kingdom,Trial of inhaled anti-viral (SNG001) for SARS-CoV-2 (COVID-19) infection,220,http://isrctn.com/ISRCTN14241621
1052,ISRCTN17898730,ISRCTN,2020-04-23,2020-07-04,False,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,150,http://isrctn.com/ISRCTN17898730
1053,EUCTR2020-001654-21-DE,EU Clinical Trials Register,2020-05-05,2020-09-16,False,Authorised,Phase 2,Interventional,Germany,"Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumonia 
",238,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001654-21
1054,EUCTR2020-000936-23-PT,EU Clinical Trials Register,2020-07-03,2020-11-08,False,Authorised,Phase 3,Interventional,"France, Portugal, Austria",Safety and efficacy of treatments of COVID-19 in hospitalized adults (Discovery),3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23
1055,EUCTR2020-001228-32-GB,EU Clinical Trials Register,2020-04-21,2020-04-05,True,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,12390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001228-32
1056,EUCTR2020-003643-29-GB,EU Clinical Trials Register,2020-10-05,2020-10-11,False,Authorised,Phase 3,Interventional,"South Africa, United Kingdom, United States, Italy, Spain, France, Germany",A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S vaccine for the Prevention of COVID-19 disease in Adults Aged 18 Years and Older,30000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003643-29
1057,ChiCTR2000038256,ChiCTR,2020-09-15,2020-09-07,True,Recruiting,Not Applicable,Interventional,China,Motion Modelling for Sedentary Behavior during the novel coronavirus pneumonia (COVID-19) pandemic: 10-min High Intensity Interval Training (HIIT) with Music Therapy (MT),118,http://www.chictr.org.cn/showproj.aspx?proj=61345
1058,ChiCTR2000038255,ChiCTR,2020-09-15,2020-05-25,True,Recruiting,Not Applicable,Interventional,China,Establishment of psychological assistance system for the bereaved during the COVID-19 pandemic,300,http://www.chictr.org.cn/showproj.aspx?proj=61390
1059,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,80,https://clinicaltrials.gov/show/NCT04244591
1060,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,0,https://clinicaltrials.gov/show/NCT04251767
1061,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,150,https://clinicaltrials.gov/show/NCT04251871
1062,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,20,https://clinicaltrials.gov/show/NCT04252118
1063,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04252274
1064,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,308,https://clinicaltrials.gov/show/NCT04252664
1065,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Not Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,86,https://clinicaltrials.gov/show/NCT04252885
1066,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",100,https://clinicaltrials.gov/show/NCT04254874
1067,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",400,https://clinicaltrials.gov/show/NCT04255017
1068,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,237,https://clinicaltrials.gov/show/NCT04257656
1069,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,380,https://clinicaltrials.gov/show/NCT04260594
1070,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",60,https://clinicaltrials.gov/show/NCT04261270
1071,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,80,https://clinicaltrials.gov/show/NCT04261426
1072,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04261517
1073,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,160,https://clinicaltrials.gov/show/NCT04261907
1074,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,100,https://clinicaltrials.gov/show/NCT04263402
1075,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,Not Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,56,https://clinicaltrials.gov/show/NCT04264533
1076,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,10,https://clinicaltrials.gov/show/NCT04264858
1077,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,120,https://clinicaltrials.gov/show/NCT04268537
1078,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,16,https://clinicaltrials.gov/show/NCT04269525
1079,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,86,https://clinicaltrials.gov/show/NCT04273321
1080,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,100,https://clinicaltrials.gov/show/NCT04273529
1081,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,40,https://clinicaltrials.gov/show/NCT04273581
1082,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,48,https://clinicaltrials.gov/show/NCT04273646
1083,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),18,https://clinicaltrials.gov/show/NCT04273763
1084,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Not Recruiting,Phase 2,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,27,https://clinicaltrials.gov/show/NCT04275414
1085,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",127,https://clinicaltrials.gov/show/NCT04276688
1086,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,100,https://clinicaltrials.gov/show/NCT04276896
1087,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Not Recruiting,Phase 1,Interventional,China,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,24,https://clinicaltrials.gov/show/NCT04276987
1088,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,300,https://clinicaltrials.gov/show/NCT04278963
1089,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-04-23,False,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,160,https://clinicaltrials.gov/show/NCT04279197
1090,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,Not Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,0,https://clinicaltrials.gov/show/NCT04280588
1091,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,230,https://clinicaltrials.gov/show/NCT04281693
1092,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,True,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,294,https://clinicaltrials.gov/show/NCT04282902
1093,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04285190
1094,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,520,https://clinicaltrials.gov/show/NCT04286503
1095,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04287686
1096,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),100,https://clinicaltrials.gov/show/NCT04288102
1097,NCT04290858,ClinicalTrials.gov,2020-02-27,2020-03-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,0,https://clinicaltrials.gov/show/NCT04290858
1098,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,0,https://clinicaltrials.gov/show/NCT04290871
1099,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,550,https://clinicaltrials.gov/show/NCT04291053
1100,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,11,https://clinicaltrials.gov/show/NCT04291729
1101,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,False,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, Singapore, United States, Italy, Spain, Japan, China, France, Germany, South Korea, Switzerland",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19),4891,https://clinicaltrials.gov/show/NCT04292899
1102,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,0,https://clinicaltrials.gov/show/NCT04293692
1103,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2ÃŸ in the Treatment of Novel Coronavirus Patients,328,https://clinicaltrials.gov/show/NCT04293887
1104,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),80,https://clinicaltrials.gov/show/NCT04295551
1105,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-07-01,False,Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),280,https://clinicaltrials.gov/show/NCT04298060
1106,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-11-10,False,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,20,https://clinicaltrials.gov/show/NCT04299152
1107,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,100,https://clinicaltrials.gov/show/NCT04299724
1108,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,24,https://clinicaltrials.gov/show/NCT04302519
1109,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,False,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,2300,https://clinicaltrials.gov/show/NCT04304053
1110,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,10,https://clinicaltrials.gov/show/NCT04304313
1111,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,140,https://clinicaltrials.gov/show/NCT04305106
1112,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,70,https://clinicaltrials.gov/show/NCT04305457
1113,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,19491,https://clinicaltrials.gov/show/NCT04306055
1114,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),65,https://clinicaltrials.gov/show/NCT04307693
1115,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04308317
1116,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,True,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,150,https://clinicaltrials.gov/show/NCT04310228
1117,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,116,https://clinicaltrials.gov/show/NCT04310865
1118,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,108,https://clinicaltrials.gov/show/NCT04313127
1119,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,5,https://clinicaltrials.gov/show/NCT04313322
1120,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,1912,https://clinicaltrials.gov/show/NCT04315298
1121,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,38,https://clinicaltrials.gov/show/NCT04315480
1122,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),500,https://clinicaltrials.gov/show/NCT04315896
1123,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,False,Not Recruiting,Phase 2,Interventional,Brazil,NestaCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,90,https://clinicaltrials.gov/show/NCT04315987
1124,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,53,https://clinicaltrials.gov/show/NCT04316377
1125,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag â„¢ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,200,https://clinicaltrials.gov/show/NCT04316728
1126,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),400,https://clinicaltrials.gov/show/NCT04318015
1127,NCT04318431,ClinicalTrials.gov,2020-03-20,2020-04-14,False,Not Recruiting,Not Applicable,Interventional,France,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,605,https://clinicaltrials.gov/show/NCT04318431
1128,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),1600,https://clinicaltrials.gov/show/NCT04318444
1129,NCT04319731,ClinicalTrials.gov,2020-03-22,2020-03-20,True,Recruiting,Phase 1,Interventional,United States,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,10,https://clinicaltrials.gov/show/NCT04319731
1130,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,True,Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,150,https://clinicaltrials.gov/show/NCT04319900
1131,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),216,https://clinicaltrials.gov/show/NCT04320056
1132,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,2944,https://clinicaltrials.gov/show/NCT04320238
1133,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",200,https://clinicaltrials.gov/show/NCT04320277
1134,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Not Recruiting,Phase 3,Interventional,"Denmark, United Kingdom, Netherlands, Canada, United States, Italy, Spain, France, Germany",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,450,https://clinicaltrials.gov/show/NCT04320615
1135,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,5,https://clinicaltrials.gov/show/NCT04320953
1136,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174
1137,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,49,https://clinicaltrials.gov/show/NCT04321421
1138,NCT04321616,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Recruiting,Phase 2/Phase 3,Interventional,Norway,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,700,https://clinicaltrials.gov/show/NCT04321616
1139,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,7576,https://clinicaltrials.gov/show/NCT04321928
1140,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,800,https://clinicaltrials.gov/show/NCT04321993
1141,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,120,https://clinicaltrials.gov/show/NCT04322344
1142,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,False,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,310,https://clinicaltrials.gov/show/NCT04322565
1143,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,False,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04322773
1144,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-09-01,False,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,40,https://clinicaltrials.gov/show/NCT04323228
1145,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,50,https://clinicaltrials.gov/show/NCT04323332
1146,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,1000,https://clinicaltrials.gov/show/NCT04323345
1147,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,500,https://clinicaltrials.gov/show/NCT04323514
1148,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-04-30,False,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,0,https://clinicaltrials.gov/show/NCT04323631
1149,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,239,https://clinicaltrials.gov/show/NCT04324073
1150,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,600,https://clinicaltrials.gov/show/NCT04324190
1151,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,4,https://clinicaltrials.gov/show/NCT04324489
1152,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-02-21,True,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,90,https://clinicaltrials.gov/show/NCT04324996
1153,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,0,https://clinicaltrials.gov/show/NCT04325672
1154,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,200,https://clinicaltrials.gov/show/NCT04325867
1155,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Not Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,259,https://clinicaltrials.gov/show/NCT04325893
1156,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,10,https://clinicaltrials.gov/show/NCT04326036
1157,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure.,900,https://clinicaltrials.gov/show/NCT04326075
1158,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,240,https://clinicaltrials.gov/show/NCT04326114
1159,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,300,https://clinicaltrials.gov/show/NCT04326426
1160,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,30,https://clinicaltrials.gov/show/NCT04326452
1161,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,False,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,30,https://clinicaltrials.gov/show/NCT04327349
1162,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Not Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,299,https://clinicaltrials.gov/show/NCT04327401
1163,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Recruiting,Not Applicable,Interventional,"French Guiana, Guadeloupe, New Caledonia",Household Transmission Investigation Study for COVID-19 in Tropical Regions,1300,https://clinicaltrials.gov/show/NCT04328129
1164,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,75,https://clinicaltrials.gov/show/NCT04328272
1165,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,False,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,1200,https://clinicaltrials.gov/show/NCT04328285
1166,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,1500,https://clinicaltrials.gov/show/NCT04328467
1167,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),829,https://clinicaltrials.gov/show/NCT04328961
1168,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Not Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,101,https://clinicaltrials.gov/show/NCT04329533
1169,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,400,https://clinicaltrials.gov/show/NCT04329572
1170,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,148,https://clinicaltrials.gov/show/NCT04329611
1171,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,False,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04329650
1172,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,85,https://clinicaltrials.gov/show/NCT04329832
1173,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),2486,https://clinicaltrials.gov/show/NCT04330144
1174,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-04-30,False,Not Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,2414,https://clinicaltrials.gov/show/NCT04330300
1175,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,False,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",800,https://clinicaltrials.gov/show/NCT04330495
1176,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04331470
1177,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,9,https://clinicaltrials.gov/show/NCT04331613
1178,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),228,https://clinicaltrials.gov/show/NCT04331808
1179,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,10,https://clinicaltrials.gov/show/NCT04332380
1180,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-09-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",60,https://clinicaltrials.gov/show/NCT04332666
1181,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-08-08,False,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",92,https://clinicaltrials.gov/show/NCT04332835
1182,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,115,https://clinicaltrials.gov/show/NCT04333251
1183,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,3170,https://clinicaltrials.gov/show/NCT04333407
1184,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,50,https://clinicaltrials.gov/show/NCT04333550
1185,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,210,https://clinicaltrials.gov/show/NCT04333589
1186,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-06-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Israel,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,5,https://clinicaltrials.gov/show/NCT04333628
1187,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Not Recruiting,Phase 1,Interventional,"Netherlands, France, United States, Belgium",Hydroxychloroquine in Outpatient Adults With COVID-19,8,https://clinicaltrials.gov/show/NCT04333654
1188,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04334005
1189,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,750,https://clinicaltrials.gov/show/NCT04334265
1190,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,1550,https://clinicaltrials.gov/show/NCT04334382
1191,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,False,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,230,https://clinicaltrials.gov/show/NCT04334629
1192,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,False,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,194,https://clinicaltrials.gov/show/NCT04334850
1193,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,13,https://clinicaltrials.gov/show/NCT04334967
1194,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-11-09,False,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),284,https://clinicaltrials.gov/show/NCT04335032
1195,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,Not Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),5,https://clinicaltrials.gov/show/NCT04335071
1196,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Not Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,172,https://clinicaltrials.gov/show/NCT04335279
1197,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-09,False,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,24,https://clinicaltrials.gov/show/NCT04335305
1198,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,False,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,651,https://clinicaltrials.gov/show/NCT04335786
1199,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,68,https://clinicaltrials.gov/show/NCT04335851
1200,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,100,https://clinicaltrials.gov/show/NCT04336462
1201,NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,440,https://clinicaltrials.gov/show/NCT04336748
1202,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,0,https://clinicaltrials.gov/show/NCT04336774
1203,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,100,https://clinicaltrials.gov/show/NCT04336904
1204,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,50,https://clinicaltrials.gov/show/NCT04337008
1205,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,Not Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,6000,https://clinicaltrials.gov/show/NCT04337541
1206,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,200,https://clinicaltrials.gov/show/NCT04337788
1207,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-16,False,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,50,https://clinicaltrials.gov/show/NCT04338568
1208,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-22,False,Recruiting,Phase 3,Interventional,Pakistan,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",500,https://clinicaltrials.gov/show/NCT04338698
1209,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,96,https://clinicaltrials.gov/show/NCT04338802
1210,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,334,https://clinicaltrials.gov/show/NCT04338906
1211,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04339660
1212,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,False,Not Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,3,https://clinicaltrials.gov/show/NCT04339816
1213,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,10,https://clinicaltrials.gov/show/NCT04340050
1214,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,True,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,10,https://clinicaltrials.gov/show/NCT04340414
1215,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,84,https://clinicaltrials.gov/show/NCT04341038
1216,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,550,https://clinicaltrials.gov/show/NCT04341142
1217,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,1000,https://clinicaltrials.gov/show/NCT04341207
1218,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),508,https://clinicaltrials.gov/show/NCT04341389
1219,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,0,https://clinicaltrials.gov/show/NCT04341610
1220,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04341675
1221,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,False,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",27,https://clinicaltrials.gov/show/NCT04341870
1222,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,False,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,670,https://clinicaltrials.gov/show/NCT04341922
1223,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,0,https://clinicaltrials.gov/show/NCT04342156
1224,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-04,True,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,400,https://clinicaltrials.gov/show/NCT04342169
1225,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Not Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),426,https://clinicaltrials.gov/show/NCT04342182
1226,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Not Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,152,https://clinicaltrials.gov/show/NCT04342650
1227,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Not Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,95,https://clinicaltrials.gov/show/NCT04342897
1228,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-10-01,False,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,0,https://clinicaltrials.gov/show/NCT04343001
1229,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Not Recruiting,Phase 1,Interventional,Iraq,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,16,https://clinicaltrials.gov/show/NCT04343092
1230,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (OptivoÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",92,https://clinicaltrials.gov/show/NCT04343144
1231,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,48,https://clinicaltrials.gov/show/NCT04343183
1232,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,48,https://clinicaltrials.gov/show/NCT04343261
1233,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Not Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,86,https://clinicaltrials.gov/show/NCT04343651
1234,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-03-27,True,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),0,https://clinicaltrials.gov/show/NCT04343690
1235,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",60,https://clinicaltrials.gov/show/NCT04343768
1236,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,Recruiting,Not Applicable,Interventional,Hong Kong,Using BiovitalsÂ® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,200,https://clinicaltrials.gov/show/NCT04343794
1237,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,436,https://clinicaltrials.gov/show/NCT04343963
1238,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,25,https://clinicaltrials.gov/show/NCT04344106
1239,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,149,https://clinicaltrials.gov/show/NCT04344210
1240,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Not Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,11,https://clinicaltrials.gov/show/NCT04344288
1241,NCT04344379,ClinicalTrials.gov,2020-03-27,2020-04-17,False,Not Recruiting,Phase 3,Interventional,France,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,122,https://clinicaltrials.gov/show/NCT04344379
1242,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04344431
1243,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-13,False,Not Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,600,https://clinicaltrials.gov/show/NCT04344444
1244,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",80,https://clinicaltrials.gov/show/NCT04344457
1245,NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,False,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,164,https://clinicaltrials.gov/show/NCT04344600
1246,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,False,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",808,https://clinicaltrials.gov/show/NCT04344756
1247,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (AvastinÂ®/ZeribevÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",130,https://clinicaltrials.gov/show/NCT04344782
1248,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",60,https://clinicaltrials.gov/show/NCT04344951
1249,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,True,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,10,https://clinicaltrials.gov/show/NCT04345276
1250,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,1100,https://clinicaltrials.gov/show/NCT04345289
1251,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,60,https://clinicaltrials.gov/show/NCT04345406
1252,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,310,https://clinicaltrials.gov/show/NCT04345445
1253,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,18,https://clinicaltrials.gov/show/NCT04345549
1254,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Not Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,17,https://clinicaltrials.gov/show/NCT04345692
1255,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),7,https://clinicaltrials.gov/show/NCT04345861
1256,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,60,https://clinicaltrials.gov/show/NCT04345887
1257,NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",120,https://clinicaltrials.gov/show/NCT04345991
1258,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,200,https://clinicaltrials.gov/show/NCT04346017
1259,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,30,https://clinicaltrials.gov/show/NCT04346082
1260,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,126,https://clinicaltrials.gov/show/NCT04346355
1261,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),20,https://clinicaltrials.gov/show/NCT04346368
1262,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,12,https://clinicaltrials.gov/show/NCT04346420
1263,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,29,https://clinicaltrials.gov/show/NCT04346446
1264,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,10,https://clinicaltrials.gov/show/NCT04346589
1265,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,False,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",120,https://clinicaltrials.gov/show/NCT04346797
1266,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-08-20,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),128,https://clinicaltrials.gov/show/NCT04346953
1267,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,138,https://clinicaltrials.gov/show/NCT04347226
1268,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Not Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,313,https://clinicaltrials.gov/show/NCT04347382
1269,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,False,Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,0,https://clinicaltrials.gov/show/NCT04347512
1270,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,False,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,575,https://clinicaltrials.gov/show/NCT04347681
1271,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,0,https://clinicaltrials.gov/show/NCT04347889
1272,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-07-11,False,Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,200,https://clinicaltrials.gov/show/NCT04347941
1273,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,122,https://clinicaltrials.gov/show/NCT04347980
1274,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,1800,https://clinicaltrials.gov/show/NCT04348370
1275,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,False,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,50,https://clinicaltrials.gov/show/NCT04348409
1276,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,200,https://clinicaltrials.gov/show/NCT04348474
1277,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,False,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04348513
1278,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,True,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,94,https://clinicaltrials.gov/show/NCT04348695
1279,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,20,https://clinicaltrials.gov/show/NCT04348877
1280,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,927,https://clinicaltrials.gov/show/NCT04348929
1281,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,False,Recruiting,Phase 2,Interventional,"United Kingdom, United States, Israel, Spain, Austria, France",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,230,https://clinicaltrials.gov/show/NCT04349098
1282,NCT04349228,ClinicalTrials.gov,2020-04-14,2020-04-28,False,Not Recruiting,Phase 3,Interventional,Tunisia,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,0,https://clinicaltrials.gov/show/NCT04349228
1283,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,False,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04349241
1284,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,1800,https://clinicaltrials.gov/show/NCT04349410
1285,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04350086
1286,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,Not Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04350281
1287,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,0,https://clinicaltrials.gov/show/NCT04350450
1288,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-17,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,0,https://clinicaltrials.gov/show/NCT04350476
1289,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04350671
1290,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04350684
1291,NCT04350723,ClinicalTrials.gov,2020-04-14,2020-06-10,False,Recruiting,Not Applicable,Interventional,"Canada, Saudi Arabia",Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,350,https://clinicaltrials.gov/show/NCT04350723
1292,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Not Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",54,https://clinicaltrials.gov/show/NCT04350736
1293,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,900,https://clinicaltrials.gov/show/NCT04350931
1294,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-20,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,90,https://clinicaltrials.gov/show/NCT04351295
1295,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,32,https://clinicaltrials.gov/show/NCT04351542
1296,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,20,https://clinicaltrials.gov/show/NCT04351620
1297,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,804,https://clinicaltrials.gov/show/NCT04351763
1298,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Recruiting,Not Applicable,Interventional,Denmark,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,66,https://clinicaltrials.gov/show/NCT04351789
1299,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,20,https://clinicaltrials.gov/show/NCT04351906
1300,NCT04351919,ClinicalTrials.gov,2020-04-15,2020-05-05,False,Not Recruiting,Phase 4,Interventional,Tunisia,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),0,https://clinicaltrials.gov/show/NCT04351919
1301,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,42,https://clinicaltrials.gov/show/NCT04352465
1302,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),744,https://clinicaltrials.gov/show/NCT04352608
1303,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,2000,https://clinicaltrials.gov/show/NCT04352751
1304,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,20,https://clinicaltrials.gov/show/NCT04352803
1305,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,False,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),1000,https://clinicaltrials.gov/show/NCT04352933
1306,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,374,https://clinicaltrials.gov/show/NCT04352946
1307,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,450,https://clinicaltrials.gov/show/NCT04353128
1308,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-06-27,False,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,60,https://clinicaltrials.gov/show/NCT04353206
1309,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,58,https://clinicaltrials.gov/show/NCT04353271
1310,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,False,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,114,https://clinicaltrials.gov/show/NCT04353284
1311,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,4000,https://clinicaltrials.gov/show/NCT04353518
1312,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-07-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,0,https://clinicaltrials.gov/show/NCT04354389
1313,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,300,https://clinicaltrials.gov/show/NCT04354428
1314,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,0,https://clinicaltrials.gov/show/NCT04354441
1315,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,200,https://clinicaltrials.gov/show/NCT04354597
1316,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,0,https://clinicaltrials.gov/show/NCT04354714
1317,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-08-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,100,https://clinicaltrials.gov/show/NCT04354805
1318,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,90,https://clinicaltrials.gov/show/NCT04355026
1319,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",250,https://clinicaltrials.gov/show/NCT04355052
1320,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,20,https://clinicaltrials.gov/show/NCT04355247
1321,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),400,https://clinicaltrials.gov/show/NCT04355351
1322,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),230,https://clinicaltrials.gov/show/NCT04355429
1323,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,40,https://clinicaltrials.gov/show/NCT04355754
1324,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,False,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04355897
1325,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,False,Recruiting,Phase 4,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,400,https://clinicaltrials.gov/show/NCT04355936
1326,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,False,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,90,https://clinicaltrials.gov/show/NCT04356482
1327,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,15,https://clinicaltrials.gov/show/NCT04356508
1328,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,40,https://clinicaltrials.gov/show/NCT04356534
1329,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,243,https://clinicaltrials.gov/show/NCT04356937
1330,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-07-13,False,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,200,https://clinicaltrials.gov/show/NCT04357028
1331,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,10,https://clinicaltrials.gov/show/NCT04357106
1332,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Not Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),122,https://clinicaltrials.gov/show/NCT04357327
1333,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04357340
1334,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-09-01,False,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,99,https://clinicaltrials.gov/show/NCT04357613
1335,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,20,https://clinicaltrials.gov/show/NCT04357782
1336,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,120,https://clinicaltrials.gov/show/NCT04357860
1337,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-09-04,False,Recruiting,Not Applicable,Interventional,Iceland,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,128,https://clinicaltrials.gov/show/NCT04357990
1338,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,12,https://clinicaltrials.gov/show/NCT04358614
1339,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",480,https://clinicaltrials.gov/show/NCT04358809
1340,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,0,https://clinicaltrials.gov/show/NCT04358835
1341,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,20,https://clinicaltrials.gov/show/NCT04359251
1342,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,392,https://clinicaltrials.gov/show/NCT04359264
1343,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,False,Not Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,77,https://clinicaltrials.gov/show/NCT04359277
1344,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-07-01,False,Not Recruiting,Phase 2,Interventional,Germany,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,15,https://clinicaltrials.gov/show/NCT04359290
1345,NCT04359303,ClinicalTrials.gov,2020-04-09,2020-07-01,False,Not Recruiting,Phase 3,Interventional,Spain,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,50,https://clinicaltrials.gov/show/NCT04359303
1346,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04359316
1347,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,110,https://clinicaltrials.gov/show/NCT04359329
1348,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,200,https://clinicaltrials.gov/show/NCT04359537
1349,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04359615
1350,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-06-16,False,Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,50,https://clinicaltrials.gov/show/NCT04359654
1351,NCT04359862,ClinicalTrials.gov,2020-04-21,2020-04-16,True,Recruiting,Phase 4,Interventional,Spain,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,50,https://clinicaltrials.gov/show/NCT04359862
1352,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-25,False,Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",1600,https://clinicaltrials.gov/show/NCT04359953
1353,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,100,https://clinicaltrials.gov/show/NCT04360122
1354,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04360356
1355,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04360551
1356,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,0,https://clinicaltrials.gov/show/NCT04360759
1357,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",3600,https://clinicaltrials.gov/show/NCT04360811
1358,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,170,https://clinicaltrials.gov/show/NCT04360824
1359,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,10,https://clinicaltrials.gov/show/NCT04360837
1360,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,0,https://clinicaltrials.gov/show/NCT04360876
1361,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,80,https://clinicaltrials.gov/show/NCT04360980
1362,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-09-04,False,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",260,https://clinicaltrials.gov/show/NCT04361032
1363,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,False,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04361214
1364,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,220,https://clinicaltrials.gov/show/NCT04361253
1365,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04361318
1366,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-12-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,300,https://clinicaltrials.gov/show/NCT04361422
1367,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,50,https://clinicaltrials.gov/show/NCT04361435
1368,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),0,https://clinicaltrials.gov/show/NCT04361461
1369,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,40,https://clinicaltrials.gov/show/NCT04361526
1370,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),0,https://clinicaltrials.gov/show/NCT04361552
1371,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-10-27,False,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,120,https://clinicaltrials.gov/show/NCT04361643
1372,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Not Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),37,https://clinicaltrials.gov/show/NCT04361916
1373,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-18,False,Recruiting,Not Applicable,Interventional,United Kingdom,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,24,https://clinicaltrials.gov/show/NCT04362059
1374,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-07-29,False,Recruiting,Phase 3,Interventional,United States,Early Treatment of Cytokine Storm Syndrome in Covid-19,30,https://clinicaltrials.gov/show/NCT04362111
1375,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-08-01,False,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,0,https://clinicaltrials.gov/show/NCT04362124
1376,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",25,https://clinicaltrials.gov/show/NCT04362332
1377,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,120,https://clinicaltrials.gov/show/NCT04362358
1378,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,104,https://clinicaltrials.gov/show/NCT04363060
1379,NCT04363177,ClinicalTrials.gov,2020-04-21,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,"China, Sweden, Hong Kong",Global Mental Health of Urban Mothers,200,https://clinicaltrials.gov/show/NCT04363177
1380,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),300,https://clinicaltrials.gov/show/NCT04363203
1381,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,66,https://clinicaltrials.gov/show/NCT04363216
1382,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-31,False,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,500,https://clinicaltrials.gov/show/NCT04363385
1383,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,70,https://clinicaltrials.gov/show/NCT04363437
1384,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),1700,https://clinicaltrials.gov/show/NCT04363450
1385,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-24,False,Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,50,https://clinicaltrials.gov/show/NCT04363528
1386,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-08-27,False,Recruiting,Not Applicable,Interventional,Mexico,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,274,https://clinicaltrials.gov/show/NCT04363541
1387,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,False,Not Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04363736
1388,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,False,Recruiting,Phase 3,Interventional,Dominican Republic,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04363814
1389,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",1080,https://clinicaltrials.gov/show/NCT04363840
1390,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Not Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04363853
1391,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-08-01,False,Not Recruiting,Phase 2,Interventional,United States,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),0,https://clinicaltrials.gov/show/NCT04363866
1392,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,50,https://clinicaltrials.gov/show/NCT04364594
1393,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-12-01,False,Not Recruiting,Phase 3,Interventional,Philippines,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,0,https://clinicaltrials.gov/show/NCT04364815
1394,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,700,https://clinicaltrials.gov/show/NCT04364893
1395,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,0,https://clinicaltrials.gov/show/NCT04365231
1396,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,128,https://clinicaltrials.gov/show/NCT04365309
1397,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-12-29,False,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,170,https://clinicaltrials.gov/show/NCT04365517
1398,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,90,https://clinicaltrials.gov/show/NCT04365608
1399,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,270,https://clinicaltrials.gov/show/NCT04365738
1400,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,20,https://clinicaltrials.gov/show/NCT04365972
1401,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,500,https://clinicaltrials.gov/show/NCT04365985
1402,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,60,https://clinicaltrials.gov/show/NCT04366063
1403,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,152,https://clinicaltrials.gov/show/NCT04366089
1404,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,314,https://clinicaltrials.gov/show/NCT04366180
1405,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-08-19,False,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),2,https://clinicaltrials.gov/show/NCT04366232
1406,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,False,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,72,https://clinicaltrials.gov/show/NCT04366245
1407,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,106,https://clinicaltrials.gov/show/NCT04366271
1408,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,41,https://clinicaltrials.gov/show/NCT04366297
1409,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,False,Not Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,26,https://clinicaltrials.gov/show/NCT04366323
1410,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,40,https://clinicaltrials.gov/show/NCT04366739
1411,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,120,https://clinicaltrials.gov/show/NCT04366817
1412,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-06-26,False,Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),500,https://clinicaltrials.gov/show/NCT04366856
1413,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,45,https://clinicaltrials.gov/show/NCT04366882
1414,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,60,https://clinicaltrials.gov/show/NCT04366947
1415,NCT04367168,ClinicalTrials.gov,2020-04-24,2020-05-27,False,Recruiting,Phase 2,Interventional,Mexico,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,174,https://clinicaltrials.gov/show/NCT04367168
1416,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,True,Not Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,130,https://clinicaltrials.gov/show/NCT04367545
1417,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,99,https://clinicaltrials.gov/show/NCT04367662
1418,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,False,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04367831
1419,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",400,https://clinicaltrials.gov/show/NCT04368013
1420,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,40,https://clinicaltrials.gov/show/NCT04368260
1421,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Recruiting,Not Applicable,Interventional,Hong Kong,Telemedicine for Follow-up of Systemic Lupus Erythematosus,150,https://clinicaltrials.gov/show/NCT04368299
1422,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,5,https://clinicaltrials.gov/show/NCT04368377
1423,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,60,https://clinicaltrials.gov/show/NCT04368923
1424,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Australia, United States",Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,1419,https://clinicaltrials.gov/show/NCT04368988
1425,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",200,https://clinicaltrials.gov/show/NCT04369365
1426,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-08-19,False,Recruiting,Not Applicable,Interventional,United States,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04369378
1427,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,115,https://clinicaltrials.gov/show/NCT04369456
1428,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-08-10,False,Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",1000,https://clinicaltrials.gov/show/NCT04369794
1429,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),100,https://clinicaltrials.gov/show/NCT04369820
1430,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,374,https://clinicaltrials.gov/show/NCT04370015
1431,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,False,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,208,https://clinicaltrials.gov/show/NCT04370223
1432,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,True,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04370288
1433,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,456517,https://clinicaltrials.gov/show/NCT04370886
1434,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,250,https://clinicaltrials.gov/show/NCT04370938
1435,NCT04371107,ClinicalTrials.gov,2020-04-27,2020-04-29,False,Not Recruiting,Phase 3,Interventional,France,Proactive Care of Ambulatory COVID19 Patients,64,https://clinicaltrials.gov/show/NCT04371107
1436,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-04-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04371406
1437,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,15475,https://clinicaltrials.gov/show/NCT04371419
1438,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,115,https://clinicaltrials.gov/show/NCT04371510
1439,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,1100,https://clinicaltrials.gov/show/NCT04371523
1440,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,60,https://clinicaltrials.gov/show/NCT04371601
1441,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,False,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,56,https://clinicaltrials.gov/show/NCT04371822
1442,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,0,https://clinicaltrials.gov/show/NCT04371926
1443,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),330,https://clinicaltrials.gov/show/NCT04371952
1444,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-09-01,False,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",24,https://clinicaltrials.gov/show/NCT04371965
1445,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-08,False,Recruiting,Phase 1,Interventional,United States,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),100,https://clinicaltrials.gov/show/NCT04372004
1446,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,False,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,1,https://clinicaltrials.gov/show/NCT04372017
1447,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,10000,https://clinicaltrials.gov/show/NCT04372030
1448,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-09-01,False,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,180,https://clinicaltrials.gov/show/NCT04372693
1449,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-09-14,False,Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,80,https://clinicaltrials.gov/show/NCT04372979
1450,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,False,Not Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",2500,https://clinicaltrials.gov/show/NCT04373135
1451,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,209,https://clinicaltrials.gov/show/NCT04373161
1452,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-07-27,False,Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,882,https://clinicaltrials.gov/show/NCT04373382
1453,NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,False,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,602,https://clinicaltrials.gov/show/NCT04373707
1454,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,50,https://clinicaltrials.gov/show/NCT04373824
1455,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,240,https://clinicaltrials.gov/show/NCT04374019
1456,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,120,https://clinicaltrials.gov/show/NCT04374032
1457,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,False,Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04374084
1458,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Not Recruiting,Phase 2,Interventional,India,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,100,https://clinicaltrials.gov/show/NCT04374487
1459,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,116,https://clinicaltrials.gov/show/NCT04374539
1460,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,0,https://clinicaltrials.gov/show/NCT04374552
1461,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,29,https://clinicaltrials.gov/show/NCT04374565
1462,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,Egypt,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,180,https://clinicaltrials.gov/show/NCT04374591
1463,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,328,https://clinicaltrials.gov/show/NCT04374786
1464,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,58,https://clinicaltrials.gov/show/NCT04374903
1465,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Not Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,58,https://clinicaltrials.gov/show/NCT04375098
1466,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,20,https://clinicaltrials.gov/show/NCT04375124
1467,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,True,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,308,https://clinicaltrials.gov/show/NCT04375202
1468,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,20,https://clinicaltrials.gov/show/NCT04375735
1469,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),10,https://clinicaltrials.gov/show/NCT04375774
1470,NCT04376034,ClinicalTrials.gov,2020-04-19,2020-04-16,True,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,240,https://clinicaltrials.gov/show/NCT04376034
1471,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,450,https://clinicaltrials.gov/show/NCT04376476
1472,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,15,https://clinicaltrials.gov/show/NCT04376788
1473,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,40,https://clinicaltrials.gov/show/NCT04376814
1474,NCT04376840,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Recruiting,Not Applicable,Interventional,France,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,270,https://clinicaltrials.gov/show/NCT04376840
1475,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,2000,https://clinicaltrials.gov/show/NCT04377308
1476,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),30,https://clinicaltrials.gov/show/NCT04377477
1477,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04377503
1478,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,660,https://clinicaltrials.gov/show/NCT04377646
1479,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,9,https://clinicaltrials.gov/show/NCT04377659
1480,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,0,https://clinicaltrials.gov/show/NCT04377737
1481,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,500,https://clinicaltrials.gov/show/NCT04377750
1482,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,400,https://clinicaltrials.gov/show/NCT04377802
1483,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04377997
1484,NCT04378244,ClinicalTrials.gov,2020-05-04,2021-01-12,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,18,https://clinicaltrials.gov/show/NCT04378244
1485,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04378257
1486,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),90,https://clinicaltrials.gov/show/NCT04378712
1487,NCT04378738,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Recruiting,Not Applicable,Interventional,Turkey,Social Media and Covid19 Pandemic,212,https://clinicaltrials.gov/show/NCT04378738
1488,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,False,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,53,https://clinicaltrials.gov/show/NCT04378803
1489,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04379336
1490,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-07-27,False,Not Recruiting,Not Applicable,Interventional,United States,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,45,https://clinicaltrials.gov/show/NCT04379375
1491,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,10,https://clinicaltrials.gov/show/NCT04379453
1492,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),562,https://clinicaltrials.gov/show/NCT04379479
1493,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,0,https://clinicaltrials.gov/show/NCT04379492
1494,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,True,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,230,https://clinicaltrials.gov/show/NCT04379531
1495,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,60,https://clinicaltrials.gov/show/NCT04380376
1496,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),372,https://clinicaltrials.gov/show/NCT04380519
1497,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Canada, Mongolia",Tableted COVID-19 Therapeutic Vaccine,20,https://clinicaltrials.gov/show/NCT04380532
1498,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,False,Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,106,https://clinicaltrials.gov/show/NCT04380818
1499,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-18,False,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,60,https://clinicaltrials.gov/show/NCT04380935
1500,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,170,https://clinicaltrials.gov/show/NCT04381000
1501,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04381052
1502,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,92,https://clinicaltrials.gov/show/NCT04381338
1503,NCT04381845,ClinicalTrials.gov,2020-05-06,2020-12-10,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Immunity and Infections in the Psychiatric Population,200,https://clinicaltrials.gov/show/NCT04381845
1504,NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,False,Not Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,196,https://clinicaltrials.gov/show/NCT04381858
1505,NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,110,https://clinicaltrials.gov/show/NCT04381871
1506,NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,False,Not Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,45,https://clinicaltrials.gov/show/NCT04381884
1507,NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,False,Not Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,46,https://clinicaltrials.gov/show/NCT04382066
1508,NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,True,Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,32,https://clinicaltrials.gov/show/NCT04382092
1509,NCT04382131,ClinicalTrials.gov,2020-05-08,2020-06-23,False,Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),405,https://clinicaltrials.gov/show/NCT04382131
1510,NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,False,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,40,https://clinicaltrials.gov/show/NCT04382547
1511,NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,True,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,80,https://clinicaltrials.gov/show/NCT04382729
1512,NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,40,https://clinicaltrials.gov/show/NCT04382768
1513,NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,333,https://clinicaltrials.gov/show/NCT04383535
1514,NCT04383548,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,100,https://clinicaltrials.gov/show/NCT04383548
1515,NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-22,False,Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),422,https://clinicaltrials.gov/show/NCT04383574
1516,NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Not Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,300,https://clinicaltrials.gov/show/NCT04383587
1517,NCT04383717,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Not Recruiting,Phase 3,Interventional,No Country Given,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,60,https://clinicaltrials.gov/show/NCT04383717
1518,NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,33,https://clinicaltrials.gov/show/NCT04384380
1519,NCT04384458,ClinicalTrials.gov,2020-05-08,2020-07-20,False,Recruiting,Not Applicable,Interventional,Brazil,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,400,https://clinicaltrials.gov/show/NCT04384458
1520,NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,False,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,50,https://clinicaltrials.gov/show/NCT04384497
1521,NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-20,False,Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,1120,https://clinicaltrials.gov/show/NCT04384549
1522,NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,True,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),100,https://clinicaltrials.gov/show/NCT04384588
1523,NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,False,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,40,https://clinicaltrials.gov/show/NCT04385017
1524,NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,400,https://clinicaltrials.gov/show/NCT04385043
1525,NCT04385108,ClinicalTrials.gov,2020-05-05,2020-03-04,True,Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,170,https://clinicaltrials.gov/show/NCT04385108
1526,NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,False,Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,60,https://clinicaltrials.gov/show/NCT04385186
1527,NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,False,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",30,https://clinicaltrials.gov/show/NCT04385576
1528,NCT04385810,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Not Recruiting,Not Applicable,Interventional,France,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,23,https://clinicaltrials.gov/show/NCT04385810
1529,NCT04386668,ClinicalTrials.gov,2020-05-12,2020-05-26,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,80,https://clinicaltrials.gov/show/NCT04386668
1530,NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,False,Not Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04386694
1531,NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,1500,https://clinicaltrials.gov/show/NCT04386850
1532,NCT04387253,ClinicalTrials.gov,2020-05-12,2020-05-23,False,Recruiting,Not Applicable,Interventional,France,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,80,https://clinicaltrials.gov/show/NCT04387253
1533,NCT04387292,ClinicalTrials.gov,2020-05-12,2020-09-07,False,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,100,https://clinicaltrials.gov/show/NCT04387292
1534,NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,59,https://clinicaltrials.gov/show/NCT04387409
1535,NCT04388410,ClinicalTrials.gov,2020-05-12,2020-08-25,False,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,410,https://clinicaltrials.gov/show/NCT04388410
1536,NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,True,Not Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,40,https://clinicaltrials.gov/show/NCT04389333
1537,NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,True,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",50,https://clinicaltrials.gov/show/NCT04389372
1538,NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),60,https://clinicaltrials.gov/show/NCT04389385
1539,NCT04389411,ClinicalTrials.gov,2020-05-13,2020-10-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,600,https://clinicaltrials.gov/show/NCT04389411
1540,NCT04389450,ClinicalTrials.gov,2020-05-14,2020-10-01,False,Recruiting,Phase 2,Interventional,"United States, Israel","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",140,https://clinicaltrials.gov/show/NCT04389450
1541,NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,160,https://clinicaltrials.gov/show/NCT04389580
1542,NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,200,https://clinicaltrials.gov/show/NCT04389801
1543,NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,True,Not Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,15,https://clinicaltrials.gov/show/NCT04389944
1544,NCT04390022,ClinicalTrials.gov,2020-05-07,2020-07-31,False,Not Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,24,https://clinicaltrials.gov/show/NCT04390022
1545,NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,116,https://clinicaltrials.gov/show/NCT04390061
1546,NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,False,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),10,https://clinicaltrials.gov/show/NCT04390178
1547,NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,5,https://clinicaltrials.gov/show/NCT04390412
1548,NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,False,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),1167,https://clinicaltrials.gov/show/NCT04390464
1549,NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,True,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,197,https://clinicaltrials.gov/show/NCT04390516
1550,NCT04390594,ClinicalTrials.gov,2020-05-14,2020-08-13,False,Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,186,https://clinicaltrials.gov/show/NCT04390594
1551,NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),231,https://clinicaltrials.gov/show/NCT04391101
1552,NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,True,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,108,https://clinicaltrials.gov/show/NCT04391127
1553,NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,False,Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,248,https://clinicaltrials.gov/show/NCT04391140
1554,NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Not Recruiting,Phase 2,Interventional,United States,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,10,https://clinicaltrials.gov/show/NCT04391712
1555,NCT04391829,ClinicalTrials.gov,2020-05-13,2020-08-31,False,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,20,https://clinicaltrials.gov/show/NCT04391829
1556,NCT04392115,ClinicalTrials.gov,2020-05-15,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The PREPARE for COVID Trial,372,https://clinicaltrials.gov/show/NCT04392115
1557,NCT04392128,ClinicalTrials.gov,2020-05-15,2020-09-02,False,Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),0,https://clinicaltrials.gov/show/NCT04392128
1558,NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Not Recruiting,Phase 1,Interventional,"United States, United Kingdom","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",130,https://clinicaltrials.gov/show/NCT04392219
1559,NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,True,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,100,https://clinicaltrials.gov/show/NCT04392232
1560,NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,True,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,500,https://clinicaltrials.gov/show/NCT04392323
1561,NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,True,Not Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,60,https://clinicaltrials.gov/show/NCT04392414
1562,NCT04392427,ClinicalTrials.gov,2020-05-12,2020-10-01,False,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04392427
1563,NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,True,Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,100,https://clinicaltrials.gov/show/NCT04392713
1564,NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,True,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,75,https://clinicaltrials.gov/show/NCT04392869
1565,NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,False,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,520,https://clinicaltrials.gov/show/NCT04392973
1566,NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Recruiting,Phase 2/Phase 3,Interventional,"United Kingdom, Belgium, Italy, Brazil, Mexico, Spain, France, Germany",ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,1034,https://clinicaltrials.gov/show/NCT04393038
1567,NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,False,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,126,https://clinicaltrials.gov/show/NCT04393051
1568,NCT04393077,ClinicalTrials.gov,2020-05-11,2020-05-10,True,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,80,https://clinicaltrials.gov/show/NCT04393077
1569,NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,False,Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,100,https://clinicaltrials.gov/show/NCT04393415
1570,NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,False,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,394,https://clinicaltrials.gov/show/NCT04393636
1571,NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Not Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,1,https://clinicaltrials.gov/show/NCT04393727
1572,NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,40,https://clinicaltrials.gov/show/NCT04393792
1573,NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Not Recruiting,Phase 3,Interventional,Spain,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,560,https://clinicaltrials.gov/show/NCT04393818
1574,NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,48,https://clinicaltrials.gov/show/NCT04393948
1575,NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,True,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,600,https://clinicaltrials.gov/show/NCT04393961
1576,NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,34,https://clinicaltrials.gov/show/NCT04394039
1577,NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,False,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,605,https://clinicaltrials.gov/show/NCT04394117
1578,NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,False,Recruiting,Not Applicable,Interventional,Spain,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,102,https://clinicaltrials.gov/show/NCT04394169
1579,NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,True,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,15,https://clinicaltrials.gov/show/NCT04394182
1580,NCT04394208,ClinicalTrials.gov,2020-05-15,2020-08-16,False,Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04394208
1581,NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,False,Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,204,https://clinicaltrials.gov/show/NCT04394416
1582,NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,True,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04394442
1583,NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-30,False,Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,236,https://clinicaltrials.gov/show/NCT04394455
1584,NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,False,Not Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,10,https://clinicaltrials.gov/show/NCT04394793
1585,NCT04395170,ClinicalTrials.gov,2020-05-15,2020-09-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,75,https://clinicaltrials.gov/show/NCT04395170
1586,NCT04395768,ClinicalTrials.gov,2020-05-18,2020-09-09,False,Recruiting,Phase 2,Interventional,Australia,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,200,https://clinicaltrials.gov/show/NCT04395768
1587,NCT04396067,ClinicalTrials.gov,2020-05-18,2020-10-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,360,https://clinicaltrials.gov/show/NCT04396067
1588,NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-26,False,Recruiting,Phase 2,Interventional,"Moldova, Republic of, South Africa, Belgium, Ukraine, United States, Brazil, Romania",Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),190,https://clinicaltrials.gov/show/NCT04396106
1589,NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,False,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,336,https://clinicaltrials.gov/show/NCT04397328
1590,NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,False,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),50,https://clinicaltrials.gov/show/NCT04397497
1591,NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,True,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,206,https://clinicaltrials.gov/show/NCT04397562
1592,NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,68,https://clinicaltrials.gov/show/NCT04397666
1593,NCT04397692,ClinicalTrials.gov,2020-05-19,2020-06-13,False,Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),20,https://clinicaltrials.gov/show/NCT04397692
1594,NCT04398147,ClinicalTrials.gov,2020-05-18,2020-08-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,696,https://clinicaltrials.gov/show/NCT04398147
1595,NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04398277
1596,NCT04398290,ClinicalTrials.gov,2020-05-20,2020-12-01,False,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,0,https://clinicaltrials.gov/show/NCT04398290
1597,NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,70,https://clinicaltrials.gov/show/NCT04398303
1598,NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,240,https://clinicaltrials.gov/show/NCT04399005
1599,NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),2000,https://clinicaltrials.gov/show/NCT04399109
1600,NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,False,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,20,https://clinicaltrials.gov/show/NCT04399317
1601,NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,100,https://clinicaltrials.gov/show/NCT04399681
1602,NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,True,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,30,https://clinicaltrials.gov/show/NCT04399746
1603,NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,False,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,13,https://clinicaltrials.gov/show/NCT04399798
1604,NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,False,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",842,https://clinicaltrials.gov/show/NCT04399967
1605,NCT04400019,ClinicalTrials.gov,2020-05-20,2020-09-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),1930,https://clinicaltrials.gov/show/NCT04400019
1606,NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-02,False,Recruiting,Phase 2,Interventional,Singapore,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,30,https://clinicaltrials.gov/show/NCT04400929
1607,NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-20,True,Recruiting,Not Applicable,Interventional,France,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,4000,https://clinicaltrials.gov/show/NCT04401046
1608,NCT04401527,ClinicalTrials.gov,2020-05-21,2020-07-22,False,Not Recruiting,Phase 2,Interventional,United States,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,0,https://clinicaltrials.gov/show/NCT04401527
1609,NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,250,https://clinicaltrials.gov/show/NCT04401644
1610,NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-28,False,Recruiting,Phase 1/Phase 2,Interventional,"United States, Brazil",A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,66,https://clinicaltrials.gov/show/NCT04402060
1611,NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,50,https://clinicaltrials.gov/show/NCT04402203
1612,NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,True,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),5,https://clinicaltrials.gov/show/NCT04402840
1613,NCT04402879,ClinicalTrials.gov,2020-05-22,2020-11-10,False,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,596,https://clinicaltrials.gov/show/NCT04402879
1614,NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,60,https://clinicaltrials.gov/show/NCT04402892
1615,NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,True,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,70,https://clinicaltrials.gov/show/NCT04403243
1616,NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",35,https://clinicaltrials.gov/show/NCT04403269
1617,NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,False,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,20,https://clinicaltrials.gov/show/NCT04403477
1618,NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04403646
1619,NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,True,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,129,https://clinicaltrials.gov/show/NCT04403685
1620,NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,200,https://clinicaltrials.gov/show/NCT04403906
1621,NCT04405271,ClinicalTrials.gov,2020-05-26,2020-07-31,False,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),1378,https://clinicaltrials.gov/show/NCT04405271
1622,NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,80,https://clinicaltrials.gov/show/NCT04405310
1623,NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",1210,https://clinicaltrials.gov/show/NCT04405492
1624,NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,True,Not Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,51,https://clinicaltrials.gov/show/NCT04405544
1625,NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,False,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",200,https://clinicaltrials.gov/show/NCT04405921
1626,NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,2000,https://clinicaltrials.gov/show/NCT04405934
1627,NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,True,Not Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,50,https://clinicaltrials.gov/show/NCT04405999
1628,NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,False,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04406181
1629,NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,True,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,50,https://clinicaltrials.gov/show/NCT04406493
1630,NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Not Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,10,https://clinicaltrials.gov/show/NCT04407208
1631,NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,100,https://clinicaltrials.gov/show/NCT04407390
1632,NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,2000,https://clinicaltrials.gov/show/NCT04408066
1633,NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,False,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,2000,https://clinicaltrials.gov/show/NCT04408131
1634,NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,True,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04408209
1635,NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,False,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,300,https://clinicaltrials.gov/show/NCT04408235
1636,NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,True,Not Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,325,https://clinicaltrials.gov/show/NCT04408456
1637,NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,55,https://clinicaltrials.gov/show/NCT04409522
1638,NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04409886
1639,NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,False,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,45,https://clinicaltrials.gov/show/NCT04410016
1640,NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,False,Not Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04410159
1641,NCT04410328,ClinicalTrials.gov,2020-05-28,2020-10-21,False,Recruiting,Phase 3,Interventional,United States,Aggrenox To Treat Acute Covid-19,132,https://clinicaltrials.gov/show/NCT04410328
1642,NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,False,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),506517,https://clinicaltrials.gov/show/NCT04410458
1643,NCT04410510,ClinicalTrials.gov,2020-05-27,2020-09-30,False,Recruiting,Phase 2/Phase 3,Interventional,Colombia,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,100,https://clinicaltrials.gov/show/NCT04410510
1644,NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-15,False,Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,25,https://clinicaltrials.gov/show/NCT04410536
1645,NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,True,Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,560,https://clinicaltrials.gov/show/NCT04410692
1646,NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,True,Not Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,24,https://clinicaltrials.gov/show/NCT04411628
1647,NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-04,False,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,100,https://clinicaltrials.gov/show/NCT04412018
1648,NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,True,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04412239
1649,NCT04412252,ClinicalTrials.gov,2020-05-30,2020-07-06,False,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,0,https://clinicaltrials.gov/show/NCT04412252
1650,NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-23,True,Not Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,241,https://clinicaltrials.gov/show/NCT04412343
1651,NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,100,https://clinicaltrials.gov/show/NCT04412486
1652,NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,True,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,942,https://clinicaltrials.gov/show/NCT04412538
1653,NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Recruiting,Phase 3,Interventional,United States,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,300,https://clinicaltrials.gov/show/NCT04412772
1654,NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,False,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,28,https://clinicaltrials.gov/show/NCT04413006
1655,NCT04413747,ClinicalTrials.gov,2020-05-29,2020-08-15,False,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID-19,1000,https://clinicaltrials.gov/show/NCT04413747
1656,NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,120,https://clinicaltrials.gov/show/NCT04413838
1657,NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,False,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",600,https://clinicaltrials.gov/show/NCT04413968
1658,NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,100,https://clinicaltrials.gov/show/NCT04414098
1659,NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,True,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,200,https://clinicaltrials.gov/show/NCT04414371
1660,NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,False,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,186,https://clinicaltrials.gov/show/NCT04415073
1661,NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,120,https://clinicaltrials.gov/show/NCT04415086
1662,NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,20,https://clinicaltrials.gov/show/NCT04415879
1663,NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04416113
1664,NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,True,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,10,https://clinicaltrials.gov/show/NCT04416139
1665,NCT04416334,ClinicalTrials.gov,2020-06-03,2020-08-19,False,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,954,https://clinicaltrials.gov/show/NCT04416334
1666,NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,True,Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,40,https://clinicaltrials.gov/show/NCT04416360
1667,NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,2014,https://clinicaltrials.gov/show/NCT04417335
1668,NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,84,https://clinicaltrials.gov/show/NCT04418128
1669,NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,False,Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,300,https://clinicaltrials.gov/show/NCT04418206
1670,NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-24,False,Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,1200,https://clinicaltrials.gov/show/NCT04418518
1671,NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,10,https://clinicaltrials.gov/show/NCT04418531
1672,NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,11120,https://clinicaltrials.gov/show/NCT04418947
1673,NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,300,https://clinicaltrials.gov/show/NCT04420260
1674,NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,True,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,120,https://clinicaltrials.gov/show/NCT04420299
1675,NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,False,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",800,https://clinicaltrials.gov/show/NCT04420338
1676,NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,41,https://clinicaltrials.gov/show/NCT04420390
1677,NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,True,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,21,https://clinicaltrials.gov/show/NCT04420806
1678,NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,False,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,500,https://clinicaltrials.gov/show/NCT04421391
1679,NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,150,https://clinicaltrials.gov/show/NCT04421534
1680,NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,True,Not Recruiting,Phase 3,Interventional,"Canada, United States",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),70,https://clinicaltrials.gov/show/NCT04421664
1681,NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,True,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,340,https://clinicaltrials.gov/show/NCT04422561
1682,NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,30,https://clinicaltrials.gov/show/NCT04422678
1683,NCT04422977,ClinicalTrials.gov,2020-06-05,2020-06-08,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Serological Study of the Exposure of Personnel to Sars-cov-2,900,https://clinicaltrials.gov/show/NCT04422977
1684,NCT04423042,ClinicalTrials.gov,2020-06-05,2020-07-30,False,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,30,https://clinicaltrials.gov/show/NCT04423042
1685,NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,True,Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04423289
1686,NCT04423861,ClinicalTrials.gov,2020-06-08,2020-12-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,380,https://clinicaltrials.gov/show/NCT04423861
1687,NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,True,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991
1688,NCT04424056,ClinicalTrials.gov,2020-06-08,2020-09-01,False,Not Recruiting,Phase 3,Interventional,France,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",216,https://clinicaltrials.gov/show/NCT04424056
1689,NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,True,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,80,https://clinicaltrials.gov/show/NCT04424134
1690,NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-24,False,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04425317
1691,NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Not Recruiting,Phase 3,Interventional,"China, Germany, Romania","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",256,https://clinicaltrials.gov/show/NCT04425460
1692,NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,60,https://clinicaltrials.gov/show/NCT04425499
1693,NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,False,Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,100,https://clinicaltrials.gov/show/NCT04425707
1694,NCT04425720,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,300,https://clinicaltrials.gov/show/NCT04425720
1695,NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,False,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),0,https://clinicaltrials.gov/show/NCT04425733
1696,NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),342,https://clinicaltrials.gov/show/NCT04425772
1697,NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,236,https://clinicaltrials.gov/show/NCT04425837
1698,NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut BergoniÃ© in the Context of the COVID-19 Pandemic,550,https://clinicaltrials.gov/show/NCT04426006
1699,NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,True,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,3500,https://clinicaltrials.gov/show/NCT04426292
1700,NCT04426344,ClinicalTrials.gov,2020-06-03,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04426344
1701,NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,True,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,300,https://clinicaltrials.gov/show/NCT04427098
1702,NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,True,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04427137
1703,NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,20,https://clinicaltrials.gov/show/NCT04427631
1704,NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,200,https://clinicaltrials.gov/show/NCT04427865
1705,NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,5,https://clinicaltrials.gov/show/NCT04427878
1706,NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,32,https://clinicaltrials.gov/show/NCT04428073
1707,NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,True,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,186,https://clinicaltrials.gov/show/NCT04428099
1708,NCT04429334,ClinicalTrials.gov,2020-05-29,2020-08-01,False,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",60,https://clinicaltrials.gov/show/NCT04429334
1709,NCT04429594,ClinicalTrials.gov,2020-06-10,2020-07-28,False,Recruiting,Not Applicable,Interventional,France,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),1000,https://clinicaltrials.gov/show/NCT04429594
1710,NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,True,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,100,https://clinicaltrials.gov/show/NCT04429711
1711,NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04429763
1712,NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,45,https://clinicaltrials.gov/show/NCT04429828
1713,NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,True,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,700,https://clinicaltrials.gov/show/NCT04429867
1714,NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,True,Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,72,https://clinicaltrials.gov/show/NCT04430608
1715,NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,False,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,403535,https://clinicaltrials.gov/show/NCT04431180
1716,NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,64,https://clinicaltrials.gov/show/NCT04431466
1717,NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,True,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04432051
1718,NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,False,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,36,https://clinicaltrials.gov/show/NCT04432103
1719,NCT04432766,ClinicalTrials.gov,2020-06-12,2020-10-20,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,174,https://clinicaltrials.gov/show/NCT04432766
1720,NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,False,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,160,https://clinicaltrials.gov/show/NCT04432805
1721,NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,True,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04432987
1722,NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,300,https://clinicaltrials.gov/show/NCT04433013
1723,NCT04433988,ClinicalTrials.gov,2020-06-13,2020-12-13,False,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,200,https://clinicaltrials.gov/show/NCT04433988
1724,NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,True,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,30,https://clinicaltrials.gov/show/NCT04434131
1725,NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,True,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,330,https://clinicaltrials.gov/show/NCT04434248
1726,NCT04435015,ClinicalTrials.gov,2020-06-16,2021-02-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,200,https://clinicaltrials.gov/show/NCT04435015
1727,NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,200,https://clinicaltrials.gov/show/NCT04435314
1728,NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,True,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,200,https://clinicaltrials.gov/show/NCT04435353
1729,NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,True,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),78,https://clinicaltrials.gov/show/NCT04435717
1730,NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,1,https://clinicaltrials.gov/show/NCT04435808
1731,NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,False,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",38,https://clinicaltrials.gov/show/NCT04436471
1732,NCT04437693,ClinicalTrials.gov,2020-06-17,2020-08-31,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04437693
1733,NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-29,False,Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",100,https://clinicaltrials.gov/show/NCT04437719
1734,NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,True,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04437823
1735,NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,False,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",38,https://clinicaltrials.gov/show/NCT04437875
1736,NCT04438057,ClinicalTrials.gov,2020-06-17,2020-08-12,False,Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,150,https://clinicaltrials.gov/show/NCT04438057
1737,NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,True,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,400,https://clinicaltrials.gov/show/NCT04438070
1738,NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,67,https://clinicaltrials.gov/show/NCT04438694
1739,NCT04438837,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,582,https://clinicaltrials.gov/show/NCT04438837
1740,NCT04439006,ClinicalTrials.gov,2020-06-17,2020-07-22,False,Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,72,https://clinicaltrials.gov/show/NCT04439006
1741,NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,False,Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,200,https://clinicaltrials.gov/show/NCT04441385
1742,NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04441398
1743,NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,True,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,49,https://clinicaltrials.gov/show/NCT04441424
1744,NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,24,https://clinicaltrials.gov/show/NCT04441632
1745,NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,True,Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",1800,https://clinicaltrials.gov/show/NCT04441684
1746,NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,True,Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",40,https://clinicaltrials.gov/show/NCT04441918
1747,NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,True,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,1000,https://clinicaltrials.gov/show/NCT04442152
1748,NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,True,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,50,https://clinicaltrials.gov/show/NCT04442191
1749,NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,True,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,60,https://clinicaltrials.gov/show/NCT04442958
1750,NCT04443270,ClinicalTrials.gov,2020-06-17,2020-07-27,False,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04443270
1751,NCT04443673,ClinicalTrials.gov,2020-06-18,2020-08-20,False,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,82,https://clinicaltrials.gov/show/NCT04443673
1752,NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04443725
1753,NCT04443868,ClinicalTrials.gov,2020-06-20,2021-01-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04443868
1754,NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,True,Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,20,https://clinicaltrials.gov/show/NCT04444271
1755,NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,True,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04444596
1756,NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-24,False,Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,2130,https://clinicaltrials.gov/show/NCT04444674
1757,NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,True,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,40,https://clinicaltrials.gov/show/NCT04445246
1758,NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,True,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04445311
1759,NCT04445324,ClinicalTrials.gov,2020-06-22,2020-08-25,False,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,30,https://clinicaltrials.gov/show/NCT04445324
1760,NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,10,https://clinicaltrials.gov/show/NCT04445337
1761,NCT04445376,ClinicalTrials.gov,2020-06-22,2020-07-03,False,Not Recruiting,Not Applicable,Interventional,Pakistan,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,20,https://clinicaltrials.gov/show/NCT04445376
1762,NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,True,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",210,https://clinicaltrials.gov/show/NCT04445389
1763,NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,True,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,20,https://clinicaltrials.gov/show/NCT04445454
1764,NCT04445467,ClinicalTrials.gov,2020-06-22,2020-08-01,False,Recruiting,Phase 2,Interventional,Australia,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,190,https://clinicaltrials.gov/show/NCT04445467
1765,NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,True,Recruiting,Not Applicable,Interventional,Belgium,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,90,https://clinicaltrials.gov/show/NCT04445597
1766,NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,False,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,128,https://clinicaltrials.gov/show/NCT04445623
1767,NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,False,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,100,https://clinicaltrials.gov/show/NCT04445935
1768,NCT04446065,ClinicalTrials.gov,2020-06-23,2020-09-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PrevifenonÂ® as Chemoprophylaxis of COVID-19 in Health Workers,524,https://clinicaltrials.gov/show/NCT04446065
1769,NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,False,Not Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,4257,https://clinicaltrials.gov/show/NCT04446104
1770,NCT04446377,ClinicalTrials.gov,2020-06-23,2020-07-15,False,Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,142,https://clinicaltrials.gov/show/NCT04446377
1771,NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-23,False,Recruiting,Phase 2,Interventional,Brazil,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,176,https://clinicaltrials.gov/show/NCT04447235
1772,NCT04447781,ClinicalTrials.gov,2020-06-16,2020-07-15,False,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",160,https://clinicaltrials.gov/show/NCT04447781
1773,NCT04448119,ClinicalTrials.gov,2020-06-24,2020-10-16,False,Recruiting,Phase 2,Interventional,Canada,Control of COVID-19 Outbreaks in Long Term Care,760,https://clinicaltrials.gov/show/NCT04448119
1774,NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-26,False,Not Recruiting,Not Applicable,Interventional,France,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),2006,https://clinicaltrials.gov/show/NCT04448769
1775,NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-18,False,Recruiting,Phase 1,Interventional,"Germany, Belgium","A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",284,https://clinicaltrials.gov/show/NCT04449276
1776,NCT04449718,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,Brazil,Vitamin D Supplementation in Patients With COVID-19,240,https://clinicaltrials.gov/show/NCT04449718
1777,NCT04449965,ClinicalTrials.gov,2020-06-24,2020-07-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Povidone-Iodine Rinses in the Management of COVID-19,81,https://clinicaltrials.gov/show/NCT04449965
1778,NCT04450004,ClinicalTrials.gov,2020-06-18,2020-07-10,False,Not Recruiting,Phase 1,Interventional,Canada,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",180,https://clinicaltrials.gov/show/NCT04450004
1779,NCT04451239,ClinicalTrials.gov,2020-06-28,2020-06-30,False,Not Recruiting,Not Applicable,Interventional,Kuwait,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,12,https://clinicaltrials.gov/show/NCT04451239
1780,NCT04451889,ClinicalTrials.gov,2020-06-29,2020-08-01,False,Recruiting,Not Applicable,Interventional,Russian Federation,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,15,https://clinicaltrials.gov/show/NCT04451889
1781,NCT04452474,ClinicalTrials.gov,2020-06-25,2020-06-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,376,https://clinicaltrials.gov/show/NCT04452474
1782,NCT04452565,ClinicalTrials.gov,2020-06-26,2020-10-15,False,Recruiting,Phase 2/Phase 3,Interventional,United States,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",525,https://clinicaltrials.gov/show/NCT04452565
1783,NCT04452643,ClinicalTrials.gov,2020-06-26,2020-10-01,False,Not Recruiting,Phase 3,Interventional,Mexico,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,0,https://clinicaltrials.gov/show/NCT04452643
1784,NCT04452773,ClinicalTrials.gov,2020-06-25,2020-07-14,False,Recruiting,Not Applicable,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Food Supplement ManremycÂ® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,315,https://clinicaltrials.gov/show/NCT04452773
1785,NCT04452799,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Hesperidin and Diosmin for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04452799
1786,NCT04452812,ClinicalTrials.gov,2020-06-29,2020-07-06,False,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,15,https://clinicaltrials.gov/show/NCT04452812
1787,NCT04453475,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Recruiting,Not Applicable,Interventional,Germany,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,1230,https://clinicaltrials.gov/show/NCT04453475
1788,NCT04453488,ClinicalTrials.gov,2020-06-30,2020-07-30,False,Not Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,315,https://clinicaltrials.gov/show/NCT04453488
1789,NCT04453514,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Recruiting,Not Applicable,Interventional,United States,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,200,https://clinicaltrials.gov/show/NCT04453514
1790,NCT04453553,ClinicalTrials.gov,2020-06-29,2020-07-02,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,CICERO- A Care Home Study of COVID-19,50,https://clinicaltrials.gov/show/NCT04453553
1791,NCT04454307,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,100,https://clinicaltrials.gov/show/NCT04454307
1792,NCT04454606,ClinicalTrials.gov,2020-06-26,2020-05-01,True,Not Recruiting,Not Applicable,Interventional,Thailand,The New Silicone N99 Half-Piece Respirator,43,https://clinicaltrials.gov/show/NCT04454606
1793,NCT04455243,ClinicalTrials.gov,2020-07-01,2020-08-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,1180,https://clinicaltrials.gov/show/NCT04455243
1794,NCT04455308,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Not Recruiting,Not Applicable,Interventional,France,COVID-19 and Chilblains,269,https://clinicaltrials.gov/show/NCT04455308
1795,NCT04455360,ClinicalTrials.gov,2020-06-26,2020-10-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,26,https://clinicaltrials.gov/show/NCT04455360
1796,NCT04456049,ClinicalTrials.gov,2020-07-01,2020-07-01,False,Not Recruiting,Phase 2,Interventional,Switzerland,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,90,https://clinicaltrials.gov/show/NCT04456049
1797,NCT04456361,ClinicalTrials.gov,2020-06-23,2020-04-16,True,Not Recruiting,Phase 1,Interventional,Mexico,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,9,https://clinicaltrials.gov/show/NCT04456361
1798,NCT04457349,ClinicalTrials.gov,2020-06-30,2020-07-25,False,Recruiting,Not Applicable,Interventional,Egypt,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,10,https://clinicaltrials.gov/show/NCT04457349
1799,NCT04457388,ClinicalTrials.gov,2020-06-30,2020-03-25,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Tele-Yoga Therapy for Chronic Pain,18,https://clinicaltrials.gov/show/NCT04457388
1800,NCT04457609,ClinicalTrials.gov,2020-05-27,2020-07-01,False,Recruiting,Phase 1,Interventional,Indonesia,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04457609
1801,NCT04457726,ClinicalTrials.gov,2020-07-02,2020-07-01,True,Recruiting,Phase 1/Phase 2,Interventional,Singapore,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,18,https://clinicaltrials.gov/show/NCT04457726
1802,NCT04458246,ClinicalTrials.gov,2020-07-01,2020-07-01,False,Recruiting,Not Applicable,Interventional,Brazil,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,140,https://clinicaltrials.gov/show/NCT04458246
1803,NCT04458948,ClinicalTrials.gov,2020-06-09,2020-03-24,True,Not Recruiting,Phase 2,Interventional,United States,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,10000,https://clinicaltrials.gov/show/NCT04458948
1804,NCT04459325,ClinicalTrials.gov,2020-07-03,2020-06-01,True,Not Recruiting,Phase 3,Interventional,Russian Federation,TigeraseÂ® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04459325
1805,NCT04459455,ClinicalTrials.gov,2020-06-29,2020-08-19,False,Not Recruiting,Not Applicable,Interventional,United States,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",500,https://clinicaltrials.gov/show/NCT04459455
1806,NCT04459520,ClinicalTrials.gov,2020-07-05,2020-07-23,False,Not Recruiting,Not Applicable,Interventional,United States,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,1400,https://clinicaltrials.gov/show/NCT04459520
1807,NCT04460105,ClinicalTrials.gov,2020-06-30,2020-10-31,False,Not Recruiting,Phase 1,Interventional,United States,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04460105
1808,NCT04460534,ClinicalTrials.gov,2020-07-02,2020-05-07,True,Recruiting,Not Applicable,Interventional,France,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),100,https://clinicaltrials.gov/show/NCT04460534
1809,NCT04460677,ClinicalTrials.gov,2020-07-06,2020-08-12,False,Recruiting,Not Applicable,Interventional,United States,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,80,https://clinicaltrials.gov/show/NCT04460677
1810,NCT04460690,ClinicalTrials.gov,2020-07-06,2020-07-13,False,Recruiting,Not Applicable,Interventional,United States,"Rapid, Onsite COVID-19 Detection",10000,https://clinicaltrials.gov/show/NCT04460690
1811,NCT04460703,ClinicalTrials.gov,2020-07-02,2020-07-03,False,Not Recruiting,Not Applicable,Interventional,United States,"COVID-19 Vaccine Messaging, Part 1",4000,https://clinicaltrials.gov/show/NCT04460703
1812,NCT04461340,ClinicalTrials.gov,2020-07-04,2020-08-15,False,Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Sirolimus in COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04461340
1813,NCT04461379,ClinicalTrials.gov,2020-07-02,2020-07-21,False,Not Recruiting,Phase 3,Interventional,Mexico,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",908,https://clinicaltrials.gov/show/NCT04461379
1814,NCT04461925,ClinicalTrials.gov,2020-07-01,2020-05-02,True,Recruiting,Phase 1/Phase 2,Interventional,Ukraine,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,30,https://clinicaltrials.gov/show/NCT04461925
1815,NCT04462848,ClinicalTrials.gov,2020-06-30,2020-08-01,False,Not Recruiting,Phase 1,Interventional,United States,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,30,https://clinicaltrials.gov/show/NCT04462848
1816,NCT04463264,ClinicalTrials.gov,2020-06-26,2020-06-26,False,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),135,https://clinicaltrials.gov/show/NCT04463264
1817,NCT04463420,ClinicalTrials.gov,2020-07-04,2020-08-15,False,Recruiting,Not Applicable,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,224,https://clinicaltrials.gov/show/NCT04463420
1818,NCT04463433,ClinicalTrials.gov,2020-04-12,2020-02-01,True,Recruiting,Not Applicable,Interventional,China,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,300,https://clinicaltrials.gov/show/NCT04463433
1819,NCT04463472,ClinicalTrials.gov,2020-07-08,2020-06-29,True,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0301-COVID19),30,https://clinicaltrials.gov/show/NCT04463472
1820,NCT04464460,ClinicalTrials.gov,2020-07-08,2020-09-25,False,Not Recruiting,Phase 1,Interventional,No Country Given,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",0,https://clinicaltrials.gov/show/NCT04464460
1821,NCT04464486,ClinicalTrials.gov,2020-06-26,2020-04-21,True,Recruiting,Not Applicable,Interventional,United States,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,300,https://clinicaltrials.gov/show/NCT04464486
1822,NCT04465695,ClinicalTrials.gov,2020-07-09,2020-07-14,False,Recruiting,Phase 2,Interventional,China,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,81,https://clinicaltrials.gov/show/NCT04465695
1823,NCT04466280,ClinicalTrials.gov,2020-07-09,2020-07-15,False,Recruiting,Not Applicable,Interventional,Iran,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",180,https://clinicaltrials.gov/show/NCT04466280
1824,NCT04466540,ClinicalTrials.gov,2020-07-03,2020-05-12,True,Recruiting,Phase 4,Interventional,Brazil,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),1300,https://clinicaltrials.gov/show/NCT04466540
1825,NCT04466605,ClinicalTrials.gov,2020-07-09,2020-03-30,True,Not Recruiting,Not Applicable,Interventional,India,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,64,https://clinicaltrials.gov/show/NCT04466605
1826,NCT04466657,ClinicalTrials.gov,2020-07-09,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,Nigeria,Antioxidant Therapy for COVID-19 Study,90,https://clinicaltrials.gov/show/NCT04466657
1827,NCT04467047,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,10,https://clinicaltrials.gov/show/NCT04467047
1828,NCT04467151,ClinicalTrials.gov,2020-07-09,2020-10-01,False,Not Recruiting,Phase 2,Interventional,United States,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",0,https://clinicaltrials.gov/show/NCT04467151
1829,NCT04467918,ClinicalTrials.gov,2020-07-03,2020-07-06,False,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,100,https://clinicaltrials.gov/show/NCT04467918
1830,NCT04468139,ClinicalTrials.gov,2020-07-05,2020-06-20,True,Recruiting,Phase 4,Interventional,Saudi Arabia,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",60,https://clinicaltrials.gov/show/NCT04468139
1831,NCT04468646,ClinicalTrials.gov,2020-07-07,2020-06-15,True,Recruiting,Phase 3,Interventional,Pakistan,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,100,https://clinicaltrials.gov/show/NCT04468646
1832,NCT04469621,ClinicalTrials.gov,2020-06-28,2020-07-17,False,Not Recruiting,Phase 1,Interventional,"Chile, Argentina, Russian Federation, Mexico, Brazil",A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,68,https://clinicaltrials.gov/show/NCT04469621
1833,NCT04470297,ClinicalTrials.gov,2020-07-12,2020-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,100,https://clinicaltrials.gov/show/NCT04470297
1834,NCT04470531,ClinicalTrials.gov,2020-07-11,2020-07-12,False,Recruiting,Phase 2,Interventional,Bangladesh,Role of Co-trimoxazole in Severe COVID-19 Patients,94,https://clinicaltrials.gov/show/NCT04470531
1835,NCT04470609,ClinicalTrials.gov,2020-07-13,2020-07-10,True,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ?60 Years,471,https://clinicaltrials.gov/show/NCT04470609
1836,NCT04470739,ClinicalTrials.gov,2020-07-12,2020-05-30,True,Recruiting,Not Applicable,Interventional,Turkey,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,20,https://clinicaltrials.gov/show/NCT04470739
1837,NCT04471831,ClinicalTrials.gov,2020-07-07,2020-07-13,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",30,https://clinicaltrials.gov/show/NCT04471831
1838,NCT04472494,ClinicalTrials.gov,2020-07-14,2020-08-24,False,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,129,https://clinicaltrials.gov/show/NCT04472494
1839,NCT04473053,ClinicalTrials.gov,2020-07-09,2020-07-03,True,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Rapid Experimental Medicine for COVID-19,60,https://clinicaltrials.gov/show/NCT04473053
1840,NCT04473170,ClinicalTrials.gov,2020-07-14,2020-04-04,True,Not Recruiting,Phase 1/Phase 2,Interventional,United Arab Emirates,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,146,https://clinicaltrials.gov/show/NCT04473170
1841,NCT04473248,ClinicalTrials.gov,2020-07-14,2020-06-28,True,Not Recruiting,Not Applicable,Interventional,Canada,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,27,https://clinicaltrials.gov/show/NCT04473248
1842,NCT04473599,ClinicalTrials.gov,2020-07-13,2020-04-17,True,Recruiting,Not Applicable,Interventional,United States,Stay Well at Home: a Text-messaging Study Social Distancing,200,https://clinicaltrials.gov/show/NCT04473599
1843,NCT04474080,ClinicalTrials.gov,2020-07-08,2021-01-15,False,Not Recruiting,Not Applicable,Interventional,Canada,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,1080,https://clinicaltrials.gov/show/NCT04474080
1844,NCT04474340,ClinicalTrials.gov,2020-07-15,2020-05-21,True,Recruiting,Phase 1,Interventional,Kuwait,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,300,https://clinicaltrials.gov/show/NCT04474340
1845,NCT04475081,ClinicalTrials.gov,2020-07-14,2020-08-17,False,Not Recruiting,Phase 3,Interventional,No Country Given,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,60,https://clinicaltrials.gov/show/NCT04475081
1846,NCT04475185,ClinicalTrials.gov,2020-07-15,2020-07-20,False,Recruiting,Not Applicable,Interventional,France,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,117,https://clinicaltrials.gov/show/NCT04475185
1847,NCT04475562,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19?,219,https://clinicaltrials.gov/show/NCT04475562
1848,NCT04475575,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19 Antibodies?,222,https://clinicaltrials.gov/show/NCT04475575
1849,NCT04475601,ClinicalTrials.gov,2020-06-08,2020-07-15,False,Recruiting,Phase 2,Interventional,Sweden,Enzalutamide Treatment in COVID-19,500,https://clinicaltrials.gov/show/NCT04475601
1850,NCT04476927,ClinicalTrials.gov,2020-06-16,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,300,https://clinicaltrials.gov/show/NCT04476927
1851,NCT04476940,ClinicalTrials.gov,2020-07-13,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Breastfeeding Guideline for African-Americans,200,https://clinicaltrials.gov/show/NCT04476940
1852,NCT04477083,ClinicalTrials.gov,2020-07-14,2020-07-15,False,Not Recruiting,Not Applicable,Interventional,Egypt,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",40,https://clinicaltrials.gov/show/NCT04477083
1853,NCT04477642,ClinicalTrials.gov,2020-04-22,2020-08-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Abatacept for Patients With COVID-19 and Respiratory Distress,0,https://clinicaltrials.gov/show/NCT04477642
1854,NCT04478071,ClinicalTrials.gov,2020-07-15,2020-08-22,False,Recruiting,Phase 2,Interventional,United States,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),300,https://clinicaltrials.gov/show/NCT04478071
1855,NCT04478539,ClinicalTrials.gov,2020-07-14,2020-06-01,True,Recruiting,Not Applicable,Interventional,North Macedonia,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,35,https://clinicaltrials.gov/show/NCT04478539
1856,NCT04479163,ClinicalTrials.gov,2020-06-29,2020-06-04,True,Not Recruiting,Not Applicable,Interventional,Argentina,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,165,https://clinicaltrials.gov/show/NCT04479163
1857,NCT04479202,ClinicalTrials.gov,2020-05-13,2020-02-08,True,Not Recruiting,Phase 4,Interventional,China,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,76,https://clinicaltrials.gov/show/NCT04479202
1858,NCT04479332,ClinicalTrials.gov,2020-07-16,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),334,https://clinicaltrials.gov/show/NCT04479332
1859,NCT04479358,ClinicalTrials.gov,2020-07-13,2020-09-10,False,Recruiting,Phase 2,Interventional,United States,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,332,https://clinicaltrials.gov/show/NCT04479358
1860,NCT04479540,ClinicalTrials.gov,2020-07-06,2020-05-26,True,Recruiting,Not Applicable,Interventional,France,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,120,https://clinicaltrials.gov/show/NCT04479540
1861,NCT04480333,ClinicalTrials.gov,2020-07-13,2020-09-15,False,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",45,https://clinicaltrials.gov/show/NCT04480333
1862,NCT04480593,ClinicalTrials.gov,2020-07-12,2020-06-02,True,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,120,https://clinicaltrials.gov/show/NCT04480593
1863,NCT04480606,ClinicalTrials.gov,2020-07-16,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,88,https://clinicaltrials.gov/show/NCT04480606
1864,NCT04480632,ClinicalTrials.gov,2020-07-17,2020-08-01,False,Not Recruiting,Phase 2,Interventional,Colombia,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,44,https://clinicaltrials.gov/show/NCT04480632
1865,NCT04481633,ClinicalTrials.gov,2020-07-21,2020-09-09,False,Recruiting,Not Applicable,Interventional,France,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,800,https://clinicaltrials.gov/show/NCT04481633
1866,NCT04482634,ClinicalTrials.gov,2020-07-21,2020-09-01,False,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation Versus Home Exercise Program in COVID-19,122,https://clinicaltrials.gov/show/NCT04482634
1867,NCT04482673,ClinicalTrials.gov,2020-07-01,2020-07-31,False,Recruiting,Phase 4,Interventional,United States,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04482673
1868,NCT04483752,ClinicalTrials.gov,2020-07-21,2020-06-08,True,Recruiting,Not Applicable,Interventional,France,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,100,https://clinicaltrials.gov/show/NCT04483752
1869,NCT04483830,ClinicalTrials.gov,2020-07-22,2020-06-05,True,Not Recruiting,Phase 2/Phase 3,Interventional,Mexico,Suloexide in the Treatment of Early Stages of COVID-19,243,https://clinicaltrials.gov/show/NCT04483830
1870,NCT04484207,ClinicalTrials.gov,2020-07-21,2020-07-06,True,Recruiting,Not Applicable,Interventional,United States,Addressing COVID-19 Mental Health Problems Among US Veterans,200,https://clinicaltrials.gov/show/NCT04484207
1871,NCT04484493,ClinicalTrials.gov,2020-07-22,2020-08-08,False,Not Recruiting,Phase 3,Interventional,Egypt,Corticosteroid Nasal Spray in COVID-19 Anosmia,100,https://clinicaltrials.gov/show/NCT04484493
1872,NCT04485169,ClinicalTrials.gov,2020-07-21,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Pakistan,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,280,https://clinicaltrials.gov/show/NCT04485169
1873,NCT04485429,ClinicalTrials.gov,2020-07-20,2020-07-20,False,Recruiting,Phase 3,Interventional,Brazil,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,268,https://clinicaltrials.gov/show/NCT04485429
1874,NCT04487171,ClinicalTrials.gov,2020-07-24,2020-07-21,True,Recruiting,Not Applicable,Interventional,France,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,248,https://clinicaltrials.gov/show/NCT04487171
1875,NCT04487444,ClinicalTrials.gov,2020-07-22,2020-09-10,False,Recruiting,Phase 2,Interventional,United States,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04487444
1876,NCT04487574,ClinicalTrials.gov,2020-07-22,2020-07-25,False,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,118,https://clinicaltrials.gov/show/NCT04487574
1877,NCT04487639,ClinicalTrials.gov,2020-07-21,2020-07-10,True,Recruiting,Not Applicable,Interventional,France,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,250,https://clinicaltrials.gov/show/NCT04487639
1878,NCT04487886,ClinicalTrials.gov,2020-07-23,2020-08-01,False,Not Recruiting,Phase 2,Interventional,United States,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),80,https://clinicaltrials.gov/show/NCT04487886
1879,NCT04487964,ClinicalTrials.gov,2020-07-24,2020-01-01,True,Recruiting,Not Applicable,Interventional,Egypt,Complementary Intervention for COVID-19,70,https://clinicaltrials.gov/show/NCT04487964
1880,NCT04488484,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Not Recruiting,Not Applicable,Interventional,France,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,450,https://clinicaltrials.gov/show/NCT04488484
1881,NCT04489628,ClinicalTrials.gov,2020-07-24,2020-08-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Tele-health Enabled Clinical Trial for COVID-19,110,https://clinicaltrials.gov/show/NCT04489628
1882,NCT04490278,ClinicalTrials.gov,2020-07-23,2020-09-29,False,Recruiting,Not Applicable,Interventional,United States,CoV-PICS: A Virtual Post-ICU Clinic,80,https://clinicaltrials.gov/show/NCT04490278
1883,NCT04490850,ClinicalTrials.gov,2020-07-28,2020-07-15,True,Recruiting,Not Applicable,Interventional,French Guiana,COVID-19 Seroprevalence Study in French Guiana,1500,https://clinicaltrials.gov/show/NCT04490850
1884,NCT04491240,ClinicalTrials.gov,2020-07-27,2020-07-20,True,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,30,https://clinicaltrials.gov/show/NCT04491240
1885,NCT04491994,ClinicalTrials.gov,2020-07-28,2020-04-10,True,Not Recruiting,Phase 3,Interventional,Pakistan,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,540,https://clinicaltrials.gov/show/NCT04491994
1886,NCT04492228,ClinicalTrials.gov,2020-07-25,2020-09-01,False,Recruiting,Not Applicable,Interventional,Italy,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,100,https://clinicaltrials.gov/show/NCT04492228
1887,NCT04492358,ClinicalTrials.gov,2020-07-28,2020-10-22,False,Recruiting,Phase 2/Phase 3,Interventional,Spain,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",144,https://clinicaltrials.gov/show/NCT04492358
1888,NCT04492501,ClinicalTrials.gov,2020-07-28,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Pakistan,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,600,https://clinicaltrials.gov/show/NCT04492501
1889,NCT04492514,ClinicalTrials.gov,2020-07-28,2020-05-20,True,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,60,https://clinicaltrials.gov/show/NCT04492514
1890,NCT04492891,ClinicalTrials.gov,2020-07-20,2020-11-23,False,Recruiting,Phase 2,Interventional,United States,Cyclosporine For The Treatment Of COVID-19(+),75,https://clinicaltrials.gov/show/NCT04492891
1891,NCT04493242,ClinicalTrials.gov,2020-07-29,2020-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Extracellular Vesicle Infusion Therapy for Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04493242
1892,NCT04493294,ClinicalTrials.gov,2020-07-29,2020-11-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,500,https://clinicaltrials.gov/show/NCT04493294
1893,NCT04493359,ClinicalTrials.gov,2020-07-29,2020-07-25,True,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,240,https://clinicaltrials.gov/show/NCT04493359
1894,NCT04494204,ClinicalTrials.gov,2020-07-28,2020-08-07,False,Recruiting,Phase 2/Phase 3,Interventional,India,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04494204
1895,NCT04494399,ClinicalTrials.gov,2020-07-28,2020-07-29,False,Recruiting,Phase 2,Interventional,Hong Kong,IFN Beta-1b and Ribavirin for Covid-19,96,https://clinicaltrials.gov/show/NCT04494399
1896,NCT04494724,ClinicalTrials.gov,2020-07-21,2020-07-13,True,Recruiting,Phase 2,Interventional,United States,Clazakizumab vs. Placebo - COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04494724
1897,NCT04494867,ClinicalTrials.gov,2020-07-29,2020-08-19,False,Recruiting,Not Applicable,Interventional,United States,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,20,https://clinicaltrials.gov/show/NCT04494867
1898,NCT04495543,ClinicalTrials.gov,2020-07-23,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,Canada,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',75,https://clinicaltrials.gov/show/NCT04495543
1899,NCT04495842,ClinicalTrials.gov,2020-07-30,2020-10-01,False,Recruiting,Not Applicable,Interventional,United States,The Effect of Aromatherapy on COVID-19-induced Anxiety,65,https://clinicaltrials.gov/show/NCT04495842
1900,NCT04497272,ClinicalTrials.gov,2020-08-03,2020-08-07,False,Recruiting,Not Applicable,Interventional,France,Assesment of the Metabolomic Signature in COVID-19 Patients,150,https://clinicaltrials.gov/show/NCT04497272
1901,NCT04497389,ClinicalTrials.gov,2020-06-09,2020-10-28,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04497389
1902,NCT04497415,ClinicalTrials.gov,2020-08-02,2020-10-21,False,Recruiting,Not Applicable,Interventional,United States,The COVID-19 and Healthcare Workers: An Active Intervention,1200,https://clinicaltrials.gov/show/NCT04497415
1903,NCT04497454,ClinicalTrials.gov,2020-07-31,2020-05-08,True,Recruiting,Not Applicable,Interventional,Brazil,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),128,https://clinicaltrials.gov/show/NCT04497454
1904,NCT04497519,ClinicalTrials.gov,2020-07-27,2020-09-15,False,Not Recruiting,Phase 1,Interventional,Netherlands,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,12,https://clinicaltrials.gov/show/NCT04497519
1905,NCT04497623,ClinicalTrials.gov,2020-07-27,2020-07-28,False,Not Recruiting,Not Applicable,Interventional,Colombia,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",5,https://clinicaltrials.gov/show/NCT04497623
1906,NCT04498936,ClinicalTrials.gov,2020-04-14,2020-07-15,False,Not Recruiting,Phase 4,Interventional,Egypt,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,240,https://clinicaltrials.gov/show/NCT04498936
1907,NCT04499313,ClinicalTrials.gov,2020-07-27,2020-08-02,False,Recruiting,Phase 3,Interventional,Bangladesh,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,60,https://clinicaltrials.gov/show/NCT04499313
1908,NCT04500067,ClinicalTrials.gov,2020-07-15,2020-05-07,True,Not Recruiting,Phase 3,Interventional,Ukraine,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",76,https://clinicaltrials.gov/show/NCT04500067
1909,NCT04500132,ClinicalTrials.gov,2020-08-04,2020-05-28,True,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,60,https://clinicaltrials.gov/show/NCT04500132
1910,NCT04500366,ClinicalTrials.gov,2020-07-31,2020-08-26,False,Recruiting,Not Applicable,Interventional,Canada,GERAS Frailty Rehabilitation at Home During COVID-19,70,https://clinicaltrials.gov/show/NCT04500366
1911,NCT04500418,ClinicalTrials.gov,2020-08-04,2020-08-25,False,Recruiting,Phase 2,Interventional,Germany,CharitÃ© Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,183,https://clinicaltrials.gov/show/NCT04500418
1912,NCT04501783,ClinicalTrials.gov,2020-08-05,2020-05-20,True,Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,168,https://clinicaltrials.gov/show/NCT04501783
1913,NCT04501965,ClinicalTrials.gov,2020-08-03,2020-06-01,True,Recruiting,Phase 2,Interventional,Guinea,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,231,https://clinicaltrials.gov/show/NCT04501965
1914,NCT04502056,ClinicalTrials.gov,2020-08-02,2020-07-31,True,Not Recruiting,Not Applicable,Interventional,United States,Covid-19 Messaging to Underserved Communities - 2nd Experiment,20000,https://clinicaltrials.gov/show/NCT04502056
1915,NCT04502069,ClinicalTrials.gov,2020-07-10,2020-08-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,0,https://clinicaltrials.gov/show/NCT04502069
1916,NCT04502342,ClinicalTrials.gov,2020-08-04,2020-06-01,True,Recruiting,Phase 2,Interventional,Guinea,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",30,https://clinicaltrials.gov/show/NCT04502342
1917,NCT04502472,ClinicalTrials.gov,2020-08-04,2020-06-06,True,Recruiting,Phase 2/Phase 3,Interventional,United States,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,200,https://clinicaltrials.gov/show/NCT04502472
1918,NCT04502667,ClinicalTrials.gov,2020-08-04,2020-07-15,True,Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,40,https://clinicaltrials.gov/show/NCT04502667
1919,NCT04504877,ClinicalTrials.gov,2020-08-04,2020-06-16,True,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,120,https://clinicaltrials.gov/show/NCT04504877
1920,NCT04505098,ClinicalTrials.gov,2020-08-05,2020-08-07,False,Recruiting,Phase 4,Interventional,United States,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,16500,https://clinicaltrials.gov/show/NCT04505098
1921,NCT04507867,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,240,https://clinicaltrials.gov/show/NCT04507867
1922,NCT04508439,ClinicalTrials.gov,2020-08-05,2020-06-20,True,Recruiting,Not Applicable,Interventional,Mexico,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,130,https://clinicaltrials.gov/show/NCT04508439
1923,NCT04508868,ClinicalTrials.gov,2020-08-10,2020-08-17,False,Recruiting,Not Applicable,Interventional,Sweden,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,154,https://clinicaltrials.gov/show/NCT04508868
1924,NCT04508985,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The McGill RAAS-COVID-19 Trial,40,https://clinicaltrials.gov/show/NCT04508985
1925,NCT04510233,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Ivermectin Nasal Spray for COVID19 Patients,60,https://clinicaltrials.gov/show/NCT04510233
1926,NCT04510402,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,50,https://clinicaltrials.gov/show/NCT04510402
1927,NCT04510493,ClinicalTrials.gov,2020-08-11,2020-10-23,False,Recruiting,Phase 3,Interventional,Switzerland,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,116,https://clinicaltrials.gov/show/NCT04510493
1928,NCT04510662,ClinicalTrials.gov,2020-08-11,2020-08-01,True,Recruiting,Phase 2,Interventional,Mexico,Telmisartan in Respiratory Failure Due to COVID-19,60,https://clinicaltrials.gov/show/NCT04510662
1929,NCT04512027,ClinicalTrials.gov,2020-08-11,2020-09-15,False,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,10,https://clinicaltrials.gov/show/NCT04512027
1930,NCT04513158,ClinicalTrials.gov,2020-08-06,2020-08-14,False,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,100,https://clinicaltrials.gov/show/NCT04513158
1931,NCT04513184,ClinicalTrials.gov,2020-08-12,2020-07-14,True,Recruiting,Phase 2,Interventional,Mexico,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04513184
1932,NCT04513314,ClinicalTrials.gov,2020-08-12,2021-11-01,False,Not Recruiting,Phase 4,Interventional,United States,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,20,https://clinicaltrials.gov/show/NCT04513314
1933,NCT04513470,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Not Recruiting,Phase 1,Interventional,Israel,Allocetra-OTS in COVID-19,5,https://clinicaltrials.gov/show/NCT04513470
1934,NCT04513990,ClinicalTrials.gov,2020-06-05,2020-04-09,True,Recruiting,Not Applicable,Interventional,United States,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),1500,https://clinicaltrials.gov/show/NCT04513990
1935,NCT04514302,ClinicalTrials.gov,2020-08-12,2020-10-20,False,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,51,https://clinicaltrials.gov/show/NCT04514302
1936,NCT04514627,ClinicalTrials.gov,2020-07-08,2020-07-13,False,Recruiting,Not Applicable,Interventional,United States,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,100,https://clinicaltrials.gov/show/NCT04514627
1937,NCT04514705,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Recruiting,Not Applicable,Interventional,Brazil,Characteristics in Post Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04514705
1938,NCT04516512,ClinicalTrials.gov,2020-08-17,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Assessment of SARS-CoV-2 Seroprevalence in Detention,2500,https://clinicaltrials.gov/show/NCT04516512
1939,NCT04516564,ClinicalTrials.gov,2020-08-13,2020-09-01,False,Recruiting,Phase 1,Interventional,New Zealand,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",32,https://clinicaltrials.gov/show/NCT04516564
1940,NCT04516811,ClinicalTrials.gov,2020-08-12,2020-09-21,False,Recruiting,Phase 3,Interventional,South Africa,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,600,https://clinicaltrials.gov/show/NCT04516811
1941,NCT04516837,ClinicalTrials.gov,2020-08-16,2020-08-31,False,Recruiting,Phase 2,Interventional,China,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),120,https://clinicaltrials.gov/show/NCT04516837
1942,NCT04516915,ClinicalTrials.gov,2020-08-10,2020-06-15,True,Recruiting,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in the Treatment of COVID-19,120,https://clinicaltrials.gov/show/NCT04516915
1943,NCT04516941,ClinicalTrials.gov,2020-08-05,2020-10-01,False,Not Recruiting,Phase 3,Interventional,Switzerland,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,420,https://clinicaltrials.gov/show/NCT04516941
1944,NCT04516954,ClinicalTrials.gov,2020-08-17,2020-08-01,True,Recruiting,Phase 1,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04516954
1945,NCT04517123,ClinicalTrials.gov,2020-08-14,2020-09-01,False,Recruiting,Not Applicable,Interventional,United States,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",100,https://clinicaltrials.gov/show/NCT04517123
1946,NCT04518514,ClinicalTrials.gov,2020-07-28,2020-04-20,True,Recruiting,Not Applicable,Interventional,Germany,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),100,https://clinicaltrials.gov/show/NCT04518514
1947,NCT04518969,ClinicalTrials.gov,2020-04-25,2020-05-03,False,Recruiting,Not Applicable,Interventional,Belgium,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,24,https://clinicaltrials.gov/show/NCT04518969
1948,NCT04519125,ClinicalTrials.gov,2020-08-18,2020-08-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,950,https://clinicaltrials.gov/show/NCT04519125
1949,NCT04519216,ClinicalTrials.gov,2020-08-12,2020-07-31,True,Recruiting,Not Applicable,Interventional,United States,Breastfeeding Education in the Time of COVID-19,39,https://clinicaltrials.gov/show/NCT04519216
1950,NCT04519320,ClinicalTrials.gov,2020-08-18,2020-05-18,True,Recruiting,Not Applicable,Interventional,France,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,140,https://clinicaltrials.gov/show/NCT04519320
1951,NCT04519385,ClinicalTrials.gov,2020-08-17,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,Egypt,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,69,https://clinicaltrials.gov/show/NCT04519385
1952,NCT04519424,ClinicalTrials.gov,2020-08-18,2020-09-01,False,Not Recruiting,Phase 2,Interventional,United States,CSL324 in COVID-19,0,https://clinicaltrials.gov/show/NCT04519424
1953,NCT04520620,ClinicalTrials.gov,2020-07-22,2020-05-02,True,Not Recruiting,Phase 4,Interventional,France,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,0,https://clinicaltrials.gov/show/NCT04520620
1954,NCT04521036,ClinicalTrials.gov,2020-08-18,2020-12-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients (CPCP),44,https://clinicaltrials.gov/show/NCT04521036
1955,NCT04521296,ClinicalTrials.gov,2020-07-07,2020-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,90,https://clinicaltrials.gov/show/NCT04521296
1956,NCT04521322,ClinicalTrials.gov,2020-08-19,2020-07-24,True,Recruiting,Phase 4,Interventional,Argentina,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,400,https://clinicaltrials.gov/show/NCT04521322
1957,NCT04521400,ClinicalTrials.gov,2020-08-18,2020-08-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",100,https://clinicaltrials.gov/show/NCT04521400
1958,NCT04522128,ClinicalTrials.gov,2020-05-12,2020-05-22,False,Recruiting,Not Applicable,Interventional,United Kingdom,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,969,https://clinicaltrials.gov/show/NCT04522128
1959,NCT04522466,ClinicalTrials.gov,2020-08-19,2020-04-03,True,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,7,https://clinicaltrials.gov/show/NCT04522466
1960,NCT04522817,ClinicalTrials.gov,2020-08-20,2020-10-05,False,Recruiting,Phase 1,Interventional,United States,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,12,https://clinicaltrials.gov/show/NCT04522817
1961,NCT04523831,ClinicalTrials.gov,2020-08-19,2020-06-01,True,Not Recruiting,Phase 3,Interventional,Bangladesh,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,400,https://clinicaltrials.gov/show/NCT04523831
1962,NCT04524052,ClinicalTrials.gov,2020-08-19,2020-08-01,True,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",32,https://clinicaltrials.gov/show/NCT04524052
1963,NCT04524156,ClinicalTrials.gov,2020-04-30,2020-10-04,False,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,100,https://clinicaltrials.gov/show/NCT04524156
1964,NCT04525378,ClinicalTrials.gov,2020-07-31,2020-07-01,True,Recruiting,Phase 1,Interventional,Brazil,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,20,https://clinicaltrials.gov/show/NCT04525378
1965,NCT04525742,ClinicalTrials.gov,2020-06-28,2020-07-05,False,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 Pandemic and Parents of Disabled Children,309,https://clinicaltrials.gov/show/NCT04525742
1966,NCT04526054,ClinicalTrials.gov,2020-08-03,2020-09-03,False,Recruiting,Not Applicable,Interventional,France,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04526054
1967,NCT04526821,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Not Recruiting,Phase 2,Interventional,Peru,Lactoferrin for Prevention of COVID-19 in Health Care Workers,336,https://clinicaltrials.gov/show/NCT04526821
1968,NCT04527133,ClinicalTrials.gov,2020-08-24,2020-06-11,True,Not Recruiting,Not Applicable,Interventional,Russian Federation,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,30,https://clinicaltrials.gov/show/NCT04527133
1969,NCT04527198,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,France,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,40,https://clinicaltrials.gov/show/NCT04527198
1970,NCT04527211,ClinicalTrials.gov,2020-08-24,2020-09-07,False,Not Recruiting,Phase 3,Interventional,Colombia,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,550,https://clinicaltrials.gov/show/NCT04527211
1971,NCT04527614,ClinicalTrials.gov,2020-08-18,2020-09-24,False,Recruiting,Not Applicable,Interventional,Belgium,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,2000,https://clinicaltrials.gov/show/NCT04527614
1972,NCT04528771,ClinicalTrials.gov,2020-08-25,2020-10-31,False,Not Recruiting,Phase 1,Interventional,United States,S-Nitrosylation Therapy of COVID-19,21,https://clinicaltrials.gov/show/NCT04528771
1973,NCT04528927,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Not Recruiting,Phase 3,Interventional,Tunisia,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",0,https://clinicaltrials.gov/show/NCT04528927
1974,NCT04530370,ClinicalTrials.gov,2020-08-26,2020-05-29,True,Recruiting,Phase 1,Interventional,Egypt,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,30,https://clinicaltrials.gov/show/NCT04530370
1975,NCT04530422,ClinicalTrials.gov,2020-08-26,2020-04-15,True,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,250,https://clinicaltrials.gov/show/NCT04530422
1976,NCT04530578,ClinicalTrials.gov,2020-08-17,2020-06-01,True,Recruiting,Phase 4,Interventional,Argentina,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,200,https://clinicaltrials.gov/show/NCT04530578
1977,NCT04530604,ClinicalTrials.gov,2020-08-25,2020-10-01,False,Recruiting,Phase 1,Interventional,United States,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),12,https://clinicaltrials.gov/show/NCT04530604
1978,NCT04531618,ClinicalTrials.gov,2020-08-19,2020-08-13,True,Recruiting,Not Applicable,Interventional,United States,Mother-infant Bonding During COVID-19,280,https://clinicaltrials.gov/show/NCT04531618
1979,NCT04531774,ClinicalTrials.gov,2020-08-26,2020-08-28,False,Recruiting,Not Applicable,Interventional,Switzerland,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,160,https://clinicaltrials.gov/show/NCT04531774
1980,NCT04532554,ClinicalTrials.gov,2020-08-24,2020-10-26,False,Not Recruiting,Phase 4,Interventional,Egypt,Growth Hormone in Obese Cases With Covid-19,0,https://clinicaltrials.gov/show/NCT04532554
1981,NCT04532931,ClinicalTrials.gov,2020-08-26,2020-09-03,False,Recruiting,Phase 2,Interventional,South Africa,COVID-19 Treatment in South Africa,250,https://clinicaltrials.gov/show/NCT04532931
1982,NCT04533399,ClinicalTrials.gov,2020-08-28,2020-08-17,True,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,4400,https://clinicaltrials.gov/show/NCT04533399
1983,NCT04534478,ClinicalTrials.gov,2020-08-31,2020-09-07,False,Not Recruiting,Phase 4,Interventional,No Country Given,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,120,https://clinicaltrials.gov/show/NCT04534478
1984,NCT04534673,ClinicalTrials.gov,2020-04-20,2020-08-05,False,Recruiting,Phase 2,Interventional,Israel,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04534673
1985,NCT04534725,ClinicalTrials.gov,2020-08-30,2020-11-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,2282,https://clinicaltrials.gov/show/NCT04534725
1986,NCT04535063,ClinicalTrials.gov,2020-08-29,2020-04-18,True,Recruiting,Phase 3,Interventional,Argentina,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04535063
1987,NCT04535700,ClinicalTrials.gov,2020-08-27,2020-09-18,False,Recruiting,Phase 4,Interventional,Spain,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,76,https://clinicaltrials.gov/show/NCT04535700
1988,NCT04535791,ClinicalTrials.gov,2020-07-30,2020-07-15,True,Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,400,https://clinicaltrials.gov/show/NCT04535791
1989,NCT04536051,ClinicalTrials.gov,2020-09-01,2020-06-02,True,Recruiting,Phase 3,Interventional,Brazil,A Study of a Candidate COVID-19 Vaccine (COV003),10300,https://clinicaltrials.gov/show/NCT04536051
1990,NCT04536090,ClinicalTrials.gov,2020-08-31,2020-11-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,150,https://clinicaltrials.gov/show/NCT04536090
1991,NCT04536363,ClinicalTrials.gov,2020-08-29,2020-10-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Cri Analog PG1 Effectiveness and Safety in Covid-19,284,https://clinicaltrials.gov/show/NCT04536363
1992,NCT04536441,ClinicalTrials.gov,2020-08-26,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Malaysia,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,161,https://clinicaltrials.gov/show/NCT04536441
1993,NCT04537130,ClinicalTrials.gov,2020-09-02,2020-12-01,False,Not Recruiting,Phase 1,Interventional,Spain,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,40,https://clinicaltrials.gov/show/NCT04537130
1994,NCT04537572,ClinicalTrials.gov,2020-09-01,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,300,https://clinicaltrials.gov/show/NCT04537572
1995,NCT04537585,ClinicalTrials.gov,2020-08-29,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,Democratic Republic of Congo,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",2000,https://clinicaltrials.gov/show/NCT04537585
1996,NCT04537858,ClinicalTrials.gov,2020-08-29,2020-06-18,True,Not Recruiting,Not Applicable,Interventional,Brazil,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,50,https://clinicaltrials.gov/show/NCT04537858
1997,NCT04540185,ClinicalTrials.gov,2020-09-04,2020-11-01,False,Recruiting,Phase 3,Interventional,"New Zealand, United States",A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,3600,https://clinicaltrials.gov/show/NCT04540185
1998,NCT04540926,ClinicalTrials.gov,2020-09-02,2020-09-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04540926
1999,NCT04540939,ClinicalTrials.gov,2020-09-04,2020-10-19,False,Recruiting,Not Applicable,Interventional,United States,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,60,https://clinicaltrials.gov/show/NCT04540939
2000,NCT04541485,ClinicalTrials.gov,2020-09-07,2020-10-06,False,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",40,https://clinicaltrials.gov/show/NCT04541485
2001,NCT04542122,ClinicalTrials.gov,2020-08-31,2020-09-03,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04542122
2002,NCT04542330,ClinicalTrials.gov,2020-09-07,2020-09-15,False,Recruiting,Phase 3,Interventional,Denmark,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,1900,https://clinicaltrials.gov/show/NCT04542330
2003,NCT04542408,ClinicalTrials.gov,2020-09-06,2020-11-12,False,Recruiting,Phase 3,Interventional,Germany,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,172,https://clinicaltrials.gov/show/NCT04542408
2004,NCT04542421,ClinicalTrials.gov,2020-09-04,2020-07-01,True,Recruiting,Not Applicable,Interventional,United States,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,90,https://clinicaltrials.gov/show/NCT04542421
2005,NCT04542447,ClinicalTrials.gov,2020-09-06,2020-09-01,True,Recruiting,Phase 1,Interventional,India,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,10,https://clinicaltrials.gov/show/NCT04542447
2006,NCT04542694,ClinicalTrials.gov,2020-09-04,2020-05-21,True,Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04542694
2007,NCT04542876,ClinicalTrials.gov,2020-09-08,2020-05-01,True,Not Recruiting,Not Applicable,Interventional,India,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,46,https://clinicaltrials.gov/show/NCT04542876
2008,NCT04543006,ClinicalTrials.gov,2020-09-08,2020-09-08,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,170,https://clinicaltrials.gov/show/NCT04543006
2009,NCT04546737,ClinicalTrials.gov,2020-09-10,2020-09-08,True,Recruiting,Not Applicable,Interventional,France,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",20,https://clinicaltrials.gov/show/NCT04546737
2010,NCT04546841,ClinicalTrials.gov,2020-08-26,2020-11-27,False,Recruiting,Phase 1,Interventional,Germany,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,36,https://clinicaltrials.gov/show/NCT04546841
2011,NCT04547283,ClinicalTrials.gov,2020-09-09,2020-06-14,True,Recruiting,Not Applicable,Interventional,United States,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04547283
2012,NCT04547634,ClinicalTrials.gov,2020-08-17,2020-07-01,True,Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Oncology Patients,30,https://clinicaltrials.gov/show/NCT04547634
2013,NCT04548531,ClinicalTrials.gov,2020-09-09,2020-09-10,False,Recruiting,Not Applicable,Interventional,United States,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,800,https://clinicaltrials.gov/show/NCT04548531
2014,NCT04548544,ClinicalTrials.gov,2020-09-11,2019-10-18,True,Not Recruiting,Not Applicable,Interventional,United States,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,21,https://clinicaltrials.gov/show/NCT04548544
2015,NCT04548557,ClinicalTrials.gov,2020-09-07,2020-09-15,False,Not Recruiting,Phase 3,Interventional,Pakistan,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,60,https://clinicaltrials.gov/show/NCT04548557
2016,NCT04549337,ClinicalTrials.gov,2020-09-09,2020-09-25,False,Recruiting,Not Applicable,Interventional,Denmark,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,10,https://clinicaltrials.gov/show/NCT04549337
2017,NCT04549376,ClinicalTrials.gov,2020-09-11,2020-07-01,True,Recruiting,Phase 2,Interventional,Bangladesh,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,200,https://clinicaltrials.gov/show/NCT04549376
2018,NCT04551274,ClinicalTrials.gov,2020-09-01,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,Canada,Music Therapy in Frontline Healthcare Workers,20,https://clinicaltrials.gov/show/NCT04551274
2019,NCT04551755,ClinicalTrials.gov,2020-09-03,2020-09-01,True,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,188,https://clinicaltrials.gov/show/NCT04551755
2020,NCT04551781,ClinicalTrials.gov,2020-09-13,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Egypt,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,450,https://clinicaltrials.gov/show/NCT04551781
2021,NCT04552483,ClinicalTrials.gov,2020-09-09,2020-06-08,True,Not Recruiting,Phase 2,Interventional,Brazil,Effects of Early Use of Nitazoxanide in Patients With COVID-19,392,https://clinicaltrials.gov/show/NCT04552483
2022,NCT04552951,ClinicalTrials.gov,2020-05-21,2020-04-04,True,Recruiting,Phase 4,Interventional,Spain,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,80,https://clinicaltrials.gov/show/NCT04552951
2023,NCT04553705,ClinicalTrials.gov,2020-09-15,2020-09-20,False,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",200,https://clinicaltrials.gov/show/NCT04553705
2024,NCT04554264,ClinicalTrials.gov,2020-09-02,2020-09-01,True,Recruiting,Not Applicable,Interventional,France,Complicated Grief in ICU in the Aftermath of COVID-19,160,https://clinicaltrials.gov/show/NCT04554264
2025,NCT04554433,ClinicalTrials.gov,2020-09-17,2020-12-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,80,https://clinicaltrials.gov/show/NCT04554433
2026,NCT04554992,ClinicalTrials.gov,2020-08-26,2020-03-20,True,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),350,https://clinicaltrials.gov/show/NCT04554992
2027,NCT04555005,ClinicalTrials.gov,2020-06-11,2020-03-10,True,Not Recruiting,Not Applicable,Interventional,Spain,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,1000,https://clinicaltrials.gov/show/NCT04555005
2028,NCT04555148,ClinicalTrials.gov,2020-09-16,2020-09-20,False,Recruiting,Phase 2,Interventional,South Korea,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),60,https://clinicaltrials.gov/show/NCT04555148
2029,NCT04557605,ClinicalTrials.gov,2020-09-09,2020-09-14,False,Not Recruiting,Not Applicable,Interventional,Canada,Effects of a Face Mask on Oxygenation During Exercise,14,https://clinicaltrials.gov/show/NCT04557605
2030,NCT04558021,ClinicalTrials.gov,2020-09-18,2020-10-08,False,Recruiting,Phase 3,Interventional,Turkey,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,200,https://clinicaltrials.gov/show/NCT04558021
2031,NCT04558411,ClinicalTrials.gov,2020-09-20,2020-09-12,True,Recruiting,Not Applicable,Interventional,United States,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",150,https://clinicaltrials.gov/show/NCT04558411
2032,NCT04558424,ClinicalTrials.gov,2020-09-21,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,Bangladesh,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",50,https://clinicaltrials.gov/show/NCT04558424
2033,NCT04558450,ClinicalTrials.gov,2020-08-31,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,France,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),360,https://clinicaltrials.gov/show/NCT04558450
2034,NCT04558463,ClinicalTrials.gov,2020-09-03,2020-04-16,True,Recruiting,Phase 3,Interventional,Indonesia,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04558463
2035,NCT04559035,ClinicalTrials.gov,2020-09-21,2020-09-24,False,Recruiting,Not Applicable,Interventional,United States,Nasal Irrigation to Reduce COVID-19 Morbidity,200,https://clinicaltrials.gov/show/NCT04559035
2036,NCT04559074,ClinicalTrials.gov,2020-08-26,2020-10-23,False,Recruiting,Phase 4,Interventional,United Kingdom,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04559074
2037,NCT04560231,ClinicalTrials.gov,2020-07-11,2020-06-01,True,Recruiting,Phase 1,Interventional,Pakistan,Remdesivir in COVID-19 Lahore General Hospital,30,https://clinicaltrials.gov/show/NCT04560231
2038,NCT04560881,ClinicalTrials.gov,2020-09-16,2020-09-16,False,Not Recruiting,Phase 3,Interventional,Argentina,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",3000,https://clinicaltrials.gov/show/NCT04560881
2039,NCT04561063,ClinicalTrials.gov,2020-09-21,2020-12-01,False,Not Recruiting,Phase 2,Interventional,South Africa,COVID-19 Prophylaxis South Africa (COVER HCW),1950,https://clinicaltrials.gov/show/NCT04561063
2040,NCT04561076,ClinicalTrials.gov,2020-09-07,2020-12-09,False,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,24,https://clinicaltrials.gov/show/NCT04561076
2041,NCT04561154,ClinicalTrials.gov,2020-09-09,2020-06-11,True,Recruiting,Not Applicable,Interventional,France,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,134,https://clinicaltrials.gov/show/NCT04561154
2042,NCT04561219,ClinicalTrials.gov,2020-09-22,2020-04-19,True,Not Recruiting,Phase 2,Interventional,Brazil,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,500,https://clinicaltrials.gov/show/NCT04561219
2043,NCT04563208,ClinicalTrials.gov,2020-09-21,2020-12-01,False,Not Recruiting,Phase 2,Interventional,South Africa,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,40,https://clinicaltrials.gov/show/NCT04563208
2044,NCT04563650,ClinicalTrials.gov,2020-09-18,2020-09-18,False,Recruiting,Not Applicable,Interventional,France,COVID-19 Serology and Immunosenescence,330,https://clinicaltrials.gov/show/NCT04563650
2045,NCT04563676,ClinicalTrials.gov,2020-09-23,2020-09-22,True,Recruiting,Not Applicable,Interventional,France,Physiopathology and Sequelae of COVID-19 Infection,400,https://clinicaltrials.gov/show/NCT04563676
2046,NCT04563689,ClinicalTrials.gov,2020-09-22,2020-06-18,True,Not Recruiting,Not Applicable,Interventional,Colombia,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,23,https://clinicaltrials.gov/show/NCT04563689
2047,NCT04564040,ClinicalTrials.gov,2020-08-27,2020-10-12,False,Recruiting,Phase 1,Interventional,Germany,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,40,https://clinicaltrials.gov/show/NCT04564040
2048,NCT04565509,ClinicalTrials.gov,2020-09-24,2020-11-20,False,Recruiting,Not Applicable,Interventional,United States,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,2500,https://clinicaltrials.gov/show/NCT04565509
2049,NCT04566276,ClinicalTrials.gov,2020-09-15,2021-01-01,False,Not Recruiting,Phase 1,Interventional,Thailand,ChulaCov19 mRNA Vaccine in Healthy Adults,96,https://clinicaltrials.gov/show/NCT04566276
2050,NCT04566770,ClinicalTrials.gov,2020-09-22,2020-09-24,False,Recruiting,Phase 2,Interventional,China,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),481,https://clinicaltrials.gov/show/NCT04566770
2051,NCT04567173,ClinicalTrials.gov,2020-09-24,2020-09-21,True,Recruiting,Phase 2/Phase 3,Interventional,Philippines,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,136,https://clinicaltrials.gov/show/NCT04567173
2052,NCT04567810,ClinicalTrials.gov,2020-09-18,2020-09-18,False,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",48,https://clinicaltrials.gov/show/NCT04567810
2053,NCT04567953,ClinicalTrials.gov,2020-09-25,2020-07-28,True,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Tests With Saliva Specimens,2000,https://clinicaltrials.gov/show/NCT04567953
2054,NCT04568096,ClinicalTrials.gov,2020-09-26,2020-11-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,160,https://clinicaltrials.gov/show/NCT04568096
2055,NCT04568356,ClinicalTrials.gov,2020-09-27,2020-04-24,True,Not Recruiting,Not Applicable,Interventional,United States,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,200,https://clinicaltrials.gov/show/NCT04568356
2056,NCT04568525,ClinicalTrials.gov,2020-09-23,2020-07-01,True,Not Recruiting,Not Applicable,Interventional,Kyrgyzstan,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,195,https://clinicaltrials.gov/show/NCT04568525
2057,NCT04568876,ClinicalTrials.gov,2020-09-24,2020-10-23,False,Recruiting,Phase 4,Interventional,Italy,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04568876
2058,NCT04569188,ClinicalTrials.gov,2020-09-04,2020-05-15,True,Not Recruiting,Phase 2,Interventional,Italy,Convalescent Plasma in COVID-19 Elderly Patients,21,https://clinicaltrials.gov/show/NCT04569188
2059,NCT04569266,ClinicalTrials.gov,2020-09-10,2020-08-07,True,Recruiting,Not Applicable,Interventional,France,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,200,https://clinicaltrials.gov/show/NCT04569266
2060,NCT04569383,ClinicalTrials.gov,2020-09-21,2020-10-05,False,Recruiting,Phase 1,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",30,https://clinicaltrials.gov/show/NCT04569383
2061,NCT04569825,ClinicalTrials.gov,2020-09-29,2020-08-01,True,Recruiting,Phase 1,Interventional,Iraq,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,250,https://clinicaltrials.gov/show/NCT04569825
2062,NCT04570449,ClinicalTrials.gov,2020-09-29,2020-09-01,True,Not Recruiting,Phase 1,Interventional,United States,Pilot Randomized Controlled Trial: Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),40,https://clinicaltrials.gov/show/NCT04570449
2063,NCT04570462,ClinicalTrials.gov,2020-07-21,2020-05-18,True,Recruiting,Not Applicable,Interventional,United States,Mild Hypothermia for COVID-19 ARDS,20,https://clinicaltrials.gov/show/NCT04570462
2064,NCT04572399,ClinicalTrials.gov,2020-09-28,2020-10-30,False,Recruiting,Not Applicable,Interventional,United States,UVA Light Device to Treat COVID-19,5,https://clinicaltrials.gov/show/NCT04572399
2065,NCT04573153,ClinicalTrials.gov,2020-09-30,2020-09-21,True,Recruiting,Phase 2/Phase 3,Interventional,Turkey,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,400,https://clinicaltrials.gov/show/NCT04573153
2066,NCT04573270,ClinicalTrials.gov,2020-09-23,2020-04-24,True,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stem Cells for the Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04573270
2067,NCT04573322,ClinicalTrials.gov,2020-09-29,2020-09-10,True,Recruiting,Phase 1/Phase 2,Interventional,Romania,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,224,https://clinicaltrials.gov/show/NCT04573322
2068,NCT04573361,ClinicalTrials.gov,2020-09-29,2020-05-02,True,Not Recruiting,Not Applicable,Interventional,Spain,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,723,https://clinicaltrials.gov/show/NCT04573361
2069,NCT04573855,ClinicalTrials.gov,2020-09-30,2020-12-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,41,https://clinicaltrials.gov/show/NCT04573855
2070,NCT04574050,ClinicalTrials.gov,2020-09-28,2020-12-03,False,Not Recruiting,Not Applicable,Interventional,No Country Given,SELF-BREATHE RCT for Chronic Breathlessness,40,https://clinicaltrials.gov/show/NCT04574050
2071,NCT04574869,ClinicalTrials.gov,2020-09-16,2020-10-01,False,Not Recruiting,Phase 1,Interventional,United States,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,42,https://clinicaltrials.gov/show/NCT04574869
2072,NCT04575558,ClinicalTrials.gov,2020-05-18,2020-06-30,False,Not Recruiting,Phase 2,Interventional,Brazil,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,0,https://clinicaltrials.gov/show/NCT04575558
2073,NCT04577235,ClinicalTrials.gov,2020-09-29,2020-06-05,True,Not Recruiting,Not Applicable,Interventional,Turkey,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,29,https://clinicaltrials.gov/show/NCT04577235
2074,NCT04577378,ClinicalTrials.gov,2020-04-13,2020-10-20,False,Not Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,45,https://clinicaltrials.gov/show/NCT04577378
2075,NCT04578210,ClinicalTrials.gov,2020-10-01,2020-09-04,True,Recruiting,Phase 1/Phase 2,Interventional,Spain,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,58,https://clinicaltrials.gov/show/NCT04578210
2076,NCT04578236,ClinicalTrials.gov,2020-10-04,2020-11-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",360,https://clinicaltrials.gov/show/NCT04578236
2077,NCT04579549,ClinicalTrials.gov,2020-10-06,2020-09-29,True,Recruiting,Not Applicable,Interventional,United States,Repeat Testing for SARS-CoV-2,10000,https://clinicaltrials.gov/show/NCT04579549
2078,NCT04581018,ClinicalTrials.gov,2020-08-11,2020-08-13,False,Recruiting,Not Applicable,Interventional,Hong Kong,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04581018
2079,NCT04581161,ClinicalTrials.gov,2020-08-19,2020-08-28,False,Recruiting,Not Applicable,Interventional,United States,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04581161
2080,NCT04581291,ClinicalTrials.gov,2020-10-04,2020-01-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,30,https://clinicaltrials.gov/show/NCT04581291
2081,NCT04582214,ClinicalTrials.gov,2020-10-06,2020-09-28,True,Recruiting,Not Applicable,Interventional,United States,Oscillation and Lung Expansion Therapy in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04582214
2082,NCT04582318,ClinicalTrials.gov,2020-10-07,2020-11-08,False,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",48,https://clinicaltrials.gov/show/NCT04582318
2083,NCT04583228,ClinicalTrials.gov,2020-09-25,2020-11-30,False,Not Recruiting,Phase 1,Interventional,No Country Given,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",40,https://clinicaltrials.gov/show/NCT04583228
2084,NCT04583449,ClinicalTrials.gov,2020-10-02,2020-08-19,True,Recruiting,Not Applicable,Interventional,United Kingdom,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,250,https://clinicaltrials.gov/show/NCT04583449
2085,NCT04584580,ClinicalTrials.gov,2020-10-06,2020-08-01,True,Recruiting,Phase 4,Interventional,Egypt,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04584580
2086,NCT04584593,ClinicalTrials.gov,2020-10-12,2020-10-02,True,Recruiting,Not Applicable,Interventional,France,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,50,https://clinicaltrials.gov/show/NCT04584593
2087,NCT04586153,ClinicalTrials.gov,2020-10-12,2020-12-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Assess the Effect of Meplazumab on COVID-19,456,https://clinicaltrials.gov/show/NCT04586153
2088,NCT04587414,ClinicalTrials.gov,2020-09-08,2019-03-06,True,Not Recruiting,Not Applicable,Interventional,Finland,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,122,https://clinicaltrials.gov/show/NCT04587414
2089,NCT04587921,ClinicalTrials.gov,2020-08-18,2020-06-22,True,Recruiting,Not Applicable,Interventional,Brazil,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,90,https://clinicaltrials.gov/show/NCT04587921
2090,NCT04589104,ClinicalTrials.gov,2020-10-12,2020-05-26,True,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience,63,https://clinicaltrials.gov/show/NCT04589104
2091,NCT04589117,ClinicalTrials.gov,2020-10-12,2020-05-27,True,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience for Parents,11,https://clinicaltrials.gov/show/NCT04589117
2092,NCT04589936,ClinicalTrials.gov,2020-10-06,2020-09-03,True,Recruiting,Not Applicable,Interventional,United Kingdom,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,56,https://clinicaltrials.gov/show/NCT04589936
2093,NCT04589949,ClinicalTrials.gov,2020-10-12,2020-10-12,False,Recruiting,Phase 3,Interventional,Netherlands,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),690,https://clinicaltrials.gov/show/NCT04589949
2094,NCT04590053,ClinicalTrials.gov,2020-10-15,2020-10-20,False,Recruiting,Phase 2,Interventional,Israel,"Allocetra-OTS in COVID-19, Phase II",24,https://clinicaltrials.gov/show/NCT04590053
2095,NCT04590209,ClinicalTrials.gov,2020-10-05,2020-10-01,True,Not Recruiting,Not Applicable,Interventional,France,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,25,https://clinicaltrials.gov/show/NCT04590209
2096,NCT04590261,ClinicalTrials.gov,2020-10-15,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Myeloid Cells in Patients With Covid-19 Pneumonia,120,https://clinicaltrials.gov/show/NCT04590261
2097,NCT04590274,ClinicalTrials.gov,2020-10-07,2020-11-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),5000,https://clinicaltrials.gov/show/NCT04590274
2098,NCT04591158,ClinicalTrials.gov,2020-09-15,2020-09-15,False,Recruiting,Not Applicable,Interventional,Canada,COVID-19 and Lung Ultrasound Utility,100,https://clinicaltrials.gov/show/NCT04591158
2099,NCT04591600,ClinicalTrials.gov,2020-10-15,2020-07-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iraq,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,140,https://clinicaltrials.gov/show/NCT04591600
2100,NCT04592354,ClinicalTrials.gov,2020-10-15,2020-10-15,False,Recruiting,Not Applicable,Interventional,United States,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,40,https://clinicaltrials.gov/show/NCT04592354
2101,NCT04592705,ClinicalTrials.gov,2020-10-07,2020-09-11,True,Recruiting,Phase 1,Interventional,United States,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,10,https://clinicaltrials.gov/show/NCT04592705
2102,NCT04592835,ClinicalTrials.gov,2020-10-07,2020-10-19,False,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",24,https://clinicaltrials.gov/show/NCT04592835
2103,NCT04593069,ClinicalTrials.gov,2020-10-12,2020-10-07,True,Recruiting,Not Applicable,Interventional,Belgium,The COGCOV Study in ICU Patients,60,https://clinicaltrials.gov/show/NCT04593069
2104,NCT04593641,ClinicalTrials.gov,2020-10-05,2020-09-04,True,Not Recruiting,Phase 1,Interventional,South Korea,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",18,https://clinicaltrials.gov/show/NCT04593641
2105,NCT04594330,ClinicalTrials.gov,2020-10-05,2020-06-01,True,Recruiting,Phase 2,Interventional,Indonesia,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04594330
2106,NCT04594460,ClinicalTrials.gov,2020-10-19,2020-10-31,False,Not Recruiting,Not Applicable,Interventional,China,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),198,https://clinicaltrials.gov/show/NCT04594460
2107,NCT04594668,ClinicalTrials.gov,2020-10-07,2020-04-24,True,Recruiting,Phase 2,Interventional,Denmark,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,46,https://clinicaltrials.gov/show/NCT04594668
2108,NCT04596085,ClinicalTrials.gov,2020-10-19,2020-09-16,True,Recruiting,Not Applicable,Interventional,India,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",124,https://clinicaltrials.gov/show/NCT04596085
2109,NCT04596657,ClinicalTrials.gov,2020-10-15,2020-10-27,False,Recruiting,Not Applicable,Interventional,United States,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,2099,https://clinicaltrials.gov/show/NCT04596657
2110,NCT04597034,ClinicalTrials.gov,2020-10-03,2020-10-02,True,Recruiting,Not Applicable,Interventional,Mexico,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,35,https://clinicaltrials.gov/show/NCT04597034
2111,NCT04597047,ClinicalTrials.gov,2020-10-19,2020-08-20,True,Recruiting,Not Applicable,Interventional,United States,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,200,https://clinicaltrials.gov/show/NCT04597047
2112,NCT04597216,ClinicalTrials.gov,2020-10-13,2020-10-15,False,Recruiting,Not Applicable,Interventional,France,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),200,https://clinicaltrials.gov/show/NCT04597216
2113,NCT04597736,ClinicalTrials.gov,2020-10-02,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,France,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),100,https://clinicaltrials.gov/show/NCT04597736
2114,NCT04597775,ClinicalTrials.gov,2020-10-18,2020-10-27,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,93,https://clinicaltrials.gov/show/NCT04597775
2115,NCT04598763,ClinicalTrials.gov,2020-10-15,2020-07-01,True,Recruiting,Not Applicable,Interventional,France,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,80,https://clinicaltrials.gov/show/NCT04598763
2116,NCT04600440,ClinicalTrials.gov,2020-10-20,2020-04-25,True,Recruiting,Not Applicable,Interventional,Sweden,Convalescent Plasma in the Treatment of Covid-19,100,https://clinicaltrials.gov/show/NCT04600440
2117,NCT04600999,ClinicalTrials.gov,2020-10-08,2020-10-07,True,Recruiting,Phase 3,Interventional,Hungary,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04600999
2118,NCT04602000,ClinicalTrials.gov,2020-10-18,2020-09-25,True,Recruiting,Phase 2/Phase 3,Interventional,South Korea,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,1020,https://clinicaltrials.gov/show/NCT04602000
2119,NCT04602442,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Recruiting,Phase 2,Interventional,Russian Federation,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,90,https://clinicaltrials.gov/show/NCT04602442
2120,NCT04602832,ClinicalTrials.gov,2020-10-23,2020-10-14,True,Recruiting,Not Applicable,Interventional,Canada,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,350,https://clinicaltrials.gov/show/NCT04602832
2121,NCT04603729,ClinicalTrials.gov,2020-10-21,2020-05-30,True,Not Recruiting,Phase 3,Interventional,Pakistan,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,100,https://clinicaltrials.gov/show/NCT04603729
2122,NCT04603794,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Recruiting,Phase 4,Interventional,United States,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,60,https://clinicaltrials.gov/show/NCT04603794
2123,NCT04603963,ClinicalTrials.gov,2020-10-25,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in Patients With COVID-19,55,https://clinicaltrials.gov/show/NCT04603963
2124,NCT04604327,ClinicalTrials.gov,2020-10-23,2020-10-26,False,Recruiting,Phase 3,Interventional,Spain,Comparison of Two Different Doses of Bemiparin in COVID-19,164,https://clinicaltrials.gov/show/NCT04604327
2125,NCT04604977,ClinicalTrials.gov,2020-10-20,2020-09-15,True,Recruiting,Not Applicable,Interventional,Italy,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,25,https://clinicaltrials.gov/show/NCT04604977
2126,NCT04606069,ClinicalTrials.gov,2020-10-26,2020-11-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Treat COVID-19 Patients With Regadenoson,40,https://clinicaltrials.gov/show/NCT04606069
2127,NCT04606563,ClinicalTrials.gov,2020-10-27,2020-10-09,True,Recruiting,Phase 3,Interventional,"Belgium, Canada, United States, Spain, Japan, France",Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,1372,https://clinicaltrials.gov/show/NCT04606563
2128,NCT04607928,ClinicalTrials.gov,2020-10-28,2020-08-01,True,Recruiting,Phase 2,Interventional,Spain,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,148,https://clinicaltrials.gov/show/NCT04607928
2129,NCT04608214,ClinicalTrials.gov,2020-10-12,2020-11-01,False,Not Recruiting,Phase 2,Interventional,France,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04608214
2130,NCT04609371,ClinicalTrials.gov,2020-10-19,2020-10-21,False,Recruiting,Not Applicable,Interventional,Canada,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,176,https://clinicaltrials.gov/show/NCT04609371
2131,NCT04609423,ClinicalTrials.gov,2020-10-22,2020-11-10,False,Recruiting,Phase 4,Interventional,Norway,Cod Liver Oil for Covid-19 Prevention Study,80000,https://clinicaltrials.gov/show/NCT04609423
2132,NCT04610489,ClinicalTrials.gov,2020-10-27,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),800,https://clinicaltrials.gov/show/NCT04610489
2133,NCT04610541,ClinicalTrials.gov,2020-10-11,2020-10-12,False,Not Recruiting,Phase 3,Interventional,Hungary,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,2000,https://clinicaltrials.gov/show/NCT04610541
2134,NCT04610801,ClinicalTrials.gov,2020-10-26,2020-08-08,True,Recruiting,Phase 3,Interventional,United States,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,200,https://clinicaltrials.gov/show/NCT04610801
2135,NCT04611256,ClinicalTrials.gov,2020-10-29,2020-08-01,True,Recruiting,Phase 1,Interventional,Mexico,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,20,https://clinicaltrials.gov/show/NCT04611256
2136,NCT04613297,ClinicalTrials.gov,2020-11-02,2020-10-19,True,Recruiting,Not Applicable,Interventional,France,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,120,https://clinicaltrials.gov/show/NCT04613297
2137,NCT04613310,ClinicalTrials.gov,2020-10-26,2020-09-25,True,Recruiting,Not Applicable,Interventional,Switzerland,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),1250,https://clinicaltrials.gov/show/NCT04613310
2138,NCT04614012,ClinicalTrials.gov,2020-11-02,2020-07-02,True,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04614012
2139,NCT04614025,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Recruiting,Phase 2,Interventional,"Germany, Israel",Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04614025
2140,NCT04615416,ClinicalTrials.gov,2020-10-26,2020-05-01,True,Recruiting,Not Applicable,Interventional,United States,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04615416
2141,NCT04615871,ClinicalTrials.gov,2020-10-29,2020-11-30,False,Not Recruiting,Phase 2,Interventional,"Canada, United Kingdom, Mexico, Brazil",Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,400,https://clinicaltrials.gov/show/NCT04615871
2142,NCT04615936,ClinicalTrials.gov,2020-11-02,2020-07-10,True,Recruiting,Not Applicable,Interventional,Canada,Nasal Photodisinfection COVID Proof of Concept Study,100,https://clinicaltrials.gov/show/NCT04615936
2143,NCT04615975,ClinicalTrials.gov,2020-10-31,2020-11-01,False,Recruiting,Not Applicable,Interventional,Italy,Ketogenic Diet as Protective Factor During COVID-19,28,https://clinicaltrials.gov/show/NCT04615975
2144,NCT04616001,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Not Recruiting,Phase 4,Interventional,United States,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,10,https://clinicaltrials.gov/show/NCT04616001
2145,NCT04616846,ClinicalTrials.gov,2020-11-02,2020-08-04,True,Recruiting,Not Applicable,Interventional,"France, Monaco",Thromboembolic Risk Screening in Patients With Cancer and COVID-19,120,https://clinicaltrials.gov/show/NCT04616846
2146,NCT04617119,ClinicalTrials.gov,2020-10-28,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,Kuwait,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,38,https://clinicaltrials.gov/show/NCT04617119
2147,NCT04617483,ClinicalTrials.gov,2020-11-04,2020-10-31,True,Recruiting,Phase 3,Interventional,China,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",1040,https://clinicaltrials.gov/show/NCT04617483
2148,NCT04619290,ClinicalTrials.gov,2020-11-04,2020-10-12,True,Recruiting,Phase 1,Interventional,Mexico,Outpatient Treatment With CoVid-19 With Prexablu,46,https://clinicaltrials.gov/show/NCT04619290
2149,NCT04620798,ClinicalTrials.gov,2020-11-04,2020-09-14,True,Not Recruiting,Not Applicable,Interventional,United States,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,1700,https://clinicaltrials.gov/show/NCT04620798
2150,NCT04621058,ClinicalTrials.gov,2020-11-06,2020-11-09,False,Recruiting,Phase 3,Interventional,Spain,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,108,https://clinicaltrials.gov/show/NCT04621058
2151,NCT04621149,ClinicalTrials.gov,2020-11-05,2020-11-09,False,Not Recruiting,Phase 2,Interventional,No Country Given,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,120,https://clinicaltrials.gov/show/NCT04621149
2152,NCT04621903,ClinicalTrials.gov,2020-11-06,2020-10-08,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,26,https://clinicaltrials.gov/show/NCT04621903
2153,NCT04622826,ClinicalTrials.gov,2020-11-04,2020-05-15,True,Recruiting,Phase 2,Interventional,Italy,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,50,https://clinicaltrials.gov/show/NCT04622826
2154,NCT04622865,ClinicalTrials.gov,2020-11-09,2020-06-01,True,Recruiting,Phase 2,Interventional,France,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,200,https://clinicaltrials.gov/show/NCT04622865
2155,NCT04622891,ClinicalTrials.gov,2020-11-06,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Egypt,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,300,https://clinicaltrials.gov/show/NCT04622891
2156,NCT04623255,ClinicalTrials.gov,2020-06-11,2020-10-16,False,Recruiting,Phase 2,Interventional,United Kingdom,Randomised Study of Plasma Exchange in Severe COVID-19,20,https://clinicaltrials.gov/show/NCT04623255
2157,NCT04623385,ClinicalTrials.gov,2020-11-08,2020-11-01,True,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,1000,https://clinicaltrials.gov/show/NCT04623385
2158,NCT04623619,ClinicalTrials.gov,2020-11-09,2020-12-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,100,https://clinicaltrials.gov/show/NCT04623619
2159,NCT04625114,ClinicalTrials.gov,2020-11-05,2020-11-04,True,Recruiting,Phase 2,Interventional,Belgium,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,150,https://clinicaltrials.gov/show/NCT04625114
2160,NCT04625738,ClinicalTrials.gov,2020-11-04,2020-11-06,False,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,30,https://clinicaltrials.gov/show/NCT04625738
2161,NCT04627233,ClinicalTrials.gov,2020-11-06,2020-12-20,False,Not Recruiting,Phase 1,Interventional,Iran,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,20,https://clinicaltrials.gov/show/NCT04627233
2162,NCT04628143,ClinicalTrials.gov,2020-11-10,2020-11-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04628143
2163,NCT04629105,ClinicalTrials.gov,2020-09-29,2020-07-24,True,Recruiting,Phase 1,Interventional,United States,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),70,https://clinicaltrials.gov/show/NCT04629105
2164,NCT04629157,ClinicalTrials.gov,2020-11-04,2020-11-05,False,Recruiting,Not Applicable,Interventional,United Kingdom,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,400,https://clinicaltrials.gov/show/NCT04629157
2165,NCT04629755,ClinicalTrials.gov,2020-11-09,2020-04-04,True,Not Recruiting,Not Applicable,Interventional,United States,A Smartphone Intervention for Relational and Mental Well Being,1765,https://clinicaltrials.gov/show/NCT04629755
2166,NCT04631367,ClinicalTrials.gov,2020-11-13,2021-02-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,404,https://clinicaltrials.gov/show/NCT04631367
2167,NCT04631380,ClinicalTrials.gov,2020-08-04,2020-08-01,True,Recruiting,Not Applicable,Interventional,Brazil,Prayer in Commbate to Corona Virus - Covid -19,200,https://clinicaltrials.gov/show/NCT04631380
2168,NCT04632082,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Recruiting,Not Applicable,Interventional,Brazil,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,2200,https://clinicaltrials.gov/show/NCT04632082
2169,NCT04632602,ClinicalTrials.gov,2020-11-16,2020-04-04,True,Recruiting,Not Applicable,Interventional,France,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04632602
2170,NCT04632719,ClinicalTrials.gov,2020-11-14,2020-11-08,True,Recruiting,Not Applicable,Interventional,Brazil,The MentalPlusÂ® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,200,https://clinicaltrials.gov/show/NCT04632719
2171,NCT04633772,ClinicalTrials.gov,2020-11-06,2020-08-05,True,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Use of Angiotensin-(1-7) in COVID-19,130,https://clinicaltrials.gov/show/NCT04633772
2172,NCT04633980,ClinicalTrials.gov,2020-11-16,2020-12-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Hydrogen Therapy in Patients With Moderate Covid-19,10,https://clinicaltrials.gov/show/NCT04633980
2173,NCT04634370,ClinicalTrials.gov,2020-11-16,2021-01-02,False,Not Recruiting,Phase 1,Interventional,Brazil,Fase I Clinical Trial on NK Cells for COVID-19,24,https://clinicaltrials.gov/show/NCT04634370
2174,NCT04634422,ClinicalTrials.gov,2020-11-14,2020-11-16,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,220,https://clinicaltrials.gov/show/NCT04634422
2175,NCT04635241,ClinicalTrials.gov,2020-11-14,2020-06-01,True,Recruiting,Phase 2/Phase 3,Interventional,"Egypt, Argentina",Inhaled Heparin for Hospitalised COVID-19 Patients,656,https://clinicaltrials.gov/show/NCT04635241
2176,NCT04635618,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Recruiting,Not Applicable,Interventional,Brazil,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,999,https://clinicaltrials.gov/show/NCT04635618
2177,NCT04636320,ClinicalTrials.gov,2020-11-18,2020-06-13,True,Recruiting,Not Applicable,Interventional,France,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,240,https://clinicaltrials.gov/show/NCT04636320
2178,NCT04637828,ClinicalTrials.gov,2020-11-17,2020-11-18,False,Recruiting,Phase 2,Interventional,France,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,178,https://clinicaltrials.gov/show/NCT04637828
2179,NCT04639349,ClinicalTrials.gov,2020-11-19,2020-11-19,False,Recruiting,Not Applicable,Interventional,Egypt,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,40,https://clinicaltrials.gov/show/NCT04639349
2180,NCT04642014,ClinicalTrials.gov,2020-11-23,2020-12-01,False,Not Recruiting,Not Applicable,Interventional,Poland,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,500,https://clinicaltrials.gov/show/NCT04642014
2181,NCT04642040,ClinicalTrials.gov,2020-11-21,2020-06-30,True,Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,100,https://clinicaltrials.gov/show/NCT04642040
2182,NCT04642326,ClinicalTrials.gov,2020-11-16,2020-06-26,True,Not Recruiting,Not Applicable,Interventional,Turkey,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,50,https://clinicaltrials.gov/show/NCT04642326
2183,NCT04642339,ClinicalTrials.gov,2020-11-16,2020-11-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",2000,https://clinicaltrials.gov/show/NCT04642339
2184,NCT04643054,ClinicalTrials.gov,2020-11-22,2020-12-01,False,Not Recruiting,Not Applicable,Interventional,Italy,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04643054
2185,NCT04643561,ClinicalTrials.gov,2020-11-24,2020-11-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Using Travelan to Boost Immune Response in Vitro to COVID-19,5,https://clinicaltrials.gov/show/NCT04643561
2186,NCT04643691,ClinicalTrials.gov,2020-11-24,2020-09-11,True,Recruiting,Phase 2,Interventional,France,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,90,https://clinicaltrials.gov/show/NCT04643691
2187,NCT04643964,ClinicalTrials.gov,2020-11-12,2020-11-01,True,Recruiting,Not Applicable,Interventional,United States,Brief Video Interventions for Depression,501,https://clinicaltrials.gov/show/NCT04643964
2188,NCT04644172,ClinicalTrials.gov,2020-11-23,2020-11-01,True,Recruiting,Phase 1/Phase 2,Interventional,United States,Improving Thinking in Everyday Life After Covid-19,40,https://clinicaltrials.gov/show/NCT04644172
2189,NCT04644705,ClinicalTrials.gov,2020-11-02,2020-11-02,False,Recruiting,Phase 1,Interventional,Germany,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,28,https://clinicaltrials.gov/show/NCT04644705
2190,NCT04645407,ClinicalTrials.gov,2020-02-15,2020-02-01,True,Not Recruiting,Phase 4,Interventional,China,Effects of Fuzheng Huayu Tablets on COVID-19,66,https://clinicaltrials.gov/show/NCT04645407
2191,NCT04646655,ClinicalTrials.gov,2020-11-22,2020-07-27,True,Recruiting,Phase 3,Interventional,Italy,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,300,https://clinicaltrials.gov/show/NCT04646655
2192,NCT04647604,ClinicalTrials.gov,2020-06-12,2020-06-23,False,Recruiting,Phase 2,Interventional,Sweden,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,40,https://clinicaltrials.gov/show/NCT04647604
2193,NCT04647656,ClinicalTrials.gov,2020-11-29,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,70,https://clinicaltrials.gov/show/NCT04647656
2194,NCT04647734,ClinicalTrials.gov,2020-11-25,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,Denmark,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,40,https://clinicaltrials.gov/show/NCT04647734
2195,ChiCTR2000038672,ChiCTR,2020-09-27,2020-11-05,False,Not Recruiting,Phase 1,Interventional,China,"A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults",12,http://www.chictr.org.cn/showproj.aspx?proj=59313
2196,ChiCTR2000038343,ChiCTR,2020-09-19,2020-10-01,False,Recruiting,Not Applicable,Interventional,China,Evaluation of primary preventive measures in populations at high risk for novel coronavirus pneumonia (COVID-19) sequelae osteonecrosis of the femoral head -- a prospective randomized controlled trial,120,http://www.chictr.org.cn/showproj.aspx?proj=61668
2197,ChiCTR2000038333,ChiCTR,2020-09-18,2020-10-01,False,Recruiting,Not Applicable,Interventional,China,Study on Screening and prevention of osteonecrosis of the femoral head during novel coronavirus pneumonia (COVID-19) recovery,120,http://www.chictr.org.cn/showproj.aspx?proj=61769
2198,EUCTR2020-002502-75-DE,EU Clinical Trials Register,2020-06-26,2020-11-26,False,Authorised,Phase 2,Interventional,Germany,Covid-19 Vaccination Trial,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002502-75
2199,EUCTR2020-001928-34-SE,EU Clinical Trials Register,2020-04-24,2020-05-28,False,Authorised,Phase 2,Interventional,Sweden,Treatment with inhalation of Ciclesonide for patients with coronavirus disease: A randomised open study.,446,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001928-34
2200,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-04,True,Not Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,680,https://anzctr.org.au/ACTRN12620000417987.aspx
2201,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",780,https://anzctr.org.au/ACTRN12620000555954.aspx
2202,ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,False,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,650,https://anzctr.org.au/ACTRN12620000501943.aspx
2203,ACTRN12620000640909,ANZCTR,2020-06-01,2020-08-14,False,Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",200,https://anzctr.org.au/ACTRN12620000640909.aspx
2204,ACTRN12620000636954,ANZCTR,2020-05-29,2020-07-23,False,Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,35,https://anzctr.org.au/ACTRN12620000636954.aspx
2205,ACTRN12620000779976,ANZCTR,2020-07-30,2020-06-08,True,Not Recruiting,Not Applicable,Interventional,"Australia, United Kingdom",The effect of Cognitive behaviour therapy on adult mental health during the COVID-19 pandemic.,100,https://anzctr.org.au/ACTRN12620000779976.aspx
2206,ACTRN12620000975998,ANZCTR,2020-09-30,2021-11-01,False,Not Recruiting,Not Applicable,Interventional,Australia,Feasibility and acceptability of a volunteer-peer telephone support programme - A COVID-19 response,100,https://anzctr.org.au/ACTRN12620000975998.aspx
2207,ACTRN12620001308987,ANZCTR,2020-12-04,2020-09-12,True,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of a novel Receptor Binding Domain (RBD) COVID-19 Vaccine in Healthy Adults",255,https://anzctr.org.au/ACTRN12620001308987.aspx
2208,ACTRN12620001371987,ANZCTR,2020-12-22,2021-05-01,False,Not Recruiting,Phase 1,Interventional,Australia,"A randomized, double-blind, placebo-controlled investigation of the safety, tolerability and pharmacokinetics of 1% SPL7013 nasal spray in healthy volunteers when administered four times a day for 14 days (1% SPL7013 nasal spray is intended to help prevent COVID-19)",40,https://anzctr.org.au/ACTRN12620001371987.aspx
2209,ISRCTN11713182,ISRCTN,2020-12-02,2020-12-21,False,Recruiting,Not Applicable,Interventional,United Kingdom,Testing the effectiveness of almitrine bismesylate in the treatment of COVID-19,116,http://isrctn.com/ISRCTN11713182
2210,ISRCTN19845486,ISRCTN,2020-12-02,2020-01-07,True,Recruiting,Not Applicable,Interventional,Ireland,"VR Baby, a virtual reality learning environment - does it help medical students to learn about complex topics in obstetrics and gynaecology?",40,http://isrctn.com/ISRCTN19845486
2211,ISRCTN77941736,ISRCTN,2020-11-23,2020-11-14,True,Recruiting,Not Applicable,Interventional,United Kingdom,Coping during COVID-19: Peer-delivered training to improve adolescent wellbeing,120,http://isrctn.com/ISRCTN77941736
2212,ISRCTN95933274,ISRCTN,2020-09-09,2020-06-30,True,Recruiting,Not Applicable,Interventional,Singapore,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients,68,http://isrctn.com/ISRCTN95933274
2213,ISRCTN37530113,ISRCTN,2020-01-31,2017-04-09,True,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,70,http://isrctn.com/ISRCTN37530113
2214,IRCT20200204046369N1,IRCT,2020-04-08,2020-08-07,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,82,http://en.irct.ir/trial/46776
2215,IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",70,http://en.irct.ir/trial/47193
2216,IRCT20200421047153N1,IRCT,2020-12-19,2020-07-04,True,Not Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine prophylaxis in preventing the severe forms of  Covid-19,1000,http://en.irct.ir/trial/47337
2217,IRCT20140312016968N2,IRCT,2020-11-01,2020-04-21,True,Not Recruiting,Not Applicable,Interventional,Iran,Study of the effects of grapefruit extract on COVID-19,20,http://en.irct.ir/trial/47381
2218,IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,True,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Nivasha oral spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47477
2219,IRCT20180610040049N6,IRCT,2020-12-04,2020-05-18,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/47626
2220,IRCT20200621047859N2,IRCT,2020-12-29,2020-08-22,True,Not Recruiting,Phase 1,Interventional,Iran,Immune cell therapy for patients with COVID-19 related pneumonia using allogenic ex vivo NK cells,15,http://en.irct.ir/trial/49382
2221,IRCT20200516047462N2,IRCT,2020-07-17,2020-07-08,True,Not Recruiting,Phase 2,Interventional,Iran,The effect of Hyoscyamus niger with propolis on covid-19,140,http://en.irct.ir/trial/49628
2222,IRCT20120703010178N22,IRCT,2020-12-07,2020-08-22,True,Not Recruiting,Phase 3,Interventional,Iran,Bromhexine hydrochloride for prophylaxis against COVID-19,1050,http://en.irct.ir/trial/49850
2223,IRCT20160131026298N5,IRCT,2020-08-23,2020-09-22,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of SINA anti-flu natural product on COVID-19,80,http://en.irct.ir/trial/49886
2224,IRCT20200727048217N1,IRCT,2020-09-13,2020-08-22,True,Recruiting,Phase 3,Interventional,Iran,Effect of ethanol and DMSO in prophylaxis and treatment of COVID-19,610,http://en.irct.ir/trial/49924
2225,IRCT20200731048257N1,IRCT,2020-11-08,2020-08-15,True,Recruiting,Phase 3,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,224,http://en.irct.ir/trial/50012
2226,IRCT20161206031255N4,IRCT,2020-12-07,2020-09-22,True,Recruiting,Phase 3,Interventional,Iran,?Efficacy of prebiotic products on admitted patients with Covid-19,60,http://en.irct.ir/trial/50229
2227,IRCT20170611034452N12,IRCT,2020-12-20,2020-04-20,True,Not Recruiting,Not Applicable,Interventional,Iran,Tele-counselling on perinatal mental health during pandemics,60,http://en.irct.ir/trial/50289
2228,IRCT20200818048444N1,IRCT,2020-09-15,2020-09-22,False,Not Recruiting,Phase 3,Interventional,Iran,Verification of the efficacy of Bromhexine-hydrochloride in treatment of patients with COVID19 disease,1300,http://en.irct.ir/trial/50780
2229,IRCT20150830023823N3,IRCT,2020-12-06,2020-11-15,True,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Barley water (Hordeum vulgare) in clinical outcome of  COVID-19 patients,50,http://en.irct.ir/trial/50854
2230,IRCT20200921048783N1,IRCT,2020-12-06,2021-01-08,False,Not Recruiting,Phase 3,Interventional,Iran,Effect of  GRAPEX in treatment of COVID-19,80,http://en.irct.ir/trial/51199
2231,IRCT20200927048849N1,IRCT,2020-12-05,2020-11-10,True,Not Recruiting,Not Applicable,Interventional,Iran,Study of the safety of hyper immune bovine milk and colostrum against covid-19,40,http://en.irct.ir/trial/51259
2232,IRCT20201004048923N1,IRCT,2020-12-13,2020-10-15,True,Recruiting,Phase 3,Interventional,Iran,"Effect of biotin, brewerâ€™s yeast and vitamin C supplements in patients with COVID-19",50,http://en.irct.ir/trial/51442
2233,IRCT20201001048894N1,IRCT,2020-12-15,2020-10-22,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Interferon beta-1-b on COVID-19 patients,90,http://en.irct.ir/trial/51492
2234,IRCT20181208041886N3,IRCT,2020-12-22,2020-12-21,True,Recruiting,Phase 3,Interventional,Iran,The effect of Montelukast on COVID 19 disease activity,60,http://en.irct.ir/trial/51633
2235,IRCT20201028049175N1,IRCT,2020-12-12,2020-11-21,True,Recruiting,Phase 3,Interventional,Iran,EVALUATION OF THE EFFECT OF FAVIPIRAVIR ON MANAGEMENT PATIENT WITH COVID-19,114,http://en.irct.ir/trial/51946
2236,IRCT20200408046987N3,IRCT,2020-12-06,2020-11-30,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients,800,http://en.irct.ir/trial/51999
2237,IRCT20080901001157N17,IRCT,2020-11-29,2020-11-15,True,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effects of herbal drug IMFLUNA on patients with COVID-19,60,http://en.irct.ir/trial/52070
2238,IRCT20180625040232N7,IRCT,2020-11-30,2020-11-10,True,Recruiting,Not Applicable,Interventional,Iran,The effect of hemoperfusion on patients with severe symptoms of covid-19 which are resistant to conventional therapies,20,http://en.irct.ir/trial/52081
2239,IRCT20110302005952N2,IRCT,2020-12-17,2020-11-25,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of orange peel and peppermint extract in coronavirus treatment,60,http://en.irct.ir/trial/52356
2240,IRCT20180205038626N7,IRCT,2020-12-27,2020-12-05,True,Recruiting,Phase 2,Interventional,Iran,The investigation of the effectiveness of ASA usage on  corona virus,36,http://en.irct.ir/trial/52374
2241,IRCT20201003048904N2,IRCT,2020-12-10,2020-12-05,True,Recruiting,Not Applicable,Interventional,Iran,combination therapy trial in COVID-19 patients,200,http://en.irct.ir/trial/52607
2242,IRCT20201128049508N1,IRCT,2020-12-28,2020-09-22,True,Recruiting,Phase 3,Interventional,Iran,effect  of  statin in  COVID19,60,http://en.irct.ir/trial/52648
2243,IRCT20171219037964N3,IRCT,2020-12-02,2020-12-21,False,Recruiting,Phase 3,Interventional,Iran,Effect of Favipiravir on outpatient treatment of Covid-19,70,http://en.irct.ir/trial/52696
2244,IRCT20201202049567N1,IRCT,2020-12-15,2020-12-21,False,Recruiting,Phase 1,Interventional,Iran,Phase 1 clinical trial of an inactivated COVID-19 vaccine (Shifa-Pharmed) in healthy individuals,56,http://en.irct.ir/trial/52701
2245,IRCT20171219037964N2,IRCT,2020-12-02,2020-12-21,False,Recruiting,Phase 3,Interventional,Iran,The effect of Steroid on the outpatient treatment of Covid-19,70,http://en.irct.ir/trial/52709
2246,IRCT20100130003227N15,IRCT,2020-12-10,2020-12-21,False,Recruiting,Not Applicable,Interventional,Iran,The effect of Hyssop and Verbascum herbal tea on clinical symptoms of Covide-19.,50,http://en.irct.ir/trial/52719
2247,IRCT20190415043279N9,IRCT,2020-12-22,2020-12-05,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Propolis COVID 19,72,http://en.irct.ir/trial/52853
2248,IRCT20170218032635N3,IRCT,2020-12-27,2021-01-20,False,Not Recruiting,Not Applicable,Interventional,Iran,The efficacy of mindfulness based stress reduction program on mental well-being and quality of life in patients with COVID-19 after discharge,100,http://en.irct.ir/trial/53134
2249,IRCT20200818048444N2,IRCT,2020-12-31,2020-11-14,True,Recruiting,Phase 3,Interventional,Iran,The Effect of Bromhexine Hydrochloride on Clinical Outcomes of Patients with COVID-19 disease,400,http://en.irct.ir/trial/53165
2250,ChiCTR2000038866,ChiCTR,2020-10-07,2020-10-15,False,Not Recruiting,Not Applicable,Interventional,China,A mHealth-based randomized controlled trial for improving mental health among people living with HIV during the COVID-19 outbreak,120,http://www.chictr.org.cn/showproj.aspx?proj=61662
2251,ChiCTR2000038827,ChiCTR,2020-10-05,2020-11-02,False,Not Recruiting,Not Applicable,Interventional,China,Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic,1500,http://www.chictr.org.cn/showproj.aspx?proj=61884
2252,JPRN-UMIN000042270,JPRN,2020-12-09,2020-10-28,True,Not Recruiting,Not Applicable,Interventional,Japan,Disinfection and cross infection tests on sports equipment in covid-19 epidemic,41,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048258
2253,JPRN-UMIN000042599,JPRN,2020-12-01,2020-12-01,False,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048622
2254,JPRN-UMIN000042807,JPRN,2020-12-23,2020-12-23,False,Not Recruiting,Not Applicable,Interventional,Asia(except Japan),"Developing an Adaptive Intervention for the Mental Health and Psychosocial Support of Health Workers in the Philippines under COVID-19 Pandemic using the Sequential, Multiple Assignment, Randomized Trial (SMART)",373,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048854
2255,EUCTR2020-003654-71-RO,EU Clinical Trials Register,2020-09-30,2020-06-10,True,Authorised,Phase 3,Interventional,"Chile, Moldova, Republic of, Greece, United States, Brazil, Mexico, Romania",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003654-71
2256,EUCTR2020-004994-27-GB,EU Clinical Trials Register,2020-10-21,2020-12-16,False,Authorised,Phase 2,Interventional,United Kingdom,Nitric Oxide Nasal Spray for COVID-19 treatment,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004994-27
2257,EUCTR2020-002504-39-DE,EU Clinical Trials Register,2020-08-14,2020-10-11,False,Authorised,Phase 3,Interventional,Germany,Hamburg Edoxaban foR anticoagulation in COvid-19 study,172,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002504-39
2258,EUCTR2020-001558-23-IT,EU Clinical Trials Register,2020-06-26,2020-09-04,False,Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23
2259,EUCTR2020-004323-16-IT,EU Clinical Trials Register,2020-11-23,2020-11-25,False,Authorised,Phase 2,Interventional,Italy,Evaluation of the efficacy of high doses of methylprednisolone in SARS-CoV2  pneumonia patients.,260,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004323-16
2260,EUCTR2020-001921-30-IT,EU Clinical Trials Register,2020-06-26,2020-05-14,True,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30
2261,EUCTR2020-004285-19-IT,EU Clinical Trials Register,2020-11-23,2020-11-25,False,Authorised,Phase 4,Interventional,"Italy, United States",Evaluation of Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004285-19
2262,EUCTR2020-001645-40-IT,EU Clinical Trials Register,2020-09-22,2020-06-05,True,Authorised,Phase 2/Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,159,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001645-40
2263,EUCTR2020-003936-25-IT,EU Clinical Trials Register,2020-11-23,2020-10-31,True,Authorised,Phase 2/Phase 3,Interventional,Italy,Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25
2264,EUCTR2020-004719-28-GB,EU Clinical Trials Register,2020-10-12,2020-11-20,False,Authorised,Phase 3,Interventional,"United States, United Kingdom","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have been potentially exposed to COVID-19"".",1125,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004719-28
2265,EUCTR2020-003367-26-GB,EU Clinical Trials Register,2020-09-21,2020-05-10,True,Authorised,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, South Korea, Ukraine, United States, Israel, Spain, Italy, Mexico, Brazil, Japan, Poland, France, Philippines",MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003367-26
2266,EUCTR2020-003368-24-GB,EU Clinical Trials Register,2020-09-21,2020-05-10,True,Authorised,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, Canada, Ukraine, United States, Israel, Spain, Italy, Mexico, Brazil, France, Germany, Philippines",MK-4482 Ph 2/3 Study in Non-Hospitalized Participants with COVID-19,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003368-24
2267,KCT0005649,CRIS,2020-12-02,2020-09-18,True,Recruiting,Phase 2,Interventional,South Korea,"A prospective, open-label, randomized, multi-center, phase 2a study to evaluate the dose response, efficacy and safety of Hyper-Ig (Hyper-immunoglobulin) GC5131 in Patients with COVID-19",60,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17659
2268,KCT0005711,CRIS,2020-12-29,2020-12-28,True,Not Recruiting,Not Applicable,Interventional,South Korea,"Effects of time use intervention on occupational balance, mental health and quality of life in COVID-19 patients",50,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18369
2269,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,False,Not Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom, United States, Mexico, Spain, Japan, Singapore, Germany, South Korea",Adaptive COVID-19 Treatment Trial (ACTT),1062,https://clinicaltrials.gov/show/NCT04280705
2270,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",1000,https://clinicaltrials.gov/show/NCT04304690
2271,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Italy, United States",Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,16,https://clinicaltrials.gov/show/NCT04324021
2272,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,Not Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),173,https://clinicaltrials.gov/show/NCT04329923
2273,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,219,https://clinicaltrials.gov/show/NCT04333914
2274,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,25,https://clinicaltrials.gov/show/NCT04339426
2275,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,3000,https://clinicaltrials.gov/show/NCT04341441
2276,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-03-23,True,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,200,https://clinicaltrials.gov/show/NCT04353336
2277,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,0,https://clinicaltrials.gov/show/NCT04355676
2278,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,500,https://clinicaltrials.gov/show/NCT04359797
2279,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Not Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,2587,https://clinicaltrials.gov/show/NCT04363593
2280,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Not Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,30,https://clinicaltrials.gov/show/NCT04368000
2281,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Not Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,233,https://clinicaltrials.gov/show/NCT04370262
2282,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,18,https://clinicaltrials.gov/show/NCT04370782
2283,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-07-06,False,Not Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,0,https://clinicaltrials.gov/show/NCT04371640
2284,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-06-13,False,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,62,https://clinicaltrials.gov/show/NCT04380688
2285,NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Recruiting,Phase 3,Interventional,Egypt,Novel Regimens in COVID-19 Treatment,160,https://clinicaltrials.gov/show/NCT04382846
2286,NCT04382924,ClinicalTrials.gov,2020-05-08,2020-08-05,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Philippines, Australia, United States, Romania",Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,682,https://clinicaltrials.gov/show/NCT04382924
2287,NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,True,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,308,https://clinicaltrials.gov/show/NCT04401293
2288,NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-27,False,Not Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,34,https://clinicaltrials.gov/show/NCT04402983
2289,NCT04405843,ClinicalTrials.gov,2020-05-23,2020-07-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),476,https://clinicaltrials.gov/show/NCT04405843
2290,NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,False,Not Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,41,https://clinicaltrials.gov/show/NCT04407286
2291,NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,False,Not Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,44,https://clinicaltrials.gov/show/NCT04410354
2292,NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,True,Not Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,80,https://clinicaltrials.gov/show/NCT04431856
2293,NCT04433546,ClinicalTrials.gov,2020-05-28,2020-07-15,False,Not Recruiting,Phase 2,Interventional,United States,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",54,https://clinicaltrials.gov/show/NCT04433546
2294,NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,False,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,50,https://clinicaltrials.gov/show/NCT04445194
2295,NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,False,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04447534
2296,NCT04453384,ClinicalTrials.gov,2020-06-22,2020-09-01,False,Recruiting,Phase 2,Interventional,France,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,414,https://clinicaltrials.gov/show/NCT04453384
2297,NCT04460443,ClinicalTrials.gov,2020-07-04,2020-08-01,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir in Treatment of COVID 19,60,https://clinicaltrials.gov/show/NCT04460443
2298,NCT04466085,ClinicalTrials.gov,2020-07-08,2020-07-12,False,Not Recruiting,Phase 2,Interventional,China,Clinical Study of Recombinant Novel Coronavirus Vaccine,900,https://clinicaltrials.gov/show/NCT04466085
2299,NCT04476745,ClinicalTrials.gov,2020-07-16,2020-10-05,False,Recruiting,Not Applicable,Interventional,Jordan,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,100,https://clinicaltrials.gov/show/NCT04476745
2300,NCT04483271,ClinicalTrials.gov,2020-07-18,2020-10-02,False,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,100,https://clinicaltrials.gov/show/NCT04483271
2301,NCT04497649,ClinicalTrials.gov,2020-08-01,2020-07-01,True,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,100,https://clinicaltrials.gov/show/NCT04497649
2302,NCT04497948,ClinicalTrials.gov,2020-06-16,2020-09-21,False,Not Recruiting,Phase 1,Interventional,"United States, Brazil",Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,8,https://clinicaltrials.gov/show/NCT04497948
2303,NCT04519437,ClinicalTrials.gov,2020-07-24,2020-07-26,False,Not Recruiting,Phase 1,Interventional,United States,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",974,https://clinicaltrials.gov/show/NCT04519437
2304,NCT04524715,ClinicalTrials.gov,2020-08-19,2021-03-31,False,Not Recruiting,Not Applicable,Interventional,United States,LLLT Treatment of Lung Inflammation in COVID-19,64,https://clinicaltrials.gov/show/NCT04524715
2305,NCT04527081,ClinicalTrials.gov,2020-08-24,2020-08-31,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0302-COVID19),30,https://clinicaltrials.gov/show/NCT04527081
2306,NCT04530136,ClinicalTrials.gov,2020-08-26,2020-11-30,False,Recruiting,Phase 2,Interventional,United States,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,120,https://clinicaltrials.gov/show/NCT04530136
2307,NCT04537975,ClinicalTrials.gov,2020-08-25,2020-09-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,0,https://clinicaltrials.gov/show/NCT04537975
2308,NCT04552366,ClinicalTrials.gov,2020-09-15,2020-09-29,False,Not Recruiting,Phase 1,Interventional,China,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,149,https://clinicaltrials.gov/show/NCT04552366
2309,NCT04552379,ClinicalTrials.gov,2020-08-21,2020-12-01,False,Recruiting,Phase 3,Interventional,Chile,The Containing Coronavirus Disease 19 (COVID-19) Trial,1240,https://clinicaltrials.gov/show/NCT04552379
2310,NCT04558372,ClinicalTrials.gov,2020-09-20,2020-04-01,True,Recruiting,Not Applicable,Interventional,Indonesia,Genosvid Diagnostic Test for Early Detection of COVID-19,1543,https://clinicaltrials.gov/show/NCT04558372
2311,NCT04559113,ClinicalTrials.gov,2020-09-15,2020-05-01,True,Recruiting,Not Applicable,Interventional,Pakistan,Methylprednisolone in COVID-19 Patients (Methyl19LGH),200,https://clinicaltrials.gov/show/NCT04559113
2312,NCT04560205,ClinicalTrials.gov,2020-07-11,2020-05-01,True,Recruiting,Phase 1,Interventional,Pakistan,Tocilizumab in COVID-19 Lahore General Hospital,50,https://clinicaltrials.gov/show/NCT04560205
2313,NCT04560257,ClinicalTrials.gov,2020-07-13,2020-05-01,True,Recruiting,Not Applicable,Interventional,Pakistan,High Flow Nasal Cannula HFNC In Covid-19 Patients,30,https://clinicaltrials.gov/show/NCT04560257
2314,NCT04564716,ClinicalTrials.gov,2020-09-24,2020-09-28,False,Not Recruiting,Phase 3,Interventional,Belarus,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",100,https://clinicaltrials.gov/show/NCT04564716
2315,NCT04565197,ClinicalTrials.gov,2020-09-24,2020-05-01,True,Not Recruiting,Phase 1,Interventional,Pakistan,Convalescent Plasma Therapy for COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04565197
2316,NCT04583189,ClinicalTrials.gov,2020-10-01,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,France,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,500,https://clinicaltrials.gov/show/NCT04583189
2317,NCT04601077,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Recruiting,Phase 1/Phase 2,Interventional,United States,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,100,https://clinicaltrials.gov/show/NCT04601077
2318,NCT04602507,ClinicalTrials.gov,2020-10-22,2020-12-07,False,Recruiting,Phase 2,Interventional,Colombia,Ivermectin in Adults With Severe COVID-19.,100,https://clinicaltrials.gov/show/NCT04602507
2319,NCT04603690,ClinicalTrials.gov,2020-10-24,2020-12-15,False,Not Recruiting,Phase 3,Interventional,No Country Given,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04603690
2320,NCT04606407,ClinicalTrials.gov,2020-10-22,2020-11-25,False,Recruiting,Not Applicable,Interventional,Israel,Inhaled NO for the Treatment of Viral Pneumonia in Adults,90,https://clinicaltrials.gov/show/NCT04606407
2321,NCT04608201,ClinicalTrials.gov,2020-10-23,2020-12-09,False,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,220,https://clinicaltrials.gov/show/NCT04608201
2322,NCT04609969,ClinicalTrials.gov,2020-10-28,2020-10-13,True,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,200,https://clinicaltrials.gov/show/NCT04609969
2323,NCT04634318,ClinicalTrials.gov,2020-11-17,2020-12-10,False,Recruiting,Not Applicable,Interventional,France,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),118,https://clinicaltrials.gov/show/NCT04634318
2324,NCT04638673,ClinicalTrials.gov,2020-11-18,2020-11-19,False,Recruiting,Phase 2,Interventional,United States,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,30,https://clinicaltrials.gov/show/NCT04638673
2325,NCT04641858,ClinicalTrials.gov,2020-11-22,2020-12-03,False,Recruiting,Phase 4,Interventional,"Mozambique, Guinea-Bissau, Cape Verde",BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,1050,https://clinicaltrials.gov/show/NCT04641858
2326,NCT04646616,ClinicalTrials.gov,2020-11-25,2021-01-06,False,Not Recruiting,Not Applicable,Interventional,United States,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,800,https://clinicaltrials.gov/show/NCT04646616
2327,NCT04647695,ClinicalTrials.gov,2020-11-27,2020-11-20,True,Recruiting,Phase 2,Interventional,Hong Kong,IFN-beta 1b and Remdesivir for COVID19,100,https://clinicaltrials.gov/show/NCT04647695
2328,NCT04648800,ClinicalTrials.gov,2020-10-18,2020-07-07,True,Recruiting,Phase 3,Interventional,Poland,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,1000,https://clinicaltrials.gov/show/NCT04648800
2329,NCT04649515,ClinicalTrials.gov,2020-11-26,2020-12-04,False,Recruiting,Phase 3,Interventional,Singapore,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",1305,https://clinicaltrials.gov/show/NCT04649515
2330,NCT04649879,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Not Recruiting,Phase 2/Phase 3,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,920,https://clinicaltrials.gov/show/NCT04649879
2331,NCT04651374,ClinicalTrials.gov,2020-11-27,2020-12-01,False,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 And Geko Evaluation: The CAGE Study,40,https://clinicaltrials.gov/show/NCT04651374
2332,NCT04652115,ClinicalTrials.gov,2020-12-01,2021-01-01,False,Not Recruiting,Phase 2,Interventional,United States,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,42,https://clinicaltrials.gov/show/NCT04652115
2333,NCT04652648,ClinicalTrials.gov,2020-12-02,2020-05-27,True,Not Recruiting,Phase 4,Interventional,United States,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,54,https://clinicaltrials.gov/show/NCT04652648
2334,NCT04653831,ClinicalTrials.gov,2020-10-27,2020-11-08,False,Recruiting,Not Applicable,Interventional,Israel,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,100,https://clinicaltrials.gov/show/NCT04653831
2335,NCT04654325,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,1280,https://clinicaltrials.gov/show/NCT04654325
2336,NCT04654481,ClinicalTrials.gov,2020-12-03,2020-12-01,True,Recruiting,Not Applicable,Interventional,United States,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04654481
2337,NCT04655716,ClinicalTrials.gov,2020-12-04,2021-02-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Urine Alkalinisation to Prevent AKI in COVID-19,80,https://clinicaltrials.gov/show/NCT04655716
2338,NCT04656613,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,1000,https://clinicaltrials.gov/show/NCT04656613
2339,NCT04656626,ClinicalTrials.gov,2020-12-04,2020-07-07,True,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,146,https://clinicaltrials.gov/show/NCT04656626
2340,NCT04658433,ClinicalTrials.gov,2020-12-05,2020-12-05,False,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,100,https://clinicaltrials.gov/show/NCT04658433
2341,NCT04658979,ClinicalTrials.gov,2020-12-02,2020-12-01,True,Recruiting,Not Applicable,Interventional,Canada,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,30,https://clinicaltrials.gov/show/NCT04658979
2342,NCT04659122,ClinicalTrials.gov,2020-12-04,2021-01-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,9,https://clinicaltrials.gov/show/NCT04659122
2343,NCT04659460,ClinicalTrials.gov,2020-07-03,2020-12-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,30,https://clinicaltrials.gov/show/NCT04659460
2344,NCT04659486,ClinicalTrials.gov,2020-12-01,2020-09-24,True,Recruiting,Not Applicable,Interventional,Brazil,Adolescents With COVID-19/MIS-C at HCFMUSP,100,https://clinicaltrials.gov/show/NCT04659486
2345,NCT04659746,ClinicalTrials.gov,2020-12-07,2020-12-09,False,Not Recruiting,Not Applicable,Interventional,Paraguay,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,96,https://clinicaltrials.gov/show/NCT04659746
2346,NCT04659941,ClinicalTrials.gov,2020-12-08,2020-10-01,True,Recruiting,Phase 2,Interventional,Brazil,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,1000,https://clinicaltrials.gov/show/NCT04659941
2347,NCT04661423,ClinicalTrials.gov,2020-12-07,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,France,Use of RDS MultiSenseÂ® in Post-ICU Patients in the COVID-19 Era,60,https://clinicaltrials.gov/show/NCT04661423
2348,NCT04661527,ClinicalTrials.gov,2020-09-10,2020-04-22,True,Recruiting,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,60,https://clinicaltrials.gov/show/NCT04661527
2349,NCT04661930,ClinicalTrials.gov,2020-12-09,2020-12-13,False,Recruiting,Phase 3,Interventional,Israel,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,50,https://clinicaltrials.gov/show/NCT04661930
2350,NCT04662684,ClinicalTrials.gov,2020-12-08,2020-10-16,True,Recruiting,Phase 3,Interventional,Brazil,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,320,https://clinicaltrials.gov/show/NCT04662684
2351,NCT04662697,ClinicalTrials.gov,2020-12-09,2020-12-11,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults (USA),918,https://clinicaltrials.gov/show/NCT04662697
2352,NCT04664010,ClinicalTrials.gov,2020-12-07,2020-02-06,True,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),60,https://clinicaltrials.gov/show/NCT04664010
2353,NCT04666116,ClinicalTrials.gov,2020-04-25,2020-04-01,True,Recruiting,Not Applicable,Interventional,Spain,Changes in Viral Load in COVID-19 After Probiotics,96,https://clinicaltrials.gov/show/NCT04666116
2354,NCT04666493,ClinicalTrials.gov,2020-12-11,2020-12-04,True,Recruiting,Not Applicable,Interventional,Canada,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,100,https://clinicaltrials.gov/show/NCT04666493
2355,NCT04666558,ClinicalTrials.gov,2020-11-30,2020-11-30,False,Recruiting,Not Applicable,Interventional,Canada,Heal-Me Personalized Online Nutrition and Exercise Routines,216,https://clinicaltrials.gov/show/NCT04666558
2356,ISRCTN14037053,ISRCTN,2020-12-31,2020-07-12,True,Recruiting,Phase 1,Interventional,Indonesia,Dendritic cell vaccine to prevent COVID-19,27,http://isrctn.com/ISRCTN14037053
2357,ChiCTR2000040044,ChiCTR,2020-11-19,2020-11-20,False,Not Recruiting,Phase 2,Interventional,China,A Phase II clinical trial of novel coronavirus pneumonia (COVID-19)  mRNA Vaccine (BNT162b2) in China,960,http://www.chictr.org.cn/showproj.aspx?proj=64544
2358,ChiCTR2000039002,ChiCTR,2020-10-13,2021-01-01,False,Recruiting,Not Applicable,Interventional,China,Psychological responses of medical staff during COVID-19 and the adjustment effect of brief mindfulness meditation,400,http://www.chictr.org.cn/showproj.aspx?proj=62120
2359,ChiCTR2000039000,ChiCTR,2020-10-13,2020-09-02,True,Recruiting,Phase 3,Interventional,Morocco,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),600,http://www.chictr.org.cn/showproj.aspx?proj=62581
2360,EUCTR2020-001370-30-FR,EU Clinical Trials Register,2020-04-16,2020-12-05,False,Not Recruiting,Phase 3,Interventional,"Hungary, United Kingdom, United States, Italy, Spain, France, Germany",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30
2361,EUCTR2020-002259-39-HU,EU Clinical Trials Register,2020-08-26,2020-09-28,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Ukraine, United States, Italy, Spain, Brazil, France, Germany, Philippines","This global, multicenter, Phase 1/2, randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of adding TL-895 treatment to standard available therapy (SAT) in subjects with cancer hospitalized for COVID-19.",146,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002259-39
2362,EUCTR2020-002234-32-IT,EU Clinical Trials Register,2021-01-04,2020-12-28,True,Authorised,Phase 3,Interventional,"Spain, Switzerland, Italy, Belgium",Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19),420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002234-32
2363,EUCTR2020-001857-31-DE,EU Clinical Trials Register,2020-07-21,2020-09-11,False,Authorised,Phase 2,Interventional,"Germany, Bulgaria, Israel",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31
2364,EUCTR2020-001513-20-IT,EU Clinical Trials Register,2020-06-24,2020-06-05,True,Authorised,Phase 2,Interventional,Italy,"Use of Defibrotide to reduce progression of acute respiratory failure rate in
patients with COVID-19 pneumonia",50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001513-20
2365,EUCTR2020-001795-15-IT,EU Clinical Trials Register,2020-06-26,2020-07-05,False,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15
2366,EUCTR2020-001987-28-IT,EU Clinical Trials Register,2020-06-24,2020-06-05,True,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28
2367,EUCTR2020-002458-25-IT,EU Clinical Trials Register,2020-08-10,2020-06-23,True,Authorised,Phase 2,Interventional,Italy,"Clinical study for the treatment with Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 patients: randomized, controlled, open label",126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002458-25
2368,EUCTR2020-001390-76-IT,EU Clinical Trials Register,2020-06-24,2020-04-27,True,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76
2369,EUCTR2020-001528-32-IT,EU Clinical Trials Register,2020-06-24,2020-05-14,True,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32
2370,EUCTR2020-002119-23-IT,EU Clinical Trials Register,2020-09-22,2020-11-16,False,Authorised,Phase 2,Interventional,Italy,prevention of complications from COVID-19 in cancer patients under active treatment,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002119-23
2371,EUCTR2020-001501-24-IT,EU Clinical Trials Register,2020-06-24,2020-04-28,True,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24
2372,EUCTR2020-002283-32-IT,EU Clinical Trials Register,2020-08-10,2020-12-06,False,Authorised,Phase 2,Interventional,"Spain, Italy","Randomized, Double-blind, Multi Centre Phase II, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19",122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002283-32
2373,EUCTR2020-001854-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-27,True,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23
2374,EUCTR2020-001441-39-IT,EU Clinical Trials Register,2020-06-24,2020-08-05,False,Authorised,Phase 3,Interventional,"Malawi, Indonesia, United Kingdom, Vietnam, Thailand, Italy, Uganda, Lao People's Democratic Republic, Kenya","Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)",40000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001441-39
2375,EUCTR2020-003872-42-IT,EU Clinical Trials Register,2020-11-23,2020-06-11,True,Authorised,Phase 2,Interventional,Italy,Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003872-42
2376,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Not Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,102,https://clinicaltrials.gov/show/NCT04339712
2377,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Not Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",152,https://clinicaltrials.gov/show/NCT04342663
2378,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,2000,https://clinicaltrials.gov/show/NCT04352348
2379,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,False,Not Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,131,https://clinicaltrials.gov/show/NCT04354831
2380,NCT04366115,ClinicalTrials.gov,2020-04-26,2021-01-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,16,https://clinicaltrials.gov/show/NCT04366115
2381,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-12-07,False,Recruiting,Not Applicable,Interventional,Canada,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,42,https://clinicaltrials.gov/show/NCT04373096
2382,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-05-07,False,Not Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,32,https://clinicaltrials.gov/show/NCT04379661
2383,NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,True,Not Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,90,https://clinicaltrials.gov/show/NCT04398004
2384,NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Not Recruiting,Not Applicable,Interventional,Canada,The COVID-19 Pandemic and Exercise Study,334,https://clinicaltrials.gov/show/NCT04400279
2385,NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,True,Not Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,60,https://clinicaltrials.gov/show/NCT04407182
2386,NCT04435275,ClinicalTrials.gov,2020-06-09,2021-01-02,False,Recruiting,Not Applicable,Interventional,Canada,Virtual Assistant for COVID-19 PPE,50,https://clinicaltrials.gov/show/NCT04435275
2387,NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-13,False,Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04435587
2388,NCT04454398,ClinicalTrials.gov,2020-06-30,2020-09-01,False,Not Recruiting,Phase 1,Interventional,United States,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,0,https://clinicaltrials.gov/show/NCT04454398
2389,NCT04469634,ClinicalTrials.gov,2020-07-13,2020-07-31,False,Not Recruiting,Not Applicable,Interventional,Belgium,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,150,https://clinicaltrials.gov/show/NCT04469634
2390,NCT04470544,ClinicalTrials.gov,2020-07-09,2020-07-28,False,Recruiting,Phase 2,Interventional,United States,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,264,https://clinicaltrials.gov/show/NCT04470544
2391,NCT04473261,ClinicalTrials.gov,2020-07-14,2020-07-14,False,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Iodine Complex Against COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04473261
2392,NCT04527562,ClinicalTrials.gov,2020-08-25,2020-07-14,True,Not Recruiting,Not Applicable,Interventional,Bangladesh,Colchicine in Moderate Symptomatic COVID-19 Patients,299,https://clinicaltrials.gov/show/NCT04527562
2393,NCT04547257,ClinicalTrials.gov,2020-04-29,2021-02-01,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,42,https://clinicaltrials.gov/show/NCT04547257
2394,NCT04550325,ClinicalTrials.gov,2020-09-10,2020-08-05,True,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",12,https://clinicaltrials.gov/show/NCT04550325
2395,NCT04574219,ClinicalTrials.gov,2020-09-24,2020-11-03,False,Recruiting,Not Applicable,Interventional,"Canada, United States",Virtual Parental Presence on Induction,184,https://clinicaltrials.gov/show/NCT04574219
2396,NCT04604678,ClinicalTrials.gov,2020-10-26,2021-02-01,False,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04604678
2397,NCT04639466,ClinicalTrials.gov,2020-11-04,2020-12-11,False,Recruiting,Phase 1,Interventional,United States,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",129,https://clinicaltrials.gov/show/NCT04639466
2398,NCT04662021,ClinicalTrials.gov,2020-12-04,2020-12-10,False,Recruiting,Not Applicable,Interventional,Egypt,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,40,https://clinicaltrials.gov/show/NCT04662021
2399,NCT04676971,ClinicalTrials.gov,2020-12-16,2020-12-11,True,Recruiting,Phase 2,Interventional,"Russian Federation, Italy",Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,105,https://clinicaltrials.gov/show/NCT04676971
2400,NCT04679415,ClinicalTrials.gov,2020-12-21,2020-12-17,True,Recruiting,Phase 2,Interventional,Indonesia,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,63,https://clinicaltrials.gov/show/NCT04679415
2401,NCT04681001,ClinicalTrials.gov,2020-12-21,2020-12-20,True,Recruiting,Not Applicable,Interventional,Austria,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers",300,https://clinicaltrials.gov/show/NCT04681001
2402,NCT04695743,ClinicalTrials.gov,2020-12-11,2020-09-01,True,Recruiting,Not Applicable,Interventional,United Kingdom,Group CST Using Zoom: A Proof of Concept Study,50,https://clinicaltrials.gov/show/NCT04695743
2403,NCT04695821,ClinicalTrials.gov,2021-01-01,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,10,https://clinicaltrials.gov/show/NCT04695821
2404,NCT04696562,ClinicalTrials.gov,2020-12-30,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",44,https://clinicaltrials.gov/show/NCT04696562
2405,NCT04696601,ClinicalTrials.gov,2020-12-23,2021-01-10,False,Not Recruiting,Not Applicable,Interventional,France,Rapid Screening for Olfactory Disorders in Covid-19 Infection,2000,https://clinicaltrials.gov/show/NCT04696601
2406,NCT04699227,ClinicalTrials.gov,2021-01-06,2020-04-23,True,Recruiting,Not Applicable,Interventional,United Kingdom,Can RIC Prevent Deterioration to Critical Care in Covid19,20,https://clinicaltrials.gov/show/NCT04699227
2407,NCT04699851,ClinicalTrials.gov,2020-11-25,2020-11-18,True,Recruiting,Not Applicable,Interventional,Canada,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,1200,https://clinicaltrials.gov/show/NCT04699851
2408,NCT04701528,ClinicalTrials.gov,2020-10-27,2020-11-15,False,Recruiting,Phase 2,Interventional,Netherlands,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,20,https://clinicaltrials.gov/show/NCT04701528
2409,NCT04703478,ClinicalTrials.gov,2021-01-04,2021-01-20,False,Not Recruiting,Not Applicable,Interventional,Spain,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,20,https://clinicaltrials.gov/show/NCT04703478
2410,NCT04703907,ClinicalTrials.gov,2021-01-08,2020-12-03,True,Recruiting,Not Applicable,Interventional,Germany,Auricular Stimulation for Relief of Stress and Anxiety,60,https://clinicaltrials.gov/show/NCT04703907
2411,NCT04705831,ClinicalTrials.gov,2021-01-07,2020-12-30,True,Recruiting,Phase 4,Interventional,United States,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04705831
2412,ACTRN12621000016831,ANZCTR,2021-01-13,2022-12-15,False,Not Recruiting,Phase 2,Interventional,Australia,Effect of Tasquinimod on COVID-19 patients,125,https://anzctr.org.au/ACTRN12621000016831.aspx
2413,ChiCTR2000040153,ChiCTR,2020-11-22,2020-11-30,False,Not Recruiting,Phase 3,Interventional,China,"A randomized, double-blind, placebo-controlled phase III clinical trial of the effectiveness and safety of inoculation of recombinant new coronavirus vaccine (CHO cells) in the prevention of COVID-19 in people 18 years and older",29000,http://www.chictr.org.cn/showproj.aspx?proj=64718
2414,ChiCTR2000034780,ChiCTR,2020-07-18,2020-07-16,True,Not Recruiting,Phase 3,Interventional,The Arab Republic of Egypt,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),45000,http://www.chictr.org.cn/showproj.aspx?proj=56651
2415,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51
2416,EUCTR2020-000982-18-SE,EU Clinical Trials Register,2020-04-20,2020-03-06,True,Not Recruiting,Phase 3,Interventional,"Sweden, Norway",A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19).,1218,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18
2417,EUCTR2020-001498-63-FR,EU Clinical Trials Register,2020-04-03,2020-07-22,False,Authorised,Phase 2,Interventional,"France, United Kingdom, United States, Belgium","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63
2418,EUCTR2020-001172-15-DK,EU Clinical Trials Register,2020-03-23,2020-03-04,True,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15
2419,EUCTR2020-004206-59-DE,EU Clinical Trials Register,2020-09-23,2021-11-01,False,Authorised,Phase 2,Interventional,"South Africa, Belgium, Netherlands, Brazil, Spain, India, Germany, Bulgaria","Clinical trial, conducted at multiple trial sites, to test the safety and effectiveness of ATR-002 in hospitalized patients diagnosed with the lung disease COVID-19.",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004206-59
2420,EUCTR2020-003505-58-IT,EU Clinical Trials Register,2020-11-06,2021-07-01,False,Authorised,Phase 2,Interventional,Italy,Use of Inhaled liposomal -Cyclosporin-A in the treatment of moderate COVID-19-related pneumonia: a two-step phase II clinical trial,31,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003505-58
2421,EUCTR2020-002233-15-DE,EU Clinical Trials Register,2020-05-13,2020-06-17,False,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered in combination and compared to placebo in COVID-19 patients",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15
2422,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),440,https://clinicaltrials.gov/show/NCT04321278
2423,NCT04341688,ClinicalTrials.gov,2020-04-06,2021-02-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04341688
2424,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,90,https://clinicaltrials.gov/show/NCT04347538
2425,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-08-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),40,https://clinicaltrials.gov/show/NCT04347954
2426,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Not Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,102,https://clinicaltrials.gov/show/NCT04350320
2427,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,0,https://clinicaltrials.gov/show/NCT04351516
2428,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Recruiting,Phase 4,Interventional,"Spain, Argentina",Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,300,https://clinicaltrials.gov/show/NCT04355637
2429,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,False,Not Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,71,https://clinicaltrials.gov/show/NCT04364009
2430,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-08-05,False,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),252,https://clinicaltrials.gov/show/NCT04364763
2431,NCT04386447,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Not Recruiting,Phase 2,Interventional,"France, Italy",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,0,https://clinicaltrials.gov/show/NCT04386447
2432,NCT04390152,ClinicalTrials.gov,2020-05-12,2020-01-13,True,Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,40,https://clinicaltrials.gov/show/NCT04390152
2433,NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,False,Not Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,150,https://clinicaltrials.gov/show/NCT04405908
2434,NCT04406064,ClinicalTrials.gov,2020-05-26,2021-01-01,False,Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,0,https://clinicaltrials.gov/show/NCT04406064
2435,NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,False,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,48,https://clinicaltrials.gov/show/NCT04407689
2436,NCT04420676,ClinicalTrials.gov,2020-06-04,2020-09-24,False,Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,120,https://clinicaltrials.gov/show/NCT04420676
2437,NCT04425252,ClinicalTrials.gov,2020-06-09,2020-08-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,23,https://clinicaltrials.gov/show/NCT04425252
2438,NCT04435184,ClinicalTrials.gov,2020-06-16,2020-07-09,False,Not Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,50,https://clinicaltrials.gov/show/NCT04435184
2439,NCT04456452,ClinicalTrials.gov,2020-06-30,2020-07-27,False,Not Recruiting,Phase 1,Interventional,United States,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,10,https://clinicaltrials.gov/show/NCT04456452
2440,NCT04457817,ClinicalTrials.gov,2020-06-24,2020-12-01,False,Recruiting,Not Applicable,Interventional,United States,Compensatory Reserve Index (CRI) for Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04457817
2441,NCT04458363,ClinicalTrials.gov,2020-06-25,2020-07-04,False,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in Pediatric COVID-19,3,https://clinicaltrials.gov/show/NCT04458363
2442,NCT04460014,ClinicalTrials.gov,2020-07-06,2020-09-30,False,Recruiting,Not Applicable,Interventional,Sweden,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,164,https://clinicaltrials.gov/show/NCT04460014
2443,NCT04460183,ClinicalTrials.gov,2020-07-03,2020-07-29,False,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,300,https://clinicaltrials.gov/show/NCT04460183
2444,NCT04477954,ClinicalTrials.gov,2020-07-16,2020-07-06,True,Not Recruiting,Phase 2,Interventional,Argentina,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,40,https://clinicaltrials.gov/show/NCT04477954
2445,NCT04482387,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Recruiting,Not Applicable,Interventional,United Kingdom,DigiVis: Self-testing Vision App for Telephone Consultations,250,https://clinicaltrials.gov/show/NCT04482387
2446,NCT04515147,ClinicalTrials.gov,2020-08-13,2020-09-28,False,Not Recruiting,Phase 2,Interventional,"Panama, Peru","A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",674,https://clinicaltrials.gov/show/NCT04515147
2447,NCT04522089,ClinicalTrials.gov,2020-08-12,2020-08-24,False,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,70,https://clinicaltrials.gov/show/NCT04522089
2448,NCT04542941,ClinicalTrials.gov,2020-08-31,2020-06-16,True,Not Recruiting,Not Applicable,Interventional,Uganda,Assessment of Safety and Efficacy of CCP,136,https://clinicaltrials.gov/show/NCT04542941
2449,NCT04545541,ClinicalTrials.gov,2020-09-05,2020-11-01,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Nebulised Heparin in Patients With Severe COVID-19,300,https://clinicaltrials.gov/show/NCT04545541
2450,NCT04565392,ClinicalTrials.gov,2020-09-21,2021-05-01,False,Not Recruiting,Phase 4,Interventional,United States,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),150,https://clinicaltrials.gov/show/NCT04565392
2451,NCT04570397,ClinicalTrials.gov,2020-09-29,2020-12-18,False,Recruiting,Phase 3,Interventional,United States,Ravulizumab and COVID-19,32,https://clinicaltrials.gov/show/NCT04570397
2452,NCT04595695,ClinicalTrials.gov,2020-10-14,2020-09-03,True,Not Recruiting,Not Applicable,Interventional,United States,The Effect of Clear Masks in Improving Patient Relationships,200,https://clinicaltrials.gov/show/NCT04595695
2453,NCT04595903,ClinicalTrials.gov,2020-10-08,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,United States,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With HemopurifierÂ® Device,40,https://clinicaltrials.gov/show/NCT04595903
2454,NCT04609722,ClinicalTrials.gov,2020-10-26,2020-07-01,True,Recruiting,Not Applicable,Interventional,Turkey,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04609722
2455,NCT04610567,ClinicalTrials.gov,2020-10-24,2020-10-27,False,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),100,https://clinicaltrials.gov/show/NCT04610567
2456,NCT04636034,ClinicalTrials.gov,2020-11-18,2021-01-12,False,Recruiting,Phase 3,Interventional,Denmark,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04636034
2457,NCT04638842,ClinicalTrials.gov,2020-11-19,2020-12-24,False,Recruiting,Not Applicable,Interventional,Mexico,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,42,https://clinicaltrials.gov/show/NCT04638842
2458,NCT04663594,ClinicalTrials.gov,2020-11-27,2020-12-04,False,Recruiting,Not Applicable,Interventional,United Kingdom,Online Culture for Mental Health in People Aged 16-24,400,https://clinicaltrials.gov/show/NCT04663594
2459,NCT04683328,ClinicalTrials.gov,2020-12-20,2021-02-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,560,https://clinicaltrials.gov/show/NCT04683328
2460,NCT04686773,ClinicalTrials.gov,2020-12-25,2021-02-10,False,Not Recruiting,Phase 2,Interventional,Azerbaijan,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",100,https://clinicaltrials.gov/show/NCT04686773
2461,NCT04705753,ClinicalTrials.gov,2021-01-06,2020-04-01,True,Not Recruiting,Phase 2/Phase 3,Interventional,Greece,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",20,https://clinicaltrials.gov/show/NCT04705753
2462,NCT04706039,ClinicalTrials.gov,2021-01-08,2021-01-01,True,Not Recruiting,Not Applicable,Interventional,France,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,3000,https://clinicaltrials.gov/show/NCT04706039
2463,NCT04706416,ClinicalTrials.gov,2020-12-31,2020-11-14,True,Not Recruiting,Phase 1,Interventional,United States,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),50,https://clinicaltrials.gov/show/NCT04706416
2464,NCT04707742,ClinicalTrials.gov,2021-01-07,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,Spain,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,84,https://clinicaltrials.gov/show/NCT04707742
2465,NCT04707820,ClinicalTrials.gov,2020-12-29,2020-04-16,True,Recruiting,Not Applicable,Interventional,France,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04707820
2466,NCT04707833,ClinicalTrials.gov,2020-12-29,2020-11-26,True,Recruiting,Not Applicable,Interventional,France,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,385,https://clinicaltrials.gov/show/NCT04707833
2467,NCT04708158,ClinicalTrials.gov,2021-01-12,2021-01-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,Novaferon for COVID-19 Treatment Trial (NCTT-005),385,https://clinicaltrials.gov/show/NCT04708158
2468,NCT04708327,ClinicalTrials.gov,2021-01-12,2021-04-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,75,https://clinicaltrials.gov/show/NCT04708327
2469,NCT04708457,ClinicalTrials.gov,2020-12-04,2021-02-01,False,Not Recruiting,Not Applicable,Interventional,"Australia, Germany","The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO",12,https://clinicaltrials.gov/show/NCT04708457
2470,NCT04709146,ClinicalTrials.gov,2021-01-11,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The Influence of Covid-19 on the Audio-vestibular System,70,https://clinicaltrials.gov/show/NCT04709146
2471,NCT04709172,ClinicalTrials.gov,2021-01-12,2021-01-05,True,Recruiting,Phase 4,Interventional,Spain,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,30,https://clinicaltrials.gov/show/NCT04709172
2472,NCT04710316,ClinicalTrials.gov,2021-01-08,2021-01-30,False,Not Recruiting,Not Applicable,Interventional,Mali,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",450,https://clinicaltrials.gov/show/NCT04710316
2473,NCT04712045,ClinicalTrials.gov,2021-01-11,2020-08-01,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,67,https://clinicaltrials.gov/show/NCT04712045
2474,NCT04712279,ClinicalTrials.gov,2021-01-13,2021-01-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),294,https://clinicaltrials.gov/show/NCT04712279
2475,NCT04712357,ClinicalTrials.gov,2021-01-07,2020-11-09,True,Recruiting,Not Applicable,Interventional,Brazil,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,219,https://clinicaltrials.gov/show/NCT04712357
2476,NCT04713878,ClinicalTrials.gov,2021-01-09,2020-05-08,True,Not Recruiting,Not Applicable,Interventional,Turkey,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,21,https://clinicaltrials.gov/show/NCT04713878
2477,NCT04715360,ClinicalTrials.gov,2021-01-15,2020-12-29,True,Recruiting,Phase 1/Phase 2,Interventional,Indonesia,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,30,https://clinicaltrials.gov/show/NCT04715360
2478,ACTRN12621000034831,ANZCTR,2021-01-15,2020-11-20,True,Recruiting,Not Applicable,Interventional,South Africa,Virucidal pilot study of NasodineÂ® (povidone-iodine 0.5%) nasal spray in people in South Africa with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,15,https://anzctr.org.au/ACTRN12621000034831.aspx
2479,ACTRN12621000048886,ANZCTR,2021-01-19,2020-07-12,True,Recruiting,Not Applicable,Interventional,Australia,The feasibility and efficacy of self-collected nasopharyngeal specimens for COVID-19 detection in an Australian oncology population,274,https://anzctr.org.au/ACTRN12621000048886.aspx
2480,ACTRN12621000031864,ANZCTR,2021-01-15,2021-01-25,False,Not Recruiting,Not Applicable,Interventional,Australia,Home-based virtual rehabililtation for people with persistent symptoms after COVID-19 disease (Long COVID-19),32,https://anzctr.org.au/ACTRN12621000031864.aspx
2481,ISRCTN18107122,ISRCTN,2021-01-11,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Participatory digital interventions for front-line staff during the coronavirus (COVID-19) pandemic,180,http://isrctn.com/ISRCTN18107122
2482,ISRCTN74727214,ISRCTN,2020-08-10,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,Oman,Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support,75,http://isrctn.com/ISRCTN74727214
2483,ChiCTR2000039212,ChiCTR,2020-10-22,2020-10-28,False,Recruiting,Phase 1,Interventional,China,"A Phase Ib clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years",120,http://www.chictr.org.cn/showproj.aspx?proj=63183
2484,ChiCTR2000038152,ChiCTR,2020-09-11,2020-09-14,False,Not Recruiting,Phase 1,Interventional,China,"A Single-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4800, Administered Intradermally Followed by Electroporation in Healthy Volunteers",45,http://www.chictr.org.cn/showproj.aspx?proj=59326
2485,ChiCTR2000032573,ChiCTR,2020-05-02,2020-05-02,False,Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bufei Huoxue Capsule in the treatment of convalescent COVID-19 patients",120,http://www.chictr.org.cn/showproj.aspx?proj=53225
2486,JPRN-jRCT1030200309,JPRN,2021-01-18,2020-12-21,True,Recruiting,Not Applicable,Interventional,Japan,The effect of telephone instructions on physical activity in community-dwelling older adults.,300,https://jrct.niph.go.jp/latest-detail/jRCT1030200309
2487,JPRN-jRCT1030200310,JPRN,2021-01-18,2020-12-21,True,Recruiting,Not Applicable,Interventional,Japan,The effect of virtual community activity on physical activity in community-dwelling older adults.,300,https://jrct.niph.go.jp/latest-detail/jRCT1030200310
2488,CTRI/2020/03/024402,CTRI,2020-03-31,2020-08-04,False,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638
2489,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Hydroxychloroquine in addition to standard therapy in COVID-19 patients,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713
2490,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967
2491,CTRI/2020/04/024706,CTRI,2020-04-17,2020-04-21,False,Not Recruiting,Phase 2,Interventional,India,Effect of convalescent plasma  in COVID-19 patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43039
2492,CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,False,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912
2493,CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,False,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933
2494,CTRI/2020/04/024747,CTRI,2020-04-21,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115
2495,CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,False,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149
2496,CTRI/2020/04/024773,CTRI,2020-04-21,2020-01-05,True,Recruiting,Phase 3,Interventional,"Argentina, Qatar, Iran, Indonesia, Peru, South Africa, Canada, Norway, Brazil, Spain, Thailand, India, Germany, Switzerland",A clinical trial to study the effects of additional treatments for patients hospitalized and receiving treatment due to  COVID -19.,7000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897
2497,CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,False,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972
2498,CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,False,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843
2499,CTRI/2020/04/024804,CTRI,2020-04-22,2020-11-05,False,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849
2500,CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,False,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160
2501,CTRI/2020/04/024833,CTRI,2020-04-24,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105
2502,CTRI/2020/04/024846,CTRI,2020-04-24,2020-04-30,False,Recruiting,Phase 3,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004
2503,CTRI/2020/04/024857,CTRI,2020-04-25,2020-04-05,True,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212
2504,CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,False,Not Recruiting,Not Applicable,Interventional,India,"Ã¢??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236
2505,CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,False,Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899
2506,CTRI/2020/04/024904,CTRI,2020-04-28,2020-11-05,False,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130
2507,CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,False,Not Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168
2508,CTRI/2020/04/024915,CTRI,2020-04-29,2020-09-05,False,Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332
2509,CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,False,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364
2510,CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,False,Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400
2511,CTRI/2020/04/024947,CTRI,2020-04-30,2020-08-05,False,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259
2512,CTRI/2020/05/024967,CTRI,2020-05-01,2020-11-05,False,Not Recruiting,Phase 4,Interventional,India,Herbal product Clinical trial on COVID-19 patients,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338
2513,CTRI/2020/05/024959,CTRI,2020-05-01,2020-01-05,True,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878
2514,CTRI/2020/05/024969,CTRI,2020-05-01,2020-10-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393
2515,CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,False,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237
2516,CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374
2517,CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,False,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204
2518,CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,False,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455
2519,CTRI/2020/05/025013,CTRI,2020-05-05,2020-06-05,False,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858
2520,CTRI/2020/05/025022,CTRI,2020-05-05,2020-06-05,False,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183
2521,CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,False,Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,6950,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019
2522,CTRI/2020/05/025049,CTRI,2020-05-06,2020-08-05,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313
2523,CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,9200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522
2524,CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,False,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449
2525,CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,False,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447
2526,CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555
2527,CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539
2528,CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,False,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504
2529,CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590
2530,CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,False,Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650
2531,CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,False,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442
2532,CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553
2533,CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,False,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557
2534,CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,False,Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378
2535,CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,False,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487
2536,CTRI/2020/05/025213,CTRI,2020-05-15,2020-05-23,False,Not Recruiting,Not Applicable,Interventional,India,Ayurveda formulation for COVID-19 prevention,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698
2537,CTRI/2020/05/025205,CTRI,2020-05-15,2020-05-24,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Arsenicum album Ã¢?? 30 as prophylactic for Covid-19,33000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721
2538,CTRI/2020/05/025214,CTRI,2020-05-15,2020-05-24,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine for the treatment of COVID-19,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727
2539,CTRI/2020/05/025209,CTRI,2020-05-15,2020-05-20,False,Recruiting,Phase 2,Interventional,India,A clinical trial for validating therapeutic efficacy of convalescent plasma in severe COVID-19 disease,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251
2540,CTRI/2020/05/025215,CTRI,2020-05-16,2020-05-25,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,"Effectiveness of Siddha medicine, Kabasura kudineer and vitamin c-zinc supplementation in the management of Mild COVID 19 patients.",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769
2541,CTRI/2020/05/025222,CTRI,2020-05-18,2020-01-06,True,Not Recruiting,Phase 4,Interventional,India,Efficacy of Tablet AOIM - Z in Prevention of  COVID - 19   in High Risk Healthy Police Personnel,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803
2542,CTRI/2020/05/025224,CTRI,2020-05-18,2020-05-24,False,Not Recruiting,Phase 2,Interventional,India,Study to efficacy of Ivermectin in patients of COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728
2543,CTRI/2020/05/025242,CTRI,2020-05-19,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,India,Hydroxychloroquine of pharmacokinetics in healthcare workers,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057
2544,CTRI/2020/05/025272,CTRI,2020-05-20,2020-05-30,False,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the efficacy of Homoeopathic medicine in the prevention of Covid-19 
",800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790
2545,CTRI/2020/05/025254,CTRI,2020-05-20,2020-05-29,False,Not Recruiting,Phase 3,Interventional,India,To Study effectiveness and outcomes of Unani Medicine prophylactic interventions on population at risk of COVID-19,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630
2546,CTRI/2020/05/025276,CTRI,2020-05-20,2020-05-29,False,Not Recruiting,Phase 3,Interventional,India,effect of Ayurvedic intervention in COVID-19 positive cases,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892
2547,CTRI/2020/05/025273,CTRI,2020-05-20,2020-05-29,False,Not Recruiting,Not Applicable,Interventional,India,Impact of effect of Ayurvedic treatment on novel Corona virus disease,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900
2548,CTRI/2020/05/025275,CTRI,2020-05-20,2020-05-30,False,Not Recruiting,Phase 3,Interventional,India,Role of Chyawanprash in the prevention of COVID-19 in health care workers,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917
2549,CTRI/2020/05/025271,CTRI,2020-05-20,2020-05-31,False,Recruiting,Phase 3,Interventional,India,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206
2550,CTRI/2020/05/025248,CTRI,2020-05-20,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,India,COVID-19 telephonic counseling model for addressing mental health concerns in different populations during corona outbreak in India,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479
2551,CTRI/2020/05/025277,CTRI,2020-05-21,2020-05-31,False,Recruiting,Phase 3,Interventional,India,Clinical Trial of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176
2552,CTRI/2020/05/025299,CTRI,2020-05-21,2020-01-06,True,Not Recruiting,Phase 2,Interventional,India,Convalescent Plasma treatment trial in COVID 19 patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752
2553,CTRI/2020/05/025298,CTRI,2020-05-21,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,India,Siddha Intervention Population Study.,21500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761
2554,CTRI/2020/05/025320,CTRI,2020-05-22,2020-05-22,False,Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Yoga & Naturopathy in patients with COVID-19,658,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576
2555,CTRI/2020/05/025317,CTRI,2020-05-22,2020-05-26,False,Not Recruiting,Phase 4,Interventional,India,SURVEY OF MOUTH-DISSOLVING TURMERIC LOZENGES IN HEALTHCARE WORKERS,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754
2556,CTRI/2020/05/025319,CTRI,2020-05-22,2020-01-06,True,Recruiting,Phase 3,Interventional,India,Trial of antihypertensive losartan for additional benefit in treating COVID 19 infection.,186,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751
2557,CTRI/2020/05/025331,CTRI,2020-05-23,2020-05-24,False,Not Recruiting,Not Applicable,Interventional,India,Home based prehabilitation via telemedicine in lung cancer patients during COVID 19,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339
2558,CTRI/2020/05/025326,CTRI,2020-05-23,2020-05-31,False,Not Recruiting,Phase 2,Interventional,India,Tablet PINAK given as treatment  to COVID positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951
2559,CTRI/2020/05/025328,CTRI,2020-05-23,2020-01-06,True,Not Recruiting,Phase 2,Interventional,India,Study to Assess the Safety and Efficacy of Convalescent Plasma on outcome of COVID-19 Associated Complications,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703
2560,CTRI/2020/05/025338,CTRI,2020-05-24,2020-02-06,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033
2561,CTRI/2020/05/025336,CTRI,2020-05-24,2020-01-06,True,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934
2562,CTRI/2020/05/025334,CTRI,2020-05-24,2020-05-30,False,Not Recruiting,Phase 2,Interventional,India,Protect and prevent onset of COVID like infections in Health Care Workers and High risk person.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935
2563,CTRI/2020/05/025337,CTRI,2020-05-24,2020-01-06,True,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940
2564,CTRI/2020/05/025335,CTRI,2020-05-24,2020-06-20,False,Not Recruiting,Phase 3,Interventional,India,"Efficacy of AYUSH-64 (a polyherbal formulation) in COVID - 19 Cases
",40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949
2565,CTRI/2020/05/025341,CTRI,2020-05-24,2020-02-06,True,Recruiting,Not Applicable,Interventional,India,A study to know the effect of Ayurvedic Kwath(Kiratiktadi Kwath) & Ashwagandha Churna along with yoga exercises in the treatment of COVID-19 Positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013
2566,CTRI/2020/05/025343,CTRI,2020-05-25,2020-05-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study results of Ayurvedic treatment on COVID patients using proprietary herbal formulation SUVED and whole colostrum REIMMUGEN.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919
2567,CTRI/2020/05/025346,CTRI,2020-05-25,2020-01-06,True,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Assess the Safety and Efficacy of Convalescent Plasma in Severe Covid-19 patients.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005
2568,CTRI/2020/05/025350,CTRI,2020-05-26,2020-05-31,False,Not Recruiting,Phase 2,Interventional,India,Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559
2569,CTRI/2020/05/025370,CTRI,2020-05-27,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,India,Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064
2570,CTRI/2020/05/025385,CTRI,2020-05-27,2020-01-06,True,Not Recruiting,Not Applicable,Interventional,India,Research study to evaluate the impact of Selected Ayurvedic interventions in containment zone,30000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953
2571,CTRI/2020/05/025369,CTRI,2020-05-27,2020-05-30,False,Recruiting,Phase 3,Interventional,India,A study on treatment of COVID-19 patients with study drug along with standard of care,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485
2572,CTRI/2020/05/025425,CTRI,2020-05-28,2020-02-06,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic intervention (Chyawanprash) in the prevention of COVID-19 pandemic  among Health Care Personnel,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043
2573,CTRI/2020/05/025398,CTRI,2020-05-28,2020-05-28,False,Recruiting,Not Applicable,Interventional,India,Study to find out the results of Ayurvedic Kwath & Ashwagandha churna with Yoga exercises to prevent our health workers against corona virus infection.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831
2574,CTRI/2020/05/025397,CTRI,2020-05-28,2020-05-06,True,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect and safety of a phytopharmaceutical drug in treatment of Coronavirus infection,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702
2575,CTRI/2020/05/025429,CTRI,2020-05-29,2020-10-06,False,Recruiting,Phase 2/Phase 3,Interventional,India,effect of Ashwagandha (Withania somnifera) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058
2576,CTRI/2020/05/025434,CTRI,2020-05-29,2020-05-31,False,Recruiting,Phase 4,Interventional,India,A clinical trial to evaluate the Medicinal effects of ZingiVir-H as Anti-Viral therapy in COVID-19 patients.,135,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957
2577,CTRI/2020/05/025483,CTRI,2020-05-30,2020-02-06,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Use of Clevira in COVID19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041
2578,CTRI/2020/05/025485,CTRI,2020-05-30,2020-06-29,False,Recruiting,Phase 2/Phase 3,Interventional,India,the effect of Guduchi (Tinospora cordifolia) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052
2579,CTRI/2020/05/025484,CTRI,2020-05-30,2020-03-06,True,Recruiting,Phase 2/Phase 3,Interventional,India,study on the effect of Chyavanprash Lehyam as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055
2580,CTRI/2020/05/025490,CTRI,2020-05-31,2020-07-06,False,Recruiting,Phase 2/Phase 3,Interventional,India,A Clinical trial to study the efficacy of pH based Integrated  SARS Cov-2 Immunity in Human Subjects.,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042
2581,CTRI/2020/05/025488,CTRI,2020-05-31,2020-03-06,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Guduchi Ghana Vati as a preventive remedy in pandemic of COVID-19,12000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062
2582,CTRI/2020/05/025491,CTRI,2020-05-31,2020-08-06,False,Recruiting,Phase 2,Interventional,India,The efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065
2583,CTRI/2020/05/025489,CTRI,2020-05-31,2020-01-06,True,Recruiting,Not Applicable,Interventional,India,To compare two intubation scopes for securing the airway during COVID pandemic in patients undergoing surgery,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376
2584,CTRI/2020/05/025492,CTRI,2020-05-31,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,India,Impact of tele-consultation for following up newborns during COVID-19 pandemic,2978,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382
2585,CTRI/2020/05/025496,CTRI,2020-05-31,2020-08-06,False,Recruiting,Phase 1,Interventional,India,Study to observe safety of CNV01 homeopathy preparation in healthy volunteers,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192
2586,CTRI/2020/06/025523,CTRI,2020-06-01,2020-08-06,False,Not Recruiting,Not Applicable,Interventional,India,The effect of meditation on well-being of SARS-Cov-2 infected patients.,84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396
2587,CTRI/2020/06/025522,CTRI,2020-06-01,2020-02-06,True,Not Recruiting,Not Applicable,Interventional,India,Comparison of two devices for intubation in COVID simulated scenario in mannequin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438
2588,CTRI/2020/06/025527,CTRI,2020-06-01,2020-01-06,True,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968
2589,CTRI/2020/06/025557,CTRI,2020-06-02,2020-11-06,False,Recruiting,Phase 2,Interventional,India,A clinical study of  Ayurvedic formulations  in the treatment  of Mild to Moderate COVID-19 patients,420,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812
2590,CTRI/2020/06/025530,CTRI,2020-06-02,2020-06-18,False,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for Prevention and Treatment of Viral Fevers including COVID19,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305
2591,CTRI/2020/06/025556,CTRI,2020-06-02,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to know the effect of VirulinaÃ‚Â® along with standard treatment in covid 19 positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144
2592,CTRI/2020/06/025558,CTRI,2020-06-02,2020-06-15,False,Not Recruiting,Phase 4,Interventional,India,Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411
2593,CTRI/2020/06/025575,CTRI,2020-06-03,2020-06-15,False,Recruiting,Phase 3/Phase 4,Interventional,India,Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trial,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076
2594,CTRI/2020/06/025590,CTRI,2020-06-03,2020-08-06,False,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate safety and efficacy of polyherbal capsule Astha-15 used as an add on therapy with standard care of therapy as an immunity booster in the suspected and COVID-19 diagnosed patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121
2595,CTRI/2020/06/025589,CTRI,2020-06-03,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,India,comparison of two different  laryngoscopes using COVID barrier box,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164
2596,CTRI/2020/06/025613,CTRI,2020-06-04,2020-06-15,False,Not Recruiting,Phase 4,Interventional,India,Melatonin Immune Boost COVID 19 Study,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346
2597,CTRI/2020/06/025637,CTRI,2020-06-05,2020-06-22,False,Not Recruiting,Not Applicable,Interventional,India,"As the present outbreak of novel coronavirus in Indian scenario we want to study about the prophylactic study in Distric Hospital, Vidisha.",10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550
2598,CTRI/2020/06/025625,CTRI,2020-06-05,2020-11-05,False,Recruiting,Phase 2,Interventional,India,Study of the effect of Siddha Treatment in addition to standard therapy in COVID-19 patients,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345
2599,CTRI/2020/06/025664,CTRI,2020-06-05,2020-06-15,False,Recruiting,Phase 2,Interventional,India,Phase II study to evaluate the Safety and Efficacy of 2-Deoxy-D-Glucose in COVID -19 patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369
2600,CTRI/2020/06/025650,CTRI,2020-06-05,2020-06-15,False,Not Recruiting,Phase 2,Interventional,India,To assess the safety and outcome of herbal medicine in prevention of COVID-19 infection among high risk population,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412
2601,CTRI/2020/06/025672,CTRI,2020-06-06,2020-06-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,To evaluate the effect of herbal medicine in prevention and management of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415
2602,CTRI/2020/06/025671,CTRI,2020-06-06,2020-06-15,False,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425
2603,CTRI/2020/06/025702,CTRI,2020-06-08,2020-06-15,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Clinical Trial On Mildly Symptomatic Covid -19 Patients And Health Care Workers Posted To Covid Wards

",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376
2604,CTRI/2020/06/025704,CTRI,2020-06-08,2020-01-07,True,Not Recruiting,Phase 3,Interventional,India,Ulinastatin for COVID-19 in patients with breathlessness,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170
2605,CTRI/2020/06/025714,CTRI,2020-06-08,2020-02-06,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Holistic Health Management through Yoga and Naturopathy for Frontline COVID Health Care Providers Ã¢?? The H2M trial,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020
2606,CTRI/2020/06/025763,CTRI,2020-06-09,2020-07-17,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Randomized controlled Clinical Trial to determine the efficacy of Siddha drugs in COVID 19 patients,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340
2607,CTRI/2020/06/025766,CTRI,2020-06-09,2020-11-06,False,Not Recruiting,Not Applicable,Interventional,India,A study of 254nm UVC ray therapy in pharynx for asymptomatic to mild cases of Corona Virus Disease,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171
2608,CTRI/2020/06/025760,CTRI,2020-06-09,2020-06-17,False,Not Recruiting,Phase 3,Interventional,India,A clinical trial to study the effect of drug named Sofosbuvir in hospitalized patients with COVID 19.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441
2609,CTRI/2020/06/025768,CTRI,2020-06-09,2020-07-20,False,Recruiting,Phase 2/Phase 3,Interventional,India,An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445
2610,CTRI/2020/06/025762,CTRI,2020-06-09,2020-06-15,False,Not Recruiting,Phase 3,Interventional,India,"An Open-Label Randomized Controlled, Proof-of-Concept (PoC) Study to
Evaluate the Safety and Efficacy of selected Siddha formulations in patients
diagnosed with COVID-19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259
2611,CTRI/2020/06/025769,CTRI,2020-06-09,2020-06-15,False,Recruiting,Phase 2/Phase 3,Interventional,India,"A prophylactic interventional study to determine the possible protective effect of Siddha Polyherbal formulation Kabasura Kudineer against the COVID 19 on
intermittent, month-long consumption by public with close contacts to COVID patients and frontline workers in Tamil Nadu, India",40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260
2612,CTRI/2020/06/025801,CTRI,2020-06-10,2020-06-19,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Role of Herbal Immunomodulators   in mild COVID-19 confirmed cases,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293
2613,CTRI/2020/06/025796,CTRI,2020-06-10,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,India,Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181
2614,CTRI/2020/06/025798,CTRI,2020-06-10,2020-06-18,False,Not Recruiting,Phase 4,Interventional,India,A Clinical trial to establish the appropriate line of management of Non Muscle Invasive Bladder Cancers who have had their intravesical BCG therapy interrupted,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460
2615,CTRI/2020/06/025779,CTRI,2020-06-10,2020-06-17,False,Not Recruiting,Not Applicable,Interventional,India,Study of AYUSH KWATH in quarantine persons,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463
2616,CTRI/2020/06/025799,CTRI,2020-06-10,2020-06-17,False,Not Recruiting,Phase 3,Interventional,India,"A study of Favipiravir in patients with mild to moderate coronavirus disease (COVID-19)
",156,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480
2617,CTRI/2020/06/025800,CTRI,2020-06-10,2020-06-22,False,Not Recruiting,Phase 2,Interventional,India,Role of Ayurveda in Covid 19 management.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485
2618,CTRI/2020/06/025804,CTRI,2020-06-11,2020-06-20,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of lying face down in improving the outcome of COVID-19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572
2619,CTRI/2020/06/025803,CTRI,2020-06-11,2020-06-18,False,Recruiting,Phase 3,Interventional,India,Effect of convalescent plasma in COVID-19 patients,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478
2620,CTRI/2020/06/025849,CTRI,2020-06-12,2020-06-15,False,Not Recruiting,Phase 2,Interventional,India,Study to Evaluate the Safety and Efficacy of a Combination of Nitazoxanide and Hydroxychloroquine Versus Hydroxychloroquine Alone in COVID-19 Patients,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408
2621,CTRI/2020/06/025852,CTRI,2020-06-12,2020-06-14,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,RNB in UPUMS SAIFAI,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204
2622,CTRI/2020/06/025844,CTRI,2020-06-12,2020-06-22,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Pre-Identified Homoeopathic Medicines In Asymptomatic Covid -19 Individuals Receiving Standard Treatment Protocol,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760
2623,CTRI/2020/06/025854,CTRI,2020-06-13,2020-06-25,False,Not Recruiting,Not Applicable,Interventional,India,BCG vaccination against COVID-19,1450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078
2624,CTRI/2020/06/025856,CTRI,2020-06-13,2020-06-25,False,Not Recruiting,Phase 2,Interventional,India,Evaluation of siddha regimen in the management of covid 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606
2625,CTRI/2020/06/025855,CTRI,2020-06-13,2020-06-15,False,Not Recruiting,Phase 2,Interventional,India,Effect of AYUSH 64 in COVID 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386
2626,CTRI/2020/06/025861,CTRI,2020-06-14,2020-06-20,False,Recruiting,Phase 3,Interventional,India,Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level study,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072
2627,CTRI/2020/06/025862,CTRI,2020-06-14,2020-06-13,True,Recruiting,Phase 1,Interventional,India,Low Dose Radiation Therapy for COVID-19,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858
2628,CTRI/2020/06/025874,CTRI,2020-06-15,2020-06-24,False,Not Recruiting,Phase 2,Interventional,India,To observe the effect of Siddha formulation Kabasura kudineer in COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684
2629,CTRI/2020/06/025927,CTRI,2020-06-16,2020-06-20,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of C-MAC and Mc-GRATH laryngoscopes for intubation in COVID scenario.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316
2630,CTRI/2020/06/025928,CTRI,2020-06-16,2020-06-30,False,Recruiting,Not Applicable,Interventional,India,Local application of Povidone Iodine solution in nose and oral gargle for house hold contacts of COVID19 cases,204,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664
2631,CTRI/2020/06/025917,CTRI,2020-06-16,2020-06-28,False,Not Recruiting,Not Applicable,Interventional,India,Psychological assessment of the health care-workers amid COVID-19 working at a tertiary care teaching hospital of the central India and impact of tele-counselling on their psychological problems,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505
2632,CTRI/2020/06/025957,CTRI,2020-06-17,2020-06-29,False,Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir and Umifenovir Compared to Favipiravir alone in Hospitalized Patients with Moderate COVID-19.,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709
2633,CTRI/2020/06/025977,CTRI,2020-06-18,2020-06-22,False,Not Recruiting,Phase 2,Interventional,India,Clinical Study to Study Safety and Efficacy of herbal formulation - Aayudh Advance,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449
2634,CTRI/2020/06/025996,CTRI,2020-06-19,2020-06-27,False,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622
2635,CTRI/2020/06/025998,CTRI,2020-06-20,2020-06-30,False,Not Recruiting,Phase 3,Interventional,India,Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707
2636,CTRI/2020/06/026001,CTRI,2020-06-21,2020-06-25,False,Recruiting,Phase 2/Phase 3,Interventional,India,Ivermectin in COVID,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196
2637,CTRI/2020/06/025999,CTRI,2020-06-21,2020-06-27,False,Not Recruiting,Phase 2,Interventional,India,Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764
2638,CTRI/2020/06/026002,CTRI,2020-06-21,2020-01-07,True,Not Recruiting,Phase 2,Interventional,India,Study of use of Ayurveda Intervention (Ayush-64) in COVID 19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799
2639,CTRI/2020/06/026045,CTRI,2020-06-22,2020-01-07,True,Not Recruiting,Phase 3,Interventional,India,A study to improve the resistance against Covid 19 illness with the help of Homoeopathic remedies.,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677
2640,CTRI/2020/06/026055,CTRI,2020-06-23,2020-06-26,False,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306
2641,CTRI/2020/06/026056,CTRI,2020-06-23,2020-06-26,False,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130
2642,CTRI/2020/06/026087,CTRI,2020-06-23,2020-08-07,False,Not Recruiting,Phase 2,Interventional,India,"Phase II, randomized, controlled, open-label study of
Pegylated IFN alfa-2b with SARS-CoV-2",40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775
2643,CTRI/2020/06/026123,CTRI,2020-06-24,2020-06-25,False,Not Recruiting,Phase 2,Interventional,India,Plasma therapy in corona patients(Severe COVID-19).,472,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667
2644,CTRI/2020/06/026119,CTRI,2020-06-24,2020-06-30,False,Not Recruiting,Not Applicable,Interventional,India,"Efficacy of Arsenic Album 30C and 200C potency in mild case of COVID-19 positive . (Isolation ward of Sir T General Hospital, Bhavnagar) patients: A randomized controlled study.",90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218
2645,CTRI/2020/06/026147,CTRI,2020-06-25,2020-10-06,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among quarantined individuals exposed to COVID 19 patients,604,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778
2646,CTRI/2020/06/026151,CTRI,2020-06-25,2020-10-06,False,Not Recruiting,Phase 2,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among healthcare workers,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770
2647,CTRI/2020/06/026161,CTRI,2020-06-26,2020-09-21,False,Not Recruiting,Not Applicable,Interventional,India,Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation II [Sanshamani Vati Plus] as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832
2648,CTRI/2020/06/026181,CTRI,2020-06-26,2020-04-07,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Herbal Steaminhaler clinical trial on  COVID patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976
2649,CTRI/2020/06/026190,CTRI,2020-06-26,2020-07-14,False,Not Recruiting,Phase 2,Interventional,India,A Trial of Shirashadi Kasai in patients with Covid-19,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005
2650,CTRI/2020/06/026187,CTRI,2020-06-26,2020-05-07,True,Not Recruiting,Phase 2,Interventional,India,Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027
2651,CTRI/2020/06/026189,CTRI,2020-06-26,2020-01-08,True,Not Recruiting,Phase 2,Interventional,India,"To Compare the safety and efficacy of Vitamin D, with Magnesium in mild to moderate Covid 19 patients",210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029
2652,CTRI/2020/06/026191,CTRI,2020-06-27,2020-01-08,True,Not Recruiting,Phase 2,Interventional,India,"To study the safety and efficacy   of Vitamin D3, Vitamin K2-7 & magnesium ,  in prevention of COVID 19 infection in health care professional (HCP)",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075
2653,CTRI/2020/06/026192,CTRI,2020-06-28,2020-07-13,False,Not Recruiting,Phase 2,Interventional,"India, Russian Federation, Ukraine, United Kingdom",The study of C21 in hospitalised subjects with COVID-19 infection not requiring mechanical ventilation,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815
2654,CTRI/2020/06/026194,CTRI,2020-06-28,2020-06-30,False,Not Recruiting,Not Applicable,Interventional,India,Using N-acetylcysteine as therapeutic drug for COVID-19 patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44341
2655,CTRI/2020/06/026195,CTRI,2020-06-28,2020-08-07,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as an add-on in treatment of COVID-19,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129
2656,CTRI/2020/06/026196,CTRI,2020-06-28,2020-08-15,False,Not Recruiting,Phase 3/Phase 4,Interventional,"Ghana, South Africa, Benin, United Kingdom, Italy, Mexico, Rwanda, India, Nigeria",Prevention of Respiratory Complications In At Surgery in COVID-19 Pandemic,6400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482
2657,CTRI/2020/06/026193,CTRI,2020-06-28,2020-07-30,False,Recruiting,Not Applicable,Interventional,India,A study of drug Lithium on patients of Covid 19 disease,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766
2658,CTRI/2020/06/026197,CTRI,2020-06-28,2020-06-07,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Validation of Classical Ayurvedic formulations in treatment of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052
2659,CTRI/2020/06/026228,CTRI,2020-06-29,2020-06-29,False,Not Recruiting,Phase 2,Interventional,"Sweden, Russian Federation, Italy, Brazil, Spain, Turkey, Japan, France, India, Germany",Study in Hospitalized COVID-19 patients with Acalabrutinib along with the Best Supportive Care versus Best Supportive Care,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554
2660,CTRI/2020/06/026222,CTRI,2020-06-29,2020-06-29,False,Not Recruiting,Phase 2,Interventional,India,Intravenous Immunoglobulin Therapy in the treatment of Moderate Pneumonia in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299
2661,CTRI/2020/06/026227,CTRI,2020-06-29,2020-07-07,False,Not Recruiting,Phase 3,Interventional,India,"A Study on Unani regimen 
for prevention of high/moderate risk population of COVID 19",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584
2662,CTRI/2020/06/026229,CTRI,2020-06-29,2020-10-07,False,Recruiting,Phase 2,Interventional,India,A clinical trial of Ayurveda formulations in COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105
2663,CTRI/2020/06/026220,CTRI,2020-06-29,2020-07-17,False,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the efficacy and safety of Nafamostat Mesilate in treatment of Coronavirus infection,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350
2664,CTRI/2020/06/026232,CTRI,2020-06-29,2020-10-07,False,Not Recruiting,Phase 3,Interventional,India,Ivermectin in the prevention of covid-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156
2665,CTRI/2020/06/026231,CTRI,2020-06-29,2020-07-15,False,Not Recruiting,Not Applicable,Interventional,India,"To study effect of ayurvedic treatment for prevention and management of asymptomatic, mild and moderate cases of COVID-19.",160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497
2666,CTRI/2020/06/026221,CTRI,2020-06-29,2020-01-07,True,Not Recruiting,Phase 2,Interventional,India,Intervention of Ayurvedic Medicine (Arogya Kashayam) in Covid-19 positive cases (Asymptomatic and Mild Symptomatic),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542
2667,CTRI/2020/06/026262,CTRI,2020-06-30,2020-01-07,True,Not Recruiting,Not Applicable,Interventional,India,"Single Center,Study on Evaluation of use of,Ã¢??AYURCOVÃ¢?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889
2668,CTRI/2020/07/026301,CTRI,2020-07-01,2020-08-07,False,Not Recruiting,Not Applicable,Interventional,India,Role of Yoga in deStressing HCWs in COVID-19 : A RCT,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651
2669,CTRI/2020/07/026337,CTRI,2020-07-02,2020-11-07,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,The Covid-19 Study with Ayurveda add-on to ICMR Guideline,36,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863
2670,CTRI/2020/07/026338,CTRI,2020-07-02,2020-07-13,False,Not Recruiting,Not Applicable,Interventional,India,Study to assess the Health care workersÃ¢?? knowledge of the Medical cause of death certification for COVID-19 related deaths in cancer patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181
2671,CTRI/2020/07/026340,CTRI,2020-07-02,2020-11-07,False,Not Recruiting,Not Applicable,Interventional,India,To study the role of Zinc combined with standard treatment for COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929
2672,CTRI/2020/07/026343,CTRI,2020-07-03,2020-11-07,False,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana treatment as an addon therapy to improve the results in management of coronavirus disease,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204
2673,CTRI/2020/07/026349,CTRI,2020-07-03,2020-04-07,True,Recruiting,Phase 3,Interventional,India,Effect of awake proning in patients with COVID-19 related respiratory failure,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918
2674,CTRI/2020/07/026355,CTRI,2020-07-04,2020-07-14,False,Not Recruiting,Not Applicable,Interventional,India,"Evaluation Of The Efficacy of AYUSH KWATH in The Prevention  of COVID-19 

",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327
2675,CTRI/2020/07/026354,CTRI,2020-07-04,2020-07-13,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Clinical trial of ozone therapy  in mild to moderate Covid-19 subjects.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173
2676,CTRI/2020/07/026353,CTRI,2020-07-04,2020-12-07,False,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266
2677,CTRI/2020/07/026352,CTRI,2020-07-04,2020-07-13,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects.,1048,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306
2678,CTRI/2020/07/026371,CTRI,2020-07-05,2020-07-13,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272
2679,CTRI/2020/07/026431,CTRI,2020-07-08,2020-01-09,True,Not Recruiting,Phase 1/Phase 2,Interventional,India,A clinical trial to find out the effectiveness of traditional awareness method and anticipatory guidance through motivational interviewing.,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340
2680,CTRI/2020/07/026433,CTRI,2020-07-08,2020-07-15,False,Not Recruiting,Not Applicable,Interventional,India,Effect of Ayurveda medicinein Covid-19 mild symptoms,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252
2681,CTRI/2020/07/026463,CTRI,2020-07-09,2020-10-07,False,Recruiting,Not Applicable,Interventional,India,Clinical study to evaluate efficacy and safety of GanjhuVir syrup and tablet in Covid-19 positive patients.,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844
2682,CTRI/2020/07/026462,CTRI,2020-07-09,2020-07-20,False,Not Recruiting,Phase 3,Interventional,India,A study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of asymptomatic mild to moderate symptomatic cases.,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637
2683,CTRI/2020/07/026471,CTRI,2020-07-10,2020-07-20,False,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus disease,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318
2684,CTRI/2020/07/026469,CTRI,2020-07-10,2020-07-14,False,Not Recruiting,Phase 4,Interventional,India,Rapid diagnostic test for the detection of COVID-19 antibodies,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336
2685,CTRI/2020/07/026468,CTRI,2020-07-10,2020-09-18,False,Recruiting,Not Applicable,Interventional,India,"Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients 
",140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844
2686,CTRI/2020/07/026470,CTRI,2020-07-10,2020-07-15,False,Not Recruiting,Phase 2,Interventional,India,Safety and Effectiveness of  Siddha Sastric Medicines for the Management of Covid-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363
2687,CTRI/2020/07/026514,CTRI,2020-07-13,2020-07-22,False,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19 Cancer Patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580
2688,CTRI/2020/07/026515,CTRI,2020-07-13,2020-07-22,False,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection with Cancer Patients.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584
2689,CTRI/2020/07/026532,CTRI,2020-07-13,2020-07-14,False,Not Recruiting,Not Applicable,Interventional,India,Comparison to two different position to relieve difficulty in breathing in COVID- 19 patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354
2690,CTRI/2020/07/026534,CTRI,2020-07-13,2020-07-20,False,Not Recruiting,Phase 3,Interventional,India,Study of antiviral nutraceutical PICOVRID in COVID 19 patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137
2691,CTRI/2020/07/026529,CTRI,2020-07-13,2020-07-20,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Study to evaluate the safety and efficacy of Eflornithine against the standard of care in human adult hospitalized COVID-19 patients,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475
2692,CTRI/2020/07/026528,CTRI,2020-07-13,2020-08-13,False,Not Recruiting,Not Applicable,Interventional,India,Herbal formulation for immunity boosting during pandemic,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269
2693,CTRI/2020/07/026530,CTRI,2020-07-13,2020-01-08,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurvedic formulations for the prevention of COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532
2694,CTRI/2020/07/026535,CTRI,2020-07-13,2020-07-20,False,Not Recruiting,Not Applicable,Interventional,India,A clinical study to observe the effects of 8.4% Sodium Bicarbonate impregnated steam inhalation on Covid-19 infected patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535
2695,CTRI/2020/07/026560,CTRI,2020-07-14,2020-07-21,False,Not Recruiting,Phase 3,Interventional,India,Neem Prophylaxis for Subjects Coming in Contact with COVID-19 Patients,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385
2696,CTRI/2020/07/026575,CTRI,2020-07-14,2020-07-20,False,Not Recruiting,Phase 2,Interventional,India,Sahadevi Choorna for COVID 19,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500
2697,CTRI/2020/07/026570,CTRI,2020-07-14,2020-07-15,False,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of Ayurvedic Capsule in mild to moderate COVID-19 infection.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007
2698,CTRI/2020/07/026579,CTRI,2020-07-14,2020-07-24,False,Not Recruiting,Phase 3,Interventional,India,Role of Herbal Immunomodulators in in Boosting the Immunity among healthcare workers assigned to COVID-19 wards,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034
2699,CTRI/2020/07/026568,CTRI,2020-07-14,2020-07-15,False,Not Recruiting,Not Applicable,Interventional,India,Ayurveda Rasayan therapy for reducing risk of COVID infection in high risk individuals with comorbidities,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035
2700,CTRI/2020/07/026602,CTRI,2020-07-15,2020-07-24,False,Not Recruiting,Phase 2,Interventional,India,Study of an Ayurveda regimen in COVID Positive patients,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628
2701,CTRI/2020/07/026608,CTRI,2020-07-15,2020-07-27,False,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to study the effects of two drugs methylprednisolone and dexamethasone in patients with severe COVID-19,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638
2702,CTRI/2020/07/026609,CTRI,2020-07-15,2020-07-24,False,Not Recruiting,Not Applicable,Interventional,India,Yoganidra benefits on COVID health care workers,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139
2703,CTRI/2020/07/026607,CTRI,2020-07-15,2020-07-22,False,Not Recruiting,Phase 2,Interventional,India,Evaluation of Non Invasive Ventilator,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998
2704,CTRI/2020/07/026601,CTRI,2020-07-15,2020-07-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A study to check effect of an Ayurvedic treatment on corona positive patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564
2705,CTRI/2020/07/026630,CTRI,2020-07-16,2020-07-22,False,Recruiting,Phase 2,Interventional,India,Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581
2706,CTRI/2020/07/026632,CTRI,2020-07-16,2020-07-27,False,Not Recruiting,Phase 2,Interventional,India,Siddha Treatment for COVID 19- a Pilot Study,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680
2707,CTRI/2020/07/026631,CTRI,2020-07-16,2020-07-19,False,Not Recruiting,Not Applicable,Interventional,India,Uses of herbal combination by taking it in hot water  in  covid 19 positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494
2708,CTRI/2020/07/026667,CTRI,2020-07-17,2020-07-17,False,Not Recruiting,Not Applicable,Interventional,India,: Efficacy of Pranayama on Positivity rate in People exposed to Covid-19 Patients and mental status,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342
2709,CTRI/2020/07/026669,CTRI,2020-07-18,2020-03-08,True,Not Recruiting,Not Applicable,Interventional,India,Unani Herbal tablets for mild cases od Covid 19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623
2710,CTRI/2020/07/026673,CTRI,2020-07-18,2020-05-08,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,Siddha formulations for the prevention of COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673
2711,CTRI/2020/07/026668,CTRI,2020-07-18,2020-05-08,True,Not Recruiting,Not Applicable,Interventional,India,To study the effect of BCG vaccine in Reducing the Incidence and severity of COVID-19 in the high-risk population,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677
2712,CTRI/2020/07/026670,CTRI,2020-07-18,2020-07-28,False,Not Recruiting,Not Applicable,Interventional,India,Role of immune boosting kit in covid disease,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713
2713,CTRI/2020/07/026671,CTRI,2020-07-18,2020-07-27,False,Not Recruiting,Not Applicable,Interventional,India,Ozone Therapy for Covid 19 patients,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728
2714,CTRI/2020/07/026674,CTRI,2020-07-19,2020-07-27,False,Not Recruiting,Phase 1,Interventional,India,Effect of Ayurveda Spice Mix Tablet for the Prevention of COVID-19 infection in people exposed to Covid 19 and in high risk patients,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712
2715,CTRI/2020/07/026675,CTRI,2020-07-19,2020-07-27,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Efficacy of Ayurveda treatment Protocol with Tulsimmune Tablet in Covid 19,76,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731
2716,CTRI/2020/07/026705,CTRI,2020-07-20,2020-07-28,False,Not Recruiting,Phase 1,Interventional,India,Efficacy and safety of AYUSH 64 tablets in treating mild to moderate Covid 19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088
2717,CTRI/2020/07/026700,CTRI,2020-07-20,2020-07-27,False,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana therapies,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207
2718,CTRI/2020/07/026757,CTRI,2020-07-23,2020-07-31,False,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824
2719,CTRI/2020/07/026756,CTRI,2020-07-23,2020-07-28,False,Not Recruiting,Not Applicable,Interventional,India,Ayurveda strength and immunity enhancing protocol and immunity in health care workers : Clinical trial of an Ayurveda Intervention,425,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755
2720,CTRI/2020/07/026791,CTRI,2020-07-25,2020-01-08,True,Recruiting,Phase 2/Phase 3,Interventional,India,Statin and Aspirin in SARS-CoV-2 infection,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814
2721,CTRI/2020/07/026796,CTRI,2020-07-25,2020-03-08,True,Not Recruiting,Not Applicable,Interventional,India,A trial to evaluate the effect of cotton face-masks and other behavioral factors on COVID-19 risk in rural Telangana,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868
2722,CTRI/2020/07/026789,CTRI,2020-07-25,2020-07-31,False,Not Recruiting,Phase 2,Interventional,India,A clinical study to see effect of  ArtemiC in patients with COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111
2723,CTRI/2020/07/026790,CTRI,2020-07-25,2020-03-08,True,Not Recruiting,Not Applicable,Interventional,India,This is the comparative study between two protective boxes which can be used by the doctors while managing critical COVID 19 patients in addition to personal protective equipment.,21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143
2724,CTRI/2020/07/026799,CTRI,2020-07-25,2020-04-08,True,Recruiting,Phase 2/Phase 3,Interventional,India,Yoga for Nurses (COVID-19),60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964
2725,CTRI/2020/07/026793,CTRI,2020-07-25,2020-07-31,False,Not Recruiting,Phase 2,Interventional,India,Panchgavya Therapy in prophylaxis and as an adjuvant therapy in management of Covid 19.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721
2726,CTRI/2020/07/026831,CTRI,2020-07-27,2020-01-08,True,Not Recruiting,Phase 3,Interventional,India,"Controlled evaluation of Angiotensin Receptor Blockers for COVID-19
Respiratory Disease
",605,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605
2727,CTRI/2020/07/026820,CTRI,2020-07-27,2020-09-08,False,Not Recruiting,Phase 4,Interventional,India,Curcumin for COVID-19 Pre Exposure Prophylaxis,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936
2728,CTRI/2020/07/026834,CTRI,2020-07-27,2020-07-08,True,Not Recruiting,Not Applicable,Interventional,India,REaCHing to you with listening ears; A friendly telephonic interaction Program for the DDU-GKY members,1480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953
2729,CTRI/2020/07/026840,CTRI,2020-07-27,2020-07-28,False,Not Recruiting,Not Applicable,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 cases,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981
2730,CTRI/2020/07/026839,CTRI,2020-07-27,2020-05-08,True,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation in management of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994
2731,CTRI/2020/07/026835,CTRI,2020-07-27,2020-07-27,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparison of two different types of simple non-invasive oxygen therapy devices in coronavirus lung infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539
2732,CTRI/2020/07/026841,CTRI,2020-07-28,2020-03-08,True,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 ( Turmeric extract ) drops in patients with Corona virus infection.",260,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659
2733,CTRI/2020/07/026925,CTRI,2020-07-30,2020-07-31,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,"to see the effect of twakadi(tea made up of dalcheeni, tulasi pepper, clove, etc)tea on police worker who have a duty in covid 19 pandemic",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587
2734,CTRI/2020/07/026922,CTRI,2020-07-30,2020-04-08,True,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic intervention in COVID-19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909
2735,CTRI/2020/07/026953,CTRI,2020-07-31,2020-03-08,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,COMPARISON OF THREE HOMOEOPATHIC DRUGS FOR COVID 19 IMMUNE BOOSTERS AGAINST STANDARD TREATMENT,704,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668
2736,CTRI/2020/07/026952,CTRI,2020-07-31,2020-01-08,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Survey and Management 
 of depression, Anxiety and Stress due to COVID-19 fear",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683
2737,CTRI/2020/08/026957,CTRI,2020-08-02,2020-07-08,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,A Clinical trial to evaluate the effect of a combination of treatment of Reginmune capsule and Immunofree tablets in the treatment of mild to moderate COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825
2738,CTRI/2020/08/026980,CTRI,2020-08-04,2020-10-08,False,Not Recruiting,Phase 3,Interventional,India,"Effect  Ayurveda decoctions, tablet and Panchagavya on COVID 19",180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082
2739,CTRI/2020/08/026977,CTRI,2020-08-04,2020-10-08,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of two online learning method of resuscitation training.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057
2740,CTRI/2020/08/026985,CTRI,2020-08-04,2020-08-14,False,Not Recruiting,Phase 2,Interventional,India,"Assessment of safety and efficacy of Kabasura
Kudineer in mild to moderate COVID-19",126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168
2741,CTRI/2020/08/026978,CTRI,2020-08-04,2020-08-19,False,No Status Given,Not Applicable,Interventional,Nepal,Effectiveness of Ayurvedic Formulation for COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435
2742,CTRI/2020/08/027007,CTRI,2020-08-05,2020-07-31,True,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827
2743,CTRI/2020/08/026999,CTRI,2020-08-05,2020-10-08,False,Not Recruiting,Phase 2,Interventional,India,Evaluate the Efficacy of Siddha Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134
2744,CTRI/2020/08/027005,CTRI,2020-08-05,2020-12-08,False,Recruiting,Phase 2,Interventional,India,Investigation of effect of homoeopathic remedy as add on therapy to standard of care (regular treatment) in adult patients with moderate to severe COVID-19,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189
2745,CTRI/2020/08/027009,CTRI,2020-08-05,2020-08-15,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Use of Herbal Medicine like Tulasi,Amruth(Giloy), Turmeric,Ashwagandha for Improving the Immunity among Health care workers.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269
2746,CTRI/2020/08/027033,CTRI,2020-08-07,2020-07-08,True,Not Recruiting,Phase 2,Interventional,India,SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096
2747,CTRI/2020/08/027032,CTRI,2020-08-07,2020-11-08,False,Not Recruiting,Not Applicable,Interventional,India,A clinical study to assess the effects of MEDITATION (MINDFUL HAPPINESS) as an additional therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920
2748,CTRI/2020/08/027038,CTRI,2020-08-07,2020-08-20,False,Not Recruiting,Phase 3,Interventional,India,Study  to assess effects of nano ozonised hydrogen peroxide nebulisation on results of RT-PCR for novel corona Virus thus infectivity and clinical course among mild to moderate sick COVID-19 Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197
2749,CTRI/2020/08/027035,CTRI,2020-08-07,2020-08-19,False,Not Recruiting,Not Applicable,Interventional,India,A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult population,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262
2750,CTRI/2020/08/027037,CTRI,2020-08-07,2020-08-17,False,Recruiting,Phase 3,Interventional,India,Effect of Yoga for COVID-19 patients in addition to regular treatment,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324
2751,CTRI/2020/08/027040,CTRI,2020-08-08,2020-12-08,False,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846
2752,CTRI/2020/08/027048,CTRI,2020-08-09,2020-08-17,False,Recruiting,Phase 3,Interventional,India,Yoga for Police personnel,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344
2753,CTRI/2020/08/027045,CTRI,2020-08-09,2020-08-17,False,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate efficacy and safety of Camphora tablets in Covid positive patients,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226
2754,CTRI/2020/08/027043,CTRI,2020-08-09,2020-10-08,False,Not Recruiting,Phase 1,Interventional,India,Mesenchymal Stem Cell Therapy For Covid 19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175
2755,CTRI/2020/08/027041,CTRI,2020-08-09,2020-08-14,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on COVID 19 patients to Improve Immunity,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258
2756,CTRI/2020/08/027044,CTRI,2020-08-09,2020-08-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the outcome of Classical Ayurvedic medicine for the treatment of COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249
2757,CTRI/2020/08/027084,CTRI,2020-08-10,2020-08-20,False,Not Recruiting,Not Applicable,Interventional,India,Evaluate the medicinal effects of both Ayurveda combinations Bio-Immune as Anti-viral and Covalix Vaccoil as alternate to Vaccine of COVID-19 on exposed individuals and Covid19 contact.,61000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420
2758,CTRI/2020/08/027061,CTRI,2020-08-10,2020-08-13,False,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated Study to see the safety and efficacy of adding Thymosin Alpha to existing standard of care in severe COVID patients.,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729
2759,CTRI/2020/08/027080,CTRI,2020-08-10,2020-08-15,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Benefit of positioning in COVID-19 patient on Bipap mechnical support,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272
2760,CTRI/2020/08/027081,CTRI,2020-08-10,2020-08-17,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparision of two barrier devices for placement of tube into trachea(windpipe)in COVID19 patients,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289
2761,CTRI/2020/08/027085,CTRI,2020-08-11,2020-08-17,False,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of citrobioShield product in improving immunity in COVID 19 patients via inhalation.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278
2762,CTRI/2020/08/027102,CTRI,2020-08-13,2020-08-15,False,Not Recruiting,Phase 2,Interventional,India,Colchichine use for preventing COVID infection in haemodialysis patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658
2763,CTRI/2020/08/027106,CTRI,2020-08-13,2020-08-20,False,Recruiting,Not Applicable,Interventional,India,"TO EVALUATE EFFICACY AND SAFETY OF Ã¢??VIRACIDEÃ¢?? 
IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)
",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639
2764,CTRI/2020/08/027109,CTRI,2020-08-13,2020-08-21,False,Recruiting,Phase 2,Interventional,"Russian Federation, Indonesia, Italy, Spain, India",Efficacy and safety assessments of BDB-001 injection in treating patients with progressive severe COVID-19,256,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44387
2765,CTRI/2020/08/027120,CTRI,2020-08-13,2020-08-20,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to know the efficacy and safety of herbal product Virowin in combination with Energy-Z capsule in treating mild to moderate COVID-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319
2766,CTRI/2020/08/027163,CTRI,2020-08-14,2020-08-23,False,Recruiting,Phase 2/Phase 3,Interventional,India,Ashwagandha in the prevention of COVID-19 in Health Care workers,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406
2767,CTRI/2020/08/027162,CTRI,2020-08-14,2020-08-20,False,Not Recruiting,Phase 2,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the standard of Care in Covid patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240
2768,CTRI/2020/08/027168,CTRI,2020-08-14,2020-08-21,False,Recruiting,Not Applicable,Interventional,India,Clinical trial study to investigate safety and efficacy of ImmunoSEB and ProbioSEB,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750
2769,CTRI/2020/08/027170,CTRI,2020-08-15,2020-08-24,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study to check the safety and immune response of a COVID-19 vaccine in healthy Indian adults.,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186
2770,CTRI/2020/08/027171,CTRI,2020-08-15,2020-08-25,False,Not Recruiting,Not Applicable,Interventional,India,Measurement of renal biomarker in COVID-19 associated acute renal failure,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527
2771,CTRI/2020/08/027224,CTRI,2020-08-18,2020-08-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608
2772,CTRI/2020/08/027225,CTRI,2020-08-18,2020-08-28,False,Not Recruiting,Not Applicable,Interventional,India,Ivermectin as a possible treatment for COVID-19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660
2773,CTRI/2020/08/027205,CTRI,2020-08-18,2020-08-21,False,Not Recruiting,Phase 2,Interventional,"Chile, Argentina, Russian Federation, South Africa, Peru, United Kingdom, Belgium, Colombia, Canada, Netherlands, United States, Brazil, Mexico, Spain, Japan, Poland, France, India",Clinical trial of otilimab in patients with severe pulmonary COVID-19 related disease.,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45488
2774,CTRI/2020/08/027222,CTRI,2020-08-18,2020-08-24,False,Not Recruiting,Phase 2,Interventional,India,Unani formulations for prevention of COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308
2775,CTRI/2020/08/027282,CTRI,2020-08-20,2020-08-31,False,Not Recruiting,Phase 3,Interventional,India,Prophylactic Ivermectin in COVID 19 Contacts,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676
2776,CTRI/2020/08/027284,CTRI,2020-08-20,2020-08-28,False,Not Recruiting,Not Applicable,Interventional,India,A study to evaluate the efficacy and safety of Aceinavir combined with supportive Standard of Care (SoC) in hospitalized patients with moderate coronavirus disease (COVID-19),44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679
2777,CTRI/2020/08/027283,CTRI,2020-08-20,2020-08-24,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy and safety of Ayurvedic kit in COVID-19 positive Patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591
2778,CTRI/2020/08/027316,CTRI,2020-08-21,2020-08-28,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,The effect of Ayurvedic intervention (Ayurveda Raksha Kit) as a preventive measure in the Pandemic of COVID-19 - A community based study,200000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680
2779,CTRI/2020/08/027286,CTRI,2020-08-21,2020-08-22,False,Recruiting,Phase 2,Interventional,India,Effectiveness of Siddha Medicines Kabasura Kudineer and Nilavembu Kudineer in the Management of Smptomatic COVID 19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511
2780,CTRI/2020/08/027300,CTRI,2020-08-21,2020-01-09,True,Not Recruiting,Not Applicable,Interventional,India,Efficacy and feasibility of Teleneurorehabilitation in Persons with Parkinsons Disease,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285
2781,CTRI/2020/08/027324,CTRI,2020-08-23,2020-01-09,True,Not Recruiting,Not Applicable,Interventional,India,"Study to assess the usefulness, effectiveness and feasibility for future use of the consultations done using telephone/whatsapp in rheumatic diseases during CoVID-19 pandemic",5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339
2782,CTRI/2020/08/027345,CTRI,2020-08-24,2020-08-31,False,Not Recruiting,Phase 3,Interventional,India,Re-purposing of Anti HCV drugs for the treatment of COVID-19 diseasr,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932
2783,CTRI/2020/08/027346,CTRI,2020-08-24,2020-08-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229
2784,CTRI/2020/08/027359,CTRI,2020-08-24,2020-09-15,False,Not Recruiting,Not Applicable,Interventional,India,"A study regarding knowledge, attitude and practice about immunity boosting measures for prevention of COVID-19 infection among healthcare workers at tertiary care hospital",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829
2785,CTRI/2020/08/027394,CTRI,2020-08-26,2020-02-09,True,Not Recruiting,Not Applicable,Interventional,India,Assessment of response of ivermectin on virological clearance in COVID 19 patients,56,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873
2786,CTRI/2020/08/027397,CTRI,2020-08-26,2020-03-09,True,Recruiting,Phase 2,Interventional,India,Role of Siddha medicine in the management of Covid-19 positive patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165
2787,CTRI/2020/08/027465,CTRI,2020-08-29,2020-04-09,True,Not Recruiting,Phase 1/Phase 2,Interventional,India,Nasal Wash and Gargle to Mitigate COVID-19,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634
2788,CTRI/2020/08/027501,CTRI,2020-08-31,2020-10-09,False,Not Recruiting,Not Applicable,Interventional,India,A study to assess aspects of safety and efficacy of NuvastaticÃ¢?Â¢ (C5OSEW5050ESA) as an immunomodulator supportive treatment to the standard care of treatment in Covid 19 patients.,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303
2789,CTRI/2020/08/027475,CTRI,2020-08-31,2020-01-09,True,Recruiting,Phase 3,Interventional,India,A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 Pneumonia,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627
2790,CTRI/2020/08/027502,CTRI,2020-08-31,2020-10-09,False,Not Recruiting,Not Applicable,Interventional,India,Comparison two types of artificial respiration in severe COVID-19 patients,216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862
2791,CTRI/2020/08/027477,CTRI,2020-08-31,2020-03-09,True,Not Recruiting,Phase 2,Interventional,India,Evaluation of safety and efficacy of T-AYU-HM Premium and Onion steam vaporization/nebulization in Covid-19 patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654
2792,CTRI/2020/08/027499,CTRI,2020-08-31,2020-05-09,True,Recruiting,Phase 2,Interventional,India,Role of siddha medicine in the management of covid -19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927
2793,CTRI/2020/08/027491,CTRI,2020-08-31,2020-06-09,True,Not Recruiting,Phase 2,Interventional,India,benefits of Siddha medicines in covid-19 positive patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256
2794,CTRI/2020/08/027503,CTRI,2020-08-31,2021-06-15,False,Not Recruiting,Not Applicable,Interventional,India,Effect of blood thinning medicine in COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980
2795,CTRI/2020/08/027467,CTRI,2020-08-31,2020-08-31,False,Not Recruiting,Phase 3,Interventional,India,Effect of Allo-vedic Preparation Raj Nirwan Bati (RNB) on Severe COVID-19 Patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524
2796,CTRI/2020/09/027535,CTRI,2020-09-01,2020-08-09,True,Recruiting,Phase 3,Interventional,India,"Efficacy and safety study of antiviral Umifenovir therapy in non-severe COVID-
19 patients.",132,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236
2797,CTRI/2020/09/027548,CTRI,2020-09-02,2020-12-09,False,Not Recruiting,Not Applicable,Interventional,India,Effects of health drink additional to standard of care treatment in COVID 19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125
2798,CTRI/2020/09/027616,CTRI,2020-09-05,2021-01-13,False,Not Recruiting,Phase 1,Interventional,India,Oral medicine trial for COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155
2799,CTRI/2020/09/027615,CTRI,2020-09-05,2020-11-09,False,Not Recruiting,Not Applicable,Interventional,India,Clinical trial of homeopathic medicine arsenic album as add on therapy in hospitalized patients admitted with Covid 19 disease.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648
2800,CTRI/2020/09/027622,CTRI,2020-09-07,2020-08-09,True,Recruiting,Not Applicable,Interventional,India,Role of female sex hormone in COVID 19 patients,64,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908
2801,CTRI/2020/09/027661,CTRI,2020-09-08,2020-09-15,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Preventive Study among COVID 19 frontline warriors and their families,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273
2802,CTRI/2020/09/027674,CTRI,2020-09-08,2020-08-09,True,Recruiting,Phase 1/Phase 2,Interventional,India,"A Phase 1, Followed by a Phase 2, vaccine given Randomly in subjects in different sites
to Evaluate the Safety, side effects, and resistance of the Virus Vaccine, BBV152D Administered between the layers of the skin(intradermal) in Healthy Volunteers.",124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312
2803,CTRI/2020/09/027684,CTRI,2020-09-09,2020-09-15,False,Recruiting,Not Applicable,Interventional,India,"Protective effect of re-vaccination with
BCG against COVID-19 in healthcare workers Ã¢?? A Pilot Study
",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179
2804,CTRI/2020/09/027680,CTRI,2020-09-09,2020-09-20,False,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, South Africa, Peru, United Kingdom, Colombia, United States, Canada, Italy, Brazil, Mexico, Spain, Turkey, Panama, France, India, Germany",Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID),402,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46451
2805,CTRI/2020/09/027687,CTRI,2020-09-09,2020-09-16,False,Not Recruiting,Not Applicable,Interventional,India,"Assessment of effect of steam inhalation, saline gargling and povidone Iodine gargling on reduction of symptoms and prevention of spread of COVID 19",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280
2806,CTRI/2020/09/027685,CTRI,2020-09-09,2020-09-16,False,Not Recruiting,Not Applicable,Interventional,India,Clinical Study to Investigate Safety and Efficacy of ImmunoSEB and ProbioSEB,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321
2807,CTRI/2020/09/027741,CTRI,2020-09-10,2020-09-15,False,Recruiting,Not Applicable,Interventional,India,Role of heat killed Mycobacterium w (Sepsivac) in Corona virus disease 2019 (COVID-19),50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197
2808,CTRI/2020/09/027775,CTRI,2020-09-11,2020-09-19,False,Not Recruiting,Phase 2,Interventional,India,Efficacy and safety clinical study of ES16001 as an adjunct in COVID positive patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367
2809,CTRI/2020/09/027786,CTRI,2020-09-14,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Management of Covid 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950
2810,CTRI/2020/09/027817,CTRI,2020-09-15,2020-09-18,False,Recruiting,Phase 3,Interventional,India,A Phase III Clinical Study to assess the Safety and Efficacy of Ayurvedic Tablets combined with the current available medicine and its impact on lab parameters in Subjects with Uncomplicated Moderate COVID-19 infection.,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041
2811,CTRI/2020/09/027841,CTRI,2020-09-16,2020-09-22,False,Recruiting,Not Applicable,Interventional,India,"In this study IMMUACTIVE would be compared with an inert substance, as a supplement in treatment of COVID-19 patients.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174
2812,CTRI/2020/09/027829,CTRI,2020-09-16,2020-09-20,False,Recruiting,Phase 3,Interventional,"Argentina, United States, Mexico, Brazil, India",DARE-19 (Dapagliflozin in Respiratory failure in patients with COVID-19),900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521
2813,CTRI/2020/09/027842,CTRI,2020-09-16,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,India,Effect of Teleyoga on health care workers involved in Covid 19 duty,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591
2814,CTRI/2020/09/027833,CTRI,2020-09-16,2020-09-16,False,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID 19 Patients having mild to moderate symptoms not requiring oxygen support,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46839
2815,CTRI/2020/09/027882,CTRI,2020-09-17,2020-09-28,False,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Evaluate the effect of an Ayurvedic Regimen administered in (COVID Ã¢?? 19) Patients,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632
2816,CTRI/2020/09/027904,CTRI,2020-09-18,2020-02-10,True,Not Recruiting,Not Applicable,Interventional,India,Autologous whole blood injection as treatment for Covid-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392
2817,CTRI/2020/09/027903,CTRI,2020-09-18,2020-09-22,False,Not Recruiting,Phase 2,Interventional,India,Testing the efficacy and safety of a blood product COVID-19 Hyper-Immuneglobulin (Human) Solution in Participants with Active COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147
2818,CTRI/2020/09/027910,CTRI,2020-09-18,2020-10-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Transcendental Meditation (TM) to reduce stress and improve immunity of health care providers during COVID-19 pandemic,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292
2819,CTRI/2020/09/027914,CTRI,2020-09-19,2020-09-22,False,Recruiting,Phase 2/Phase 3,Interventional,India,"Evaluation of efficacy of Fixed Ayurvedic Regimen of Giloy Ki Ghan Vati,Tulsi Tablets,Kalmegh Tablets and Dabur Chyawanprash in COVID-19",72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442
2820,CTRI/2020/09/027915,CTRI,2020-09-21,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,India,Tele-yoga for prevention and management of COVID-19,136,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754
2821,CTRI/2020/09/027941,CTRI,2020-09-21,2020-09-26,False,Not Recruiting,Phase 4,Interventional,India,Single arm study of Itolizumab in the treatment of COVID 19 complication.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023
2822,CTRI/2020/09/027938,CTRI,2020-09-21,2020-09-25,False,Not Recruiting,Phase 3,Interventional,India,Study of Particle Life Sciences Formulation in management of COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586
2823,CTRI/2020/09/027916,CTRI,2020-09-21,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,India,Covid19 Post Treatment Restorative Healthcare,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333
2824,CTRI/2020/09/027974,CTRI,2020-09-22,2020-10-15,False,Not Recruiting,Phase 2,Interventional,India,Clinical Evaluation of Chyawanprash for the prevention of COVID-19 among Health Care Personnel .,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658
2825,CTRI/2020/09/027944,CTRI,2020-09-22,2020-09-22,False,Not Recruiting,Phase 3,Interventional,India,"An open label, prospective comparative study to evaluate the proposed therapy in adults with mild symptomatic COVID-19 patients receiving the standard treatment of COVID infection.",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392
2826,CTRI/2020/09/027975,CTRI,2020-09-22,2020-02-10,True,Not Recruiting,Phase 3,Interventional,India,Utility of Medihope as an addon therapy for Covid 19 patients,880,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748
2827,CTRI/2020/09/027992,CTRI,2020-09-23,2020-09-25,False,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated  Study to Evaluate the Effectiveness and Safety of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) in Moderate COVID-19 Patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389
2828,CTRI/2020/09/028045,CTRI,2020-09-24,2020-09-28,False,Not Recruiting,Not Applicable,Interventional,India,Online learning programme for providing cardiopulmonary resuscitation among Nurses,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046
2829,CTRI/2020/09/028044,CTRI,2020-09-24,2020-09-30,False,Recruiting,Phase 4,Interventional,India,Phase IV study to evaluate the safety and efficacy of Artemisinin- a herbal supplement on COVID-19 subjects,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432
2830,CTRI/2020/09/028043,CTRI,2020-09-24,2020-09-21,True,Not Recruiting,Phase 4,Interventional,India,"Clinical study to assess role of Vasa Ghana, Guduchi Ghana and Vasa-Guduchi
Ghana in therapeutic management of symptoms in Covid19",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443
2831,CTRI/2020/09/028046,CTRI,2020-09-24,2020-05-10,True,Not Recruiting,Not Applicable,Interventional,India,Homoeopathy management for covid 19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038
2832,CTRI/2020/09/028086,CTRI,2020-09-28,2020-08-10,True,Not Recruiting,Not Applicable,Interventional,India,Effect of 12-weeks of Online Sudarshan Kriya Yoga practice on Burnout and Health Parameters among COVID-19 Frontline Warriors.,43,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819
2833,CTRI/2020/09/028088,CTRI,2020-09-28,2020-10-31,False,Not Recruiting,Not Applicable,Interventional,India,"Open Label Randomized trial of Colchicine, Aspirin and Montelukast in Covid-19",34,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829
2834,CTRI/2020/09/028131,CTRI,2020-09-29,2020-02-10,True,Recruiting,Not Applicable,Interventional,India,A study of Cordyceps Capsules as an Add-On Therapy in patients with moderate COVID 19 Infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887
2835,CTRI/2020/09/028122,CTRI,2020-09-29,2020-06-10,True,Not Recruiting,Phase 3,Interventional,India,Homoeopathy in the prevention of COVID-19,15992,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851
2836,CTRI/2020/09/028133,CTRI,2020-09-29,2020-05-10,True,Recruiting,Not Applicable,Interventional,India,Oral VIRAHALT (Novel Immunomodulatory Herbal combination) Compared to standard of care in Subjects with Moderate to Severe COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866
2837,CTRI/2020/09/028158,CTRI,2020-09-30,2020-05-10,True,Recruiting,Not Applicable,Interventional,India,Ayurvedic Proprietary Medicine (VIRANORM) clinical trial on  COVID-19 patients,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896
2838,CTRI/2020/09/028164,CTRI,2020-09-30,2021-04-10,False,Not Recruiting,Not Applicable,Interventional,India,A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843
2839,CTRI/2020/10/028195,CTRI,2020-10-01,2020-08-10,True,Recruiting,Not Applicable,Interventional,India,The role of Yogic breathing techniques in progression and recovery from COVID-19.,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893
2840,CTRI/2020/10/028179,CTRI,2020-10-01,2020-07-10,True,No Status Given,Not Applicable,Interventional,Bangladesh,An experimental study to find out the impact of post COVID physiotherapy and rehabilitation in Bangladesh,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847
2841,CTRI/2020/10/028230,CTRI,2020-10-05,2020-12-10,False,Not Recruiting,Phase 2,Interventional,India,clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188
2842,CTRI/2020/10/028233,CTRI,2020-10-05,2020-10-10,False,Not Recruiting,Not Applicable,Interventional,India,Study on use of Homoeopathy Medicines in Treatment of Covid 19 cases,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982
2843,CTRI/2020/10/028231,CTRI,2020-10-05,2020-12-10,False,Not Recruiting,Not Applicable,Interventional,India,Proof of Concept Study of Ketoji (Liquid) for its Effectiveness in Treatment and Management of COVID-19 Patients,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237
2844,CTRI/2020/10/028234,CTRI,2020-10-05,2020-12-10,False,Not Recruiting,Phase 4,Interventional,India,Study to compare the effect of different antiviral medicines in  COVID-19 infected sick children,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844
2845,CTRI/2020/10/028253,CTRI,2020-10-06,2020-10-10,False,Not Recruiting,Phase 2,Interventional,India,A clinical trial to test the effectiveness of thalidomide in reducing immune dysfunction in covid-19 disease.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986
2846,CTRI/2020/10/028256,CTRI,2020-10-06,2020-10-13,False,Not Recruiting,Not Applicable,Interventional,India,A study to know whether we can supervise cancer patients infected with COVID-19 from without admission in hospitals. We will test how much helpful is a software called Datos health along with pulse oximeter and thermometer in this supervision by doctors.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118
2847,CTRI/2020/10/028250,CTRI,2020-10-06,2020-10-14,False,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effects of stem cells in patients with Acute Respiratory Distress syndrome caused by Pneumonia due to COVID-19,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119
2848,CTRI/2020/10/028280,CTRI,2020-10-07,2020-10-15,False,Not Recruiting,Not Applicable,Interventional,India,A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of COVID-19,18000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199
2849,CTRI/2020/10/028277,CTRI,2020-10-07,2020-12-10,False,Not Recruiting,Phase 3,Interventional,India,"A study to assess the safety and effectiveness of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) used for the treatment of Moderate to severe COVID 19 Patients.

",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691
2850,CTRI/2020/10/028279,CTRI,2020-10-07,2020-12-10,False,Not Recruiting,Not Applicable,Interventional,India,Standard of care with homoeopathy as adjuvant in COVID19,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085
2851,CTRI/2020/10/028297,CTRI,2020-10-08,2020-10-26,False,Not Recruiting,Phase 2,Interventional,India,Cotrimoxazole in hospitalised patients with moderate to early-severe COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268
2852,CTRI/2020/10/028333,CTRI,2020-10-09,2020-10-13,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Prospective on evaluation of use of , Ã¢??AyurCoro3Ã¢?? as an add on medication  for the treatment purpose in COVID-19 patients",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137
2853,CTRI/2020/10/028335,CTRI,2020-10-09,2020-12-10,False,Not Recruiting,Phase 3,Interventional,India,A clinical study to assess the efficacy and safety of Tinefcon in patients with moderate COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359
2854,CTRI/2020/10/028324,CTRI,2020-10-09,2020-09-10,True,Not Recruiting,Not Applicable,Interventional,India,"Evaluation of use of , Ã¢??study medication Ã¢??for prophylaxis in frontline health care workers involved in treating COVID-19 patients",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697
2855,CTRI/2020/10/028326,CTRI,2020-10-09,2020-10-20,False,Not Recruiting,Not Applicable,Interventional,India,Assessment of memory cells response to Mycobacterium Indicus Pranii vaccination,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214
2856,CTRI/2020/10/028325,CTRI,2020-10-09,2020-10-19,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of Tocilizumab Vs Itolizumab in covid 19 patient.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319
2857,CTRI/2020/10/028364,CTRI,2020-10-12,2020-10-19,False,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to evaluate the effectiveness and safety of Vedicinals-9-a Herbal Formulation in Mild to Moderate COVID-19
Patients.",124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152
2858,CTRI/2020/10/028362,CTRI,2020-10-12,2020-10-15,False,Not Recruiting,Not Applicable,Interventional,India,Study to assess the efficacy of deep breathing Pranayama technique in  addition to conventional allopathic treatment in management of COVID19,278,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109
2859,CTRI/2020/10/028376,CTRI,2020-10-13,2020-10-22,False,Not Recruiting,Not Applicable,Interventional,India,A Clinical Study to evaluate the safety and efficacy of CoviToneÃ¢?Â¢ in Mild to moderate Covid patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426
2860,CTRI/2020/10/028414,CTRI,2020-10-15,2020-02-11,True,Not Recruiting,Phase 2,Interventional,India,Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010
2861,CTRI/2020/10/028423,CTRI,2020-10-15,2020-10-28,False,Recruiting,Phase 2,Interventional,India,A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infection,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514
2862,CTRI/2020/10/028424,CTRI,2020-10-15,2020-10-30,False,Not Recruiting,Phase 3,Interventional,India,Clinical study to evaluate the effect of Ayurveda intervention as a prophylaxis for COVID-19 in Healthcare workers,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294
2863,CTRI/2020/10/028437,CTRI,2020-10-16,2020-02-11,True,Not Recruiting,Phase 3,Interventional,India,Effect of Ayurvedic Treatment Regimen in COVID-19 Patients,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956
2864,CTRI/2020/10/028472,CTRI,2020-10-19,2020-10-29,False,Not Recruiting,Not Applicable,Interventional,India,Study of Edaravone as adjunctive treatment in COVID,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524
2865,CTRI/2020/10/028471,CTRI,2020-10-19,2020-02-11,True,Not Recruiting,Not Applicable,Interventional,India,"Effect of the drug Ã¢??ImmuneÃ¢??- an Ayurveda medication in COVID-19 patients
",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593
2866,CTRI/2020/10/028486,CTRI,2020-10-20,2020-02-11,True,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 Patients with mild symptoms,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223
2867,CTRI/2020/10/028485,CTRI,2020-10-20,2020-02-11,True,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 healthcare workers,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619
2868,CTRI/2020/10/028568,CTRI,2020-10-22,2020-10-26,False,Not Recruiting,Phase 2,Interventional,India,"Evaluate Safety 
and Efficacy of RV Forte Capsule as an immunomodulator in adult 
Covid 19 positive patients",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761
2869,CTRI/2020/10/028566,CTRI,2020-10-22,2020-02-11,True,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 asymptomatic patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585
2870,CTRI/2020/10/028537,CTRI,2020-10-22,2020-10-22,False,Not Recruiting,Phase 2,Interventional,India,Clinical trial of Ayurvedic Medicines in Patients with Asymptomatic and/or Mild Symptoms of COVID-19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342
2871,CTRI/2020/10/028570,CTRI,2020-10-22,2020-05-11,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,To study the effect of Vyaghradi Kashay tablet on COVID-19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600
2872,CTRI/2020/10/028597,CTRI,2020-10-23,2020-06-11,True,Not Recruiting,Phase 2,Interventional,India,Low dose lung X-ray therapy for COVID-19,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730
2873,CTRI/2020/10/028602,CTRI,2020-10-23,2020-03-11,True,Not Recruiting,Phase 2,Interventional,"India, South Africa",Phase II Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797
2874,CTRI/2020/10/028581,CTRI,2020-10-23,2020-10-23,False,Not Recruiting,Not Applicable,Interventional,India,Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID cases,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042
2875,CTRI/2020/10/028580,CTRI,2020-10-23,2020-10-26,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of an online training module with lectures and videos regarding maternal and newborn care during COVID 19 pandemic on the knowledge and acceptability among nursing students,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581
2876,CTRI/2020/10/028637,CTRI,2020-10-26,2020-04-11,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Best Larnyngoscopes for tracheal intubation in covid patient with intubation box,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357
2877,CTRI/2020/10/028635,CTRI,2020-10-26,2020-02-11,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,use of VIRUNIL an Ayurvedic medicie as a supportive treatment in management of COVID-19.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783
2878,CTRI/2020/10/028695,CTRI,2020-10-28,2020-05-11,True,Not Recruiting,Phase 4,Interventional,India,Can Vitamin C reduces COVID-19 symptoms,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749
2879,CTRI/2020/10/028731,CTRI,2020-10-29,2020-01-11,True,Not Recruiting,Phase 3,Interventional,"Denmark, India",Higher vs. Lower Doses of Steroids in Patients with COVID-19,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46442
2880,CTRI/2020/11/028799,CTRI,2020-11-02,2020-02-11,True,Not Recruiting,Not Applicable,Interventional,India,The study of psychological interventions either individually or in groups and comparing its effect in reduction of  psychological distress  in covid-19 positive patients.,55,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864
2881,CTRI/2020/11/028811,CTRI,2020-11-02,2020-07-11,True,Not Recruiting,Not Applicable,Interventional,India,Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960
2882,CTRI/2020/11/028779,CTRI,2020-11-02,2020-05-11,True,Not Recruiting,Phase 1,Interventional,India,Effect of SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment) in hospitalised COVID-19 patients with moderate disease.,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578
2883,CTRI/2020/11/028827,CTRI,2020-11-03,2020-04-11,True,Not Recruiting,Not Applicable,Interventional,India,Yoga program on COVID 19 patients,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946
2884,CTRI/2020/11/028905,CTRI,2020-11-04,2020-12-11,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,An academic trial to study the prophylactic activity of Vishasura Kudineer(VSK)in healthcare workers exposed/non-exposed to COVID-19 patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668
2885,CTRI/2020/11/028903,CTRI,2020-11-04,2020-09-11,True,Not Recruiting,Not Applicable,Interventional,India,Telephonic intervention for people tested positive for Covid,0,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964
2886,CTRI/2020/11/028897,CTRI,2020-11-04,2020-11-16,False,Not Recruiting,Phase 3,Interventional,India,"To Evaluate the Efficacy and Safety of ANT-V Syrup to show antiviral action of upper respiratory
tract like common cold and act as an immune booster to fight against infection, flu, fever, sore
throat, nasal and chest congestion Breathlessness in COVID-19 patients.",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480
2887,CTRI/2020/11/028959,CTRI,2020-11-06,2020-06-11,True,Not Recruiting,Not Applicable,Interventional,India,Effect of recombinant erythropoietin in covid-19 patients.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272
2888,CTRI/2020/11/028976,CTRI,2020-11-09,2020-11-11,False,Not Recruiting,Phase 3,Interventional,India,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity,and Lot-to-Lot consistency of BBV152, a Whole virion Inactivated Vaccine in Adults greater than or equal to 18 Years of Age.",25800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057
2889,CTRI/2020/11/029025,CTRI,2020-11-10,2020-11-15,False,Recruiting,Not Applicable,Interventional,India,An open label observational study on post covid complications and radiological pattern changes on those patients treated with ZingiVir H .,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174
2890,CTRI/2020/11/029032,CTRI,2020-11-10,2020-11-16,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Biological EÃ¢??s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.,360,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329
2891,CTRI/2020/11/029038,CTRI,2020-11-11,2020-10-19,True,Not Recruiting,Phase 3,Interventional,India,"Can combination of Haldi, Pomegranate and Zinger extract tablets help in reducing duration of hospital stay of mild to moderate COVID-19 patients.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233
2892,CTRI/2020/11/029058,CTRI,2020-11-11,2020-11-20,False,Not Recruiting,Not Applicable,Interventional,India,Study to assess the impact of COVID 19 infection on pulmonary function tests in children,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392
2893,CTRI/2020/11/029063,CTRI,2020-11-12,2020-12-11,False,Not Recruiting,Phase 3,Interventional,India,To study the effect of povidone iodine gargle and nasal drops on disease transmissibility in SARS-CoV-2 infected patients,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939
2894,CTRI/2020/11/029130,CTRI,2020-11-16,2020-11-16,False,Not Recruiting,Not Applicable,Interventional,India,The lying in prone position effect on oxygen saturation in patients in early stage and not intubated having mild to moderate Lung Disease with COVID-19,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155
2895,CTRI/2020/11/029146,CTRI,2020-11-16,2020-11-23,False,Not Recruiting,Not Applicable,Interventional,India,Use of a new breathing device for covid 19 patients,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879
2896,CTRI/2020/11/029170,CTRI,2020-11-17,2020-11-20,False,Not Recruiting,Not Applicable,Interventional,India,Lignocaine nebulisation in covid pneumonia,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412
2897,CTRI/2020/11/029166,CTRI,2020-11-17,2020-01-12,True,Not Recruiting,Phase 3,Interventional,India,Curaneum 20 for Covid 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785
2898,CTRI/2020/11/029233,CTRI,2020-11-19,2020-12-15,False,Not Recruiting,Not Applicable,Interventional,India,An observation and comparison of the efficacy and relative satisfaction of Health Care Workers while being monitored by the  standard BUDDY technique versus the Remote Audio Visual Doffing Surveillance (RADS) of the doffing process during the COVID 19 Pandemic,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177
2899,CTRI/2020/11/029232,CTRI,2020-11-19,2020-11-25,False,Not Recruiting,Phase 3,Interventional,India,Role Of Montelukast In Management Of COVID 19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293
2900,CTRI/2020/11/029230,CTRI,2020-11-19,2020-11-20,False,Not Recruiting,Phase 3,Interventional,India,ROLE OF VITAMIN C IN MANAGEMENT OF COVID 19,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295
2901,CTRI/2020/11/029263,CTRI,2020-11-20,2020-11-30,False,Recruiting,Phase 4,Interventional,India,A clinical study on Favipiravir in mild to moderate COVID-19 patients,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353
2902,CTRI/2020/11/029265,CTRI,2020-11-20,2020-11-30,False,Not Recruiting,Phase 3,Interventional,India,Preventive trial of Homoeopathic medicines in COVID-19,20000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401
2903,CTRI/2020/11/029289,CTRI,2020-11-23,2020-11-25,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial of Siddha drugs M V kashayam (Internally) for the management   and  treatment of COVID 19,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077
2904,CTRI/2020/11/029305,CTRI,2020-11-24,2020-11-25,False,Not Recruiting,Not Applicable,Interventional,India,Clarithromycin in Post Covid 19 parenchymal organizing pneumonia,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195
2905,CTRI/2020/11/029328,CTRI,2020-11-24,2020-11-30,False,Not Recruiting,Phase 2,Interventional,India,A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are hospitalized SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.,118,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552
2906,CTRI/2020/11/029356,CTRI,2020-11-25,2020-11-25,False,Not Recruiting,Phase 2,Interventional,India,A clinical study to compare high flow nasal oxygen and non invasive ventilation in patients with covid-19.,82,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432
2907,CTRI/2020/11/029346,CTRI,2020-11-25,2020-11-26,False,Not Recruiting,Not Applicable,Interventional,India,Spectrum of eye infections in COVID-19 affected individuals,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444
2908,CTRI/2020/11/029345,CTRI,2020-11-25,2020-11-25,False,Not Recruiting,Phase 4,Interventional,"United States, India, Mexico, Brazil","To determine efficacy, safety and optimal dosing of anticoagulant strategies to prevent adverse outcomes in hospitalized COVID-19 patients.
",3600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48213
2909,CTRI/2020/11/029396,CTRI,2020-11-26,2020-01-12,True,Not Recruiting,Not Applicable,Interventional,India,Safety of an aerosol having as its active ingredient 8.4 % sodium bicarbonate and xylitol 5% when administered to the nasopharynx and oropharynx,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442
2910,CTRI/2020/11/029399,CTRI,2020-11-26,2020-10-12,True,Not Recruiting,Phase 1,Interventional,India,Develop homeopathic Nosodes for Immunity Against COVID 19.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714
2911,CTRI/2020/11/029388,CTRI,2020-11-26,2020-11-27,False,Not Recruiting,Not Applicable,Interventional,India,Pirdal Nasal Spray in preventing symptomatic manifestation of disease in Covid-19 proven cases,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529
2912,CTRI/2020/11/029444,CTRI,2020-11-27,2020-03-12,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to study effect of Madhav Rasayan tablets in COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712
2913,CTRI/2020/12/029475,CTRI,2020-12-01,2020-07-12,True,Not Recruiting,Not Applicable,Interventional,India,A clinical study to determine the effect of CL20189 and CL20193 in mild to moderate COVID-19 patients,66,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49723
2914,CTRI/2020/12/029476,CTRI,2020-12-01,2020-12-15,False,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect of herbal medicine on enhancing immune function in COVID recovery patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48455
2915,CTRI/2020/12/029575,CTRI,2020-12-04,2020-04-12,True,Not Recruiting,Phase 3,Interventional,India,Effectiveness of Unani add-on therapy in preventing the disease severity  of  COVID-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49430
2916,CTRI/2020/12/029587,CTRI,2020-12-04,2020-12-15,False,Not Recruiting,Not Applicable,Interventional,India,To compare the effect of lying in face down position along with oxygen therapy given through high flow nasal cannula device versus lying face down with oxygen given by non-rebreathing face mask in COVID-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49803
2917,CTRI/2020/12/029585,CTRI,2020-12-04,2020-12-12,False,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to compare the effect of non-invasive ventilation with high-flow nasal oxygen therapy versus only high flow nasal oxygen therapy in COVID 19 patients with respiratory failure.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49854
2918,CTRI/2020/12/029614,CTRI,2020-12-07,2020-12-16,False,Not Recruiting,Phase 2,Interventional,India,Liberal use of oxygen in early stage of COVID-19 patients.,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49680
2919,CTRI/2020/12/029615,CTRI,2020-12-07,2020-12-15,False,Not Recruiting,Not Applicable,Interventional,India,Remdesivir plus Tocilizumab efficacy trial in moderate to severe COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731
2920,CTRI/2020/12/029613,CTRI,2020-12-07,2020-12-14,False,Not Recruiting,Not Applicable,Interventional,India,Drug to prevent lung injury secondary to COVID 19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026
2921,CTRI/2020/12/029668,CTRI,2020-12-09,2021-01-01,False,Not Recruiting,Phase 2,Interventional,India,Add-on homoeopathic treatment of COVID-19 patients,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45821
2922,CTRI/2020/12/029669,CTRI,2020-12-09,2020-12-21,False,Not Recruiting,Not Applicable,Interventional,India,Assessment of pulmonary function test in patients recovered from COVID 19 infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50175
2923,CTRI/2020/12/029713,CTRI,2020-12-10,2020-12-15,False,Recruiting,Phase 2,Interventional,India,A STUDY TO ASSESS THE EFFECTIVENESS OF IMMUNRICH IN COVID 19 POSITIVE PATIENTS,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46813
2924,CTRI/2020/12/029714,CTRI,2020-12-10,2020-12-15,False,Recruiting,Phase 2,Interventional,India,A STUDY TO ASSESS THE EFFECTIVENESS OF CAP ASMO IN COVID 19 POSITIVE CASES,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46814
2925,CTRI/2020/12/029735,CTRI,2020-12-11,2020-12-15,False,Recruiting,Phase 3,Interventional,India,A Study to Assess the Safety and Efficacy of CoroQuil-Zn 750 in Comparison to the Standard of Care for the Treatment of Mild to Moderate COVID-19.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48763
2926,CTRI/2020/12/029745,CTRI,2020-12-11,2020-12-12,False,Not Recruiting,Not Applicable,Interventional,India,Efficacy of Homoeopathic prophylaxis Arsenicum Album against COVID-19,15000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49613
2927,CTRI/2020/12/029783,CTRI,2020-12-14,2020-12-14,False,Not Recruiting,Not Applicable,Interventional,India,nintedanib therapy will improve management in covid 19 fibrosis if given early or not.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49405
2928,CTRI/2020/12/029805,CTRI,2020-12-15,2020-12-24,False,Not Recruiting,Not Applicable,Interventional,India,Evaluating efficacy and safety of goggles with or without inbuilt fan in health care workers inside COVID ICU,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50445
2929,CTRI/2020/12/029803,CTRI,2020-12-15,2020-12-25,False,Not Recruiting,Not Applicable,Interventional,India,Oxygen therapy in covid positive patients,122,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49947
2930,CTRI/2020/12/029814,CTRI,2020-12-15,2020-12-16,False,Not Recruiting,Not Applicable,Interventional,India,comparison of two drugs for better treatment of covid-19 related lung problems,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49778
2931,CTRI/2020/12/029793,CTRI,2020-12-15,2020-12-31,False,Not Recruiting,Phase 3,Interventional,India,The use of tocilizumab in patients with severe COVID 19 pneumonia - a trial to know its efficacy in those on steroids,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50303
2932,CTRI/2020/12/029841,CTRI,2020-12-16,2020-12-18,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of a techniques named  goal directed therapy with clinician guided regime for fluid management in COVID -19 critical care unit,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48427
2933,CTRI/2020/12/029855,CTRI,2020-12-16,2020-12-28,False,Recruiting,Phase 3,Interventional,India,"Phase III, Randomized, Controlled, Open-Label Study of
Pegylated Interferon Alfa-2b With SARS-CoV-2",250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49858
2934,CTRI/2020/12/029869,CTRI,2020-12-16,2021-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Effectiveness of Siddha Medicines on COVID-19 patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50422
2935,CTRI/2020/12/029885,CTRI,2020-12-17,2020-12-28,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of transport media s for detecting COVID-19 positivity.,394,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50606
2936,CTRI/2020/12/029894,CTRI,2020-12-18,2020-12-20,False,Not Recruiting,Not Applicable,Interventional,India,"A study to compare the effectiveness of two drugs, Dexamethasone versus Methylprednisolone in the treatment of moderate Covid 19 patients",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49273
2937,CTRI/2020/12/029898,CTRI,2020-12-18,2020-12-27,False,Not Recruiting,Not Applicable,Interventional,India,Self-prone positioning to reduce need of ventilatory support in COVID-19 patients,190,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48811
2938,CTRI/2020/12/029902,CTRI,2020-12-18,2021-01-15,False,Not Recruiting,Not Applicable,Interventional,India,"A clinical trial of a new product to understand the effectiveness and safety to manage the symptoms of covid positive adult patients.
",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49842
2939,CTRI/2020/12/029957,CTRI,2020-12-21,2020-12-22,False,Not Recruiting,Not Applicable,Interventional,India,To study the effectiveness of pulmonary rehabilitation program in people who have recovered from covid 19 pneumonia and Acute Respiratory Distress,217,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48186
2940,CTRI/2020/12/029954,CTRI,2020-12-21,2020-12-28,False,Not Recruiting,Phase 3,Interventional,India,Use of soapy nasal irrigation in covid 19 positive cases to reduce  viral load in nasopharynx and oropharynx,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50385
2941,CTRI/2020/12/029985,CTRI,2020-12-23,2020-12-28,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,An Open labeled study in efficacy of add-on Ayurveda intervention in comparison with standard  in Covid-19 patients with moderate severity and with type 2 diabetes followed by 60 day follwo-up,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50354
2942,CTRI/2020/12/030013,CTRI,2020-12-24,2020-12-25,False,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate the efficacy and safety of Sofosbuvir/Daclatasvir (tablet) with or without Nitazoxanide when given with the standard of care in Moderate COVID-19 Patients.,366,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50222
2943,CTRI/2020/12/030072,CTRI,2020-12-28,2020-12-30,False,Not Recruiting,Not Applicable,Interventional,"India, United Kingdom",Investigator Initiated Study To Evaluate Leflunomide for the Treatment of Corona Virus Disease 2019 (COVID-19),178,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50013
2944,CTRI/2020/12/030051,CTRI,2020-12-28,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,India,ImmunoModulatory Efficacy of Nichi Glucan in Covid19 Patients.,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48880
2945,CTRI/2020/12/030083,CTRI,2020-12-29,2020-12-31,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,To Study the Role of Vitamin D in the Treatment of Confirmed COVID-19 Infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46899
2946,CTRI/2020/12/030085,CTRI,2020-12-29,2021-04-01,False,Not Recruiting,Phase 3,Interventional,India,Efficacy of Mycobacterium w in preventing COVID-19 among peri-urban population of Haryana,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50812
2947,CTRI/2020/12/030165,CTRI,2020-12-31,2021-08-01,False,Recruiting,Not Applicable,Interventional,India,"To assess the body resistance improvement and to evaluate the clinical use and well-being of DailyTabÃ¢?Â¢Gold immuno booster and DailyTabÃ¢?Â¢Gold immuno booster (For cardiac, diabetic and neuro conditions) along with standard of care in novel corona virus (COVID-19) patients.",45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50753
2948,CTRI/2020/12/030143,CTRI,2020-12-31,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,India,comparison of different steroid regimes in critically ill adult patients of COVID-19,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50886
2949,CTRI/2021/01/030169,CTRI,2021-01-01,2021-04-01,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Study to evaluate the effect of two herbal drugs NIFAy.C-19(CONTAZAP)and AYUSH 64 in corona patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50842
2950,CTRI/2021/01/030231,CTRI,2021-01-04,2021-12-01,False,Not Recruiting,Phase 3,Interventional,India,"A randomized, two treatment group clinical study to evaluate the effectiveness and safety of study drug  2-Deoxy-D-Glucose with SOC compared to SOC alone in treatment of moderate to severe COVID-19 patients",220,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50985
2951,CTRI/2021/01/030236,CTRI,2021-01-05,2021-01-18,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of Hypertonic saline nasal irrigation and gargling in COVID-19,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50290
2952,CTRI/2021/01/030333,CTRI,2021-01-08,2021-10-01,False,Not Recruiting,Not Applicable,Interventional,India,An eKnee School  for patients suffering from knee osteoarthritis,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50964
2953,CTRI/2021/01/030373,CTRI,2021-01-11,2021-11-01,False,Not Recruiting,Phase 3/Phase 4,Interventional,"Australia, Russian Federation, South Africa, United Kingdom, Belgium, Brazil, Spain, Austria, India",ETHIC trial: Early LMWH in symptomatic COVID-19 positive patients,1370,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50288
2954,CTRI/2021/01/030416,CTRI,2021-01-12,2021-01-20,False,Recruiting,Phase 3,Interventional,India,"Novel Corona Virus-2019-nCov vaccine by intradermal route in
healthy subjects.",28216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51254
2955,CTRI/2021/01/030454,CTRI,2021-01-14,2021-01-22,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Zandu Chyavanprash as a preventive remedy in pandemic of Covid-19.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51491
2956,CTRI/2021/01/030477,CTRI,2021-01-14,2021-01-19,False,Not Recruiting,Not Applicable,Interventional,India,Study to find out whether immunosuppressant Mycophenolate Sodium is effective in the treatment of Covid 19 infection.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48197
2957,CTRI/2021/01/030529,CTRI,2021-01-18,2021-01-18,False,Not Recruiting,Not Applicable,Interventional,India,Ã¢?? Ayurvedic intervention in the management of COVID-19 positive childrenÃ¢??,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51315
2958,CTRI/2021/01/030533,CTRI,2021-01-18,2021-01-25,False,Not Recruiting,Not Applicable,Interventional,India,Sildenafil Use in Covid-19 Patients - A Pilot Study,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51393
2959,CTRI/2021/01/030601,CTRI,2021-01-20,2021-01-20,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Cardamom Extract Clinical trial on Covid patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50754
2960,CTRI/2021/01/030651,CTRI,2021-01-21,2021-01-31,False,Not Recruiting,Not Applicable,Interventional,India,"Knowledge, Attitude and Practices regarding COVID care in ICU",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49805
2961,CTRI/2021/01/030733,CTRI,2021-01-25,2021-01-02,True,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Clinical study on Zandu Chyawanprash, Zandu Pure Honey, Trishun Tablets and Immuzan Tablets as an add to treatment of Covid 19",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51715
2962,CTRI/2021/01/030729,CTRI,2021-01-25,2021-01-30,False,Not Recruiting,Not Applicable,Interventional,India,"Effect of Crocodile breathing versus Prone positioning on heart rate,respiratory rate and oxygen saturation and pulmonary Function test in patients affected by COVID-19: A Pilot Study.",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51654
2963,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,False,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, Singapore, United States, Italy, Spain, Japan, China, France, Germany, Iran, South Korea, Switzerland",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,1113,https://clinicaltrials.gov/show/NCT04292730
2964,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Not Recruiting,Phase 3,Interventional,"South Africa, Canada, United States, Brazil, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),4506,https://clinicaltrials.gov/show/NCT04322682
2965,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,False,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04335136
2966,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,False,Recruiting,Phase 2/Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,1500,https://clinicaltrials.gov/show/NCT04342689
2967,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-05-11,False,Recruiting,Phase 2,Interventional,United States,Ramipril for the Treatment of COVID-19,560,https://clinicaltrials.gov/show/NCT04366050
2968,NCT04386239,ClinicalTrials.gov,2020-05-07,2021-01-01,False,Recruiting,Phase 1,Interventional,Italy,Study on the Use of Sarilumab in Patients With COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04386239
2969,NCT04406389,ClinicalTrials.gov,2020-05-26,2020-10-13,False,Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),186,https://clinicaltrials.gov/show/NCT04406389
2970,NCT04409509,ClinicalTrials.gov,2020-05-28,2020-07-01,False,Not Recruiting,Phase 2,Interventional,United States,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),124,https://clinicaltrials.gov/show/NCT04409509
2971,NCT04409925,ClinicalTrials.gov,2020-05-13,2020-12-25,False,Recruiting,Phase 1,Interventional,Canada,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),25,https://clinicaltrials.gov/show/NCT04409925
2972,NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,True,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,714,https://clinicaltrials.gov/show/NCT04410562
2973,NCT04414124,ClinicalTrials.gov,2020-06-01,2020-08-02,False,Not Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,350,https://clinicaltrials.gov/show/NCT04414124
2974,NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,True,Not Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,55,https://clinicaltrials.gov/show/NCT04425005
2975,NCT04425616,ClinicalTrials.gov,2020-06-03,2020-06-04,False,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,1100,https://clinicaltrials.gov/show/NCT04425616
2976,NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-14,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 and the Healthy Minds Program for Educators,733,https://clinicaltrials.gov/show/NCT04426318
2977,NCT04455815,ClinicalTrials.gov,2020-06-25,2020-09-25,False,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,389,https://clinicaltrials.gov/show/NCT04455815
2978,NCT04456088,ClinicalTrials.gov,2020-07-01,2020-07-15,False,Not Recruiting,Phase 2,Interventional,No Country Given,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),0,https://clinicaltrials.gov/show/NCT04456088
2979,NCT04468009,ClinicalTrials.gov,2020-07-09,2020-06-25,True,Recruiting,Phase 2,Interventional,Argentina,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,36,https://clinicaltrials.gov/show/NCT04468009
2980,NCT04476888,ClinicalTrials.gov,2020-07-16,2020-04-26,True,Not Recruiting,Not Applicable,Interventional,Pakistan,Convalescent Plasma Treatment in COVID-19,110,https://clinicaltrials.gov/show/NCT04476888
2981,NCT04482595,ClinicalTrials.gov,2020-07-17,2020-11-11,False,Recruiting,Phase 2,Interventional,United States,BIO 300 Oral Suspension in Discharged COVID-19 Patients,66,https://clinicaltrials.gov/show/NCT04482595
2982,NCT04483960,ClinicalTrials.gov,2020-07-22,2020-07-28,False,Recruiting,Phase 3,Interventional,Australia,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,2400,https://clinicaltrials.gov/show/NCT04483960
2983,NCT04502433,ClinicalTrials.gov,2020-08-03,2021-01-06,False,Recruiting,Phase 2,Interventional,United Kingdom,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),85,https://clinicaltrials.gov/show/NCT04502433
2984,NCT04522492,ClinicalTrials.gov,2020-08-07,2020-08-11,False,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of COVID-19 on Mental Health of Patients With Skin Picking,18,https://clinicaltrials.gov/show/NCT04522492
2985,NCT04526990,ClinicalTrials.gov,2020-08-22,2020-09-15,False,Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, Pakistan, Mexico",Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,40000,https://clinicaltrials.gov/show/NCT04526990
2986,NCT04530396,ClinicalTrials.gov,2020-08-25,2020-09-07,False,Not Recruiting,Phase 3,Interventional,Russian Federation,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",33758,https://clinicaltrials.gov/show/NCT04530396
2987,NCT04542343,ClinicalTrials.gov,2020-09-03,2020-11-01,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Risk Reduction Among African American Parishioners,265,https://clinicaltrials.gov/show/NCT04542343
2988,NCT04545242,ClinicalTrials.gov,2020-09-05,2021-02-08,False,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,980,https://clinicaltrials.gov/show/NCT04545242
2989,NCT04572412,ClinicalTrials.gov,2020-09-29,2020-11-25,False,Recruiting,Not Applicable,Interventional,United Kingdom,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,13,https://clinicaltrials.gov/show/NCT04572412
2990,NCT04587219,ClinicalTrials.gov,2020-10-13,2020-10-22,False,Not Recruiting,Phase 2,Interventional,Russian Federation,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",110,https://clinicaltrials.gov/show/NCT04587219
2991,NCT04605887,ClinicalTrials.gov,2020-10-27,2021-01-18,False,Recruiting,Phase 2,Interventional,Israel,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,120,https://clinicaltrials.gov/show/NCT04605887
2992,NCT04609865,ClinicalTrials.gov,2020-10-23,2020-11-04,False,Recruiting,Phase 3,Interventional,France,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,100,https://clinicaltrials.gov/show/NCT04609865
2993,NCT04630054,ClinicalTrials.gov,2020-11-13,2020-11-15,False,Recruiting,Not Applicable,Interventional,Bangladesh,Face Masks to Reduce COVID-19 in Bangladesh,450000,https://clinicaltrials.gov/show/NCT04630054
2994,NCT04634799,ClinicalTrials.gov,2020-11-17,2021-01-08,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,80,https://clinicaltrials.gov/show/NCT04634799
2995,NCT04661410,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Recruiting,Not Applicable,Interventional,United States,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04661410
2996,NCT04665115,ClinicalTrials.gov,2020-12-10,2021-06-30,False,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),134,https://clinicaltrials.gov/show/NCT04665115
2997,NCT04712344,ClinicalTrials.gov,2020-12-30,2021-01-18,False,Recruiting,Phase 2,Interventional,Germany,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),58,https://clinicaltrials.gov/show/NCT04712344
2998,NCT04715295,ClinicalTrials.gov,2020-10-02,2020-10-05,False,Recruiting,Phase 4,Interventional,Cameroon,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,200,https://clinicaltrials.gov/show/NCT04715295
2999,NCT04715997,ClinicalTrials.gov,2021-01-18,2020-12-30,True,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults",170,https://clinicaltrials.gov/show/NCT04715997
3000,NCT04716179,ClinicalTrials.gov,2021-01-17,2021-01-18,False,Recruiting,Not Applicable,Interventional,Russian Federation,Prospective Two-arm Study of Fertility in Men With COVID-19,88,https://clinicaltrials.gov/show/NCT04716179
3001,NCT04716647,ClinicalTrials.gov,2021-01-18,2020-10-09,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,28,https://clinicaltrials.gov/show/NCT04716647
3002,NCT04716998,ClinicalTrials.gov,2021-01-17,2021-01-01,True,Recruiting,Phase 1/Phase 2,Interventional,Israel,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,35,https://clinicaltrials.gov/show/NCT04716998
3003,NCT04718285,ClinicalTrials.gov,2021-01-15,2021-01-30,False,Not Recruiting,Phase 2,Interventional,Turkey,Investigation the Effect of Montelukast in COVID-19,380,https://clinicaltrials.gov/show/NCT04718285
3004,NCT04718480,ClinicalTrials.gov,2021-01-18,2020-11-27,True,Recruiting,Phase 2,Interventional,Hungary,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,100,https://clinicaltrials.gov/show/NCT04718480
3005,NCT04718506,ClinicalTrials.gov,2021-01-16,2021-01-12,True,Recruiting,Not Applicable,Interventional,Spain,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,56,https://clinicaltrials.gov/show/NCT04718506
3006,NCT04719208,ClinicalTrials.gov,2020-10-21,2020-10-06,True,Recruiting,Not Applicable,Interventional,United States,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,60,https://clinicaltrials.gov/show/NCT04719208
3007,NCT04719234,ClinicalTrials.gov,2021-01-20,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,Turkey,Lung Ultrasonography in COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04719234
3008,NCT04720404,ClinicalTrials.gov,2021-01-12,2020-06-23,True,Recruiting,Not Applicable,Interventional,Netherlands,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),220,https://clinicaltrials.gov/show/NCT04720404
3009,NCT04720612,ClinicalTrials.gov,2021-01-13,2021-02-01,False,Not Recruiting,Phase 2,Interventional,Canada,COVID-19 Immunologic Antiviral Therapy With Omalizumab,200,https://clinicaltrials.gov/show/NCT04720612
3010,NCT04720794,ClinicalTrials.gov,2020-10-13,2020-09-25,True,Not Recruiting,Not Applicable,Interventional,United States,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,101,https://clinicaltrials.gov/show/NCT04720794
3011,NCT04721236,ClinicalTrials.gov,2021-01-20,2020-11-19,True,Recruiting,Not Applicable,Interventional,Italy,Early Use of Hyperimmune Plasma in COVID-19,300,https://clinicaltrials.gov/show/NCT04721236
3012,NCT04721457,ClinicalTrials.gov,2021-01-19,2021-01-03,True,Recruiting,Phase 4,Interventional,Saudi Arabia,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,120,https://clinicaltrials.gov/show/NCT04721457
3013,NCT04723550,ClinicalTrials.gov,2021-01-21,2021-01-05,True,Recruiting,Not Applicable,Interventional,China,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,120,https://clinicaltrials.gov/show/NCT04723550
3014,NCT04723576,ClinicalTrials.gov,2021-01-14,2020-12-03,True,Recruiting,Not Applicable,Interventional,United States,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),2132,https://clinicaltrials.gov/show/NCT04723576
3015,NCT04723589,ClinicalTrials.gov,2020-11-26,2021-02-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),40,https://clinicaltrials.gov/show/NCT04723589
3016,NCT04724538,ClinicalTrials.gov,2020-12-29,2020-10-15,True,Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,15,https://clinicaltrials.gov/show/NCT04724538
3017,NCT04724616,ClinicalTrials.gov,2021-01-10,2021-01-06,True,Recruiting,Not Applicable,Interventional,Austria,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,60,https://clinicaltrials.gov/show/NCT04724616
3018,NCT04724629,ClinicalTrials.gov,2020-10-05,2021-01-05,False,Recruiting,Phase 3,Interventional,Brazil,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),60,https://clinicaltrials.gov/show/NCT04724629
3019,NCT04724681,ClinicalTrials.gov,2020-10-21,2021-02-01,False,Recruiting,Not Applicable,Interventional,Denmark,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,800,https://clinicaltrials.gov/show/NCT04724681
3020,NCT04728243,ClinicalTrials.gov,2021-01-20,2021-02-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,WHO QualityRights E-training in Ghana,216,https://clinicaltrials.gov/show/NCT04728243
3021,ACTRN12620000516987,ANZCTR,2020-04-27,2020-11-25,False,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,90,https://anzctr.org.au/ACTRN12620000516987.aspx
3022,ACTRN12620000634976,ANZCTR,2020-05-29,2020-06-23,False,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,46,https://anzctr.org.au/ACTRN12620000634976.aspx
3023,ACTRN12621000067875,ANZCTR,2021-01-27,2021-02-17,False,Not Recruiting,Phase 1,Interventional,Australia,Assessment of the safety and tolerability of inhaled aerosolised ethanol in adult volunteers for COVID-19,18,https://anzctr.org.au/ACTRN12621000067875.aspx
3024,ACTRN12620000982910,ANZCTR,2020-09-30,2021-02-15,False,Not Recruiting,Phase 3,Interventional,Australia,A randomized double-blind placebo-controlled trial of oral ivermectin for outpatient treatment of those at high risk for hospitalization due to COVID-19,400,https://anzctr.org.au/ACTRN12620000982910.aspx
3025,ISRCTN17941313,ISRCTN,2021-01-20,2020-01-02,True,Recruiting,Not Applicable,Interventional,"Tanzania, Nigeria",Determining trustworthiness and safety of remote consulting during the COVID-19 pandemic in primary healthcare for chronic disease populations in Nigeria and Tanzania,800,http://isrctn.com/ISRCTN17941313
3026,ISRCTN33260034,ISRCTN,2020-08-20,2020-10-20,False,Recruiting,Phase 2,Interventional,United Kingdom,Adalimumab for coronavirus in community care,750,http://isrctn.com/ISRCTN33260034
3027,ChiCTR2000040146,ChiCTR,2020-11-22,2020-12-02,False,Not Recruiting,Phase 2,Interventional,China,"A Phase II, Randomized, Double-Blinded, Placebo-Controlled, Dose-Finding Clinical Trial to Evaluate the Safety and Immunogenicity of Different Doses of COVID-19 DNA Vaccine INO-4800 Administered Intradermally Followed by Electroporation in Healthy Adult and Elderly Volunteers",640,http://www.chictr.org.cn/showproj.aspx?proj=64452
3028,ChiCTR2000039462,ChiCTR,2020-10-28,2020-10-27,True,Recruiting,Phase 2,Interventional,China,A phase II clinical trial for inactivated SARS-CoV-2 (COVID-19) Vaccine (Vero Cells),1000,http://www.chictr.org.cn/showproj.aspx?proj=63353
3029,ChiCTR2000039369,ChiCTR,2020-10-24,2020-02-28,True,Not Recruiting,Not Applicable,Interventional,China,The Effects of Narrative Exposure Therapy on COVID-19 Patients with Post-Traumatic Stress Disorder: a Randomized Controlled Trial,111,http://www.chictr.org.cn/showproj.aspx?proj=63048
3030,ChiCTR2000032457,ChiCTR,2020-04-29,2020-05-01,False,Recruiting,Not Applicable,Interventional,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,60,http://www.chictr.org.cn/showproj.aspx?proj=52925
3031,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,228,https://clinicaltrials.gov/show/NCT04333225
3032,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-07-30,False,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),30,https://clinicaltrials.gov/show/NCT04334434
3033,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-07-13,False,Not Recruiting,Not Applicable,Interventional,France,Dynamic Evaluation of COVID-19 Diagnostic Tests,8,https://clinicaltrials.gov/show/NCT04337996
3034,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,False,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,200,https://clinicaltrials.gov/show/NCT04338958
3035,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-08,False,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,161,https://clinicaltrials.gov/show/NCT04341584
3036,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,320,https://clinicaltrials.gov/show/NCT04346693
3037,NCT04347031,ClinicalTrials.gov,2020-04-07,2020-04-08,False,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,320,https://clinicaltrials.gov/show/NCT04347031
3038,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,40,https://clinicaltrials.gov/show/NCT04347174
3039,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,False,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04347915
3040,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-06-02,False,Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,38,https://clinicaltrials.gov/show/NCT04354155
3041,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Not Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,40,https://clinicaltrials.gov/show/NCT04365127
3042,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,100,https://clinicaltrials.gov/show/NCT04368845
3043,NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,40,https://clinicaltrials.gov/show/NCT04390477
3044,NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,False,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",1968,https://clinicaltrials.gov/show/NCT04403100
3045,NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,True,Not Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,1008,https://clinicaltrials.gov/show/NCT04411433
3046,NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,32,https://clinicaltrials.gov/show/NCT04412668
3047,NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-18,False,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,2038,https://clinicaltrials.gov/show/NCT04435379
3048,NCT04452669,ClinicalTrials.gov,2020-06-29,2020-09-15,False,Recruiting,Phase 2,Interventional,United States,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,20,https://clinicaltrials.gov/show/NCT04452669
3049,NCT04459962,ClinicalTrials.gov,2020-07-03,2020-06-29,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Covid-19 Breath Test,330,https://clinicaltrials.gov/show/NCT04459962
3050,NCT04462627,ClinicalTrials.gov,2020-07-07,2020-04-14,True,Recruiting,Not Applicable,Interventional,Belgium,Reduction of COVID 19 Transmission to Health Care Professionals,500,https://clinicaltrials.gov/show/NCT04462627
3051,NCT04469114,ClinicalTrials.gov,2020-07-10,2020-09-16,False,Not Recruiting,Phase 2,Interventional,Brazil,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,260,https://clinicaltrials.gov/show/NCT04469114
3052,NCT04486001,ClinicalTrials.gov,2020-07-22,2020-12-15,False,Recruiting,Phase 1,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,20,https://clinicaltrials.gov/show/NCT04486001
3053,NCT04488575,ClinicalTrials.gov,2020-07-23,2020-08-26,False,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04488575
3054,NCT04497922,ClinicalTrials.gov,2020-07-30,2021-01-25,False,Recruiting,Not Applicable,Interventional,United States,Virtual White Boards for Patient Satisfaction,100,https://clinicaltrials.gov/show/NCT04497922
3055,NCT04498377,ClinicalTrials.gov,2020-07-31,2021-01-26,False,Recruiting,Phase 2,Interventional,United States,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,38,https://clinicaltrials.gov/show/NCT04498377
3056,NCT04498442,ClinicalTrials.gov,2020-08-03,2020-05-22,True,Not Recruiting,Not Applicable,Interventional,United States,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",8519,https://clinicaltrials.gov/show/NCT04498442
3057,NCT04509999,ClinicalTrials.gov,2020-08-07,2020-10-26,False,Recruiting,Phase 3,Interventional,United States,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04509999
3058,NCT04519411,ClinicalTrials.gov,2020-08-18,2020-05-21,True,Recruiting,Not Applicable,Interventional,United States,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,10,https://clinicaltrials.gov/show/NCT04519411
3059,NCT04528368,ClinicalTrials.gov,2020-08-19,2020-12-11,False,Recruiting,Phase 2,Interventional,Brazil,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,60,https://clinicaltrials.gov/show/NCT04528368
3060,NCT04528667,ClinicalTrials.gov,2020-08-20,2021-01-06,False,Recruiting,Phase 2,Interventional,Brazil,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,400,https://clinicaltrials.gov/show/NCT04528667
3061,NCT04535856,ClinicalTrials.gov,2020-08-28,2020-11-14,False,Not Recruiting,Phase 1,Interventional,Indonesia,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,9,https://clinicaltrials.gov/show/NCT04535856
3062,NCT04537208,ClinicalTrials.gov,2020-09-02,2020-09-03,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,440,https://clinicaltrials.gov/show/NCT04537208
3063,NCT04557046,ClinicalTrials.gov,2020-09-17,2020-06-26,True,Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,400,https://clinicaltrials.gov/show/NCT04557046
3064,NCT04581746,ClinicalTrials.gov,2020-09-22,2020-11-25,False,Recruiting,Not Applicable,Interventional,France,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),1800,https://clinicaltrials.gov/show/NCT04581746
3065,NCT04591613,ClinicalTrials.gov,2020-10-10,2020-12-31,False,Recruiting,Not Applicable,Interventional,"France, French Guiana",Late Clinical Events Associated With COVID-19 Infection,1000,https://clinicaltrials.gov/show/NCT04591613
3066,NCT04595084,ClinicalTrials.gov,2020-10-19,2021-02-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,240,https://clinicaltrials.gov/show/NCT04595084
3067,NCT04599959,ClinicalTrials.gov,2020-10-22,2020-10-26,False,Not Recruiting,Not Applicable,Interventional,Mexico,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With SalivetteÂ® Cortisol for Viral RNA Sampling for RT-qPCR,144,https://clinicaltrials.gov/show/NCT04599959
3068,NCT04605926,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Not Recruiting,Phase 3,Interventional,Colombia,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,0,https://clinicaltrials.gov/show/NCT04605926
3069,NCT04610138,ClinicalTrials.gov,2020-10-28,2021-02-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,276,https://clinicaltrials.gov/show/NCT04610138
3070,NCT04613050,ClinicalTrials.gov,2020-10-30,2020-07-02,True,Recruiting,Not Applicable,Interventional,Egypt,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,80,https://clinicaltrials.gov/show/NCT04613050
3071,NCT04613271,ClinicalTrials.gov,2020-10-25,2020-10-15,True,Not Recruiting,Phase 3,Interventional,Indonesia,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,210,https://clinicaltrials.gov/show/NCT04613271
3072,NCT04623021,ClinicalTrials.gov,2020-11-05,2020-09-25,True,Not Recruiting,Phase 2,Interventional,Russian Federation,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,104,https://clinicaltrials.gov/show/NCT04623021
3073,NCT04635605,ClinicalTrials.gov,2020-09-28,2020-11-05,False,Recruiting,Phase 2,Interventional,Switzerland,Methylene Blue Treatment of COVID-19,64,https://clinicaltrials.gov/show/NCT04635605
3074,NCT04640038,ClinicalTrials.gov,2020-11-19,2020-12-18,False,Recruiting,Phase 3,Interventional,United States,Contrast Enhanced Ultrasound in COVID-19,30,https://clinicaltrials.gov/show/NCT04640038
3075,NCT04646109,ClinicalTrials.gov,2020-11-15,2020-05-11,True,Not Recruiting,Phase 3,Interventional,Turkey,Ivermectin for Severe COVID-19 Management,66,https://clinicaltrials.gov/show/NCT04646109
3076,NCT04674644,ClinicalTrials.gov,2020-12-16,2020-10-16,True,Not Recruiting,Not Applicable,Interventional,Turkey,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,850,https://clinicaltrials.gov/show/NCT04674644
3077,NCT04682041,ClinicalTrials.gov,2020-12-18,2020-12-22,False,Recruiting,Not Applicable,Interventional,Spain,Evaluating the Impact of EnteraGam In People With COVID-19,420,https://clinicaltrials.gov/show/NCT04682041
3078,NCT04689542,ClinicalTrials.gov,2020-12-29,2021-01-01,False,Recruiting,Not Applicable,Interventional,Belgium,Surgical Face Mask Effects in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04689542
3079,NCT04691180,ClinicalTrials.gov,2020-12-17,2021-01-05,False,Recruiting,Phase 1,Interventional,China,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",24,https://clinicaltrials.gov/show/NCT04691180
3080,NCT04695301,ClinicalTrials.gov,2020-12-29,2020-07-01,True,Recruiting,Not Applicable,Interventional,Brazil,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,50,https://clinicaltrials.gov/show/NCT04695301
3081,NCT04707534,ClinicalTrials.gov,2021-01-11,2021-01-21,False,Recruiting,Phase 4,Interventional,United States,Dexamethasone for COVID-19,300,https://clinicaltrials.gov/show/NCT04707534
3082,NCT04715763,ClinicalTrials.gov,2021-01-14,2021-02-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,INvestigating TELmisartin Study,40,https://clinicaltrials.gov/show/NCT04715763
3083,NCT04721535,ClinicalTrials.gov,2021-01-20,2021-01-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,1012,https://clinicaltrials.gov/show/NCT04721535
3084,NCT04723524,ClinicalTrials.gov,2021-01-22,2020-09-22,True,Recruiting,Phase 2,Interventional,Pakistan,Jinhua Qinggan Granules in the Treatment of COVID-19,300,https://clinicaltrials.gov/show/NCT04723524
3085,NCT04725110,ClinicalTrials.gov,2021-01-21,2021-03-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,250,https://clinicaltrials.gov/show/NCT04725110
3086,NCT04726098,ClinicalTrials.gov,2021-01-23,2021-01-15,True,Recruiting,Phase 4,Interventional,Spain,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,198,https://clinicaltrials.gov/show/NCT04726098
3087,NCT04726111,ClinicalTrials.gov,2021-01-21,2020-12-30,True,Recruiting,Not Applicable,Interventional,France,COVID-19 and Pregnancy: Placental and Immunological Impacts,200,https://clinicaltrials.gov/show/NCT04726111
3088,NCT04726163,ClinicalTrials.gov,2021-01-19,2021-01-29,False,Recruiting,Not Applicable,Interventional,France,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,60,https://clinicaltrials.gov/show/NCT04726163
3089,NCT04726371,ClinicalTrials.gov,2021-01-15,2021-01-08,True,Recruiting,Not Applicable,Interventional,United States,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,5350,https://clinicaltrials.gov/show/NCT04726371
3090,NCT04728594,ClinicalTrials.gov,2021-01-26,2021-01-15,True,Not Recruiting,Not Applicable,Interventional,United States,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,9656,https://clinicaltrials.gov/show/NCT04728594
3091,NCT04728698,ClinicalTrials.gov,2021-01-26,2021-03-01,False,Not Recruiting,Phase 2,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04728698
3092,NCT04728906,ClinicalTrials.gov,2021-01-26,2021-03-05,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Heart Patch for Myocardial Infarction COVID-19,10,https://clinicaltrials.gov/show/NCT04728906
3093,NCT04728958,ClinicalTrials.gov,2021-01-11,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Reflective Tasks With Healthcare Workers During COVID-19,219,https://clinicaltrials.gov/show/NCT04728958
3094,NCT04729491,ClinicalTrials.gov,2021-01-25,2020-06-30,True,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,EAT-DUTA AndroCoV Trial,138,https://clinicaltrials.gov/show/NCT04729491
3095,NCT04730284,ClinicalTrials.gov,2020-08-25,2020-08-25,False,Recruiting,Not Applicable,Interventional,Hong Kong,Evaluation of a Synbiotic Formula in Patient With COVID-19,20,https://clinicaltrials.gov/show/NCT04730284
3096,NCT04730323,ClinicalTrials.gov,2021-01-26,2020-05-12,True,Not Recruiting,Phase 4,Interventional,Pakistan,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,93,https://clinicaltrials.gov/show/NCT04730323
3097,NCT04730427,ClinicalTrials.gov,2021-01-20,2021-01-01,True,Recruiting,Phase 1,Interventional,South Korea,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04730427
3098,NCT04731051,ClinicalTrials.gov,2021-01-28,2021-03-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Jordan,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,28,https://clinicaltrials.gov/show/NCT04731051
3099,NCT04731116,ClinicalTrials.gov,2021-01-28,2021-01-10,True,Recruiting,Phase 1/Phase 2,Interventional,Israel,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,40,https://clinicaltrials.gov/show/NCT04731116
3100,NCT04733625,ClinicalTrials.gov,2021-01-31,2020-09-15,True,Not Recruiting,Not Applicable,Interventional,Egypt,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,56,https://clinicaltrials.gov/show/NCT04733625
3101,NCT04733833,ClinicalTrials.gov,2021-01-27,2021-01-26,True,Recruiting,Phase 2,Interventional,Israel,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04733833
3102,NCT04734886,ClinicalTrials.gov,2020-12-10,2020-11-27,True,Recruiting,Not Applicable,Interventional,Sweden,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,400,https://clinicaltrials.gov/show/NCT04734886
3103,NCT04734912,ClinicalTrials.gov,2021-01-13,2021-01-13,False,Recruiting,Not Applicable,Interventional,Germany,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04734912
3104,ACTRN12620000445976,ANZCTR,2020-04-06,2020-07-28,False,Recruiting,Phase 3,Interventional,"India, New Zealand, Australia","Australasian COVID-19 Trial: An Adaptive Platform Trial (ASCOT-ADAPT). A multi-centre randomised adaptive platform clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19)",2500,https://anzctr.org.au/ACTRN12620000445976.aspx
3105,ACTRN12621000112864,ANZCTR,2021-02-04,2020-12-18,True,Recruiting,Not Applicable,Interventional,"United States, Australia",The effect of an online diabetes risk communication intervention for people impacted by alcohol and other drugs: A randomized controlled trial,360,https://anzctr.org.au/ACTRN12621000112864.aspx
3106,ChiCTR2000039640,ChiCTR,2020-11-04,2020-11-30,False,Recruiting,Not Applicable,Interventional,China,Application of an intelligent mobile isolation operating cabin preventing COVID-19 infection,10,http://www.chictr.org.cn/showproj.aspx?proj=61895
3107,ChiCTR2000039592,ChiCTR,2020-11-02,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,China,Effect of Group Otago Exercise Program on Cognitive Frailty in the Nursing Home: a Randomised Controlled Trial,62,http://www.chictr.org.cn/showproj.aspx?proj=62882
3108,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,False,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,19,https://clinicaltrials.gov/show/NCT04325061
3109,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-09-01,False,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044
3110,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-06-22,False,Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",600,https://clinicaltrials.gov/show/NCT04335084
3111,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,False,Not Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,550,https://clinicaltrials.gov/show/NCT04344730
3112,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-06-12,False,Not Recruiting,Phase 2,Interventional,"Chile, Argentina, Russian Federation, South Africa, Peru, Italy, Brazil, Mexico, Turkey, Japan, Spain, France, India, Germany",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,177,https://clinicaltrials.gov/show/NCT04346199
3113,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,150,https://clinicaltrials.gov/show/NCT04348383
3114,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),30,https://clinicaltrials.gov/show/NCT04358926
3115,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,1407,https://clinicaltrials.gov/show/NCT04359680
3116,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,False,Not Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,2,https://clinicaltrials.gov/show/NCT04361344
3117,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,False,Not Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,5,https://clinicaltrials.gov/show/NCT04363346
3118,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-10-21,False,Recruiting,Phase 2/Phase 3,Interventional,United States,INB03 for the Treatment of Pulmonary Complications From COVID-19,366,https://clinicaltrials.gov/show/NCT04370236
3119,NCT04382625,ClinicalTrials.gov,2020-04-14,2020-10-01,False,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,0,https://clinicaltrials.gov/show/NCT04382625
3120,NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-29,False,Recruiting,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,20,https://clinicaltrials.gov/show/NCT04384731
3121,NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,False,Not Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,26,https://clinicaltrials.gov/show/NCT04385901
3122,NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Not Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,42,https://clinicaltrials.gov/show/NCT04388683
3123,NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,False,Not Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,72,https://clinicaltrials.gov/show/NCT04407130
3124,NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,False,Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,20,https://clinicaltrials.gov/show/NCT04408027
3125,NCT04409327,ClinicalTrials.gov,2020-05-28,2020-07-11,False,Not Recruiting,Phase 2,Interventional,United States,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,36,https://clinicaltrials.gov/show/NCT04409327
3126,NCT04409821,ClinicalTrials.gov,2020-05-22,2020-05-29,False,Recruiting,Not Applicable,Interventional,Denmark,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,50,https://clinicaltrials.gov/show/NCT04409821
3127,NCT04416399,ClinicalTrials.gov,2020-06-03,2020-07-16,False,Not Recruiting,Phase 2,Interventional,United Kingdom,STerOids in COVID-19 Study,146,https://clinicaltrials.gov/show/NCT04416399
3128,NCT04435522,ClinicalTrials.gov,2020-06-15,2020-10-01,False,Not Recruiting,Phase 1,Interventional,United States,Maraviroc in Patients With Moderate and Severe COVID-19,9,https://clinicaltrials.gov/show/NCT04435522
3129,NCT04453657,ClinicalTrials.gov,2020-06-26,2021-02-04,False,Recruiting,Not Applicable,Interventional,United States,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",270,https://clinicaltrials.gov/show/NCT04453657
3130,NCT04459286,ClinicalTrials.gov,2020-07-03,2020-10-09,False,Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,98,https://clinicaltrials.gov/show/NCT04459286
3131,NCT04466241,ClinicalTrials.gov,2020-07-06,2020-11-27,False,Recruiting,Phase 2/Phase 3,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,294,https://clinicaltrials.gov/show/NCT04466241
3132,NCT04490486,ClinicalTrials.gov,2020-07-27,2021-09-01,False,Not Recruiting,Phase 1,Interventional,United States,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,21,https://clinicaltrials.gov/show/NCT04490486
3133,NCT04492475,ClinicalTrials.gov,2020-07-28,2020-08-05,False,Not Recruiting,Phase 3,Interventional,"South Korea, United States, Mexico, Japan, Singapore",Adaptive COVID-19 Treatment Trial 3 (ACTT-3),969,https://clinicaltrials.gov/show/NCT04492475
3134,NCT04510454,ClinicalTrials.gov,2020-08-11,2020-11-02,False,Recruiting,Not Applicable,Interventional,France,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,200,https://clinicaltrials.gov/show/NCT04510454
3135,NCT04511923,ClinicalTrials.gov,2020-08-10,2020-12-23,False,Recruiting,Phase 1/Phase 2,Interventional,Ireland,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,40,https://clinicaltrials.gov/show/NCT04511923
3136,NCT04511949,ClinicalTrials.gov,2020-08-12,2020-07-12,True,Not Recruiting,Not Applicable,Interventional,France,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,500,https://clinicaltrials.gov/show/NCT04511949
3137,NCT04525417,ClinicalTrials.gov,2020-08-21,2020-04-25,True,Not Recruiting,Not Applicable,Interventional,France,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,75,https://clinicaltrials.gov/show/NCT04525417
3138,NCT04529499,ClinicalTrials.gov,2020-08-19,2020-08-20,False,Not Recruiting,Phase 3,Interventional,Kuwait,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,780,https://clinicaltrials.gov/show/NCT04529499
3139,NCT04536376,ClinicalTrials.gov,2020-08-26,2021-01-15,False,Recruiting,Not Applicable,Interventional,United States,First Responder Resiliency Program During COVID-19,10,https://clinicaltrials.gov/show/NCT04536376
3140,NCT04542395,ClinicalTrials.gov,2020-09-03,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,310,https://clinicaltrials.gov/show/NCT04542395
3141,NCT04548934,ClinicalTrials.gov,2020-09-02,2020-09-13,False,Not Recruiting,Not Applicable,Interventional,Italy,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,34,https://clinicaltrials.gov/show/NCT04548934
3142,NCT04581200,ClinicalTrials.gov,2020-10-04,2021-01-25,False,Recruiting,Not Applicable,Interventional,United States,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,300,https://clinicaltrials.gov/show/NCT04581200
3143,NCT04584567,ClinicalTrials.gov,2020-10-06,2020-11-20,False,Recruiting,Phase 3,Interventional,Tunisia,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 """,1100,https://clinicaltrials.gov/show/NCT04584567
3144,NCT04584710,ClinicalTrials.gov,2020-10-08,2020-10-13,False,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,60,https://clinicaltrials.gov/show/NCT04584710
3145,NCT04603079,ClinicalTrials.gov,2020-10-19,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Nurse Leadership for Hospital Infection Control,200,https://clinicaltrials.gov/show/NCT04603079
3146,NCT04607915,ClinicalTrials.gov,2020-07-30,2021-02-05,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,30,https://clinicaltrials.gov/show/NCT04607915
3147,NCT04615429,ClinicalTrials.gov,2020-10-25,2020-09-15,True,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,20,https://clinicaltrials.gov/show/NCT04615429
3148,NCT04639375,ClinicalTrials.gov,2020-11-16,2020-11-15,True,Recruiting,Phase 4,Interventional,United States,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),300,https://clinicaltrials.gov/show/NCT04639375
3149,NCT04643678,ClinicalTrials.gov,2020-11-24,2020-10-30,True,Recruiting,Phase 2/Phase 3,Interventional,Qatar,Anakinra in the Management of COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04643678
3150,NCT04647747,ClinicalTrials.gov,2020-11-27,2020-11-30,False,Recruiting,Not Applicable,Interventional,Norway,Silent Hypoxia and Awake Proning in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04647747
3151,NCT04663555,ClinicalTrials.gov,2020-12-09,2021-02-02,False,Recruiting,Phase 4,Interventional,Czech Republic,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,300,https://clinicaltrials.gov/show/NCT04663555
3152,NCT04663945,ClinicalTrials.gov,2020-12-08,2020-12-11,False,Recruiting,Not Applicable,Interventional,United States,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,45,https://clinicaltrials.gov/show/NCT04663945
3153,NCT04668625,ClinicalTrials.gov,2020-12-09,2020-11-30,True,Not Recruiting,Not Applicable,Interventional,Spain,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",1000,https://clinicaltrials.gov/show/NCT04668625
3154,NCT04672395,ClinicalTrials.gov,2020-12-16,2021-03-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Dominican Republic, Nepal, South Africa, Colombia, Belgium, Brazil, Poland, Panama, Germany, Philippines",A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,22000,https://clinicaltrials.gov/show/NCT04672395
3155,NCT04678687,ClinicalTrials.gov,2020-12-02,2021-01-01,False,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 and Tissue Damage in Vital Organs,10,https://clinicaltrials.gov/show/NCT04678687
3156,NCT04678700,ClinicalTrials.gov,2020-12-12,2021-03-01,False,Recruiting,Not Applicable,Interventional,Spain,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,40,https://clinicaltrials.gov/show/NCT04678700
3157,NCT04703036,ClinicalTrials.gov,2021-01-06,2021-01-11,False,Recruiting,Phase 1,Interventional,United States,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",64,https://clinicaltrials.gov/show/NCT04703036
3158,NCT04713488,ClinicalTrials.gov,2021-01-13,2021-01-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",110,https://clinicaltrials.gov/show/NCT04713488
3159,NCT04730661,ClinicalTrials.gov,2021-01-19,2020-12-21,True,Recruiting,Not Applicable,Interventional,France,Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19,146,https://clinicaltrials.gov/show/NCT04730661
3160,NCT04733651,ClinicalTrials.gov,2021-01-31,2021-02-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,250,https://clinicaltrials.gov/show/NCT04733651
3161,NCT04734171,ClinicalTrials.gov,2021-01-29,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,United States,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",1200,https://clinicaltrials.gov/show/NCT04734171
3162,NCT04734717,ClinicalTrials.gov,2021-02-01,2021-01-12,True,Recruiting,Not Applicable,Interventional,Hungary,Coordination and Locomotor Problems in Patients With Covid-19 Virus,2,https://clinicaltrials.gov/show/NCT04734717
3163,NCT04738175,ClinicalTrials.gov,2021-02-02,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMGâ„¢) to Treat COVID-19,209,https://clinicaltrials.gov/show/NCT04738175
3164,NCT04739410,ClinicalTrials.gov,2021-02-02,2020-05-01,True,Not Recruiting,Phase 4,Interventional,Pakistan,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04739410
3165,NCT04742049,ClinicalTrials.gov,2021-01-17,2020-12-28,True,Recruiting,Not Applicable,Interventional,Turkey,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",30,https://clinicaltrials.gov/show/NCT04742049
3166,NCT04742595,ClinicalTrials.gov,2021-02-03,2020-12-18,True,Recruiting,Phase 1,Interventional,United States,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,16,https://clinicaltrials.gov/show/NCT04742595
3167,NCT04742738,ClinicalTrials.gov,2021-02-04,2021-01-20,True,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),260,https://clinicaltrials.gov/show/NCT04742738
3168,NCT04742842,ClinicalTrials.gov,2021-01-28,2021-02-15,False,Not Recruiting,Phase 1,Interventional,Australia,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,150,https://clinicaltrials.gov/show/NCT04742842
3169,NCT04742946,ClinicalTrials.gov,2021-02-03,2021-02-15,False,Not Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Covid-19 After Hospital Discharge,237,https://clinicaltrials.gov/show/NCT04742946
3170,NCT04743232,ClinicalTrials.gov,2021-02-03,2021-03-01,False,Recruiting,Not Applicable,Interventional,Netherlands,COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,1000,https://clinicaltrials.gov/show/NCT04743232
3171,NCT04743349,ClinicalTrials.gov,2021-02-05,2021-01-26,True,Recruiting,Not Applicable,Interventional,Italy,Steam Inhalations in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04743349
3172,NCT04743908,ClinicalTrials.gov,2021-02-05,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,2400,https://clinicaltrials.gov/show/NCT04743908
3173,NCT04748471,ClinicalTrials.gov,2021-01-24,2021-02-10,False,Not Recruiting,Phase 2,Interventional,No Country Given,Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y),180,https://clinicaltrials.gov/show/NCT04748471
3174,ACTRN12620000468921,ANZCTR,2020-04-14,2020-05-20,False,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,240,https://anzctr.org.au/ACTRN12620000468921.aspx
3175,ACTRN12621000131853,ANZCTR,2021-02-09,2021-04-19,False,Not Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety, tolerability (how well a substance is tolerated by participants), and Pharmacokinetics (PK, the measure of how the human body processes a substance), of different dosages of TTI-0102 when given to healthy participants as either a single oral dose, or as an oral dose give twice daily on one day (as a potential treatment for COVID-19), compared with a single oral dose of the marketed product Cystagon (registered trademark).",12,https://anzctr.org.au/ACTRN12621000131853.aspx
3176,ChiCTR2000040324,ChiCTR,2020-11-27,2020-12-01,False,Recruiting,Not Applicable,Interventional,China,Special project to support elderly singleton or doubleton in the new wave of COVID-19 pandemic,11000,http://www.chictr.org.cn/showproj.aspx?proj=65022
3177,ChiCTR2000039715,ChiCTR,2020-11-06,2020-11-17,False,Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),720,http://www.chictr.org.cn/showproj.aspx?proj=63754
3178,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,Recruiting,Not Applicable,Interventional,"Canada, Israel",Medical Masks vs N95 Respirators for COVID-19,576,https://clinicaltrials.gov/show/NCT04296643
3179,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,580,https://clinicaltrials.gov/show/NCT04311177
3180,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Not Recruiting,Phase 2,Interventional,Denmark,Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,117,https://clinicaltrials.gov/show/NCT04322396
3181,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19,100,https://clinicaltrials.gov/show/NCT04328012
3182,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,False,Not Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,16,https://clinicaltrials.gov/show/NCT04331600
3183,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-08,False,Not Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,12,https://clinicaltrials.gov/show/NCT04333355
3184,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-05-20,False,Recruiting,Phase 2,Interventional,Italy,Defibrotide in COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04335201
3185,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Not Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,160,https://clinicaltrials.gov/show/NCT04336332
3186,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,False,Not Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,143,https://clinicaltrials.gov/show/NCT04337918
3187,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Not Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,47,https://clinicaltrials.gov/show/NCT04338828
3188,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Not Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,214,https://clinicaltrials.gov/show/NCT04342728
3189,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-05-07,False,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,165,https://clinicaltrials.gov/show/NCT04346147
3190,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,200,https://clinicaltrials.gov/show/NCT04348864
3191,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-21,False,Not Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,8,https://clinicaltrials.gov/show/NCT04349371
3192,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04349618
3193,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Not Recruiting,Not Applicable,Interventional,France,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,176,https://clinicaltrials.gov/show/NCT04352959
3194,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),1000,https://clinicaltrials.gov/show/NCT04357366
3195,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),30,https://clinicaltrials.gov/show/NCT04357808
3196,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,30,https://clinicaltrials.gov/show/NCT04361448
3197,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Not Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),2300,https://clinicaltrials.gov/show/NCT04363827
3198,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-05-07,False,Recruiting,Phase 2,Interventional,Spain,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,1008,https://clinicaltrials.gov/show/NCT04366908
3199,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Not Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,110,https://clinicaltrials.gov/show/NCT04368156
3200,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Recruiting,Phase 1/Phase 2,Interventional,France,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",90,https://clinicaltrials.gov/show/NCT04378920
3201,NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,False,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04384965
3202,NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,True,Not Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,143,https://clinicaltrials.gov/show/NCT04389294
3203,NCT04392453,ClinicalTrials.gov,2020-05-15,2020-10-26,False,Recruiting,Not Applicable,Interventional,Italy,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,40,https://clinicaltrials.gov/show/NCT04392453
3204,NCT04392531,ClinicalTrials.gov,2020-05-03,2020-04-16,True,Recruiting,Phase 4,Interventional,Spain,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,120,https://clinicaltrials.gov/show/NCT04392531
3205,NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,120,https://clinicaltrials.gov/show/NCT04394403
3206,NCT04397705,ClinicalTrials.gov,2020-05-20,2020-10-12,False,Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,30,https://clinicaltrials.gov/show/NCT04397705
3207,NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,0,https://clinicaltrials.gov/show/NCT04409483
3208,NCT04414293,ClinicalTrials.gov,2020-06-01,2020-10-01,False,Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,41,https://clinicaltrials.gov/show/NCT04414293
3209,NCT04436458,ClinicalTrials.gov,2020-06-16,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,100,https://clinicaltrials.gov/show/NCT04436458
3210,NCT04449588,ClinicalTrials.gov,2020-06-26,2020-07-23,False,Recruiting,Phase 2/Phase 3,Interventional,"Indonesia, Bangladesh, Spain, China, India",Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,368,https://clinicaltrials.gov/show/NCT04449588
3211,NCT04456595,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Not Recruiting,Phase 3,Interventional,Brazil,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,12688,https://clinicaltrials.gov/show/NCT04456595
3212,NCT04472585,ClinicalTrials.gov,2020-07-14,2020-11-14,False,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,180,https://clinicaltrials.gov/show/NCT04472585
3213,NCT04490824,ClinicalTrials.gov,2020-07-27,2020-10-01,False,Recruiting,Not Applicable,Interventional,United States,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,100,https://clinicaltrials.gov/show/NCT04490824
3214,NCT04494984,ClinicalTrials.gov,2020-07-29,2020-07-27,True,Not Recruiting,Phase 2/Phase 3,Interventional,Argentina,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",242,https://clinicaltrials.gov/show/NCT04494984
3215,NCT04501458,ClinicalTrials.gov,2020-08-05,2020-08-10,False,Not Recruiting,Not Applicable,Interventional,Kenya,Western Kenya Integrated COVID-19 Response,200000,https://clinicaltrials.gov/show/NCT04501458
3216,NCT04512079,ClinicalTrials.gov,2020-08-11,2020-09-08,False,Recruiting,Phase 4,Interventional,"Colombia, United States, Mexico, Brazil, India",FREEDOM COVID-19 Anticoagulation Strategy,3600,https://clinicaltrials.gov/show/NCT04512079
3217,NCT04517162,ClinicalTrials.gov,2020-08-14,2020-08-19,False,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04517162
3218,NCT04517188,ClinicalTrials.gov,2020-08-15,2021-04-01,False,Not Recruiting,Phase 4,Interventional,No Country Given,Halodine Nasal Antiseptic in Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04517188
3219,NCT04524962,ClinicalTrials.gov,2020-08-19,2020-09-15,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Descartes-30 in Acute Respiratory Distress Syndrome,30,https://clinicaltrials.gov/show/NCT04524962
3220,NCT04529525,ClinicalTrials.gov,2020-08-21,2020-08-19,True,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Ivermectin to Prevent Hospitalizations in COVID-19,500,https://clinicaltrials.gov/show/NCT04529525
3221,NCT04530409,ClinicalTrials.gov,2020-08-24,2020-08-26,False,Recruiting,Phase 4,Interventional,Egypt,Timing of Corticosteroids in COVID-19,450,https://clinicaltrials.gov/show/NCT04530409
3222,NCT04530539,ClinicalTrials.gov,2020-08-26,2020-10-05,False,Recruiting,Not Applicable,Interventional,United States,The Effect of Melatonin and Vitamin C on COVID-19,150,https://clinicaltrials.gov/show/NCT04530539
3223,NCT04530656,ClinicalTrials.gov,2020-08-27,2020-08-28,False,Not Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),168,https://clinicaltrials.gov/show/NCT04530656
3224,NCT04534790,ClinicalTrials.gov,2020-08-05,2020-07-24,True,Not Recruiting,Not Applicable,Interventional,Mexico,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04534790
3225,NCT04542434,ClinicalTrials.gov,2020-09-04,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide in COVID-19,148,https://clinicaltrials.gov/show/NCT04542434
3226,NCT04547660,ClinicalTrials.gov,2020-09-09,2020-07-16,True,Not Recruiting,Phase 3,Interventional,Brazil,Convalescent Plasma for Severe COVID-19 Patients,160,https://clinicaltrials.gov/show/NCT04547660
3227,NCT04557241,ClinicalTrials.gov,2020-09-16,2020-01-14,True,Not Recruiting,Not Applicable,Interventional,United States,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,1017,https://clinicaltrials.gov/show/NCT04557241
3228,NCT04568811,ClinicalTrials.gov,2020-09-28,2020-09-26,True,Not Recruiting,Phase 1,Interventional,China,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,89,https://clinicaltrials.gov/show/NCT04568811
3229,NCT04568889,ClinicalTrials.gov,2020-09-24,2020-09-28,False,Not Recruiting,Not Applicable,Interventional,United States,Minnesota COVID-19 Testing Project,1000,https://clinicaltrials.gov/show/NCT04568889
3230,NCT04581863,ClinicalTrials.gov,2020-10-07,2020-11-30,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Watch + COVID-19 Pulse,850,https://clinicaltrials.gov/show/NCT04581863
3231,NCT04584697,ClinicalTrials.gov,2020-10-07,2020-12-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMGâ„¢) in Outpatients With COVID-19",0,https://clinicaltrials.gov/show/NCT04584697
3232,NCT04593433,ClinicalTrials.gov,2020-10-13,2021-03-04,False,Not Recruiting,Not Applicable,Interventional,Canada,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,40,https://clinicaltrials.gov/show/NCT04593433
3233,NCT04621461,ClinicalTrials.gov,2020-11-06,2020-12-20,False,Not Recruiting,Phase 4,Interventional,United States,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,3,https://clinicaltrials.gov/show/NCT04621461
3234,NCT04652596,ClinicalTrials.gov,2020-11-30,2021-02-08,False,Recruiting,Not Applicable,Interventional,United States,Reducing Food Insecurity During COVID-19,250,https://clinicaltrials.gov/show/NCT04652596
3235,NCT04652765,ClinicalTrials.gov,2020-12-02,2021-02-03,False,Recruiting,Phase 1,Interventional,United States,Camostat With Bicalutamide for COVID-19,60,https://clinicaltrials.gov/show/NCT04652765
3236,NCT04659239,ClinicalTrials.gov,2020-12-05,2021-01-28,False,Recruiting,Phase 3,Interventional,"Malaysia, Brazil","The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",34020,https://clinicaltrials.gov/show/NCT04659239
3237,NCT04662671,ClinicalTrials.gov,2020-12-09,2020-11-18,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",31,https://clinicaltrials.gov/show/NCT04662671
3238,NCT04703140,ClinicalTrials.gov,2020-11-30,2021-02-11,False,Recruiting,Not Applicable,Interventional,France,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,350,https://clinicaltrials.gov/show/NCT04703140
3239,NCT04739020,ClinicalTrials.gov,2021-02-01,2021-01-18,True,Recruiting,Not Applicable,Interventional,Germany,Respiratory Aerosols in Patients With COVID-19 and Healthy Controls,525,https://clinicaltrials.gov/show/NCT04739020
3240,NCT04739462,ClinicalTrials.gov,2021-02-01,2021-02-03,False,Recruiting,Not Applicable,Interventional,"Uganda, United States",SMS Maama Project COVID-19,248,https://clinicaltrials.gov/show/NCT04739462
3241,NCT04745442,ClinicalTrials.gov,2021-02-08,2020-04-27,True,Not Recruiting,Phase 2,Interventional,Spain,Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19,48,https://clinicaltrials.gov/show/NCT04745442
3242,NCT04746365,ClinicalTrials.gov,2021-02-06,2020-12-06,True,Not Recruiting,Phase 4,Interventional,Egypt,Ivermectin Role in Covid-19 Clinical Trial,300,https://clinicaltrials.gov/show/NCT04746365
3243,NCT04747132,ClinicalTrials.gov,2021-02-06,2020-07-20,True,Not Recruiting,Not Applicable,Interventional,Mexico,Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency,110,https://clinicaltrials.gov/show/NCT04747132
3244,NCT04747249,ClinicalTrials.gov,2021-02-08,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,France,Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19,115,https://clinicaltrials.gov/show/NCT04747249
3245,NCT04747405,ClinicalTrials.gov,2021-02-09,2021-02-22,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study,100,https://clinicaltrials.gov/show/NCT04747405
3246,NCT04747756,ClinicalTrials.gov,2021-02-03,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,United States,Creating a Virtual Village for People Aging With HIV During COVID-19,80,https://clinicaltrials.gov/show/NCT04747756
3247,NCT04748120,ClinicalTrials.gov,2021-02-05,2020-12-28,True,Recruiting,Not Applicable,Interventional,United States,Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients,50,https://clinicaltrials.gov/show/NCT04748120
3248,NCT04749121,ClinicalTrials.gov,2021-02-04,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Thailand,Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators,20,https://clinicaltrials.gov/show/NCT04749121
3249,NCT04750317,ClinicalTrials.gov,2021-02-10,2020-05-11,True,Not Recruiting,Phase 2,Interventional,Russian Federation,Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia,414,https://clinicaltrials.gov/show/NCT04750317
3250,NCT04750343,ClinicalTrials.gov,2021-02-10,2021-02-03,True,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19),320,https://clinicaltrials.gov/show/NCT04750343
3251,NCT04751604,ClinicalTrials.gov,2021-02-03,2021-02-01,True,Recruiting,Not Applicable,Interventional,Germany,Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19,840,https://clinicaltrials.gov/show/NCT04751604
3252,NCT04751617,ClinicalTrials.gov,2021-02-05,2021-01-01,True,Recruiting,Not Applicable,Interventional,Poland,Pulmonary Rehabilitation of Patients With a History of COVID-19,60,https://clinicaltrials.gov/show/NCT04751617
3253,NCT04751630,ClinicalTrials.gov,2021-02-09,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Effects of COVID-19 Hospitalization on Physical Performance,78,https://clinicaltrials.gov/show/NCT04751630
3254,NCT04751695,ClinicalTrials.gov,2021-02-09,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines",20,https://clinicaltrials.gov/show/NCT04751695
3255,NCT04751721,ClinicalTrials.gov,2021-02-09,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines",20,https://clinicaltrials.gov/show/NCT04751721
3256,NCT04754113,ClinicalTrials.gov,2021-02-06,2021-02-07,False,Not Recruiting,Not Applicable,Interventional,China,Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19,10,https://clinicaltrials.gov/show/NCT04754113
3257,ChiCTR2000039994,ChiCTR,2020-11-17,2020-11-17,False,Recruiting,Phase 2,Interventional,China,Recombinant COVID-19 Vaccine (Sf9 cells) Phase II Clinical Trial,960,http://www.chictr.org.cn/showproj.aspx?proj=64449
3258,IRCT20190409043215N2,IRCT,2021-02-14,2020-12-20,True,Recruiting,Phase 3,Interventional,Iran,Effect of Viola odorata syrup on aleviating the manifestations of COVID-19 (Corona) infection: A double-blind placebo controlled trial,100,http://en.irct.ir/trial/46581
3259,IRCT20150303021315N22,IRCT,2021-01-27,2020-07-04,True,Not Recruiting,Phase 2,Interventional,Iran,Adalimumab effectiveness in COVID-19,40,http://en.irct.ir/trial/46955
3260,IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,200,http://en.irct.ir/trial/47173
3261,IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,100,http://en.irct.ir/trial/47295
3262,IRCT20200424047184N1,IRCT,2021-01-16,2020-04-03,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Hydroxychloroquine in prevention of sever forms of COVID-19 in healthcare workers,400,http://en.irct.ir/trial/47775
3263,IRCT20081027001411N4,IRCT,2020-07-09,2020-04-29,True,Not Recruiting,Phase 2,Interventional,Iran,Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19,40,http://en.irct.ir/trial/48396
3264,IRCT20200611047727N3,IRCT,2021-01-03,2020-07-22,True,Not Recruiting,Phase 3,Interventional,Iran,Corton's effect in improving patients with covid-19,60,http://en.irct.ir/trial/49116
3265,IRCT20180103038199N3,IRCT,2020-08-30,2020-10-22,False,Recruiting,Phase 2,Interventional,Iran,effects of three products containing Noscapine on COVID-19,160,http://en.irct.ir/trial/49775
3266,IRCT20191211045691N1,IRCT,2020-07-28,2020-07-30,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patients,100,http://en.irct.ir/trial/49879
3267,IRCT20200906048638N1,IRCT,2021-02-01,2020-12-21,True,Recruiting,Phase 4,Interventional,Iran,Efficacy of Atorvastatin on in-hospital outcome of COVID-19 infection,90,http://en.irct.ir/trial/50860
3268,IRCT20200921048794N1,IRCT,2020-11-19,2021-02-19,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the Effects of L-carnitine Supplementation on Patients with COVID-19,64,http://en.irct.ir/trial/51120
3269,IRCT20200928048865N1,IRCT,2021-01-01,2020-11-05,True,Not Recruiting,Not Applicable,Interventional,Iran,The effect of environmental health education on self-efficacy and anxiety caused of Covid-19,60,http://en.irct.ir/trial/51258
3270,IRCT20191125045496N3,IRCT,2021-01-25,2020-04-20,True,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the Effect of Pulmonary Rehabilitation in COVID-19 Patients,40,http://en.irct.ir/trial/51644
3271,IRCT20201024049134N1,IRCT,2020-11-02,2021-01-20,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Arbidol in treatment of COVID-19,80,http://en.irct.ir/trial/51847
3272,IRCT20111121008146N34,IRCT,2021-01-24,2020-09-22,True,Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of laser acupuncture in controlling COVID-19 compared to common medical treatments,60,http://en.irct.ir/trial/51948
3273,IRCT20201111049348N1,IRCT,2021-01-03,2021-01-29,False,Not Recruiting,Phase 3,Interventional,Iran,The Effect of  Licorice Root Extract on the Treatment of Patients with Covid-19,120,http://en.irct.ir/trial/52276
3274,IRCT20200611047735N2,IRCT,2021-02-13,2020-10-22,True,Not Recruiting,Phase 2,Interventional,Iran,The effect of Plasmapheresis in the treatment of patients with COVID-19,45,http://en.irct.ir/trial/52426
3275,IRCT20201122049463N1,IRCT,2021-01-18,2021-01-20,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of chest wall hyperthermia on the blood oxygen saturation of Covid-19 patients,60,http://en.irct.ir/trial/52495
3276,IRCT20200927048849N2,IRCT,2021-01-06,2020-11-27,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patients,40,http://en.irct.ir/trial/52537
3277,IRCT20201125049486N1,IRCT,2020-12-24,2020-12-21,True,Not Recruiting,Phase 3,Interventional,Iran,The use of oxygen-enrich water in therapy of patients with  Covid 19,44,http://en.irct.ir/trial/52541
3278,IRCT20170123032129N9,IRCT,2021-01-05,2020-12-10,True,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of information support on patient's resilience, fear and anxiety",84,http://en.irct.ir/trial/52574
3279,IRCT20201128049520N1,IRCT,2021-02-22,2021-03-05,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,effect of olive leaf extract on Covid-19 patients,129,http://en.irct.ir/trial/52677
3280,IRCT20201119049445N1,IRCT,2021-02-13,2021-01-20,True,Recruiting,Not Applicable,Interventional,Iran,Comparing the effect of psychotherapy on the grief experience and quality of life in first-degree relatives of the deceased caused by COVID 19,40,http://en.irct.ir/trial/52747
3281,IRCT20201202049566N1,IRCT,2021-01-22,2020-02-20,True,Not Recruiting,Not Applicable,Interventional,Iran,"treatment strategy  Included: hydroxychloroquine, naproxen, and oseltamivir for outpatient patients with Covid 19",150,http://en.irct.ir/trial/52800
3282,IRCT20190717044241N3,IRCT,2020-12-31,2020-12-21,True,Recruiting,Phase 2,Interventional,Iran,Cell therapy in patients with COVID-19,20,http://en.irct.ir/trial/52820
3283,IRCT20160808029255N10,IRCT,2021-01-10,2021-01-20,False,Recruiting,Not Applicable,Interventional,Iran,"The effect of Remote Group intervention on sexual health literacy, sexual function, sexual self-efficacy and quality of sexual life of women in reproductive age",110,http://en.irct.ir/trial/52822
3284,IRCT20200621047859N4,IRCT,2021-01-03,2020-10-28,True,Recruiting,Phase 1,Interventional,Iran,The effects of mesenchymal stem cells in COVID-19,20,http://en.irct.ir/trial/52947
3285,IRCT20201213049693N1,IRCT,2021-02-13,2020-12-29,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of educational intervention based on social support theory on the reduction of Stress related Covid-19 in Diabetic Patients in Bandar Abbas,212,http://en.irct.ir/trial/53006
3286,IRCT20180316039112N3,IRCT,2021-02-01,2020-06-21,True,Not Recruiting,Phase 2,Interventional,Iran,Plasmapheresis in the treatment of patients with COVID-19,100,http://en.irct.ir/trial/53059
3287,IRCT20200318046812N3,IRCT,2021-01-12,2020-12-20,True,Not Recruiting,Phase 3,Interventional,Iran,"Efficacy and safety of ""BioBoost"" supplement on the incidence of COVID-19 symptoms of asymptomatic family members of COVID-19 patients",500,http://en.irct.ir/trial/53187
3288,IRCT20201127049505N1,IRCT,2021-02-06,2020-12-28,True,Not Recruiting,Phase 3,Interventional,Iran,Study on the evaluation of the safety and efficacy of Sofosbuvir  in participants with mild coronavirus in outpatients (COVID-19),360,http://en.irct.ir/trial/53212
3289,IRCT20170807035551N2,IRCT,2021-01-16,2021-01-20,False,Recruiting,Phase 3,Interventional,Iran,Efficacy of Tadalafil on improvement of erectile dysfunction,60,http://en.irct.ir/trial/53252
3290,IRCT20160110025929N34,IRCT,2021-01-16,2021-01-19,False,Recruiting,Not Applicable,Interventional,Iran,effect of virtual relaxation technique training (Jacobson and Benson) on anxiety in patients with Covid -19,60,http://en.irct.ir/trial/53265
3291,IRCT20201223049816N1,IRCT,2021-01-11,2020-12-20,True,Recruiting,Phase 1,Interventional,Iran,Evaluation of the effectiveness of PHR-160 spray in hospitalized patients with Covid-19,240,http://en.irct.ir/trial/53342
3292,IRCT20201028049175N3,IRCT,2021-01-15,2021-02-19,False,Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin to decrease intensity of clinical manifestations in patient with COVID19,100,http://en.irct.ir/trial/53410
3293,IRCT20200223046586N3,IRCT,2021-01-11,2021-01-13,False,Recruiting,Not Applicable,Interventional,Iran,multimedia-based peer support groups on anxiety in patients,100,http://en.irct.ir/trial/53538
3294,IRCT20210109049978N1,IRCT,2021-01-13,2021-01-18,False,Recruiting,Not Applicable,Interventional,Iran,Effect of Internet- Based Psychoeducational Support on Perceived Stress and Caring Burden in Caregivers of Patients with COVID-19,70,http://en.irct.ir/trial/53594
3295,IRCT20110425006280N11,IRCT,2021-01-27,2021-01-19,True,Recruiting,Phase 2,Interventional,Iran,The effect of pentoxifylline in the treatment of Covid-19 disease,20,http://en.irct.ir/trial/53644
3296,IRCT20210111050011N1,IRCT,2021-02-16,2021-02-19,False,Recruiting,Not Applicable,Interventional,Iran,The Effect of Tele-Nursing on Caregiver Burden in Family Caregivers and Self-Efficacy in Patients With Covid-19,60,http://en.irct.ir/trial/53741
3297,IRCT20210120050092N1,IRCT,2021-02-19,2020-04-20,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of stress and anxiety due to Covid 19 epidemic in pregnant women,100,http://en.irct.ir/trial/53834
3298,IRCT20190804044429N6,IRCT,2021-02-20,2021-02-18,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Nasal spray of mometasone 0.05% effects on olfactory improvement in  COVID-19,60,http://en.irct.ir/trial/54008
3299,IRCT20210205050247N1,IRCT,2021-02-13,2021-02-18,False,Recruiting,Phase 1,Interventional,Iran,The effect of olfactory training and vitamin A in the olfactory loss of patients with covid-19.,90,http://en.irct.ir/trial/54178
3300,IRCT20200506047323N7,IRCT,2021-02-16,2021-02-28,False,Not Recruiting,Phase 3,Interventional,Iran,melatonin in patients with COVID-19,60,http://en.irct.ir/trial/54268
3301,IRCT20210214050350N1,IRCT,2021-02-22,2021-02-14,True,Recruiting,Phase 3,Interventional,Iran,Comparing the effectiveness of Kaletra/Hydroxychloroquine and Atazanavir/Dolutegravir/Hydroxychloroquine treatment regiments in COVID-19 treatment,60,http://en.irct.ir/trial/54295
3302,IRCT20210214050356N1,IRCT,2021-02-22,2021-02-19,True,Recruiting,Not Applicable,Interventional,Iran,Effect of Muscle Release Treatment in Patients Infected by Corona- Virus,50,http://en.irct.ir/trial/54351
3303,IRCT20200509047364N3,IRCT,2021-02-20,2021-03-02,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of N-Acetylcysteine on COVID-19,40,http://en.irct.ir/trial/54372
3304,IRCT20190804044429N5,IRCT,2021-02-18,2021-02-22,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Colchicine effects on treatment of COVID-19,110,http://en.irct.ir/trial/54385
3305,KCT0005834,CRIS,2021-01-28,2020-08-18,True,Recruiting,Phase 2,Interventional,South Korea,"A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase ? Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients",76,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18138
3306,KCT0005896,CRIS,2021-02-16,2020-09-04,True,Not Recruiting,Phase1,Interventional,South Korea,"A Phase 1 study to Evaluate the Safety, Tolerability and Virology of CT-P59 in Patient with Mild COVID-19",18,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18143
3307,JPRN-jRCTs052200134,JPRN,2021-02-15,2021-02-15,False,Recruiting,Phase 1/Phase 2,Interventional,Japan,A clinical study of a new virus adsorption therapy in patients with severe COVID-19 infection,25,https://jrct.niph.go.jp/latest-detail/jRCTs052200134
3308,CTRI/2021/01/030752,CTRI,2021-01-27,2021-01-30,False,Not Recruiting,Not Applicable,Interventional,India,Effect of Online Yoga for 12-weeks in comparison to no-treatment on change in Burnout and Professional Quality of Life among COVID-19 Frontline Warriors.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51380
3309,CTRI/2021/01/030795,CTRI,2021-01-28,2021-01-02,True,Recruiting,Phase 2,Interventional,India,Clinical study to evaluate the safety and efficacy of ATRICOV 452 for the treatment of COVID-19 along with the standard of care.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51391
3310,CTRI/2021/01/030793,CTRI,2021-01-28,2021-01-30,False,Recruiting,Phase 3,Interventional,India,A clinical trial of Intravenous Glutathione along with standard treatment in Moderate COVID-19 Pneumonia Patients.,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48850
3311,CTRI/2021/01/030826,CTRI,2021-01-29,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,India,Clinical virtual simulation is effective in nursing education,52,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47638
3312,CTRI/2021/01/030829,CTRI,2021-01-29,2021-05-02,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of HFNC Vs non rebreathing mask for oxygen therapy in COVID 19 pneumonia,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51297
3313,CTRI/2021/01/030830,CTRI,2021-01-29,2021-08-02,False,Not Recruiting,Phase 3,Interventional,"Sweden, Georgia, United Kingdom, Japan, Poland, France, Denmark, Greece, United States, Germany, Switzerland, Argentina, Brazil, Mexico, Nigeria, Singapore, Chile, Australia, Peru, Portugal, Thailand, Israel, Spain, India",Therapeutics for Inpatients with COVID-19 (TICO),1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52067
3314,CTRI/2021/01/030825,CTRI,2021-01-29,2021-01-02,True,Not Recruiting,Phase 3,Interventional,India,"Role of Unani drugs (Tiryaqe Wabai, Arque-e-Ajeeb, Habb-e- Loban) in the treatment of COVID-19 patients.",46,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51863
3315,CTRI/2021/01/030824,CTRI,2021-01-29,2021-01-29,False,Recruiting,Phase 2,Interventional,India,Efficacy and Safety Study of COVID-19 Hyperimmunoglobulin in patients with COVID-19,66,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50900
3316,CTRI/2021/02/030887,CTRI,2021-02-01,2021-10-02,False,Recruiting,Phase 2,Interventional,India,A safety and efficacy study of Eflornithine (NSRT2020Ã¢?Â¢) against the standard of care in adult hospitalized patients showing signs and symptoms of moderate COVID-19 infection.,208,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48386
3317,CTRI/2021/02/030892,CTRI,2021-02-01,2021-01-02,True,Recruiting,Phase 3,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients,416,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49972
3318,CTRI/2021/02/030897,CTRI,2021-02-01,2021-11-02,False,Not Recruiting,Not Applicable,Interventional,India,Covid yoga practice among health care professionals having stress anxiety and depression,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52184
3319,CTRI/2021/02/030957,CTRI,2021-02-03,2021-02-15,False,Not Recruiting,Not Applicable,Interventional,India,A clinical study to determine whether an alkaline barrier created in the oropharynx by use of spray containing 8.4% sodium bicarbonate can mitigate  development of Influenza Like Illness (ILI) and Covid-19 infection.,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52251
3320,CTRI/2021/02/030986,CTRI,2021-02-04,2021-05-02,False,Not Recruiting,Phase 2,Interventional,India,A trial of sodium-copper-chlorophyllin given along with treatment of physicianÃ¢??s choice versus treatment of physicianÃ¢??s choice in asymptomatic or mildly symptomatic patients with Covid-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51800
3321,CTRI/2021/02/031012,CTRI,2021-02-04,2021-02-15,False,Recruiting,Not Applicable,Interventional,India,Cotrimoxazole in hospitalised patients with severe COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51954
3322,CTRI/2021/02/031036,CTRI,2021-02-05,2021-10-02,False,Not Recruiting,Not Applicable,Interventional,India,Effect of Gayatri Mantra and Pranayama on covid-19 patients.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51219
3323,CTRI/2021/02/031052,CTRI,2021-02-05,2021-02-20,False,Not Recruiting,Not Applicable,Interventional,India,"comparison of  ease and duration of intubation with Macintosh versus King vision video-laryngoscope using COVID-19 barrier box on manikins, so that we can use one of them (according to study outcome showing ease of intubation) for intubation of COVID patients",32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46372
3324,CTRI/2021/02/031176,CTRI,2021-02-10,2021-02-14,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of Phase I Cardiac Rehabilitation among Patients Undergoing CABG Surgery - A Randomized Controlled Trial,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52050
3325,CTRI/2021/02/031232,CTRI,2021-02-11,2021-02-03,True,Not Recruiting,Phase 2,Interventional,India,Perceived stress and potential correlates among the frontline nurses during the COVID -19  pandemic.,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52011
3326,CTRI/2021/02/031256,CTRI,2021-02-12,2021-02-19,False,Not Recruiting,Phase 2,Interventional,India,Madhav Rasayan Plus in subjects of COVID 19.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52613
3327,CTRI/2021/02/031295,CTRI,2021-02-15,2021-02-20,False,Not Recruiting,Phase 1,Interventional,India,Intranasal Adenoviral vector COVID-19 vaccine (BBV154) Phase 1 study,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327
3328,CTRI/2021/02/031286,CTRI,2021-02-15,2021-04-27,False,Not Recruiting,Not Applicable,Interventional,India,Internet based self-guided intervention for COVID-19 related dysfunctional worry,290,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52451
3329,CTRI/2021/02/031322,CTRI,2021-02-16,2021-03-16,False,Not Recruiting,Not Applicable,Interventional,India,Study of Effectiveness of Telemedicine Based Pulmonary Rehabilitation in Recovered patients of Covid 19 Lung Infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52024
3330,CTRI/2021/02/031353,CTRI,2021-02-17,2021-02-24,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurveda clinical trial on mildly symptomatic COVID- 19 patientsÃ¢??,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52810
3331,CTRI/2021/02/031375,CTRI,2021-02-17,2021-08-03,False,Not Recruiting,Not Applicable,Interventional,India,Non Invasive Ventilation by Helmet mask vs. Facemask in Covid pneumonia patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52608
3332,CTRI/2021/02/031420,CTRI,2021-02-19,2021-02-27,False,Not Recruiting,Phase 2,Interventional,India,Effectivenes of Siddha Supplement MAM Granules in the Management of Pre Symptomatic COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52957
3333,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Not Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,2,https://clinicaltrials.gov/show/NCT04331366
3334,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Not Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,275,https://clinicaltrials.gov/show/NCT04331834
3335,NCT04349592,ClinicalTrials.gov,2020-04-12,2020-04-14,False,Not Recruiting,Not Applicable,Interventional,Qatar,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,456,https://clinicaltrials.gov/show/NCT04349592
3336,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),64,https://clinicaltrials.gov/show/NCT04355962
3337,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-05-21,False,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,1000,https://clinicaltrials.gov/show/NCT04361838
3338,NCT04364828,ClinicalTrials.gov,2020-04-22,2020-10-21,False,Recruiting,Not Applicable,Interventional,Germany,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,1000,https://clinicaltrials.gov/show/NCT04364828
3339,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,100,https://clinicaltrials.gov/show/NCT04367636
3340,NCT04374474,ClinicalTrials.gov,2020-04-29,2021-01-10,False,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),0,https://clinicaltrials.gov/show/NCT04374474
3341,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Not Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,447,https://clinicaltrials.gov/show/NCT04377789
3342,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Slovakia",Efficacy and Safety of PolyoxidoniumÂ® in Hospitalized Patients With Coronavirus Disease COVID-19,394,https://clinicaltrials.gov/show/NCT04381377
3343,NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,False,Not Recruiting,Phase 2,Interventional,"Spain, Mexico, United States, Brazil",A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,410,https://clinicaltrials.gov/show/NCT04386616
3344,NCT04390217,ClinicalTrials.gov,2020-05-13,2021-10-31,False,Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,120,https://clinicaltrials.gov/show/NCT04390217
3345,NCT04395430,ClinicalTrials.gov,2020-02-03,2020-09-18,False,Recruiting,Not Applicable,Interventional,Singapore,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,40,https://clinicaltrials.gov/show/NCT04395430
3346,NCT04395456,ClinicalTrials.gov,2020-05-19,2021-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),144,https://clinicaltrials.gov/show/NCT04395456
3347,NCT04408040,ClinicalTrials.gov,2020-05-15,2020-07-14,False,Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,700,https://clinicaltrials.gov/show/NCT04408040
3348,NCT04408287,ClinicalTrials.gov,2020-05-20,2020-09-15,False,Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,50,https://clinicaltrials.gov/show/NCT04408287
3349,NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,False,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",120,https://clinicaltrials.gov/show/NCT04412291
3350,NCT04414631,ClinicalTrials.gov,2020-05-19,2020-08-06,False,Recruiting,Phase 2,Interventional,"Switzerland, Mexico, Brazil",Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,120,https://clinicaltrials.gov/show/NCT04414631
3351,NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,17,https://clinicaltrials.gov/show/NCT04425538
3352,NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Not Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04428268
3353,NCT04431297,ClinicalTrials.gov,2020-06-12,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04431297
3354,NCT04442178,ClinicalTrials.gov,2020-06-19,2020-09-15,False,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),48,https://clinicaltrials.gov/show/NCT04442178
3355,NCT04456153,ClinicalTrials.gov,2020-06-30,2020-07-22,False,Not Recruiting,Phase 2,Interventional,United States,Atovaquone for Treatment of COVID-19,61,https://clinicaltrials.gov/show/NCT04456153
3356,NCT04463004,ClinicalTrials.gov,2020-07-07,2020-09-02,False,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,2,https://clinicaltrials.gov/show/NCT04463004
3357,NCT04463849,ClinicalTrials.gov,2020-07-02,2020-06-30,True,Recruiting,Not Applicable,Interventional,Italy,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,90,https://clinicaltrials.gov/show/NCT04463849
3358,NCT04473898,ClinicalTrials.gov,2020-07-14,2020-06-19,True,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation After Coronavirus,35,https://clinicaltrials.gov/show/NCT04473898
3359,NCT04476667,ClinicalTrials.gov,2020-07-13,2020-06-15,True,Recruiting,Not Applicable,Interventional,Canada,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",80,https://clinicaltrials.gov/show/NCT04476667
3360,NCT04476953,ClinicalTrials.gov,2020-07-15,2020-08-03,False,Recruiting,Phase 2,Interventional,United States,COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation,70,https://clinicaltrials.gov/show/NCT04476953
3361,NCT04477668,ClinicalTrials.gov,2020-07-09,2021-02-08,False,Recruiting,Not Applicable,Interventional,Saudi Arabia,Helmet Non-Invasive Ventilation for COVID-19 Patients,320,https://clinicaltrials.gov/show/NCT04477668
3362,NCT04486482,ClinicalTrials.gov,2020-07-23,2021-01-12,False,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,50,https://clinicaltrials.gov/show/NCT04486482
3363,NCT04527575,ClinicalTrials.gov,2020-08-11,2020-07-27,True,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",100,https://clinicaltrials.gov/show/NCT04527575
3364,NCT04533347,ClinicalTrials.gov,2020-08-28,2021-02-19,False,Recruiting,Phase 2,Interventional,United States,Tafenoquine in Patients With Mild to Moderate COVID-19,275,https://clinicaltrials.gov/show/NCT04533347
3365,NCT04534803,ClinicalTrials.gov,2020-08-21,2021-09-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),2100,https://clinicaltrials.gov/show/NCT04534803
3366,NCT04540419,ClinicalTrials.gov,2020-08-17,2020-09-11,False,Not Recruiting,Phase 3,Interventional,Russian Federation,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,500,https://clinicaltrials.gov/show/NCT04540419
3367,NCT04561180,ClinicalTrials.gov,2020-09-22,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,96,https://clinicaltrials.gov/show/NCT04561180
3368,NCT04582344,ClinicalTrials.gov,2020-10-01,2020-09-14,True,Recruiting,Phase 3,Interventional,Turkey,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),13000,https://clinicaltrials.gov/show/NCT04582344
3369,NCT04583410,ClinicalTrials.gov,2020-09-28,2020-10-22,False,Recruiting,Phase 3,Interventional,France,Efficacy of Nicotine in Preventing COVID-19 Infection,1633,https://clinicaltrials.gov/show/NCT04583410
3370,NCT04594525,ClinicalTrials.gov,2020-10-12,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Maternal Telemental Health Interventions in Response to Covid-19*,58,https://clinicaltrials.gov/show/NCT04594525
3371,NCT04600141,ClinicalTrials.gov,2020-10-22,2020-11-10,False,Recruiting,Phase 3,Interventional,Brazil,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection,308,https://clinicaltrials.gov/show/NCT04600141
3372,NCT04657809,ClinicalTrials.gov,2020-12-02,2020-10-01,True,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,40,https://clinicaltrials.gov/show/NCT04657809
3373,NCT04673292,ClinicalTrials.gov,2020-12-16,2021-02-08,False,Recruiting,Not Applicable,Interventional,United States,Community Collaboration to Combat COVID-19 (C-FORWARD),3000,https://clinicaltrials.gov/show/NCT04673292
3374,NCT04704544,ClinicalTrials.gov,2021-01-06,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,United States,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE),320,https://clinicaltrials.gov/show/NCT04704544
3375,NCT04715854,ClinicalTrials.gov,2021-01-03,2021-02-19,False,Not Recruiting,Not Applicable,Interventional,Belgium,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,15,https://clinicaltrials.gov/show/NCT04715854
3376,NCT04741061,ClinicalTrials.gov,2021-02-02,2021-02-19,False,Recruiting,Phase 3,Interventional,Russian Federation,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light",6000,https://clinicaltrials.gov/show/NCT04741061
3377,NCT04749173,ClinicalTrials.gov,2021-01-20,2020-11-21,True,Recruiting,Phase 1,Interventional,South Korea,"To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.",24,https://clinicaltrials.gov/show/NCT04749173
3378,NCT04750759,ClinicalTrials.gov,2021-02-08,2021-02-03,True,Recruiting,Phase 2,Interventional,Germany,Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat,40,https://clinicaltrials.gov/show/NCT04750759
3379,NCT04756128,ClinicalTrials.gov,2021-01-28,2021-01-25,True,Recruiting,Phase 2,Interventional,United States,Impact of Colchicine and Low-dose Naltrexone on COVID-19,164,https://clinicaltrials.gov/show/NCT04756128
3380,NCT04756271,ClinicalTrials.gov,2021-02-13,2021-02-11,True,Recruiting,Phase 3,Interventional,Egypt,Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04756271
3381,NCT04756323,ClinicalTrials.gov,2021-02-09,2020-10-27,True,Not Recruiting,Phase 2,Interventional,China,A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),1000,https://clinicaltrials.gov/show/NCT04756323
3382,NCT04756609,ClinicalTrials.gov,2021-02-06,2021-02-12,False,Not Recruiting,Not Applicable,Interventional,France,"Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID",104000,https://clinicaltrials.gov/show/NCT04756609
3383,NCT04756830,ClinicalTrials.gov,2021-02-15,2021-02-01,True,Not Recruiting,Phase 4,Interventional,Brazil,A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19,1200,https://clinicaltrials.gov/show/NCT04756830
3384,NCT04757298,ClinicalTrials.gov,2021-02-15,2021-02-12,True,Recruiting,Not Applicable,Interventional,United States,COVID-19 Treatment Cascade Optimization Study,670,https://clinicaltrials.gov/show/NCT04757298
3385,NCT04757818,ClinicalTrials.gov,2021-02-16,2021-02-04,True,Recruiting,Not Applicable,Interventional,Spain,"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.",140,https://clinicaltrials.gov/show/NCT04757818
3386,NCT04758273,ClinicalTrials.gov,2021-02-09,2020-10-07,True,Not Recruiting,Phase 1,Interventional,China,A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),180,https://clinicaltrials.gov/show/NCT04758273
3387,NCT04758286,ClinicalTrials.gov,2021-02-11,2020-07-01,True,Not Recruiting,Not Applicable,Interventional,Egypt,Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19,209,https://clinicaltrials.gov/show/NCT04758286
3388,NCT04760418,ClinicalTrials.gov,2021-02-10,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic,6,https://clinicaltrials.gov/show/NCT04760418
3389,NCT04760561,ClinicalTrials.gov,2021-02-15,2021-02-20,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Self-prone Positioning for Awake Non-intubated Patients With COVID-19,82,https://clinicaltrials.gov/show/NCT04760561
3390,NCT04760730,ClinicalTrials.gov,2021-02-17,2021-03-17,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19),100,https://clinicaltrials.gov/show/NCT04760730
3391,NCT04760743,ClinicalTrials.gov,2021-02-17,2020-12-17,True,Not Recruiting,Phase 1,Interventional,South Korea,Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19),50,https://clinicaltrials.gov/show/NCT04760743
3392,NCT04760821,ClinicalTrials.gov,2021-02-17,2020-12-10,True,Recruiting,Phase 2,Interventional,Brazil,Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19,80,https://clinicaltrials.gov/show/NCT04760821
3393,NCT04761692,ClinicalTrials.gov,2021-02-02,2021-10-01,False,Not Recruiting,Not Applicable,Interventional,United States,"Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake",570,https://clinicaltrials.gov/show/NCT04761692
3394,NCT04762186,ClinicalTrials.gov,2021-02-11,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19,51,https://clinicaltrials.gov/show/NCT04762186
3395,NCT04762628,ClinicalTrials.gov,2021-02-11,2020-10-27,True,Not Recruiting,Not Applicable,Interventional,Ukraine,"Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients",600,https://clinicaltrials.gov/show/NCT04762628
3396,NCT04764721,ClinicalTrials.gov,2021-02-19,2021-04-12,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID,50,https://clinicaltrials.gov/show/NCT04764721
3397,NCT04764981,ClinicalTrials.gov,2021-02-14,2021-05-01,False,Recruiting,Not Applicable,Interventional,Brazil,Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19),350,https://clinicaltrials.gov/show/NCT04764981
3398,NCT04765436,ClinicalTrials.gov,2021-02-16,2021-01-14,True,Recruiting,Phase 1,Interventional,Canada,"PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64",60,https://clinicaltrials.gov/show/NCT04765436
3399,NCT04767087,ClinicalTrials.gov,2021-02-20,2021-02-05,True,Recruiting,Phase 2/Phase 3,Interventional,Pakistan,Honey and Nigella Sativa in COVID-19 Prophylaxis,1000,https://clinicaltrials.gov/show/NCT04767087
3400,ACTRN12621000183886,ANZCTR,2021-02-22,2021-02-22,False,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a peer and clinician co-facilitated group program for people with borderline personality disorder,120,https://anzctr.org.au/ACTRN12621000183886.aspx
3401,ISRCTN11204126,ISRCTN,2021-02-17,2021-05-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Contact tracing in care homes using digital technology for improving infection control including COVID-19,400,http://isrctn.com/ISRCTN11204126
3402,ISRCTN69564614,ISRCTN,2020-12-16,2021-06-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Moving on trial: COVID-19 and homelessness,1200,http://isrctn.com/ISRCTN69564614
3403,ISRCTN48734830,ISRCTN,2020-07-10,2020-03-08,True,Recruiting,Phase 4,Interventional,Sweden,Using the blood pressure medication losartan to improve outcomes for patients with SARS CoV-2,750,http://isrctn.com/ISRCTN48734830
3404,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,"United States, Israel",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,196,https://clinicaltrials.gov/show/NCT04311697
3405,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-24,False,Not Recruiting,Phase 3,Interventional,France,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04325633
3406,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,120,https://clinicaltrials.gov/show/NCT04334460
3407,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Recruiting,Phase 1,Interventional,Hungary,Anti COVID-19 Convalescent Plasma Therapy,20,https://clinicaltrials.gov/show/NCT04345679
3408,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,False,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),500,https://clinicaltrials.gov/show/NCT04351724
3409,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Not Recruiting,Phase 4,Interventional,"Germany, Austria",Stopping ACE-inhibitors in COVID-19,216,https://clinicaltrials.gov/show/NCT04353596
3410,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04355728
3411,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,False,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,2000,https://clinicaltrials.gov/show/NCT04358003
3412,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,100,https://clinicaltrials.gov/show/NCT04366141
3413,NCT04369274,ClinicalTrials.gov,2020-04-23,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,30,https://clinicaltrials.gov/show/NCT04369274
3414,NCT04384445,ClinicalTrials.gov,2020-05-09,2020-09-08,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Zofin (Organicell Flow) for Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04384445
3415,NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,0,https://clinicaltrials.gov/show/NCT04388709
3416,NCT04394013,ClinicalTrials.gov,2020-05-18,2020-08-26,False,Not Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,70,https://clinicaltrials.gov/show/NCT04394013
3417,NCT04395976,ClinicalTrials.gov,2020-05-19,2020-05-10,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04395976
3418,NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,50,https://clinicaltrials.gov/show/NCT04397510
3419,NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Not Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",204,https://clinicaltrials.gov/show/NCT04405570
3420,NCT04410549,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Recruiting,Not Applicable,Interventional,"Italy, Brazil",Pulmonary Optical Coherence Tomography in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04410549
3421,NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,True,Recruiting,Phase 1,Interventional,United States,Intermediate IND Severe Illness COVID-19 CP,90,https://clinicaltrials.gov/show/NCT04411602
3422,NCT04429555,ClinicalTrials.gov,2020-06-09,2021-01-11,False,Recruiting,Phase 2,Interventional,United States,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",40,https://clinicaltrials.gov/show/NCT04429555
3423,NCT04456413,ClinicalTrials.gov,2020-06-30,2020-11-06,False,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,306,https://clinicaltrials.gov/show/NCT04456413
3424,NCT04472611,ClinicalTrials.gov,2020-07-14,2020-10-30,False,Recruiting,Phase 3,Interventional,United States,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,466,https://clinicaltrials.gov/show/NCT04472611
3425,NCT04472728,ClinicalTrials.gov,2020-07-06,2020-06-16,True,Recruiting,Phase 2/Phase 3,Interventional,"Belgium, Puerto Rico, United States, Brazil, France",Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,310,https://clinicaltrials.gov/show/NCT04472728
3426,NCT04475913,ClinicalTrials.gov,2020-07-14,2018-07-11,True,Not Recruiting,Not Applicable,Interventional,Egypt,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,56,https://clinicaltrials.gov/show/NCT04475913
3427,NCT04495816,ClinicalTrials.gov,2020-07-30,2020-07-15,True,Recruiting,Phase 2,Interventional,United States,COVID-19 Anosmia Study,126,https://clinicaltrials.gov/show/NCT04495816
3428,NCT04505774,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Recruiting,Phase 4,Interventional,"Spain, United States",Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),2000,https://clinicaltrials.gov/show/NCT04505774
3429,NCT04533048,ClinicalTrials.gov,2020-08-22,2020-08-07,True,Not Recruiting,Phase 1,Interventional,China,A Clinical Study to Evaluate MW33 Injection,42,https://clinicaltrials.gov/show/NCT04533048
3430,NCT04535674,ClinicalTrials.gov,2020-08-31,2020-10-09,False,Recruiting,Phase 2,Interventional,"Spain, Russian Federation",Asunercept in Patients With Severe COVID-19,400,https://clinicaltrials.gov/show/NCT04535674
3431,NCT04535869,ClinicalTrials.gov,2020-08-28,2020-12-28,False,Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),50,https://clinicaltrials.gov/show/NCT04535869
3432,NCT04541979,ClinicalTrials.gov,2020-06-05,2020-06-04,True,Recruiting,Phase 2,Interventional,Sweden,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04541979
3433,NCT04542850,ClinicalTrials.gov,2020-08-16,2020-11-15,False,Recruiting,Not Applicable,Interventional,Bahrain,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",40,https://clinicaltrials.gov/show/NCT04542850
3434,NCT04568707,ClinicalTrials.gov,2020-08-31,2020-10-23,False,Recruiting,Not Applicable,Interventional,France,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),200,https://clinicaltrials.gov/show/NCT04568707
3435,NCT04588415,ClinicalTrials.gov,2020-10-08,2021-01-03,False,Recruiting,Not Applicable,Interventional,Canada,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04588415
3436,NCT04603781,ClinicalTrials.gov,2020-10-03,2020-12-04,False,Recruiting,Phase 2/Phase 3,Interventional,United States,CBD Oil for Reducing Emotional Impact of COVID-19,160,https://clinicaltrials.gov/show/NCT04603781
3437,NCT04613739,ClinicalTrials.gov,2020-10-29,2020-12-08,False,Recruiting,Not Applicable,Interventional,United States,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,430,https://clinicaltrials.gov/show/NCT04613739
3438,NCT04614844,ClinicalTrials.gov,2020-11-02,2021-01-06,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),84,https://clinicaltrials.gov/show/NCT04614844
3439,NCT04627584,ClinicalTrials.gov,2020-11-12,2020-12-29,False,Recruiting,Phase 2,Interventional,China,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04627584
3440,NCT04632043,ClinicalTrials.gov,2020-11-15,2020-11-18,False,Recruiting,Not Applicable,Interventional,Greece,Early Versus Delayed Intubation of Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04632043
3441,NCT04651790,ClinicalTrials.gov,2020-11-20,2020-11-27,False,Recruiting,Phase 3,Interventional,Chile,"Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults",2300,https://clinicaltrials.gov/show/NCT04651790
3442,NCT04659707,ClinicalTrials.gov,2020-12-07,2021-02-22,False,Recruiting,Phase 1,Interventional,United States,Hyperpolarized 129Xe MRI of Survivors of COVID-19,20,https://clinicaltrials.gov/show/NCT04659707
3443,NCT04678843,ClinicalTrials.gov,2020-12-17,2021-02-09,False,Recruiting,Phase 1,Interventional,Canada,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,36,https://clinicaltrials.gov/show/NCT04678843
3444,NCT04679909,ClinicalTrials.gov,2020-12-21,2021-02-01,False,Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),180,https://clinicaltrials.gov/show/NCT04679909
3445,NCT04681053,ClinicalTrials.gov,2020-12-16,2021-02-25,False,Recruiting,Phase 3,Interventional,Egypt,Inhaled Ivermectin and COVID-19,80,https://clinicaltrials.gov/show/NCT04681053
3446,NCT04695197,ClinicalTrials.gov,2020-12-14,2021-01-08,False,Recruiting,Phase 3,Interventional,"Kenya, Burkina Faso",Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,142,https://clinicaltrials.gov/show/NCT04695197
3447,NCT04700462,ClinicalTrials.gov,2021-01-06,2021-02-05,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Preventive Behavior in African Americans,250,https://clinicaltrials.gov/show/NCT04700462
3448,NCT04701502,ClinicalTrials.gov,2021-01-04,2020-11-09,True,Not Recruiting,Phase 2,Interventional,Bulgaria,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04701502
3449,NCT04701710,ClinicalTrials.gov,2021-01-07,2020-10-15,True,Not Recruiting,Phase 1/Phase 2,Interventional,Argentina,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,300,https://clinicaltrials.gov/show/NCT04701710
3450,NCT04713176,ClinicalTrials.gov,2021-01-14,2021-02-02,False,Recruiting,Phase 3,Interventional,South Korea,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,1022,https://clinicaltrials.gov/show/NCT04713176
3451,NCT04723563,ClinicalTrials.gov,2021-01-22,2021-02-22,False,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19,50,https://clinicaltrials.gov/show/NCT04723563
3452,NCT04729595,ClinicalTrials.gov,2021-01-25,2021-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Evaluate Tempol (MBM-02) to Help Prevent Hospitalizations in COVID-19 Patients.,310,https://clinicaltrials.gov/show/NCT04729595
3453,NCT04747158,ClinicalTrials.gov,2021-01-27,2020-08-10,True,Not Recruiting,Phase 2/Phase 3,Interventional,Paraguay,COVID-19 Convalescent Plasma Therapy,350,https://clinicaltrials.gov/show/NCT04747158
3454,NCT04757857,ClinicalTrials.gov,2021-02-08,2020-09-29,True,Recruiting,Phase 4,Interventional,Brazil,COVID-19 Antithrombotic Rivaroxaban Evaluation,1000,https://clinicaltrials.gov/show/NCT04757857
3455,NCT04760132,ClinicalTrials.gov,2021-02-08,2021-02-08,False,Recruiting,Phase 4,Interventional,Denmark,National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE),10000,https://clinicaltrials.gov/show/NCT04760132
3456,NCT04768179,ClinicalTrials.gov,2021-02-14,2021-02-19,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients,490,https://clinicaltrials.gov/show/NCT04768179
3457,NCT04769297,ClinicalTrials.gov,2021-02-22,2020-04-15,True,Not Recruiting,Phase 4,Interventional,United States,"Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic",30,https://clinicaltrials.gov/show/NCT04769297
3458,NCT04769999,ClinicalTrials.gov,2020-07-13,2020-06-04,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Computer Assisted Lessening of Intrusive Memories in the Emergency Department,14,https://clinicaltrials.gov/show/NCT04769999
3459,NCT04770740,ClinicalTrials.gov,2021-02-24,2021-02-22,True,Recruiting,Phase 2,Interventional,Netherlands,Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19,40,https://clinicaltrials.gov/show/NCT04770740
3460,NCT04771585,ClinicalTrials.gov,2021-01-26,2021-03-15,False,Recruiting,Not Applicable,Interventional,Germany,Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19,30,https://clinicaltrials.gov/show/NCT04771585
3461,NCT04771598,ClinicalTrials.gov,2021-02-21,2021-02-25,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Breathing Exercise After COVID-19 Pneumonia,52,https://clinicaltrials.gov/show/NCT04771598
3462,NCT04773756,ClinicalTrials.gov,2021-02-22,2020-11-01,True,Not Recruiting,Phase 4,Interventional,Egypt,Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt,54,https://clinicaltrials.gov/show/NCT04773756
3463,NCT04776941,ClinicalTrials.gov,2021-02-09,2020-08-07,True,Recruiting,Not Applicable,Interventional,United States,Expressive Writing for the Management of Stress in Cancer Survivors,120,https://clinicaltrials.gov/show/NCT04776941
3464,NCT04779138,ClinicalTrials.gov,2021-02-27,2021-09-11,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Increasing Vaccine Uptake in Underresourced Public Housing Areas,600,https://clinicaltrials.gov/show/NCT04779138
3465,ISRCTN15615992,ISRCTN,2021-02-23,2021-01-05,True,Recruiting,Not Applicable,Interventional,United Kingdom,Neuropsychological evaluation and rehabilitation in multiple sclerosis â€“ qualitative case study,35,http://isrctn.com/ISRCTN15615992
3466,ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,False,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,10300,http://isrctn.com/ISRCTN89951424
3467,ChiCTR2000041375,ChiCTR,2020-12-24,2020-05-07,True,Recruiting,Not Applicable,Interventional,China,Study on the safety and efficacy of donor-specific transfusions in deceased-donor liver transplantation during COVID-19 outbreaks,56,http://www.chictr.org.cn/showproj.aspx?proj=62474
3468,EUCTR2020-001366-11-ES,EU Clinical Trials Register,2020-03-26,2020-03-27,False,Not Recruiting,Phase 4,Interventional,"Ireland, Portugal, Slovakia, Italy, Spain, Latvia, Lithuania, Romania",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11
3469,EUCTR2020-001608-40-DE,EU Clinical Trials Register,2020-04-14,2020-07-15,False,Not Recruiting,Phase 3,Interventional,"China, Germany","A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients with COVID-19-Moderate Typ",256,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001608-40
3470,EUCTR2021-000166-15-HU,EU Clinical Trials Register,2021-01-25,2021-03-03,False,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ivermectin in asymptomatic and mild severity COVID-19 patients",70,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000166-15
3471,EUCTR2020-005539-62-HU,EU Clinical Trials Register,2021-01-25,2021-04-03,False,Authorised,Phase 2/Phase 3,Interventional,Hungary,BGP-15 effect on the hospitalization rate of COVID-19 patients,660,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005539-62
3472,EUCTR2021-000516-37-HU,EU Clinical Trials Register,2021-02-04,2021-04-03,False,Authorised,Phase 1/Phase 2,Interventional,Hungary,The efficacy and the safety of TS-020 in acute viral infection,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000516-37
3473,EUCTR2020-005915-39-IT,EU Clinical Trials Register,2021-03-01,2021-02-19,True,Authorised,Phase 2/Phase 3,Interventional,"Chile, Argentina, South Africa, Indonesia, Belgium, Italy, Brazil, Poland, France, Germany, Malaysia, Czech Republic",A Clinical Study with GRAd-COV2 Vaccine for the Prevention of COVID-19 in Adults,10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005915-39
3474,EUCTR2021-001072-41-NL,EU Clinical Trials Register,2021-02-27,2021-02-03,True,Authorised,Phase 4,Interventional,Netherlands,COBRA-KAI study: COVID-19 vaccination in patients with a hematological disease,850,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001072-41
3475,EUCTR2020-005315-44-HU,EU Clinical Trials Register,2021-03-02,2021-01-03,True,Authorised,Phase 3,Interventional,"Hungary, Russian Federation, United Kingdom, United States, Mexico, Spain, Italy, Japan, Germany","Phase 3, Double-blind, Placebo-controlled Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults",1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005315-44
3476,EUCTR2020-001936-86-DE,EU Clinical Trials Register,2020-08-20,2020-10-19,False,Authorised,Phase 2,Interventional,Germany,Clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001936-86
3477,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),402,https://clinicaltrials.gov/show/NCT04317092
3478,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,False,Not Recruiting,Phase 4,Interventional,"Italy, Belgium",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),80,https://clinicaltrials.gov/show/NCT04326920
3479,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-03,False,Not Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,342,https://clinicaltrials.gov/show/NCT04330638
3480,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",32,https://clinicaltrials.gov/show/NCT04331795
3481,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-11-02,False,Not Recruiting,Phase 1,Interventional,"Canada, Australia, United States","Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",24,https://clinicaltrials.gov/show/NCT04334980
3482,NCT04340232,ClinicalTrials.gov,2020-04-03,2021-03-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,0,https://clinicaltrials.gov/show/NCT04340232
3483,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,416,https://clinicaltrials.gov/show/NCT04343729
3484,NCT04345601,ClinicalTrials.gov,2020-04-10,2021-02-12,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),30,https://clinicaltrials.gov/show/NCT04345601
3485,NCT04348071,ClinicalTrials.gov,2020-04-13,2021-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,0,https://clinicaltrials.gov/show/NCT04348071
3486,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-05-05,False,Not Recruiting,Phase 3,Interventional,"United States, Brazil",Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,520,https://clinicaltrials.gov/show/NCT04351152
3487,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Not Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,50,https://clinicaltrials.gov/show/NCT04359901
3488,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-08-28,False,Recruiting,Not Applicable,Interventional,"France, Monaco",Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,400,https://clinicaltrials.gov/show/NCT04363463
3489,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,200,https://clinicaltrials.gov/show/NCT04372680
3490,NCT04374279,ClinicalTrials.gov,2020-05-04,2021-04-01,False,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,0,https://clinicaltrials.gov/show/NCT04374279
3491,NCT04377165,ClinicalTrials.gov,2020-05-04,2020-05-06,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities,34,https://clinicaltrials.gov/show/NCT04377165
3492,NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Not Recruiting,Phase 2,Interventional,"India, Israel","A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",50,https://clinicaltrials.gov/show/NCT04382040
3493,NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,False,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,60,https://clinicaltrials.gov/show/NCT04382391
3494,NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-22,False,Not Recruiting,Phase 2,Interventional,Belgium,ZilucoplanÂ® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,81,https://clinicaltrials.gov/show/NCT04382755
3495,NCT04387760,ClinicalTrials.gov,2020-05-09,2020-08-11,False,Recruiting,Phase 2,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine vs Control in COVID -19,150,https://clinicaltrials.gov/show/NCT04387760
3496,NCT04389359,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,0,https://clinicaltrials.gov/show/NCT04389359
3497,NCT04390503,ClinicalTrials.gov,2020-05-14,2021-03-01,False,Recruiting,Phase 2,Interventional,"United States, Brazil",Convalescent Plasma for Early Treatment of COVID-19,150,https://clinicaltrials.gov/show/NCT04390503
3498,NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-06,False,Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,198,https://clinicaltrials.gov/show/NCT04397718
3499,NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,True,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,160,https://clinicaltrials.gov/show/NCT04402918
3500,NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin as a Novel Therapy in COVID-19 Treatment,160,https://clinicaltrials.gov/show/NCT04403555
3501,NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-02,False,Not Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preventing Smoking Relapse,108,https://clinicaltrials.gov/show/NCT04409496
3502,NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,False,Not Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,83,https://clinicaltrials.gov/show/NCT04412057
3503,NCT04416919,ClinicalTrials.gov,2020-05-13,2020-05-20,False,Not Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,20,https://clinicaltrials.gov/show/NCT04416919
3504,NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Not Recruiting,Not Applicable,Interventional,United States,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,52,https://clinicaltrials.gov/show/NCT04417270
3505,NCT04420273,ClinicalTrials.gov,2020-06-03,2020-07-02,False,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,1000,https://clinicaltrials.gov/show/NCT04420273
3506,NCT04427254,ClinicalTrials.gov,2020-05-26,2020-06-26,False,Recruiting,Not Applicable,Interventional,France,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,500,https://clinicaltrials.gov/show/NCT04427254
3507,NCT04447469,ClinicalTrials.gov,2020-06-23,2020-07-27,False,Recruiting,Phase 2/Phase 3,Interventional,"Chile, South Africa, Peru, United States, Brazil",Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,588,https://clinicaltrials.gov/show/NCT04447469
3508,NCT04447833,ClinicalTrials.gov,2020-06-20,2020-06-17,True,Not Recruiting,Phase 1,Interventional,Sweden,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,7,https://clinicaltrials.gov/show/NCT04447833
3509,NCT04464408,ClinicalTrials.gov,2020-06-28,2020-07-23,False,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Favipiravir Therapy in Adults With Mild COVID-19,576,https://clinicaltrials.gov/show/NCT04464408
3510,NCT04465604,ClinicalTrials.gov,2020-07-02,2021-02-01,False,Recruiting,Not Applicable,Interventional,Saudi Arabia,Hypertonic Saline for COVID-19 Symptoms,50,https://clinicaltrials.gov/show/NCT04465604
3511,NCT04469491,ClinicalTrials.gov,2020-07-13,2020-09-20,False,Recruiting,Phase 2,Interventional,France,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,146,https://clinicaltrials.gov/show/NCT04469491
3512,NCT04470622,ClinicalTrials.gov,2020-07-13,2020-07-20,False,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),100,https://clinicaltrials.gov/show/NCT04470622
3513,NCT04471766,ClinicalTrials.gov,2020-07-14,2020-07-20,False,Not Recruiting,Not Applicable,Interventional,Guinea-Bissau,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,40000,https://clinicaltrials.gov/show/NCT04471766
3514,NCT04490200,ClinicalTrials.gov,2020-07-19,2021-03-01,False,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,1000,https://clinicaltrials.gov/show/NCT04490200
3515,NCT04517396,ClinicalTrials.gov,2020-08-17,2020-08-18,False,Recruiting,Phase 2,Interventional,United States,FEnofibRate as a Metabolic INtervention for COVID-19,700,https://clinicaltrials.gov/show/NCT04517396
3516,NCT04530435,ClinicalTrials.gov,2020-08-25,2020-10-06,False,Not Recruiting,Not Applicable,Interventional,Denmark,PEP Flute-selfcare in COVID-19,400,https://clinicaltrials.gov/show/NCT04530435
3517,NCT04542993,ClinicalTrials.gov,2020-09-08,2020-09-08,False,Not Recruiting,Phase 2,Interventional,United States,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,60,https://clinicaltrials.gov/show/NCT04542993
3518,NCT04547127,ClinicalTrials.gov,2020-09-10,2020-04-29,True,Not Recruiting,Phase 2,Interventional,Spain,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),200,https://clinicaltrials.gov/show/NCT04547127
3519,NCT04551898,ClinicalTrials.gov,2020-09-10,2020-12-02,False,Not Recruiting,Phase 2,Interventional,"Australia, South Africa, United States, Mexico, Brazil",Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),181,https://clinicaltrials.gov/show/NCT04551898
3520,NCT04555096,ClinicalTrials.gov,2020-09-16,2020-09-09,True,Recruiting,Phase 2,Interventional,United States,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,50,https://clinicaltrials.gov/show/NCT04555096
3521,NCT04569786,ClinicalTrials.gov,2020-09-24,2020-10-29,False,Not Recruiting,Phase 1,Interventional,United States,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),232,https://clinicaltrials.gov/show/NCT04569786
3522,NCT04590430,ClinicalTrials.gov,2020-10-08,2020-10-20,False,Not Recruiting,Phase 1,Interventional,United States,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",24,https://clinicaltrials.gov/show/NCT04590430
3523,NCT04604704,ClinicalTrials.gov,2020-10-26,2021-01-28,False,Recruiting,Phase 2,Interventional,United States,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,60,https://clinicaltrials.gov/show/NCT04604704
3524,NCT04617262,ClinicalTrials.gov,2020-11-02,2021-01-05,False,Recruiting,Not Applicable,Interventional,United States,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,100,https://clinicaltrials.gov/show/NCT04617262
3525,NCT04649424,ClinicalTrials.gov,2020-11-27,2020-12-22,False,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Nasal Swab Trial,72,https://clinicaltrials.gov/show/NCT04649424
3526,NCT04659772,ClinicalTrials.gov,2020-12-07,2020-12-03,True,Not Recruiting,Phase 2,Interventional,United States,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,1,https://clinicaltrials.gov/show/NCT04659772
3527,NCT04690413,ClinicalTrials.gov,2020-08-31,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,United States,NOWDx Test for the Detection of Antibodies to COVID-19,129,https://clinicaltrials.gov/show/NCT04690413
3528,NCT04695704,ClinicalTrials.gov,2021-01-04,2021-04-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:,284,https://clinicaltrials.gov/show/NCT04695704
3529,NCT04706403,ClinicalTrials.gov,2021-01-05,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,United States,Views on COVID-19 and Vaccination,3000,https://clinicaltrials.gov/show/NCT04706403
3530,NCT04716556,ClinicalTrials.gov,2021-01-14,2020-07-16,True,Not Recruiting,Not Applicable,Interventional,Italy,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,474,https://clinicaltrials.gov/show/NCT04716556
3531,NCT04730401,ClinicalTrials.gov,2021-01-26,2021-01-27,False,Recruiting,Phase 2,Interventional,Finland,Convalescent Plasma in the Treatment of Covid-19,390,https://clinicaltrials.gov/show/NCT04730401
3532,NCT04747574,ClinicalTrials.gov,2021-01-26,2020-09-25,True,Recruiting,Phase 1,Interventional,Israel,Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection,35,https://clinicaltrials.gov/show/NCT04747574
3533,NCT04756466,ClinicalTrials.gov,2021-01-21,2021-01-01,True,Not Recruiting,Not Applicable,Interventional,Spain,Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly,201,https://clinicaltrials.gov/show/NCT04756466
3534,NCT04771559,ClinicalTrials.gov,2021-02-17,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,Turkey,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,1000,https://clinicaltrials.gov/show/NCT04771559
3535,NCT04777981,ClinicalTrials.gov,2021-02-25,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,United States,(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC,60,https://clinicaltrials.gov/show/NCT04777981
3536,NCT04778059,ClinicalTrials.gov,2021-02-26,2021-04-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19,184,https://clinicaltrials.gov/show/NCT04778059
3537,NCT04779879,ClinicalTrials.gov,2021-03-01,2021-02-18,True,Recruiting,Phase 2,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19",40,https://clinicaltrials.gov/show/NCT04779879
3538,NCT04780035,ClinicalTrials.gov,2021-02-25,2020-11-18,True,Not Recruiting,Phase 3,Interventional,Russian Federation,"Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19",3000,https://clinicaltrials.gov/show/NCT04780035
3539,NCT04780581,ClinicalTrials.gov,2021-02-15,2021-02-01,True,Recruiting,Phase 4,Interventional,Spain,Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients,290,https://clinicaltrials.gov/show/NCT04780581
3540,NCT04780659,ClinicalTrials.gov,2021-02-19,2021-02-23,False,Recruiting,Phase 4,Interventional,Sweden,COVID-19 Vaccination of Immunodeficient Persons (COVAXID),540,https://clinicaltrials.gov/show/NCT04780659
3541,NCT04780685,ClinicalTrials.gov,2021-03-01,2021-03-20,False,Recruiting,Phase 2,Interventional,United States,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,40,https://clinicaltrials.gov/show/NCT04780685
3542,NCT04781400,ClinicalTrials.gov,2021-02-22,2021-02-08,True,Recruiting,Not Applicable,Interventional,South Africa,"Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young People",600,https://clinicaltrials.gov/show/NCT04781400
3543,NCT04782336,ClinicalTrials.gov,2021-02-17,2020-12-12,True,Recruiting,Not Applicable,Interventional,United Kingdom,"Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test",3500,https://clinicaltrials.gov/show/NCT04782336
3544,NCT04785781,ClinicalTrials.gov,2021-02-24,2021-02-01,True,Recruiting,Not Applicable,Interventional,Turkey,Effects of Face Masks on Cardiopulmonary Capacity in Healthy Individuals,16,https://clinicaltrials.gov/show/NCT04785781
3545,NCT04785807,ClinicalTrials.gov,2021-02-23,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic,140,https://clinicaltrials.gov/show/NCT04785807
3546,NCT04785898,ClinicalTrials.gov,2021-03-01,2020-11-09,True,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance of the ID Nowâ„¢ COVID-19 Screening Test Versus Simplexaâ„¢ COVID-19 Direct Assay,1000,https://clinicaltrials.gov/show/NCT04785898
3547,NCT04786080,ClinicalTrials.gov,2021-02-24,2021-03-15,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Supporting Parents & Kids Through Lockdown Experiences (SPARKLE).,616,https://clinicaltrials.gov/show/NCT04786080
3548,NCT04786483,ClinicalTrials.gov,2021-02-24,2020-11-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Laughter Therapy on Students in the COVID-19 Pandemic,80,https://clinicaltrials.gov/show/NCT04786483
3549,NCT04788355,ClinicalTrials.gov,2020-09-05,2020-07-01,True,Not Recruiting,Phase 3,Interventional,Brazil,Prevention of Complications (SARS-CoV-2): Clinical Study,176,https://clinicaltrials.gov/show/NCT04788355
3550,ACTRN12620000447954,ANZCTR,2020-04-06,,False,No Status Given,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,150,https://anzctr.org.au/ACTRN12620000447954.aspx
3551,ACTRN12620000473965,ANZCTR,2020-04-15,2020-08-18,False,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx
3552,ISRCTN47591507,ISRCTN,2020-02-20,2018-10-22,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,Treating auditory impairment and cognition pilot trial,76,http://isrctn.com/ISRCTN47591507
3553,EUCTR2020-001224-33-DE,EU Clinical Trials Register,2020-03-24,2020-03-25,False,Not Recruiting,Phase 2,Interventional,Germany,Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019 â€“ COVID-19,220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001224-33
3554,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Not Recruiting,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34
3555,EUCTR2020-003904-15-DK,EU Clinical Trials Register,2020-08-11,2020-08-27,False,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for seniors to prevent infections during the COVID-19 pandemic.,1900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003904-15
3556,EUCTR2021-001054-57-NL,EU Clinical Trials Register,2021-03-08,2021-08-03,False,Authorised,"Human pharmacology (Phase I): yes
Therapeutic exploratory (Phase II): no
Therapeutic confirmatory - (Phase III): no
Therapeutic use (Phase IV): yes
",Interventional,Netherlands,SARS-CoV-2 vaccination study in people living with HIV,1650,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001054-57
3557,EUCTR2020-002130-33-BE,EU Clinical Trials Register,2020-05-06,2020-05-26,False,Authorised,Phase 2,Interventional,Belgium,ZilucoplanÂ® in patients with acute hypoxic respiratory failure due to COVID-19,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33
3558,EUCTR2021-001279-18-Outside-EU/EEA,EU Clinical Trials Register,2021-03-09,,False,Not Available,Phase 4,Interventional,United Kingdom,Embedded RCT Short Title: Smartphone app-based mental health and wellbeing intervention for healthcare workers during Covid-19.,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001279-18
3559,EUCTR2020-005979-12-GR,EU Clinical Trials Register,2021-02-08,2021-03-03,False,Authorised,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and safety of XAV-19 for the treatment of moderate to severe COVID-19,722,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005979-12
3560,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-08-19,False,Recruiting,Phase 3,Interventional,Thailand,Fight COVID-19 Trial,320,https://clinicaltrials.gov/show/NCT04303299
3561,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,False,Not Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,24,https://clinicaltrials.gov/show/NCT04312243
3562,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,34,https://clinicaltrials.gov/show/NCT04324528
3563,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,479,https://clinicaltrials.gov/show/NCT04332991
3564,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-05-06,False,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04336254
3565,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Remdesivir Efficacy in Coronavirus Disease,120,https://clinicaltrials.gov/show/NCT04345419
3566,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,Not Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,125,https://clinicaltrials.gov/show/NCT04346667
3567,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,False,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,1000,https://clinicaltrials.gov/show/NCT04348305
3568,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Not Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,137,https://clinicaltrials.gov/show/NCT04351191
3569,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment,300,https://clinicaltrials.gov/show/NCT04351347
3570,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,0,https://clinicaltrials.gov/show/NCT04351490
3571,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,Not Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,21,https://clinicaltrials.gov/show/NCT04353037
3572,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-07-30,False,Not Recruiting,Phase 2,Interventional,"Spain, Romania",Rhu-pGSN for Severe Covid-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04358406
3573,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),24,https://clinicaltrials.gov/show/NCT04361942
3574,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,0,https://clinicaltrials.gov/show/NCT04372082
3575,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,False,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,75,https://clinicaltrials.gov/show/NCT04373200
3576,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,84,https://clinicaltrials.gov/show/NCT04374461
3577,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,False,Not Recruiting,Phase 3,Interventional,"Russian Federation, United States",Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),211,https://clinicaltrials.gov/show/NCT04377620
3578,NCT04382378,ClinicalTrials.gov,2020-05-04,2021-02-01,False,Recruiting,Not Applicable,Interventional,Brazil,Effects of NMES in Critically Ill Patients,120,https://clinicaltrials.gov/show/NCT04382378
3579,NCT04385771,ClinicalTrials.gov,2020-04-19,2020-09-01,False,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,80,https://clinicaltrials.gov/show/NCT04385771
3580,NCT04387240,ClinicalTrials.gov,2020-05-12,2022-01-01,False,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,22,https://clinicaltrials.gov/show/NCT04387240
3581,NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Not Recruiting,Phase 3,Interventional,"Russian Federation, Ukraine, United States",Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,208,https://clinicaltrials.gov/show/NCT04400058
3582,NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,False,Not Recruiting,Phase 3,Interventional,"Russian Federation, United States, Brazil, Spain, France",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,649,https://clinicaltrials.gov/show/NCT04409262
3583,NCT04412395,ClinicalTrials.gov,2020-05-15,2021-06-01,False,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,516,https://clinicaltrials.gov/show/NCT04412395
3584,NCT04414618,ClinicalTrials.gov,2020-05-26,2020-07-02,False,Not Recruiting,Phase 2,Interventional,"United States, Israel",A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,42,https://clinicaltrials.gov/show/NCT04414618
3585,NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,False,Not Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,80,https://clinicaltrials.gov/show/NCT04420741
3586,NCT04427566,ClinicalTrials.gov,2020-06-05,2020-07-23,False,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,24,https://clinicaltrials.gov/show/NCT04427566
3587,NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-02,True,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04432324
3588,NCT04439825,ClinicalTrials.gov,2020-06-18,2020-07-20,False,Not Recruiting,Phase 1,Interventional,United States,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,45,https://clinicaltrials.gov/show/NCT04439825
3589,NCT04453371,ClinicalTrials.gov,2020-06-26,2020-10-15,False,Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),0,https://clinicaltrials.gov/show/NCT04453371
3590,NCT04466683,ClinicalTrials.gov,2020-06-20,2020-08-28,False,Recruiting,Phase 2,Interventional,"United States, Colombia",Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,100,https://clinicaltrials.gov/show/NCT04466683
3591,NCT04494386,ClinicalTrials.gov,2020-07-24,2020-07-23,True,Recruiting,Phase 1/Phase 2,Interventional,United States,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,60,https://clinicaltrials.gov/show/NCT04494386
3592,NCT04498247,ClinicalTrials.gov,2020-08-03,2020-08-27,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Belgium, United States, Austria","A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",263,https://clinicaltrials.gov/show/NCT04498247
3593,NCT04504240,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Not Recruiting,Phase 3,Interventional,Bangladesh,Role of Famotidine in the Clinical Improvement of COVID-19 Patients.,200,https://clinicaltrials.gov/show/NCT04504240
3594,NCT04506268,ClinicalTrials.gov,2020-08-07,2020-09-09,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 SAFE Enrollment,412,https://clinicaltrials.gov/show/NCT04506268
3595,NCT04508075,ClinicalTrials.gov,2020-08-07,2020-08-10,False,Not Recruiting,Phase 3,Interventional,Indonesia,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",1620,https://clinicaltrials.gov/show/NCT04508075
3596,NCT04510038,ClinicalTrials.gov,2020-08-10,2020-01-01,True,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,75,https://clinicaltrials.gov/show/NCT04510038
3597,NCT04525820,ClinicalTrials.gov,2020-08-17,2020-12-15,False,Recruiting,Not Applicable,Interventional,Switzerland,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",80,https://clinicaltrials.gov/show/NCT04525820
3598,NCT04539626,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Recruiting,Not Applicable,Interventional,Mexico,Estrogen Therapy in Non-severe COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04539626
3599,NCT04545008,ClinicalTrials.gov,2020-09-01,2020-10-20,False,Recruiting,Phase 1,Interventional,United States,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,42,https://clinicaltrials.gov/show/NCT04545008
3600,NCT04575038,ClinicalTrials.gov,2020-10-01,2020-11-19,False,Not Recruiting,Phase 2,Interventional,United States,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,115,https://clinicaltrials.gov/show/NCT04575038
3601,NCT04629989,ClinicalTrials.gov,2020-11-13,2020-11-13,False,Not Recruiting,Not Applicable,Interventional,Belgium,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,27,https://clinicaltrials.gov/show/NCT04629989
3602,NCT04661540,ClinicalTrials.gov,2020-12-04,2021-03-02,False,Recruiting,Phase 2,Interventional,United States,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,36,https://clinicaltrials.gov/show/NCT04661540
3603,NCT04666441,ClinicalTrials.gov,2020-12-10,2020-12-15,False,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,1164,https://clinicaltrials.gov/show/NCT04666441
3604,NCT04671017,ClinicalTrials.gov,2020-12-15,2020-12-16,False,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults",153,https://clinicaltrials.gov/show/NCT04671017
3605,NCT04684446,ClinicalTrials.gov,2020-12-23,2021-03-30,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Russian Federation, Belarus",AstraZeneca Vax - Sputnik V Combination Study,100,https://clinicaltrials.gov/show/NCT04684446
3606,NCT04710303,ClinicalTrials.gov,2021-01-13,2021-03-02,False,Recruiting,Phase 1,Interventional,South Africa,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,35,https://clinicaltrials.gov/show/NCT04710303
3607,NCT04713111,ClinicalTrials.gov,2021-01-08,2020-05-04,True,Not Recruiting,Not Applicable,Interventional,United States,Stress and Recovery in Frontline COVID-19 Workers,383,https://clinicaltrials.gov/show/NCT04713111
3608,NCT04715607,ClinicalTrials.gov,2021-01-12,2021-01-22,False,Recruiting,Not Applicable,Interventional,Denmark,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens",22000,https://clinicaltrials.gov/show/NCT04715607
3609,NCT04750720,ClinicalTrials.gov,2021-02-09,2020-08-27,True,Recruiting,Not Applicable,Interventional,France,Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection,300,https://clinicaltrials.gov/show/NCT04750720
3610,NCT04776044,ClinicalTrials.gov,2021-02-26,2021-03-01,False,Recruiting,Phase 2,Interventional,"South Africa, Netherlands, Spain, India, Germany",Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19,220,https://clinicaltrials.gov/show/NCT04776044
3611,NCT04780425,ClinicalTrials.gov,2021-02-28,2021-01-26,True,Not Recruiting,Not Applicable,Interventional,Ghana,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana",206,https://clinicaltrials.gov/show/NCT04780425
3612,NCT04780672,ClinicalTrials.gov,2021-02-25,2021-03-09,False,Recruiting,Phase 3,Interventional,Russian Federation,Clinical Study in the Treatment of Patients With COVID-19,330,https://clinicaltrials.gov/show/NCT04780672
3613,NCT04787211,ClinicalTrials.gov,2021-03-04,2021-03-01,True,Not Recruiting,Phase 2,Interventional,China,"A Phase 2 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",24,https://clinicaltrials.gov/show/NCT04787211
3614,NCT04788407,ClinicalTrials.gov,2021-03-07,2020-12-01,True,Recruiting,Phase 4,Interventional,Argentina,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts,456,https://clinicaltrials.gov/show/NCT04788407
3615,NCT04789525,ClinicalTrials.gov,2021-03-05,2020-03-10,True,Not Recruiting,Not Applicable,Interventional,Egypt,Physical Training and Diet for Childhood Obesity,76,https://clinicaltrials.gov/show/NCT04789525
3616,NCT04791072,ClinicalTrials.gov,2021-02-27,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-coaching in Patients With COVID-19,36,https://clinicaltrials.gov/show/NCT04791072
3617,NCT04791241,ClinicalTrials.gov,2021-02-22,2021-03-03,False,Recruiting,Not Applicable,Interventional,France,A Check-list Including Lung Ultrasound for ED Patients With ARF,105,https://clinicaltrials.gov/show/NCT04791241
3618,NCT04792021,ClinicalTrials.gov,2021-03-07,2021-03-09,False,Recruiting,Phase 3,Interventional,Egypt,Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04792021
3619,NCT04793243,ClinicalTrials.gov,2021-03-03,2020-08-17,True,Not Recruiting,Not Applicable,Interventional,Mexico,Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico,42,https://clinicaltrials.gov/show/NCT04793243
3620,NCT04793984,ClinicalTrials.gov,2021-03-09,2021-03-08,True,Recruiting,Not Applicable,Interventional,Austria,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,228,https://clinicaltrials.gov/show/NCT04793984
3621,NCT04794374,ClinicalTrials.gov,2021-03-09,2020-11-16,True,Recruiting,Not Applicable,Interventional,Turkey,Effects of Telerehabilitation After Discharge in COVID-19 Survivors,30,https://clinicaltrials.gov/show/NCT04794374
3622,NCT04794803,ClinicalTrials.gov,2021-03-08,2020-05-05,True,Not Recruiting,Phase 2/Phase 3,Interventional,"Italy, Brazil",Reparixin in COVID-19 Pneumonia - Efficacy and Safety,55,https://clinicaltrials.gov/show/NCT04794803
3623,NCT04795557,ClinicalTrials.gov,2021-03-08,2021-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Adaptogens in Patients With Long COVID-19,100,https://clinicaltrials.gov/show/NCT04795557
3624,NCT04796064,ClinicalTrials.gov,2021-03-10,2020-03-30,True,Not Recruiting,Not Applicable,Interventional,Egypt,Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia,76,https://clinicaltrials.gov/show/NCT04796064
3625,NCT04797871,ClinicalTrials.gov,2021-03-08,2021-03-08,False,Recruiting,Not Applicable,Interventional,Spain,Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19,100,https://clinicaltrials.gov/show/NCT04797871
3626,NCT04797936,ClinicalTrials.gov,2021-03-08,2020-05-01,True,Not Recruiting,Phase 4,Interventional,Ukraine,BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19,133,https://clinicaltrials.gov/show/NCT04797936
3627,NCT04798599,ClinicalTrials.gov,2021-03-08,2020-12-01,True,Recruiting,Not Applicable,Interventional,Brazil,Information and Communication Technologies (ICTS) in Dentistry for SUS,368,https://clinicaltrials.gov/show/NCT04798599
3628,NCT04799561,ClinicalTrials.gov,2021-03-01,2021-03-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Teleprehabilitation for Surgical Cancer Patients,100,https://clinicaltrials.gov/show/NCT04799561
3629,NCT04802187,ClinicalTrials.gov,2021-03-12,2020-12-01,True,Recruiting,Not Applicable,Interventional,United States,Implementation of SARS-CoV Testing Strategies in Community Health Centers,76300,https://clinicaltrials.gov/show/NCT04802187
3630,ACTRN12621000283875,ANZCTR,2021-03-16,2021-03-22,False,Not Recruiting,Not Applicable,Interventional,Australia,"A randomised trial comparing a brief wellbeing intervention delivered by coaches with a self-directed intervention to promote recovery in Victorian regional and rural communities impacted by bushfires, drought, and COVID-19.",80,https://anzctr.org.au/ACTRN12621000283875.aspx
3631,ISRCTN39426207,ISRCTN,2021-03-04,2018-01-06,True,Recruiting,Not Applicable,Interventional,Canada,High-intensity functional interval training in heart failure,30,http://isrctn.com/ISRCTN39426207
3632,ISRCTN85787008,ISRCTN,2021-01-08,2020-07-21,True,Not Recruiting,Not Applicable,Interventional,United States,Effect of heartfulness meditation on loneliness and sleep in physicians and advance practice providers,200,http://isrctn.com/ISRCTN85787008
3633,ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,False,Not Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,200,http://isrctn.com/ISRCTN59048638
3634,ISRCTN10974028,ISRCTN,2020-01-08,2020-01-02,True,Recruiting,Not Applicable,Interventional,United Kingdom,Language intervention in the early years - comparing the effectiveness of language intervention approaches for pre-school children with language difficulties,104,http://isrctn.com/ISRCTN10974028
3635,EUCTR2020-002345-42-ES,EU Clinical Trials Register,2020-07-22,2020-08-26,False,Authorised,Phase 2,Interventional,"Sweden, Russian Federation, Brazil, Spain, France","A randomized, placebo controlled, double-blind, multi-center, phase II trial investigating the efficacy and safety of trimodulin (BT588) as add-on therapy to standard of care in adult subjects with severe COVID-19",114,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002345-42
3636,EUCTR2020-005963-29-DK,EU Clinical Trials Register,2020-12-18,2021-02-22,False,Authorised,Phase 3,Interventional,"Denmark, New Zealand, Australia, India",Clinical trial of anti-coagulant drug for COVID-19 inpatients,2400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005963-29
3637,EUCTR2020-005961-16-DK,EU Clinical Trials Register,2020-12-15,2021-05-02,False,Authorised,Phase 2,Interventional,Denmark,Coenzym Q10 til behandling af senfÃ¸lger efter COVID-19 (QVID studiet),120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005961-16
3638,EUCTR2021-000320-35-CZ,EU Clinical Trials Register,2021-02-04,2021-05-03,False,Authorised,Phase 2,Interventional,Czech Republic,Study to evaluate safety and efficacy of Bazedoxifene in addition to Standard of Care in hospitalized COVID-19 patients suffering from moderate to severe Pneumonia,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000320-35
3639,EUCTR2021-000710-42-NL,EU Clinical Trials Register,2021-03-08,2021-03-15,False,Authorised,Phase 4,Interventional,Netherlands,Research into the effect of the COVID-vaccine in patients who are treated with rituximab (RTX-COVAC study),270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000710-42
3640,EUCTR2020-001504-42-BE,EU Clinical Trials Register,2020-05-03,2020-12-06,False,Authorised,Phase 2/Phase 3,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",730,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42
3641,EUCTR2021-000842-16-SE,EU Clinical Trials Register,2021-02-18,2021-03-18,False,Authorised,Phase 4,Interventional,Sweden,The effects of Perfluoroalkyl substances on SARS-CoV-2 vaccination.,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000842-16
3642,EUCTR2020-002982-33-SE,EU Clinical Trials Register,2020-12-21,2021-02-03,False,Authorised,Phase 1/Phase 2,Interventional,Sweden,"A study to to evaluate the efficacy, safety and tolerability of PDNO (nitrosooxypropanol) infusion in COVID-19 patients with high blood pressure in lung arteries.",16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002982-33
3643,ChiCTR2100041706,ChiCTR,2021-01-01,2021-01-05,False,Recruiting,Not Applicable,Interventional,China,Safety and immunogenicity of New Coronavirus vaccine (COVID-19) inactivated by safety personnel: a randomized controlled trial,360,http://www.chictr.org.cn/showproj.aspx?proj=66405
3644,ChiCTR2100041705,ChiCTR,2021-01-01,2021-01-02,False,Recruiting,Not Applicable,Interventional,China,"A randomized, controlled trial for the safety and immunogenicity of novel coronavirus pneumonia (COVID-19) inactivated vaccine in airline ground staff",360,http://www.chictr.org.cn/showproj.aspx?proj=66407
3645,ChiCTR2100041704,ChiCTR,2021-01-01,2020-09-29,True,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized controlled trial for the safety and immunogenicity of novel coronavirus pneumonia (COVID-19) inactivated vaccine in medical and health services personnel",360,http://www.chictr.org.cn/showproj.aspx?proj=66464
3646,ChiCTR2000040632,ChiCTR,2020-12-04,2020-03-17,True,Not Recruiting,Phase 1,Interventional,Pakistan,COVID-19 Cure Using Integrative Treatment,34,http://www.chictr.org.cn/showproj.aspx?proj=65372
3647,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,False,Not Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,2271,https://clinicaltrials.gov/show/NCT04332107
3648,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-05-06,False,Not Recruiting,Phase 2,Interventional,Spain,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,100,https://clinicaltrials.gov/show/NCT04348461
3649,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),60,https://clinicaltrials.gov/show/NCT04379154
3650,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-06-25,False,Recruiting,Phase 2,Interventional,United States,Atorvastatin as Adjunctive Therapy in COVID-19,300,https://clinicaltrials.gov/show/NCT04380402
3651,NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,True,Not Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,820,https://clinicaltrials.gov/show/NCT04385095
3652,NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,False,Not Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,100,https://clinicaltrials.gov/show/NCT04391179
3653,NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,13,https://clinicaltrials.gov/show/NCT04395144
3654,NCT04396314,ClinicalTrials.gov,2020-05-15,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,54,https://clinicaltrials.gov/show/NCT04396314
3655,NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,185,https://clinicaltrials.gov/show/NCT04408157
3656,NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,True,Not Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,483,https://clinicaltrials.gov/show/NCT04429854
3657,NCT04433910,ClinicalTrials.gov,2020-05-06,2020-08-30,False,Not Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,106,https://clinicaltrials.gov/show/NCT04433910
3658,NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-24,False,Not Recruiting,Phase 3,Interventional,Canada,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,122,https://clinicaltrials.gov/show/NCT04439045
3659,NCT04445220,ClinicalTrials.gov,2020-06-22,2020-11-19,False,Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,22,https://clinicaltrials.gov/show/NCT04445220
3660,NCT04452097,ClinicalTrials.gov,2020-06-28,2021-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,39,https://clinicaltrials.gov/show/NCT04452097
3661,NCT04470999,ClinicalTrials.gov,2020-07-09,2020-04-15,True,Recruiting,Not Applicable,Interventional,United States,Changes in Cellular Immune Profile During COVID-19 Infection,25,https://clinicaltrials.gov/show/NCT04470999
3662,NCT04476680,ClinicalTrials.gov,2020-07-16,2020-09-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion,900,https://clinicaltrials.gov/show/NCT04476680
3663,NCT04483375,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",33,https://clinicaltrials.gov/show/NCT04483375
3664,NCT04487691,ClinicalTrials.gov,2020-07-23,2020-12-08,False,Not Recruiting,Not Applicable,Interventional,United States,Nebulized PL for Post-COVID-19 Syndrome,1,https://clinicaltrials.gov/show/NCT04487691
3665,NCT04495803,ClinicalTrials.gov,2020-07-30,2020-09-01,False,Recruiting,Not Applicable,Interventional,Canada,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),120,https://clinicaltrials.gov/show/NCT04495803
3666,NCT04497324,ClinicalTrials.gov,2020-07-31,2020-09-21,False,Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04497324
3667,NCT04521309,ClinicalTrials.gov,2020-05-07,2020-06-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,Pakistan,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04521309
3668,NCT04522986,ClinicalTrials.gov,2020-08-20,2020-08-21,False,Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,6,https://clinicaltrials.gov/show/NCT04522986
3669,NCT04542213,ClinicalTrials.gov,2020-09-03,2020-08-01,True,Not Recruiting,Phase 3,Interventional,Mexico,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,70,https://clinicaltrials.gov/show/NCT04542213
3670,NCT04551339,ClinicalTrials.gov,2020-09-09,2020-09-28,False,Not Recruiting,Not Applicable,Interventional,United States,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,4500,https://clinicaltrials.gov/show/NCT04551339
3671,NCT04565379,ClinicalTrials.gov,2020-09-23,2020-09-25,False,Recruiting,Phase 2,Interventional,Romania,Clinical Trial to Investigate the Efficacy and Safety of NuSepinÂ® in COVID-19 Pneumonia Patients,60,https://clinicaltrials.gov/show/NCT04565379
3672,NCT04568863,ClinicalTrials.gov,2020-09-28,2020-06-20,True,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,18,https://clinicaltrials.gov/show/NCT04568863
3673,NCT04570202,ClinicalTrials.gov,2020-09-28,2020-11-20,False,Recruiting,Not Applicable,Interventional,France,Health cAre woRkers exposeD to COVID-19,900,https://clinicaltrials.gov/show/NCT04570202
3674,NCT04604223,ClinicalTrials.gov,2020-10-26,2021-01-18,False,Recruiting,Phase 4,Interventional,"Kuwait, Qatar",Effect of Pioglitazone on T2DM Patients With COVID-19,1506,https://clinicaltrials.gov/show/NCT04604223
3675,NCT04610502,ClinicalTrials.gov,2020-09-15,2020-09-06,True,Not Recruiting,Phase 2,Interventional,Costa Rica,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,26,https://clinicaltrials.gov/show/NCT04610502
3676,NCT04611399,ClinicalTrials.gov,2020-10-08,2021-03-05,False,Recruiting,Not Applicable,Interventional,Italy,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,90,https://clinicaltrials.gov/show/NCT04611399
3677,NCT04619719,ClinicalTrials.gov,2020-11-05,2021-03-15,False,Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia,360,https://clinicaltrials.gov/show/NCT04619719
3678,NCT04621123,ClinicalTrials.gov,2020-11-04,2020-10-30,True,Recruiting,Phase 2,Interventional,Spain,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,474,https://clinicaltrials.gov/show/NCT04621123
3679,NCT04635943,ClinicalTrials.gov,2020-11-09,2020-08-29,True,Recruiting,Phase 2,Interventional,Peru,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,186,https://clinicaltrials.gov/show/NCT04635943
3680,NCT04637906,ClinicalTrials.gov,2020-11-18,2020-11-18,False,Recruiting,Not Applicable,Interventional,Italy,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),290,https://clinicaltrials.gov/show/NCT04637906
3681,NCT04641481,ClinicalTrials.gov,2020-11-09,2020-11-16,False,Not Recruiting,Phase 3,Interventional,India,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,25800,https://clinicaltrials.gov/show/NCT04641481
3682,NCT04661813,ClinicalTrials.gov,2020-10-29,2021-03-01,False,Recruiting,Not Applicable,Interventional,United States,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,75,https://clinicaltrials.gov/show/NCT04661813
3683,NCT04663737,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Recruiting,Phase 2,Interventional,United States,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",20,https://clinicaltrials.gov/show/NCT04663737
3684,NCT04705844,ClinicalTrials.gov,2021-01-10,2021-05-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT),1444,https://clinicaltrials.gov/show/NCT04705844
3685,NCT04716569,ClinicalTrials.gov,2021-01-19,2021-01-20,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,150,https://clinicaltrials.gov/show/NCT04716569
3686,NCT04723459,ClinicalTrials.gov,2021-01-20,2021-01-23,False,Recruiting,Not Applicable,Interventional,Egypt,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,150,https://clinicaltrials.gov/show/NCT04723459
3687,NCT04727424,ClinicalTrials.gov,2021-01-25,2021-01-19,True,Recruiting,Phase 3,Interventional,Brazil,Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms,2724,https://clinicaltrials.gov/show/NCT04727424
3688,NCT04738045,ClinicalTrials.gov,2021-01-31,2020-11-01,True,Recruiting,Phase 4,Interventional,Egypt,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04738045
3689,NCT04741282,ClinicalTrials.gov,2021-01-30,2021-09-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,52,https://clinicaltrials.gov/show/NCT04741282
3690,NCT04746339,ClinicalTrials.gov,2021-02-08,2021-03-04,False,Recruiting,Phase 4,Interventional,Brazil,Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19,1000,https://clinicaltrials.gov/show/NCT04746339
3691,NCT04750265,ClinicalTrials.gov,2021-02-09,2021-01-21,True,Recruiting,Not Applicable,Interventional,Germany,Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04750265
3692,NCT04765384,ClinicalTrials.gov,2021-02-19,2021-03-12,False,Not Recruiting,Phase 2,Interventional,"Australia, South Africa, United Kingdom, Canada, United States, Brazil, Spain, Finland",A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19),400,https://clinicaltrials.gov/show/NCT04765384
3693,NCT04779047,ClinicalTrials.gov,2021-02-25,2020-10-01,True,Recruiting,Phase 4,Interventional,Egypt,Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.,150,https://clinicaltrials.gov/show/NCT04779047
3694,NCT04780061,ClinicalTrials.gov,2021-03-01,2021-04-01,False,Not Recruiting,Phase 3,Interventional,Canada,Dietary Supplements for COVID-19,200,https://clinicaltrials.gov/show/NCT04780061
3695,NCT04788459,ClinicalTrials.gov,2021-03-01,2021-02-25,True,Recruiting,Phase 1/Phase 2,Interventional,Italy,"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers",160,https://clinicaltrials.gov/show/NCT04788459
3696,NCT04789356,ClinicalTrials.gov,2021-03-05,2021-03-18,False,Recruiting,Phase 4,Interventional,Brazil,Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity,10156,https://clinicaltrials.gov/show/NCT04789356
3697,NCT04790851,ClinicalTrials.gov,2021-03-08,2021-02-23,True,Recruiting,Phase 4,Interventional,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1152,https://clinicaltrials.gov/show/NCT04790851
3698,NCT04797208,ClinicalTrials.gov,2021-03-11,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Remote Glucose Monitoring in Hospital Settings,30,https://clinicaltrials.gov/show/NCT04797208
3699,NCT04797975,ClinicalTrials.gov,2021-03-12,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19,54,https://clinicaltrials.gov/show/NCT04797975
3700,NCT04798716,ClinicalTrials.gov,2021-03-12,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,55,https://clinicaltrials.gov/show/NCT04798716
3701,NCT04799743,ClinicalTrials.gov,2021-03-10,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,Hong Kong,The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04799743
3702,NCT04800120,ClinicalTrials.gov,2020-11-13,2021-02-15,False,Recruiting,Not Applicable,Interventional,United States,Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress,10,https://clinicaltrials.gov/show/NCT04800120
3703,NCT04801017,ClinicalTrials.gov,2021-03-01,2021-04-01,False,Not Recruiting,Phase 2,Interventional,Brazil,A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects,18,https://clinicaltrials.gov/show/NCT04801017
3704,NCT04801030,ClinicalTrials.gov,2021-03-11,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Vaccine Hesitancy Among African Americans,300,https://clinicaltrials.gov/show/NCT04801030
3705,NCT04801134,ClinicalTrials.gov,2021-03-11,2021-03-22,False,Not Recruiting,Not Applicable,Interventional,United States,Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04801134
3706,NCT04801888,ClinicalTrials.gov,2021-03-15,2021-03-01,True,Not Recruiting,Phase 4,Interventional,China,Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine,480,https://clinicaltrials.gov/show/NCT04801888
3707,NCT04801940,ClinicalTrials.gov,2021-03-12,2021-03-01,True,Not Recruiting,Phase 3,Interventional,No Country Given,HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID),2631,https://clinicaltrials.gov/show/NCT04801940
3708,NCT04802382,ClinicalTrials.gov,2021-03-10,2021-04-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19,252,https://clinicaltrials.gov/show/NCT04802382
3709,NCT04802408,ClinicalTrials.gov,2021-03-10,2021-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial,200,https://clinicaltrials.gov/show/NCT04802408
3710,NCT04803227,ClinicalTrials.gov,2021-02-12,2021-03-11,False,Recruiting,Phase 1,Interventional,United States,Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19,50,https://clinicaltrials.gov/show/NCT04803227
3711,NCT04803370,ClinicalTrials.gov,2021-03-09,2020-07-08,True,Recruiting,Not Applicable,Interventional,Spain,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,100,https://clinicaltrials.gov/show/NCT04803370
3712,NCT04803812,ClinicalTrials.gov,2021-02-08,2021-01-26,True,Recruiting,Not Applicable,Interventional,Canada,Supporting the Wellness of Ontario Physicians During COVID-19,19000,https://clinicaltrials.gov/show/NCT04803812
3713,NCT04805086,ClinicalTrials.gov,2021-03-03,2021-03-08,False,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19,5,https://clinicaltrials.gov/show/NCT04805086
3714,NCT04805203,ClinicalTrials.gov,2020-12-15,2020-12-16,False,Recruiting,Not Applicable,Interventional,France,Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma,400,https://clinicaltrials.gov/show/NCT04805203
3715,NCT04805684,ClinicalTrials.gov,2021-03-15,2021-01-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia,59,https://clinicaltrials.gov/show/NCT04805684
3716,NCT04806061,ClinicalTrials.gov,2021-03-15,2021-04-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Urine Alkalinisation in COVID-19,80,https://clinicaltrials.gov/show/NCT04806061
3717,NCT04806074,ClinicalTrials.gov,2021-03-17,2020-08-14,True,Not Recruiting,Not Applicable,Interventional,Portugal,FOODLIT-PRO: Improving Food Literacy and Food Sustainability Amidst the COVID-19 Pandemic,215,https://clinicaltrials.gov/show/NCT04806074
3718,NCT04806529,ClinicalTrials.gov,2021-03-17,2020-12-15,True,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older",0,https://clinicaltrials.gov/show/NCT04806529
3719,NCT04808284,ClinicalTrials.gov,2021-03-16,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Neuromodulation in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04808284
3720,NCT04808882,ClinicalTrials.gov,2021-03-08,2021-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,ANTIcoagulation in Severe COVID-19 Patients,353,https://clinicaltrials.gov/show/NCT04808882
3721,NCT04808895,ClinicalTrials.gov,2021-03-15,2021-04-01,False,Not Recruiting,Phase 3,Interventional,Italy,Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19,204,https://clinicaltrials.gov/show/NCT04808895
3722,NCT04808986,ClinicalTrials.gov,2021-03-17,2021-04-02,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,2000,https://clinicaltrials.gov/show/NCT04808986
3723,NCT04809272,ClinicalTrials.gov,2021-03-15,2021-03-08,True,Recruiting,Not Applicable,Interventional,United Kingdom,ePLH Pilot Study: Online Support Parent Groups - ParentChat,900,https://clinicaltrials.gov/show/NCT04809272
3724,NCT04810689,ClinicalTrials.gov,2021-03-17,2021-03-01,True,Recruiting,Phase 2,Interventional,United States,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19",60,https://clinicaltrials.gov/show/NCT04810689
3725,NCT04819919,ClinicalTrials.gov,2021-03-24,2021-04-15,False,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Viral Load Reduction of a Single Dose of Plitidepsin in Adult Patients With COVID-19,122,https://clinicaltrials.gov/show/NCT04819919
3726,ACTRN12620000612910,ANZCTR,2020-05-25,2020-01-06,True,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,24,https://anzctr.org.au/ACTRN12620000612910.aspx
3727,ACTRN12620001355965,ANZCTR,2020-12-16,2021-01-27,False,Not Recruiting,Not Applicable,Interventional,Australia,Optimising COVID-19 testing intentions and behaviour with enhanced messaging,1430,https://anzctr.org.au/ACTRN12620001355965.aspx
3728,ACTRN12621000344897,ANZCTR,2021-03-25,2020-12-15,True,Recruiting,Not Applicable,Interventional,Australia,Addressing the hidden burden of wound care amid the COVID-19 pandemic: A Virtual Wound Care Command Centre.,60,https://anzctr.org.au/ACTRN12621000344897.aspx
3729,ACTRN12621000309886,ANZCTR,2021-03-19,2021-05-04,False,Not Recruiting,Not Applicable,Interventional,Spain,"Immediate effects of a respiratory telerehabilitation program in confined
patients affected by COVID-19",60,https://anzctr.org.au/ACTRN12621000309886.aspx
3730,ISRCTN16806663,ISRCTN,2021-03-11,2020-09-20,True,Not Recruiting,Phase 2,Interventional,India,A clinical trial to evaluate the effects of inhaled nitric oxide gas among COVID-19 patients with pneumonia,25,http://isrctn.com/ISRCTN16806663
3731,ISRCTN13593711,ISRCTN,2021-01-21,2020-03-04,True,Not Recruiting,Not Applicable,Interventional,"Denmark, United Kingdom, Netherlands, Canada, United States, Italy, Spain, France, Germany",A study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia,450,http://isrctn.com/ISRCTN13593711
3732,ISRCTN11970082,ISRCTN,2020-11-20,2020-08-16,True,Not Recruiting,Not Applicable,Interventional,India,Effect of the drug indomethacin in the treatment of COVID-19 patients,250,http://isrctn.com/ISRCTN11970082
3733,ISRCTN12792822,ISRCTN,2020-11-18,2020-11-21,False,Recruiting,Not Applicable,Interventional,Kenya,Cash transfers to stimulate school re-enrollment among vulnerable adolescent girls in urban informal settlements as Kenya responds to COVID-19,1700,http://isrctn.com/ISRCTN12792822
3734,ISRCTN15874265,ISRCTN,2020-11-03,2020-06-03,True,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, United States, Korea, South, Italy, Spain, Japan, France, Germany, Singapore, Switzerland",Study to assess the safety and effectiveness of remdesivir in people with severe COVID-19,6000,http://isrctn.com/ISRCTN15874265
3735,ISRCTN31062548,ISRCTN,2020-09-07,2020-09-14,False,Recruiting,Phase 2,Interventional,United Kingdom,"GETAFIX (Glasgow Early Treatment Arm Favipiravir) â€“ a study to compare the effectiveness of adding the antiviral drug favipiravir to standard care in COVID-19 patients, compared with standard care alone",302,http://isrctn.com/ISRCTN31062548
3736,ISRCTN17896927,ISRCTN,2020-07-27,2020-07-17,True,Not Recruiting,Not Applicable,Interventional,United States,Encouraging behavior to reduce the spread of COVID-19,3000,http://isrctn.com/ISRCTN17896927
3737,ISRCTN14212905,ISRCTN,2020-07-22,2020-03-07,True,Recruiting,Phase 2,Interventional,United Kingdom,Understanding how COVID-19 leads to respiratory failure in COVID-19 positive patients,100,http://isrctn.com/ISRCTN14212905
3738,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Not Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),116,http://isrctn.com/ISRCTN13311119
3739,ChiCTR2100041956,ChiCTR,2021-01-10,2021-03-01,False,Recruiting,Not Applicable,Interventional,China,Effect evaluation of mental health intervention for junior middle school students based on new media under the background of COVID-19,1540,http://www.chictr.org.cn/showproj.aspx?proj=64751
3740,ChiCTR2100041855,ChiCTR,2021-01-08,2021-01-11,False,Recruiting,Phase 2,Interventional,China,A Phase II clinical trial to evaluate the immunogenicity and safety of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years,420,http://www.chictr.org.cn/showproj.aspx?proj=119719
3741,EUCTR2020-005801-14-PL,EU Clinical Trials Register,2020-12-30,2021-08-02,False,Authorised,Phase 3,Interventional,"Germany, United States, Poland",A Phase 3 Study to Evaluate 3 Dose Levels of Ad26.COV2.S Administered As Single-Dose And Two-Dose Schedules in Healthy Adults,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005801-14
3742,EUCTR2021-000182-33-NL,EU Clinical Trials Register,2021-01-21,2021-03-25,False,Authorised,Phase 4,Interventional,Netherlands,"Impact of BCG vaccination, originally made to prevent tuberculosis, on the immune response to the COVID-19 vaccine in health care workers",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000182-33
3743,EUCTR2021-000206-17-SE,EU Clinical Trials Register,2021-02-10,2021-10-03,False,Authorised,Phase 4,Interventional,Sweden,"Studies of ongoing and completed SARS-CoV-2 infection (which causes COVID-19) within the healthcare in Stockholm County, with regard to vaccinations.",10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000206-17
3744,EUCTR2021-000349-42-SE,EU Clinical Trials Register,2021-02-08,2021-03-26,False,Authorised,Phase 4,Interventional,Sweden,Evaluation of How Long Immune Responses to SARS-CoV-2 Persist Following COVID-19 Vaccination,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000349-42
3745,EUCTR2020-005291-35-IT,EU Clinical Trials Register,2021-03-22,2021-03-02,True,Authorised,Phase 3,Interventional,Italy,A multicenter randomized trial to evaluate the efficacy of tocilizumab in patients with severe Coronavirus Disease 2019 (Covid-19) pneumonia failing glucocorticoids.,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005291-35
3746,EUCTR2020-005763-31-IT,EU Clinical Trials Register,2021-03-22,2021-12-03,False,Authorised,Phase 2,Interventional,"Portugal, Italy, United States, Spain, Poland",FREEDOM COVID Anticoagulation Strategy Randomized Trial,3600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005763-31
3747,EUCTR2021-000454-26-NL,EU Clinical Trials Register,2021-03-25,2021-03-25,False,Authorised,Phase 1/Phase 2,Interventional,Netherlands,"Safety and protection after vaccination against SARS-CoV-2, by injecting the vaccine in the skin",150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000454-26
3748,EUCTR2020-005828-11-GR,EU Clinical Trials Register,2020-12-09,2020-12-16,False,Authorised,Phase 3,Interventional,Greece,Anakinra treatment to prevent respiratory failure in COVID-19,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005828-11
3749,JPRN-jRCT2032200381,JPRN,2021-03-15,2021-02-03,True,Recruiting,Phase 2,Interventional,Japan,Pilot Study of NOA-001,35,https://jrct.niph.go.jp/latest-detail/jRCT2032200381
3750,JPRN-jRCT2051200153,JPRN,2021-03-12,2021-10-03,False,Not Recruiting,Phase 1,Interventional,Japan,"A Phase 1, single-dose and multiple-dose study of DS-2319b inhalation powder to assess the safety and pharmacokinetics of DS-2319a in healthy Japanese subjects",76,https://jrct.niph.go.jp/latest-detail/jRCT2051200153
3751,JPRN-UMIN000043400,JPRN,2021-02-21,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation of operational capacity of mobile &quot;street laboratory&quot;: a pilot study using PCR test and antibody test for COVID-19,2400,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049552
3752,JPRN-UMIN000043537,JPRN,2021-03-05,2021-01-01,True,Recruiting,Not Applicable,Interventional,Africa,Post COVID-19 Anosmia,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049715
3753,JPRN-UMIN000043566,JPRN,2021-03-09,2021-03-09,False,Recruiting,Phase 1,Interventional,Japan,A pilot study of frailty prevention program during the COVID-19 pandemic,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049753
3754,EUCTR2020-001602-34-FR,EU Clinical Trials Register,2020-04-03,2020-10-04,False,Not Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D supplementation: a multicenter randomized controlled Trial of high dose versus standard dose vitamin D3 in high-risk COVID-19 patients,260,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001602-34
3755,EUCTR2020-002091-12-BG,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Not Recruiting,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12
3756,EUCTR2020-001498-63-BE,EU Clinical Trials Register,2020-05-03,2020-05-18,False,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, United States, Brazil, France","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63
3757,EUCTR2020-004408-32-GR,EU Clinical Trials Register,2020-10-01,2020-10-23,False,Authorised,Phase 2,Interventional,Greece,Clinical trial of the investigational drug AMY-101 for the treatment of patients with severe COVID-19.,62,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004408-32
3758,EUCTR2020-002772-12-FR,EU Clinical Trials Register,2020-06-03,2020-07-17,False,Authorised,Phase 2,Interventional,France,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002772-12
3759,EUCTR2020-001749-38-IT,EU Clinical Trials Register,2020-07-01,2020-02-10,True,Authorised,Phase 1/Phase 2,Interventional,Italy,Visualization of inflammation in COVID-19 patients,4,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001749-38
3760,EUCTR2020-002345-42-FR,EU Clinical Trials Register,2020-09-23,2020-12-16,False,Authorised,Phase 2,Interventional,"Sweden, Russian Federation, Brazil, Spain, France","A randomized, placebo controlled, double-blind, multi-center, phase II trial investigating the efficacy and safety of trimodulin (BT588) as add-on therapy to standard of care in adult subjects with severe COVID-19",114,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002345-42
3761,EUCTR2020-003614-13-IT,EU Clinical Trials Register,2020-11-23,2020-12-18,False,Authorised,Phase 2,Interventional,"Russian Federation, Italy","Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled study",105,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003614-13
3762,EUCTR2020-001325-31-NL,EU Clinical Trials Register,2020-04-07,2020-05-20,False,Not Recruiting,Phase 2,Interventional,Netherlands,RDG-PET/CT imaging in COVID-19 patients.,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001325-31
3763,EUCTR2020-004571-41-HU,EU Clinical Trials Register,2020-12-22,2021-01-22,False,Authorised,Phase 2,Interventional,"Hungary, Slovakia, Ukraine, Poland, Bulgaria, Romania","A Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety and Efficacy of Rabeximod Compared to Standard of Care in Patients With Moderate Coronavirus Disease (COVID-19)",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004571-41
3764,EUCTR2020-005919-51-IT,EU Clinical Trials Register,2021-01-25,2021-01-19,True,Authorised,Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,303,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005919-51
3765,EUCTR2020-001038-36-DE,EU Clinical Trials Register,2020-04-14,2020-04-20,False,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of vaccines in adults.,618,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001038-36
3766,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-04-05,True,Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10
3767,EUCTR2020-003349-12-IE,EU Clinical Trials Register,2020-08-14,2020-09-10,False,Authorised,Phase 2,Interventional,Ireland,This is a proof of principle / feasibility study aiming to evaluate the effect of nebulised unfractionated heparin on procoagulant markers related to acute respiratory distress syndrome in patients invasively ventilated for Covid 19 lung disease.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003349-12
3768,EUCTR2020-005447-23-NL,EU Clinical Trials Register,2021-01-28,2021-01-28,False,Authorised,Phase 2,Interventional,Netherlands,Intravenous imatinib for corona virus-related lung injury.,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005447-23
3769,EUCTR2020-003363-25-DK,EU Clinical Trials Register,2020-07-17,2020-08-18,False,Authorised,Phase 3,Interventional,"Denmark, Sweden, India",Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Oxygen Deficiency: the COVID STEROID 2 trial,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003363-25
3770,EUCTR2020-001335-28-DE,EU Clinical Trials Register,2020-04-03,2020-04-30,False,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, South Africa, Peru, Belgium, Netherlands, United States, Brazil, Mexico, France, Germany",A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28
3771,EUCTR2020-002027-10-SE,EU Clinical Trials Register,2020-04-24,2020-07-13,False,Authorised,Phase 2,Interventional,Sweden,"A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19)",600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002027-10
3772,EUCTR2020-002190-10-IE,EU Clinical Trials Register,2021-01-22,2021-05-02,False,Authorised,Phase 3,Interventional,Ireland,A Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002190-10
3773,EUCTR2020-001644-25-FR,EU Clinical Trials Register,2020-04-11,2020-06-05,False,Not Recruiting,Phase 2,Interventional,"Sweden, Italy, United States, Spain, France, Germany",A Phase 2 Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19,428,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25
3774,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Not Recruiting,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42
3775,EUCTR2021-000515-24-NL,EU Clinical Trials Register,2021-02-05,2021-02-15,False,Authorised,Phase 4,Interventional,Netherlands,Vaccination Against Covid in Primary Immune Deficiencies,700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000515-24
3776,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE CYCLOSPORINE VS. NON TREATMENT ASSOCIATED TO STANDARD OF CARE TO COMPARE THEIR EFFICACY IN THE  COVID-19 PNEUMONIA.,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11
3777,EUCTR2020-003734-20-IT,EU Clinical Trials Register,2021-02-15,2021-03-02,False,Authorised,Phase 1/Phase 2,Interventional,Italy,"Study to determine the safety and immunogenicity of COVID-eVax, a vaccine for COVID-19 in healthy adult volunteers.",160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003734-20
3778,EUCTR2020-005410-18-PL,EU Clinical Trials Register,2020-11-16,2020-02-12,True,Authorised,Phase 2/Phase 3,Interventional,Poland,"Multicentre, randomized, double-blind, placebo-controlled, non-commercial clinical trial to evaluate the efficacy and safety of specific anti-SARS-CoV-2 immunoglobulin in the treatment of COVID-19",480,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005410-18
3779,EUCTR2021-000868-30-NL,EU Clinical Trials Register,2021-02-17,2021-02-17,False,Authorised,Phase 4,Interventional,Netherlands,The efficacy and safety of COVID-19 vaccination in patients with a kidney disease,850,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000868-30
3780,EUCTR2021-000412-28-BE,EU Clinical Trials Register,2021-02-04,2021-02-17,False,Authorised,Phase 4,Interventional,Belgium,Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000412-28
3781,EUCTR2021-000461-33-BE,EU Clinical Trials Register,2021-02-04,2021-02-17,False,Authorised,Phase 4,Interventional,Belgium,Covid-19: Sars-Cov2 vaccination in hemodialysis patient: a phase IV study of the immunogenicity and its determinants,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000461-33
3782,EUCTR2020-001760-29-ES,EU Clinical Trials Register,2020-11-19,2020-09-09,True,Authorised,Phase 2,Interventional,Spain,Phase III clinical trial to evaluate the efficacy and safety of inhaled ethanol in the treatment of early-stage COVID-19.,156,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001760-29
3783,EUCTR2020-006042-39-HU,EU Clinical Trials Register,2021-01-12,2021-02-19,False,Authorised,Phase 2,Interventional,Hungary,Safety and efficacy of Favipiravir,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006042-39
3784,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,False,Not Recruiting,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10
3785,EUCTR2020-004715-27-DE,EU Clinical Trials Register,2020-12-16,2021-03-02,False,Authorised,Phase 2,Interventional,Germany,"A study to investigate the effect of NOC-100 in terms of efficacy, safety, tolerability and drug levels in the blood in patients with acute and chronic cough.",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004715-27
3786,EUCTR2021-000413-17-SE,EU Clinical Trials Register,2021-02-15,2021-02-24,False,Authorised,Phase 4,Interventional,Sweden,COVERS (COVID-Vaccination Efficiency Risk and Safety Study),4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000413-17
3787,EUCTR2020-002542-16-GR,EU Clinical Trials Register,2020-09-29,2020-10-16,False,Authorised,Phase 3,Interventional,"Denmark, Argentina, Portugal, Greece, United Kingdom, Belgium, Peru, United States, Thailand, Spain, Israel, Mexico, Japan, Poland, France, Germany, Nigeria",Treatment of patients with coronavirus infection with immunoglobulin,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002542-16
3788,EUCTR2020-001251-41-FR,EU Clinical Trials Register,2020-03-25,2020-04-17,False,Not Recruiting,Phase 2,Interventional,France,STUDY TESTING THE VALUE OF IMATINIB IN PREVENTION OF COVID-19 IN AGED PATIENTS.,382,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001251-41
3789,EUCTR2020-001870-32-HU,EU Clinical Trials Register,2020-05-05,2020-05-14,False,Not Recruiting,Phase 2,Interventional,"Denmark, Hungary, Netherlands, Spain, Germany","Study to assess efficacy and safety of DFV890 in patients with COVID-19 pneumonia and impaired respiratory function
",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001870-32
3790,EUCTR2020-003654-71-GR,EU Clinical Trials Register,2020-11-26,2020-04-12,True,Not Recruiting,Phase 3,Interventional,"Chile, Moldova, Republic of, Greece, United States, Brazil, Mexico, Israel, Romania",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003654-71
3791,EUCTR2020-000936-23-AT,EU Clinical Trials Register,2020-05-14,2020-05-14,False,Not Recruiting,Phase 3,Interventional,"France, Portugal, Austria","This study is an adaptive, randomized, open clinical trial to evaluate the safety and efficacy of possible therapeutic agents in hospitalized adult patients diagnosed with COVID-19.",3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23
3792,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-11-04,False,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26
3793,EUCTR2020-002913-16-BE,EU Clinical Trials Register,2020-11-05,2020-11-26,False,Authorised,Phase 2/Phase 3,Interventional,"Denmark, Sweden, Russian Federation, Portugal, United Kingdom, Belgium, Netherlands, Italy, Brazil, Spain, Austria, China, France, Germany",The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19.,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002913-16
3794,EUCTR2020-002299-11-HU,EU Clinical Trials Register,2020-06-02,2020-09-17,False,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled, adaptive-design study to assess the safety and efficacy of daily 200 mg fluvoxamine as add-on therapy to standard of care in moderate severity COVID-19 patients",100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002299-11
3795,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-24,False,Not Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,243,https://clinicaltrials.gov/show/NCT04317040
3796,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,False,Not Recruiting,Phase 2,Interventional,"Gibraltar, Greece",The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,105,https://clinicaltrials.gov/show/NCT04326790
3797,NCT04333472,ClinicalTrials.gov,2020-04-01,2021-01-06,False,Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04333472
3798,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,False,Not Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,1363,https://clinicaltrials.gov/show/NCT04334148
3799,NCT04340349,ClinicalTrials.gov,2020-04-02,2021-02-01,False,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,214,https://clinicaltrials.gov/show/NCT04340349
3800,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Not Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,44,https://clinicaltrials.gov/show/NCT04341493
3801,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,False,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),800,https://clinicaltrials.gov/show/NCT04343248
3802,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-08-10,False,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation for Patients Diagnosed With Coronavirus,30,https://clinicaltrials.gov/show/NCT04346927
3803,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-05-14,False,Not Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",100,https://clinicaltrials.gov/show/NCT04348435
3804,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,True,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),227,https://clinicaltrials.gov/show/NCT04351243
3805,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Recruiting,Not Applicable,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,40,https://clinicaltrials.gov/show/NCT04353674
3806,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-05-04,False,Not Recruiting,Not Applicable,Interventional,France,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",2500,https://clinicaltrials.gov/show/NCT04355234
3807,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-07-29,False,Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,1000,https://clinicaltrials.gov/show/NCT04355533
3808,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,False,Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,66,https://clinicaltrials.gov/show/NCT04356833
3809,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,20,https://clinicaltrials.gov/show/NCT04358081
3810,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-06-30,False,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04362189
3811,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-07-20,False,Not Recruiting,Not Applicable,Interventional,Switzerland,Convalescent Plasma for COVID-19,11,https://clinicaltrials.gov/show/NCT04365439
3812,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-06-25,False,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04368676
3813,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Not Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,223,https://clinicaltrials.gov/show/NCT04371393
3814,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Not Recruiting,Phase 2,Interventional,United States,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,20,https://clinicaltrials.gov/show/NCT04374149
3815,NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,True,Not Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,69,https://clinicaltrials.gov/show/NCT04382560
3816,NCT04397614,ClinicalTrials.gov,2020-05-20,2020-07-22,False,Recruiting,Phase 2,Interventional,United States,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,500,https://clinicaltrials.gov/show/NCT04397614
3817,NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",40,https://clinicaltrials.gov/show/NCT04400305
3818,NCT04401150,ClinicalTrials.gov,2020-05-21,2020-08-14,False,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,800,https://clinicaltrials.gov/show/NCT04401150
3819,NCT04401410,ClinicalTrials.gov,2020-05-21,2020-11-04,False,Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,58,https://clinicaltrials.gov/show/NCT04401410
3820,NCT04401423,ClinicalTrials.gov,2020-05-21,2021-02-10,False,Recruiting,Phase 2,Interventional,United States,TXA127 for the Treatment of Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04401423
3821,NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,True,Not Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246
3822,NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Recruiting,Phase 2,Interventional,United States,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,225,https://clinicaltrials.gov/show/NCT04408183
3823,NCT04411446,ClinicalTrials.gov,2020-05-26,2020-08-11,False,Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,1264,https://clinicaltrials.gov/show/NCT04411446
3824,NCT04428801,ClinicalTrials.gov,2020-04-08,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,200,https://clinicaltrials.gov/show/NCT04428801
3825,NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,False,Not Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease",22,https://clinicaltrials.gov/show/NCT04432298
3826,NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-17,False,Not Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,20,https://clinicaltrials.gov/show/NCT04441996
3827,NCT04458298,ClinicalTrials.gov,2020-06-29,2020-08-11,False,Not Recruiting,Phase 2,Interventional,United States,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,24,https://clinicaltrials.gov/show/NCT04458298
3828,NCT04466098,ClinicalTrials.gov,2020-07-08,2020-07-30,False,Not Recruiting,Phase 2,Interventional,United States,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),9,https://clinicaltrials.gov/show/NCT04466098
3829,NCT04466800,ClinicalTrials.gov,2020-07-09,2020-07-30,False,Recruiting,Not Applicable,Interventional,France,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),160,https://clinicaltrials.gov/show/NCT04466800
3830,NCT04476992,ClinicalTrials.gov,2020-07-16,2020-07-24,False,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,20,https://clinicaltrials.gov/show/NCT04476992
3831,NCT04482647,ClinicalTrials.gov,2020-07-21,2020-06-17,True,Recruiting,Phase 1,Interventional,United States,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04482647
3832,NCT04486313,ClinicalTrials.gov,2020-07-23,2020-08-13,False,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,1092,https://clinicaltrials.gov/show/NCT04486313
3833,NCT04496245,ClinicalTrials.gov,2020-07-26,2020-08-24,False,Not Recruiting,Phase 3,Interventional,Australia,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,59,https://clinicaltrials.gov/show/NCT04496245
3834,NCT04510207,ClinicalTrials.gov,2020-08-03,2020-07-16,True,Recruiting,Phase 3,Interventional,"Egypt, Bahrain, United Arab Emirates, Jordan","A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",45000,https://clinicaltrials.gov/show/NCT04510207
3835,NCT04511819,ClinicalTrials.gov,2020-08-08,2020-08-28,False,Not Recruiting,Phase 3,Interventional,"Mexico, Peru, United States, Brazil",Losmapimod Safety and Efficacy in COVID-19,410,https://clinicaltrials.gov/show/NCT04511819
3836,NCT04523246,ClinicalTrials.gov,2020-08-20,2020-09-01,False,Recruiting,Phase 1,Interventional,United States,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,250,https://clinicaltrials.gov/show/NCT04523246
3837,NCT04526145,ClinicalTrials.gov,2020-08-10,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,30,https://clinicaltrials.gov/show/NCT04526145
3838,NCT04527224,ClinicalTrials.gov,2020-08-21,2021-12-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,10,https://clinicaltrials.gov/show/NCT04527224
3839,NCT04527354,ClinicalTrials.gov,2020-08-24,2020-09-01,False,Not Recruiting,Phase 2,Interventional,Russian Federation,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04527354
3840,NCT04528329,ClinicalTrials.gov,2020-08-24,2020-08-30,False,Recruiting,Phase 4,Interventional,Egypt,Anosmia and / or Ageusia and Early Corticosteroid Use,300,https://clinicaltrials.gov/show/NCT04528329
3841,NCT04528641,ClinicalTrials.gov,2020-08-19,2020-08-10,True,Not Recruiting,Phase 1,Interventional,Italy,GRAd-COV2 Vaccine Against COVID-19,90,https://clinicaltrials.gov/show/NCT04528641
3842,NCT04583592,ClinicalTrials.gov,2020-10-07,2020-11-09,False,Not Recruiting,Phase 2,Interventional,United States,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),295,https://clinicaltrials.gov/show/NCT04583592
3843,NCT04594278,ClinicalTrials.gov,2020-10-18,2021-11-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Burnout Study,100,https://clinicaltrials.gov/show/NCT04594278
3844,NCT04600713,ClinicalTrials.gov,2020-10-09,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,180,https://clinicaltrials.gov/show/NCT04600713
3845,NCT04600895,ClinicalTrials.gov,2020-09-15,2020-11-30,False,Recruiting,Phase 3,Interventional,United States,The Prevent Severe COVID-19 (PRESECO) Study,826,https://clinicaltrials.gov/show/NCT04600895
3846,NCT04603742,ClinicalTrials.gov,2020-10-21,2021-07-01,False,Not Recruiting,Phase 2,Interventional,United States,"Anakinra, COVID-19, Cytokine Storm",170,https://clinicaltrials.gov/show/NCT04603742
3847,NCT04606784,ClinicalTrials.gov,2020-10-27,2020-10-28,False,Not Recruiting,Phase 1,Interventional,United States,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,40,https://clinicaltrials.gov/show/NCT04606784
3848,NCT04608266,ClinicalTrials.gov,2020-10-28,2020-12-03,False,Recruiting,Phase 3,Interventional,France,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,596,https://clinicaltrials.gov/show/NCT04608266
3849,NCT04609462,ClinicalTrials.gov,2020-09-24,2020-08-11,True,Not Recruiting,Not Applicable,Interventional,Colombia,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,199,https://clinicaltrials.gov/show/NCT04609462
3850,NCT04619680,ClinicalTrials.gov,2020-11-05,2020-11-18,False,Recruiting,Phase 4,Interventional,United States,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,120,https://clinicaltrials.gov/show/NCT04619680
3851,NCT04626050,ClinicalTrials.gov,2020-11-10,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,United States,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",120,https://clinicaltrials.gov/show/NCT04626050
3852,NCT04631536,ClinicalTrials.gov,2020-10-28,2021-01-10,False,Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,80,https://clinicaltrials.gov/show/NCT04631536
3853,NCT04632537,ClinicalTrials.gov,2020-11-04,2020-12-07,False,Not Recruiting,Phase 3,Interventional,United States,BCG Vaccination to Prevent COVID-19,0,https://clinicaltrials.gov/show/NCT04632537
3854,NCT04640402,ClinicalTrials.gov,2020-11-19,2020-11-17,True,Recruiting,Phase 2,Interventional,China,A Phase ? Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),960,https://clinicaltrials.gov/show/NCT04640402
3855,NCT04642638,ClinicalTrials.gov,2020-11-23,2020-11-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",401,https://clinicaltrials.gov/show/NCT04642638
3856,NCT04644276,ClinicalTrials.gov,2020-11-18,2021-02-17,False,Recruiting,Not Applicable,Interventional,United States,Mask Adhesive Institutional Study,30,https://clinicaltrials.gov/show/NCT04644276
3857,NCT04655586,ClinicalTrials.gov,2020-12-02,2020-12-10,False,Recruiting,Phase 2/Phase 3,Interventional,United States,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",100,https://clinicaltrials.gov/show/NCT04655586
3858,NCT04666012,ClinicalTrials.gov,2020-12-10,2020-12-29,False,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,150,https://clinicaltrials.gov/show/NCT04666012
3859,NCT04668209,ClinicalTrials.gov,2020-12-02,2021-01-01,False,Recruiting,Phase 2,Interventional,United States,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),40,https://clinicaltrials.gov/show/NCT04668209
3860,NCT04668339,ClinicalTrials.gov,2020-11-25,2021-01-07,False,Not Recruiting,Phase 2,Interventional,"Singapore, United States",A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,600,https://clinicaltrials.gov/show/NCT04668339
3861,NCT04678739,ClinicalTrials.gov,2020-12-19,2020-08-15,True,Not Recruiting,Phase 3,Interventional,Bangladesh,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,205,https://clinicaltrials.gov/show/NCT04678739
3862,NCT04679493,ClinicalTrials.gov,2020-12-18,2020-12-24,False,Not Recruiting,Phase 1,Interventional,Russian Federation,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers",16,https://clinicaltrials.gov/show/NCT04679493
3863,NCT04680949,ClinicalTrials.gov,2020-12-18,2020-12-23,False,Not Recruiting,Phase 3,Interventional,"Italy, Greece",suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,606,https://clinicaltrials.gov/show/NCT04680949
3864,NCT04689399,ClinicalTrials.gov,2020-12-26,2020-12-26,False,Not Recruiting,Not Applicable,Interventional,Denmark,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,4697,https://clinicaltrials.gov/show/NCT04689399
3865,NCT04690387,ClinicalTrials.gov,2020-12-28,2020-12-07,True,Not Recruiting,Phase 1,Interventional,Indonesia,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",27,https://clinicaltrials.gov/show/NCT04690387
3866,NCT04695652,ClinicalTrials.gov,2020-12-31,2020-12-30,True,Not Recruiting,Phase 2,Interventional,"Taiwan, Vietnam",A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,3700,https://clinicaltrials.gov/show/NCT04695652
3867,NCT04700163,ClinicalTrials.gov,2021-01-05,2021-01-11,False,Not Recruiting,Phase 1,Interventional,United States,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,23,https://clinicaltrials.gov/show/NCT04700163
3868,NCT04701606,ClinicalTrials.gov,2021-01-06,2021-03-29,False,Recruiting,Phase 2/Phase 3,Interventional,Philippines,The Safety and Efficacy of Pyronaridine-artesunate (PyramaxÂ® or ArtecomÂ®)in COVID-19 Patients,402,https://clinicaltrials.gov/show/NCT04701606
3869,NCT04709328,ClinicalTrials.gov,2021-01-13,2021-03-28,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,690,https://clinicaltrials.gov/show/NCT04709328
3870,NCT04710394,ClinicalTrials.gov,2021-01-13,2021-01-11,True,Not Recruiting,Not Applicable,Interventional,United States,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,240,https://clinicaltrials.gov/show/NCT04710394
3871,NCT04712110,ClinicalTrials.gov,2021-01-14,2021-02-24,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),200,https://clinicaltrials.gov/show/NCT04712110
3872,NCT04723290,ClinicalTrials.gov,2021-01-21,2020-06-20,True,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,2817,https://clinicaltrials.gov/show/NCT04723290
3873,NCT04729140,ClinicalTrials.gov,2020-12-30,2020-12-28,True,Recruiting,Phase 4,Interventional,United States,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,150,https://clinicaltrials.gov/show/NCT04729140
3874,NCT04737486,ClinicalTrials.gov,2020-12-31,2020-12-16,True,Not Recruiting,Phase 1,Interventional,United States,A First-in-Human Study of AV-001 in Healthy Subjects,48,https://clinicaltrials.gov/show/NCT04737486
3875,NCT04756141,ClinicalTrials.gov,2021-02-12,2021-03-03,False,Recruiting,Not Applicable,Interventional,United States,CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)),20,https://clinicaltrials.gov/show/NCT04756141
3876,NCT04764422,ClinicalTrials.gov,2021-02-08,2021-03-20,False,Recruiting,Phase 1/Phase 2,Interventional,Thailand,Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand,460,https://clinicaltrials.gov/show/NCT04764422
3877,NCT04765475,ClinicalTrials.gov,2021-01-29,2021-03-08,False,Recruiting,Not Applicable,Interventional,United States,Protecting Native Families From COVID-19,600,https://clinicaltrials.gov/show/NCT04765475
3878,NCT04766931,ClinicalTrials.gov,2021-02-04,2021-03-27,False,Recruiting,Phase 1,Interventional,United States,The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection,32,https://clinicaltrials.gov/show/NCT04766931
3879,NCT04767958,ClinicalTrials.gov,2021-02-19,2021-03-19,False,Recruiting,Not Applicable,Interventional,Canada,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,2500,https://clinicaltrials.gov/show/NCT04767958
3880,NCT04793464,ClinicalTrials.gov,2021-02-25,2021-02-04,True,Recruiting,Not Applicable,Interventional,United States,COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos),3600,https://clinicaltrials.gov/show/NCT04793464
3881,NCT04794088,ClinicalTrials.gov,2021-02-26,2021-03-14,False,Recruiting,Phase 2,Interventional,Netherlands,Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04794088
3882,NCT04798677,ClinicalTrials.gov,2021-03-12,2020-10-29,True,Recruiting,Not Applicable,Interventional,Spain,Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine,90,https://clinicaltrials.gov/show/NCT04798677
3883,NCT04800965,ClinicalTrials.gov,2021-02-06,2021-01-31,True,Recruiting,Not Applicable,Interventional,United States,Text-based Interventions to Promote COVID-19 Vaccinations,400000,https://clinicaltrials.gov/show/NCT04800965
3884,NCT04801524,ClinicalTrials.gov,2021-03-15,2021-02-07,True,Recruiting,Not Applicable,Interventional,United States,Text-based Reminders to Promote COVID-19 Vaccinations,250000,https://clinicaltrials.gov/show/NCT04801524
3885,NCT04802018,ClinicalTrials.gov,2021-03-16,2021-03-09,True,Not Recruiting,Not Applicable,Interventional,Spain,Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04802018
3886,NCT04810637,ClinicalTrials.gov,2021-03-17,2020-11-01,True,Recruiting,Phase 2,Interventional,Indonesia,A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19,210,https://clinicaltrials.gov/show/NCT04810637
3887,NCT04810949,ClinicalTrials.gov,2021-03-18,2020-08-05,True,Not Recruiting,Not Applicable,Interventional,Mexico,Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml,41,https://clinicaltrials.gov/show/NCT04810949
3888,NCT04811339,ClinicalTrials.gov,2021-03-20,2020-09-02,True,Recruiting,Phase 4,Interventional,United States,Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol),35,https://clinicaltrials.gov/show/NCT04811339
3889,NCT04811859,ClinicalTrials.gov,2021-02-25,2021-01-10,True,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Inspiratory Muscle Training in Post COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04811859
3890,NCT04812184,ClinicalTrials.gov,2021-03-17,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,United States,Adhesive Tape Placement on Patients' Masks in the ED Increases Compliance of Proper Face Mask Use,123,https://clinicaltrials.gov/show/NCT04812184
3891,NCT04813471,ClinicalTrials.gov,2021-03-22,2021-01-20,True,Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH,70,https://clinicaltrials.gov/show/NCT04813471
3892,NCT04813497,ClinicalTrials.gov,2021-03-21,2021-02-05,True,Recruiting,Not Applicable,Interventional,Belgium,Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members,4000,https://clinicaltrials.gov/show/NCT04813497
3893,NCT04813575,ClinicalTrials.gov,2021-02-08,2021-04-01,False,Recruiting,Not Applicable,Interventional,Saudi Arabia,COVID-19 Pathophysiology of Long Term Implications,60,https://clinicaltrials.gov/show/NCT04813575
3894,NCT04815096,ClinicalTrials.gov,2021-03-23,2021-04-15,False,Recruiting,Phase 1,Interventional,United States,Imaging Immune Activation in COVID-19,20,https://clinicaltrials.gov/show/NCT04815096
3895,NCT04816084,ClinicalTrials.gov,2021-03-19,2020-11-05,True,Not Recruiting,Not Applicable,Interventional,France,SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes,389,https://clinicaltrials.gov/show/NCT04816084
3896,NCT04816656,ClinicalTrials.gov,2021-03-24,2020-08-03,True,Not Recruiting,Not Applicable,Interventional,Belgium,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,43,https://clinicaltrials.gov/show/NCT04816656
3897,NCT04816682,ClinicalTrials.gov,2021-03-19,2021-03-17,True,Recruiting,Phase 4,Interventional,Slovakia,Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes,30,https://clinicaltrials.gov/show/NCT04816682
3898,NCT04816942,ClinicalTrials.gov,2021-02-12,2020-04-23,True,Not Recruiting,Phase 3,Interventional,Egypt,Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt,102,https://clinicaltrials.gov/show/NCT04816942
3899,NCT04817332,ClinicalTrials.gov,2021-01-25,2020-06-05,True,Not Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19,400,https://clinicaltrials.gov/show/NCT04817332
3900,NCT04817371,ClinicalTrials.gov,2021-03-15,2021-03-01,True,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.,192,https://clinicaltrials.gov/show/NCT04817371
3901,NCT04818489,ClinicalTrials.gov,2021-02-13,2021-03-25,False,Recruiting,Phase 4,Interventional,Egypt,Colchicine and Post-COVID-19 Pulmonary Fibrosis,250,https://clinicaltrials.gov/show/NCT04818489
3902,NCT04818801,ClinicalTrials.gov,2021-03-19,2021-04-01,False,Not Recruiting,Phase 1,Interventional,New Zealand,"Safety, Reactogenicity and Immunogenicity Study of ReCOV",160,https://clinicaltrials.gov/show/NCT04818801
3903,NCT04820751,ClinicalTrials.gov,2021-03-25,2021-04-10,False,Not Recruiting,Phase 3,Interventional,No Country Given,Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial,200,https://clinicaltrials.gov/show/NCT04820751
3904,NCT04820803,ClinicalTrials.gov,2021-03-23,2021-02-03,True,Recruiting,Not Applicable,Interventional,Spain,Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04820803
3905,NCT04821674,ClinicalTrials.gov,2021-03-25,2021-03-15,True,Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects,152,https://clinicaltrials.gov/show/NCT04821674
3906,NCT04821934,ClinicalTrials.gov,2021-03-26,2021-03-26,False,Recruiting,Not Applicable,Interventional,Italy,Tele-rehabilitation Program After Hospitalization for COVID-19,74,https://clinicaltrials.gov/show/NCT04821934
3907,NCT04821973,ClinicalTrials.gov,2021-03-25,2020-09-22,True,Recruiting,Not Applicable,Interventional,France,Respiratory Tele Monitoring COVID 19 (TMR COVID-19),80,https://clinicaltrials.gov/show/NCT04821973
3908,NCT04822285,ClinicalTrials.gov,2021-03-26,2020-01-22,True,Not Recruiting,Not Applicable,Interventional,Egypt,Effect Psychological Triaging Intervention on Students' Psychological Distress and Resilience Capacity,64,https://clinicaltrials.gov/show/NCT04822285
3909,NCT04822818,ClinicalTrials.gov,2021-03-25,2021-04-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEVÂ®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19,174,https://clinicaltrials.gov/show/NCT04822818
3910,NCT04823351,ClinicalTrials.gov,2021-03-25,2021-04-08,False,Not Recruiting,Not Applicable,Interventional,Switzerland,Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks,1200,https://clinicaltrials.gov/show/NCT04823351
3911,NCT04824222,ClinicalTrials.gov,2021-03-26,2021-04-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters,366,https://clinicaltrials.gov/show/NCT04824222
3912,NCT04824391,ClinicalTrials.gov,2021-03-25,2021-02-10,True,Recruiting,Phase 2,Interventional,Turkey,"Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19",250,https://clinicaltrials.gov/show/NCT04824391
3913,NCT04824638,ClinicalTrials.gov,2021-03-07,2021-03-08,False,Recruiting,Phase 2,Interventional,France,BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers,300,https://clinicaltrials.gov/show/NCT04824638
3914,NCT04825093,ClinicalTrials.gov,2020-12-02,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19,500,https://clinicaltrials.gov/show/NCT04825093
3915,NCT04826367,ClinicalTrials.gov,2021-03-29,2021-01-20,True,Recruiting,Not Applicable,Interventional,Turkey,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,64,https://clinicaltrials.gov/show/NCT04826367
3916,NCT04826822,ClinicalTrials.gov,2021-03-28,2021-02-24,True,Recruiting,Phase 3,Interventional,Russian Federation,Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19,440,https://clinicaltrials.gov/show/NCT04826822
3917,NCT04828161,ClinicalTrials.gov,2021-03-24,2021-04-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19",2100,https://clinicaltrials.gov/show/NCT04828161
3918,NCT04828538,ClinicalTrials.gov,2021-03-12,2021-03-01,True,Recruiting,Not Applicable,Interventional,Mexico,"Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19",3600,https://clinicaltrials.gov/show/NCT04828538
3919,NCT04828564,ClinicalTrials.gov,2021-04-01,2021-04-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Turkey,Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04828564
3920,NCT04828668,ClinicalTrials.gov,2021-03-10,2021-04-02,False,Recruiting,Not Applicable,Interventional,United States,Study to Evaluate Benefits & Safety of Endourage Formula Câ„¢ Oral Drops in People With Post-Acute COVID-19 Syndrome.,60,https://clinicaltrials.gov/show/NCT04828668
3921,NCT04829188,ClinicalTrials.gov,2021-03-26,2021-03-30,False,Recruiting,Not Applicable,Interventional,United States,Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia,1668,https://clinicaltrials.gov/show/NCT04829188
3922,NCT04830020,ClinicalTrials.gov,2021-03-31,2021-02-26,True,Recruiting,Phase 2,Interventional,Italy,Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes,200,https://clinicaltrials.gov/show/NCT04830020
3923,NCT04830800,ClinicalTrials.gov,2021-03-12,2021-03-10,True,Recruiting,Phase 1/Phase 2,Interventional,Vietnam,A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC,420,https://clinicaltrials.gov/show/NCT04830800
3924,NCT04830943,ClinicalTrials.gov,2020-12-24,2020-08-01,True,Not Recruiting,Phase 4,Interventional,Egypt,Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia,100,https://clinicaltrials.gov/show/NCT04830943
3925,NCT04831853,ClinicalTrials.gov,2021-04-01,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,France,Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB),400,https://clinicaltrials.gov/show/NCT04831853
3926,NCT04832880,ClinicalTrials.gov,2020-10-12,2021-04-06,False,Not Recruiting,Phase 3,Interventional,Italy,Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial),4000,https://clinicaltrials.gov/show/NCT04832880
3927,NCT04833010,ClinicalTrials.gov,2021-02-09,2021-01-20,True,Recruiting,Not Applicable,Interventional,United States,Effects of Face Masks During Exercise,100,https://clinicaltrials.gov/show/NCT04833010
3928,NCT04834115,ClinicalTrials.gov,2021-03-28,2020-11-17,True,Recruiting,Phase 3,Interventional,Paraguay,Efficacy of Ivermectin in Outpatients With Non-severe COVID-19,400,https://clinicaltrials.gov/show/NCT04834115
3929,NCT04834375,ClinicalTrials.gov,2021-03-31,2021-03-19,True,Recruiting,Phase 4,Interventional,United States,Randomized Open Investigation Determining Steroid Dose,142,https://clinicaltrials.gov/show/NCT04834375
3930,ACTRN12620001048976,ANZCTR,2020-10-15,2021-05-04,False,Not Recruiting,Phase 1,Interventional,"United States, Puerto Rico, New Zealand, Germany","A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to
Evaluate the Pharmacokinetics of Remdesivir and Metabolites in
Participants with Normal Renal Function and Renal Impairment",80,https://anzctr.org.au/ACTRN12620001048976.aspx
3931,ACTRN12621000387820,ANZCTR,2021-04-08,2021-04-19,False,Not Recruiting,Not Applicable,Interventional,Australia,Comparing the effects of a diet and exercise program versus psychological treatment for reducing depression in adults with COVID-19 related distress: The CALM trial,184,https://anzctr.org.au/ACTRN12621000387820.aspx
3932,ACTRN12620001249943,ANZCTR,2020-11-20,2021-03-29,False,Recruiting,Phase 1/Phase 2,Interventional,Australia,"Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 (COVID-19)  as a passive immunity modality in healthy individuals: an open-label, active control Phase 1/2 Study",30,https://anzctr.org.au/ACTRN12620001249943.aspx
3933,ACTRN12621000347864,ANZCTR,2021-03-26,2021-05-04,False,Not Recruiting,Not Applicable,Interventional,Spain,Efficacy of a telerehabilitation program for therapeutic toning and respiratory exercises in patients affected by Covid-19 sequelae,60,https://anzctr.org.au/ACTRN12621000347864.aspx
3934,ISRCTN14081521,ISRCTN,2021-03-31,2021-01-04,True,Recruiting,Not Applicable,Interventional,United Kingdom,"Can people with cystic fibrosis safely stop taking some of their nebulised treatments if they are established on the new modulator therapy, Kaftrio?",764,http://isrctn.com/ISRCTN14081521
3935,ISRCTN16393332,ISRCTN,2021-03-24,2020-10-26,True,Recruiting,Not Applicable,Interventional,United Kingdom,Remote monitoring of blood pressure in patients with high blood pressure during the COVID-19 pandemic,1000,http://isrctn.com/ISRCTN16393332
3936,ISRCTN21085622,ISRCTN,2021-03-23,2020-09-29,True,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Assessing the safety and effectiveness of sofosbuvir plus daclatasvir or ravidasvir in Egyptian adults with COVID-19,120,http://isrctn.com/ISRCTN21085622
3937,ISRCTN70307341,ISRCTN,2021-03-23,2021-01-04,True,Recruiting,Not Applicable,Interventional,United Kingdom,A study to test a package of support to help women who have stopped smoking while pregnant to stay smoke-free after giving birth,880,http://isrctn.com/ISRCTN70307341
3938,ISRCTN17441953,ISRCTN,2021-03-22,2021-01-08,True,Recruiting,Not Applicable,Interventional,United Kingdom,Ultrasound visual biofeedback versus standard treatment for children with cleft lip and palate,40,http://isrctn.com/ISRCTN17441953
3939,ISRCTN17846723,ISRCTN,2021-03-16,2021-03-16,False,Recruiting,Not Applicable,Interventional,Canada,A web-based referral service to facilitate rapid and direct access to mental health care for youth,180,http://isrctn.com/ISRCTN17846723
3940,ISRCTN85436698,ISRCTN,2021-02-03,2021-12-01,False,Recruiting,Phase 3,Interventional,"Argentina, Portugal, United Kingdom, Colombia, Belgium, Netherlands, United States, Italy, Brazil, Israel, Mexico, Serbia, Spain, France, India, Germany, Romania",Phase III trial of inhaled SNG001 compared to placebo for the treatment of patients hospitalised due to moderate COVID-19,610,http://isrctn.com/ISRCTN85436698
3941,ISRCTN82411169,ISRCTN,2020-12-17,2020-12-16,True,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A phase I/II study to evaluate the safety of and immunological response to a vaccine candidate (VLA2001) against COVID-19,150,http://isrctn.com/ISRCTN82411169
3942,ISRCTN90437126,ISRCTN,2020-11-17,2020-09-15,True,Recruiting,Phase 3,Interventional,Brazil,Study on the effects of using ivermectin to prevent COVID-19 in an adult population in Brazil,800,http://isrctn.com/ISRCTN90437126
3943,ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,False,Not Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,45,http://isrctn.com/ISRCTN40302986
3944,ISRCTN88057279,ISRCTN,2020-05-14,2020-01-10,True,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Preventative treatment for patients at risk of COVID-19 infection (PROTECT),500,http://isrctn.com/ISRCTN88057279
3945,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,False,Not Recruiting,Phase 3,Interventional,"Saudi Arabia, Canada, Norway, Honduras, Ireland, Indonesia, Germany, Lebanon, Switzerland, Argentina, South Africa, Italy, Brazil, Malaysia, Philippines, Kenya, Iran, Qatar, Peru, Thailand, Israel, Spain, India",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,10000,http://isrctn.com/ISRCTN83971151
3946,ISRCTN14966097,ISRCTN,2020-02-27,2020-02-03,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,"Exploring the impact on patients with lupus and related autoimmune diseases of peer support, relationships with clinicians and COVID-19 changes to care",180,http://isrctn.com/ISRCTN14966097
3947,ChiCTR2100043012,ChiCTR,2021-02-04,2021-02-04,False,Not Recruiting,Phase 4,Interventional,China,Real-world study on the prevention effect of Lian-Hua Qing-Wen Capsules on close contacts of new coronavirus pneumonia,2200,http://www.chictr.org.cn/showproj.aspx?proj=120867
3948,ChiCTR2100042192,ChiCTR,2021-01-15,2021-01-14,True,Recruiting,Not Applicable,Interventional,China,Investigation and intervention study on psychosomatic health status of quarantinable inbound people during the COVID-19 epidemic,106,http://www.chictr.org.cn/showproj.aspx?proj=119629
3949,ChiCTR2100042150,ChiCTR,2021-01-14,2021-01-14,False,Not Recruiting,Phase 1,Interventional,China,"Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic profile and immunogenicity of JMB-2002  injection in Chinese healthy subjects after intravenous infusion of single dose",40,http://www.chictr.org.cn/showproj.aspx?proj=66096
3950,ChiCTR2100042069,ChiCTR,2021-01-12,2021-01-01,True,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of COVID-19 patients with mild and common-type",120,http://www.chictr.org.cn/showproj.aspx?proj=120071
3951,ChiCTR2100042068,ChiCTR,2021-01-12,2021-01-01,True,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of severe novel coronavirus pneumonia",20,http://www.chictr.org.cn/showproj.aspx?proj=120075
3952,ChiCTR2100042066,ChiCTR,2021-01-13,2021-01-01,True,Recruiting,Phase 4,Interventional,China,"A randomized, open-label,  blank-controlled, multi-center clinical study for Lian-Hua Qing-Wen Capsule/Granule in the treatment of asymptomatic patients with novel coronavirus pneumonia",120,http://www.chictr.org.cn/showproj.aspx?proj=120077
3953,ChiCTR2100042004,ChiCTR,2021-01-12,2020-02-19,True,No Status Given,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=65719
3954,ChiCTR2100042003,ChiCTR,2021-01-12,2020-06-01,True,Not Recruiting,Not Applicable,Interventional,China,"Effect of whole process management on nausea and vomiting during oropharyngeal swab collection in cancer patients in the Covid-19 pandemic: a single-blind, randomized controlled trial",2485,http://www.chictr.org.cn/showproj.aspx?proj=64795
3955,ChiCTR2000040847,ChiCTR,2020-12-11,2021-01-01,False,Recruiting,Not Applicable,Interventional,China,A clinical study of new aerosol inhalation in the treatment of severe patients with respiratory virus infection,20,http://www.chictr.org.cn/showproj.aspx?proj=53028
3956,EUCTR2020-001411-25-DE,EU Clinical Trials Register,2020-04-01,2020-05-18,False,Not Recruiting,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, Italy, Israel, Spain, United States, Austria, France, India, Germany, Malaysia",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25
3957,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-07-04,False,Not Recruiting,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27
3958,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-01-04,True,Not Recruiting,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16
3959,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Not Recruiting,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26
3960,EUCTR2020-005827-35-FR,EU Clinical Trials Register,2020-12-11,2021-03-25,False,Authorised,Phase 4,Interventional,France,Neurotropism and neuroinflammation in COVID-19 patients with delirium,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005827-35
3961,EUCTR2020-001310-38-DE,EU Clinical Trials Register,2020-03-31,2020-06-04,False,Not Recruiting,Phase 2,Interventional,Germany,Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38
3962,EUCTR2021-000880-63-SE,EU Clinical Trials Register,2021-02-23,2021-11-03,False,Authorised,Phase 4,Interventional,Sweden,COVID-19 vaccine in patients with rheumatic diseases: The impact of treatments on the vaccine response  protection against infection (COVID19-REUMA),868,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000880-63
3963,EUCTR2021-000905-26-SE,EU Clinical Trials Register,2021-03-12,2021-03-31,False,Authorised,Phase 4,Interventional,Sweden,Response to Covid-19 vaccination in patients with cancer,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000905-26
3964,EUCTR2021-000864-32-NL,EU Clinical Trials Register,2021-03-19,2021-03-29,False,Authorised,Phase 1/Phase 2,Interventional,Netherlands,The ConvP COVig PKPD study: an investigation for the use of plasma or antibodies against the novel coronavirus (SARS-CoV-2),104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000864-32
3965,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Not Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,17,https://clinicaltrials.gov/show/NCT04275245
3966,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,30,https://clinicaltrials.gov/show/NCT04280224
3967,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,200,https://clinicaltrials.gov/show/NCT04312009
3968,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,False,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),500,https://clinicaltrials.gov/show/NCT04323800
3969,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,False,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),1090,https://clinicaltrials.gov/show/NCT04324606
3970,NCT04329195,ClinicalTrials.gov,2020-03-28,2020-04-09,False,Not Recruiting,Phase 3,Interventional,France,ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic,44,https://clinicaltrials.gov/show/NCT04329195
3971,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Not Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,152,https://clinicaltrials.gov/show/NCT04338009
3972,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Not Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,31,https://clinicaltrials.gov/show/NCT04341415
3973,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,False,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,20,https://clinicaltrials.gov/show/NCT04343976
3974,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Auxora in Patients With Severe COVID-19 Pneumonia,346,https://clinicaltrials.gov/show/NCT04345614
3975,NCT04353180,ClinicalTrials.gov,2020-04-10,2021-04-01,False,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),100000,https://clinicaltrials.gov/show/NCT04353180
3976,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-10-23,False,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,30,https://clinicaltrials.gov/show/NCT04357444
3977,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,22000,https://clinicaltrials.gov/show/NCT04359875
3978,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-23,False,Not Recruiting,Phase 3,Interventional,"Switzerland, Brazil",Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,326,https://clinicaltrials.gov/show/NCT04364022
3979,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),400,https://clinicaltrials.gov/show/NCT04367077
3980,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-08-11,False,Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System,36,https://clinicaltrials.gov/show/NCT04369599
3981,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,False,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,1344,https://clinicaltrials.gov/show/NCT04373460
3982,NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,False,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,30,https://clinicaltrials.gov/show/NCT04390139
3983,NCT04395716,ClinicalTrials.gov,2020-05-19,2020-01-01,True,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCureâ„¢ to Treat COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04395716
3984,NCT04402944,ClinicalTrials.gov,2020-05-12,2020-07-05,False,Recruiting,Phase 2,Interventional,United States,Pulmozyme to Improve COVID-19 ARDS Outcomes,60,https://clinicaltrials.gov/show/NCT04402944
3985,NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,False,Not Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,38,https://clinicaltrials.gov/show/NCT04405986
3986,NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,752,https://clinicaltrials.gov/show/NCT04415060
3987,NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,False,Not Recruiting,Phase 2,Interventional,Italy,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,180,https://clinicaltrials.gov/show/NCT04428021
3988,NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,False,Not Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",32,https://clinicaltrials.gov/show/NCT04429529
3989,NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Belgium",A Study of Ad26.COV2.S in Adults (COVID-19),1085,https://clinicaltrials.gov/show/NCT04436276
3990,NCT04440007,ClinicalTrials.gov,2020-06-17,2020-10-09,False,Not Recruiting,Phase 2,Interventional,United States,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,80,https://clinicaltrials.gov/show/NCT04440007
3991,NCT04459247,ClinicalTrials.gov,2020-07-03,2020-06-15,True,Not Recruiting,Not Applicable,Interventional,India,"Short Term, High Dose Vitamin D Supplementation for COVID-19",30,https://clinicaltrials.gov/show/NCT04459247
3992,NCT04459702,ClinicalTrials.gov,2020-06-25,2020-07-01,False,Not Recruiting,Phase 2,Interventional,United States,A Study of Combination Therapies to Treat COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04459702
3993,NCT04471636,ClinicalTrials.gov,2020-07-09,2020-09-18,False,Recruiting,Not Applicable,Interventional,Germany,Telemedicine in Outpatient Covid-19 Patients,600,https://clinicaltrials.gov/show/NCT04471636
3994,NCT04477993,ClinicalTrials.gov,2020-07-13,2020-08-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,5,https://clinicaltrials.gov/show/NCT04477993
3995,NCT04478019,ClinicalTrials.gov,2020-07-15,2020-07-07,True,Recruiting,Phase 1,Interventional,United States,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,250,https://clinicaltrials.gov/show/NCT04478019
3996,NCT04479631,ClinicalTrials.gov,2020-07-14,2020-07-12,True,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",16,https://clinicaltrials.gov/show/NCT04479631
3997,NCT04479644,ClinicalTrials.gov,2020-07-14,2020-07-13,True,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",17,https://clinicaltrials.gov/show/NCT04479644
3998,NCT04482699,ClinicalTrials.gov,2020-07-20,2020-12-30,False,Recruiting,Phase 1/Phase 2,Interventional,United States,RAPA-501-Allo Therapy of COVID-19-ARDS,88,https://clinicaltrials.gov/show/NCT04482699
3999,NCT04488796,ClinicalTrials.gov,2020-07-22,2020-09-07,False,Not Recruiting,Not Applicable,Interventional,Canada,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,148,https://clinicaltrials.gov/show/NCT04488796
4000,NCT04497298,ClinicalTrials.gov,2020-07-31,2020-08-10,False,Not Recruiting,Phase 1,Interventional,"France, Belgium",Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,90,https://clinicaltrials.gov/show/NCT04497298
4001,NCT04505761,ClinicalTrials.gov,2020-07-03,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,Netherlands,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",48,https://clinicaltrials.gov/show/NCT04505761
4002,NCT04522830,ClinicalTrials.gov,2020-08-18,2020-07-30,True,Not Recruiting,Phase 2,Interventional,United States,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,28,https://clinicaltrials.gov/show/NCT04522830
4003,NCT04539262,ClinicalTrials.gov,2020-08-26,2020-09-14,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",156,https://clinicaltrials.gov/show/NCT04539262
4004,NCT04558125,ClinicalTrials.gov,2020-09-19,2020-09-08,True,Recruiting,Phase 4,Interventional,United States,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,45,https://clinicaltrials.gov/show/NCT04558125
4005,NCT04563702,ClinicalTrials.gov,2020-09-21,2020-09-21,False,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,35,https://clinicaltrials.gov/show/NCT04563702
4006,NCT04573764,ClinicalTrials.gov,2020-10-01,2021-02-01,False,Recruiting,Not Applicable,Interventional,Denmark,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04573764
4007,NCT04581915,ClinicalTrials.gov,2020-09-16,2020-09-08,True,Recruiting,Phase 2/Phase 3,Interventional,South Africa,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,420,https://clinicaltrials.gov/show/NCT04581915
4008,NCT04594343,ClinicalTrials.gov,2020-10-18,2020-11-20,False,Recruiting,Phase 2,Interventional,Brazil,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,200,https://clinicaltrials.gov/show/NCT04594343
4009,NCT04602871,ClinicalTrials.gov,2020-10-21,2020-07-03,True,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,108,https://clinicaltrials.gov/show/NCT04602871
4010,NCT04602884,ClinicalTrials.gov,2020-10-21,2020-09-22,True,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis,50,https://clinicaltrials.gov/show/NCT04602884
4011,NCT04602949,ClinicalTrials.gov,2020-10-21,2020-11-12,False,Recruiting,Not Applicable,Interventional,Israel,Detection of COVID-19 Using Breath Analysis - Validation Study,4000,https://clinicaltrials.gov/show/NCT04602949
4012,NCT04621071,ClinicalTrials.gov,2020-11-05,2021-01-12,False,Recruiting,Not Applicable,Interventional,Canada,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,84,https://clinicaltrials.gov/show/NCT04621071
4013,NCT04625985,ClinicalTrials.gov,2020-10-23,2020-07-14,True,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",20,https://clinicaltrials.gov/show/NCT04625985
4014,NCT04626089,ClinicalTrials.gov,2020-10-23,2021-02-01,False,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",0,https://clinicaltrials.gov/show/NCT04626089
4015,NCT04627467,ClinicalTrials.gov,2020-10-30,2020-03-28,True,Not Recruiting,Phase 2,Interventional,Colombia,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),3217,https://clinicaltrials.gov/show/NCT04627467
4016,NCT04644185,ClinicalTrials.gov,2020-11-22,2021-03-27,False,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Argentina, Peru, Colombia, United States, Brazil, Mexico",The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,795,https://clinicaltrials.gov/show/NCT04644185
4017,NCT04685447,ClinicalTrials.gov,2020-12-22,2020-03-16,True,Recruiting,Not Applicable,Interventional,Italy,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,30,https://clinicaltrials.gov/show/NCT04685447
4018,NCT04710199,ClinicalTrials.gov,2021-01-05,2021-02-08,False,Recruiting,Phase 2,Interventional,Spain,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),40,https://clinicaltrials.gov/show/NCT04710199
4019,NCT04716426,ClinicalTrials.gov,2021-01-18,2021-01-28,False,Not Recruiting,Not Applicable,Interventional,Brazil,APTâ„¢ T3X on the COVID-19 Contamination Rate,100,https://clinicaltrials.gov/show/NCT04716426
4020,NCT04718220,ClinicalTrials.gov,2021-01-16,2021-03-01,False,Recruiting,Not Applicable,Interventional,United States,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",420,https://clinicaltrials.gov/show/NCT04718220
4021,NCT04720235,ClinicalTrials.gov,2021-01-15,2020-12-09,True,Not Recruiting,Not Applicable,Interventional,United States,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,304,https://clinicaltrials.gov/show/NCT04720235
4022,NCT04732468,ClinicalTrials.gov,2021-01-27,2021-02-24,False,Recruiting,Phase 1,Interventional,United States,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,65,https://clinicaltrials.gov/show/NCT04732468
4023,NCT04734561,ClinicalTrials.gov,2020-12-31,2021-02-08,False,Recruiting,Not Applicable,Interventional,Spain,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,88,https://clinicaltrials.gov/show/NCT04734561
4024,NCT04734860,ClinicalTrials.gov,2021-01-29,2021-04-01,False,Recruiting,Phase 2,Interventional,United States,Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Adults With Mild COVID-19 Symptoms,500,https://clinicaltrials.gov/show/NCT04734860
4025,NCT04747821,ClinicalTrials.gov,2021-02-05,2021-02-07,False,Not Recruiting,Phase 4,Interventional,Brazil,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,27711,https://clinicaltrials.gov/show/NCT04747821
4026,NCT04748783,ClinicalTrials.gov,2021-02-09,2021-03-26,False,Not Recruiting,Phase 2,Interventional,United States,Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19,2,https://clinicaltrials.gov/show/NCT04748783
4027,NCT04751669,ClinicalTrials.gov,2021-02-11,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,Spain,Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial,300,https://clinicaltrials.gov/show/NCT04751669
4028,NCT04762173,ClinicalTrials.gov,2021-02-15,2020-11-06,True,Not Recruiting,Not Applicable,Interventional,United States,Self-Help for Stress Related to COVID-19,585,https://clinicaltrials.gov/show/NCT04762173
4029,NCT04762771,ClinicalTrials.gov,2021-02-18,2020-12-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19),75,https://clinicaltrials.gov/show/NCT04762771
4030,NCT04771351,ClinicalTrials.gov,2021-02-23,2021-04-01,False,Recruiting,Phase 2,Interventional,United States,Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Hospitalized Adults With COVID-19,280,https://clinicaltrials.gov/show/NCT04771351
4031,NCT04789499,ClinicalTrials.gov,2021-03-08,2021-03-15,False,Recruiting,Phase 2,Interventional,United States,Smell in Covid-19 and Efficacy of Nasal Theophylline,50,https://clinicaltrials.gov/show/NCT04789499
4032,NCT04791423,ClinicalTrials.gov,2021-02-22,2021-03-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Study of GRAd-COV2 for the Prevention of COVID-19 in Adults,10300,https://clinicaltrials.gov/show/NCT04791423
4033,NCT04794036,ClinicalTrials.gov,2021-03-01,2021-04-05,False,Recruiting,Not Applicable,Interventional,Spain,Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient,32,https://clinicaltrials.gov/show/NCT04794036
4034,NCT04796402,ClinicalTrials.gov,2021-03-10,2021-03-17,False,Recruiting,Phase 4,Interventional,Canada,A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19,576,https://clinicaltrials.gov/show/NCT04796402
4035,NCT04798053,ClinicalTrials.gov,2021-03-10,2021-04-08,False,Recruiting,Not Applicable,Interventional,France,Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients,318,https://clinicaltrials.gov/show/NCT04798053
4036,NCT04800133,ClinicalTrials.gov,2021-03-01,2021-04-01,False,Recruiting,Phase 2,Interventional,China,Covid-19 Vaccination in Adolescents,900,https://clinicaltrials.gov/show/NCT04800133
4037,NCT04800939,ClinicalTrials.gov,2021-03-11,2021-04-05,False,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness,60,https://clinicaltrials.gov/show/NCT04800939
4038,NCT04808921,ClinicalTrials.gov,2021-03-18,2021-01-09,True,Not Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test,151,https://clinicaltrials.gov/show/NCT04808921
4039,NCT04810065,ClinicalTrials.gov,2021-03-19,2021-03-29,False,Recruiting,Not Applicable,Interventional,Ireland,SingStrong: Strong Lungs Through Song - Long COVID-19 Study,35,https://clinicaltrials.gov/show/NCT04810065
4040,NCT04815057,ClinicalTrials.gov,2021-03-11,2020-11-02,True,Not Recruiting,Not Applicable,Interventional,Turkey,The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period,176,https://clinicaltrials.gov/show/NCT04815057
4041,NCT04818281,ClinicalTrials.gov,2021-03-24,2021-03-27,False,Recruiting,Phase 1,Interventional,Turkey,Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults,36,https://clinicaltrials.gov/show/NCT04818281
4042,NCT04830761,ClinicalTrials.gov,2021-03-25,2021-03-26,False,Recruiting,Not Applicable,Interventional,Switzerland,Behavior Change in Context to Contain the Spread of COVID-19,710,https://clinicaltrials.gov/show/NCT04830761
4043,NCT04833088,ClinicalTrials.gov,2021-04-01,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Exploratory Study About the Implementation of Technology in the Rehabilitation,100,https://clinicaltrials.gov/show/NCT04833088
4044,NCT04834089,ClinicalTrials.gov,2021-04-01,2021-05-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases,618,https://clinicaltrials.gov/show/NCT04834089
4045,NCT04834128,ClinicalTrials.gov,2021-03-29,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,TCB008 in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04834128
4046,NCT04834739,ClinicalTrials.gov,2021-01-10,2021-01-04,True,Recruiting,Not Applicable,Interventional,Turkey,Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19,60,https://clinicaltrials.gov/show/NCT04834739
4047,NCT04834856,ClinicalTrials.gov,2021-04-06,2021-04-01,True,Recruiting,Phase 2,Interventional,Netherlands,"Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients",40,https://clinicaltrials.gov/show/NCT04834856
4048,NCT04836052,ClinicalTrials.gov,2021-03-14,2020-12-24,True,Recruiting,Phase 3,Interventional,Qatar,Omega-3 Oil Use in COVID-19 Patients in Qatar,372,https://clinicaltrials.gov/show/NCT04836052
4049,NCT04836260,ClinicalTrials.gov,2021-04-06,2021-04-08,False,Recruiting,Phase 3,Interventional,Switzerland,Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04836260
4050,NCT04836299,ClinicalTrials.gov,2021-03-02,2021-05-08,False,Not Recruiting,Phase 2,Interventional,Bolivia,"Clinical Trial to ""Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)",90,https://clinicaltrials.gov/show/NCT04836299
4051,NCT04836351,ClinicalTrials.gov,2021-03-29,2021-03-01,True,Recruiting,Not Applicable,Interventional,Norway,Rehabilitation for Patients With Persistent Symptoms Post COVID-19,20,https://clinicaltrials.gov/show/NCT04836351
4052,NCT04836780,ClinicalTrials.gov,2021-03-18,2021-04-01,False,Not Recruiting,Phase 3,Interventional,Spain,DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia,126,https://clinicaltrials.gov/show/NCT04836780
4053,NCT04838080,ClinicalTrials.gov,2021-04-06,2021-03-19,True,Recruiting,Phase 1,Interventional,Turkey,Safety and Immunogenicity of the Inactivated KoÃ§ak-19 Inaktif Adjuvanli COVID-19 Vaccine Compared to Placebo,38,https://clinicaltrials.gov/show/NCT04838080
4054,NCT04838847,ClinicalTrials.gov,2021-04-08,2021-05-14,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19,180,https://clinicaltrials.gov/show/NCT04838847
4055,NCT04839315,ClinicalTrials.gov,2021-04-05,2021-02-15,True,Recruiting,Phase 1,Interventional,United States,COVID-19 Vaccination in Rheumatic Disease Patients,100,https://clinicaltrials.gov/show/NCT04839315
4056,NCT04840082,ClinicalTrials.gov,2021-04-06,2021-03-07,True,Not Recruiting,Not Applicable,Interventional,Denmark,Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs,109,https://clinicaltrials.gov/show/NCT04840082
4057,NCT04840459,ClinicalTrials.gov,2021-04-05,2020-11-20,True,Recruiting,Phase 2,Interventional,United States,Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting,1000,https://clinicaltrials.gov/show/NCT04840459
4058,NCT04840992,ClinicalTrials.gov,2021-04-08,2021-04-20,False,Not Recruiting,Phase 1/Phase 2,Interventional,China,Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation,840,https://clinicaltrials.gov/show/NCT04840992
4059,NCT04841681,ClinicalTrials.gov,2021-04-06,2020-06-07,True,Not Recruiting,Not Applicable,Interventional,Indonesia,Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta,42,https://clinicaltrials.gov/show/NCT04841681
4060,NCT04842708,ClinicalTrials.gov,2020-12-29,2020-12-24,True,Recruiting,Not Applicable,Interventional,Israel,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,50,https://clinicaltrials.gov/show/NCT04842708
4061,NCT04842734,ClinicalTrials.gov,2021-04-10,2021-03-27,True,Not Recruiting,Not Applicable,Interventional,Turkey,Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04842734
4062,ACTRN12621000420842,ANZCTR,2021-04-15,2021-01-06,True,Not Recruiting,Not Applicable,Interventional,Australia,The Pomerium Trial: Effect of a Specialised Nutritional Supplementation on Immune Function in Older Adults Living in Residential Aged Care Facilities,160,https://anzctr.org.au/ACTRN12621000420842.aspx
4063,ISRCTN17472338,ISRCTN,2021-04-07,2021-04-15,False,Recruiting,Not Applicable,Interventional,United Kingdom,"Advancing understanding of adolescent exposome exposure and methodology, intervention development, and translation for prevention strategies and policy",296,http://isrctn.com/ISRCTN17472338
4064,ISRCTN72605600,ISRCTN,2021-03-24,2021-03-02,True,Recruiting,Not Applicable,Interventional,United Kingdom,What messaging is effective in recruiting schools to take up tutoring? A randomised controlled trial of email messages to schools.,2000,http://isrctn.com/ISRCTN72605600
4065,ISRCTN51046126,ISRCTN,2021-03-11,2021-04-30,False,Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of providing additional oxygen in patients with resistant high blood pressure and obstructive sleep apnoea,20,http://isrctn.com/ISRCTN51046126
4066,ISRCTN57085639,ISRCTN,2020-09-24,2020-08-05,True,Recruiting,Phase 2,Interventional,United Kingdom,A platform to investigate the safety and effectiveness of several new medicines for the treatment of COVID-19 in hospitalised patients,1800,http://isrctn.com/ISRCTN57085639
4067,ChiCTR2100042356,ChiCTR,2021-01-20,2020-04-30,True,Not Recruiting,Not Applicable,Interventional,China,Self-help Cognitive Behavioral Therapy Application for COVID-19-related Mental Health Problems: a Longitudinal Trial,154,http://www.chictr.org.cn/showproj.aspx?proj=120364
4068,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Not Recruiting,Phase 2,Interventional,Ireland,"A randomized double-blind placebo-controlled, pilot trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.",36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15
4069,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),630,https://clinicaltrials.gov/show/NCT04322123
4070,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Not Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,24,https://clinicaltrials.gov/show/NCT04344080
4071,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),394,https://clinicaltrials.gov/show/NCT04347239
4072,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,Not Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),405,https://clinicaltrials.gov/show/NCT04358939
4073,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,Not Recruiting,Phase 2,Interventional,United States,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),45,https://clinicaltrials.gov/show/NCT04365153
4074,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,False,Not Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,400,https://clinicaltrials.gov/show/NCT04377711
4075,NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,120,https://clinicaltrials.gov/show/NCT04392141
4076,NCT04393311,ClinicalTrials.gov,2020-05-15,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,160,https://clinicaltrials.gov/show/NCT04393311
4077,NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,False,Not Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,2,https://clinicaltrials.gov/show/NCT04395807
4078,NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,False,Not Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),9453,https://clinicaltrials.gov/show/NCT04416308
4079,NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,False,Not Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,0,https://clinicaltrials.gov/show/NCT04433078
4080,NCT04459676,ClinicalTrials.gov,2020-07-03,2020-07-31,False,Not Recruiting,Phase 2,Interventional,Brazil,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04459676
4081,NCT04470258,ClinicalTrials.gov,2020-06-10,2020-06-25,False,Not Recruiting,Not Applicable,Interventional,Brazil,Elmo Respiratory Support Project - COVID-19,10,https://clinicaltrials.gov/show/NCT04470258
4082,NCT04476979,ClinicalTrials.gov,2020-07-16,2020-07-16,False,Recruiting,Phase 2,Interventional,French Guiana,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,660,https://clinicaltrials.gov/show/NCT04476979
4083,NCT04477655,ClinicalTrials.gov,2020-07-15,2020-05-03,True,Not Recruiting,Not Applicable,Interventional,Mexico,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,430,https://clinicaltrials.gov/show/NCT04477655
4084,NCT04486508,ClinicalTrials.gov,2020-07-22,2020-07-30,False,Not Recruiting,Phase 3,Interventional,Iran,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,600,https://clinicaltrials.gov/show/NCT04486508
4085,NCT04492254,ClinicalTrials.gov,2020-07-22,2020-09-15,False,Recruiting,Phase 3,Interventional,"Australia, South Africa, Belgium",Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,1370,https://clinicaltrials.gov/show/NCT04492254
4086,NCT04500626,ClinicalTrials.gov,2020-07-31,2021-04-15,False,Recruiting,Phase 2/Phase 3,Interventional,Canada,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,234,https://clinicaltrials.gov/show/NCT04500626
4087,NCT04501796,ClinicalTrials.gov,2020-07-27,2020-11-27,False,Recruiting,Phase 1,Interventional,United States,A Trial of NT-I7 in COVID-19 (SPESELPIS),30,https://clinicaltrials.gov/show/NCT04501796
4088,NCT04504032,ClinicalTrials.gov,2020-08-05,2020-09-02,False,Not Recruiting,Phase 2,Interventional,"United States, United Kingdom",A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),497,https://clinicaltrials.gov/show/NCT04504032
4089,NCT04509947,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Not Recruiting,Phase 1,Interventional,Japan,A Study of Ad26.COV2.S in Adults (COVID-19),250,https://clinicaltrials.gov/show/NCT04509947
4090,NCT04523181,ClinicalTrials.gov,2020-08-19,2020-10-08,False,Recruiting,Phase 2,Interventional,"Argentina, Peru, United States",Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,174,https://clinicaltrials.gov/show/NCT04523181
4091,NCT04524598,ClinicalTrials.gov,2020-08-20,2020-07-20,True,Recruiting,Not Applicable,Interventional,United States,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,355,https://clinicaltrials.gov/show/NCT04524598
4092,NCT04530448,ClinicalTrials.gov,2020-08-20,2020-10-05,False,Recruiting,Phase 4,Interventional,United States,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,40,https://clinicaltrials.gov/show/NCT04530448
4093,NCT04549922,ClinicalTrials.gov,2020-09-09,2020-10-22,False,Not Recruiting,Phase 2,Interventional,Brazil,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,111,https://clinicaltrials.gov/show/NCT04549922
4094,NCT04565665,ClinicalTrials.gov,2020-09-22,2020-07-29,True,Recruiting,Phase 1/Phase 2,Interventional,United States,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,70,https://clinicaltrials.gov/show/NCT04565665
4095,NCT04570384,ClinicalTrials.gov,2020-09-17,2020-10-15,False,Recruiting,Phase 2,Interventional,United States,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,60,https://clinicaltrials.gov/show/NCT04570384
4096,NCT04570501,ClinicalTrials.gov,2020-09-28,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,160,https://clinicaltrials.gov/show/NCT04570501
4097,NCT04584684,ClinicalTrials.gov,2020-10-09,2020-12-18,False,Recruiting,Phase 2,Interventional,United States,Mouth Rinses for Inactivation of COVID-19,480,https://clinicaltrials.gov/show/NCT04584684
4098,NCT04591015,ClinicalTrials.gov,2020-10-05,2021-02-01,False,Recruiting,Phase 3,Interventional,United States,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,172,https://clinicaltrials.gov/show/NCT04591015
4099,NCT04598581,ClinicalTrials.gov,2020-10-20,2020-11-02,False,Not Recruiting,Not Applicable,Interventional,Switzerland,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",22,https://clinicaltrials.gov/show/NCT04598581
4100,NCT04611425,ClinicalTrials.gov,2020-10-07,2020-11-30,False,Recruiting,Phase 2,Interventional,France,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",30,https://clinicaltrials.gov/show/NCT04611425
4101,NCT04622332,ClinicalTrials.gov,2020-11-03,2020-12-18,False,Recruiting,Phase 1,Interventional,United States,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04622332
4102,NCT04659304,ClinicalTrials.gov,2020-12-07,2021-06-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19,18,https://clinicaltrials.gov/show/NCT04659304
4103,NCT04667286,ClinicalTrials.gov,2020-12-11,2021-01-16,False,Recruiting,Not Applicable,Interventional,Italy,Awake Pronation for Covid-19 Treatment,100,https://clinicaltrials.gov/show/NCT04667286
4104,NCT04678830,ClinicalTrials.gov,2020-12-14,2021-03-01,False,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Long-Haulers Study,56,https://clinicaltrials.gov/show/NCT04678830
4105,NCT04685655,ClinicalTrials.gov,2020-12-23,2020-01-07,True,Recruiting,Not Applicable,Interventional,Germany,RescuE pLAsma eXchange in Severe COVID-19,228,https://clinicaltrials.gov/show/NCT04685655
4106,NCT04711863,ClinicalTrials.gov,2021-01-13,2021-01-16,False,Not Recruiting,Phase 2,Interventional,South Korea,Fluvoxamine for Adults With Mild to Moderate COVID-19,400,https://clinicaltrials.gov/show/NCT04711863
4107,NCT04737161,ClinicalTrials.gov,2021-02-01,2021-03-01,False,Not Recruiting,Phase 1,Interventional,United States,Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome,0,https://clinicaltrials.gov/show/NCT04737161
4108,NCT04743011,ClinicalTrials.gov,2021-02-03,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Enriched Heparin Anti COVID-19 Trial,50,https://clinicaltrials.gov/show/NCT04743011
4109,NCT04751474,ClinicalTrials.gov,2021-02-08,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,"The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction",93,https://clinicaltrials.gov/show/NCT04751474
4110,NCT04773665,ClinicalTrials.gov,2021-02-24,2021-03-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,"Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)",780,https://clinicaltrials.gov/show/NCT04773665
4111,NCT04800224,ClinicalTrials.gov,2021-03-12,2021-04-12,False,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2),200,https://clinicaltrials.gov/show/NCT04800224
4112,NCT04810728,ClinicalTrials.gov,2021-03-16,2020-06-20,True,Not Recruiting,Phase 3,Interventional,Indonesia,Efficacy of Psidii Guava's Extract For COVID-19,90,https://clinicaltrials.gov/show/NCT04810728
4113,NCT04830774,ClinicalTrials.gov,2021-04-01,2021-04-15,False,Not Recruiting,Not Applicable,Interventional,"Belgium, Italy, United States, Turkey, Switzerland",Natural History of COVID-19-Related Atrial Fibrillation,200,https://clinicaltrials.gov/show/NCT04830774
4114,NCT04834908,ClinicalTrials.gov,2021-03-23,2021-05-01,False,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,160,https://clinicaltrials.gov/show/NCT04834908
4115,NCT04838795,ClinicalTrials.gov,2021-02-17,2021-02-18,False,Recruiting,Phase 3,Interventional,South Africa,Sisonke (Together): OPEN LABEL TRIAL COVID-19,500000,https://clinicaltrials.gov/show/NCT04838795
4116,NCT04839146,ClinicalTrials.gov,2021-03-11,2021-03-11,False,Recruiting,Phase 1,Interventional,Netherlands,Safety and Tolerability of COVID-19 Vaccine (ABNCoV2),42,https://clinicaltrials.gov/show/NCT04839146
4117,NCT04844268,ClinicalTrials.gov,2021-04-08,2021-05-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,"Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19",78,https://clinicaltrials.gov/show/NCT04844268
4118,NCT04844346,ClinicalTrials.gov,2021-04-13,2021-04-19,False,Recruiting,Not Applicable,Interventional,Netherlands,Plant Stanol Esters and COVID-19 Vaccination Response,100,https://clinicaltrials.gov/show/NCT04844346
4119,NCT04844554,ClinicalTrials.gov,2021-03-29,2021-04-19,False,Not Recruiting,Not Applicable,Interventional,Brazil,Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS,60,https://clinicaltrials.gov/show/NCT04844554
4120,NCT04844567,ClinicalTrials.gov,2021-03-18,2020-11-26,True,Recruiting,Not Applicable,Interventional,Switzerland,Virtual Reality Intervention to Alleviate Breathlessness (COVID-19),35,https://clinicaltrials.gov/show/NCT04844567
4121,NCT04844658,ClinicalTrials.gov,2021-04-12,2021-02-17,True,Recruiting,Not Applicable,Interventional,Belgium,"Covid-19, Hospitalized, PatIents, Nasafytol",50,https://clinicaltrials.gov/show/NCT04844658
4122,NCT04844710,ClinicalTrials.gov,2021-04-12,2020-09-01,True,Not Recruiting,Not Applicable,Interventional,Indonesia,The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms,22,https://clinicaltrials.gov/show/NCT04844710
4123,NCT04845880,ClinicalTrials.gov,2021-04-13,2020-10-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,SARS Cov_2 Incidence of Healthy Health Workers,182,https://clinicaltrials.gov/show/NCT04845880
4124,NCT04845971,ClinicalTrials.gov,2020-11-17,2020-11-05,True,Recruiting,Phase 2,Interventional,Italy,Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia,97,https://clinicaltrials.gov/show/NCT04845971
4125,NCT04846790,ClinicalTrials.gov,2021-04-14,2021-06-01,False,Recruiting,Not Applicable,Interventional,United States,The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers,90,https://clinicaltrials.gov/show/NCT04846790
4126,NCT04847349,ClinicalTrials.gov,2021-04-13,2021-04-13,False,Recruiting,Not Applicable,Interventional,United States,Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial,45,https://clinicaltrials.gov/show/NCT04847349
4127,NCT04847362,ClinicalTrials.gov,2021-04-12,2021-04-11,True,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic,74,https://clinicaltrials.gov/show/NCT04847362
4128,NCT04847375,ClinicalTrials.gov,2021-04-10,2021-04-20,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients,60,https://clinicaltrials.gov/show/NCT04847375
4129,NCT04847518,ClinicalTrials.gov,2021-04-13,2021-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Georgia,Assessment of Efficacy of KAN-JANGÂ® in Mild COVID-19,140,https://clinicaltrials.gov/show/NCT04847518
4130,NCT04847544,ClinicalTrials.gov,2021-04-13,2021-03-31,True,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.",30,https://clinicaltrials.gov/show/NCT04847544
4131,NCT04847661,ClinicalTrials.gov,2021-04-14,2021-03-28,True,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial",1500,https://clinicaltrials.gov/show/NCT04847661
4132,NCT04847791,ClinicalTrials.gov,2021-04-12,2021-01-14,True,Recruiting,Not Applicable,Interventional,Italy,Lactoferrin in Covid-19 Hospitalized Patients,194,https://clinicaltrials.gov/show/NCT04847791
4133,NCT04849598,ClinicalTrials.gov,2021-04-13,2021-04-13,False,Recruiting,Not Applicable,Interventional,Germany,Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection,15,https://clinicaltrials.gov/show/NCT04849598
4134,NCT04849637,ClinicalTrials.gov,2021-03-19,2020-10-22,True,Recruiting,Phase 2,Interventional,Philippines,Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients,74,https://clinicaltrials.gov/show/NCT04849637
4135,NCT04849793,ClinicalTrials.gov,2021-04-08,2021-04-13,False,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Anxiety Level,52,https://clinicaltrials.gov/show/NCT04849793
4136,NCT04852055,ClinicalTrials.gov,2021-04-16,2021-04-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a COVID-specific Advance Care Planning Intervention,3000,https://clinicaltrials.gov/show/NCT04852055
4137,NCT04853901,ClinicalTrials.gov,2021-03-01,2020-07-27,True,Not Recruiting,Phase 3,Interventional,Egypt,Remdesivir Efficacy In Management Of COVID-19 Patients,77,https://clinicaltrials.gov/show/NCT04853901
4138,NCT04853966,ClinicalTrials.gov,2021-04-18,2021-04-17,True,Recruiting,Not Applicable,Interventional,Turkey,The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients,30,https://clinicaltrials.gov/show/NCT04853966
4139,ACTRN12621000468820,ANZCTR,2021-04-20,2021-05-31,False,Not Recruiting,Phase 1,Interventional,Australia,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of of PRTX007 in  Healthy Adults",88,https://anzctr.org.au/ACTRN12621000468820.aspx
4140,ISRCTN18304314,ISRCTN,2021-04-13,2020-03-06,True,Not Recruiting,Not Applicable,Interventional,Suriname,Effect of convalescent plasma therapy on intensive care unit (ICU) deaths from COVID-19 in Suriname,180,http://isrctn.com/ISRCTN18304314
4141,ISRCTN13035264,ISRCTN,2020-07-24,2020-03-31,True,Not Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom",Adaptive COVID-19 treatment trial in the EU & UK,400,http://isrctn.com/ISRCTN13035264
4142,ISRCTN11384058,ISRCTN,2020-05-26,2020-01-04,True,Not Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",300,http://isrctn.com/ISRCTN11384058
4143,EUCTR2020-005128-12-LT,EU Clinical Trials Register,2020-11-04,2021-01-02,False,Authorised,Phase 3,Interventional,Lithuania,"An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia
",96,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005128-12
4144,EUCTR2020-005214-18-LT,EU Clinical Trials Register,2020-11-04,2021-01-02,False,Authorised,Phase 3,Interventional,Lithuania,"An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia
",75,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005214-18
4145,EUCTR2021-000566-14-CZ,EU Clinical Trials Register,2021-02-17,2021-03-17,False,Authorised,Phase 4,Interventional,Czech Republic,Post-authorization Phase IV effectiveness and safety multicentric study of COVID-19 vaccines â€“ CoVigi,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000566-14
4146,EUCTR2020-006130-12-IT,EU Clinical Trials Register,2021-02-25,2021-03-25,False,Authorised,Phase 3,Interventional,Italy,Acetylsalicylic acid in the prevention of severe COVID-19 pneumonia in hospitalised patients,204,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006130-12
4147,EUCTR2021-000365-33-NL,EU Clinical Trials Register,2021-03-02,2021-03-17,False,Authorised,Phase 2,Interventional,Netherlands,"Viral clearance, PK and tolerability of ensovibep in COVID-19 patients",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000365-33
4148,EUCTR2020-005759-18-BE,EU Clinical Trials Register,2021-03-11,2021-01-04,True,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18
4149,EUCTR2020-006075-15-NL,EU Clinical Trials Register,2021-03-19,2021-03-25,False,Authorised,Phase 3,Interventional,Netherlands,"An infusion of antibodies to COVID-19 for patients with B cell disorder, a randomized (randomized) study (COVID Compromise study).",86,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006075-15
4150,EUCTR2021-000701-24-NL,EU Clinical Trials Register,2021-03-22,2021-03-31,False,Authorised,Phase 4,Interventional,Netherlands,Switching of COVID-19 Vaccines: a solution for the problems?,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000701-24
4151,EUCTR2021-001655-13-NL,EU Clinical Trials Register,2021-03-24,2021-01-04,True,Authorised,Phase 4,Interventional,Netherlands,SARS-CoV2 vaccination and activation of the clotting system,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001655-13
4152,EUCTR2021-001414-10-NL,EU Clinical Trials Register,2021-03-24,2021-03-30,False,Authorised,Phase 4,Interventional,Netherlands,Response to corona vaccination in patients with primary SjÃ¶gren's syndrome,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001414-10
4153,EUCTR2021-001080-24-NL,EU Clinical Trials Register,2021-03-18,2021-08-04,False,Authorised,Phase 4,Interventional,Netherlands,Plant stanol esters and COVID-19 vaccination response,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001080-24
4154,EUCTR2021-000440-22-BE,EU Clinical Trials Register,2021-02-25,2021-03-25,False,Authorised,Phase 4,Interventional,Belgium,Vaccination against COVID-19 in Pregnant and Lactating Women in Belgium,420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000440-22
4155,EUCTR2021-001665-20-HU,EU Clinical Trials Register,2021-03-26,2021-04-20,False,Authorised,Phase 2,Interventional,Hungary,Efficacy of nebulized 4.2% sodium-bicarbonate in COVID-19 pneumonia,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001665-20
4156,EUCTR2021-000455-39-SE,EU Clinical Trials Register,2021-02-15,2021-09-04,False,Authorised,Phase 2,Interventional,Sweden,"A double-blind, placebo-controlled, interventional parallel group study to evaluate the antiviral effect of a single nasal application of LTX-109 3% gel, in comparison to placebo gel, in subjects with COVID-19 infection",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000455-39
4157,EUCTR2020-004272-17-BE,EU Clinical Trials Register,2020-11-18,2021-03-25,False,Authorised,Phase 2/Phase 3,Interventional,"Dominican Republic, South Africa, Nepal, Belgium, Colombia, Brazil, Guatemala, Poland, Panama, Germany, Philippines",A controlled Phase 2/3 study of adjuvanted recombinant SARS-CoV-2 trimeric S-protein vaccine (SCB-2019) for the prevention of COVID-19,22000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004272-17
4158,EUCTR2020-002584-63-DE,EU Clinical Trials Register,2020-08-12,2020-02-09,True,Authorised,Phase 2,Interventional,"Argentina, United Kingdom, Netherlands, Canada, United States, Brazil, Spain, Germany","A Study to Evaluate Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive, Adults Aged 65 Years and Healthy Adolescents Aged 12 to 17 Years",1285,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002584-63
4159,EUCTR2021-000175-37-SE,EU Clinical Trials Register,2021-01-22,2021-09-02,False,Authorised,Phase 4,Interventional,Sweden,"Immunologiskt svar efter vaccinering med mRNA vaccin mot covid-19, Comirnaty, hos immunsupprimerade och immunkompetenta personer. En Ã¶ppen icke randomiserad multicenterstudie i fas IV.",540,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000175-37
4160,EUCTR2021-000872-13-NL,EU Clinical Trials Register,2021-02-27,2021-02-03,True,Authorised,Phase 4,Interventional,Netherlands,Vaccination against cOvid In CancEr,873,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000872-13
4161,EUCTR2020-002282-33-DE,EU Clinical Trials Register,2020-05-29,2020-01-10,True,Authorised,Phase 2,Interventional,Germany,"Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)
",400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002282-33
4162,EUCTR2020-004070-22-BE,EU Clinical Trials Register,2021-03-12,2021-12-04,False,Authorised,Phase 3,Interventional,Belgium,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARSCoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities",1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004070-22
4163,EUCTR2020-001493-29-DE,EU Clinical Trials Register,2020-04-14,2020-11-05,False,Authorised,Phase 2,Interventional,Germany,CharitÃ© trial of Cenicriviroc (CVC) treatment for COVID-19 patients,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001493-29
4164,EUCTR2020-002869-34-BE,EU Clinical Trials Register,2020-08-29,2020-11-08,False,Authorised,Phase 2,Interventional,"Argentina, Moldova, Republic of, South Africa, Belgium, Ukraine, United States, Brazil, Egypt, Spain, Philippines, Romania","Safety and effectiveness of AT-527 compared to placebo, in moderate Covid-19 disease",190,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002869-34
4165,EUCTR2020-001857-31-BG,EU Clinical Trials Register,2020-11-13,2021-04-03,False,Authorised,Phase 2,Interventional,"Germany, Bulgaria, Israel",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31
4166,EUCTR2020-006003-42-DK,EU Clinical Trials Register,2020-12-21,2020-12-30,False,Authorised,Phase 4,Interventional,Denmark,Same as above,10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006003-42
4167,EUCTR2020-003998-22-DE,EU Clinical Trials Register,2020-11-19,2020-11-12,True,Authorised,Phase 2/Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Belgium, Netherlands, Colombia, Mexico, Spain, Panama, Germany",Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older,36500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003998-22
4168,EUCTR2020-003779-17-DE,EU Clinical Trials Register,2020-11-13,2020-12-15,False,Authorised,Phase 2/Phase 3,Interventional,Germany,A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory problems,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003779-17
4169,IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,True,Not Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,200,http://en.irct.ir/trial/46867
4170,IRCT20200610047722N1,IRCT,2020-07-07,2020-06-21,True,Not Recruiting,Not Applicable,Interventional,Iran,?Effect of Allicin derivatives capsule in treatment of patients with new Coronavirus,25,http://en.irct.ir/trial/48869
4171,IRCT20150725023332N4,IRCT,2021-03-08,2020-04-20,True,Not Recruiting,Phase 3,Interventional,Iran,The effect of morphine and fentanyl use in patients with corona,60,http://en.irct.ir/trial/49124
4172,IRCT20150725023332N5,IRCT,2021-04-06,2020-06-21,True,Not Recruiting,Phase 3,Interventional,Iran,TheÂ effectÂ ofÂ hesperidinÂ useÂ onÂ theÂ clinicalÂ conditionÂ ofÂ patientsÂ withÂ theÂ newÂ coronavirus,60,http://en.irct.ir/trial/49150
4173,IRCT20200629047953N1,IRCT,2021-03-17,2021-04-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of olfactory training on anosmia of COVID-19,40,http://en.irct.ir/trial/49449
4174,IRCT20200707048047N1,IRCT,2021-03-27,2020-07-22,True,Recruiting,Phase 2,Interventional,Iran,colchicine effect on persistent dyspnea  in COVID19,40,http://en.irct.ir/trial/49766
4175,IRCT20200509047373N2,IRCT,2021-04-13,2021-04-08,True,Recruiting,Phase 3,Interventional,Iran,Effect of  herbal medicine containing Zataria multiflora and Glycyrrhiza glabra on clinical and paraclinical symptoms in COVID-19,120,http://en.irct.ir/trial/50551
4176,IRCT20150815023620N9,IRCT,2021-03-13,2020-04-01,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of herbal food product in patients with COVID 19,150,http://en.irct.ir/trial/52045
4177,IRCT20130812014333N164,IRCT,2021-04-01,2020-12-05,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effects of the exosomes on patients with COVID-19,8,http://en.irct.ir/trial/52416
4178,IRCT20200927048849N3,IRCT,2021-03-17,2021-03-20,False,Recruiting,Phase 3,Interventional,Iran,Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patients,600,http://en.irct.ir/trial/52429
4179,IRCT20200823048495N1,IRCT,2020-12-12,2020-01-17,True,Not Recruiting,Phase 1,Interventional,Pakistan,COVID-19 Cure Using Integrative Treatment,39,http://en.irct.ir/trial/52742
4180,IRCT20110423006257N3,IRCT,2021-04-03,2021-04-09,False,Recruiting,Phase 3,Interventional,Iran,Thalidomide effects in COVID-19,66,http://en.irct.ir/trial/53279
4181,IRCT20201111049348N2,IRCT,2021-02-25,2021-02-28,False,Not Recruiting,Phase 3,Interventional,Iran,The Effect of Turmeric Extract on the Treatment of Patients with Covid-19,120,http://en.irct.ir/trial/53645
4182,IRCT20160516027929N8,IRCT,2021-03-02,2020-06-21,True,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of high flow oxygen delivery through the nasal cannula in comparison with non-invasive ventilation in patients with COVID-19,60,http://en.irct.ir/trial/53646
4183,IRCT20150902023864N2,IRCT,2021-02-08,2021-01-20,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Lemon Balm/ Star anice in treatment of COVID-19 patients as well as their prophylactic effects in close contacts with COVID-19 patients,120,http://en.irct.ir/trial/53653
4184,IRCT20210102049912N1,IRCT,2021-04-07,2021-04-09,False,Recruiting,Phase 3,Interventional,Iran,The effect of vitamin A supplementation in outpatients with COVID-19,140,http://en.irct.ir/trial/53693
4185,IRCT20201212049681N1,IRCT,2021-02-28,2021-01-20,True,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of gargling with Hydrogen Peroxide 1% and Povidine Iodine 0.25% on viral load of SARS-CoV-2 in covid19 patients,60,http://en.irct.ir/trial/53702
4186,IRCT20150711023153N2,IRCT,2021-02-28,2021-02-28,False,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the Effects of natural Pomegranate juice (Punica granatum)   in patients with covid-19,48,http://en.irct.ir/trial/53860
4187,IRCT20210123050116N1,IRCT,2021-03-04,2021-04-21,False,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of acceptance and commitment counseling on body image and breastfeeding self-efficacy,90,http://en.irct.ir/trial/53872
4188,IRCT20111224008507N4,IRCT,2021-01-31,2021-02-19,False,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in treatment of outpatients with COVID-19,1000,http://en.irct.ir/trial/53949
4189,IRCT20140810018754N12,IRCT,2021-03-15,2021-02-08,True,Recruiting,Not Applicable,Interventional,Iran,Effect of pulmonary tele-rehabilitation and progressive muscle relaxation training in COVID-19 patients,52,http://en.irct.ir/trial/54036
4190,IRCT20210203050233N1,IRCT,2021-04-14,2021-02-19,True,Recruiting,Phase 3,Interventional,Iran,Assessment of effect of crocin on Covid-19 patients,60,http://en.irct.ir/trial/54085
4191,IRCT20210202050219N1,IRCT,2021-04-08,2021-03-05,True,Recruiting,Not Applicable,Interventional,Iran,Investigating the effect of education on stress and anxiety of COVID-19 patients' caregivers,25,http://en.irct.ir/trial/54110
4192,IRCT20210204050238N1,IRCT,2021-03-02,2021-03-21,False,Recruiting,Not Applicable,Interventional,Iran,The effect of zinc supplementation on COVID-19,44,http://en.irct.ir/trial/54136
4193,IRCT20111224008507N5,IRCT,2021-02-22,2021-02-19,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in treatment of patients admitted with COVID-19,1000,http://en.irct.ir/trial/54402
4194,IRCT20210218050404N1,IRCT,2021-03-10,2021-06-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Control of inflammatory process in patients with coronavirus affected by polyflavonoid extract of Mangifera indica leaf,60,http://en.irct.ir/trial/54447
4195,IRCT20180728040617N3,IRCT,2021-03-14,2021-03-10,True,Recruiting,Not Applicable,Interventional,Iran,Effect of Stress Management Program on Psychological Distress of Cancer Patients and Caring Burden and Quality of Life of Their Caregivers during the COVID-19 Epidemic,60,http://en.irct.ir/trial/54613
4196,IRCT20200405046958N2,IRCT,2021-04-14,2021-03-10,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of plasmapheresis in the treatment of Covid 19,42,http://en.irct.ir/trial/54653
4197,IRCT20160808029264N10,IRCT,2021-04-13,2021-04-03,True,Recruiting,Not Applicable,Interventional,Iran,The effects of laser therapy in patients with COVID-19,30,http://en.irct.ir/trial/54655
4198,IRCT20210223050466N1,IRCT,2021-03-27,2021-03-21,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison between dexamethasone and methylprednisolone in treatment of COVID-19,140,http://en.irct.ir/trial/54662
4199,IRCT20201124049480N1,IRCT,2021-03-28,2021-04-21,False,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Levamisol in Treating COVID-19,250,http://en.irct.ir/trial/54675
4200,IRCT20210301050536N1,IRCT,2021-03-15,2021-03-16,False,Recruiting,Not Applicable,Interventional,Iran,The effect of using short message information system on the level of anxiety and awareness of patient companions during surgery and wound care after surgery,110,http://en.irct.ir/trial/54698
4201,IRCT20210213050344N1,IRCT,2021-04-06,2021-04-10,False,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 Patients,375,http://en.irct.ir/trial/54710
4202,IRCT20180226038870N1,IRCT,2021-03-05,2021-05-10,False,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of pulmonary rehabilitation and exercise therapy in reducing the length of hospital stay of patients with Covid-19,100,http://en.irct.ir/trial/54725
4203,IRCT20201202049568N3,IRCT,2021-03-05,2021-03-05,False,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosome therapy in ARDS patients,72,http://en.irct.ir/trial/54758
4204,IRCT20200329046892N2,IRCT,2021-03-09,2021-03-15,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of tofacitinib in COVID-19,60,http://en.irct.ir/trial/54800
4205,IRCT20200413047063N2,IRCT,2021-04-14,2021-03-21,True,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosomes Derived from placental Mesenchymal Stem Cells as Treatment for Severe COVID-19: Phase 1 & 2 Clinical Trials,50,http://en.irct.ir/trial/54828
4206,IRCT20201202049567N3,IRCT,2021-03-13,2021-03-14,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluate the safety and efficacy of COVID-19 inactivated vaccine,20000,http://en.irct.ir/trial/54881
4207,IRCT20200527047581N2,IRCT,2021-03-17,2021-04-09,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Chlorhexidine 0/12% and 0/2 % Povidone-iodine mouth rinse on clinical characteristics of patients with COVID-19,180,http://en.irct.ir/trial/54884
4208,IRCT20201202049567N2,IRCT,2021-03-13,2021-03-13,False,Recruiting,Phase 1,Interventional,Iran,Phase 1 clinical trial of an inactivated COVID-19 vaccine (Shifa-Pharmed) in healthy individuals aged 51-75 years,32,http://en.irct.ir/trial/54885
4209,IRCT20210302050555N1,IRCT,2021-03-28,2021-04-21,False,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of mobile-learning on stress and self-efficacy among diabetes patients with covid-19,70,http://en.irct.ir/trial/54915
4210,IRCT20180721040538N1,IRCT,2021-03-25,2021-04-03,False,Recruiting,Not Applicable,Interventional,Iran,The effect of combined and online protocol  ergonomic advice-exercise in comparison with ergonomic advice protocol on forward head deformity of students during Covid-19 pandemic,180,http://en.irct.ir/trial/54933
4211,IRCT20180619040147N6,IRCT,2021-04-01,2021-04-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,menstrual blood stem cell therapy for covid-19,30,http://en.irct.ir/trial/54971
4212,IRCT20210311050671N1,IRCT,2021-04-13,2021-04-04,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of laser acupuncture on improving the sense of smell in patients with COVID-19,90,http://en.irct.ir/trial/54973
4213,IRCT20171219037964N4,IRCT,2021-03-20,2021-04-09,False,Recruiting,Not Applicable,Interventional,Iran,study the effect of cognitive therapy on insomnia and heart rate variability of health care workers,70,http://en.irct.ir/trial/55028
4214,IRCT20180302038915N1,IRCT,2021-04-05,2021-04-14,False,Recruiting,Phase 3,Interventional,Iran,Safety and efficacy of sofosbuvir in the moderate COVID19,50,http://en.irct.ir/trial/55052
4215,IRCT20151226025699N5,IRCT,2021-04-07,2021-04-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"The effect of vitamin A, B, C, D, and E supplementations in COVID-19",135,http://en.irct.ir/trial/55074
4216,IRCT20131129015584N4,IRCT,2021-04-04,2021-04-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of Padzahr tablets on the symptoms of COVID-19,68,http://en.irct.ir/trial/55081
4217,IRCT20190303042889N1,IRCT,2021-03-30,2021-05-05,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of complementary therapy with Portulaca oleracea capsule on the clinical symptoms of outpatients with COVID-19,70,http://en.irct.ir/trial/55153
4218,IRCT20210324050760N1,IRCT,2021-04-17,2021-04-21,False,Not Recruiting,Phase 4,Interventional,Iran,Effect of Remdesivir in treatment of COVID-19,100,http://en.irct.ir/trial/55187
4219,IRCT20200329046892N3,IRCT,2021-03-29,2021-04-09,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of ivermectin in COVID-19,60,http://en.irct.ir/trial/55216
4220,IRCT20201214049709N2,IRCT,2021-04-13,2021-04-21,False,Not Recruiting,Phase 2,Interventional,Iran,"Phase II, Safety and Immunogenicity of recombinant vaccine for COVID-19",500,http://en.irct.ir/trial/55238
4221,IRCT20111210008348N51,IRCT,2021-04-10,2021-04-21,False,Not Recruiting,Not Applicable,Interventional,Iran,The effect of Jacobsen relaxation application on anxiety and job stress of nurses,70,http://en.irct.ir/trial/55240
4222,IRCT20210325050769N1,IRCT,2021-04-12,2021-04-19,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of herbal therapeutic supplements (Marsh - Mallow, Sweet violet, Malva sylvestris, Damask rose, Liquorice root) against corona disease",200,http://en.irct.ir/trial/55493
4223,ChiCTR2100042401,ChiCTR,2021-01-21,2021-01-13,True,Recruiting,Not Applicable,Interventional,China,The effectiveness of guided narrative technique on improving COVID-19 related positive and negative emotions and cognition: a randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=120319
4224,ChiCTR2100042374,ChiCTR,2021-01-21,2021-01-28,False,Recruiting,Phase 2,Interventional,China,Phase IIb clinical trial of recombinant novel coronavirus pneumonia (COVID-19) vaccine (Sf9 cells),4800,http://www.chictr.org.cn/showproj.aspx?proj=120494
4225,CTRI/2021/02/031430,CTRI,2021-02-22,2021-02-24,False,Not Recruiting,Not Applicable,Interventional,India,Remdesevir and Hydroxychloroquine in moderate to severe Covid 19 patient.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47292
4226,CTRI/2021/02/031479,CTRI,2021-02-23,2021-02-26,False,Not Recruiting,Not Applicable,Interventional,India,Effects of online Mindfulness program on Stress,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48898
4227,CTRI/2021/02/031484,CTRI,2021-02-23,2021-02-28,False,Not Recruiting,Not Applicable,Interventional,India,"Effectiveness of Holistic Traditional Complementary Alternative Medicine (HTCAM) on immuno, metabolic, clinical and psychosocial outcomes in suspected isolated cases of SARS CoV-2 : a Pilot Randomized Control Trial",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52585
4228,CTRI/2021/02/031520,CTRI,2021-02-24,2021-02-25,False,Recruiting,Phase 2,Interventional,India,A clinical study  to see the effect of ArtemiC in patients with COVID-19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52515
4229,CTRI/2021/02/031570,CTRI,2021-02-25,2021-02-28,False,Not Recruiting,Not Applicable,Interventional,India,Mindfulness for children,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53018
4230,CTRI/2021/02/031566,CTRI,2021-02-25,2021-03-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of Equine antibody treatment in patient with COVID 19 infection,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51849
4231,CTRI/2021/02/031547,CTRI,2021-02-25,2021-02-25,False,Recruiting,Phase 2,Interventional,India,A clinical trial to induce immunity and herd immunity against viruses including covid 19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43929
4232,CTRI/2021/02/031543,CTRI,2021-02-25,2021-11-03,False,Not Recruiting,Not Applicable,Interventional,India,COVID-19 Pandemic- Impact of online yoga on mental health and quality of life in adolescents,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52892
4233,CTRI/2021/02/031554,CTRI,2021-02-25,2021-02-26,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,The study to check the safety and immune response of (Covid-19 vaccine) COVOVAX in adults,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49327
4234,CTRI/2021/03/031665,CTRI,2021-03-02,2021-03-15,False,Not Recruiting,Phase 4,Interventional,India,Ivermectin prophylaxis for  Covid-19 Infection in Health care Personnel,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53325
4235,CTRI/2021/03/031664,CTRI,2021-03-02,2021-08-03,False,Not Recruiting,Not Applicable,Interventional,India,"Open Label Study to Evaluate the Safety and Efficacy of SwasVimochan, SwasanRakshak, Swasamrit, Immune Energy Tablets with Mild to Moderate COVID-19 Patients",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52574
4236,CTRI/2021/03/031667,CTRI,2021-03-02,2021-03-25,False,Not Recruiting,Phase 3,Interventional,India,Effect of Chatushashti Prahari Pippali in the management of Post COVID syndrome,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53117
4237,CTRI/2021/03/031684,CTRI,2021-03-03,2021-10-03,False,Not Recruiting,Phase 3,Interventional,India,clinical study of Vardhamana Pippli Rasayana and WHO rehabilitation guidelines in the management of post Covid syndrome,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52741
4238,CTRI/2021/03/031686,CTRI,2021-03-03,2021-10-03,False,Not Recruiting,Phase 3,Interventional,India,Clinical Trial on Post Covid 19 through Ayurvedic intervention Agastya Haritaki amd Ashwagandha along with Yoga,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53215
4239,CTRI/2021/03/031721,CTRI,2021-03-04,2021-03-16,False,Not Recruiting,Not Applicable,Interventional,India,Spironolactone on  COVID-19 patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53532
4240,CTRI/2021/03/031720,CTRI,2021-03-04,2021-03-15,False,Not Recruiting,Not Applicable,Interventional,India,The study to explore the effect of  Bacillus calusii and Bacillus Coagulans (the Probiotics) on Covid-19 disease progression in addition to routine Covid-19 treatment.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53161
4241,CTRI/2021/03/031790,CTRI,2021-03-08,2021-03-15,False,Not Recruiting,Phase 2,Interventional,India,Ketoji a nutritional therapy  in management of symptoms of Covid-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53090
4242,CTRI/2021/03/031815,CTRI,2021-03-09,2021-03-15,False,Not Recruiting,Phase 3,Interventional,India,An Anti-Viral Ayurvedic formulation for the treatment of COVID-19 Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52987
4243,CTRI/2021/03/031939,CTRI,2021-03-12,2021-03-15,False,Not Recruiting,Not Applicable,Interventional,India,Immediate effect of  positioning on oxygen level in patients with COVID 19.,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49214
4244,CTRI/2021/03/031940,CTRI,2021-03-12,2021-03-16,False,Not Recruiting,Not Applicable,Interventional,India,Clinical trial for TADIOS as supplemental therapy in mild to moderate COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53172
4245,CTRI/2021/03/031969,CTRI,2021-03-15,2021-03-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Reducing systemic inflammation in cancer patients with COVID-19 using Topotecan with Dexamethasone and Remdesivir,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52816
4246,CTRI/2021/03/032051,CTRI,2021-03-16,2021-03-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Trial to evaluate 3mg dose of Covid Vaccine of Cadila healthcare Limited,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53226
4247,CTRI/2021/03/032072,CTRI,2021-03-17,2021-03-19,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,A study to assess Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53003
4248,CTRI/2021/03/032059,CTRI,2021-03-17,2021-03-22,False,Not Recruiting,Not Applicable,Interventional,India,Investigator initiated study to evaluate the effect of Marketed Colchicine 0.5mg given along marketed Asprin 75mg with SOC and Marketed aspirin 75mg with SOC on COVID 19 patients,62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53115
4249,CTRI/2021/03/032060,CTRI,2021-03-17,2021-03-22,False,Not Recruiting,Not Applicable,Interventional,India,"
                Investigator initiated study to evaluate the effect of Marketed Colchicine 0.5mg given along
                marketed Asprin 75mg with SOC and Marketed aspirin 75mg with SOC on COVID 19 patients
",62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53231
4250,CTRI/2021/03/032135,CTRI,2021-03-18,2021-03-25,False,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of spirometry and neurophysiological facilitation technique to reduce the level of dyspnea in post covid-19 patient-A randomized controlled trial,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51532
4251,CTRI/2021/03/032158,CTRI,2021-03-19,2021-03-24,False,Recruiting,Not Applicable,Interventional,India,Effects of Covieshield vaccine on Liver cirrhosis patients,2200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54015
4252,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Not Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,222,https://clinicaltrials.gov/show/NCT04325906
4253,NCT04338126,ClinicalTrials.gov,2020-04-06,2021-09-30,False,Not Recruiting,Phase 2,Interventional,United States,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,0,https://clinicaltrials.gov/show/NCT04338126
4254,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-07-12,False,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,149,https://clinicaltrials.gov/show/NCT04346628
4255,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,False,Not Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,17,https://clinicaltrials.gov/show/NCT04348500
4256,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),100,https://clinicaltrials.gov/show/NCT04355364
4257,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,20,https://clinicaltrials.gov/show/NCT04358068
4258,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,1000,https://clinicaltrials.gov/show/NCT04362176
4259,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,False,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,102,https://clinicaltrials.gov/show/NCT04363606
4260,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-10-07,False,Not Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,0,https://clinicaltrials.gov/show/NCT04377568
4261,NCT04380701,ClinicalTrials.gov,2020-05-06,2020-04-23,True,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,476,https://clinicaltrials.gov/show/NCT04380701
4262,NCT04381923,ClinicalTrials.gov,2020-05-07,2021-06-15,False,Not Recruiting,Not Applicable,Interventional,United States,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04381923
4263,NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,True,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,4,https://clinicaltrials.gov/show/NCT04381988
4264,NCT04395599,ClinicalTrials.gov,2020-05-19,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,40,https://clinicaltrials.gov/show/NCT04395599
4265,NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,15,https://clinicaltrials.gov/show/NCT04400032
4266,NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,False,Not Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,200,https://clinicaltrials.gov/show/NCT04404361
4267,NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,False,Not Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,180,https://clinicaltrials.gov/show/NCT04412356
4268,NCT04428008,ClinicalTrials.gov,2020-06-07,2021-01-12,False,Recruiting,Phase 2,Interventional,United States,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,240,https://clinicaltrials.gov/show/NCT04428008
4269,NCT04451291,ClinicalTrials.gov,2020-06-26,2020-09-25,False,Recruiting,Not Applicable,Interventional,Canada,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04451291
4270,NCT04455958,ClinicalTrials.gov,2020-07-01,2021-05-01,False,Not Recruiting,Phase 2,Interventional,United States,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,0,https://clinicaltrials.gov/show/NCT04455958
4271,NCT04463602,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Not Recruiting,Phase 2,Interventional,Mexico,Desidustat in the Management of COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04463602
4272,NCT04465513,ClinicalTrials.gov,2020-07-08,2020-08-31,False,Recruiting,Not Applicable,Interventional,Canada,Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04465513
4273,NCT04486144,ClinicalTrials.gov,2020-07-20,2020-05-20,True,Not Recruiting,Not Applicable,Interventional,United States,Impact Nerium Oleander on Immune Function,82,https://clinicaltrials.gov/show/NCT04486144
4274,NCT04495933,ClinicalTrials.gov,2020-07-13,2020-07-13,False,Recruiting,Phase 1,Interventional,Australia,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",216,https://clinicaltrials.gov/show/NCT04495933
4275,NCT04527471,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Not Recruiting,Phase 2,Interventional,United States,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,45,https://clinicaltrials.gov/show/NCT04527471
4276,NCT04539873,ClinicalTrials.gov,2020-08-29,2021-04-30,False,Not Recruiting,Phase 3,Interventional,Colombia,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,128,https://clinicaltrials.gov/show/NCT04539873
4277,NCT04542031,ClinicalTrials.gov,2020-09-07,2020-12-14,False,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,7911,https://clinicaltrials.gov/show/NCT04542031
4278,NCT04550338,ClinicalTrials.gov,2020-09-13,2021-08-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,0,https://clinicaltrials.gov/show/NCT04550338
4279,NCT04570488,ClinicalTrials.gov,2020-09-25,2020-05-15,True,Recruiting,Not Applicable,Interventional,United States,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,1200,https://clinicaltrials.gov/show/NCT04570488
4280,NCT04578158,ClinicalTrials.gov,2020-10-06,2020-09-29,True,Not Recruiting,Phase 3,Interventional,Pakistan,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,152,https://clinicaltrials.gov/show/NCT04578158
4281,NCT04588792,ClinicalTrials.gov,2020-10-14,2021-04-16,False,Recruiting,Phase 2/Phase 3,Interventional,Canada,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,640,https://clinicaltrials.gov/show/NCT04588792
4282,NCT04591184,ClinicalTrials.gov,2020-09-23,2021-04-07,False,Recruiting,Phase 1,Interventional,Canada,A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,72,https://clinicaltrials.gov/show/NCT04591184
4283,NCT04608305,ClinicalTrials.gov,2020-10-26,2020-10-28,False,Recruiting,Phase 1/Phase 2,Interventional,Israel,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",1040,https://clinicaltrials.gov/show/NCT04608305
4284,NCT04623671,ClinicalTrials.gov,2020-10-07,2020-11-15,False,Recruiting,Phase 2,Interventional,United States,Intravenous Infusion of CAP-1002 in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04623671
4285,NCT04641195,ClinicalTrials.gov,2020-11-19,2021-04-22,False,Recruiting,Phase 3,Interventional,India,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,700,https://clinicaltrials.gov/show/NCT04641195
4286,NCT04649775,ClinicalTrials.gov,2020-10-14,2021-04-09,False,Recruiting,Not Applicable,Interventional,United States,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,50,https://clinicaltrials.gov/show/NCT04649775
4287,NCT04651387,ClinicalTrials.gov,2020-12-01,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,74,https://clinicaltrials.gov/show/NCT04651387
4288,NCT04659109,ClinicalTrials.gov,2020-11-30,2020-12-16,False,Recruiting,Phase 2,Interventional,France,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,60,https://clinicaltrials.gov/show/NCT04659109
4289,NCT04681092,ClinicalTrials.gov,2020-12-22,2021-04-12,False,Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Anti-COVID19 AKS-452 - ACT Study,130,https://clinicaltrials.gov/show/NCT04681092
4290,NCT04681859,ClinicalTrials.gov,2020-12-22,2021-04-17,False,Recruiting,Not Applicable,Interventional,Bangladesh,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04681859
4291,NCT04682197,ClinicalTrials.gov,2020-12-16,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Cereset Research In Healthcare Workers During COVID-19,100,https://clinicaltrials.gov/show/NCT04682197
4292,NCT04685213,ClinicalTrials.gov,2020-12-23,2020-08-18,True,Recruiting,Phase 1,Interventional,United States,Electrical Stimulation for Critically Ill Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04685213
4293,NCT04723446,ClinicalTrials.gov,2021-01-05,2021-04-20,False,Recruiting,Not Applicable,Interventional,United Kingdom,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,40,https://clinicaltrials.gov/show/NCT04723446
4294,NCT04748536,ClinicalTrials.gov,2021-02-01,2021-01-29,True,Not Recruiting,Phase 1,Interventional,United Kingdom,Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers,18,https://clinicaltrials.gov/show/NCT04748536
4295,NCT04748757,ClinicalTrials.gov,2021-02-02,2021-04-20,False,Recruiting,Phase 2,Interventional,Canada,Annexin A5 in Patients With Severe COVID-19 Disease,60,https://clinicaltrials.gov/show/NCT04748757
4296,NCT04751643,ClinicalTrials.gov,2021-02-05,2021-04-19,False,Recruiting,Not Applicable,Interventional,France,Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections,132,https://clinicaltrials.gov/show/NCT04751643
4297,NCT04756856,ClinicalTrials.gov,2021-02-15,2021-04-21,False,Recruiting,Not Applicable,Interventional,Italy,Muscle-targeted Nutritional Therapy for the Recovery From COVID-19,50,https://clinicaltrials.gov/show/NCT04756856
4298,NCT04761874,ClinicalTrials.gov,2021-02-15,2019-12-01,True,Not Recruiting,Not Applicable,Interventional,United States,Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic,296,https://clinicaltrials.gov/show/NCT04761874
4299,NCT04765371,ClinicalTrials.gov,2021-02-18,2021-03-03,False,Recruiting,Phase 3,Interventional,France,"Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19",220,https://clinicaltrials.gov/show/NCT04765371
4300,NCT04772859,ClinicalTrials.gov,2021-02-13,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,Mexico,Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic,54,https://clinicaltrials.gov/show/NCT04772859
4301,NCT04780321,ClinicalTrials.gov,2020-09-23,2020-10-30,False,Recruiting,Phase 1/Phase 2,Interventional,China,JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects,90,https://clinicaltrials.gov/show/NCT04780321
4302,NCT04783311,ClinicalTrials.gov,2021-03-03,2021-02-23,True,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults",280,https://clinicaltrials.gov/show/NCT04783311
4303,NCT04784481,ClinicalTrials.gov,2021-02-20,2020-09-20,True,Not Recruiting,Phase 1/Phase 2,Interventional,Argentina,Ivermectin Reproposing for Mild Stage COVID-19 Outpatients,254,https://clinicaltrials.gov/show/NCT04784481
4304,NCT04784767,ClinicalTrials.gov,2021-03-03,2021-04-05,False,Recruiting,Phase 1,Interventional,United States,SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults,72,https://clinicaltrials.gov/show/NCT04784767
4305,NCT04803409,ClinicalTrials.gov,2021-03-16,2021-03-22,False,Recruiting,Not Applicable,Interventional,United States,UNITE Study (UCSD-SW) for COVID-19,40,https://clinicaltrials.gov/show/NCT04803409
4306,NCT04809974,ClinicalTrials.gov,2021-03-19,2021-05-15,False,Not Recruiting,Phase 4,Interventional,United States,Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID),100,https://clinicaltrials.gov/show/NCT04809974
4307,NCT04833101,ClinicalTrials.gov,2021-04-03,2021-04-07,False,Not Recruiting,Phase 4,Interventional,China,Study on Sequential Immunization of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine,120,https://clinicaltrials.gov/show/NCT04833101
4308,NCT04839042,ClinicalTrials.gov,2021-04-07,2021-06-01,False,Not Recruiting,Phase 1,Interventional,Australia,"A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers",40,https://clinicaltrials.gov/show/NCT04839042
4309,NCT04847583,ClinicalTrials.gov,2021-04-14,2021-04-30,False,Not Recruiting,Phase 2,Interventional,No Country Given,"A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients",66,https://clinicaltrials.gov/show/NCT04847583
4310,NCT04852705,ClinicalTrials.gov,2021-04-20,2021-05-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,"A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)",28000,https://clinicaltrials.gov/show/NCT04852705
4311,NCT04852770,ClinicalTrials.gov,2020-12-22,2021-04-23,False,Recruiting,Not Applicable,Interventional,Brazil,"Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics",135,https://clinicaltrials.gov/show/NCT04852770
4312,NCT04852978,ClinicalTrials.gov,2021-04-19,2021-04-20,False,Not Recruiting,Phase 2,Interventional,No Country Given,"COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers",180,https://clinicaltrials.gov/show/NCT04852978
4313,NCT04853069,ClinicalTrials.gov,2021-04-06,2021-05-17,False,Not Recruiting,Phase 2,Interventional,Qatar,Oestrogen Treatment for COVID-19 Symptoms,2000,https://clinicaltrials.gov/show/NCT04853069
4314,NCT04853134,ClinicalTrials.gov,2021-04-19,2020-11-01,True,Not Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for COVID-19 Female Outpatients,200,https://clinicaltrials.gov/show/NCT04853134
4315,NCT04853836,ClinicalTrials.gov,2021-04-16,2021-04-25,False,Not Recruiting,Phase 4,Interventional,Italy,Olfactory Disfunction and Co-ultraPEALut,400,https://clinicaltrials.gov/show/NCT04853836
4316,NCT04853927,ClinicalTrials.gov,2021-04-17,2021-02-08,True,Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit,600,https://clinicaltrials.gov/show/NCT04853927
4317,NCT04854759,ClinicalTrials.gov,2021-04-17,2021-03-15,True,Recruiting,Phase 3,Interventional,Poland,The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms,200,https://clinicaltrials.gov/show/NCT04854759
4318,NCT04854941,ClinicalTrials.gov,2021-04-07,2020-12-10,True,Not Recruiting,Not Applicable,Interventional,Russian Federation,Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection,200,https://clinicaltrials.gov/show/NCT04854941
4319,NCT04858412,ClinicalTrials.gov,2021-04-21,2021-04-01,True,Recruiting,Not Applicable,Interventional,United States,Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19,48,https://clinicaltrials.gov/show/NCT04858412
4320,NCT04858542,ClinicalTrials.gov,2021-03-22,2021-02-26,True,Recruiting,Not Applicable,Interventional,United States,Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19,10,https://clinicaltrials.gov/show/NCT04858542
4321,NCT04858581,ClinicalTrials.gov,2021-04-15,2021-04-01,True,Not Recruiting,Not Applicable,Interventional,France,Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.,100,https://clinicaltrials.gov/show/NCT04858581
4322,NCT04858620,ClinicalTrials.gov,2021-02-04,2020-08-30,True,Recruiting,Phase 3,Interventional,United States,A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection,200,https://clinicaltrials.gov/show/NCT04858620
4323,NCT04860219,ClinicalTrials.gov,2021-04-21,2020-07-08,True,Recruiting,Not Applicable,Interventional,Egypt,Lactoferrin Use in (SARS-CoV-2) Management,54,https://clinicaltrials.gov/show/NCT04860219
4324,NCT04860271,ClinicalTrials.gov,2021-04-23,2021-03-09,True,Recruiting,Not Applicable,Interventional,Indonesia,Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety,36,https://clinicaltrials.gov/show/NCT04860271
4325,NCT04860284,ClinicalTrials.gov,2021-04-23,2020-09-18,True,Not Recruiting,Phase 2,Interventional,Uganda,Hydroxychloroquine for Treatment of Non-Severe COVID-19,105,https://clinicaltrials.gov/show/NCT04860284
4326,NCT04860518,ClinicalTrials.gov,2021-04-22,2021-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS,140,https://clinicaltrials.gov/show/NCT04860518
4327,ISRCTN48563324,ISRCTN,2021-04-22,2021-01-06,True,Recruiting,Not Applicable,Interventional,United Kingdom,Bathing adaptations in the homes of older adults 2,360,http://isrctn.com/ISRCTN48563324
4328,ISRCTN15851697,ISRCTN,2021-04-21,2021-04-23,False,Recruiting,Not Applicable,Interventional,United Kingdom,Helping alleviate the longer-term consequences of COVID-19,1754,http://isrctn.com/ISRCTN15851697
4329,ISRCTN14396374,ISRCTN,2021-04-12,2021-04-15,False,Recruiting,Not Applicable,Interventional,Colombia,"A research study in Colombia, to build capacity in school mental health and to adapt an intervention called DIALOG+ for use in adolescents in post-conflict Colombia during the COVID-19 pandemic",222,http://isrctn.com/ISRCTN14396374
4330,ISRCTN14722499,ISRCTN,2020-11-04,2020-11-15,False,Recruiting,Phase 3,Interventional,"South Africa, United Kingdom, Colombia, Belgium, United States, Spain, France, Germany, Philippines",A study of the Ad26.COV2.S vaccine candidate for the prevention of SARS-CoV-2-mediated COVID-19 in adults,30000,http://isrctn.com/ISRCTN14722499
4331,ISRCTN14602359,ISRCTN,2020-08-12,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Germ Defence: a website to improve infection control during the COVID-19 pandemic,6822,http://isrctn.com/ISRCTN14602359
4332,ISRCTN67000769,ISRCTN,2020-07-20,2019-05-28,True,Recruiting,Not Applicable,Interventional,"Hungary, Australia, Croatia, Ireland, New Zealand, Belgium, Netherlands, Canada, Portugal, Saudi Arabia, United Kingdom, United States, Spain, Finland, France, Germany",An international platform trial for severely ill patients with community-acquired pneumonia or COVID-19,6000,http://isrctn.com/ISRCTN67000769
4333,EUCTR2020-001306-35-FR,EU Clinical Trials Register,2020-03-27,2020-05-04,False,Not Recruiting,Phase 3,Interventional,France,Protective role of inhaled steroids for COVID-19 infection,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001306-35
4334,EUCTR2020-001490-68-SE,EU Clinical Trials Register,2020-04-01,2020-04-15,False,Not Recruiting,Phase 2,Interventional,Sweden,Inhaled Nitric Oxide Gas Therapy in Respiratory Treated Patients with COVID-19 infection,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001490-68
4335,EUCTR2020-001411-25-AT,EU Clinical Trials Register,2020-04-03,2020-04-14,False,Not Recruiting,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, Italy, Israel, Spain, United States, Austria, France, India, Germany, Malaysia",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25
4336,EUCTR2020-002038-33-FI,EU Clinical Trials Register,2020-06-26,2020-07-16,False,Not Recruiting,Phase 2,Interventional,Finland,Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002038-33
4337,EUCTR2020-003210-13-RO,EU Clinical Trials Register,2020-10-20,2020-10-27,False,Authorised,Phase 2,Interventional,"Australia, United Kingdom, United States, Brazil, Spain, Romania","A Phase 2 Randomized, Double-blind, Placebo-controlled Safety and Efficacy Trial of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003210-13
4338,EUCTR2020-001264-28-BG,EU Clinical Trials Register,2020-05-07,2020-05-27,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Moldova, Republic of, Hungary, Russian Federation, Greece, Macedonia, the former Yugoslav Republic of, Ukraine, United States, Bosnia and Herzegovina, Germany, Bulgaria, Romania",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28
4339,EUCTR2020-001623-13-GR,EU Clinical Trials Register,2020-04-22,2020-05-20,False,Not Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13
4340,EUCTR2020-001673-75-DE,EU Clinical Trials Register,2020-04-27,2020-10-07,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Belgium, Italy, Brazil, Spain, Mexico, France, Germany","Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress.

",1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75
4341,EUCTR2021-000893-27-BE,EU Clinical Trials Register,2021-03-04,2021-04-27,False,Authorised,Phase 4,Interventional,Belgium,COVID-19: study to detect transfer of SARS-Cov-2 antibodies in breastmilk,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000893-27
4342,EUCTR2021-000930-32-BE,EU Clinical Trials Register,2021-03-04,2021-04-27,False,Authorised,Phase 4,Interventional,Belgium,COVID-19: Determination of effect of COVID vaccination on immunity of hemodialysis patients,580,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000930-32
4343,EUCTR2021-001040-10-AT,EU Clinical Trials Register,2021-03-26,2021-04-26,False,Authorised,Phase 4,Interventional,Austria,Humoral (antibodies) and cellular (white blood cells) immune response to COVID-19  vaccines in immunocompromised (people with impaired immune system) and healthy individuals â€“ The CoVVac study,390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001040-10
4344,EUCTR2020-005580-32-AT,EU Clinical Trials Register,2021-04-15,2021-04-26,False,Authorised,Phase 2,Interventional,Austria,Pilot study on silibinin as a possible therapeutic agent for mildly ill COVID-19 patients,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005580-32
4345,EUCTR2021-000492-36-BE,EU Clinical Trials Register,2021-04-21,,False,Not Available,Phase 2,Interventional,Belgium,Home and?Outpatients?Precocious?Eradication of?COVID-19,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000492-36
4346,EUCTR2021-001144-98-PL,EU Clinical Trials Register,2021-04-23,2021-04-20,True,Authorised,Phase 3,Interventional,Poland,The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001144-98
4347,EUCTR2020-005849-16-DE,EU Clinical Trials Register,2020-12-18,2021-09-03,False,Authorised,Phase 2,Interventional,"Germany, Switzerland","An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on  COVID-19 development in hospitalized patients infected with  SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2)",432,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005849-16
4348,EUCTR2020-004066-19-DE,EU Clinical Trials Register,2020-11-20,2020-12-18,False,Authorised,Phase 3,Interventional,Germany,Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany),2520,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004066-19
4349,EUCTR2020-002102-58-BE,EU Clinical Trials Register,2020-05-06,2020-12-06,False,Authorised,Phase 2,Interventional,Belgium,Therapy with stem cells for Patients with severe COVID-19 infection,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002102-58
4350,EUCTR2020-002208-37-DK,EU Clinical Trials Register,2020-06-08,2021-04-29,False,Authorised,Phase 2,Interventional,Denmark,"CIMMCov: A randomized clinical study for prevention of severe disease in mild-to-moderate COVID-19 patients, using the inhaled medication Ciclesonide.",138,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002208-37
4351,EUCTR2020-005015-40-SK,EU Clinical Trials Register,2021-03-25,2021-04-29,False,Authorised,Phase 3,Interventional,"Spain, Czech Republic, Italy, Slovakia",Ivermectin to prevent SARS-CoV-2 (COVID-19) hospitalisation in subjects over 50,832,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005015-40
4352,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,233,https://clinicaltrials.gov/show/NCT04319445
4353,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,False,Recruiting,Phase 1/Phase 2,Interventional,"Denmark, Sweden",The Impact of Camostat Mesilate on COVID-19 Infection,580,https://clinicaltrials.gov/show/NCT04321096
4354,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Recruiting,Phase 3,Interventional,"Chile, Russian Federation, Saudi Arabia, United Arab Emirates, Colombia, Canada, Pakistan, Brazil, Egypt, Ecuador, India, Philippines",Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,4000,https://clinicaltrials.gov/show/NCT04324463
4355,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Not Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,1279,https://clinicaltrials.gov/show/NCT04328480
4356,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Not Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),260,https://clinicaltrials.gov/show/NCT04344041
4357,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,82,https://clinicaltrials.gov/show/NCT04344535
4358,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-03-30,True,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia,0,https://clinicaltrials.gov/show/NCT04344548
4359,NCT04344665,ClinicalTrials.gov,2020-04-09,2020-04-23,False,Not Recruiting,Not Applicable,Interventional,Canada,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,905,https://clinicaltrials.gov/show/NCT04344665
4360,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-03-30,True,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,0,https://clinicaltrials.gov/show/NCT04346329
4361,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,False,Not Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,8,https://clinicaltrials.gov/show/NCT04356690
4362,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,0,https://clinicaltrials.gov/show/NCT04365582
4363,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Not Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,13,https://clinicaltrials.gov/show/NCT04374942
4364,NCT04376515,ClinicalTrials.gov,2020-03-31,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),300,https://clinicaltrials.gov/show/NCT04376515
4365,NCT04386070,ClinicalTrials.gov,2020-04-30,2021-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://clinicaltrials.gov/show/NCT04386070
4366,NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-15,False,Recruiting,Phase 3,Interventional,Switzerland,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04400799
4367,NCT04401475,ClinicalTrials.gov,2020-05-21,2020-11-25,False,Recruiting,Phase 2,Interventional,"Canada, United States, Colombia","A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",396,https://clinicaltrials.gov/show/NCT04401475
4368,NCT04406532,ClinicalTrials.gov,2020-05-22,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,0,https://clinicaltrials.gov/show/NCT04406532
4369,NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-12,False,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,191,https://clinicaltrials.gov/show/NCT04421508
4370,NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,True,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04424901
4371,NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-15,False,Not Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID-19,3400,https://clinicaltrials.gov/show/NCT04445428
4372,NCT04449380,ClinicalTrials.gov,2020-06-23,2020-11-02,False,Not Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 Patients,56,https://clinicaltrials.gov/show/NCT04449380
4373,NCT04452318,ClinicalTrials.gov,2020-06-26,2020-07-13,False,Not Recruiting,Phase 3,Interventional,"Moldova, Republic of, United States, Romania",COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,3750,https://clinicaltrials.gov/show/NCT04452318
4374,NCT04460027,ClinicalTrials.gov,2020-07-01,2020-06-22,True,Not Recruiting,Phase 1,Interventional,United States,W-SUDs for COVID-19,180,https://clinicaltrials.gov/show/NCT04460027
4375,NCT04462757,ClinicalTrials.gov,2020-06-12,2020-05-28,True,Not Recruiting,Phase 2,Interventional,United Kingdom,SCIL-1Ra in COVID-19 Feasibility & PK/PD,5,https://clinicaltrials.gov/show/NCT04462757
4376,NCT04462783,ClinicalTrials.gov,2020-07-07,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Emergency Department (ED) Self-Monitoring Pilot COVID-19,200,https://clinicaltrials.gov/show/NCT04462783
4377,NCT04468893,ClinicalTrials.gov,2020-07-10,2020-05-20,True,Recruiting,Not Applicable,Interventional,Mexico,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,128,https://clinicaltrials.gov/show/NCT04468893
4378,NCT04480424,ClinicalTrials.gov,2020-07-20,2020-09-17,False,Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04480424
4379,NCT04489446,ClinicalTrials.gov,2020-07-25,2020-08-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,Chile,Sildenafil in COVID-19,40,https://clinicaltrials.gov/show/NCT04489446
4380,NCT04490239,ClinicalTrials.gov,2020-07-20,2020-10-09,False,Not Recruiting,Phase 1,Interventional,United States,Intranasal Heparin Tolerability Study,6,https://clinicaltrials.gov/show/NCT04490239
4381,NCT04495101,ClinicalTrials.gov,2020-07-28,2020-07-29,False,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,100,https://clinicaltrials.gov/show/NCT04495101
4382,NCT04499677,ClinicalTrials.gov,2020-06-16,2020-09-24,False,Recruiting,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,240,https://clinicaltrials.gov/show/NCT04499677
4383,NCT04514900,ClinicalTrials.gov,2020-07-20,2020-09-23,False,Not Recruiting,Not Applicable,Interventional,United States,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,73,https://clinicaltrials.gov/show/NCT04514900
4384,NCT04517422,ClinicalTrials.gov,2020-08-16,2020-08-19,False,Not Recruiting,Not Applicable,Interventional,Mexico,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,300,https://clinicaltrials.gov/show/NCT04517422
4385,NCT04530357,ClinicalTrials.gov,2020-08-26,2020-09-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCovid-inÂ® COVID-19 Vaccine",244,https://clinicaltrials.gov/show/NCT04530357
4386,NCT04539795,ClinicalTrials.gov,2020-09-03,2021-01-25,False,Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Study of Safety and Tolerability of Alvelestat,15,https://clinicaltrials.gov/show/NCT04539795
4387,NCT04540120,ClinicalTrials.gov,2020-08-13,2020-09-25,False,Recruiting,Phase 2,Interventional,"Netherlands, United States, Switzerland",Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,80,https://clinicaltrials.gov/show/NCT04540120
4388,NCT04540406,ClinicalTrials.gov,2020-09-03,2021-05-27,False,Recruiting,Phase 2,Interventional,United States,NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04540406
4389,NCT04555122,ClinicalTrials.gov,2020-04-29,2021-10-01,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Ad Intervention,0,https://clinicaltrials.gov/show/NCT04555122
4390,NCT04563065,ClinicalTrials.gov,2020-09-19,2020-08-01,True,Recruiting,Not Applicable,Interventional,Spain,Active Pregnancy Against COVID-19,280,https://clinicaltrials.gov/show/NCT04563065
4391,NCT04581031,ClinicalTrials.gov,2020-05-04,2020-07-11,False,Recruiting,Not Applicable,Interventional,United Kingdom,COntinuous Signs Monitoring In Covid-19 Patients,60,https://clinicaltrials.gov/show/NCT04581031
4392,NCT04584541,ClinicalTrials.gov,2020-06-10,2020-06-11,False,Recruiting,Not Applicable,Interventional,France,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,150,https://clinicaltrials.gov/show/NCT04584541
4393,NCT04588441,ClinicalTrials.gov,2020-10-13,2021-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,30,https://clinicaltrials.gov/show/NCT04588441
4394,NCT04588480,ClinicalTrials.gov,2020-10-14,2020-10-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",160,https://clinicaltrials.gov/show/NCT04588480
4395,NCT04590365,ClinicalTrials.gov,2020-05-28,2020-12-17,False,Recruiting,Not Applicable,Interventional,United Kingdom,Carrageenan Nasal Spray for COVID-19 Prophylaxis,480,https://clinicaltrials.gov/show/NCT04590365
4396,NCT04608097,ClinicalTrials.gov,2020-10-28,2020-10-28,False,Not Recruiting,Not Applicable,Interventional,Sweden,Understanding Reactions to Emotional Material in the Media During COVID-19,74,https://clinicaltrials.gov/show/NCT04608097
4397,NCT04612972,ClinicalTrials.gov,2020-08-18,2020-09-09,False,Not Recruiting,Phase 3,Interventional,Peru,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru",12000,https://clinicaltrials.gov/show/NCT04612972
4398,NCT04613986,ClinicalTrials.gov,2020-11-02,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,20,https://clinicaltrials.gov/show/NCT04613986
4399,NCT04615741,ClinicalTrials.gov,2020-10-29,2020-11-09,False,Not Recruiting,Not Applicable,Interventional,Canada,Finding Wellness in the Pandemic,187,https://clinicaltrials.gov/show/NCT04615741
4400,NCT04636086,ClinicalTrials.gov,2020-11-17,2020-11-12,True,Recruiting,Phase 4,Interventional,Belgium,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04636086
4401,NCT04636671,ClinicalTrials.gov,2020-11-18,2021-04-14,False,Recruiting,Phase 3,Interventional,Italy,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),680,https://clinicaltrials.gov/show/NCT04636671
4402,NCT04647305,ClinicalTrials.gov,2020-11-24,2021-01-16,False,Not Recruiting,Not Applicable,Interventional,Colombia,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,233,https://clinicaltrials.gov/show/NCT04647305
4403,NCT04652518,ClinicalTrials.gov,2020-12-02,2020-12-11,False,Recruiting,Phase 2,Interventional,"Philippines, United Kingdom, United States, Romania",LYT-100 in Post-acute COVID-19 Respiratory Disease,168,https://clinicaltrials.gov/show/NCT04652518
4404,NCT04656691,ClinicalTrials.gov,2020-12-04,2021-01-04,False,Not Recruiting,Phase 4,Interventional,United States,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,4000,https://clinicaltrials.gov/show/NCT04656691
4405,NCT04659928,ClinicalTrials.gov,2020-11-30,2021-06-01,False,Not Recruiting,Phase 4,Interventional,United States,Evaluation of Aerosol in a Dental Clinic,50,https://clinicaltrials.gov/show/NCT04659928
4406,NCT04665193,ClinicalTrials.gov,2020-12-08,2020-11-23,True,Not Recruiting,Not Applicable,Interventional,Canada,An Approach to Screening for COVID-19 at Vancouver Airport,592,https://clinicaltrials.gov/show/NCT04665193
4407,NCT04668222,ClinicalTrials.gov,2020-11-30,2021-04-30,False,Not Recruiting,Phase 1/Phase 2,Interventional,Hong Kong,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,480,https://clinicaltrials.gov/show/NCT04668222
4408,NCT04673318,ClinicalTrials.gov,2020-10-23,2021-02-26,False,Recruiting,Not Applicable,Interventional,United States,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,87,https://clinicaltrials.gov/show/NCT04673318
4409,NCT04678778,ClinicalTrials.gov,2020-12-11,2019-03-19,True,Not Recruiting,Not Applicable,Interventional,United States,Virtual Reality Study - COVID-19 Protocol,14,https://clinicaltrials.gov/show/NCT04678778
4410,NCT04685681,ClinicalTrials.gov,2020-12-07,2021-01-07,False,Not Recruiting,Not Applicable,Interventional,United States,The Get Outside Study,53,https://clinicaltrials.gov/show/NCT04685681
4411,NCT04688502,ClinicalTrials.gov,2020-12-24,2021-06-11,False,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Wearing a Face Mask During CrossFit Exercise,24,https://clinicaltrials.gov/show/NCT04688502
4412,NCT04691908,ClinicalTrials.gov,2020-12-21,2020-12-25,False,Not Recruiting,Phase 3,Interventional,Kazakhstan,"Immunogenicity, Efficacy and Safety of QazCovid-inÂ® COVID-19 Vaccine",3000,https://clinicaltrials.gov/show/NCT04691908
4413,NCT04697654,ClinicalTrials.gov,2021-01-04,2020-10-14,True,Recruiting,Phase 1,Interventional,"Taiwan, Australia","The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",30,https://clinicaltrials.gov/show/NCT04697654
4414,NCT04700137,ClinicalTrials.gov,2021-01-05,2021-01-18,False,Recruiting,Not Applicable,Interventional,United States,"Mental Health Among Patients, Providers, and Staff During the COVID-19 Era",660,https://clinicaltrials.gov/show/NCT04700137
4415,NCT04703114,ClinicalTrials.gov,2020-11-30,2021-02-05,False,Recruiting,Not Applicable,Interventional,France,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),80,https://clinicaltrials.gov/show/NCT04703114
4416,NCT04715438,ClinicalTrials.gov,2021-01-11,2021-01-08,True,Recruiting,Not Applicable,Interventional,Netherlands,Vaccination Against COVID-19 in Cancer,873,https://clinicaltrials.gov/show/NCT04715438
4417,NCT04732819,ClinicalTrials.gov,2021-01-27,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,United States,Improving COVID-19 Vaccine Uptake in Nursing Homes,25332,https://clinicaltrials.gov/show/NCT04732819
4418,NCT04748588,ClinicalTrials.gov,2021-02-08,2021-02-12,False,Recruiting,Phase 4,Interventional,Canada,Treatment of Nosocomial COVID-19,648,https://clinicaltrials.gov/show/NCT04748588
4419,NCT04750278,ClinicalTrials.gov,2021-02-02,2021-04-06,False,Recruiting,Phase 2/Phase 3,Interventional,United States,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)",403,https://clinicaltrials.gov/show/NCT04750278
4420,NCT04767477,ClinicalTrials.gov,2020-12-21,2021-03-28,False,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors,60,https://clinicaltrials.gov/show/NCT04767477
4421,NCT04790786,ClinicalTrials.gov,2021-02-26,2021-03-10,False,Recruiting,Phase 3,Interventional,United States,"UPMC OPTIMISE-C19 Trial, a COVID-19 Study",5000,https://clinicaltrials.gov/show/NCT04790786
4422,NCT04809389,ClinicalTrials.gov,2021-03-19,2021-03-29,False,Recruiting,Phase 1,Interventional,Hong Kong,A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19,115,https://clinicaltrials.gov/show/NCT04809389
4423,NCT04817319,ClinicalTrials.gov,2021-03-23,2021-05-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,40,https://clinicaltrials.gov/show/NCT04817319
4424,NCT04824365,ClinicalTrials.gov,2021-03-26,2021-04-12,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections,60,https://clinicaltrials.gov/show/NCT04824365
4425,NCT04841746,ClinicalTrials.gov,2021-04-09,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy of FES Cycling After a Severe Form of COVID-19,70,https://clinicaltrials.gov/show/NCT04841746
4426,NCT04842721,ClinicalTrials.gov,2021-04-11,2021-07-01,False,Not Recruiting,Phase 2,Interventional,Canada,Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.,20,https://clinicaltrials.gov/show/NCT04842721
4427,NCT04843787,ClinicalTrials.gov,2021-04-09,2021-05-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,SLV213 Treatment in COVID-19 Patients,81,https://clinicaltrials.gov/show/NCT04843787
4428,NCT04844580,ClinicalTrials.gov,2021-03-25,2021-03-10,True,Recruiting,Phase 2,Interventional,Turkey,A Clinical Study Evaluating Inhaled Aviptadil on COVID-19,80,https://clinicaltrials.gov/show/NCT04844580
4429,NCT04854486,ClinicalTrials.gov,2021-04-17,2020-11-16,True,Recruiting,Phase 3,Interventional,United States,Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients,250,https://clinicaltrials.gov/show/NCT04854486
4430,NCT04854928,ClinicalTrials.gov,2021-04-21,2021-04-01,True,Recruiting,Phase 2,Interventional,Sweden,Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.,60,https://clinicaltrials.gov/show/NCT04854928
4431,NCT04856111,ClinicalTrials.gov,2021-04-19,2021-03-17,True,Recruiting,Phase 4,Interventional,India,Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia,48,https://clinicaltrials.gov/show/NCT04856111
4432,NCT04857060,ClinicalTrials.gov,2021-04-20,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Palliative Care Educator,4800,https://clinicaltrials.gov/show/NCT04857060
4433,NCT04859244,ClinicalTrials.gov,2021-04-19,2021-01-01,True,Not Recruiting,Phase 1,Interventional,United States,First-in-Human Study of Orally Administered GS-441524 for COVID-19,1,https://clinicaltrials.gov/show/NCT04859244
4434,NCT04860297,ClinicalTrials.gov,2021-04-21,2021-04-16,True,Recruiting,Phase 3,Interventional,United States,A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants,240,https://clinicaltrials.gov/show/NCT04860297
4435,NCT04860739,ClinicalTrials.gov,2021-04-22,2021-04-24,False,Not Recruiting,Phase 2,Interventional,Spain,Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose,676,https://clinicaltrials.gov/show/NCT04860739
4436,NCT04860895,ClinicalTrials.gov,2021-04-25,2021-02-11,True,Recruiting,Not Applicable,Interventional,Turkey,Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System,4400,https://clinicaltrials.gov/show/NCT04860895
4437,NCT04861298,ClinicalTrials.gov,2021-04-25,2021-01-11,True,Recruiting,Not Applicable,Interventional,Pakistan,Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home,142,https://clinicaltrials.gov/show/NCT04861298
4438,NCT04862806,ClinicalTrials.gov,2021-03-21,2021-02-01,True,Recruiting,Not Applicable,Interventional,Israel,"Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL",1000,https://clinicaltrials.gov/show/NCT04862806
4439,NCT04863131,ClinicalTrials.gov,2021-04-15,2021-04-28,False,Recruiting,Phase 1/Phase 2,Interventional,Japan,Safety and Immunogenicity of EXG-5003,60,https://clinicaltrials.gov/show/NCT04863131
4440,NCT04864015,ClinicalTrials.gov,2021-04-27,2021-03-17,True,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece,80,https://clinicaltrials.gov/show/NCT04864015
4441,NCT04864899,ClinicalTrials.gov,2021-03-19,2021-06-01,False,Recruiting,Not Applicable,Interventional,Hong Kong,Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR),112,https://clinicaltrials.gov/show/NCT04864899
4442,NCT04864925,ClinicalTrials.gov,2021-04-25,2020-12-28,True,Not Recruiting,Phase 3,Interventional,United States,Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products,30,https://clinicaltrials.gov/show/NCT04864925
4443,NCT04865029,ClinicalTrials.gov,2021-04-21,2021-05-01,False,Not Recruiting,Phase 2,Interventional,United States,Estradiol and Progesterone in Hospitalized COVID-19 Patients,120,https://clinicaltrials.gov/show/NCT04865029
4444,NCT04865237,ClinicalTrials.gov,2021-04-01,2021-03-06,True,Recruiting,Not Applicable,Interventional,United Kingdom,SARS-CoV-2 Human Challenge Characterisation Study,90,https://clinicaltrials.gov/show/NCT04865237
4445,NCT04866303,ClinicalTrials.gov,2021-04-27,2021-04-26,True,Recruiting,Not Applicable,Interventional,United States,Protecting Our Community: COVID-19 Testing,400,https://clinicaltrials.gov/show/NCT04866303
4446,NCT04868890,ClinicalTrials.gov,2021-04-22,2021-04-01,True,Recruiting,Phase 2,Interventional,United States,A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19,200,https://clinicaltrials.gov/show/NCT04868890
4447,NCT04868903,ClinicalTrials.gov,2021-04-06,2020-11-30,True,Recruiting,Not Applicable,Interventional,United States,Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19,2000,https://clinicaltrials.gov/show/NCT04868903
4448,NCT04869072,ClinicalTrials.gov,2021-04-08,2020-04-29,True,Not Recruiting,Phase 1,Interventional,Switzerland,Convalescent Plasma Therapy - Zurich Protocol,30,https://clinicaltrials.gov/show/NCT04869072
4449,NCT04869579,ClinicalTrials.gov,2021-04-29,2021-06-01,False,Not Recruiting,Phase 2,Interventional,United States,"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.",100,https://clinicaltrials.gov/show/NCT04869579
4450,NCT04870307,ClinicalTrials.gov,2021-02-15,2020-09-30,True,Recruiting,Not Applicable,Interventional,United States,Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations,780,https://clinicaltrials.gov/show/NCT04870307
4451,NCT04870333,ClinicalTrials.gov,2021-03-01,2021-02-19,True,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V,1500,https://clinicaltrials.gov/show/NCT04870333
4452,NCT04870723,ClinicalTrials.gov,2021-04-23,2021-03-01,True,Recruiting,Not Applicable,Interventional,"Canada, India, Thailand",#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support,900,https://clinicaltrials.gov/show/NCT04870723
4453,NCT04870775,ClinicalTrials.gov,2021-04-29,2020-11-01,True,Recruiting,Not Applicable,Interventional,Spain,Effectiveness of a Mindfulness Training Program in Health Care Proffesional,40,https://clinicaltrials.gov/show/NCT04870775
4454,NCT04871633,ClinicalTrials.gov,2021-01-11,2020-08-01,True,Not Recruiting,Not Applicable,Interventional,Pakistan,Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore,66,https://clinicaltrials.gov/show/NCT04871633
4455,NCT04871776,ClinicalTrials.gov,2021-04-30,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19,10000,https://clinicaltrials.gov/show/NCT04871776
4456,NCT04871802,ClinicalTrials.gov,2021-03-21,2021-05-10,False,Not Recruiting,Not Applicable,Interventional,Russian Federation,Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04871802
4457,NCT04871815,ClinicalTrials.gov,2021-04-27,2021-04-27,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.,50,https://clinicaltrials.gov/show/NCT04871815
4458,NCT04871893,ClinicalTrials.gov,2021-04-29,2021-06-14,False,Not Recruiting,Not Applicable,Interventional,Germany,Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy,40,https://clinicaltrials.gov/show/NCT04871893
4459,NCT04871958,ClinicalTrials.gov,2021-04-29,2021-03-19,True,Recruiting,Not Applicable,Interventional,Italy,"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward",66,https://clinicaltrials.gov/show/NCT04871958
4460,NCT04872712,ClinicalTrials.gov,2021-05-02,2021-05-03,False,Not Recruiting,Not Applicable,Interventional,Indonesia,THE ROLE OF MANUAL ACUPUNCTURE USING PRESS NEEDLES COMPARED WITH FILIFORM NEEDLES IN IMPROVING SYMPTOMS OF INSOMNIA AND MELATONIN HORMONE FOR HEALTHCARE WORKERS TREATING COVID-19 PATIENTS.,34,https://clinicaltrials.gov/show/NCT04872712
4461,ACTRN12620000478910,ANZCTR,2020-04-16,2021-01-07,False,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,24,https://anzctr.org.au/ACTRN12620000478910.aspx
4462,ISRCTN10839729,ISRCTN,2021-04-29,2020-01-11,True,Not Recruiting,Not Applicable,Interventional,Iran,Anti-viral photodynamic therapy in COVID-19 management: a novel approach in treating patients in early infection stages,140,http://isrctn.com/ISRCTN10839729
4463,ISRCTN12890382,ISRCTN,2020-10-23,2020-02-11,True,Recruiting,Not Applicable,Interventional,United Kingdom,Child anxiety treatment in the context of COVID-19,560,http://isrctn.com/ISRCTN12890382
4464,ISRCTN50212645,ISRCTN,2020-05-20,2020-01-06,True,Recruiting,Not Applicable,Interventional,United Kingdom,"
                COG-UK Project Hospital-Onset COVID-19 Infections (HOCI) Study: How effective are infection
                prevention and control measures that are informed by genetic analysis of coronavirus (rapid and
                standard) at preventing COVID-19 in NHS hospitals?
",2380,http://isrctn.com/ISRCTN50212645
4465,ChiCTR2100042726,ChiCTR,2021-01-27,2020-03-27,True,Not Recruiting,Not Applicable,Interventional,China,Mindfulness and Psychological Intervention Programs for College Students in the Context of COVID-19: A Randomized Controlled Trial,114,http://www.chictr.org.cn/showproj.aspx?proj=66123
4466,ChiCTR2100042717,ChiCTR,2021-01-26,2021-01-11,True,Recruiting,Not Applicable,Interventional,China,Study on the impact of metabolic disorders on novel coronavirus pneumonia (COVID-19) vaccination and related mechanisms,200,http://www.chictr.org.cn/showproj.aspx?proj=121027
4467,ChiCTR2000029618,ChiCTR,2020-02-07,2020-08-01,False,Recruiting,Not Applicable,Interventional,China,"Effect of the online-guide direct and indirect pelvic floor muscle training during pregnancy on SUI prevention during the COVID-19 pandemic: protocol for a multicenter, randomized controlled trial",734,http://www.chictr.org.cn/showproj.aspx?proj=48903
4468,EUCTR2021-000235-30-NL,EU Clinical Trials Register,2021-01-28,2021-09-02,False,Not Recruiting,Phase 4,Interventional,Netherlands,The COPPER study: Do people with Corona recover faster through early treatment with dexamethasone?,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000235-30
4469,EUCTR2020-005020-11-ES,EU Clinical Trials Register,2021-02-01,2021-04-05,False,Authorised,Phase 2,Interventional,Spain,Study on ozonated blood in COVID-19 severe pneumonia,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005020-11
4470,EUCTR2020-005280-31-ES,EU Clinical Trials Register,2021-02-01,2021-04-21,False,Authorised,Phase 4,Interventional,Spain,Study to evaluate the impact of early treatment with a budesonide / formoterol versus standard of care on the evolution of the disease in vulnerable patients with COVID-19: INHALAVID Trial,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005280-31
4471,EUCTR2020-003369-20-IE,EU Clinical Trials Register,2020-09-14,2020-11-13,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Hungary, Russian Federation, Ireland, Peru, South Africa, Ukraine, United States, Italy, Spain, Mexico, Brazil, Poland, India, South Korea, Romania",Trial to evaluate the Efficacy and Safety CT-P59 in Combination with Standard of Care in Outpatients with SARS-CoV-2 Infection (COVID-19),1472,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003369-20
4472,EUCTR2021-000988-68-SE,EU Clinical Trials Register,2021-03-08,2021-03-31,False,Authorised,Phase 4,Interventional,Sweden,Immune response after covid-19 vaccination in patients with renal failure stadium 4 or 5 .,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000988-68
4473,EUCTR2021-000981-13-PL,EU Clinical Trials Register,2021-03-17,2021-03-30,False,Authorised,Phase 3,Interventional,Poland,Skutecznosc leczenia amantadyna chorych na COVID-19,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000981-13
4474,EUCTR2021-001304-15-BE,EU Clinical Trials Register,2021-03-16,2021-06-05,False,Authorised,Phase 4,Interventional,Belgium,Immuneresponse after vaccination against SARS-COV-2,85,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001304-15
4475,EUCTR2021-001520-18-NL,EU Clinical Trials Register,2021-03-25,2021-09-04,False,Authorised,Phase 4,Interventional,Netherlands,Long term efficacy and safety of COVID-19 vaccination in patients with a kidney disease,24300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001520-18
4476,EUCTR2021-001357-31-NL,EU Clinical Trials Register,2021-04-20,2021-03-05,True,Authorised,Phase 4,Interventional,Netherlands,Study of the immune response after corona vaccination,1800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001357-31
4477,EUCTR2020-005952-39-DE,EU Clinical Trials Register,2021-02-03,2021-12-03,False,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to test COR-101 in hospitalized patients with moderate to severe Covid-19,261,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005952-39
4478,EUCTR2020-001635-27-FR,EU Clinical Trials Register,2020-04-06,2020-04-05,True,Authorised,Phase 2,Interventional,France,Evaluation of a combination of Masitinib and Isoquercetin in the Treatment of Hospitalized COVID-19 Patients.,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001635-27
4479,EUCTR2021-001202-30-NL,EU Clinical Trials Register,2021-04-16,2021-04-05,True,Authorised,Phase 4,Interventional,Netherlands,SARS-CoV-2 immune response,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001202-30
4480,EUCTR2021-001978-37-ES,EU Clinical Trials Register,2021-05-06,2021-04-19,True,Authorised,Phase 2,Interventional,Spain,"A Phase 2, Comparative, Randomised, Adaptive Trial to Evaluate the safety and immunogenicity of one dose of COMIRNATY in subjects that had received one dose of VAXZEVRIA.",600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001978-37
4481,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,False,Recruiting,Not Applicable,Interventional,"Nepal, Indonesia, Benin, United Kingdom, Zambia, Ethiopia, Bangladesh, Pakistan, Italy, Thailand, Mali, Lao People's Democratic Republic, Niger, Kenya",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,40000,https://clinicaltrials.gov/show/NCT04303507
4482,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,Not Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441
4483,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19),276,https://clinicaltrials.gov/show/NCT04332094
4484,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-04-04,False,Not Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,34,https://clinicaltrials.gov/show/NCT04335123
4485,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,206,https://clinicaltrials.gov/show/NCT04344015
4486,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Not Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04344236
4487,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,False,Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,240,https://clinicaltrials.gov/show/NCT04354259
4488,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-08-11,False,Not Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,511,https://clinicaltrials.gov/show/NCT04355767
4489,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,False,Not Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04357730
4490,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-24,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,10,https://clinicaltrials.gov/show/NCT04366791
4491,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Canada, Mexico, United States, Brazil",Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),1203,https://clinicaltrials.gov/show/NCT04372589
4492,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-06-01,False,Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,600,https://clinicaltrials.gov/show/NCT04372628
4493,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Not Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),30,https://clinicaltrials.gov/show/NCT04377672
4494,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-09-04,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,64,https://clinicaltrials.gov/show/NCT04379518
4495,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Not Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,107,https://clinicaltrials.gov/show/NCT04380909
4496,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-29,False,Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),446,https://clinicaltrials.gov/show/NCT04381364
4497,NCT04381962,ClinicalTrials.gov,2020-05-07,2020-06-03,False,Not Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),298,https://clinicaltrials.gov/show/NCT04381962
4498,NCT04385264,ClinicalTrials.gov,2020-04-21,2022-01-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,800,https://clinicaltrials.gov/show/NCT04385264
4499,NCT04387955,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Recruiting,Not Applicable,Interventional,France,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),11,https://clinicaltrials.gov/show/NCT04387955
4500,NCT04402957,ClinicalTrials.gov,2020-05-12,2020-10-14,False,Not Recruiting,Phase 2,Interventional,"Turkey, Canada, United States",LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),60,https://clinicaltrials.gov/show/NCT04402957
4501,NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,False,Not Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",660,https://clinicaltrials.gov/show/NCT04405076
4502,NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-07,False,Not Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,49,https://clinicaltrials.gov/show/NCT04409743
4503,NCT04409873,ClinicalTrials.gov,2020-05-28,2021-03-31,False,Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),150,https://clinicaltrials.gov/show/NCT04409873
4504,NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-30,False,Not Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,20,https://clinicaltrials.gov/show/NCT04412785
4505,NCT04420364,ClinicalTrials.gov,2020-06-04,2021-05-03,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,0,https://clinicaltrials.gov/show/NCT04420364
4506,NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-09,False,Not Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,34,https://clinicaltrials.gov/show/NCT04421404
4507,NCT04421612,ClinicalTrials.gov,2020-06-04,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,Norway,COVID-19 - No Health Without Mental Health,91,https://clinicaltrials.gov/show/NCT04421612
4508,NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,False,Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,2300,https://clinicaltrials.gov/show/NCT04421625
4509,NCT04422509,ClinicalTrials.gov,2020-06-03,2020-10-30,False,Not Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,43,https://clinicaltrials.gov/show/NCT04422509
4510,NCT04432272,ClinicalTrials.gov,2020-06-12,2020-07-16,False,Not Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),71,https://clinicaltrials.gov/show/NCT04432272
4511,NCT04453852,ClinicalTrials.gov,2020-06-03,2020-06-30,False,Not Recruiting,Phase 1,Interventional,Australia,Monovalent Recombinant COVID19 Vaccine,40,https://clinicaltrials.gov/show/NCT04453852
4512,NCT04485130,ClinicalTrials.gov,2020-07-22,2021-05-01,False,Recruiting,Phase 2,Interventional,United States,DISulfiram for COvid-19 (DISCO) Trial,60,https://clinicaltrials.gov/show/NCT04485130
4513,NCT04527432,ClinicalTrials.gov,2020-08-24,2020-12-16,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Health Professional Impact Study,1504,https://clinicaltrials.gov/show/NCT04527432
4514,NCT04528888,ClinicalTrials.gov,2020-08-21,2020-11-25,False,Recruiting,Phase 3,Interventional,Italy,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,210,https://clinicaltrials.gov/show/NCT04528888
4515,NCT04531748,ClinicalTrials.gov,2020-08-27,2021-12-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Selective Estrogen Modulation and Melatonin in Early COVID-19,0,https://clinicaltrials.gov/show/NCT04531748
4516,NCT04532372,ClinicalTrials.gov,2020-08-25,2020-10-23,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,30,https://clinicaltrials.gov/show/NCT04532372
4517,NCT04537962,ClinicalTrials.gov,2020-07-14,2020-06-11,True,Recruiting,Not Applicable,Interventional,Brazil,Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices,202,https://clinicaltrials.gov/show/NCT04537962
4518,NCT04540393,ClinicalTrials.gov,2020-08-26,2020-09-02,False,Not Recruiting,Phase 3,Interventional,Russian Federation,AZD1222 Vaccine for the Prevention of COVID-19,100,https://clinicaltrials.gov/show/NCT04540393
4519,NCT04542967,ClinicalTrials.gov,2020-09-04,2020-06-23,True,Not Recruiting,Phase 2,Interventional,Mexico,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,150,https://clinicaltrials.gov/show/NCT04542967
4520,NCT04545060,ClinicalTrials.gov,2020-09-04,2020-08-27,True,Not Recruiting,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Canada, United States, Brazil, Spain, Austria, France",VIR-7831 for the Early Treatment of COVID-19 in Outpatients,1360,https://clinicaltrials.gov/show/NCT04545060
4521,NCT04551768,ClinicalTrials.gov,2020-09-15,2021-02-10,False,Recruiting,Phase 1,Interventional,"Greece, Mexico",Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,50,https://clinicaltrials.gov/show/NCT04551768
4522,NCT04551911,ClinicalTrials.gov,2020-09-15,2020-10-26,False,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,160,https://clinicaltrials.gov/show/NCT04551911
4523,NCT04592549,ClinicalTrials.gov,2020-10-12,2020-12-04,False,Recruiting,Phase 1,Interventional,United States,Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19,40,https://clinicaltrials.gov/show/NCT04592549
4524,NCT04602286,ClinicalTrials.gov,2020-10-19,2020-10-28,False,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),292,https://clinicaltrials.gov/show/NCT04602286
4525,NCT04602312,ClinicalTrials.gov,2020-10-19,2020-10-28,False,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),624,https://clinicaltrials.gov/show/NCT04602312
4526,NCT04603924,ClinicalTrials.gov,2020-10-20,2020-10-07,True,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,436,https://clinicaltrials.gov/show/NCT04603924
4527,NCT04611802,ClinicalTrials.gov,2020-10-30,2020-12-27,False,Recruiting,Phase 3,Interventional,"Puerto Rico, United States, Mexico","A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults = 18 Years With a Pediatric Expansion in Adolescents (12-17 Years) at Risk for SARS-CoV-2",33000,https://clinicaltrials.gov/show/NCT04611802
4528,NCT04615052,ClinicalTrials.gov,2020-10-29,2020-09-26,True,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise in COVID-19 Survivors,60,https://clinicaltrials.gov/show/NCT04615052
4529,NCT04619628,ClinicalTrials.gov,2020-11-05,2020-12-11,False,Not Recruiting,Phase 1,Interventional,United Kingdom,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",48,https://clinicaltrials.gov/show/NCT04619628
4530,NCT04632381,ClinicalTrials.gov,2020-11-12,2021-05-07,False,Not Recruiting,Phase 1,Interventional,United States,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,36,https://clinicaltrials.gov/show/NCT04632381
4531,NCT04642950,ClinicalTrials.gov,2020-11-19,2020-12-17,False,Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,60,https://clinicaltrials.gov/show/NCT04642950
4532,NCT04644328,ClinicalTrials.gov,2020-11-13,2020-11-14,False,Not Recruiting,Not Applicable,Interventional,United States,The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign,20000000,https://clinicaltrials.gov/show/NCT04644328
4533,NCT04646590,ClinicalTrials.gov,2020-11-25,2020-12-16,False,Recruiting,Phase 3,Interventional,"Indonesia, Pakistan, Uzbekistan, Ecuador, China",A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,29000,https://clinicaltrials.gov/show/NCT04646590
4534,NCT04646603,ClinicalTrials.gov,2020-11-24,2021-01-28,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,18,https://clinicaltrials.gov/show/NCT04646603
4535,NCT04652674,ClinicalTrials.gov,2020-12-02,2020-09-28,True,Recruiting,Not Applicable,Interventional,United States,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04652674
4536,NCT04668235,ClinicalTrials.gov,2020-12-04,2021-04-23,False,Recruiting,Phase 3,Interventional,Brazil,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),342,https://clinicaltrials.gov/show/NCT04668235
4537,NCT04681430,ClinicalTrials.gov,2020-12-17,2021-01-08,False,Recruiting,Phase 2,Interventional,Germany,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,1094,https://clinicaltrials.gov/show/NCT04681430
4538,NCT04715932,ClinicalTrials.gov,2021-01-15,2021-02-18,False,Not Recruiting,Phase 2,Interventional,Canada,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),216,https://clinicaltrials.gov/show/NCT04715932
4539,NCT04746430,ClinicalTrials.gov,2021-02-08,2021-02-16,False,Not Recruiting,Phase 4,Interventional,Netherlands,COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study,17,https://clinicaltrials.gov/show/NCT04746430
4540,NCT04753645,ClinicalTrials.gov,2021-02-11,2020-09-19,True,Not Recruiting,Not Applicable,Interventional,Bangladesh,BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition,3840,https://clinicaltrials.gov/show/NCT04753645
4541,NCT04766333,ClinicalTrials.gov,2021-02-10,2021-05-03,False,Recruiting,Not Applicable,Interventional,United States,New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations,2000,https://clinicaltrials.gov/show/NCT04766333
4542,NCT04779827,ClinicalTrials.gov,2021-02-21,2021-05-04,False,Recruiting,Not Applicable,Interventional,United States,Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks,1920,https://clinicaltrials.gov/show/NCT04779827
4543,NCT04797858,ClinicalTrials.gov,2021-03-05,2021-05-05,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Self-Testing Through Rapid Network Distribution,1048,https://clinicaltrials.gov/show/NCT04797858
4544,NCT04813770,ClinicalTrials.gov,2021-03-23,2021-04-06,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions,1113,https://clinicaltrials.gov/show/NCT04813770
4545,NCT04813796,ClinicalTrials.gov,2021-03-22,2021-03-11,True,Recruiting,Phase 1,Interventional,United States,"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19",125,https://clinicaltrials.gov/show/NCT04813796
4546,NCT04816019,ClinicalTrials.gov,2021-03-15,2021-04-01,False,Recruiting,Phase 1,Interventional,United Kingdom,A Study of Intranasal ChAdOx1 nCOV-19,54,https://clinicaltrials.gov/show/NCT04816019
4547,NCT04816071,ClinicalTrials.gov,2021-03-23,2021-05-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Essential Amino Acid Supplementation in Older Adult COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04816071
4548,NCT04834726,ClinicalTrials.gov,2021-04-06,2021-04-29,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccine Text Outreach,20500,https://clinicaltrials.gov/show/NCT04834726
4549,NCT04841759,ClinicalTrials.gov,2021-04-07,2021-04-01,True,Recruiting,Not Applicable,Interventional,Austria,The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome,30,https://clinicaltrials.gov/show/NCT04841759
4550,NCT04847479,ClinicalTrials.gov,2021-04-14,2021-05-06,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Close Contact Self-Testing Study,210,https://clinicaltrials.gov/show/NCT04847479
4551,NCT04852861,ClinicalTrials.gov,2021-04-14,2021-05-10,False,Recruiting,Phase 4,Interventional,Belgium,COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine,150,https://clinicaltrials.gov/show/NCT04852861
4552,NCT04858425,ClinicalTrials.gov,2021-04-21,2021-04-30,False,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection,148,https://clinicaltrials.gov/show/NCT04858425
4553,NCT04859023,ClinicalTrials.gov,2021-04-22,2021-02-22,True,Not Recruiting,Not Applicable,Interventional,France,Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).,10000,https://clinicaltrials.gov/show/NCT04859023
4554,NCT04860258,ClinicalTrials.gov,2021-04-22,2021-04-22,False,Recruiting,Phase 3,Interventional,Belgium,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19",1200,https://clinicaltrials.gov/show/NCT04860258
4555,NCT04865107,ClinicalTrials.gov,2021-04-27,2021-04-27,False,Recruiting,Phase 2,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,54,https://clinicaltrials.gov/show/NCT04865107
4556,NCT04866069,ClinicalTrials.gov,2021-04-26,2021-04-25,True,Recruiting,Phase 1,Interventional,Turkey,Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults,50,https://clinicaltrials.gov/show/NCT04866069
4557,NCT04866589,ClinicalTrials.gov,2021-04-15,2021-05-03,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: The Effectiveness of Free Face Mask Distribution,10,https://clinicaltrials.gov/show/NCT04866589
4558,NCT04869228,ClinicalTrials.gov,2021-04-29,2021-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,"A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients",724,https://clinicaltrials.gov/show/NCT04869228
4559,NCT04869592,ClinicalTrials.gov,2021-04-24,2021-04-25,False,Recruiting,Phase 1/Phase 2,Interventional,China,A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19,3580,https://clinicaltrials.gov/show/NCT04869592
4560,NCT04870164,ClinicalTrials.gov,2021-04-28,2020-11-18,True,Recruiting,Phase 1,Interventional,United Kingdom,"Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)",24,https://clinicaltrials.gov/show/NCT04870164
4561,NCT04871672,ClinicalTrials.gov,2021-04-24,2021-05-23,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Effects of Pilates Exercises on Core Stability After Recovery From COVID -19,30,https://clinicaltrials.gov/show/NCT04871672
4562,NCT04871828,ClinicalTrials.gov,2021-05-01,2021-02-28,True,Recruiting,Phase 3,Interventional,Saudi Arabia,The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19),66,https://clinicaltrials.gov/show/NCT04871828
4563,NCT04873349,ClinicalTrials.gov,2021-05-04,2021-05-10,False,Not Recruiting,Phase 2,Interventional,No Country Given,Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04873349
4564,NCT04873401,ClinicalTrials.gov,2021-03-24,2021-05-20,False,Not Recruiting,Not Applicable,Interventional,United States,Leveraging Social Networks to Increase COVID-19 Testing Uptake,500,https://clinicaltrials.gov/show/NCT04873401
4565,NCT04874805,ClinicalTrials.gov,2021-04-16,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,France,Oxygen Saturation: Analytical Comparison for COVID,40,https://clinicaltrials.gov/show/NCT04874805
4566,NCT04875520,ClinicalTrials.gov,2021-04-29,2021-05-07,False,Not Recruiting,Not Applicable,Interventional,United States,Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population,10000,https://clinicaltrials.gov/show/NCT04875520
4567,NCT04876417,ClinicalTrials.gov,2021-03-15,2021-02-01,True,Recruiting,Not Applicable,Interventional,United States,tDCS for Post COVID-19 Fatigue,50,https://clinicaltrials.gov/show/NCT04876417
4568,NCT04876560,ClinicalTrials.gov,2021-04-27,2020-03-11,True,Not Recruiting,Not Applicable,Interventional,Greece,Implementation of a CDSS in Oncology Patients During COVID-19,44,https://clinicaltrials.gov/show/NCT04876560
4569,NCT04876573,ClinicalTrials.gov,2021-05-03,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19,60,https://clinicaltrials.gov/show/NCT04876573
4570,NCT04876885,ClinicalTrials.gov,2021-05-03,2021-05-06,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations,100,https://clinicaltrials.gov/show/NCT04876885
4571,NCT04877002,ClinicalTrials.gov,2021-05-03,2021-04-29,True,Recruiting,Not Applicable,Interventional,Canada,Performance Study of SONA Saliva C-19 Rapid Test,500,https://clinicaltrials.gov/show/NCT04877002
4572,NCT04877704,ClinicalTrials.gov,2021-05-05,2021-05-31,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,Symprove (Probiotic) as an add-on to COVID-19 Management,60,https://clinicaltrials.gov/show/NCT04877704
4573,NCT04877769,ClinicalTrials.gov,2021-05-04,2021-04-25,True,Recruiting,Phase 1,Interventional,United Kingdom,Bronchopulmonary PK of AT-527 (R07496998),24,https://clinicaltrials.gov/show/NCT04877769
4574,NCT04878042,ClinicalTrials.gov,2021-05-04,2021-04-09,True,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray,200,https://clinicaltrials.gov/show/NCT04878042
4575,NCT04878328,ClinicalTrials.gov,2021-04-30,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO,250,https://clinicaltrials.gov/show/NCT04878328
4576,NCT04880122,ClinicalTrials.gov,2021-05-05,2020-08-01,True,Not Recruiting,Not Applicable,Interventional,Belgium,Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).,440,https://clinicaltrials.gov/show/NCT04880122
4577,NCT04880135,ClinicalTrials.gov,2021-05-06,2021-03-01,True,Recruiting,Not Applicable,Interventional,Pakistan,Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19,404,https://clinicaltrials.gov/show/NCT04880135
4578,NCT04880161,ClinicalTrials.gov,2021-05-06,2021-05-01,True,Recruiting,Phase 1,Interventional,United States,A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID),30,https://clinicaltrials.gov/show/NCT04880161
4579,NCT04880174,ClinicalTrials.gov,2021-04-16,2021-03-22,True,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination,800,https://clinicaltrials.gov/show/NCT04880174
4580,NCT04880317,ClinicalTrials.gov,2021-05-02,2021-05-01,True,Recruiting,Not Applicable,Interventional,Italy,Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT,188,https://clinicaltrials.gov/show/NCT04880317
4581,NCT04880668,ClinicalTrials.gov,2021-04-27,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Aerosol Box Use on Healthcare Provider Contamination,132,https://clinicaltrials.gov/show/NCT04880668
4582,NCT04884490,ClinicalTrials.gov,2021-05-05,2021-05-15,False,Not Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients,94,https://clinicaltrials.gov/show/NCT04884490
4583,NCT04884776,ClinicalTrials.gov,2021-04-29,2021-05-10,False,Not Recruiting,Not Applicable,Interventional,Hong Kong,Modulation of Gut Microbiota to Enhance Health and Immunity,484,https://clinicaltrials.gov/show/NCT04884776
4584,NCT04885764,ClinicalTrials.gov,2021-05-08,2021-02-23,True,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University,4000,https://clinicaltrials.gov/show/NCT04885764
4585,ACTRN12620001104943,ANZCTR,2020-10-26,2020-12-11,False,Not Recruiting,Phase 1,Interventional,Australia,A Single Dose Study to Determine the Safety and Tolerability of Intranasal REVTx-99 in Healthy Adult Volunteers,48,https://anzctr.org.au/ACTRN12620001104943.aspx
4586,ISRCTN18100261,ISRCTN,2021-05-04,2021-03-22,True,Recruiting,Not Applicable,Interventional,United Kingdom,Daily contact testing schools and colleges trial,200000,http://isrctn.com/ISRCTN18100261
4587,ISRCTN12721265,ISRCTN,2021-04-30,2021-10-05,False,Recruiting,Not Applicable,Interventional,Indonesia,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients in Indonesia,68,http://isrctn.com/ISRCTN12721265
4588,ISRCTN22331899,ISRCTN,2021-04-07,2020-01-07,True,Not Recruiting,Not Applicable,Interventional,United States,How effective is framing public service announcements using identity-based messaging in increasing the likelihood of compliance with COVID-19 guidelines?,300,http://isrctn.com/ISRCTN22331899
4589,ISRCTN14391248,ISRCTN,2021-03-30,2021-03-29,True,Recruiting,Phase 4,Interventional,United Kingdom,Combining influenza and COVID-19 vaccination (ComFluCOV) study,756,http://isrctn.com/ISRCTN14391248
4590,ISRCTN27106947,ISRCTN,2020-12-07,2020-08-09,True,Recruiting,Phase 1/Phase 2,Interventional,"South Africa, United Kingdom",A study to assess several different treatments that may be useful for patients with COVID-19,180,http://isrctn.com/ISRCTN27106947
4591,ISRCTN10197987,ISRCTN,2020-10-05,2020-08-09,True,Not Recruiting,Not Applicable,Interventional,Qatar,The possible beneficial role of the regular use of potent mouthwash solutions in the treatment of COVID-19,100,http://isrctn.com/ISRCTN10197987
4592,ISRCTN16912075,ISRCTN,2020-04-06,2020-06-04,False,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 â€“ CPAP, high-flow nasal oxygen, and standard care",4002,http://isrctn.com/ISRCTN16912075
4593,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15
4594,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Not Recruiting,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11
4595,EUCTR2020-001469-35-PL,EU Clinical Trials Register,2020-04-08,2020-08-04,False,Not Recruiting,Phase 4,Interventional,Poland,"A multicenter, open, randomized, non-commercial study to evaluate the efficacy and safety of chloroquine phosphate in the outpatient treatment of COVID-19 in combination with telemedicine care for patients with SARS-CoV-2 infection with the risk of developing complications to reduce the risk of COVID-19-related hospitalization and death.",400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001469-35
4596,EUCTR2020-001546-19-BE,EU Clinical Trials Register,2020-04-09,2020-04-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19
4597,EUCTR2020-001345-38-GR,EU Clinical Trials Register,2020-03-31,2020-02-04,True,Not Recruiting,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38
4598,EUCTR2020-001264-28-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Moldova, Republic of, Hungary, Russian Federation, Greece, Macedonia, the former Yugoslav Republic of, Ukraine, United States, Bosnia and Herzegovina, Germany, Bulgaria, Romania",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28
4599,EUCTR2020-001236-10-BE,EU Clinical Trials Register,2020-11-16,2020-11-12,True,Authorised,Phase 2,Interventional,"Netherlands, Belgium",Countering Lung Damage in COVID-19 infection: the CounterCovid Study,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10
4600,EUCTR2020-004356-16-BE,EU Clinical Trials Register,2020-10-25,2020-11-25,False,Authorised,Phase 3,Interventional,"Russian Federation, United Kingdom, Belgium, United States, Spain, France","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection",5000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004356-16
4601,EUCTR2020-002472-12-NL,EU Clinical Trials Register,2020-05-14,2020-11-06,False,Not Recruiting,Phase 4,Interventional,Netherlands,Lanadelumab for treatment of COVID-19 disease,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002472-12
4602,EUCTR2021-000683-30-SE,EU Clinical Trials Register,2021-02-23,2021-03-03,False,Authorised,Phase 4,Interventional,Sweden,CoVacc - Immune response to vaccination against Covid-19,3000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000683-30
4603,EUCTR2020-005759-18-DE,EU Clinical Trials Register,2021-03-11,2021-10-05,False,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18
4604,EUCTR2021-001031-72-DK,EU Clinical Trials Register,2021-03-04,2021-08-04,False,Authorised,Phase 2,Interventional,Denmark,Metabolic MRI of patients with long-term symptoms after COVID19-infection,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001031-72
4605,EUCTR2020-005576-35-HU,EU Clinical Trials Register,2021-04-07,2021-06-05,False,Authorised,Phase 3,Interventional,"Argentina, Hungary, Peru, United Kingdom, Colombia, Canada, United States, Mexico, Spain, Brazil, Poland",COVID-19 Vaccine in Adults 18 Years of Age or Older,30000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005576-35
4606,EUCTR2021-001512-28-DE,EU Clinical Trials Register,2021-04-13,2021-11-05,False,Authorised,Phase 4,Interventional,Germany,Immune response and correlates of protection of COVID-19 vaccines in medical staff and special risk populations,2250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001512-28
4607,EUCTR2021-002014-14-CZ,EU Clinical Trials Register,2021-04-16,2021-04-20,False,Authorised,Phase 4,Interventional,Czech Republic,Monitoring of antibody response 28 days after the first dose of COVID19 vaccine in clinically stable subjects with functional kidney transplantation.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002014-14
4608,EUCTR2020-001302-30-AT,EU Clinical Trials Register,2020-04-09,2020-04-15,False,Authorised,Phase 2,Interventional,Austria,"A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with a lung disease caused by coronavirus infection

ACOVACT (Austrian CoronaVirus Adaptive Clinical Trial)",500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001302-30
4609,EUCTR2020-005299-36-BE,EU Clinical Trials Register,2021-03-29,2021-04-21,False,Authorised,Phase 1/Phase 2,Interventional,"Portugal, Belgium, United States, Mexico, Spain, Italy, France, Romania","A Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19",279,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005299-36
4610,EUCTR2020-003403-33-BE,EU Clinical Trials Register,2020-12-16,2021-01-20,False,Authorised,Phase 2,Interventional,"Hungary, Russian Federation, Georgia, Belgium, Poland",Study to assess the ability of E4 to improve the percentage of patients who recover by Day 28 compared to placebo in those with confirmed SARS-CoV-2 infection who are hospitalized with moderate COVID-19 (i.e. not on high flow oxygen or mechanical ventilation).,162,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003403-33
4611,EUCTR2020-005315-44-DE,EU Clinical Trials Register,2021-01-14,2021-08-04,False,Authorised,Phase 3,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Italy, United States, Spain, Mexico, Brazil, Japan, Poland, Germany, Czech Republic","Phase 3, Double-blind, Placebo-controlled Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults",1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005315-44
4612,ChiCTR2100046272,ChiCTR,2021-05-12,2021-06-15,False,Not Recruiting,Phase 3,Prevention,Malaysia,A global phase III clinical trial of recombinant COVID-19 vaccine (Sf9 cells) in adults aged 18 years and older,40000,http://www.chictr.org.cn/showproj.aspx?proj=126252
4613,ChiCTR2100046227,ChiCTR,2021-05-11,2021-05-14,False,Not Recruiting,Phase 4,Prevention,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1404,http://www.chictr.org.cn/showproj.aspx?proj=126385
4614,ChiCTR2100046174,ChiCTR,2021-05-08,2021-05-12,False,Not Recruiting,Phase 4,Prevention,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1152,http://www.chictr.org.cn/showproj.aspx?proj=126277
4615,ChiCTR2100045993,ChiCTR,2021-05-01,2021-03-09,True,Not Recruiting,Not Applicable,Interventional,China,To evaluate the exploratory clinical trial of homoharringtonine in the treatment of adult COVID-19 patients,40,http://www.chictr.org.cn/showproj.aspx?proj=126032
4616,ChiCTR2100045991,ChiCTR,2021-05-01,2021-04-30,True,Not Recruiting,Phase 1,Interventional,China,Evaluation of safety and immunogenicity of COVID-19 vaccine in patients previously infected with SARS-Cov2,90,http://www.chictr.org.cn/showproj.aspx?proj=126041
4617,ChiCTR2100045984,ChiCTR,2021-05-01,2021-03-26,True,Recruiting,Phase 1,Interventional,No Country Given,"Randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of mRNACOVID-19 vaccine in healthy susceptible populations aged 18 years and older people",240,http://www.chictr.org.cn/showproj.aspx?proj=126046
4618,ChiCTR2100045845,ChiCTR,2021-04-25,2021-04-25,False,Not Recruiting,Not Applicable,Interventional,China,A study on 3D hologram with mixed reality techniques for better understanding the pulmonary lesions of COVID-19,60,http://www.chictr.org.cn/showproj.aspx?proj=125761
4619,ChiCTR2100045109,ChiCTR,2021-04-07,2021-04-09,False,Recruiting,Not Applicable,Interventional,China,The Impact of Timing of Vaccination on the Immune Reaction to Vaccine against SARS-CoV-2,472,http://www.chictr.org.cn/showproj.aspx?proj=124650
4620,ChiCTR2100045108,ChiCTR,2021-04-07,2021-02-22,True,Recruiting,Phase 1,Prevention,China,"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Healthy Subjects",150,http://www.chictr.org.cn/showproj.aspx?proj=124140
4621,ChiCTR2100045107,ChiCTR,2021-04-07,2021-03-28,True,Not Recruiting,Phase 2,Prevention,China,"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Healthy Subjects",720,http://www.chictr.org.cn/showproj.aspx?proj=124702
4622,ChiCTR2100044860,ChiCTR,2021-03-30,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial on the treatment of COVID-19 by Qingfei Paidu Granule,80,http://www.chictr.org.cn/showproj.aspx?proj=124310
4623,ChiCTR2100044249,ChiCTR,2021-03-12,2020-09-22,True,Recruiting,Phase 3,Interventional,Russia,Global phase III trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in adults 18 years of age and older,40000,http://www.chictr.org.cn/showproj.aspx?proj=65034
4624,ChiCTR2100044026,ChiCTR,2021-03-06,2020-03-15,True,Not Recruiting,Phase 4,Interventional,Saudi Arabia,Effects of high-intensity aerobic training with high protein diet in childhood obesity following COVID-19 infection.,76,http://www.chictr.org.cn/showproj.aspx?proj=122577
4625,ChiCTR2100043907,ChiCTR,2021-03-05,2020-12-28,True,Recruiting,Phase 4,Prevention,China,Comprehensive evaluations of dynamic changes in the immune system of healthy volunteers after vaccination with inactivated Novel Coronavirus Pneumonia (COVID-19) vaccine (Vero cells),16,http://www.chictr.org.cn/showproj.aspx?proj=122756
4626,ChiCTR2100042822,ChiCTR,2021-01-29,2021-01-29,False,Recruiting,Not Applicable,Interventional,China,Qing-Jin Yi-Qi granule for patients in the rehabilitation phase of COVID-19: a randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=121247
4627,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50306
4628,JPRN-JapicCTI-205270,JPRN,2020-04-23,2020-05-25,False,Not Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270
4629,JPRN-JapicCTI-205326,JPRN,2020-06-15,2020-01-07,True,Recruiting,Phase 1,Interventional,Japan,Phase 1 study of FOY-305(FOY-305-02)(COVID-19),7,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205326
4630,JPRN-JapicCTI-205465,JPRN,2020-08-27,2020-12-17,False,Recruiting,Phase 1,Interventional,Japan,Umbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress Syndrome,12,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465
4631,JPRN-jRCT1030200279,JPRN,2020-12-25,2020-12-25,False,Recruiting,Not Applicable,Interventional,Japan,COVID-CP Banking,100,https://jrct.niph.go.jp/latest-detail/jRCT1030200279
4632,JPRN-jRCT1030210037,JPRN,2021-04-14,2021-12-04,False,Recruiting,Not Applicable,Interventional,Japan,Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial,200,https://jrct.niph.go.jp/latest-detail/jRCT1030210037
4633,JPRN-jRCT1051200078,JPRN,2020-11-24,2020-11-30,False,Recruiting,Phase 2,Interventional,Japan,Study on reduction of salivary virus by povidone iodine on COVID-19,440,https://jrct.niph.go.jp/latest-detail/jRCT1051200078
4634,JPRN-jRCT2021200018,JPRN,2020-08-18,2020-07-10,True,Not Recruiting,Phase 2,Interventional,Japan,An exploratory Phase II investigator-initiated clinical trial of the efficacy and safety of TM5614 in patients with novel coronavirus  pneumonia,30,https://jrct.niph.go.jp/latest-detail/jRCT2021200018
4635,JPRN-jRCT2031200035,JPRN,2020-05-20,2020-06-22,False,Not Recruiting,Phase 3,Interventional,"Denmark, United Kingdom, United States, Mexico, Spain, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",35,https://jrct.niph.go.jp/latest-detail/jRCT2031200035
4636,JPRN-jRCT2031200092,JPRN,2020-08-21,2020-08-20,True,Not Recruiting,Phase 3,Interventional,"United States, Mexico, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200092
4637,JPRN-jRCT2031200120,JPRN,2020-09-16,2020-08-10,True,Recruiting,Phase 2,Interventional,Japan,double-blind study in COvid-19 patients with iveRmectin,240,https://jrct.niph.go.jp/latest-detail/jRCT2031200120
4638,JPRN-jRCT2031200126,JPRN,2020-09-23,2020-10-09,False,Not Recruiting,Phase 3,Interventional,"United Kingdom, United States, Spain, Japan, France","A Phase 3 Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome",270,https://jrct.niph.go.jp/latest-detail/jRCT2031200126
4639,JPRN-jRCT2031200180,JPRN,2020-11-04,2021-08-02,False,Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,60,https://jrct.niph.go.jp/latest-detail/jRCT2031200180
4640,JPRN-jRCT2031200198,JPRN,2020-11-12,2020-09-11,True,Recruiting,Phase 3,Interventional,Japan,FOY-305-01:FOY-305 Phase 3(COVID-19),110,https://jrct.niph.go.jp/latest-detail/jRCT2031200198
4641,JPRN-jRCT2031200252,JPRN,2020-12-18,2021-01-14,False,Recruiting,Phase 3,Interventional,"United States, Mexico, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200252
4642,JPRN-jRCT2031200368,JPRN,2021-02-19,2021-03-31,False,Recruiting,Phase 3,Interventional,"UK, Hungary, Poland Rep, United States, Russia, Italy, Mexico, Spain, Peru Rep, Czech Rep, Japan, Germany","A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200368
4643,JPRN-jRCT2031210010,JPRN,2021-04-05,2021-12-04,False,Recruiting,Phase 1,Interventional,Japan,Single and Multiple Dose Study of MK-4482 in Healthy Japanese Adults,72,https://jrct.niph.go.jp/latest-detail/jRCT2031210010
4644,JPRN-jRCT2051200085,JPRN,2020-11-12,2020-11-19,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Phase I / II study of intracutaneous inoculation of COVID-19 DNA vaccine (AG0302-COVID19),20,https://jrct.niph.go.jp/latest-detail/jRCT2051200085
4645,JPRN-jRCT2051200088,JPRN,2020-11-19,2020-11-23,False,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),500,https://jrct.niph.go.jp/latest-detail/jRCT2051200088
4646,JPRN-jRCT2051200159,JPRN,2021-03-19,2021-08-03,False,Not Recruiting,Phase 3,Interventional,Japan,"A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Aerosolized JH509  in Hospitalized Adult Patients with Mild to Moderate COVID 19",385,https://jrct.niph.go.jp/latest-detail/jRCT2051200159
4647,JPRN-jRCT2071200023,JPRN,2020-07-21,2020-07-22,False,Recruiting,Phase 1/Phase 2,Interventional,Japan,Evaluation of Nelfinavir for asymptomatic and mild COVID-19,120,https://jrct.niph.go.jp/latest-detail/jRCT2071200023
4648,JPRN-jRCT2071200041,JPRN,2020-10-12,2020-11-25,False,Recruiting,Phase 2,Interventional,Japan,Therapeutic development of adrenomedullin for severe pneumonia caused by COVID-19,40,https://jrct.niph.go.jp/latest-detail/jRCT2071200041
4649,JPRN-jRCT2071200045,JPRN,2020-10-20,2020-10-21,False,Not Recruiting,Phase 1,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",160,https://jrct.niph.go.jp/latest-detail/jRCT2071200045
4650,JPRN-jRCT2071200078,JPRN,2021-01-07,2021-01-13,False,Recruiting,Phase 2,Interventional,Japan,A randomized double-blind placebo controlled phase 2 clinical trial to assess anti-inflammatory effect of colchicine (DRC3633) in mild to moderately severe COVID-19 patients. - DRC-06C,100,https://jrct.niph.go.jp/latest-detail/jRCT2071200078
4651,JPRN-jRCT2071200109,JPRN,2021-03-08,2021-08-03,False,Recruiting,Phase 1,Interventional,Japan,FOY-305-03:FOY-305 TQT study(COVID-19),39,https://jrct.niph.go.jp/latest-detail/jRCT2071200109
4652,JPRN-jRCT2071200110,JPRN,2021-03-10,2021-03-15,False,Recruiting,Phase 1/Phase 2,Interventional,Japan,"A Phase 1/2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adults and elderly subjects",152,https://jrct.niph.go.jp/latest-detail/jRCT2071200110
4653,JPRN-jRCT2071200117,JPRN,2021-03-29,2021-03-31,False,Recruiting,Phase 1,Interventional,Japan,A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS,22,https://jrct.niph.go.jp/latest-detail/jRCT2071200117
4654,JPRN-jRCTs021200020,JPRN,2020-08-25,2020-08-25,False,Recruiting,Phase 3,Interventional,Japan,Study of the additional effect of Kampo medicine on common cold symptoms in COVID-19 patients,150,https://jrct.niph.go.jp/latest-detail/jRCTs021200020
4655,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-03-04,True,Not Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269
4656,JPRN-jRCTs031200026,JPRN,2020-05-01,2020-11-06,False,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026
4657,JPRN-jRCTs031200124,JPRN,2020-09-17,2020-01-10,True,Recruiting,Not Applicable,Interventional,Japan,COVIPLA-R,59,https://jrct.niph.go.jp/latest-detail/jRCTs031200124
4658,JPRN-jRCTs031200150,JPRN,2020-10-14,2020-11-27,False,Recruiting,Phase 3,Interventional,Japan,Prophylactic study for COVID-19 with Kampo medicines,6000,https://jrct.niph.go.jp/latest-detail/jRCTs031200150
4659,JPRN-jRCTs032200131,JPRN,2020-09-28,2020-08-10,True,Recruiting,Phase 2,Interventional,Japan,PMX-DHP for COVID-19,30,https://jrct.niph.go.jp/latest-detail/jRCTs032200131
4660,JPRN-jRCTs051200036,JPRN,2020-07-27,2020-07-29,False,Recruiting,Phase 2,Interventional,Japan,Efficacy  of nintedanib on severe COVID-19 pneumonia.,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200036
4661,JPRN-jRCTs052200053,JPRN,2020-09-07,2020-11-26,False,Recruiting,Phase 3,Interventional,Japan,Specified clinical trial for ECMO system for COVID-19 resipiratory failure,50,https://jrct.niph.go.jp/latest-detail/jRCTs052200053
4662,JPRN-jRCTs052200157,JPRN,2021-03-17,2021-03-17,False,Recruiting,Not Applicable,Interventional,Japan,Exploratory research on Anti-SARS-CoV-2 testing,20,https://jrct.niph.go.jp/latest-detail/jRCTs052200157
4663,JPRN-jRCTs071200048,JPRN,2020-10-29,2021-04-02,False,Recruiting,Phase 2,Interventional,Japan,Exploratory examination of Efficacy and safety of functional food included 5-aminolevulinic phosphoric acid/sodium ferrous citrate on COVID-19,50,https://jrct.niph.go.jp/latest-detail/jRCTs071200048
4664,JPRN-UMIN000040744,JPRN,2020-06-16,2020-06-22,False,Not Recruiting,Not Applicable,Interventional,Japan,Clinical study to evaluate the efficiency of specific antibody against SARS-CoV-2 for the purpose of its social implementation,5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508
4665,JPRN-UMIN000041421,JPRN,2020-08-14,2020-08-14,False,Not Recruiting,Not Applicable,Interventional,Japan,Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290
4666,JPRN-UMIN000041990,JPRN,2020-10-02,2020-09-29,True,Not Recruiting,Not Applicable,Interventional,Japan,Intervention to promote exercise behavior among older adults under the epidemic of COVID-19,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925
4667,JPRN-UMIN000042384,JPRN,2020-11-16,2020-11-16,False,Recruiting,Not Applicable,Interventional,Japan,Verification of stress relief by introducing online visits to the restrictions on visits of COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379
4668,JPRN-UMIN000042477,JPRN,2020-11-17,2020-11-17,False,Not Recruiting,Not Applicable,Interventional,Japan,Prospective research for early detection of COVID-19 pneumonia using mobile CT vehicle at specialized accommodation facilities,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432
4669,JPRN-UMIN000043350,JPRN,2021-03-08,2021-03-15,False,Not Recruiting,Not Applicable,Interventional,Japan,Clinical trial of laboratory testing for immune response induced by COVID-19 vaccine,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049495
4670,JPRN-UMIN000043369,JPRN,2021-02-18,2021-03-19,False,Not Recruiting,Not Applicable,Interventional,Japan,"Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia. Immune Modulation-2 DOMAIN",136,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049195
4671,JPRN-UMIN000043769,JPRN,2021-03-30,2021-04-05,False,Not Recruiting,Not Applicable,Interventional,Japan,Research on vaccination against SARS-CoV-2 and cross-saliva antibody,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049963
4672,JPRN-UMIN000043788,JPRN,2021-03-30,2021-02-10,True,Recruiting,Not Applicable,Interventional,Japan,A multicenter seroepidemiological study of SARS-CoV-2 antibody prevalence in oral surgery medical staff.,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049983
4673,JPRN-UMIN000043820,JPRN,2021-04-02,2021-04-05,False,Recruiting,Not Applicable,Interventional,Japan,The effectiveness of support to prevent COVID-19 infection and decline in cognitive and physical function for care givers of elderly people with dementia,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049505
4674,JPRN-UMIN000043867,JPRN,2021-04-08,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,Japan,A Study on the Concentration of Inhaled Oxygen when Oxygen is Administered with an Oxygen Mask while Using a Surgical Mask:A study on the appropriate oxygen administration method under Covid 19 epidemic conditions.,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050077
4675,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,Not Recruiting,Phase 3,Interventional,"Canada, United States",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,1312,https://clinicaltrials.gov/show/NCT04308668
4676,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,False,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, Canada, Italy, Brazil, Israel, Spain, Japan, France, Germany",Sarilumab COVID-19,420,https://clinicaltrials.gov/show/NCT04327388
4677,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Not Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,436,https://clinicaltrials.gov/show/NCT04331054
4678,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-09-04,False,Recruiting,Phase 3,Interventional,"Ghana, Australia, South Africa, Ireland, United Kingdom, Zambia, Netherlands, Canada, United States, Uganda, Zimbabwe",CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,30000,https://clinicaltrials.gov/show/NCT04333732
4679,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,214,https://clinicaltrials.gov/show/NCT04335097
4680,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,False,Not Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,5,https://clinicaltrials.gov/show/NCT04338074
4681,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,Not Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,180,https://clinicaltrials.gov/show/NCT04343989
4682,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,False,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,70,https://clinicaltrials.gov/show/NCT04344561
4683,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Not Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,350,https://clinicaltrials.gov/show/NCT04345523
4684,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,48,https://clinicaltrials.gov/show/NCT04345653
4685,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,False,Not Recruiting,Phase 3,Interventional,"Argentina, United Kingdom, Canada, United States, Brazil, Mexico, India",Dapagliflozin in Respiratory Failure in Patients With COVID-19,1250,https://clinicaltrials.gov/show/NCT04350593
4686,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Not Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,57,https://clinicaltrials.gov/show/NCT04354610
4687,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,Not Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,130,https://clinicaltrials.gov/show/NCT04354870
4688,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-09-03,False,Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,212,https://clinicaltrials.gov/show/NCT04357457
4689,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-07-03,False,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04359511
4690,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Plasma Therapy of COVID-19 in Severely Ill Patients,223,https://clinicaltrials.gov/show/NCT04359810
4691,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,False,Not Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,120,https://clinicaltrials.gov/show/NCT04361474
4692,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Not Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,465,https://clinicaltrials.gov/show/NCT04362085
4693,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,Not Recruiting,Phase 2,Interventional,United States,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,384,https://clinicaltrials.gov/show/NCT04364737
4694,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,Not Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,10,https://clinicaltrials.gov/show/NCT04365699
4695,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-18,False,Not Recruiting,Phase 3,Interventional,Denmark,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,1293,https://clinicaltrials.gov/show/NCT04373291
4696,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,False,Not Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,46,https://clinicaltrials.gov/show/NCT04375397
4697,NCT04383002,ClinicalTrials.gov,2020-05-01,2020-09-02,False,Not Recruiting,Phase 1,Interventional,Canada,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),21,https://clinicaltrials.gov/show/NCT04383002
4698,NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,340,https://clinicaltrials.gov/show/NCT04383613
4699,NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,True,Not Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,200,https://clinicaltrials.gov/show/NCT04397523
4700,NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,40,https://clinicaltrials.gov/show/NCT04399980
4701,NCT04409834,ClinicalTrials.gov,2020-05-28,2020-08-05,False,Recruiting,Phase 4,Interventional,United States,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,750,https://clinicaltrials.gov/show/NCT04409834
4702,NCT04419623,ClinicalTrials.gov,2020-06-03,2020-07-09,False,Not Recruiting,Phase 1,Interventional,United States,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,7,https://clinicaltrials.gov/show/NCT04419623
4703,NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,True,Not Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,142,https://clinicaltrials.gov/show/NCT04420247
4704,NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,True,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,60,https://clinicaltrials.gov/show/NCT04422353
4705,NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,False,Not Recruiting,Phase 1/Phase 2,Interventional,"Chile, Moldova, Republic of, United States, Mexico, Brazil, Romania","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",6900,https://clinicaltrials.gov/show/NCT04426695
4706,NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,True,Not Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),72,https://clinicaltrials.gov/show/NCT04438980
4707,NCT04442230,ClinicalTrials.gov,2020-06-17,2020-10-10,False,Recruiting,Phase 2,Interventional,United States,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),96,https://clinicaltrials.gov/show/NCT04442230
4708,NCT04444700,ClinicalTrials.gov,2020-06-22,2020-07-04,False,Not Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,465,https://clinicaltrials.gov/show/NCT04444700
4709,NCT04475120,ClinicalTrials.gov,2020-07-16,2020-04-15,True,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,92,https://clinicaltrials.gov/show/NCT04475120
4710,NCT04482621,ClinicalTrials.gov,2020-07-21,2020-09-14,False,Recruiting,Phase 2,Interventional,United States,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,40,https://clinicaltrials.gov/show/NCT04482621
4711,NCT04482686,ClinicalTrials.gov,2020-07-21,2020-12-09,False,Recruiting,Phase 2,Interventional,United States,Trial of Combination Therapy to Treat COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04482686
4712,NCT04487990,ClinicalTrials.gov,2020-07-23,2020-06-29,True,Not Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,118,https://clinicaltrials.gov/show/NCT04487990
4713,NCT04494646,ClinicalTrials.gov,2020-07-29,2020-09-08,False,Not Recruiting,Phase 2,Interventional,United States,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),40,https://clinicaltrials.gov/show/NCT04494646
4714,NCT04501445,ClinicalTrials.gov,2020-08-04,2020-09-14,False,Not Recruiting,Not Applicable,Interventional,United States,Psychological Symptoms and Families of COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04501445
4715,NCT04505592,ClinicalTrials.gov,2020-08-06,2020-09-25,False,Recruiting,Phase 2,Interventional,United States,Tenecteplase in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04505592
4716,NCT04516759,ClinicalTrials.gov,2020-08-14,2020-08-12,True,Not Recruiting,Phase 2,Interventional,"Czech Republic, United Kingdom, Romania",AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,156,https://clinicaltrials.gov/show/NCT04516759
4717,NCT04537806,ClinicalTrials.gov,2020-09-01,2020-12-18,False,Recruiting,Phase 3,Interventional,United States,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,100,https://clinicaltrials.gov/show/NCT04537806
4718,NCT04555213,ClinicalTrials.gov,2020-09-16,2020-09-30,False,Not Recruiting,Phase 1,Interventional,"Moldova, Republic of",A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,41,https://clinicaltrials.gov/show/NCT04555213
4719,NCT04579393,ClinicalTrials.gov,2020-10-06,2020-10-08,False,Not Recruiting,Phase 2,Interventional,United States,Fostamatinib for Hospitalized Adults With COVID-19,62,https://clinicaltrials.gov/show/NCT04579393
4720,NCT04584437,ClinicalTrials.gov,2020-10-09,2021-05-25,False,Not Recruiting,Not Applicable,Interventional,Canada,Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure,0,https://clinicaltrials.gov/show/NCT04584437
4721,NCT04604184,ClinicalTrials.gov,2020-10-26,2020-11-03,False,Not Recruiting,Phase 2,Interventional,"Chile, Puerto Rico, United States, Mexico, Brazil, Spain",ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,129,https://clinicaltrials.gov/show/NCT04604184
4722,NCT04619706,ClinicalTrials.gov,2020-11-05,2020-12-14,False,Recruiting,Phase 2,Interventional,United States,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,350,https://clinicaltrials.gov/show/NCT04619706
4723,NCT04631666,ClinicalTrials.gov,2020-11-05,2020-12-08,False,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion,57,https://clinicaltrials.gov/show/NCT04631666
4724,NCT04632368,ClinicalTrials.gov,2020-11-11,2020-11-20,False,Not Recruiting,Not Applicable,Interventional,United States,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,80,https://clinicaltrials.gov/show/NCT04632368
4725,NCT04644198,ClinicalTrials.gov,2020-11-18,2021-06-01,False,Recruiting,Phase 2,Interventional,Jamaica,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,30,https://clinicaltrials.gov/show/NCT04644198
4726,NCT04647669,ClinicalTrials.gov,2020-10-15,2021-06-01,False,Not Recruiting,Phase 3,Interventional,Jamaica,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,100,https://clinicaltrials.gov/show/NCT04647669
4727,NCT04649736,ClinicalTrials.gov,2020-11-30,2020-10-26,True,Recruiting,Not Applicable,Interventional,Peru,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,108,https://clinicaltrials.gov/show/NCT04649736
4728,NCT04674566,ClinicalTrials.gov,2020-12-17,2021-04-21,False,Recruiting,Phase 1/Phase 2,Interventional,Germany,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,45,https://clinicaltrials.gov/show/NCT04674566
4729,NCT04707703,ClinicalTrials.gov,2021-01-08,2021-03-16,False,Recruiting,Phase 3,Interventional,United States,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,162,https://clinicaltrials.gov/show/NCT04707703
4730,NCT04742725,ClinicalTrials.gov,2021-02-03,2021-05-23,False,Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Evaluate the Efficacy and Safety of Prothioneâ„¢ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),200,https://clinicaltrials.gov/show/NCT04742725
4731,NCT04771013,ClinicalTrials.gov,2021-02-24,2021-02-10,True,Not Recruiting,Phase 2,Interventional,Honduras,Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras,22,https://clinicaltrials.gov/show/NCT04771013
4732,NCT04779450,ClinicalTrials.gov,2021-03-01,2021-08-01,False,Recruiting,Not Applicable,Interventional,Brazil,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors",30,https://clinicaltrials.gov/show/NCT04779450
4733,NCT04783025,ClinicalTrials.gov,2021-02-25,2021-06-01,False,Recruiting,Not Applicable,Interventional,Hong Kong,A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes,188,https://clinicaltrials.gov/show/NCT04783025
4734,NCT04789603,ClinicalTrials.gov,2021-03-04,2021-05-10,False,Recruiting,Not Applicable,Interventional,Spain,Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19,50,https://clinicaltrials.gov/show/NCT04789603
4735,NCT04799392,ClinicalTrials.gov,2021-03-14,2021-04-01,False,Recruiting,Not Applicable,Interventional,United States,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,339,https://clinicaltrials.gov/show/NCT04799392
4736,NCT04801836,ClinicalTrials.gov,2021-03-12,2020-11-19,True,Not Recruiting,Phase 2,Interventional,"Hungary, Russian Federation, Poland, Belgium",Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection,162,https://clinicaltrials.gov/show/NCT04801836
4737,NCT04818736,ClinicalTrials.gov,2021-03-24,2021-04-15,False,Not Recruiting,Phase 4,Interventional,Canada,COVID-19 Vaccine For Indirect Protection,0,https://clinicaltrials.gov/show/NCT04818736
4738,NCT04824469,ClinicalTrials.gov,2021-03-25,2021-05-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life",128,https://clinicaltrials.gov/show/NCT04824469
4739,NCT04832919,ClinicalTrials.gov,2021-04-02,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures,810,https://clinicaltrials.gov/show/NCT04832919
4740,NCT04839965,ClinicalTrials.gov,2021-04-08,2021-05-01,False,Recruiting,Phase 2,Interventional,United States,Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen,200,https://clinicaltrials.gov/show/NCT04839965
4741,NCT04842435,ClinicalTrials.gov,2021-04-12,2021-04-12,False,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Clinical Study in the Treatment of Patients With Moderate Course of COVID-19,376,https://clinicaltrials.gov/show/NCT04842435
4742,NCT04847102,ClinicalTrials.gov,2021-04-13,2021-05-28,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above,28000,https://clinicaltrials.gov/show/NCT04847102
4743,NCT04863638,ClinicalTrials.gov,2021-04-27,2021-04-29,False,Recruiting,Phase 4,Interventional,China,"A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated",4400,https://clinicaltrials.gov/show/NCT04863638
4744,NCT04870606,ClinicalTrials.gov,2021-04-27,2021-04-24,True,Recruiting,Phase 3,Interventional,United States,Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness,668,https://clinicaltrials.gov/show/NCT04870606
4745,NCT04871646,ClinicalTrials.gov,2021-04-29,2021-06-01,False,Not Recruiting,Phase 3,Interventional,South Korea,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314,586,https://clinicaltrials.gov/show/NCT04871646
4746,NCT04872686,ClinicalTrials.gov,2021-04-26,2021-04-10,True,Recruiting,Phase 3,Interventional,Bangladesh,Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx,798,https://clinicaltrials.gov/show/NCT04872686
4747,NCT04880109,ClinicalTrials.gov,2021-04-29,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.,80,https://clinicaltrials.gov/show/NCT04880109
4748,NCT04880642,ClinicalTrials.gov,2021-04-28,2021-07-01,False,Not Recruiting,Phase 3,Interventional,United States,A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects,600,https://clinicaltrials.gov/show/NCT04880642
4749,NCT04881214,ClinicalTrials.gov,2020-07-03,2020-07-01,True,Recruiting,Not Applicable,Interventional,Switzerland,"COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program",60,https://clinicaltrials.gov/show/NCT04881214
4750,NCT04883203,ClinicalTrials.gov,2021-04-20,2020-04-22,True,Not Recruiting,Phase 3,Interventional,Tunisia,The Effect of Vitamin D Supplementation on COVID-19 Recovery,130,https://clinicaltrials.gov/show/NCT04883203
4751,NCT04883528,ClinicalTrials.gov,2021-05-06,2021-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019,50,https://clinicaltrials.gov/show/NCT04883528
4752,NCT04884529,ClinicalTrials.gov,2021-05-07,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,Canada,Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial,60,https://clinicaltrials.gov/show/NCT04884529
4753,NCT04885517,ClinicalTrials.gov,2021-05-11,2021-02-01,True,Recruiting,Not Applicable,Interventional,Italy,"Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus",72,https://clinicaltrials.gov/show/NCT04885517
4754,NCT04886362,ClinicalTrials.gov,2021-05-10,2021-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectina Colombia (IVERCOL),966,https://clinicaltrials.gov/show/NCT04886362
4755,NCT04886414,ClinicalTrials.gov,2021-05-10,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-based Care and Hand Hygiene Interventions in Honduras,1647,https://clinicaltrials.gov/show/NCT04886414
4756,NCT04887116,ClinicalTrials.gov,2021-05-13,2021-07-01,False,Not Recruiting,Phase 1,Interventional,United States,Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic,20,https://clinicaltrials.gov/show/NCT04887116
4757,NCT04887129,ClinicalTrials.gov,2021-05-13,2021-05-03,True,Recruiting,Not Applicable,Interventional,United States,Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD),950,https://clinicaltrials.gov/show/NCT04887129
4758,NCT04887207,ClinicalTrials.gov,2021-05-06,2021-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Global Phase III Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells),40000,https://clinicaltrials.gov/show/NCT04887207
4759,NCT04887233,ClinicalTrials.gov,2021-05-13,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19),60,https://clinicaltrials.gov/show/NCT04887233
4760,NCT04887272,ClinicalTrials.gov,2021-03-02,2021-05-15,False,Not Recruiting,Not Applicable,Interventional,United States,"Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19",40,https://clinicaltrials.gov/show/NCT04887272
4761,NCT04887350,ClinicalTrials.gov,2021-05-05,2021-06-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,SSIPP vs. PST vs. WLC,45,https://clinicaltrials.gov/show/NCT04887350
4762,NCT04888832,ClinicalTrials.gov,2021-05-07,2022-01-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of Work Requirements in SNAP in Virginia,12500,https://clinicaltrials.gov/show/NCT04888832
4763,NCT04889274,ClinicalTrials.gov,2021-05-06,2021-05-10,False,Recruiting,Phase 1,Interventional,United Kingdom,Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19),98,https://clinicaltrials.gov/show/NCT04889274
4764,NCT04894721,ClinicalTrials.gov,2021-05-06,2021-03-20,True,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC),750,https://clinicaltrials.gov/show/NCT04894721
4765,NCT04895449,ClinicalTrials.gov,2021-04-24,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19",240,https://clinicaltrials.gov/show/NCT04895449
4766,ACTRN12621000567820,ANZCTR,2021-05-14,2021-01-06,True,Not Recruiting,Not Applicable,Interventional,Australia,Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a parallel crossover randomised controlled trial,400,https://anzctr.org.au/ACTRN12621000567820.aspx
4767,ACTRN12621000607875,ANZCTR,2021-05-20,2021-01-06,True,Not Recruiting,Phase 1,Interventional,Australia,INNA-051 intranasal safety and tolerability study,124,https://anzctr.org.au/ACTRN12621000607875.aspx
4768,ISRCTN13857593,ISRCTN,2021-05-12,2021-05-17,False,Recruiting,Not Applicable,Interventional,Italy,Study on the performance and safety of Sentinox in COVID-19 patients,57,http://isrctn.com/ISRCTN13857593
4769,ISRCTN85874083,ISRCTN,2021-02-09,2021-02-15,False,Recruiting,Not Applicable,Interventional,India,Comparing cotrimoxazole to standard care for the treatment of severe coronavirus (COVID-19) infection in hospitalised patients,200,http://isrctn.com/ISRCTN85874083
4770,ISRCTN51124684,ISRCTN,2021-01-13,2021-01-05,True,Recruiting,Not Applicable,Interventional,United Kingdom,Can drinking beetroot juice prevent and reduce the severity of winter viral infections in residential and nursing homes?,416,http://isrctn.com/ISRCTN51124684
4771,ISRCTN10989132,ISRCTN,2020-11-06,2021-01-07,False,Recruiting,Not Applicable,Interventional,United Kingdom,ASK: Improving access to kidney transplantation,60,http://isrctn.com/ISRCTN10989132
4772,ISRCTN79623250,ISRCTN,2020-11-04,2020-04-30,True,Not Recruiting,Not Applicable,Interventional,United Kingdom,The digital Hope programme for people living with cancer during COVID-19,40,http://isrctn.com/ISRCTN79623250
4773,ChiCTR2100043210,ChiCTR,2021-02-08,2021-02-20,False,Recruiting,Not Applicable,Interventional,China,"Clinical study on the efficacy evaluation of traditional Chinese medicine auricular point acupressure in alleviating pain, fatigue and gastrointestinal adverse reactions after injection of novel coronavirus-19 vaccines",360,http://www.chictr.org.cn/showproj.aspx?proj=121519
4774,ChiCTR2100043108,ChiCTR,2021-02-05,2020-07-01,True,Recruiting,Phase 4,Interventional,China,"A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescence",200,http://www.chictr.org.cn/showproj.aspx?proj=66027
4775,ChiCTR2100043045,ChiCTR,2021-02-04,2021-01-29,True,Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qing Jin Yi Qi granule in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia(COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=121511
4776,CTRI/2021/03/032199,CTRI,2021-03-22,2021-03-31,False,Not Recruiting,Phase 3,Interventional,India,Pirfenidone for COVID-19 related lung fibrosis,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49593
4777,CTRI/2021/03/032225,CTRI,2021-03-23,2021-03-30,False,Not Recruiting,Phase 3,Interventional,India,Homoeopathic treatment of respiratory sequelae of post- covid cases: an open label prospective study,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50734
4778,CTRI/2021/03/032293,CTRI,2021-03-25,2021-04-20,False,Not Recruiting,Phase 3,Interventional,India,Associated lung condition in viral infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45649
4779,CTRI/2021/03/032410,CTRI,2021-03-30,2021-05-15,False,Not Recruiting,Not Applicable,Interventional,India,"Effect of Ã¢??Kriya YogaÃ¢?? on brain activity and perceived stress in health care providers, during COVID-19 Pandemic",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54078
4780,CTRI/2021/03/032369,CTRI,2021-03-30,2021-01-04,True,Not Recruiting,Phase 2,Interventional,India,Tele-Yoga programme for work-from-home employees due to Covid-19 pandemic,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52318
4781,CTRI/2021/03/032385,CTRI,2021-03-30,2021-05-04,False,Not Recruiting,Not Applicable,Interventional,India,"Use of three different drugs for reduction in severity of COVID-19 disease using Arterial Stiffness as a clinical marker
",160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54420
4782,CTRI/2021/03/032444,CTRI,2021-03-31,2021-03-04,True,Not Recruiting,Not Applicable,Interventional,India,A clinical trial of Yoga On Immunity In Doctors During COVID 19 Pandemic- A Pilot Study,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54405
4783,CTRI/2021/04/032501,CTRI,2021-04-01,2021-04-15,False,Not Recruiting,Not Applicable,Interventional,India,Comparison of effect of High Flow Nasal Cannula with Continuous Positive Airway Pressure in reducing incidence of invasive mechanical ventilation in severe COVID 19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54364
4784,CTRI/2021/04/032541,CTRI,2021-04-05,2024-10-04,False,Recruiting,Phase 2,Interventional,India,Clinical trial of Madhav Rasayan in subjects of COVID 19.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54622
4785,CTRI/2021/04/032531,CTRI,2021-04-05,2021-12-04,False,Recruiting,Phase 2,Interventional,India,Clinical trial to Compare effects and safety of Etanercept in Patients with Moderate COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53930
4786,CTRI/2021/04/032555,CTRI,2021-04-06,2021-07-04,False,Not Recruiting,Phase 2,Interventional,India,"A Clinical Trial to Assess the Efficacy, Safety and tolerability of Colchicine for Covid-19 Disease Treatment in Indian Patients.",84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54560
4787,CTRI/2021/04/032593,CTRI,2021-04-07,2021-04-15,False,Recruiting,Not Applicable,Interventional,India,Vitamin D and Zinc for COVID-19 patients,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54510
4788,CTRI/2021/04/032647,CTRI,2021-04-08,2021-12-04,False,Not Recruiting,Phase 2,Interventional,India,To see the effect of Unani formulation as an add-on therapy along with Allopathic treatment in the Covid-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53666
4789,CTRI/2021/04/032688,CTRI,2021-04-08,2021-04-19,False,Recruiting,Phase 1/Phase 2,Interventional,India,Safety and immunogenicity study of mRNA based vaccine (HGCO19) against COVID-19 in healthy adult participants.,620,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54697
4790,CTRI/2021/04/032648,CTRI,2021-04-08,2021-10-05,False,Recruiting,Phase 3,Interventional,India,"study to access effectiveness of new drug therapy (aspirin,atorvastatin and nicorandil) in covid-19",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51131
4791,CTRI/2021/04/032755,CTRI,2021-04-12,2021-04-18,False,Not Recruiting,Phase 4,Interventional,India,Ayurveda medicines role in Treatment of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54896
4792,CTRI/2021/04/032766,CTRI,2021-04-13,2021-04-15,False,Not Recruiting,Not Applicable,Interventional,India,To Compare and Evaluate the Effect of Corona affected Patients Undergoing Current Treatment Along with Food Supplements,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54786
4793,CTRI/2021/04/032804,CTRI,2021-04-13,2021-04-18,False,Not Recruiting,Phase 3,Interventional,India,Effect of AEV01 (Kutki) for Mild COVID19 Elderly patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54539
4794,CTRI/2021/04/032791,CTRI,2021-04-13,2021-04-06,True,Not Recruiting,Phase 3,Interventional,"Argentina, Portugal, United Kingdom, Colombia, Belgium, Netherlands, Serbia , United States, Italy, Brazil, Israel, Mexico, Spain, France, India, Germany, Romania",Study to Assess Efficacy and Safety of Inhaled Interferon-Beta Therapy for COVID-19,610,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53300
4795,CTRI/2021/04/032788,CTRI,2021-04-13,2021-04-27,False,Not Recruiting,Not Applicable,Interventional,India,Effect of Telerehabilitation based Physiotherapeutic exercises on Physical Function and Quality of life. in patients with COVID 19.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55016
4796,CTRI/2021/04/032845,CTRI,2021-04-15,2021-08-05,False,Not Recruiting,Not Applicable,Interventional,India,Yoga interventions for the management of COVID 19 in asymptomatic patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52521
4797,CTRI/2021/04/032952,CTRI,2021-04-20,2021-04-25,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Role of Kabasura Kudineer in managing Covid patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55118
4798,CTRI/2021/04/032976,CTRI,2021-04-20,2021-01-06,True,Not Recruiting,Not Applicable,Interventional,India,"HIV Selftesting Implementation Study

",118440,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50046
4799,CTRI/2021/04/032989,CTRI,2021-04-22,2021-04-27,False,Recruiting,Not Applicable,Interventional,India,"A study to assess the safety and efficacy of ""pHoxvedic"", an ayurvedic nasal spray in prevention COVID-19 infection in healthy high-risk healthcare professionals
",648,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55273
4800,CTRI/2021/04/033058,CTRI,2021-04-23,2021-01-05,True,Recruiting,Not Applicable,Interventional,India,Effect of early mobility in patients with severe COVID-19 admitted in ICU,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46761
4801,CTRI/2021/04/033073,CTRI,2021-04-23,2021-04-24,False,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for the Treatment of Fever due to COVID19 and addressing the associated Respiratory distress.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55218
4802,CTRI/2021/04/033118,CTRI,2021-04-26,2021-04-30,False,Recruiting,Phase 3,Interventional,India,A clinical trial of Intravenous Aviptadil along with standard treatment in severe COVID-19 Patients with respiratory failure.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53211
4803,CTRI/2021/04/033175,CTRI,2021-04-27,2021-04-30,False,Recruiting,Phase 3,Interventional,India,"PROVE Trial - Positive pRessure therapy in COVid-19 infEction 
",1800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44604
4804,CTRI/2021/04/033158,CTRI,2021-04-27,2021-05-17,False,Not Recruiting,Phase 2,Interventional,India,Low dose X-ray therapy for COVID-19,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55418
4805,CTRI/2021/04/033143,CTRI,2021-04-27,2021-03-05,True,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on Covid 19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55493
4806,CTRI/2021/04/033142,CTRI,2021-04-27,2021-03-05,True,Not Recruiting,Not Applicable,Interventional,India,"To see how Methylene blue drug which is used to increase O2 saturation levels, is helpful in treating Covid 19 patients.",10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55513
4807,CTRI/2021/04/033188,CTRI,2021-04-28,2021-05-05,False,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on Covid 19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55568
4808,CTRI/2021/04/033201,CTRI,2021-04-28,2021-05-05,False,Not Recruiting,Not Applicable,Interventional,India,Gayathri mantra chanting for the Stress and Quality Of Life in  COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52520
4809,CTRI/2021/04/033257,CTRI,2021-04-29,2021-05-14,False,Not Recruiting,Not Applicable,Interventional,India,Effect of yoga on immunity in COVID positive patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55549
4810,CTRI/2021/04/033263,CTRI,2021-04-30,2021-06-05,False,Not Recruiting,Not Applicable,Interventional,India,A comparison of high dose steroid and tocilizumab in COVID ARDS,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55585
4811,CTRI/2021/04/033264,CTRI,2021-04-30,2021-05-28,False,Not Recruiting,Not Applicable,Interventional,India,Effect of OM chanting on             management Of   Stress and Quality Of Life in COVID 19 Patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51322
4812,CTRI/2021/04/033260,CTRI,2021-04-30,2021-04-30,False,Not Recruiting,Not Applicable,Interventional,India,Pranayama and meditation to decrease COVID-19 related anxiety,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54998
4813,CTRI/2021/05/033303,CTRI,2021-05-03,2021-05-05,False,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the impact of guided meditation on  anxiety, coping strategy and sleep quality among COVID-19 patients admitted in AIIMS, New Delhi.",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48255
4814,CTRI/2021/05/033339,CTRI,2021-05-04,2021-09-05,False,Not Recruiting,Phase 3,Interventional,India,To evaluate the efficacy of BIOWIN/BIOWN in asymptomatic mild Covid-19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55649
4815,CTRI/2021/05/033374,CTRI,2021-05-04,2021-05-25,False,Not Recruiting,Not Applicable,Interventional,India,Yoga based stress reduction program for health care professionals,188,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55771
4816,CTRI/2021/05/033402,CTRI,2021-05-05,2021-05-16,False,Not Recruiting,Not Applicable,Interventional,India,Surviving Covid 19 and Beyond,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55460
4817,CTRI/2021/05/033472,CTRI,2021-05-07,2021-05-17,False,Not Recruiting,Phase 2,Interventional,India,Clinical trial of CIM-Meg19 to combat the severity of disorders in COVID-19 and post COVID-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55846
4818,CTRI/2021/05/033523,CTRI,2021-05-10,2021-05-17,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,A comparative study of High dose corticosteroids pulse versus standard of care in severe COVID19 pneumonia,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55876
4819,CTRI/2021/05/033499,CTRI,2021-05-10,2021-05-14,False,Recruiting,Not Applicable,Interventional,India,Efficacy of Karpoor and Ajwain inhalation in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55679
4820,CTRI/2021/05/033537,CTRI,2021-05-11,2021-05-24,False,Not Recruiting,Not Applicable,Interventional,India,Will treatment with a drug named colchicine be useful in treating Corona virus infection in kidney failure patients who are on regular dialysis?,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55323
4821,CTRI/2021/05/033543,CTRI,2021-05-11,2021-05-17,False,Not Recruiting,Phase 2,Interventional,India,Clinical trial of CIM-Meg19 in COVID-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55879
4822,CTRI/2021/05/033544,CTRI,2021-05-11,2021-05-20,False,Not Recruiting,Phase 2,Interventional,India,Comparison of efficacy of Indomethacin vs Paracetamol along with standard care of treatment in mild and moderate Covid-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55941
4823,CTRI/2021/05/033546,CTRI,2021-05-11,2021-05-31,False,Not Recruiting,Phase 2,Interventional,"India, United Kingdom, Mexico",COVID-19 viral disease,1407,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48547
4824,CTRI/2021/05/033576,CTRI,2021-05-12,2021-05-22,False,Not Recruiting,Phase 2,Interventional,India,"Study to investigate the safety and efficacy of the health supplements ImmunoSEB and ProbioSEB CSC3 on patients suffering from COVID-19 Induced Fatigue/Post Viral Fatigue Syndrome.

",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54949
4825,CTRI/2021/05/033599,CTRI,2021-05-13,2021-05-25,False,Not Recruiting,Not Applicable,Interventional,India,"Effect of Online Classroom in Infection Prevention
and Control Training of Undergraduate Students during COVID-l9 Pandemic",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55286
4826,CTRI/2021/05/033622,CTRI,2021-05-14,2021-05-21,False,Not Recruiting,Not Applicable,Interventional,India,Plasma therapy (IgG) in moderate to severe COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56002
4827,CTRI/2021/05/033623,CTRI,2021-05-16,2021-05-22,False,Not Recruiting,Phase 4,Interventional,India,"Recording of the effects of select AYUSH drugs, Ayush-64 and Kabasura Kudineer in Covid-19 patients in home isolation.",500000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56044
4828,CTRI/2021/05/033626,CTRI,2021-05-17,2021-05-18,False,Recruiting,Not Applicable,Interventional,India,A study of Ayurvedic medicine Ã¢??CoReachÃ¢?? in COVID-19 positive patients.,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54292
4829,CTRI/2021/05/033651,CTRI,2021-05-17,2021-05-25,False,Not Recruiting,Not Applicable,Interventional,India,"A clinical study on Ayurveda intervention along with Standard Care Treatment in mild to moderate patients of COVID-19 


",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55951
4830,CTRI/2021/05/033665,CTRI,2021-05-18,2021-05-24,False,Not Recruiting,Phase 3,Interventional,India,A Clinical Study to Test the Side Effects and Antibody Levels after Hetero-COVID Vaccine in Healthy Adults,228,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56122
4831,CTRI/2021/05/033703,CTRI,2021-05-20,2021-05-23,False,Not Recruiting,Phase 3,Interventional,India,A Clinical Study to Test the Effectiveness and Side Effects of Hetero-Tocilizumab in Severe COVID-19 Patients,188,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56095
4832,CTRI/2021/05/033693,CTRI,2021-05-20,2021-05-24,False,Not Recruiting,Phase 3,Interventional,India,"A multi-center, Phase- III clinical trial of Molnupiravir capsules.",1218,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55936
4833,CTRI/2021/05/033696,CTRI,2021-05-20,2021-05-25,False,Not Recruiting,Phase 3,Interventional,India,Emergency management of low oxygen level using ayurved formulation with special referemce to SPO2,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56026
4834,CTRI/2021/05/033695,CTRI,2021-05-20,2021-05-25,False,Not Recruiting,Phase 3,Interventional,India,Role of Kankasav in the management of spo2 level of covid 19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56031
4835,KCT0006152,CRIS,2021-05-20,2021-05-03,True,Not Recruiting,Not Applicable,Interventional,South Korea,Feasibility of detection of COVID-19 in Self-Obtained Oral Sample.,34,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19307
4836,IRCT20200330046897N1,IRCT,2021-04-22,2021-04-21,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of spirulina extract on patients with coronavirus,105,http://en.irct.ir/trial/46918
4837,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",30,http://en.irct.ir/trial/46933
4838,IRCT20201111049347N1,IRCT,2021-04-16,2021-04-21,False,Recruiting,Phase 3,Interventional,Iran,Effectiveness of enriched garlic extract in patients with COVID-19,248,http://en.irct.ir/trial/52245
4839,IRCT20201127049504N1,IRCT,2020-12-25,2020-12-25,False,Not Recruiting,Not Applicable,Interventional,Iran,Effect of acupuncture and warm cupping on clinical manifestations of COVID-19,90,http://en.irct.ir/trial/52621
4840,IRCT20201204049600N1,IRCT,2021-04-06,2021-05-31,False,Not Recruiting,Phase 3,Interventional,Iran,Investigating the impact of breathing exercises on general health of patient infected with Covid-19,70,http://en.irct.ir/trial/52772
4841,IRCT20200904048616N1,IRCT,2021-05-06,2021-05-21,False,Recruiting,Phase 3,Interventional,Iran,efficacy and safety of adding fluoxetine to therapeutic regimen of patients with COVID-19 pneumonia,72,http://en.irct.ir/trial/52777
4842,IRCT20201229049872N1,IRCT,2021-04-22,2021-01-20,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Colchicine in Treatment of Covid-19,80,http://en.irct.ir/trial/53333
4843,IRCT20201229049873N1,IRCT,2021-05-23,2021-01-22,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Infliximab effectiveness in COVID-19 patients,40,http://en.irct.ir/trial/53791
4844,IRCT20171203037733N3,IRCT,2021-05-11,2021-05-20,False,Recruiting,Not Applicable,Interventional,Iran,The effect of body position on vital signs and comfort pattern of patients with coronary disease,90,http://en.irct.ir/trial/54252
4845,IRCT20170903036041N3,IRCT,2021-05-23,2021-05-05,True,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of Modafinil on improving consciousness with COVID-19,60,http://en.irct.ir/trial/54376
4846,IRCT20210222050457N1,IRCT,2021-04-20,2021-03-04,True,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Determining the effect of Pinen.Hydronoplacton.Ribonucleic acid (PHR) spray  in reducing the length of hospital stay of patients with Covid-19,188,http://en.irct.ir/trial/54525
4847,IRCT20210111050007N1,IRCT,2021-05-18,2021-04-09,True,Recruiting,Not Applicable,Interventional,Iran,The effects of resistance training associated with blood-flow restriction on the quadriceps muscles in CORONA virus survivors after recovery,18,http://en.irct.ir/trial/54533
4848,IRCT20180612040068N1,IRCT,2021-04-19,2021-03-05,True,Not Recruiting,Phase 3,Interventional,Iran,To study the effect of Metronidazole and Ivermectin in hospitalized patients with COVID-19.,135,http://en.irct.ir/trial/54625
4849,IRCT20210303050558N1,IRCT,2021-04-24,2021-04-25,False,Not Recruiting,Phase 3,Interventional,Iran,"Efficacy, safety and immunogenicity of Soberana 02 vaccine (product of Finlay Institute): a double-blind, randomized, placebo-controlled phase III clinical trial",24000,http://en.irct.ir/trial/54833
4850,IRCT20180103038199N4,IRCT,2021-04-24,2021-04-30,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Basil on outpatients with COVID-19,140,http://en.irct.ir/trial/54965
4851,IRCT20200611047727N4,IRCT,2021-04-28,2021-04-19,True,Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of high flow oxygen delivery under different temperatures in COVID-19 patients,30,http://en.irct.ir/trial/55024
4852,IRCT20200325046854N2,IRCT,2021-05-03,2021-03-16,True,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19,70,http://en.irct.ir/trial/55085
4853,IRCT20210317050734N1,IRCT,2021-05-03,2021-05-20,False,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of neonatal health index and anxiety of active and inactive pregnant women with Covid19,50,http://en.irct.ir/trial/55130
4854,IRCT20180205038626N8,IRCT,2021-05-09,2021-04-21,True,Recruiting,Phase 2,Interventional,Iran,"Effects of green tea consumption on fatigue, depression and anxiety scores in COVID-19 patients",84,http://en.irct.ir/trial/55208
4855,IRCT20200721048159N2,IRCT,2021-04-22,2021-05-04,False,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup in the treatment of COVID-19,66,http://en.irct.ir/trial/55368
4856,IRCT20190101042197N2,IRCT,2021-04-19,2021-03-25,True,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosome therapy in COVID-19 patients,72,http://en.irct.ir/trial/55380
4857,IRCT20210327050775N1,IRCT,2021-05-25,2021-05-22,True,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D on the prognosis of patients with COVID-19,120,http://en.irct.ir/trial/55405
4858,IRCT20210406050871N1,IRCT,2021-04-25,2021-04-30,False,Recruiting,Not Applicable,Interventional,Iran,The effect of percutaneous electrical nerve stimulation on the respiratory outcomes of patients with Covid-19 with moderate pulmonary involvement,120,http://en.irct.ir/trial/55531
4859,IRCT20201129049525N1,IRCT,2021-05-16,2021-05-20,False,Recruiting,Not Applicable,Interventional,Iran,The effect of aerobic training at home and vitamin D supplementation in MS During Covid-19 quarantine,36,http://en.irct.ir/trial/55602
4860,IRCT20200411047029N1,IRCT,2021-04-24,2021-04-21,True,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of PHR-160 spray in recovery of hospitalized patients with Covid-19 in Isfahan province in 1399,198,http://en.irct.ir/trial/55615
4861,IRCT20200914048719N2,IRCT,2021-05-03,2021-04-21,True,Not Recruiting,Not Applicable,Interventional,Iran,The Efficacy of  Positive Psychological Intervention (PPI) on Improving Well-Being Among Students of Hamadan Universities,252,http://en.irct.ir/trial/55619
4862,IRCT20210413050957N1,IRCT,2021-05-01,2021-05-05,False,Recruiting,Phase 3,Interventional,Iran,Survey the effect of magnesium citrate supplementation on clinical symptoms and TNF-a  and hs-CRP  factors in patients with COVID-19,60,http://en.irct.ir/trial/55660
4863,IRCT20210416050988N1,IRCT,2021-05-24,2021-04-26,True,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the Effect of Educational Intervention Based on Health Belief Model on COVID-19 Preventive Behaviors among teachers,140,http://en.irct.ir/trial/55671
4864,IRCT20151020024625N12,IRCT,2021-04-30,2021-04-21,True,Recruiting,Phase 3,Interventional,Iran,Assessing of prone and supine position on oxygenation of patients with COVID-19,30,http://en.irct.ir/trial/55690
4865,IRCT20160516027929N10,IRCT,2021-05-03,2021-04-21,True,Recruiting,Not Applicable,Interventional,Iran,The effect of exercise on respiratory function of patients with Covid-19,40,http://en.irct.ir/trial/55715
4866,IRCT20111224008507N6,IRCT,2021-05-07,2021-05-10,False,Recruiting,Phase 3,Interventional,Iran,Phage therapy for prevention of secondary bacterial pneumonia in COVID-19,60,http://en.irct.ir/trial/55727
4867,IRCT20210408050899N1,IRCT,2021-05-25,2021-04-25,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of The effect of tocilizumab on patients with severe Covid 19,15,http://en.irct.ir/trial/55757
4868,IRCT20200723048178N2,IRCT,2021-04-28,2021-05-02,False,Recruiting,Not Applicable,Interventional,Pakistan,Intermittent CPAP in hypoxemic COVID patients,93,http://en.irct.ir/trial/55771
4869,IRCT20210424051067N1,IRCT,2021-05-11,2021-05-22,False,Recruiting,Not Applicable,Interventional,Iran,The effect of education on the quality of nutrition of patients undergoing hemodialysis,60,http://en.irct.ir/trial/55820
4870,IRCT20160316027081N2,IRCT,2021-05-13,2021-04-21,True,Recruiting,Phase 3,Interventional,Iran,Blood exchange in COVID-19,60,http://en.irct.ir/trial/56035
4871,IRCT20210315050710N1,IRCT,2021-05-10,2020-10-22,True,Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of plasmapheresis on patients with severe COVID-19,30,http://en.irct.ir/trial/56041
4872,IRCT20121216011763N52,IRCT,2021-05-13,2021-05-15,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in coronary hospitalized patients,50,http://en.irct.ir/trial/56149
4873,IRCT20150303021315N23,IRCT,2021-05-24,2021-05-29,False,Not Recruiting,Phase 2,Interventional,Iran,evaluate efficacy and safety of SpikoGenÂ® vaccine on healthy adults to prevent COVID-19 disease,400,http://en.irct.ir/trial/56287
4874,IRCT20210510051243N1,IRCT,2021-05-25,2021-05-31,False,Not Recruiting,Phase 2,Interventional,Iran,Chitosan supplementation and Coronavirus,80,http://en.irct.ir/trial/56289
4875,IRCT20080901001165N64,IRCT,2021-05-21,2021-05-31,False,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of efficacy and safety of Glurunic acid (G2013) in patients with COVID-19,180,http://en.irct.ir/trial/56367
4876,IRCT20200223046586N4,IRCT,2021-05-24,2021-06-04,False,Not Recruiting,Not Applicable,Interventional,Iran,The Video communication between patient and family member on hospital anxiety and depression and perceived stress of  family member,80,http://en.irct.ir/trial/56369
4877,IRCT20200506047323N8,IRCT,2021-05-24,2021-06-05,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,epinephrine in COVID-19,84,http://en.irct.ir/trial/56388
4878,IRCT20160305026917N2,IRCT,2021-05-25,2021-07-21,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of jujube and saffron supplement on Covid-19,60,http://en.irct.ir/trial/56417
4879,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,False,Not Recruiting,Phase 2,Interventional,"Sweden, United States",Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,200,https://clinicaltrials.gov/show/NCT04306393
4880,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,Not Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,10,https://clinicaltrials.gov/show/NCT04328493
4881,NCT04330690,ClinicalTrials.gov,2020-03-23,2020-03-18,True,Recruiting,Phase 2,Interventional,Canada,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,2900,https://clinicaltrials.gov/show/NCT04330690
4882,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-25,False,Not Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,120,https://clinicaltrials.gov/show/NCT04331899
4883,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",120,https://clinicaltrials.gov/show/NCT04336410
4884,NCT04340557,ClinicalTrials.gov,2020-04-06,2020-03-27,True,Not Recruiting,Phase 4,Interventional,United States,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,31,https://clinicaltrials.gov/show/NCT04340557
4885,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),384,https://clinicaltrials.gov/show/NCT04341116
4886,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,200,https://clinicaltrials.gov/show/NCT04345848
4887,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,Not Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,50,https://clinicaltrials.gov/show/NCT04358549
4888,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Not Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,31,https://clinicaltrials.gov/show/NCT04358783
4889,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-08-18,False,Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,1200,https://clinicaltrials.gov/show/NCT04359095
4890,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-05-02,False,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, Peru, United Kingdom, Colombia, Canada, United States, Brazil, Mexico, Spain, Turkey, Italy, France, Germany",Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm,432,https://clinicaltrials.gov/show/NCT04362137
4891,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,False,Recruiting,Phase 2/Phase 3,Interventional,"Argentina, South Africa, United States, Brazil, Turkey, Germany","Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",43998,https://clinicaltrials.gov/show/NCT04368728
4892,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",1971,https://clinicaltrials.gov/show/NCT04369066
4893,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,False,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,1,https://clinicaltrials.gov/show/NCT04370834
4894,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Not Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",208,https://clinicaltrials.gov/show/NCT04371367
4895,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-10-01,False,Not Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,64,https://clinicaltrials.gov/show/NCT04371978
4896,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-10-12,False,Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,28,https://clinicaltrials.gov/show/NCT04372602
4897,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Not Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",6,https://clinicaltrials.gov/show/NCT04373044
4898,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,False,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,29,https://clinicaltrials.gov/show/NCT04374526
4899,NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,False,Not Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04384900
4900,NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,True,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04385199
4901,NCT04385849,ClinicalTrials.gov,2020-05-07,2020-07-22,False,Not Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,1,https://clinicaltrials.gov/show/NCT04385849
4902,NCT04385940,ClinicalTrials.gov,2020-05-08,2021-03-19,False,Recruiting,Phase 3,Interventional,Canada,Vitamin D and COVID-19 Management,64,https://clinicaltrials.gov/show/NCT04385940
4903,NCT04386252,ClinicalTrials.gov,2020-05-11,2021-09-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,175,https://clinicaltrials.gov/show/NCT04386252
4904,NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,360,https://clinicaltrials.gov/show/NCT04386291
4905,NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,3,https://clinicaltrials.gov/show/NCT04389840
4906,NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,True,Not Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,30,https://clinicaltrials.gov/show/NCT04392778
4907,NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,False,Not Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",100,https://clinicaltrials.gov/show/NCT04395105
4908,NCT04397796,ClinicalTrials.gov,2020-05-18,2020-08-03,False,Not Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,45,https://clinicaltrials.gov/show/NCT04397796
4909,NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,False,Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,30,https://clinicaltrials.gov/show/NCT04399889
4910,NCT04400890,ClinicalTrials.gov,2020-05-22,2020-09-12,False,Not Recruiting,Phase 2,Interventional,United States,"Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19",100,https://clinicaltrials.gov/show/NCT04400890
4911,NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,False,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,183,https://clinicaltrials.gov/show/NCT04401202
4912,NCT04404426,ClinicalTrials.gov,2020-05-22,2020-11-04,False,Not Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,33,https://clinicaltrials.gov/show/NCT04404426
4913,NCT04405102,ClinicalTrials.gov,2020-05-26,2020-09-16,False,Recruiting,Phase 2,Interventional,Canada,COVID-19 Ozanimod Intervention Study,48,https://clinicaltrials.gov/show/NCT04405102
4914,NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Recruiting,Phase 2,Interventional,United States,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),96,https://clinicaltrials.gov/show/NCT04405739
4915,NCT04407507,ClinicalTrials.gov,2020-05-27,2020-07-01,False,Not Recruiting,Phase 2,Interventional,Mexico,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",66,https://clinicaltrials.gov/show/NCT04407507
4916,NCT04415151,ClinicalTrials.gov,2020-06-02,2020-10-14,False,Recruiting,Phase 2,Interventional,United States,Tofacitinib for Treatment of Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04415151
4917,NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,False,Not Recruiting,Phase 2,Interventional,"Canada, United States",Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,240,https://clinicaltrials.gov/show/NCT04417257
4918,NCT04419025,ClinicalTrials.gov,2020-06-03,2020-09-23,False,Not Recruiting,Phase 2,Interventional,United States,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,165,https://clinicaltrials.gov/show/NCT04419025
4919,NCT04419610,ClinicalTrials.gov,2020-04-16,2020-10-09,False,Not Recruiting,Phase 1,Interventional,United Kingdom,RAS and Coagulopathy in COVID19,30,https://clinicaltrials.gov/show/NCT04419610
4920,NCT04420182,ClinicalTrials.gov,2020-05-29,2020-08-17,False,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,2000,https://clinicaltrials.gov/show/NCT04420182
4921,NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-09,False,Not Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04424082
4922,NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,False,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Romania, United States, Mexico","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",6420,https://clinicaltrials.gov/show/NCT04425629
4923,NCT04429724,ClinicalTrials.gov,2020-06-10,2020-07-06,False,Not Recruiting,Not Applicable,Interventional,France,Health Professional Exposure Assessment to Covid-19,2129,https://clinicaltrials.gov/show/NCT04429724
4924,NCT04441047,ClinicalTrials.gov,2020-06-17,2021-06-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Universal Anti-Viral Vaccine for Healthy Elderly Adults,40,https://clinicaltrials.gov/show/NCT04441047
4925,NCT04442048,ClinicalTrials.gov,2020-06-19,2020-06-25,False,Not Recruiting,Phase 3,Interventional,Canada,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,195,https://clinicaltrials.gov/show/NCT04442048
4926,NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,True,Not Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),179,https://clinicaltrials.gov/show/NCT04443881
4927,NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,True,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,44,https://clinicaltrials.gov/show/NCT04445285
4928,NCT04451174,ClinicalTrials.gov,2020-06-26,2020-06-23,True,Not Recruiting,Phase 3,Interventional,Chile,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04451174
4929,NCT04453774,ClinicalTrials.gov,2020-05-06,2020-11-01,False,Recruiting,Not Applicable,Interventional,Canada,At Home Monitoring for Patients With Covid19,1000,https://clinicaltrials.gov/show/NCT04453774
4930,NCT04456062,ClinicalTrials.gov,2020-06-30,2020-08-04,False,Not Recruiting,Not Applicable,Interventional,Canada,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,102,https://clinicaltrials.gov/show/NCT04456062
4931,NCT04458519,ClinicalTrials.gov,2020-07-01,2020-07-16,False,Not Recruiting,Not Applicable,Interventional,Canada,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,23,https://clinicaltrials.gov/show/NCT04458519
4932,NCT04460651,ClinicalTrials.gov,2020-07-02,2020-08-14,False,Recruiting,Phase 3,Interventional,Argentina,PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial,4000,https://clinicaltrials.gov/show/NCT04460651
4933,NCT04467086,ClinicalTrials.gov,2020-06-30,2020-12-11,False,Recruiting,Phase 3,Interventional,Canada,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,108,https://clinicaltrials.gov/show/NCT04467086
4934,NCT04468087,ClinicalTrials.gov,2020-07-03,2021-02-15,False,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Antiviral Agents Against COVID-19 Infection,1005,https://clinicaltrials.gov/show/NCT04468087
4935,NCT04471519,ClinicalTrials.gov,2020-07-11,2020-07-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,India,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,755,https://clinicaltrials.gov/show/NCT04471519
4936,NCT04475107,ClinicalTrials.gov,2020-07-14,2020-07-09,True,Not Recruiting,Phase 2,Interventional,South Korea,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,113,https://clinicaltrials.gov/show/NCT04475107
4937,NCT04475991,ClinicalTrials.gov,2020-07-15,2021-06-01,False,Not Recruiting,Phase 2,Interventional,Mexico,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,100,https://clinicaltrials.gov/show/NCT04475991
4938,NCT04480138,ClinicalTrials.gov,2020-07-20,2020-08-11,False,Recruiting,Phase 2,Interventional,Mexico,Pegylated Interferon - a2b With SARSCoV- 2 (COVID-19),40,https://clinicaltrials.gov/show/NCT04480138
4939,NCT04482712,ClinicalTrials.gov,2020-07-21,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,0,https://clinicaltrials.gov/show/NCT04482712
4940,NCT04483635,ClinicalTrials.gov,2020-06-29,2021-02-08,False,Not Recruiting,Phase 3,Interventional,Canada,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,34,https://clinicaltrials.gov/show/NCT04483635
4941,NCT04487210,ClinicalTrials.gov,2020-07-22,2020-10-07,False,Not Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,45,https://clinicaltrials.gov/show/NCT04487210
4942,NCT04492527,ClinicalTrials.gov,2020-07-28,2020-07-28,False,Not Recruiting,Not Applicable,Interventional,Canada,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,75,https://clinicaltrials.gov/show/NCT04492527
4943,NCT04517006,ClinicalTrials.gov,2020-08-14,2021-01-31,False,Not Recruiting,Not Applicable,Interventional,Canada,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,1328,https://clinicaltrials.gov/show/NCT04517006
4944,NCT04530474,ClinicalTrials.gov,2020-08-26,2021-04-01,False,Not Recruiting,Phase 3,Interventional,United States,Outpatient Use of Ivermectin in COVID-19,0,https://clinicaltrials.gov/show/NCT04530474
4945,NCT04532294,ClinicalTrials.gov,2020-08-27,2020-09-08,False,Not Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",18,https://clinicaltrials.gov/show/NCT04532294
4946,NCT04536350,ClinicalTrials.gov,2020-08-21,2021-05-18,False,Recruiting,Phase 2,Interventional,Switzerland,Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS,82,https://clinicaltrials.gov/show/NCT04536350
4947,NCT04537351,ClinicalTrials.gov,2020-08-25,2020-08-24,True,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause,24,https://clinicaltrials.gov/show/NCT04537351
4948,NCT04537663,ClinicalTrials.gov,2020-08-28,2020-08-25,True,Recruiting,Phase 4,Interventional,Netherlands,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,5200,https://clinicaltrials.gov/show/NCT04537663
4949,NCT04543760,ClinicalTrials.gov,2020-09-08,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,France,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,18,https://clinicaltrials.gov/show/NCT04543760
4950,NCT04558476,ClinicalTrials.gov,2020-09-14,2020-09-01,True,Recruiting,Phase 2,Interventional,Belgium,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,500,https://clinicaltrials.gov/show/NCT04558476
4951,NCT04565249,ClinicalTrials.gov,2020-09-15,2020-10-22,False,Recruiting,Phase 2,Interventional,United States,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",36,https://clinicaltrials.gov/show/NCT04565249
4952,NCT04569877,ClinicalTrials.gov,2020-09-25,2020-09-24,True,Recruiting,Phase 2,Interventional,Germany,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,238,https://clinicaltrials.gov/show/NCT04569877
4953,NCT04570254,ClinicalTrials.gov,2020-09-26,2020-08-19,True,Not Recruiting,Not Applicable,Interventional,Mexico,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,110,https://clinicaltrials.gov/show/NCT04570254
4954,NCT04575610,ClinicalTrials.gov,2020-08-05,2020-11-27,False,Recruiting,Phase 2,Interventional,United States,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),68,https://clinicaltrials.gov/show/NCT04575610
4955,NCT04579640,ClinicalTrials.gov,2020-10-06,2020-10-27,False,Not Recruiting,Phase 3,Interventional,United Kingdom,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,6200,https://clinicaltrials.gov/show/NCT04579640
4956,NCT04581811,ClinicalTrials.gov,2020-10-07,2020-11-10,False,Not Recruiting,Not Applicable,Interventional,United States,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),52,https://clinicaltrials.gov/show/NCT04581811
4957,NCT04581954,ClinicalTrials.gov,2020-10-05,2020-10-02,True,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Inflammatory Signal Inhibitors for COVID-19 (MATIS),456,https://clinicaltrials.gov/show/NCT04581954
4958,NCT04590469,ClinicalTrials.gov,2020-10-13,2021-03-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Improving Wellbeing and Health for Care Home Residents During COVID-19,2880,https://clinicaltrials.gov/show/NCT04590469
4959,NCT04591717,ClinicalTrials.gov,2020-10-13,2020-10-19,False,Recruiting,Phase 1,Interventional,United States,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,60,https://clinicaltrials.gov/show/NCT04591717
4960,NCT04595136,ClinicalTrials.gov,2020-10-15,2020-11-02,False,Recruiting,Phase 1/Phase 2,Interventional,Colombia,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,60,https://clinicaltrials.gov/show/NCT04595136
4961,NCT04595773,ClinicalTrials.gov,2020-10-20,2021-01-22,False,Recruiting,Phase 1/Phase 2,Interventional,United States,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",90,https://clinicaltrials.gov/show/NCT04595773
4962,NCT04596839,ClinicalTrials.gov,2020-10-20,2020-09-04,True,Not Recruiting,Phase 2,Interventional,Bangladesh,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),60,https://clinicaltrials.gov/show/NCT04596839
4963,NCT04604145,ClinicalTrials.gov,2020-10-23,2021-02-03,False,Recruiting,Not Applicable,Interventional,United States,Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR,60,https://clinicaltrials.gov/show/NCT04604145
4964,NCT04604743,ClinicalTrials.gov,2020-10-25,2021-04-20,False,Recruiting,Not Applicable,Interventional,United States,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,4,https://clinicaltrials.gov/show/NCT04604743
4965,NCT04625725,ClinicalTrials.gov,2020-11-10,2020-11-21,False,Not Recruiting,Phase 3,Interventional,"United Kingdom, Belgium, United States, Spain, France","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",5198,https://clinicaltrials.gov/show/NCT04625725
4966,NCT04625972,ClinicalTrials.gov,2020-11-10,2020-12-02,False,Not Recruiting,Phase 3,Interventional,"United States, United Kingdom","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",1121,https://clinicaltrials.gov/show/NCT04625972
4967,NCT04634903,ClinicalTrials.gov,2020-11-11,2020-11-19,False,Not Recruiting,Not Applicable,Interventional,United States,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",2452,https://clinicaltrials.gov/show/NCT04634903
4968,NCT04636333,ClinicalTrials.gov,2020-11-17,2020-10-30,True,Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),216,https://clinicaltrials.gov/show/NCT04636333
4969,NCT04636697,ClinicalTrials.gov,2020-11-12,2020-11-19,False,Recruiting,Phase 2/Phase 3,Interventional,"Canada, United Kingdom, United States, Brazil",Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,30918,https://clinicaltrials.gov/show/NCT04636697
4970,NCT04638634,ClinicalTrials.gov,2020-11-19,2021-02-02,False,Not Recruiting,Phase 1,Interventional,Australia,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",24,https://clinicaltrials.gov/show/NCT04638634
4971,NCT04640168,ClinicalTrials.gov,2020-11-19,2020-11-24,False,Not Recruiting,Phase 3,Interventional,"South Korea, United States, Mexico, Japan, Singapore",Adaptive COVID-19 Treatment Trial 4 (ACTT-4),1010,https://clinicaltrials.gov/show/NCT04640168
4972,NCT04644120,ClinicalTrials.gov,2020-11-23,2020-12-10,False,Not Recruiting,Phase 1,Interventional,"Hungary, Netherlands, Puerto Rico, United States, Israel",Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19),24,https://clinicaltrials.gov/show/NCT04644120
4973,NCT04646044,ClinicalTrials.gov,2020-11-14,2020-11-13,True,Not Recruiting,Phase 1,Interventional,United States,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,30,https://clinicaltrials.gov/show/NCT04646044
4974,NCT04649086,ClinicalTrials.gov,2020-09-29,2020-06-05,True,Recruiting,Not Applicable,Interventional,France,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,120,https://clinicaltrials.gov/show/NCT04649086
4975,NCT04650087,ClinicalTrials.gov,2020-11-30,2021-02-15,False,Recruiting,Phase 3,Interventional,United States,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,5320,https://clinicaltrials.gov/show/NCT04650087
4976,NCT04652102,ClinicalTrials.gov,2020-12-01,2020-12-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Colombia, Belgium, Netherlands, Mexico, Spain, Panama, Germany",A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,36500,https://clinicaltrials.gov/show/NCT04652102
4977,NCT04662060,ClinicalTrials.gov,2020-12-08,2021-04-23,False,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,120,https://clinicaltrials.gov/show/NCT04662060
4978,NCT04662073,ClinicalTrials.gov,2020-12-08,2021-04-23,False,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,120,https://clinicaltrials.gov/show/NCT04662073
4979,NCT04662086,ClinicalTrials.gov,2020-12-08,2021-04-23,False,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,240,https://clinicaltrials.gov/show/NCT04662086
4980,NCT04664101,ClinicalTrials.gov,2020-12-10,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,United States,"REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)",20,https://clinicaltrials.gov/show/NCT04664101
4981,NCT04668950,ClinicalTrials.gov,2020-12-11,2020-12-22,False,Not Recruiting,Phase 3,Interventional,"Canada, United States",Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),1100,https://clinicaltrials.gov/show/NCT04668950
4982,NCT04672564,ClinicalTrials.gov,2020-12-16,2021-03-30,False,Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia, Ukraine, United States, Brazil, Mexico, India, Philippines",Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,300,https://clinicaltrials.gov/show/NCT04672564
4983,NCT04677660,ClinicalTrials.gov,2020-12-18,2021-01-21,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),200,https://clinicaltrials.gov/show/NCT04677660
4984,NCT04686760,ClinicalTrials.gov,2020-12-24,2020-11-15,True,Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04686760
4985,NCT04699916,ClinicalTrials.gov,2021-01-06,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,Chile,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,50,https://clinicaltrials.gov/show/NCT04699916
4986,NCT04706299,ClinicalTrials.gov,2021-01-10,2021-01-12,False,Not Recruiting,Not Applicable,Interventional,United States,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",20,https://clinicaltrials.gov/show/NCT04706299
4987,NCT04708340,ClinicalTrials.gov,2021-01-04,2021-03-25,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Tolerability and Efficacy of RJX in Patients With COVID-19,237,https://clinicaltrials.gov/show/NCT04708340
4988,NCT04715243,ClinicalTrials.gov,2021-01-09,2021-02-02,False,Recruiting,Not Applicable,Interventional,Oman,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",360,https://clinicaltrials.gov/show/NCT04715243
4989,NCT04716985,ClinicalTrials.gov,2021-01-13,2021-01-22,False,Recruiting,Not Applicable,Interventional,"Serbia, France, Morocco",Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,450,https://clinicaltrials.gov/show/NCT04716985
4990,NCT04718467,ClinicalTrials.gov,2021-01-20,2021-02-01,False,Not Recruiting,Phase 2,Interventional,China,Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells),0,https://clinicaltrials.gov/show/NCT04718467
4991,NCT04730895,ClinicalTrials.gov,2021-01-28,2021-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.,360,https://clinicaltrials.gov/show/NCT04730895
4992,NCT04732949,ClinicalTrials.gov,2021-01-28,2021-01-12,True,Recruiting,Phase 3,Interventional,"Portugal, United Kingdom, Belgium, United States, Israel, Serbia, France, India",Study to Assess Efficacy and Safety of Inhaled Interferon-ÃŸ Therapy for COVID-19,610,https://clinicaltrials.gov/show/NCT04732949
4993,NCT04743401,ClinicalTrials.gov,2021-01-12,2021-07-05,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04743401
4994,NCT04746183,ClinicalTrials.gov,2020-10-13,2020-07-03,True,Recruiting,Phase 1/Phase 2,Interventional,"South Africa, United Kingdom",AGILE (Early Phase Platform Trial for COVID-19),600,https://clinicaltrials.gov/show/NCT04746183
4995,NCT04753476,ClinicalTrials.gov,2021-02-11,2020-06-08,True,Recruiting,Phase 2,Interventional,Indonesia,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,48,https://clinicaltrials.gov/show/NCT04753476
4996,NCT04758299,ClinicalTrials.gov,2021-02-12,2021-03-13,False,Not Recruiting,Not Applicable,Interventional,United States,Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits,360,https://clinicaltrials.gov/show/NCT04758299
4997,NCT04762680,ClinicalTrials.gov,2021-02-18,2021-02-24,False,Not Recruiting,Phase 2,Interventional,"Honduras, United States",Study of Recombinant Protein Vaccine With Adjuvant Against COVID-19 in Adults 18 Years of Age and Older,722,https://clinicaltrials.gov/show/NCT04762680
4998,NCT04765839,ClinicalTrials.gov,2021-02-02,2021-02-12,False,Not Recruiting,Not Applicable,Interventional,United States,Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations,74,https://clinicaltrials.gov/show/NCT04765839
4999,NCT04775069,ClinicalTrials.gov,2021-02-24,2021-05-21,False,Recruiting,Phase 4,Interventional,Hong Kong,Antibody Response to COVID-19 Vaccines in Liver Disease Patients,900,https://clinicaltrials.gov/show/NCT04775069
5000,NCT04776174,ClinicalTrials.gov,2021-02-08,2021-03-01,False,Recruiting,Not Applicable,Interventional,France,Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children,40,https://clinicaltrials.gov/show/NCT04776174
5001,NCT04790240,ClinicalTrials.gov,2021-02-23,2021-02-01,True,Recruiting,Phase 1/Phase 2,Interventional,United States,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),120,https://clinicaltrials.gov/show/NCT04790240
5002,NCT04798001,ClinicalTrials.gov,2021-03-09,2021-04-12,False,Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,130,https://clinicaltrials.gov/show/NCT04798001
5003,NCT04805671,ClinicalTrials.gov,2021-03-17,2021-07-01,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19,1084,https://clinicaltrials.gov/show/NCT04805671
5004,NCT04805931,ClinicalTrials.gov,2021-03-11,2021-03-15,False,Recruiting,Not Applicable,Interventional,United States,VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans,4311,https://clinicaltrials.gov/show/NCT04805931
5005,NCT04813562,ClinicalTrials.gov,2021-03-19,2021-03-23,False,Recruiting,Phase 2,Interventional,China,Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells),480,https://clinicaltrials.gov/show/NCT04813562
5006,NCT04816643,ClinicalTrials.gov,2021-03-19,2021-03-24,False,Recruiting,Phase 1/Phase 2,Interventional,"Spain, Finland, United States, Poland","Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age",4644,https://clinicaltrials.gov/show/NCT04816643
5007,NCT04816669,ClinicalTrials.gov,2021-03-24,2021-04-01,False,Not Recruiting,Phase 3,Interventional,United States,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults",610,https://clinicaltrials.gov/show/NCT04816669
5008,NCT04818970,ClinicalTrials.gov,2021-03-24,2021-05-21,False,Recruiting,Not Applicable,Interventional,United States,Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04818970
5009,NCT04821037,ClinicalTrials.gov,2021-03-26,2021-06-01,False,Recruiting,Not Applicable,Interventional,Switzerland,Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19,10,https://clinicaltrials.gov/show/NCT04821037
5010,NCT04828135,ClinicalTrials.gov,2021-03-11,2021-05-26,False,Recruiting,Phase 2,Interventional,United States,Dual MRI for Cardiopulmonary COVID-19 Long Haulers,30,https://clinicaltrials.gov/show/NCT04828135
5011,NCT04838821,ClinicalTrials.gov,2021-03-23,2021-03-29,False,Recruiting,Phase 2/Phase 3,Interventional,Costa Rica,Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients,156,https://clinicaltrials.gov/show/NCT04838821
5012,NCT04842448,ClinicalTrials.gov,2021-04-09,2021-06-01,False,Not Recruiting,Phase 2,Interventional,Sweden,Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome,80,https://clinicaltrials.gov/show/NCT04842448
5013,NCT04844138,ClinicalTrials.gov,2021-04-05,2021-04-30,False,Recruiting,Not Applicable,Interventional,Canada,Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program,100,https://clinicaltrials.gov/show/NCT04844138
5014,NCT04846010,ClinicalTrials.gov,2021-03-31,2021-03-01,True,Recruiting,Phase 1/Phase 2,Interventional,United States,"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2",2000,https://clinicaltrials.gov/show/NCT04846010
5015,NCT04847141,ClinicalTrials.gov,2021-04-14,2021-04-28,False,Recruiting,Phase 3,Interventional,Spain,A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients,801,https://clinicaltrials.gov/show/NCT04847141
5016,NCT04870385,ClinicalTrials.gov,2021-04-07,2021-04-11,False,Not Recruiting,Not Applicable,Interventional,Malaysia,An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic,120,https://clinicaltrials.gov/show/NCT04870385
5017,NCT04871737,ClinicalTrials.gov,2021-04-21,2021-05-20,False,Recruiting,Phase 1,Interventional,Mexico,Study of a Live rNDV Based Vaccine Against COVID-19,90,https://clinicaltrials.gov/show/NCT04871737
5018,NCT04874766,ClinicalTrials.gov,2021-04-23,2021-05-28,False,Recruiting,Not Applicable,Interventional,Canada,The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19,24,https://clinicaltrials.gov/show/NCT04874766
5019,NCT04884295,ClinicalTrials.gov,2021-05-06,2021-05-01,True,Recruiting,Phase 1/Phase 2,Interventional,Belgium,"Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19",279,https://clinicaltrials.gov/show/NCT04884295
5020,NCT04885491,ClinicalTrials.gov,2021-02-15,2021-05-07,False,Recruiting,Phase 1/Phase 2,Interventional,Sweden,"A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH",16,https://clinicaltrials.gov/show/NCT04885491
5021,NCT04890483,ClinicalTrials.gov,2021-05-17,2021-05-17,False,Recruiting,Not Applicable,Interventional,Brazil,tDCS in Post-Acute COVID-19 Patients With SARDs,20,https://clinicaltrials.gov/show/NCT04890483
5022,NCT04890509,ClinicalTrials.gov,2021-05-17,2020-10-20,True,Not Recruiting,Phase 2,Interventional,India,A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,120,https://clinicaltrials.gov/show/NCT04890509
5023,NCT04890626,ClinicalTrials.gov,2021-05-17,2020-04-04,True,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19,2193,https://clinicaltrials.gov/show/NCT04890626
5024,NCT04890665,ClinicalTrials.gov,2021-05-17,2021-06-20,False,Not Recruiting,Not Applicable,Interventional,Mexico,"Online Multi-component Psychological Intervention for Anxiety, Depression, and Burnout on Healthcare Workers During the COVID-19 Pandemic",42,https://clinicaltrials.gov/show/NCT04890665
5025,NCT04891172,ClinicalTrials.gov,2021-05-17,2021-06-01,False,Recruiting,Phase 2/Phase 3,Interventional,Pakistan,Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients,310,https://clinicaltrials.gov/show/NCT04891172
5026,NCT04891250,ClinicalTrials.gov,2021-05-11,2021-06-01,False,Not Recruiting,Phase 4,Interventional,Zambia,The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19,800,https://clinicaltrials.gov/show/NCT04891250
5027,NCT04891302,ClinicalTrials.gov,2021-05-13,2021-03-19,True,Recruiting,Phase 2,Interventional,South Korea,The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19,80,https://clinicaltrials.gov/show/NCT04891302
5028,NCT04892979,ClinicalTrials.gov,2021-03-01,2020-10-01,True,Recruiting,Not Applicable,Interventional,Hong Kong,3R Rehabilitation Management of COVID-19 Survivors,400,https://clinicaltrials.gov/show/NCT04892979
5029,NCT04893265,ClinicalTrials.gov,2021-05-17,2021-06-30,False,Not Recruiting,Not Applicable,Interventional,United States,Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination,240,https://clinicaltrials.gov/show/NCT04893265
5030,NCT04894227,ClinicalTrials.gov,2021-05-10,2021-05-11,False,Not Recruiting,Phase 4,Interventional,China,Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults,1080,https://clinicaltrials.gov/show/NCT04894227
5031,NCT04894266,ClinicalTrials.gov,2021-05-05,2021-06-12,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,An Open-Label Study of Apabetalone in Covid Infection,100,https://clinicaltrials.gov/show/NCT04894266
5032,NCT04894409,ClinicalTrials.gov,2021-05-16,2020-04-24,True,Not Recruiting,Not Applicable,Interventional,Mexico,Evaluation of Silver Nanoparticles for the Prevention of COVID-19,231,https://clinicaltrials.gov/show/NCT04894409
5033,NCT04895085,ClinicalTrials.gov,2021-05-14,2021-04-27,True,Recruiting,Not Applicable,Interventional,United States,"ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance",50,https://clinicaltrials.gov/show/NCT04895085
5034,NCT04895267,ClinicalTrials.gov,2021-05-15,2020-07-03,True,Recruiting,Not Applicable,Interventional,Mexico,Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients,17,https://clinicaltrials.gov/show/NCT04895267
5035,NCT04895683,ClinicalTrials.gov,2021-05-17,2021-05-11,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Using Text Messages to Improve COVID-19 Vaccination Uptake,120000,https://clinicaltrials.gov/show/NCT04895683
5036,NCT04895982,ClinicalTrials.gov,2021-05-05,2021-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants =2 Years",360,https://clinicaltrials.gov/show/NCT04895982
5037,NCT04896541,ClinicalTrials.gov,2021-02-26,2021-03-16,False,Recruiting,Phase 1,Interventional,Japan,"Phase I Double-blind, Placebo-controlled Study of AZD7442",40,https://clinicaltrials.gov/show/NCT04896541
5038,NCT04896606,ClinicalTrials.gov,2021-05-19,2021-06-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease,50,https://clinicaltrials.gov/show/NCT04896606
5039,NCT04896788,ClinicalTrials.gov,2021-05-18,2021-05-19,False,Recruiting,Not Applicable,Interventional,France,Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff,300,https://clinicaltrials.gov/show/NCT04896788
5040,NCT04896840,ClinicalTrials.gov,2021-05-14,2021-05-20,False,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04896840
5041,NCT04896853,ClinicalTrials.gov,2021-05-18,2021-05-18,False,Recruiting,Phase 1,Interventional,Sweden,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTransÂ®,9,https://clinicaltrials.gov/show/NCT04896853
5042,NCT04896866,ClinicalTrials.gov,2021-05-17,2021-03-01,True,Recruiting,Not Applicable,Interventional,Canada,Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP),558,https://clinicaltrials.gov/show/NCT04896866
5043,NCT04896970,ClinicalTrials.gov,2021-05-11,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall,1390,https://clinicaltrials.gov/show/NCT04896970
5044,NCT04898062,ClinicalTrials.gov,2021-05-20,2021-05-05,True,Recruiting,Not Applicable,Interventional,Germany,"CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19",50,https://clinicaltrials.gov/show/NCT04898062
5045,NCT04898088,ClinicalTrials.gov,2021-05-21,2020-01-01,True,Not Recruiting,Not Applicable,Interventional,Turkey,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04898088
5046,NCT04898127,ClinicalTrials.gov,2021-05-21,2021-05-01,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.,30000,https://clinicaltrials.gov/show/NCT04898127
5047,NCT04898205,ClinicalTrials.gov,2021-05-17,2021-01-21,True,Recruiting,Not Applicable,Interventional,United States,Cardiopulmonary Rehabilitation in COVID-19 Longhaulers,24,https://clinicaltrials.gov/show/NCT04898205
5048,NCT04898738,ClinicalTrials.gov,2021-05-19,2021-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prospective COVID-19 Cohort Study, Dominican Republic",2000,https://clinicaltrials.gov/show/NCT04898738
5049,NCT04899232,ClinicalTrials.gov,2021-05-20,2021-06-17,False,Not Recruiting,Phase 2,Interventional,United States,Antithrombin III in Infectious Disease Caused by COVID-19,75,https://clinicaltrials.gov/show/NCT04899232
5050,NCT04899245,ClinicalTrials.gov,2021-05-19,2021-05-04,True,Recruiting,Not Applicable,Interventional,United States,ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff,115,https://clinicaltrials.gov/show/NCT04899245
5051,NCT04900129,ClinicalTrials.gov,2021-05-18,2020-12-01,True,Not Recruiting,Phase 1,Interventional,Bangladesh,"Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study",43,https://clinicaltrials.gov/show/NCT04900129
5052,NCT04900155,ClinicalTrials.gov,2021-05-09,2020-11-20,True,Recruiting,Not Applicable,Interventional,Russian Federation,Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19,200,https://clinicaltrials.gov/show/NCT04900155
5053,NCT04900337,ClinicalTrials.gov,2021-05-19,2021-02-09,True,Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.",100,https://clinicaltrials.gov/show/NCT04900337
5054,NCT04900415,ClinicalTrials.gov,2021-05-17,2020-07-22,True,Recruiting,Phase 2,Interventional,Hong Kong,Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction,25,https://clinicaltrials.gov/show/NCT04900415
5055,NCT04900428,ClinicalTrials.gov,2021-05-20,2021-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (UK),350,https://clinicaltrials.gov/show/NCT04900428
5056,NCT04900454,ClinicalTrials.gov,2021-05-20,2021-06-15,False,Not Recruiting,Phase 1,Interventional,No Country Given,Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19,18,https://clinicaltrials.gov/show/NCT04900454
5057,NCT04900961,ClinicalTrials.gov,2021-05-10,2021-05-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,CISCO-21 Prevent and Treat Long COVID-19.,220,https://clinicaltrials.gov/show/NCT04900961
5058,NCT04901065,ClinicalTrials.gov,2021-05-14,2021-05-11,True,Recruiting,Phase 2/Phase 3,Interventional,Canada,Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs,88,https://clinicaltrials.gov/show/NCT04901065
5059,NCT04901624,ClinicalTrials.gov,2021-03-29,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities,2160,https://clinicaltrials.gov/show/NCT04901624
5060,NCT04901676,ClinicalTrials.gov,2021-05-24,2021-06-01,False,Not Recruiting,Phase 3,Interventional,Brazil,Leronlimab in Moderatelly Ill Patients With COVID-19 Pneumonia,594,https://clinicaltrials.gov/show/NCT04901676
5061,NCT04901689,ClinicalTrials.gov,2021-05-24,2021-06-01,False,Not Recruiting,Phase 3,Interventional,Brazil,Leronlimab in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation,306,https://clinicaltrials.gov/show/NCT04901689
5062,NCT04902976,ClinicalTrials.gov,2021-05-24,2021-04-04,True,Recruiting,Not Applicable,Interventional,Brazil,Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes,105,https://clinicaltrials.gov/show/NCT04902976
5063,NCT04903184,ClinicalTrials.gov,2021-05-21,2020-12-09,True,Recruiting,Phase 2,Interventional,Argentina,Exploratory Study to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,369,https://clinicaltrials.gov/show/NCT04903184
5064,NCT04903327,ClinicalTrials.gov,2021-05-21,2021-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04903327
5065,NCT04904471,ClinicalTrials.gov,2021-05-26,2021-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells),40000,https://clinicaltrials.gov/show/NCT04904471
5066,NCT04904484,ClinicalTrials.gov,2021-04-15,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04904484
5067,NCT04904497,ClinicalTrials.gov,2021-04-30,2021-04-01,True,Recruiting,Not Applicable,Interventional,Chile,Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19,60,https://clinicaltrials.gov/show/NCT04904497
5068,NCT04904510,ClinicalTrials.gov,2021-05-19,2020-11-20,True,Not Recruiting,Not Applicable,Interventional,United States,Evaluation of the INDICAIDâ„¢ COVID-19 Rapid Antigen Test,22994,https://clinicaltrials.gov/show/NCT04904510
5069,NCT04904536,ClinicalTrials.gov,2021-05-21,2021-06-01,False,Not Recruiting,Phase 3,Interventional,Australia,Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy,400,https://clinicaltrials.gov/show/NCT04904536
5070,NCT04904744,ClinicalTrials.gov,2021-05-25,2021-05-24,True,Not Recruiting,Not Applicable,Interventional,United States,"Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination",1068,https://clinicaltrials.gov/show/NCT04904744
5071,NCT04905836,ClinicalTrials.gov,2021-05-27,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04905836
5072,NCT04906694,ClinicalTrials.gov,2021-05-26,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (US),72,https://clinicaltrials.gov/show/NCT04906694
5073,NCT04907877,ClinicalTrials.gov,2021-05-28,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients,300,https://clinicaltrials.gov/show/NCT04907877
5074,NCT04907903,ClinicalTrials.gov,2021-04-07,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to COVID-19",128,https://clinicaltrials.gov/show/NCT04907903
5075,NCT04907942,ClinicalTrials.gov,2021-04-02,2020-10-29,True,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management,82,https://clinicaltrials.gov/show/NCT04907942
5076,NCT04909892,ClinicalTrials.gov,2021-05-29,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",30,https://clinicaltrials.gov/show/NCT04909892
5077,NCT04909918,ClinicalTrials.gov,2021-05-30,2021-05-28,True,Recruiting,Phase 3,Interventional,Egypt,Impact of Steroids on Inflammatory Response in Covid-19,60,https://clinicaltrials.gov/show/NCT04909918
5078,NCT04909996,ClinicalTrials.gov,2021-05-28,2021-05-20,True,Recruiting,Not Applicable,Interventional,Italy,Study on the Performance and Safety of Sentinox in COVID-19 Patients,57,https://clinicaltrials.gov/show/NCT04909996
5079,NCT04910191,ClinicalTrials.gov,2021-02-23,2020-05-27,True,Recruiting,Not Applicable,Interventional,Israel,Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04910191
5080,NCT04910542,ClinicalTrials.gov,2021-03-30,2021-03-09,True,Recruiting,Not Applicable,Interventional,Puerto Rico,Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing,3060,https://clinicaltrials.gov/show/NCT04910542
5081,ACTRN12621000532808,ANZCTR,2021-05-06,2021-01-04,True,Recruiting,Not Applicable,Interventional,Australia,Vaccination of kidney transplant and dialysis patients and their close household contacts against COVID-19,200,https://anzctr.org.au/ACTRN12621000532808.aspx
5082,ACTRN12621000661875,ANZCTR,2021-06-01,2021-10-05,False,Recruiting,Phase 4,Interventional,Australia,Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease,100,https://anzctr.org.au/ACTRN12621000661875.aspx
5083,ISRCTN17395671,ISRCTN,2021-05-24,2021-01-07,True,Recruiting,Not Applicable,Interventional,United Kingdom,Does an infant feeding helper service increase infant feeding practices in firstborn babies?,2730,http://isrctn.com/ISRCTN17395671
5084,ISRCTN18003630,ISRCTN,2021-05-19,2021-02-18,True,Recruiting,Not Applicable,Interventional,United Kingdom,The development of an online advance care planning resource for nursing homes during a COVID-19 outbreak,99,http://isrctn.com/ISRCTN18003630
5085,ISRCTN47802196,ISRCTN,2021-05-19,1996-01-06,True,Recruiting,Not Applicable,Interventional,Brazil,Effect of BCG vaccination for tuberculosis on COVID-19 in Brazil,200805,http://isrctn.com/ISRCTN47802196
5086,ISRCTN16205138,ISRCTN,2021-02-26,2021-03-15,False,Recruiting,Not Applicable,Interventional,China,Effectiveness of short-term audio mindfulness in the Chinese community: a pilot study,140,http://isrctn.com/ISRCTN16205138
5087,ISRCTN11203922,ISRCTN,2021-02-09,2021-01-09,True,Recruiting,Not Applicable,Interventional,United Kingdom,Neuropsychological evaluation and rehabilitation in multiple sclerosis â€“ feasibility study,2545,http://isrctn.com/ISRCTN11203922
5088,ISRCTN37254291,ISRCTN,2021-01-13,2021-01-18,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,"In the general population, do specific forms of COVID-19 vaccine information, above simple information that they are safe and effective, increase willingness to be vaccinated?",18500,http://isrctn.com/ISRCTN37254291
5089,ISRCTN53038326,ISRCTN,2020-09-23,2020-06-22,True,Recruiting,Phase 2,Interventional,United Kingdom,IMU838 and oseltamivir in the treatment of COVID-19,120,http://isrctn.com/ISRCTN53038326
5090,ISRCTN13177364,ISRCTN,2020-09-09,2020-01-11,True,Recruiting,Not Applicable,Interventional,United Kingdom,"The development, testing and evaluation of a COVID-19 fundamental nursing care protocol",840,http://isrctn.com/ISRCTN13177364
5091,ISRCTN90906759,ISRCTN,2020-05-07,2020-05-28,False,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a vaccine against COVID-19,12390,http://isrctn.com/ISRCTN90906759
5092,ISRCTN15281137,ISRCTN,2020-04-06,2020-03-26,True,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,"A phase I/II study to determine efficacy, safety and immunogenicity of the candidate coronavirus disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers",1112,http://isrctn.com/ISRCTN15281137
5093,EUCTR2020-001324-33-FR,EU Clinical Trials Register,2020-03-29,2020-09-04,False,Not Recruiting,Phase 4,Interventional,France,Use of a respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in patients with severe confirmed COVID-19 pneumonia,194,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001324-33
5094,EUCTR2020-001748-24-SE,EU Clinical Trials Register,2020-04-20,2020-05-15,False,Not Recruiting,Phase 2,Interventional,Sweden,"A multi-center, randomized, open-label study in patients with COVID-19 and respiratory distress not requiring mechanical ventilation, to compare standard-of-care with anakinra and tocilizumab treatment.
The Immunomodulation-CoV Assessment (ImmCoVA) study.",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001748-24
5095,EUCTR2020-001172-15-DE,EU Clinical Trials Register,2020-03-23,2020-08-04,False,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15
5096,EUCTR2020-001782-37-SK,EU Clinical Trials Register,2020-06-15,2020-07-11,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Slovakia, Italy, Brazil, Poland, France, Romania","A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg PolyoxidoniumÂ®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19).",464,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001782-37
5097,EUCTR2021-001769-19-SE,EU Clinical Trials Register,2021-03-29,2021-04-15,False,Authorised,Phase 4,Interventional,Sweden,"Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trial",1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001769-19
5098,EUCTR2020-005979-12-BG,EU Clinical Trials Register,2021-04-12,2021-05-17,False,Authorised,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and safety of XAV-19 for the treatment of moderate to severe COVID-19,722,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005979-12
5099,EUCTR2020-005366-34-ES,EU Clinical Trials Register,2021-04-20,2021-02-06,True,Authorised,Phase 2,Interventional,"Ireland, Greece, United Kingdom, Spain, Poland, Bulgaria","A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005366-34
5100,EUCTR2021-002245-15-DE,EU Clinical Trials Register,2021-04-30,2021-05-25,False,Authorised,Phase 4,Interventional,Germany,An observational study to investigate the effectiveness and safety of Corona vaccines in patients with rheumatologic diseases.,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002245-15
5101,EUCTR2020-005759-18-PT,EU Clinical Trials Register,2021-04-28,2021-05-25,False,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18
5102,EUCTR2021-002327-38-NL,EU Clinical Trials Register,2021-05-17,2021-05-26,False,Authorised,Phase 4,Interventional,Netherlands,PREGCOVAC-19: the follow up of pregnant women who received COVID-19 vaccination in the Dutch national vaccination program,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002327-38
5103,EUCTR2021-002098-25-DE,EU Clinical Trials Register,2021-05-19,2021-05-27,False,Authorised,Phase 2,Interventional,Germany,An unblinded clinical trial investigating the active substance infliximab in the treatment of severe COVID-19 at multiple study centers,88,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002098-25
5104,EUCTR2021-000724-35-DE,EU Clinical Trials Register,2021-03-31,2021-11-05,False,Authorised,Phase 2,Interventional,"Canada, Germany, South Korea, United States","A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate  the Safety, Tolerability and Pharmacokinetics of VIR-7831 in Non-Hospitalized Participants with Mild to Moderate Coronavirus Disease 2019 (COVID-19)",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000724-35
5105,EUCTR2021-001177-22-DK,EU Clinical Trials Register,2021-03-29,2021-04-26,False,Authorised,Phase 3,Interventional,Denmark,"Treatment of mild COVID-19: a randomized, double blinded, placebo controlled study",226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001177-22
5106,EUCTR2021-000307-20-DE,EU Clinical Trials Register,2021-02-12,2021-04-28,False,Authorised,Phase 4,Interventional,Germany,Tracking the immune response to SARS-CoV-2 modRNA vaccines in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s.c. (KYRIOS),40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000307-20
5107,ChiCTR2100043319,ChiCTR,2021-02-10,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,China,Clinical service quality improvement and implementation strategy for COVID-19 under acute myocardial infarction,20000,http://www.chictr.org.cn/showproj.aspx?proj=121890
5108,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-05-21,False,Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,3,https://clinicaltrials.gov/show/NCT04331665
5109,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,False,Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),0,https://clinicaltrials.gov/show/NCT04341285
5110,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,52,https://clinicaltrials.gov/show/NCT04343755
5111,NCT04344184,ClinicalTrials.gov,2020-04-09,2020-12-18,False,Recruiting,Phase 2,Interventional,United States,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),60,https://clinicaltrials.gov/show/NCT04344184
5112,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,False,Not Recruiting,Not Applicable,Interventional,"Spain, United States",Awake Prone Position for Early Hypoxemia in COVID-19,305,https://clinicaltrials.gov/show/NCT04344587
5113,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,False,Not Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,146,https://clinicaltrials.gov/show/NCT04350580
5114,NCT04352400,ClinicalTrials.gov,2020-04-03,2021-06-04,False,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),256,https://clinicaltrials.gov/show/NCT04352400
5115,NCT04359225,ClinicalTrials.gov,2020-04-16,2021-09-30,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,80,https://clinicaltrials.gov/show/NCT04359225
5116,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,False,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,300,https://clinicaltrials.gov/show/NCT04364802
5117,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,False,Not Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,17,https://clinicaltrials.gov/show/NCT04371029
5118,NCT04375046,ClinicalTrials.gov,2020-05-01,2021-07-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2,24,https://clinicaltrials.gov/show/NCT04375046
5119,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04376593
5120,NCT04377334,ClinicalTrials.gov,2020-04-16,2021-09-01,False,Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),40,https://clinicaltrials.gov/show/NCT04377334
5121,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-06-27,False,Not Recruiting,Not Applicable,Interventional,Argentina,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,50,https://clinicaltrials.gov/show/NCT04379037
5122,NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-11,False,Not Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,140,https://clinicaltrials.gov/show/NCT04382651
5123,NCT04382950,ClinicalTrials.gov,2020-05-08,2021-07-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications,24,https://clinicaltrials.gov/show/NCT04382950
5124,NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,True,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,52,https://clinicaltrials.gov/show/NCT04389710
5125,NCT04391309,ClinicalTrials.gov,2020-05-14,2021-04-12,False,Recruiting,Phase 2,Interventional,United States,COVID-19 and Anti-CD14 Treatment Trial,300,https://clinicaltrials.gov/show/NCT04391309
5126,NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,True,Not Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,73,https://clinicaltrials.gov/show/NCT04422613
5127,NCT04426201,ClinicalTrials.gov,2020-06-09,2020-12-20,False,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),48,https://clinicaltrials.gov/show/NCT04426201
5128,NCT04439071,ClinicalTrials.gov,2020-06-17,2020-07-09,False,Recruiting,Phase 2/Phase 3,Interventional,"Australia, Portugal, Belgium, United States, Brazil, Mexico, Spain",A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19),380,https://clinicaltrials.gov/show/NCT04439071
5129,NCT04444297,ClinicalTrials.gov,2020-06-20,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Non-clinical Validation,40,https://clinicaltrials.gov/show/NCT04444297
5130,NCT04444323,ClinicalTrials.gov,2020-06-20,2021-10-01,False,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Cohort Study,50,https://clinicaltrials.gov/show/NCT04444323
5131,NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,True,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,495,https://clinicaltrials.gov/show/NCT04445272
5132,NCT04466670,ClinicalTrials.gov,2020-07-08,2020-07-11,False,Recruiting,Phase 2,Interventional,Brazil,Hemostasis in COVID-19: an Adaptive Clinical Trial,379,https://clinicaltrials.gov/show/NCT04466670
5133,NCT04498325,ClinicalTrials.gov,2020-07-30,2021-07-31,False,Not Recruiting,Phase 1,Interventional,United States,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",42,https://clinicaltrials.gov/show/NCT04498325
5134,NCT04501952,ClinicalTrials.gov,2020-08-05,2020-09-18,False,Not Recruiting,Phase 3,Interventional,"Denmark, Portugal, United Kingdom, United States, Spain",Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,585,https://clinicaltrials.gov/show/NCT04501952
5135,NCT04505722,ClinicalTrials.gov,2020-07-31,2020-09-07,False,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Ukraine, United States, Brazil, Mexico, Philippines",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,44325,https://clinicaltrials.gov/show/NCT04505722
5136,NCT04510194,ClinicalTrials.gov,2020-08-07,2021-01-01,False,Recruiting,Phase 2/Phase 3,Interventional,United States,"Outpatient Treatment of SARS-CoV-2 With Ivermectin, Fluvoxamine, and Metformin (COVID-19)",1160,https://clinicaltrials.gov/show/NCT04510194
5137,NCT04523090,ClinicalTrials.gov,2020-08-20,2020-08-27,False,Recruiting,Phase 2/Phase 3,Interventional,South Africa,Catalysing the Containment of COVID-19,440,https://clinicaltrials.gov/show/NCT04523090
5138,NCT04524507,ClinicalTrials.gov,2020-08-21,2020-08-27,False,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,56,https://clinicaltrials.gov/show/NCT04524507
5139,NCT04535778,ClinicalTrials.gov,2020-08-12,2020-11-16,False,Recruiting,Not Applicable,Interventional,United Kingdom,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04535778
5140,NCT04537299,ClinicalTrials.gov,2020-09-01,2021-06-01,False,Recruiting,Phase 2,Interventional,United States,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,150,https://clinicaltrials.gov/show/NCT04537299
5141,NCT04539821,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Not Recruiting,Not Applicable,Interventional,United States,Virtual Pain Care Management (COVID-19),60,https://clinicaltrials.gov/show/NCT04539821
5142,NCT04545749,ClinicalTrials.gov,2020-09-02,2020-09-25,False,Not Recruiting,Phase 1,Interventional,Taiwan,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",60,https://clinicaltrials.gov/show/NCT04545749
5143,NCT04547140,ClinicalTrials.gov,2020-09-10,2021-01-29,False,Recruiting,Phase 2,Interventional,"Chile, United States, Brazil",Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04547140
5144,NCT04616989,ClinicalTrials.gov,2020-10-20,2020-11-01,False,Not Recruiting,Not Applicable,Interventional,Uganda,Mental Health in Communities Affected by COVID-19 in Uganda,814,https://clinicaltrials.gov/show/NCT04616989
5145,NCT04627675,ClinicalTrials.gov,2020-11-06,2020-12-30,False,Not Recruiting,Phase 1,Interventional,United States,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),36,https://clinicaltrials.gov/show/NCT04627675
5146,NCT04628039,ClinicalTrials.gov,2020-11-09,2021-05-28,False,Recruiting,Not Applicable,Interventional,United States,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",506,https://clinicaltrials.gov/show/NCT04628039
5147,NCT04637867,ClinicalTrials.gov,2020-11-16,2020-11-23,False,Not Recruiting,Not Applicable,Interventional,France,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),189,https://clinicaltrials.gov/show/NCT04637867
5148,NCT04640233,ClinicalTrials.gov,2020-11-17,2020-11-30,False,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-?ov-2) Infection,1600,https://clinicaltrials.gov/show/NCT04640233
5149,NCT04649151,ClinicalTrials.gov,2020-11-30,2020-12-09,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",3732,https://clinicaltrials.gov/show/NCT04649151
5150,NCT04655638,ClinicalTrials.gov,2020-12-03,2021-02-10,False,Recruiting,Not Applicable,Interventional,"Italy, Greece",HFNT vs. COT in COVID-19,364,https://clinicaltrials.gov/show/NCT04655638
5151,NCT04667247,ClinicalTrials.gov,2020-12-03,2020-12-03,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Mushroom-based Product for COVID-19,66,https://clinicaltrials.gov/show/NCT04667247
5152,NCT04676867,ClinicalTrials.gov,2020-12-17,2021-01-11,False,Not Recruiting,Phase 2,Interventional,Canada,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,227,https://clinicaltrials.gov/show/NCT04676867
5153,NCT04701489,ClinicalTrials.gov,2021-01-05,2021-01-14,False,Not Recruiting,Not Applicable,Interventional,United States,UNITE Study (UMN-GE) for COVID-19,30,https://clinicaltrials.gov/show/NCT04701489
5154,NCT04703608,ClinicalTrials.gov,2021-01-06,2021-01-22,False,Recruiting,Phase 3,Interventional,Gambia,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,1200,https://clinicaltrials.gov/show/NCT04703608
5155,NCT04710381,ClinicalTrials.gov,2021-01-13,2021-02-01,False,Recruiting,Phase 4,Interventional,Czech Republic,IMUNORÂ® Preparation in the Prevention of COVID-19,100,https://clinicaltrials.gov/show/NCT04710381
5156,NCT04720378,ClinicalTrials.gov,2021-01-21,2021-05-30,False,Recruiting,Phase 1,Interventional,United States,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,12,https://clinicaltrials.gov/show/NCT04720378
5157,NCT04730206,ClinicalTrials.gov,2021-01-28,2021-06-01,False,Not Recruiting,Phase 3,Interventional,Belgium,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,1316,https://clinicaltrials.gov/show/NCT04730206
5158,NCT04730856,ClinicalTrials.gov,2021-01-14,2021-02-01,False,Recruiting,Phase 3,Interventional,Spain,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),600,https://clinicaltrials.gov/show/NCT04730856
5159,NCT04763681,ClinicalTrials.gov,2021-02-13,2021-01-01,True,Recruiting,Not Applicable,Interventional,Canada,Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction),140,https://clinicaltrials.gov/show/NCT04763681
5160,NCT04765449,ClinicalTrials.gov,2021-02-19,2021-07-30,False,Not Recruiting,Phase 1,Interventional,United States,Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection,24,https://clinicaltrials.gov/show/NCT04765449
5161,NCT04770467,ClinicalTrials.gov,2021-02-22,2021-02-01,True,Not Recruiting,Phase 2,Interventional,China,"A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19",0,https://clinicaltrials.gov/show/NCT04770467
5162,NCT04771000,ClinicalTrials.gov,2021-02-24,2021-02-08,True,Recruiting,Phase 2,Interventional,Spain,A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19,150,https://clinicaltrials.gov/show/NCT04771000
5163,NCT04771611,ClinicalTrials.gov,2021-02-24,2021-06-01,False,Recruiting,Phase 2,Interventional,United States,COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications,150,https://clinicaltrials.gov/show/NCT04771611
5164,NCT04773067,ClinicalTrials.gov,2021-02-23,2021-01-30,True,Recruiting,Phase 2,Interventional,Taiwan,"A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers",3850,https://clinicaltrials.gov/show/NCT04773067
5165,NCT04773899,ClinicalTrials.gov,2021-02-19,2021-07-09,False,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Associated Endothelial Dysfunction Study,75,https://clinicaltrials.gov/show/NCT04773899
5166,NCT04780152,ClinicalTrials.gov,2021-03-02,2021-10-01,False,Recruiting,Phase 2/Phase 3,Interventional,Mexico,TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic,172,https://clinicaltrials.gov/show/NCT04780152
5167,NCT04784897,ClinicalTrials.gov,2021-03-03,2021-02-22,True,Not Recruiting,Phase 2,Interventional,"Russian Federation, United States",A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19,120,https://clinicaltrials.gov/show/NCT04784897
5168,NCT04793997,ClinicalTrials.gov,2021-02-28,2021-02-01,True,Not Recruiting,Not Applicable,Interventional,Belgium,Microbiome Therapy in Covid-19 Primary Care Support,150,https://clinicaltrials.gov/show/NCT04793997
5169,NCT04794400,ClinicalTrials.gov,2021-03-10,2021-02-04,True,Not Recruiting,Not Applicable,Interventional,Sweden,The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.,18,https://clinicaltrials.gov/show/NCT04794400
5170,NCT04813718,ClinicalTrials.gov,2021-03-15,2021-06-02,False,Recruiting,Not Applicable,Interventional,Austria,Post COVID-19 Syndrome and the Gut-lung Axis,20,https://clinicaltrials.gov/show/NCT04813718
5171,NCT04828434,ClinicalTrials.gov,2021-03-23,2021-04-01,False,Recruiting,Not Applicable,Interventional,United Kingdom,Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study,34,https://clinicaltrials.gov/show/NCT04828434
5172,NCT04841707,ClinicalTrials.gov,2021-03-31,2021-05-10,False,Recruiting,Not Applicable,Interventional,United States,Total-Body Parametric 18F-FDG PET of COVID-19,15,https://clinicaltrials.gov/show/NCT04841707
5173,NCT04848467,ClinicalTrials.gov,2021-04-16,2021-10-01,False,Not Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia","COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older",1000,https://clinicaltrials.gov/show/NCT04848467
5174,NCT04851821,ClinicalTrials.gov,2021-02-06,2021-01-04,True,Recruiting,Phase 1,Interventional,Tunisia,The Effectiveness of Phytotherapy in SARS-COV2(COVID-19),80,https://clinicaltrials.gov/show/NCT04851821
5175,NCT04854798,ClinicalTrials.gov,2021-04-20,2021-04-29,False,Recruiting,Not Applicable,Interventional,United States,UNITE Study (UMN-SW) for COVID-19,58,https://clinicaltrials.gov/show/NCT04854798
5176,NCT04854876,ClinicalTrials.gov,2021-04-21,2021-06-20,False,Not Recruiting,Not Applicable,Interventional,No Country Given,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19",200,https://clinicaltrials.gov/show/NCT04854876
5177,NCT04867265,ClinicalTrials.gov,2021-04-26,2021-05-03,False,Not Recruiting,Not Applicable,Interventional,Czech Republic,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic,104,https://clinicaltrials.gov/show/NCT04867265
5178,NCT04869358,ClinicalTrials.gov,2021-04-29,2021-05-27,False,Recruiting,Phase 4,Interventional,Germany,Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab,40,https://clinicaltrials.gov/show/NCT04869358
5179,NCT04873414,ClinicalTrials.gov,2021-04-26,2020-12-01,True,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Convalescent Plasma as Adjunct Therapy for COVID-19,364,https://clinicaltrials.gov/show/NCT04873414
5180,NCT04878211,ClinicalTrials.gov,2021-05-03,2021-05-31,False,Not Recruiting,Phase 4,Interventional,No Country Given,A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,66,https://clinicaltrials.gov/show/NCT04878211
5181,NCT04883138,ClinicalTrials.gov,2021-05-04,2021-05-24,False,Recruiting,Phase 1,Interventional,United States,Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients,18,https://clinicaltrials.gov/show/NCT04883138
5182,NCT04884685,ClinicalTrials.gov,2021-05-07,2021-05-03,True,Not Recruiting,Phase 2,Interventional,China,Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents,500,https://clinicaltrials.gov/show/NCT04884685
5183,NCT04885907,ClinicalTrials.gov,2021-05-09,2021-05-25,False,Not Recruiting,Phase 4,Interventional,Canada,Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients,120,https://clinicaltrials.gov/show/NCT04885907
5184,NCT04891133,ClinicalTrials.gov,2021-05-07,2021-05-01,True,Recruiting,Phase 2/Phase 3,Interventional,"Hungary, Ireland, Belgium, Luxembourg, Italy, Norway, Spain, Turkey, France, Germany",EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial,1900,https://clinicaltrials.gov/show/NCT04891133
5185,NCT04892459,ClinicalTrials.gov,2021-05-10,2021-05-25,False,Recruiting,Phase 4,Interventional,China,Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector),300,https://clinicaltrials.gov/show/NCT04892459
5186,NCT04893512,ClinicalTrials.gov,2021-05-14,2021-06-07,False,Not Recruiting,Phase 1,Interventional,No Country Given,First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects,45,https://clinicaltrials.gov/show/NCT04893512
5187,NCT04894305,ClinicalTrials.gov,2021-05-18,2021-05-21,False,Recruiting,Phase 1,Interventional,Netherlands,A Study of Ad26.COV2.S in Healthy Adults (COVID-19),380,https://clinicaltrials.gov/show/NCT04894305
5188,NCT04895371,ClinicalTrials.gov,2021-05-15,2021-06-12,False,Not Recruiting,Not Applicable,Interventional,Iran,Tele-Physiotherapy After COVID-19 Hospitalization,72,https://clinicaltrials.gov/show/NCT04895371
5189,NCT04896710,ClinicalTrials.gov,2021-05-05,2021-05-26,False,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample,569,https://clinicaltrials.gov/show/NCT04896710
5190,NCT04909879,ClinicalTrials.gov,2021-05-29,2021-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,100,https://clinicaltrials.gov/show/NCT04909879
5191,NCT04909905,ClinicalTrials.gov,2021-05-30,2021-05-30,False,Recruiting,Phase 3,Interventional,Egypt,Glutamine Supplementation and Short-term Mortality in Covid-19,60,https://clinicaltrials.gov/show/NCT04909905
5192,NCT04910230,ClinicalTrials.gov,2021-05-24,2020-03-01,True,Not Recruiting,Not Applicable,Interventional,China,Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19,24,https://clinicaltrials.gov/show/NCT04910230
5193,NCT04910516,ClinicalTrials.gov,2021-05-27,2021-04-10,True,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,88,https://clinicaltrials.gov/show/NCT04910516
5194,NCT04911790,ClinicalTrials.gov,2021-06-02,2021-06-05,False,Not Recruiting,Phase 4,Interventional,No Country Given,Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults,121000,https://clinicaltrials.gov/show/NCT04911790
5195,NCT04912011,ClinicalTrials.gov,2021-06-01,2021-01-01,True,Recruiting,Phase 4,Interventional,Poland,Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.,50,https://clinicaltrials.gov/show/NCT04912011
5196,NCT04912817,ClinicalTrials.gov,2021-05-31,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,PR-VR At-home Program During and After COVID-19,60,https://clinicaltrials.gov/show/NCT04912817
5197,NCT04912895,ClinicalTrials.gov,2021-06-02,2021-04-14,True,Recruiting,Not Applicable,Interventional,United States,Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19,90,https://clinicaltrials.gov/show/NCT04912895
5198,NCT04912921,ClinicalTrials.gov,2020-10-15,2020-10-20,False,Recruiting,Not Applicable,Interventional,United States,Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19,60,https://clinicaltrials.gov/show/NCT04912921
5199,NCT04913129,ClinicalTrials.gov,2021-05-31,2021-06-14,False,Not Recruiting,Not Applicable,Interventional,United States,The Burden of COVID-19 Survivorship,50,https://clinicaltrials.gov/show/NCT04913129
5200,NCT04913740,ClinicalTrials.gov,2021-06-02,2021-06-01,True,Not Recruiting,Not Applicable,Interventional,China,Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic,170,https://clinicaltrials.gov/show/NCT04913740
5201,NCT04913779,ClinicalTrials.gov,2021-06-01,2021-06-01,False,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Study to Evaluate the Safety and Effectiveness of an Immunobiological Drug (Anti SARS-CoV-2) in the Treatment of CoViD-19,200,https://clinicaltrials.gov/show/NCT04913779
5202,NCT04914377,ClinicalTrials.gov,2021-06-02,2021-06-01,True,Recruiting,Phase 2,Interventional,United States,To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants,60,https://clinicaltrials.gov/show/NCT04914377
5203,NCT04914767,ClinicalTrials.gov,2021-05-28,2021-03-01,True,Recruiting,Phase 1,Interventional,Tunisia,Nigella 5 in the Treatment of SARS COV2 (COVID-19),500,https://clinicaltrials.gov/show/NCT04914767
5204,NCT04914832,ClinicalTrials.gov,2021-06-01,2021-06-30,False,Not Recruiting,Phase 4,Interventional,Swaziland,Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death,600,https://clinicaltrials.gov/show/NCT04914832
5205,NCT04915989,ClinicalTrials.gov,2021-06-03,2021-02-16,True,Not Recruiting,Phase 1,Interventional,South Korea,"Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals",30,https://clinicaltrials.gov/show/NCT04915989
5206,NCT04916639,ClinicalTrials.gov,2021-05-31,2021-05-27,True,Not Recruiting,Not Applicable,Interventional,No Country Given,Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.,370,https://clinicaltrials.gov/show/NCT04916639
5207,NCT04916886,ClinicalTrials.gov,2021-05-30,2021-06-03,False,Recruiting,Not Applicable,Interventional,China,A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.,2016,https://clinicaltrials.gov/show/NCT04916886
5208,NCT04917523,ClinicalTrials.gov,2021-06-04,2021-06-06,False,Not Recruiting,Phase 3,Interventional,United Arab Emirates,Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above,1800,https://clinicaltrials.gov/show/NCT04917523
5209,ACTRN12620000579998,ANZCTR,2020-05-19,2020-03-06,True,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",9,https://anzctr.org.au/ACTRN12620000579998.aspx
5210,ACTRN12621000704897,ANZCTR,2021-06-08,2021-06-27,False,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Australia","Study to evaluate the safety, tolerability, and efficacy of enoxaparin for inhalation alone and in combination with N-acetylcysteine  in healthy volunteers and hospitalised COVID-19 patients",60,https://anzctr.org.au/ACTRN12621000704897.aspx
5211,ACTRN12621000722897,ANZCTR,2021-06-09,2021-05-07,True,Not Recruiting,Not Applicable,Interventional,New Zealand,The efficacy of a brief mindset intervention on side effect reporting and experience of the COVID-19 vaccination,660,https://anzctr.org.au/ACTRN12621000722897.aspx
5212,ISRCTN15317247,ISRCTN,2021-06-03,2021-07-06,False,Recruiting,Not Applicable,Interventional,United Kingdom,Using text messages to boost COVID-19 vaccine booking rate,4270000,http://isrctn.com/ISRCTN15317247
5213,ISRCTN23016116,ISRCTN,2021-06-02,2021-05-01,True,Recruiting,Not Applicable,Interventional,Italy,Effect of prone positioning in patients with severe SARS-CoV-2 pneumonia treated with noninvasive ventilation,165,http://isrctn.com/ISRCTN23016116
5214,ISRCTN13848929,ISRCTN,2021-05-06,2019-09-30,True,Not Recruiting,Not Applicable,Interventional,Spain,"Does a new leaflet with information about the breast cancer screening program, its benefits and risks, affect participation in the screening program?",9640,http://isrctn.com/ISRCTN13848929
5215,ISRCTN77689525,ISRCTN,2020-12-02,2020-08-25,True,Not Recruiting,Not Applicable,Interventional,"Uganda, Tanzania, Zambia","Sharing Stories: A digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania, and Uganda",720,http://isrctn.com/ISRCTN77689525
5216,ISRCTN10207947,ISRCTN,2020-07-21,2020-04-29,True,Recruiting,Phase 3,Interventional,"Indonesia, Benin, United Kingdom, Zambia, Ethiopia, Pakistan, Thailand, Laos, Mali, Niger, Kenya",Study of chloroquine/hydroxychloroquine and coronavirus disease (COVID-19) in the healthcare setting,40000,http://isrctn.com/ISRCTN10207947
5217,EUCTR2020-001793-30-DK,EU Clinical Trials Register,2020-05-24,2020-01-07,True,Authorised,Phase 4,Interventional,Denmark,High dose Vitamin D in Preventing Aggravation of COVID-19,480,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001793-30
5218,EUCTR2021-000408-39-BE,EU Clinical Trials Register,2021-05-06,2021-02-06,True,Authorised,Phase 3,Interventional,"Argentina, Russian Federation, Belgium, Netherlands, Canada, Ukraine, United States, Mexico, Spain, Egypt, Brazil, Poland, France, India, Germany, Lebanon, Philippines",A study to test whether BI 767551 can prevent COVID-19 in people who might have been exposed to SARS-CoV-2,1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000408-39
5219,EUCTR2021-002348-57-AT,EU Clinical Trials Register,2021-05-10,2021-05-30,False,Authorised,Phase 2,Interventional,Austria,"A Randomized, Parallel Group, Single-Blind, Phase 2 Study to Evaluate the immune response of two classes of SARS-Cov-2 Vaccines employed as Second Boost in Patients under current Rituximab Therapy and no humoral response after standard mRNA vaccination",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002348-57
5220,EUCTR2021-000291-11-AT,EU Clinical Trials Register,2021-05-11,2021-05-30,False,Authorised,Phase 3,Interventional,Austria,Immuneresponse and clinical efficacy after SARS-CoV-2 Vaccination in immunodefficient patients or those undergoing immunosuppresive therapy (COVID-19),3000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000291-11
5221,EUCTR2020-006082-11-GR,EU Clinical Trials Register,2021-05-21,2021-02-06,True,Authorised,Phase 2/Phase 3,Interventional,"Chile, Argentina, Hungary, South Africa, Peru, Greece, Ukraine, Mexico, Turkey, Brazil, Poland, Germany, Bulgaria","A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)",1084,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006082-11
5222,EUCTR2021-001735-10-BE,EU Clinical Trials Register,2021-06-04,2021-05-28,True,Authorised,Phase 3,Interventional,"Spain, Germany, Austria, Belgium","COVID-19: A study to learn about the safety, local and systemic reactions, and the immune responses to the SARS-CoV-2 mRNA Vaccine (CVnCoV) when given to participants 45 years or older who have either a solid tumor or blood cancer and are already taking or about to start systemic anticancer therapy
",620,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001735-10
5223,EUCTR2020-005752-38-DE,EU Clinical Trials Register,2021-01-19,2021-03-18,False,Authorised,Phase 4,Interventional,Germany,An open-label multicenter study to assess response to SARS-CoV-2 modRNA vaccines in participants with secondary progressive multiple sclerosis treated with Mayzent (siponimod) (AMA-VACC),60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005752-38
5224,EUCTR2020-002322-85-SE,EU Clinical Trials Register,2020-05-14,2020-02-07,True,Authorised,Phase 2,Interventional,"Denmark, Sweden","KAND567 Versus Placebo in Subjects Hospitalized with COVID-19. A Phase II, Randomized, 2-Arm Parallel-Group, Double-blind Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics.",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002322-85
5225,EUCTR2020-004695-18-DE,EU Clinical Trials Register,2020-10-15,2020-02-12,True,Authorised,Phase 2,Interventional,Germany,Plasma from Covid 19 recovered patients or camostat as a therapy for early SARS-CoV-2 infection in high risk individuals,497,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004695-18
5226,EUCTR2020-003267-26-DE,EU Clinical Trials Register,2020-07-08,2020-02-09,True,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of a vaccine in healthy adults.,96,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003267-26
5227,JPRN-jRCT2021210006,JPRN,2021-05-28,2021-10-06,False,Not Recruiting,Phase 2,Interventional,Japan,"A Placebo-Controlled, Double-Blind, Phase II Physician-Initiated Trial of TM5614 in Patients with SARS-CoV-2 Pneumonia",100,https://jrct.niph.go.jp/latest-detail/jRCT2021210006
5228,JPRN-jRCT2031200443,JPRN,2021-03-25,2021-03-19,True,Not Recruiting,Phase 3,Interventional,"United States, Japan","REMAP-CAP:Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia Immune Modulation-2 Domain",136,https://jrct.niph.go.jp/latest-detail/jRCT2031200443
5229,JPRN-jRCT2041210004,JPRN,2021-04-14,2021-04-14,False,Recruiting,Phase 3,Interventional,Japan,Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors,316,https://jrct.niph.go.jp/latest-detail/jRCT2041210004
5230,JPRN-jRCT2041210013,JPRN,2021-04-23,2021-05-13,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Safety and Immunogenicity of EXG-5003.,60,https://jrct.niph.go.jp/latest-detail/jRCT2041210013
5231,JPRN-jRCT2051200092,JPRN,2020-12-09,2020-12-16,False,Recruiting,Phase 1/Phase 2,Interventional,Japan,A Phase 1/2 study of S-268019 in Japanese adult participants,300,https://jrct.niph.go.jp/latest-detail/jRCT2051200092
5232,JPRN-jRCT2071200106,JPRN,2021-03-03,2021-02-03,True,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Placebo-controlled, multicenter, double-blind, randomized, parallel-group, comparative study to evaluate the safety and immunogenicity of KD-414, a vaccine against COVID-19, in healthy adults aged >=20 years to <65 years, and healthy elderly subjects aged >=65 years.",210,https://jrct.niph.go.jp/latest-detail/jRCT2071200106
5233,JPRN-jRCT2071200111,JPRN,2021-03-10,2021-03-16,False,Recruiting,Phase 1,Interventional,Japan,"A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7442 in Healthy Japanese Participants",32,https://jrct.niph.go.jp/latest-detail/jRCT2071200111
5234,JPRN-jRCTs031200196,JPRN,2020-11-11,2020-11-11,False,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,"Combination therapy of favipiravir, camostat mesilate and inhaled ciclesonide for COVID-19 pneumonia",118,https://jrct.niph.go.jp/latest-detail/jRCTs031200196
5235,JPRN-jRCTs031200374,JPRN,2021-02-24,2021-02-25,False,Recruiting,Phase 2/Phase 3,Interventional,Japan,"An open-label, randomized, controlled trial to evaluate the efficacy of convalescent plasma therapy for COVID-19.",200,https://jrct.niph.go.jp/latest-detail/jRCTs031200374
5236,JPRN-jRCTs031200436,JPRN,2021-03-23,2021-05-13,False,Recruiting,Phase 2,Interventional,Japan,Safety and efficacy of favipiravir and camostat mesilate in patients with COVID-19.,200,https://jrct.niph.go.jp/latest-detail/jRCTs031200436
5237,JPRN-jRCTs031210123,JPRN,2021-05-31,2021-05-31,False,Recruiting,Phase 2/Phase 3,Interventional,Japan,Safety study of health food containing 5-aminolevulinic acid phosphate in patients with COVID-19 sequelae using smart watch and electronic research collaborator diary.,40,https://jrct.niph.go.jp/latest-detail/jRCTs031210123
5238,JPRN-jRCTs041200072,JPRN,2020-12-10,2021-02-15,False,Recruiting,Phase 2,Interventional,Japan,"COVID-19 Prevention of worsening of symptoms in asymptomatic to mild patients by combined use of kakkonto and hochuekkito:
Exploratory open-label randomized controlled trial",100,https://jrct.niph.go.jp/latest-detail/jRCTs041200072
5239,JPRN-jRCTs051200049,JPRN,2020-08-26,2020-02-11,True,Recruiting,Phase 2,Interventional,Japan,Therapeutic drug development program for COVID-19,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200049
5240,JPRN-jRCTs051200060,JPRN,2020-09-25,2020-09-25,False,Not Recruiting,Phase 1,Interventional,Japan,Prohylaxis with hydroxichloroquine aiming at prevention of COVID-19 for medical care workers,500,https://jrct.niph.go.jp/latest-detail/jRCTs051200060
5241,JPRN-jRCTs061200002,JPRN,2020-05-20,2020-07-15,False,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002
5242,JPRN-jRCTs071210011,JPRN,2021-04-13,2021-12-05,False,Recruiting,Not Applicable,Interventional,Japan,"CAM (Clarithromycin) Effectivity for COVID-19 pneumonia which does not require oxygen administration; multicenter, randomized-controlled, open-label, 3-armed parallel group comparison, exploratory trial",60,https://jrct.niph.go.jp/latest-detail/jRCTs071210011
5243,JPRN-UMIN000040235,JPRN,2020-04-25,2020-04-23,True,Not Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901
5244,JPRN-UMIN000040602,JPRN,2020-06-01,2020-06-15,False,Not Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338
5245,JPRN-UMIN000042556,JPRN,2020-12-01,2020-12-05,False,Not Recruiting,Not Applicable,Interventional,Japan,Effect of Internet-delivered psychoeducation program named &quot;Imacoco-care&quot; on improving psychological distress among workers under COVID-19 infection,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048548
5246,JPRN-UMIN000044145,JPRN,2021-05-31,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,"Japan,Asia(except Japan)",A randomized controlled trial of the effect of an Internet cognitive behavioral therapy e-learning program for nurses in Vietnam and Thailand,1200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050128
5247,JPRN-UMIN000044519,JPRN,2021-06-13,2021-06-14,False,Not Recruiting,Not Applicable,Interventional,Japan,COVID-19 Antibody quantification and vaccination history and association with viral genotype (variant),40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050864
5248,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,False,Not Recruiting,Phase 3,Interventional,"Portugal, Belgium, Luxembourg, Austria, France",Trial of Treatments for COVID-19 in Hospitalized Adults,2416,https://clinicaltrials.gov/show/NCT04315948
5249,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,False,Not Recruiting,Phase 3,Interventional,"Australia, United Kingdom, Netherlands, Brazil, Spain",BCG Vaccination to Protect Healthcare Workers Against COVID-19,10078,https://clinicaltrials.gov/show/NCT04327206
5250,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-06-22,False,Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,600,https://clinicaltrials.gov/show/NCT04334512
5251,NCT04341935,ClinicalTrials.gov,2020-04-06,2021-06-30,False,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,0,https://clinicaltrials.gov/show/NCT04341935
5252,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-04-22,False,Not Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,56,https://clinicaltrials.gov/show/NCT04349631
5253,NCT04360096,ClinicalTrials.gov,2020-04-21,2021-02-15,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Inhaled ZYESAMIâ„¢ (Aviptadil Acetate) for the Treatment of Severe COVID-19,144,https://clinicaltrials.gov/show/NCT04360096
5254,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-06-16,False,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04361396
5255,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,False,Not Recruiting,Phase 3,Interventional,"Hungary, Russian Federation, United Kingdom, Italy, United States, Spain, France, Germany",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,451,https://clinicaltrials.gov/show/NCT04362813
5256,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-08-01,False,Not Recruiting,Phase 2,Interventional,United Kingdom,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,0,https://clinicaltrials.gov/show/NCT04363372
5257,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04363502
5258,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,False,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),220,https://clinicaltrials.gov/show/NCT04365257
5259,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Not Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,189,https://clinicaltrials.gov/show/NCT04366960
5260,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),131,https://clinicaltrials.gov/show/NCT04369742
5261,NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Not Recruiting,Phase 3,Interventional,"United Kingdom, Mexico, Brazil",Early Intervention in COVID-19: Favipiravir Verses Standard Care,502,https://clinicaltrials.gov/show/NCT04373733
5262,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,False,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,48,https://clinicaltrials.gov/show/NCT04379076
5263,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Not Recruiting,Phase 2,Interventional,"Argentina, Russian Federation, South Africa, United States, Mexico, Brazil, Spain",A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,212,https://clinicaltrials.gov/show/NCT04380961
5264,NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,32,https://clinicaltrials.gov/show/NCT04388527
5265,NCT04389671,ClinicalTrials.gov,2020-05-13,2020-11-02,False,Recruiting,Phase 2,Interventional,United States,The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19),20,https://clinicaltrials.gov/show/NCT04389671
5266,NCT04393246,ClinicalTrials.gov,2020-05-16,2020-07-03,False,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,1407,https://clinicaltrials.gov/show/NCT04393246
5267,NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,False,Not Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,615,https://clinicaltrials.gov/show/NCT04394377
5268,NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,True,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,80,https://clinicaltrials.gov/show/NCT04397757
5269,NCT04399252,ClinicalTrials.gov,2020-05-19,2020-06-24,False,Not Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,182,https://clinicaltrials.gov/show/NCT04399252
5270,NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Not Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,32,https://clinicaltrials.gov/show/NCT04412330
5271,NCT04416048,ClinicalTrials.gov,2020-06-02,2020-11-30,False,Recruiting,Phase 2,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,400,https://clinicaltrials.gov/show/NCT04416048
5272,NCT04418505,ClinicalTrials.gov,2020-06-03,2020-09-02,False,Not Recruiting,Not Applicable,Interventional,"Canada, United States",Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,295,https://clinicaltrials.gov/show/NCT04418505
5273,NCT04421027,ClinicalTrials.gov,2020-06-05,2020-06-12,False,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, United Kingdom, Puerto Rico, United States, Brazil, Italy, Mexico, Japan, Spain, India, Germany, South Korea",A Study of Baricitinib (LY3009104) in Participants With COVID-19,1400,https://clinicaltrials.gov/show/NCT04421027
5274,NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,True,Not Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,140,https://clinicaltrials.gov/show/NCT04426305
5275,NCT04464395,ClinicalTrials.gov,2020-07-07,2020-07-01,True,Not Recruiting,Phase 1,Interventional,United States,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04464395
5276,NCT04467840,ClinicalTrials.gov,2020-07-09,2020-08-21,False,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Peru, United Kingdom, Colombia, Italy, Israel, United States, Brazil, Mexico, Poland","Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",464,https://clinicaltrials.gov/show/NCT04467840
5277,NCT04470427,ClinicalTrials.gov,2020-07-11,2020-07-27,False,Not Recruiting,Phase 3,Interventional,United States,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",30420,https://clinicaltrials.gov/show/NCT04470427
5278,NCT04473690,ClinicalTrials.gov,2020-07-14,2020-12-30,False,Recruiting,Phase 1/Phase 2,Interventional,"Canada, United States",KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,180,https://clinicaltrials.gov/show/NCT04473690
5279,NCT04474483,ClinicalTrials.gov,2020-05-15,2020-11-06,False,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,30,https://clinicaltrials.gov/show/NCT04474483
5280,NCT04475302,ClinicalTrials.gov,2020-07-16,2020-07-01,True,Recruiting,Phase 3,Interventional,India,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,2175,https://clinicaltrials.gov/show/NCT04475302
5281,NCT04475588,ClinicalTrials.gov,2020-07-16,2020-05-01,True,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,32,https://clinicaltrials.gov/show/NCT04475588
5282,NCT04492410,ClinicalTrials.gov,2020-07-28,2020-07-21,True,Not Recruiting,Not Applicable,Interventional,France,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),500,https://clinicaltrials.gov/show/NCT04492410
5283,NCT04497987,ClinicalTrials.gov,2020-07-31,2020-08-02,False,Not Recruiting,Phase 3,Interventional,United States,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,1374,https://clinicaltrials.gov/show/NCT04497987
5284,NCT04504734,ClinicalTrials.gov,2020-08-04,2020-11-27,False,Recruiting,Phase 3,Interventional,"Puerto Rico, United States",Bucillamine in Treatment of Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04504734
5285,NCT04524663,ClinicalTrials.gov,2020-04-10,2020-12-19,False,Not Recruiting,Phase 2,Interventional,United States,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,48,https://clinicaltrials.gov/show/NCT04524663
5286,NCT04526717,ClinicalTrials.gov,2020-07-30,2021-12-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04526717
5287,NCT04536298,ClinicalTrials.gov,2020-08-27,2020-12-28,False,Recruiting,Phase 3,Interventional,United States,Vitamin D and COVID-19 Trial,2700,https://clinicaltrials.gov/show/NCT04536298
5288,NCT04539275,ClinicalTrials.gov,2020-08-27,2020-11-16,False,Recruiting,Phase 3,Interventional,"Puerto Rico, United States",COVID-19 (VA CURES-1),702,https://clinicaltrials.gov/show/NCT04539275
5289,NCT04569227,ClinicalTrials.gov,2020-09-28,2021-04-30,False,Recruiting,Phase 2,Interventional,United States,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,60,https://clinicaltrials.gov/show/NCT04569227
5290,NCT04576312,ClinicalTrials.gov,2020-09-28,2020-06-29,True,Not Recruiting,Phase 1,Interventional,Denmark,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,64,https://clinicaltrials.gov/show/NCT04576312
5291,NCT04582201,ClinicalTrials.gov,2020-10-06,2020-09-21,True,Recruiting,Phase 1,Interventional,United States,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,55,https://clinicaltrials.gov/show/NCT04582201
5292,NCT04583956,ClinicalTrials.gov,2020-10-09,2020-10-14,False,Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04583956
5293,NCT04591210,ClinicalTrials.gov,2020-10-06,2021-01-27,False,Recruiting,Phase 3,Interventional,"Canada, Mexico, Brazil",The COVID-RASi Trial (COVID-19),1155,https://clinicaltrials.gov/show/NCT04591210
5294,NCT04593940,ClinicalTrials.gov,2020-09-23,2020-10-15,False,Recruiting,Phase 3,Interventional,"Argentina, Peru, United States, Brazil",Immune Modulators for Treating COVID-19,2160,https://clinicaltrials.gov/show/NCT04593940
5295,NCT04595097,ClinicalTrials.gov,2020-10-19,2021-03-01,False,Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in COVID-19 Patients,138,https://clinicaltrials.gov/show/NCT04595097
5296,NCT04605588,ClinicalTrials.gov,2020-10-26,2020-12-02,False,Not Recruiting,Phase 2,Interventional,United States,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,7,https://clinicaltrials.gov/show/NCT04605588
5297,NCT04614883,ClinicalTrials.gov,2020-11-02,2020-10-21,True,Not Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,130,https://clinicaltrials.gov/show/NCT04614883
5298,NCT04627519,ClinicalTrials.gov,2020-11-10,2020-12-09,False,Not Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and Safety of Rhea Health ToneÂ® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,85,https://clinicaltrials.gov/show/NCT04627519
5299,NCT04640181,ClinicalTrials.gov,2020-11-19,2020-12-01,False,Not Recruiting,Phase 2,Interventional,United States,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),150,https://clinicaltrials.gov/show/NCT04640181
5300,NCT04657497,ClinicalTrials.gov,2020-11-09,2020-11-09,False,Not Recruiting,Phase 3,Interventional,Japan,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),155,https://clinicaltrials.gov/show/NCT04657497
5301,NCT04672291,ClinicalTrials.gov,2020-10-05,2021-06-15,False,Not Recruiting,Phase 1,Interventional,Canada,Nasal Poly-ICLC (HiltonolÂ®) in Healthy COVID-19 Vaccinated Adults,43,https://clinicaltrials.gov/show/NCT04672291
5302,NCT04708236,ClinicalTrials.gov,2021-01-08,2021-04-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia,0,https://clinicaltrials.gov/show/NCT04708236
5303,NCT04713553,ClinicalTrials.gov,2021-01-15,2021-02-15,False,Recruiting,Phase 3,Interventional,United States,"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants",1530,https://clinicaltrials.gov/show/NCT04713553
5304,NCT04724720,ClinicalTrials.gov,2021-01-13,2021-01-19,False,Not Recruiting,Phase 2,Interventional,United States,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,56,https://clinicaltrials.gov/show/NCT04724720
5305,NCT04738136,ClinicalTrials.gov,2021-01-27,2021-06-15,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",30,https://clinicaltrials.gov/show/NCT04738136
5306,NCT04739449,ClinicalTrials.gov,2021-02-03,2021-10-04,False,Not Recruiting,Not Applicable,Interventional,No Country Given,'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,100,https://clinicaltrials.gov/show/NCT04739449
5307,NCT04745351,ClinicalTrials.gov,2021-02-08,2021-03-31,False,Recruiting,Phase 3,Interventional,"Spain, Portugal, United States, United Kingdom",Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19),1116,https://clinicaltrials.gov/show/NCT04745351
5308,NCT04784754,ClinicalTrials.gov,2021-02-22,2021-04-01,False,Recruiting,Phase 2,Interventional,United States,Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,50,https://clinicaltrials.gov/show/NCT04784754
5309,NCT04798027,ClinicalTrials.gov,2021-03-11,2021-03-12,False,Recruiting,Phase 1/Phase 2,Interventional,"Honduras, United States",Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older,333,https://clinicaltrials.gov/show/NCT04798027
5310,NCT04801056,ClinicalTrials.gov,2021-03-11,2021-05-01,False,Not Recruiting,Phase 1,Interventional,United States,Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19,0,https://clinicaltrials.gov/show/NCT04801056
5311,NCT04804072,ClinicalTrials.gov,2021-02-18,2021-06-02,False,Recruiting,Not Applicable,Interventional,United States,INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit,860,https://clinicaltrials.gov/show/NCT04804072
5312,NCT04805892,ClinicalTrials.gov,2021-03-17,2021-03-17,False,Recruiting,Not Applicable,Interventional,United States,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.",250,https://clinicaltrials.gov/show/NCT04805892
5313,NCT04806113,ClinicalTrials.gov,2021-03-12,2021-03-11,True,Not Recruiting,Phase 3,Interventional,Canada,COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases,220,https://clinicaltrials.gov/show/NCT04806113
5314,NCT04811664,ClinicalTrials.gov,2021-03-19,2021-03-24,False,Recruiting,Phase 3,Interventional,United States,A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine,37500,https://clinicaltrials.gov/show/NCT04811664
5315,NCT04822025,ClinicalTrials.gov,2021-03-25,2021-05-20,False,Recruiting,Phase 2,Interventional,Taiwan,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults,400,https://clinicaltrials.gov/show/NCT04822025
5316,NCT04826809,ClinicalTrials.gov,2021-03-18,2021-04-09,False,Recruiting,Not Applicable,Interventional,United States,New Reusable Mask Design With Superior Filtration and Fit,40,https://clinicaltrials.gov/show/NCT04826809
5317,NCT04830735,ClinicalTrials.gov,2021-04-01,2021-07-15,False,Not Recruiting,Phase 2,Interventional,United States,Dasatinib for the Treatment of Moderate and Severe COVID-19,144,https://clinicaltrials.gov/show/NCT04830735
5318,NCT04842292,ClinicalTrials.gov,2021-04-08,2021-05-20,False,Recruiting,Phase 2,Interventional,United States,Nebulized Heparin for COVID19-associated Acute Respiratory Failure,40,https://clinicaltrials.gov/show/NCT04842292
5319,NCT04843722,ClinicalTrials.gov,2021-04-09,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,540,https://clinicaltrials.gov/show/NCT04843722
5320,NCT04843761,ClinicalTrials.gov,2021-04-09,2021-04-20,False,Recruiting,Phase 3,Interventional,United States,ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19,640,https://clinicaltrials.gov/show/NCT04843761
5321,NCT04845191,ClinicalTrials.gov,2021-04-09,2021-06-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,540,https://clinicaltrials.gov/show/NCT04845191
5322,NCT04847050,ClinicalTrials.gov,2021-04-14,2021-04-28,False,Recruiting,Phase 2,Interventional,United States,"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy",120,https://clinicaltrials.gov/show/NCT04847050
5323,NCT04853979,ClinicalTrials.gov,2021-04-12,2021-05-16,False,Recruiting,Not Applicable,Interventional,Qatar,Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure,200,https://clinicaltrials.gov/show/NCT04853979
5324,NCT04858633,ClinicalTrials.gov,2021-03-22,2021-03-22,False,Recruiting,Phase 3,Interventional,India,Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,1000,https://clinicaltrials.gov/show/NCT04858633
5325,NCT04864561,ClinicalTrials.gov,2021-04-23,2021-04-26,False,Not Recruiting,Phase 3,Interventional,United Kingdom,"Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine",4019,https://clinicaltrials.gov/show/NCT04864561
5326,NCT04867174,ClinicalTrials.gov,2021-04-27,2021-05-24,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccination Take-Up,10000,https://clinicaltrials.gov/show/NCT04867174
5327,NCT04869397,ClinicalTrials.gov,2021-04-29,2021-06-14,False,Recruiting,Phase 2,Interventional,Canada,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,48,https://clinicaltrials.gov/show/NCT04869397
5328,NCT04871854,ClinicalTrials.gov,2021-04-25,2021-04-26,False,Recruiting,Phase 2,Interventional,Egypt,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,60,https://clinicaltrials.gov/show/NCT04871854
5329,NCT04873128,ClinicalTrials.gov,2021-04-30,2021-06-10,False,Recruiting,Not Applicable,Interventional,Germany,Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach,110,https://clinicaltrials.gov/show/NCT04873128
5330,NCT04880694,ClinicalTrials.gov,2021-04-25,2021-05-20,False,Recruiting,Phase 2,Interventional,Belgium,A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019(COVID-19)Pneumonia,25,https://clinicaltrials.gov/show/NCT04880694
5331,NCT04885361,ClinicalTrials.gov,2021-05-07,2021-05-26,False,Recruiting,Phase 1,Interventional,Belgium,"To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults",48,https://clinicaltrials.gov/show/NCT04885361
5332,NCT04885530,ClinicalTrials.gov,2021-04-30,2021-06-08,False,Recruiting,Phase 3,Interventional,United States,ACTIV-6: COVID-19 Study of Repurposed Medications,15000,https://clinicaltrials.gov/show/NCT04885530
5333,NCT04887948,ClinicalTrials.gov,2021-05-10,2021-05-20,False,Recruiting,Phase 3,Interventional,United States,Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2,600,https://clinicaltrials.gov/show/NCT04887948
5334,NCT04894435,ClinicalTrials.gov,2021-05-18,2021-05-20,False,Recruiting,Phase 2,Interventional,Canada,Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity,1200,https://clinicaltrials.gov/show/NCT04894435
5335,NCT04894474,ClinicalTrials.gov,2021-05-18,2021-06-17,False,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2,1700,https://clinicaltrials.gov/show/NCT04894474
5336,NCT04900467,ClinicalTrials.gov,2021-05-21,2021-05-28,False,Recruiting,Not Applicable,Interventional,France,Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine,400,https://clinicaltrials.gov/show/NCT04900467
5337,NCT04902183,ClinicalTrials.gov,2021-05-21,2021-06-09,False,Recruiting,Phase 2,Interventional,Greece,Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19,90,https://clinicaltrials.gov/show/NCT04902183
5338,NCT04904549,ClinicalTrials.gov,2021-05-26,2021-05-26,False,Recruiting,Phase 3,Interventional,United States,Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older,37430,https://clinicaltrials.gov/show/NCT04904549
5339,NCT04904783,ClinicalTrials.gov,2021-05-25,2021-06-01,False,Recruiting,Not Applicable,Interventional,India,Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study,20,https://clinicaltrials.gov/show/NCT04904783
5340,NCT04910269,ClinicalTrials.gov,2021-06-01,2021-06-01,False,Not Recruiting,Phase 3,Interventional,No Country Given,Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19,820,https://clinicaltrials.gov/show/NCT04910269
5341,NCT04910932,ClinicalTrials.gov,2021-06-01,2021-06-10,False,Recruiting,Not Applicable,Interventional,Turkey,"Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic",50,https://clinicaltrials.gov/show/NCT04910932
5342,NCT04913675,ClinicalTrials.gov,2021-05-27,2021-06-09,False,Not Recruiting,Phase 3,Interventional,No Country Given,Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19,1020,https://clinicaltrials.gov/show/NCT04913675
5343,NCT04916574,ClinicalTrials.gov,2021-06-03,2021-03-20,True,Not Recruiting,Not Applicable,Interventional,Estonia,Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum,16,https://clinicaltrials.gov/show/NCT04916574
5344,NCT04916821,ClinicalTrials.gov,2021-05-26,2021-05-15,True,Not Recruiting,Not Applicable,Interventional,Turkey,Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19),45,https://clinicaltrials.gov/show/NCT04916821
5345,NCT04918914,ClinicalTrials.gov,2021-05-27,2020-10-18,True,Recruiting,Phase 1,Interventional,United States,Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment,100,https://clinicaltrials.gov/show/NCT04918914
5346,NCT04918927,ClinicalTrials.gov,2021-06-04,2021-07-01,False,Not Recruiting,Phase 2,Interventional,Mexico,Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19,120,https://clinicaltrials.gov/show/NCT04918927
5347,NCT04918940,ClinicalTrials.gov,2021-06-04,2021-05-21,True,Recruiting,Not Applicable,Interventional,France,Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma,40,https://clinicaltrials.gov/show/NCT04918940
5348,NCT04919031,ClinicalTrials.gov,2021-06-07,2021-04-20,True,Recruiting,Not Applicable,Interventional,Egypt,Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms,30,https://clinicaltrials.gov/show/NCT04919031
5349,NCT04920760,ClinicalTrials.gov,2021-06-09,2021-06-21,False,Not Recruiting,Phase 2,Interventional,No Country Given,Vitamin A Supplementation in Children With Moderate to Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04920760
5350,NCT04920773,ClinicalTrials.gov,2021-06-06,2021-05-03,True,Not Recruiting,Not Applicable,Interventional,India,Community-based Post-exposure Prophylaxis for COVID-19,216,https://clinicaltrials.gov/show/NCT04920773
5351,NCT04920838,ClinicalTrials.gov,2021-05-04,2021-04-12,True,Recruiting,Phase 2/Phase 3,Interventional,"Guinea, Burkina Faso",Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection,600,https://clinicaltrials.gov/show/NCT04920838
5352,NCT04920890,ClinicalTrials.gov,2021-05-26,2021-06-16,False,Recruiting,Not Applicable,Interventional,Spain,Radiofrequency Intervention in Post COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04920890
5353,NCT04920916,ClinicalTrials.gov,2021-06-08,2021-05-25,True,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04920916
5354,NCT04921228,ClinicalTrials.gov,2021-05-20,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Biofeedback for CHAMPS,28,https://clinicaltrials.gov/show/NCT04921228
5355,NCT04922632,ClinicalTrials.gov,2021-06-08,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19,280,https://clinicaltrials.gov/show/NCT04922632
5356,NCT04922788,ClinicalTrials.gov,2021-06-08,2021-06-07,True,Recruiting,Phase 3,Interventional,Vietnam,"Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19",13000,https://clinicaltrials.gov/show/NCT04922788
5357,NCT04922814,ClinicalTrials.gov,2021-06-08,2021-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19,40,https://clinicaltrials.gov/show/NCT04922814
5358,NCT04922827,ClinicalTrials.gov,2021-06-10,2021-07-01,False,Not Recruiting,Phase 2,Interventional,Germany,Infliximab in the Treatment of Patients With Severe COVID-19 Disease,88,https://clinicaltrials.gov/show/NCT04922827
5359,NCT04922905,ClinicalTrials.gov,2021-06-09,2020-04-02,True,Not Recruiting,Not Applicable,Interventional,France,Nervous System Symptoms Associated With COVID 19,99,https://clinicaltrials.gov/show/NCT04922905
5360,NCT04922918,ClinicalTrials.gov,2021-06-09,2020-10-01,True,Recruiting,Not Applicable,Interventional,Spain,Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home,25,https://clinicaltrials.gov/show/NCT04922918
5361,NCT04922957,ClinicalTrials.gov,2021-06-09,2021-09-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)",152,https://clinicaltrials.gov/show/NCT04922957
5362,NCT04923061,ClinicalTrials.gov,2021-06-05,2021-04-06,True,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Sleep Quality and Fatigue,68,https://clinicaltrials.gov/show/NCT04923061
5363,NCT04924660,ClinicalTrials.gov,2021-06-09,2021-06-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Novel Experimental COVID-19 Therapies Affecting Host Response,1600,https://clinicaltrials.gov/show/NCT04924660
5364,NCT04924803,ClinicalTrials.gov,2021-06-09,2021-12-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs,500,https://clinicaltrials.gov/show/NCT04924803
5365,NCT04924881,ClinicalTrials.gov,2021-06-10,2021-07-01,False,Not Recruiting,Phase 2,Interventional,Hong Kong,Chinese Medicine for Patients With LCOVID-19 Symptoms,68,https://clinicaltrials.gov/show/NCT04924881
5366,NCT04925258,ClinicalTrials.gov,2021-05-03,2021-03-01,True,Recruiting,Not Applicable,Interventional,Canada,Supporting Parent and Child Engagement,40,https://clinicaltrials.gov/show/NCT04925258
5367,NCT04930185,ClinicalTrials.gov,2021-06-03,2021-09-01,False,Not Recruiting,Not Applicable,Interventional,Malaysia,Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme,600,https://clinicaltrials.gov/show/NCT04930185
5368,ACTRN12621000738820,ANZCTR,2021-06-11,2021-07-06,False,Recruiting,Phase 1,Interventional,Australia,A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine (IVX-411) in Healthy Adults,84,https://anzctr.org.au/ACTRN12621000738820.aspx
5369,ISRCTN31161020,ISRCTN,2021-06-08,2021-11-06,False,Recruiting,Not Applicable,Interventional,United Kingdom,Reducing stress in the workplace using a digital intervention designed to improve employee wellbeing and help them stay engaged and productive in work,420,http://isrctn.com/ISRCTN31161020
5370,ISRCTN82492510,ISRCTN,2021-06-07,2021-02-08,True,Recruiting,Not Applicable,Interventional,United Kingdom,Kidney-specific psychosocial assessment and support,36,http://isrctn.com/ISRCTN82492510
5371,ISRCTN79815558,ISRCTN,2021-04-27,2021-04-28,False,Recruiting,Phase 3,Interventional,United Kingdom,COV-COMPARE: A study to compare the VLA2001 and AZD1222 vaccines against COVID-19 in adults,4000,http://isrctn.com/ISRCTN79815558
5372,ISRCTN46897021,ISRCTN,2021-03-15,2021-01-10,True,Recruiting,Not Applicable,Interventional,United Kingdom,"An exploratory study in primary care to test the feasibility of an intervention called DIALOG+, designed to improve quality of life for people in primary care with poor mental and physical health",10,http://isrctn.com/ISRCTN46897021
5373,ISRCTN15638344,ISRCTN,2021-02-11,2021-02-15,False,Recruiting,Phase 2,Interventional,United Kingdom,A phase II study of a candidate COVID-19 vaccine in children (COV006),300,http://isrctn.com/ISRCTN15638344
5374,ISRCTN11466448,ISRCTN,2020-11-23,2020-11-30,False,Recruiting,Not Applicable,Interventional,United Kingdom,A randomized trial to assess the effects of physical and mental health rehabilitation for people recovering from COVID-19,535,http://isrctn.com/ISRCTN11466448
5375,ISRCTN34160010,ISRCTN,2020-09-14,2020-01-06,True,Not Recruiting,Not Applicable,Interventional,Russian Federation,A low-intervention study of pre-exposure prophylaxis (PrEP) in healthy volunteers at high risk of coronavirus (SARS-CoV-2) infection.,100,http://isrctn.com/ISRCTN34160010
5376,EUCTR2020-002039-31-FI,EU Clinical Trials Register,2020-04-28,2020-06-17,False,Not Recruiting,Phase 3,Interventional,Finland,Use of Tocilizumab in the inflammatory phase of COVID-19 / new coronavirus disease,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002039-31
5377,EUCTR2020-001431-27-DE,EU Clinical Trials Register,2020-04-07,2020-05-06,False,Not Recruiting,Phase 2,Interventional,Germany,Is there a benefit in treating novel corona virus (Sars-CoV2) infections with the established antihypertensive valsartan?,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001431-27
5378,EUCTR2020-001549-38-DE,EU Clinical Trials Register,2020-04-06,2020-06-29,False,Not Recruiting,Phase 3,Interventional,Germany,An international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care - WHO-SOLIDARITY-GERMANY,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001549-38
5379,EUCTR2020-005763-31-PL,EU Clinical Trials Register,2020-12-29,2021-03-15,False,Authorised,Phase 2,Interventional,"Portugal, Italy, United States, Spain, Poland",FREEDOM COVID Anticoagulation Strategy Randomized Trial,3600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005763-31
5380,EUCTR2021-000627-12-BE,EU Clinical Trials Register,2021-05-05,2021-01-06,True,Authorised,Phase 3,Interventional,"Russian Federation, United Kingdom, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A Six-Month Follow-Up Study of Patients with COVID-19 Previously Enrolled in a RO7496998 (AT-527) Study

",1040,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000627-12
5381,EUCTR2021-002184-22-GR,EU Clinical Trials Register,2021-05-05,2021-05-14,False,Authorised,Phase 2,Interventional,Greece,A study for patients with moderate or severe COVID-19 for the evaluation of the safety and efficacy of a new investigational drug using exosomes,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002184-22
5382,EUCTR2020-005227-37-NL,EU Clinical Trials Register,2020-12-17,2021-03-03,False,Authorised,Phase 2,Interventional,"Netherlands, Italy, United States, Switzerland",The safety and efficacy of dapansutrile for the treatment of moderate COVID-19 symptoms,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005227-37
5383,EUCTR2020-001675-33-DE,EU Clinical Trials Register,2020-04-17,2020-05-29,False,Authorised,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce elderly people's days with severe respiratory infectious diseases at hospital and/or at home,2038,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001675-33
5384,EUCTR2021-001036-25-DE,EU Clinical Trials Register,2021-04-01,2021-01-06,True,Authorised,Phase 2,Interventional,Germany,Study to test UNI91103 in adults with Covid-19 and no or only mild symptoms,330,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001036-25
5385,EUCTR2020-005997-82-NL,EU Clinical Trials Register,2021-02-27,2021-12-03,False,Authorised,Phase 1/Phase 2,Interventional,Netherlands,Vaccination phase I/II study against COVID-19,176,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005997-82
5386,EUCTR2021-000673-83-BE,EU Clinical Trials Register,2021-02-19,2021-11-03,False,Authorised,Phase 4,Interventional,Belgium,Impact of the immune system on response to COVID-19 vaccine in allogeneic stem cell recipients,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000673-83
5387,EUCTR2020-005366-34-IE,EU Clinical Trials Register,2020-12-21,2021-12-02,False,Authorised,Phase 2,Interventional,"Croatia, Ireland, Greece, United Kingdom, Canada, United States, Spain, Latvia, Poland, Lithuania, Bulgaria","A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005366-34
5388,EUCTR2020-005911-27-BE,EU Clinical Trials Register,2021-02-15,2021-03-17,False,Authorised,Phase 3,Interventional,Belgium,The DAWN camostat trial: the efficacy of camostat in ambulatory patients with confirmed COVID-19 infection compared to placebo.,1306,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005911-27
5389,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-11-26,False,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,100,http://www.drks.de/DRKS00021447
5390,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-01-04,True,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,30,http://www.drks.de/DRKS00021420
5391,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,100,http://www.drks.de/DRKS00021527
5392,DRKS00022857,German Clinical Trials Register,2020-12-28,2021-03-15,False,Recruiting,Phase 2,Interventional,"Spain, Germany",Safety and Performance Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the treatment of patients with COVID-19,42,http://www.drks.de/DRKS00022857
5393,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,Not Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",24,http://www.drks.de/DRKS00021573
5394,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Not Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,220,http://www.drks.de/DRKS00021585
5395,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-08-05,False,Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,1000,http://www.drks.de/DRKS00021588
5396,DRKS00021582,German Clinical Trials Register,2020-05-12,2020-05-31,False,Not Recruiting,Not Applicable,Interventional,"United Kingdom, United States, Mexico, Spain, France, Germany","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",20000,http://www.drks.de/DRKS00021582
5397,DRKS00023822,German Clinical Trials Register,2020-12-21,2020-12-16,True,Recruiting,Phase 3,Interventional,Germany,Validation of a SARS-CoV-2 (COVID-19) rapid antigen test in the daily routine of general practitioners for the diagnosis of corona infection,4600,http://www.drks.de/DRKS00023822
5398,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-04-04,False,Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,840,http://www.drks.de/DRKS00021214
5399,DRKS00022553,German Clinical Trials Register,2020-09-14,2020-01-10,True,Recruiting,Phase 4,Interventional,Germany,Psychodiagnostic Screening in U-Examinations,5670,http://www.drks.de/DRKS00022553
5400,DRKS00023880,German Clinical Trials Register,2021-01-07,2020-11-23,True,Recruiting,Not Applicable,Interventional,Germany,Radiological and immunological effects of COVID-19 infection on the central nervous system,170,http://www.drks.de/DRKS00023880
5401,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-07-04,False,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on â€“ tackling worries and finding strength for the crisis (COVID-19) in 10 steps,352,http://www.drks.de/DRKS00021153
5402,DRKS00022484,German Clinical Trials Register,2020-07-17,2020-09-04,False,Not Recruiting,Not Applicable,Interventional,Germany,Clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (COVID-19),50,http://www.drks.de/DRKS00022484
5403,DRKS00023911,German Clinical Trials Register,2020-12-18,2020-10-18,True,Not Recruiting,Not Applicable,Interventional,Germany,"German research network ""Applied Surveillance and Testing"" - Workpackage schools and Nurseries (COVID-19)",7500,http://www.drks.de/DRKS00023911
5404,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-04-06,True,Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,240,http://www.drks.de/DRKS00021301
5405,DRKS00023971,German Clinical Trials Register,2021-02-02,2021-02-21,False,Recruiting,Not Applicable,Interventional,Germany,Breath-assisted stimulation of the anti-inflammatory reflex of the vagus nerve in covid-19 disease: a randomized-controlled trial,60,http://www.drks.de/DRKS00023971
5406,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Recruiting,Not Applicable,Interventional,"Chile, Argentina, South Africa, Ireland, Italy, Brazil, Spain, Austria, Germany",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,544,http://www.drks.de/DRKS00021273
5407,DRKS00022305,German Clinical Trials Register,2020-07-31,2020-03-08,True,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of the Patient-Doctor-Relationship during the COVID-19 pandemia,500,http://www.drks.de/DRKS00022305
5408,DRKS00023650,German Clinical Trials Register,2021-02-09,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,"China, United States","An entertainment-education approach to improve vaccine confidence during the COVID-19 pandemic: an online randomized controlled experiment with 24,000 participants",24000,http://www.drks.de/DRKS00023650
5409,DRKS00023567,German Clinical Trials Register,2021-05-06,2021-04-23,True,Recruiting,Not Applicable,Interventional,Germany,Effects of personalized supplements on the incidence of respiratory diseases,62,http://www.drks.de/DRKS00023567
5410,DRKS00023721,German Clinical Trials Register,2020-12-15,2020-01-10,True,Recruiting,Not Applicable,Interventional,Germany,WÃ¼rzburg Childcare Study during the COVID-19 pandemic: A study into the acceptance of different screening measures for the detection of infections with the novel coronavirus (SARS-CoV-2) in child daycare centres in WÃ¼rzburg,1000,http://www.drks.de/DRKS00023721
5411,DRKS00023406,German Clinical Trials Register,2020-11-09,2020-11-15,False,Not Recruiting,Not Applicable,Interventional,Germany,Intubation with VieScope vs. Videolaryngoskopy in complete personal protecion gear in asimulated COVID-19-Patient - A randomized controll trail,35,http://www.drks.de/DRKS00023406
5412,DRKS00024664,German Clinical Trials Register,2021-02-26,2020-10-14,True,Recruiting,Not Applicable,Interventional,Germany,Transsectoral communication in the regional management of the pandemic (COVID-19),30,http://www.drks.de/DRKS00024664
5413,DRKS00022067,German Clinical Trials Register,2020-06-12,2020-06-25,False,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,134,http://www.drks.de/DRKS00022067
5414,DRKS00022083,German Clinical Trials Register,2020-06-09,2020-05-20,True,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact personsâ€™ immune status and termination of quarantine and self-isolation â€“ a prospective pilot study,70,http://www.drks.de/DRKS00022083
5415,DRKS00023500,German Clinical Trials Register,2020-11-05,2020-06-18,True,Not Recruiting,Not Applicable,Interventional,Germany,"Rapidly applicable surveillance process for COVID-19 
in day care centers with dual swabs",1250,http://www.drks.de/DRKS00023500
5416,DRKS00024845,German Clinical Trials Register,2021-03-18,2021-03-19,False,Not Recruiting,Not Applicable,Interventional,Germany,The Potential of home-based Screening for SARS-CoV-2 when opening schools in Baden-WÃ¼rttemberg (COVID-19),100,http://www.drks.de/DRKS00024845
5417,DRKS00023553,German Clinical Trials Register,2020-11-30,2020-01-12,True,Not Recruiting,Not Applicable,Interventional,Germany,Remote Patient Monitoring (RPM) for patients with COVID-19 and other infection,120,http://www.drks.de/DRKS00023553
5418,DRKS00022203,German Clinical Trials Register,2020-06-15,2020-06-20,False,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled study",90,http://www.drks.de/DRKS00022203
5419,DRKS00024787,German Clinical Trials Register,2021-05-05,2021-05-17,False,Not Recruiting,Not Applicable,Interventional,Germany,Pilot study to analyze COVID-19 vaccination response,60,http://www.drks.de/DRKS00024787
5420,DRKS00024520,German Clinical Trials Register,2021-02-12,2021-09-03,False,Recruiting,Phase 2,Interventional,Germany,Double-blind placebo-controlled proof-of-concept trial to demonstrate the anti-viral efficacy of different doses of azelastine in COVID-19 positive patients,90,http://www.drks.de/DRKS00024520
5421,DRKS00024440,German Clinical Trials Register,2021-03-04,2021-08-03,False,Not Recruiting,I-II,Interventional,Germany,Piloting the app-based prevention program â€žbounceâ€œ for the promotion of resilience during the COVID-19 pandemic,100,http://www.drks.de/DRKS00024440
5422,DRKS00024412,German Clinical Trials Register,2021-02-15,2021-03-02,False,Recruiting,Not Applicable,Interventional,Germany,Quantification of the reduction on the viral load (SARS-CoV-2) on persons with COVID-19 after gargling with Linola sept mouthwash,80,http://www.drks.de/DRKS00024412
5423,DRKS00024422,German Clinical Trials Register,2021-02-19,2021-01-03,True,Not Recruiting,Not Applicable,Interventional,Germany,"Prospective sample collection, data collection and analysis for the clinical applicability of immunome profiles in the discrimination and therapy monitoring of COVID-19 patients in different disease stages as well as for the identification and characterization of long-term consequences of a SARS-CoV-2 infection in comparison to patients with a respiratory non-COVID-19 viral infectious disease and healthy controls.",200,http://www.drks.de/DRKS00024422
5424,DRKS00024455,German Clinical Trials Register,2021-02-09,2021-02-28,False,Not Recruiting,Not Applicable,Interventional,Germany,Force controlled coronavirus  (COVID-19) swab study,80,http://www.drks.de/DRKS00024455
5425,DRKS00024454,German Clinical Trials Register,2021-02-08,2020-10-22,True,Not Recruiting,Not Applicable,Interventional,Germany,"Randomized, placebo-controlled clinical trial on the efficacy of a mouthrinse containing 0.1% benzalkoniumchloride on the reduction of intraoral viral load and infectivity in SARS-CoV-2 positive subjects (COVID-19)",50,http://www.drks.de/DRKS00024454
5426,DRKS00023184,German Clinical Trials Register,2020-10-07,2020-09-20,True,Recruiting,Not Applicable,Interventional,Germany,Impact of personal protective equipment (PPE) during a simulated cardiac arrest in times of the COVID-19 pandemic,400,http://www.drks.de/DRKS00023184
5427,DRKS00023171,German Clinical Trials Register,2020-10-26,2020-02-11,True,Not Recruiting,Not Applicable,Interventional,Germany,Virtual Assisted Living,207,http://www.drks.de/DRKS00023171
5428,DRKS00024531,German Clinical Trials Register,2021-02-18,2021-01-14,True,Recruiting,Not Applicable,Interventional,Germany,Impact of wearing face masks as part of Covid-19 infection prevention on physical strain - Part I Effects of different face masks on physical performance and physiological parameters during a standardized bicycle ergometer test.,36,http://www.drks.de/DRKS00024531
5429,DRKS00023271,German Clinical Trials Register,2020-11-30,2020-11-18,True,Not Recruiting,Not Applicable,Interventional,Germany,"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population: study protocol for a cluster-randomised, two-factorial controlled trial.",10000,http://www.drks.de/DRKS00023271
5430,DRKS00024585,German Clinical Trials Register,2021-02-25,2021-01-19,True,Recruiting,Phase 2/Phase 3,Interventional,Germany,"A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)
- COVARI study -",150,http://www.drks.de/DRKS00024585
5431,DRKS00023091,German Clinical Trials Register,2020-09-24,2020-09-16,True,Not Recruiting,Not Applicable,Interventional,Germany,"Early detection of SARS-CoV-2 (COVID-19) in schools in the state of Hesse, Germany",1000,http://www.drks.de/DRKS00023091
5432,DRKS00024028,German Clinical Trials Register,2021-02-11,2021-01-24,True,Recruiting,Not Applicable,Interventional,Germany,Antiseptic gargle in COVID-19,60,http://www.drks.de/DRKS00024028
5433,DRKS00024117,German Clinical Trials Register,2021-02-09,2021-01-18,True,Recruiting,Not Applicable,Interventional,Germany,Rapidly applicable surveillance process for COVID-19 in day care centers with dual swabs 2,1500,http://www.drks.de/DRKS00024117
5434,DRKS00024162,German Clinical Trials Register,2021-02-09,2021-02-25,False,Not Recruiting,Not Applicable,Interventional,Germany,Identification of cardiovascular and molecular prognostic factors for the morbidity and mortality in COVID-19-sepsis,320,http://www.drks.de/DRKS00024162
5435,DRKS00025199,German Clinical Trials Register,2021-04-30,2020-04-11,True,Not Recruiting,Not Applicable,Interventional,Germany,Training Basic Life Support in COVID-19 times,346,http://www.drks.de/DRKS00025199
5436,DRKS00022958,German Clinical Trials Register,2020-10-07,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,Germany,Covid-19-associated research on hand eczema in the health sector â€“ Part 2,35,http://www.drks.de/DRKS00022958
5437,DRKS00021706,German Clinical Trials Register,2020-05-15,2020-09-06,False,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),40,http://www.drks.de/DRKS00021706
5438,DRKS00025271,German Clinical Trials Register,2021-05-11,2021-05-19,False,Recruiting,Phase 4,Interventional,Germany,Evaluation of immunogenicity and reactogenicity of heterologous covid-19 vaccine combination ChAdOx-1S followed by BNT162b2,154,http://www.drks.de/DRKS00025271
5439,SLCTR/2021/008,SLCTR,2021-03-15,2021-03-15,False,Not Recruiting,Phase 2,Interventional,Sri Lanka,"Randomized double blind controlled trial to assess the safety and efficacy of three investigational herbal preparations (nut meg based preparation, sudarshana churna, coriandum based preparation) for the treatment of patients with COVID-19",0,https://slctr.lk/trials/slctr-2021-008
5440,SLCTR/2021/005,SLCTR,2021-02-28,2021-03-10,False,Not Recruiting,Phase 2,Interventional,Sri Lanka,Assessment of efficacy of the Indigenous poly herbal drug â€œDesandun Kalkaâ€ against mild symptomatic patients with SARS-CoV- 2 infection - A randomized clinical trial,0,https://slctr.lk/trials/slctr-2021-005
5441,SLCTR/2021/002,SLCTR,2021-01-08,2021-01-08,False,Not Recruiting,Phase 2,Interventional,Sri Lanka,"Efficacy and safety of  Link Natural Sudarshana tablet (an Ayurvedic medicine)  against COVID-19 infection â€“ A single center, randomized double-blind, placebo-controlled clinical trial",0,https://slctr.lk/trials/slctr-2021-002
5442,SLCTR/2021/001,SLCTR,2021-01-05,2021-01-05,False,Recruiting,Phase 1-2,Interventional,Sri Lanka,Randomized double-blind placebo controlled parallel-group phase 1-2 proof-of-concept clinical trial of the herbal preparation Sri Weera Badhra Dhamma Prathishakthi Jeewa PanayaÂ© for patients with asymptomatic or with mild to moderate COVID-19.,0,https://slctr.lk/trials/slctr-2021-001
5443,SLCTR/2020/026,SLCTR,2020-12-21,2020-12-22,False,Recruiting,Not Applicable,Interventional,American Samoa,"Effects on the clinical evolution of patients with respiratory infection secondary to the Sars-CoV-2 virus, when they are maintaining communication with family/friends through mobile devices compared to patients not having an option of communication",0,https://slctr.lk/trials/slctr-2020-026
5444,SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,False,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",0,https://slctr.lk/trials/slctr-2020-011
5445,IRCT20191231045967N1,IRCT,2020-02-11,2020-02-20,False,Not Recruiting,Phase 3,Interventional,Iran,Determining the effect of vitamin D3 and positive group counseling with lifestyle changes in premenstrual women of reproductive age,84,http://en.irct.ir/trial/45331
5446,IRCT20200404046937N3,IRCT,2020-06-25,2020-06-27,False,Not Recruiting,Phase 3,Interventional,Iran,"Evaluating the effect of Phyllanthus Emblica, Rosa Damascene, Marshmallow and Honey on COVID 19",60,http://en.irct.ir/trial/49029
5447,IRCT20200509047364N1,IRCT,2020-08-09,2020-06-21,True,Recruiting,Phase 2,Interventional,Iran,Effect of erythropoietin on COVID-19,20,http://en.irct.ir/trial/49282
5448,IRCT20200404046937N4,IRCT,2020-08-06,2020-07-30,True,Not Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of Ivermectin on covid 19 patients,60,http://en.irct.ir/trial/49935
5449,IRCT20170315033086N10,IRCT,2021-03-14,2021-03-05,True,Not Recruiting,Phase 2,Interventional,Iran,Investigation of the efficacy of inflawell syrup on covid-19 patients,40,http://en.irct.ir/trial/51631
5450,IRCT20201101049219N1,IRCT,2021-06-10,2020-07-22,True,Not Recruiting,Not Applicable,Interventional,Iran,Effects of spiritual practice on recovery of Covid-19,70,http://en.irct.ir/trial/52099
5451,IRCT20201024049130N1,IRCT,2021-06-21,2021-05-31,True,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of Silymarin in patients with COVID-19,50,http://en.irct.ir/trial/52381
5452,IRCT20200818048444N3,IRCT,2021-06-20,2020-12-02,True,Not Recruiting,Phase 1,Interventional,Iran,Ivermectine effect in treatment and prophylaxis of patients and exposed idividuals with COVID-19,25,http://en.irct.ir/trial/52565
5453,IRCT20201220049771N1,IRCT,2020-12-31,2020-12-21,True,Not Recruiting,Not Applicable,Interventional,Iran,"study of the effectiveness of ""SALIRAVIRA"" as a natural product on the treatment of COVID-19 patients",120,http://en.irct.ir/trial/53131
5454,IRCT20210216050373N1,IRCT,2021-05-28,2021-03-03,True,Recruiting,Phase 3,Interventional,Iran,The effect of Spirulina platensis supplement in the treatment of coronavirus,60,http://en.irct.ir/trial/54375
5455,IRCT20210310050663N1,IRCT,2021-05-31,2021-04-21,True,Recruiting,Not Applicable,Interventional,Iran,The effect of respiratory-physical exercises on fatigue and quality of life,60,http://en.irct.ir/trial/54929
5456,IRCT20200721048159N3,IRCT,2021-06-03,2021-06-21,False,Recruiting,Phase 3,Interventional,Iran,The Effectiveness of Pentoxifylline and Colchicine in the Treatment of Covid-19,100,http://en.irct.ir/trial/54937
5457,IRCT20210316050722N1,IRCT,2021-05-30,2021-04-21,True,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effects of lung rehabilitation and prone condition on respiratory parameters in patients with Covid-19,105,http://en.irct.ir/trial/55500
5458,IRCT20210422051044N1,IRCT,2021-05-28,2021-07-06,False,Not Recruiting,Phase 3,Interventional,Iran,Effect of Organosulfur Compounds on COVID-19 patients,60,http://en.irct.ir/trial/55824
5459,IRCT20210427051100N1,IRCT,2021-06-19,2021-06-30,False,Not Recruiting,Phase 3,Interventional,Iran,selenium in covid_19,40,http://en.irct.ir/trial/55898
5460,IRCT20210427051101N1,IRCT,2021-06-19,2021-06-21,False,Recruiting,Phase 3,Interventional,Iran,"Assessment the effect of virtual self-care education on COVID-19 anxiety, among the community dwelling elderly",122,http://en.irct.ir/trial/55906
5461,IRCT20150711023153N3,IRCT,2021-06-04,2021-07-11,False,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation the Effects of green tea supplement in Covid 19 patients,74,http://en.irct.ir/trial/55948
5462,IRCT20210508051225N1,IRCT,2021-06-14,2021-05-22,True,Recruiting,Phase 3,Interventional,Iran,Effects of Shilajit (Momiai) on COVID-19 disease,110,http://en.irct.ir/trial/56223
5463,IRCT20201129049524N1,IRCT,2021-05-26,2021-06-15,False,Recruiting,Not Applicable,Interventional,Iran,The effect of aerobic exercise at home and turmeric supplementation in type 2 diabetes during Covid -19 quarantine,40,http://en.irct.ir/trial/56329
5464,IRCT20140824018915N9,IRCT,2021-06-04,2021-06-05,False,Recruiting,Phase 3,Interventional,Iran,The effect of captopril on definitive patients with coronavirus pneumonia,40,http://en.irct.ir/trial/56384
5465,IRCT20210426051090N1,IRCT,2021-06-12,2021-06-22,False,Not Recruiting,Phase 3,Interventional,Iran,The effect of atorvastatin on Covid 19,80,http://en.irct.ir/trial/56387
5466,IRCT20140804018677N9,IRCT,2021-06-19,2021-05-28,True,Recruiting,Phase 3,Interventional,Iran,"Effect of Astaxanthin Phytochemical, Vitamin D3, Omega-3 and Vitamin E supplement on severity of mild to moderate COVID-19 Symptoms",40,http://en.irct.ir/trial/56509
5467,IRCT20141209020258N160,IRCT,2021-06-06,2021-06-15,False,Recruiting,Phase 3,Interventional,Iran,Comparison of the effect of vitamin C and N-acetyl cysteine (NAC) on improving clinical symptoms and reducing the duration of hospitalization in patients with covid-19,232,http://en.irct.ir/trial/56545
5468,IRCT20201024049134N2,IRCT,2021-06-04,2021-06-22,False,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of tocilizumab in the treatment of hospitalized patients with COVD-19,60,http://en.irct.ir/trial/56613
5469,IRCT20201024049134N3,IRCT,2021-06-21,2021-06-22,False,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of colchicine in the treatment of COVID-19 patients,500,http://en.irct.ir/trial/56624
5470,IRCT20210522051363N1,IRCT,2021-06-13,2021-08-23,False,Not Recruiting,Not Applicable,Interventional,Iran,The effect of Omega-3 supplementation in Covid-19,40,http://en.irct.ir/trial/56697
5471,IRCT20210423051056N1,IRCT,2021-06-18,2021-05-22,True,Recruiting,Not Applicable,Interventional,Iran,The combined effect of deep breathing and prone position on common respiratory symptoms in patients with COVID-19,96,http://en.irct.ir/trial/56733
5472,IRCT20120215009014N398,IRCT,2021-06-20,2021-07-06,False,Not Recruiting,Phase 3,Interventional,Iran,Effect of 0.1% sodium hypochlorite mouthwash versus normal saline in early reducing intraoral viral load among patients with COVID-19,118,http://en.irct.ir/trial/56922
5473,LBCTR2021014651,LBCTR,2021-02-08,2020-11-15,True,Not Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical  Trial  at the Lebanese American University Medical Center- Rizk Hospital,66,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4651
5474,LBCTR2020043495,LBCTR,2020-11-04,2020-04-27,True,Not Recruiting,Phase 3,Interventional,Lebanon,An international randomised trial of additional  treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,1000,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4658
5475,LBCTR2021034768,LBCTR,2021-03-07,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,Lebanon,In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2,90,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4770
5476,LBCTR2021044780,LBCTR,2021-04-18,2021-04-19,False,Not Recruiting,Not Applicable,Interventional,Lebanon,Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19,90,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4780
5477,PACTR202004801273802,PACTR,2020-04-02,2020-04-20,False,Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928
5478,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953
5479,PACTR202004761408382,PACTR,2020-04-13,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957
5480,PACTR202005599385499,PACTR,2020-04-16,2020-04-20,False,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971
5481,PACTR202004893013257,PACTR,2020-04-21,2020-04-25,False,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981
5482,PACTR202005681895696,PACTR,2020-04-26,2020-01-10,True,Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988
5483,PACTR202009786901147,PACTR,2020-05-07,2020-01-10,True,Recruiting,Phase 3,Interventional,Kenya,Hydroxychloroquine for prevention of COVID-19,1600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019
5484,PACTR202006473370201,PACTR,2020-05-12,2020-04-30,True,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised COVID-19 patients,10000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037
5485,PACTR202007653923168,PACTR,2020-05-13,2020-01-08,True,Not Recruiting,Phase 3,Interventional,Kenya,A clinical trial comparing use of convalescent plasma therapy plus standard treatment to standard treatment alone in patients with severe COVID-19 infection,206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047
5486,PACTR202005622389003,PACTR,2020-05-14,2020-01-06,True,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053
5487,PACTR202006717277937,PACTR,2020-05-25,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088
5488,PACTR202006899597082,PACTR,2020-05-29,2020-04-29,True,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103
5489,PACTR202007589336711,PACTR,2020-06-04,2020-07-13,False,Not Recruiting,Not Applicable,Interventional,Nigeria,"Physiotherapy as a Complimentary treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors with COVID-19: A Clinical-Controlled Study",30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115
5490,PACTR202010519682638,PACTR,2020-06-12,2020-08-27,False,Not Recruiting,Phase 3,Interventional,Nigeria,Efficay of two hydroxychloroquine based drug combination regimens in comparison to standard of care  in The Treatment of Hospitalized COVID-19 Patients,210,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147
5491,PACTR202006537901307,PACTR,2020-06-15,2020-07-20,False,Recruiting,Phase 3,Interventional,"Cote d'Ivoire, Ghana, Equatorial Guinea, Tanzania, Democratic Republic of the Congo, Burkina Faso, Mozambique, Ethiopia, Cameroon, Sudan, Uganda, Guinea, Kenya","An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19",3000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150
5492,PACTR202007606032743,PACTR,2020-06-19,2020-06-15,True,Recruiting,Not Applicable,Interventional,Egypt,Nebulized heparin in patients with mainly moderate coronavirus disease 2019: Randomized controlled trial. COVID-19,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158
5493,PACTR202006922165132,PACTR,2020-06-22,2020-06-24,False,Recruiting,Phase 1,Interventional,South Africa,COVID-19 vaccine (ChAdOx1 nCoV-19) trial in South African Adults with and without HIV-infection,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166
5494,PACTR202006760881890,PACTR,2020-06-23,2020-01-08,True,Recruiting,Phase 2,Interventional,Nigeria,Lagos Covid-19 Convalescent Plasma Trial (LACCPT),100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168
5495,PACTR202006883882711,PACTR,2020-06-30,2020-01-07,True,Not Recruiting,Phase 3,Interventional,Egypt,"Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19",200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175
5496,PACTR202007720062393,PACTR,2020-07-02,2020-07-20,False,Not Recruiting,Phase 2,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV),294,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183
5497,PACTR202007611764617,PACTR,2020-07-06,2020-01-09,True,Not Recruiting,Phase 3,Interventional,Nigeria,Lagos COVID-19 Black Seed Oil Trial (LACBSOT),80,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192
5498,PACTR202007700757139,PACTR,2020-07-07,2020-07-13,False,Not Recruiting,Phase 2,Interventional,South Africa,TOGETHER 3 Trial. COVID-19,420,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194
5499,PACTR202008485004797,PACTR,2020-07-17,2020-03-08,True,Not Recruiting,Not Applicable,Interventional,South Africa,TRACE - Transmission of Covid-19 in Crowded Environments,720,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214
5500,PACTR202008855701534,PACTR,2020-08-05,2020-09-21,False,Not Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,98,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12266
5501,PACTR202009726132275,PACTR,2020-08-25,2020-07-30,True,Not Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Safety and Effectiveness of a COVID-19 Vaccine Plus Adjuvant in South African Adults,4404,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319
5502,PACTR202009769021840,PACTR,2020-08-31,2020-09-15,False,Not Recruiting,Phase 2,Interventional,Kenya,Whole-lung low dose radiation therapy (LDRT) in the treatment of severe COVID-19 pneumonia,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333
5503,PACTR202009642148520,PACTR,2020-09-02,2020-01-11,True,Recruiting,Phase 3,Interventional,"Burkina Faso, Kenya",Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso,142,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343
5504,PACTR202010537777617,PACTR,2020-09-13,2020-01-11,True,Not Recruiting,Phase 2,Interventional,Kenya,FLAVOCOV Distributed Clinical Trial. COVID-19,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365
5505,PACTR202009483194545,PACTR,2020-09-20,2020-10-15,False,Recruiting,Phase 2,Interventional,Togo,Evaluation of phytopharmaceuticals to improve the prognosis of Covid-19 disease in Togo.,250,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381
5506,PACTR202010729372570,PACTR,2020-09-25,2020-05-10,True,Not Recruiting,Phase 3,Interventional,Uganda,The COVID-19 Community Engagement Study,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392
5507,PACTR202010690466874,PACTR,2020-10-01,2020-01-11,True,Not Recruiting,Phase 2,Interventional,Ghana,KNUST COVID-19 CLINICAL TRIAL,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403
5508,PACTR202010781639956,PACTR,2020-10-07,2020-09-21,True,Recruiting,Phase 3,Interventional,"Ghana, Equatorial Guinea, Democratic Republic of the Congo, Mozambique, Ethiopia, Sudan, Kenya","The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan Africa
Ancillary Study of the ANTICOV Study:
An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",1000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420
5509,PACTR202010472402152,PACTR,2020-10-07,2020-12-10,False,Not Recruiting,Not Applicable,Interventional,Gambia,COVADIS study,1100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421
5510,PACTR202010718451278,PACTR,2020-10-14,2020-02-11,True,Not Recruiting,Phase 3,Interventional,"Mozambique, Ghana, Equatorial Guinea, Kenya","Factors affecting transmission of SARS-CoV-2 in Households of SARS-CoV-2 patients in Sub-Saharan Africa Ancillary study of the ANTICOV Study: An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",2800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432
5511,PACTR202101544570971,PACTR,2020-10-27,2020-01-12,True,Not Recruiting,Phase 3,Interventional,Gambia,Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a  randomized clinical trial (PaTS-COVID)   COVID-19,1200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13461
5512,PACTR202011523101903,PACTR,2020-11-02,2020-01-12,True,Not Recruiting,Phase 3,Interventional,Kenya,"Study of Recombinant Protein Vaccine with Adjuvant against COVID-19 in Adults 18 Years of Age and Older.
",34520,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475
5513,PACTR202101794986980,PACTR,2020-11-21,2021-01-29,False,Not Recruiting,Phase 3,Interventional,Ghana,CROWN CORONATION; COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,150,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14507
5514,PACTR202012892855610,PACTR,2020-11-22,2020-07-12,True,Not Recruiting,Not Applicable,Interventional,Nigeria,Safety and Efficacy of Artemisinin 500 mg capsule in Treatment of Adult Subjects with COVID-19,120,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14510
5515,PACTR202012898601759,PACTR,2020-12-03,2020-12-20,False,Not Recruiting,Phase 2,Interventional,Nigeria,PHASE  2 TRIAL: EVALUATION OF SILYMARIN FOR TREATMENT OF PATIENTS WITH COVID-19,314,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14547
5516,PACTR202102846261362,PACTR,2021-01-22,2021-01-02,True,Not Recruiting,Not Applicable,Interventional,Uganda,Using community influencer groups to address COVID-19 misinformation and potential vaccine hesitancy in Uganda,632,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14631
5517,PACTR202101875903773,PACTR,2021-01-22,2021-01-26,False,Not Recruiting,Not Applicable,Interventional,Egypt,A novel drug combination and route for COVID-19 treatment,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14632
5518,PACTR202102867544936,PACTR,2021-02-03,2021-07-02,False,Recruiting,Not Applicable,Interventional,Tunisia,Endothelial Dysfunction during The COVID-19 follow-up: TUN-EndCOV study,600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14657
5519,PACTR202102588777597,PACTR,2021-02-05,2021-02-02,True,Recruiting,Phase 3,Interventional,Nigeria,Ivermectin Treatment Trial (ITT),240,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14661
5520,PACTR202102616421588,PACTR,2021-02-08,2020-01-11,True,Not Recruiting,Not Applicable,Interventional,Democratic Republic of the Congo,"Effect of a Community-Driven Water, Sanitation, and Hygiene Program on Covid-19 knowledge, behavior, and health:
A Randomized Control Trial in the Democratic Republic of Congo 
",1312,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14670
5521,PACTR202102848675636,PACTR,2021-02-10,2021-01-03,True,Not Recruiting,Phase 2,Interventional,Nigeria,"Double Blind, Community-based, Randomized Controlled Trial on the Use of Ivermectin as Post Exposure Chemo-prophylaxis for COVID-19 among High Risk Individuals in Lagos (IVERPEPCOV)  COVID-19",2100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14678
5522,PACTR202102855526180,PACTR,2021-02-13,2021-01-03,True,Recruiting,Phase 3,Interventional,South Africa,"Sisonke (Together): OPEN LABEL TRIAL
Open-label, single-arm phase 3B implementation study to monitor the effectiveness of the single-dose Ad26.COV2.S COVID-19 vaccine among health care workers in South Africa (VAC31518COV3012
",500000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15686
5523,PACTR202102535686338,PACTR,2021-02-14,2021-02-22,False,Not Recruiting,Phase 3,Interventional,Nigeria,Efficacy of Ivermectin for the Treatment and Prophylaxis of COVID-19 disease,240,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15689
5524,PACTR202103574924457,PACTR,2021-03-03,2021-01-26,True,Not Recruiting,Not Applicable,Interventional,Ghana,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana (SMSCOVID)    COVID-19",206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15726
5525,PACTR202103845381761,PACTR,2021-03-03,2021-01-04,True,Not Recruiting,Phase 3,Interventional,Kenya,A global Phase III clinical trial of recombinant COVID-19 vaccine (Sf9 cells) in adults aged 18 years and older,40000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15727
5526,PACTR202103601407640,PACTR,2021-03-19,2021-01-18,True,Recruiting,Phase 3,Interventional,Madagascar,"Clinical trial, phase 3, to evaluate the efficacy of CVO +  for the treatment of COVID-19.",338,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15764
5527,PACTR202104601572565,PACTR,2021-04-12,2021-01-05,True,Not Recruiting,Phase 3,Interventional,Ghana,SPUTNIK-LIGHT.  COVID-19,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15817
5528,PACTR202106588702901,PACTR,2021-05-13,2021-06-30,False,Not Recruiting,Phase 3,Interventional,"Ghana, Uganda, Nigeria, Kenya","Study of Monovalent and Bivalent Recombinant Protein Vaccines against COVID-19 in Adults
18 Years of Age and Older",37430,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15870
5529,PACTR202105817814362,PACTR,2021-05-20,2021-06-14,False,Not Recruiting,Phase 3,Interventional,"Malawi, South Africa, Swaziland, Zambia, Uganda, Zimbabwe, Botswana, Kenya","Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern",14000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15890
5530,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En
5531,RPCEC00000307,RPCEC,2020-04-14,2020-10-04,False,Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En
5532,RPCEC00000308,RPCEC,2020-05-03,2020-04-05,True,Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En
5533,RPCEC00000309,RPCEC,2020-05-05,2021-04-30,False,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,200,https://rpcec.sld.cu/en/trials/RPCEC00000309-En
5534,RPCEC00000311,RPCEC,2020-05-12,2020-03-28,True,Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En
5535,RPCEC00000313,RPCEC,2020-05-14,2020-03-31,True,Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En
5536,RPCEC00000314,RPCEC,2020-05-22,2020-04-24,True,Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En
5537,RPCEC00000315,RPCEC,2020-05-22,2020-05-19,True,Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En
5538,RPCEC00000316,RPCEC,2020-05-28,2020-03-07,True,Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En
5539,RPCEC00000317,RPCEC,2020-05-28,2020-01-06,True,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En
5540,RPCEC00000320,RPCEC,2020-06-05,2020-08-06,False,Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En
5541,RPCEC00000321,RPCEC,2020-06-22,2020-04-27,True,Recruiting,Not Applicable,Interventional,Cuba,VIDA study,0,https://rpcec.sld.cu/en/trials/RPCEC00000321-En
5542,RPCEC00000322,RPCEC,2020-07-03,2020-05-05,True,Recruiting,Not Applicable,Interventional,Cuba,Stem cells in patients with lung lesions (COVID-19),20,https://rpcec.sld.cu/en/trials/RPCEC00000322-En
5543,RPCEC00000330,RPCEC,2020-08-11,2020-11-08,False,Not Recruiting,Phase 2,Interventional,Mexico,DALIA Study,60,https://rpcec.sld.cu/en/trials/RPCEC00000330-En
5544,RPCEC00000332,RPCEC,2020-08-13,2020-08-24,False,Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA 01,676,https://rpcec.sld.cu/en/trials/RPCEC00000332-En
5545,RPCEC00000334,RPCEC,2020-09-10,2020-09-14,False,Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T in older adult for protection in events of local transmission of COVID-19,0,https://rpcec.sld.cu/en/trials/RPCEC00000334-En
5546,RPCEC00000335,RPCEC,2020-09-19,2020-09-26,False,Recruiting,Not Applicable,Interventional,Cuba,BIOMODULINA T in a long-lived population at high risk of COVID-19 infection,0,https://rpcec.sld.cu/en/trials/RPCEC00000335-En
5547,RPCEC00000337,RPCEC,2020-10-01,2020-12-10,False,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,OLIVO Study,80,https://rpcec.sld.cu/en/trials/RPCEC00000337-En
5548,RPCEC00000338,RPCEC,2020-10-17,2020-10-19,False,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01A,60,https://rpcec.sld.cu/en/trials/RPCEC00000338-En
5549,RPCEC00000340,RPCEC,2020-10-27,2020-02-11,True,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 02,40,https://rpcec.sld.cu/en/trials/RPCEC00000340-En
5550,RPCEC00000345,RPCEC,2020-11-26,2020-07-12,True,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,MAMBISA Study,88,https://rpcec.sld.cu/en/trials/RPCEC00000345-En
5551,RPCEC00000346,RPCEC,2020-11-26,2020-07-12,True,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ABDALA Clinical Study,0,https://rpcec.sld.cu/en/trials/RPCEC00000346-En
5552,RPCEC00000347,RPCEC,2020-12-17,2020-12-21,False,Not Recruiting,Phase 2,Interventional,Cuba,SOBERANA 02A,910,https://rpcec.sld.cu/en/trials/RPCEC00000347-En
5553,RPCEC00000348,RPCEC,2020-12-21,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study,60,https://rpcec.sld.cu/en/trials/RPCEC00000348-En
5554,RPCEC00000349,RPCEC,2021-01-05,2021-09-01,False,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01B,30,https://rpcec.sld.cu/en/trials/RPCEC00000349-En
5555,RPCEC00000353,RPCEC,2021-03-01,2021-01-04,True,Not Recruiting,Phase 2/Phase 3,Interventional,Cuba,AVATAR-2020,354,https://rpcec.sld.cu/en/trials/RPCEC00000353-En
5556,RPCEC00000354,RPCEC,2021-03-03,2021-05-03,False,Not Recruiting,Phase 3,Interventional,Cuba,SOBERANA 02-FaseIII,44010,https://rpcec.sld.cu/en/trials/RPCEC00000354-En
5557,RPCEC00000356,RPCEC,2021-03-11,2021-12-03,False,Not Recruiting,Not Applicable,Interventional,Cuba,CIGB2020- ARI elderly contacts,1440,https://rpcec.sld.cu/en/trials/RPCEC00000356-En
5558,RPCEC00000357,RPCEC,2021-03-16,2020-09-24,True,Not Recruiting,Phase 2,Interventional,Mexico,Oropharyngeal sanitization with electrolyzed superoxidation solution with neutral pH to prevent COVID-19,170,https://rpcec.sld.cu/en/trials/RPCEC00000357-En
5559,RPCEC00000359,RPCEC,2021-03-18,2021-03-22,False,Not Recruiting,Phase 3,Interventional,Cuba,ABDALA Clinical Study - Phase III,48000,https://rpcec.sld.cu/en/trials/RPCEC00000359-En
5560,RPCEC00000360,RPCEC,2021-03-19,2021-03-22,False,Not Recruiting,Not Applicable,Interventional,Cuba,SOBERANA - INTERVENTION,0,https://rpcec.sld.cu/en/trials/RPCEC00000360-En
5561,RPCEC00000361,RPCEC,2021-03-26,2021-01-04,True,Not Recruiting,Not Applicable,Interventional,Cuba,Itolizumab Safety and Efficacy Study in Covid 19,20,https://rpcec.sld.cu/en/trials/RPCEC00000361-En
5562,RPCEC00000363,RPCEC,2021-03-27,2021-03-29,False,Not Recruiting,Not Applicable,Interventional,Cuba,ABDALA-Intervention,124000,https://rpcec.sld.cu/en/trials/RPCEC00000363-En
5563,RPCEC00000366,RPCEC,2021-04-09,2021-04-17,False,Not Recruiting,Phase 2,Interventional,Cuba,SOBERANA PLUS,0,https://rpcec.sld.cu/en/trials/RPCEC00000366-En
5564,RPCEC00000369,RPCEC,2021-05-21,2021-05-24,False,Not Recruiting,Phase 1,Interventional,Cuba,Nimotuzumab in COVID-19,40,https://rpcec.sld.cu/en/trials/RPCEC00000369-En
5565,RPCEC00000374,RPCEC,2021-06-10,2021-06-14,False,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA PEDIATRIA,350,https://rpcec.sld.cu/en/trials/RPCEC00000374-En
5566,RPCEC00000375,RPCEC,2021-06-18,2021-06-25,False,Not Recruiting,Phase 2,Interventional,Cuba,CIMAvax-EGFÂ®-post-COVID19 convalescent with respiratory disorders-adults-Phase II  (CORVAXCIM),100,https://rpcec.sld.cu/en/trials/RPCEC00000375-En
5567,RPCEC00000376,RPCEC,2021-06-18,2021-06-25,False,Not Recruiting,Phase 2,Interventional,Cuba,"iorÂ®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders",120,https://rpcec.sld.cu/en/trials/RPCEC00000376-En
5568,TCTR20210615002,TCTR,2021-06-15,2021-06-16,False,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,Effect of Combined Fluvoxamine with Favipiravir versus Favipiravir Monotherapy in Prevention of Clinical Deterioration among mild to moderate COVID-19 patients Monitoring by Telemedicine in Virtual Clinic: Open-label Randomized Controlled Trial,296,www.thaiclinicaltrials.org/show/TCTR20210615002
5569,TCTR20210609001,TCTR,2021-06-09,2021-11-06,False,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,"Efficacy of Andrographis paniculata extract Combined with Favipiravir Treatment to Prevent Disease Progression in mild to moderate COVID-19 Patients:  A Double-blind, Randomized, Placebo-Controlled Study",146,www.thaiclinicaltrials.org/show/TCTR20210609001
5570,TCTR20210602002,TCTR,2021-06-02,2020-10-26,True,Not Recruiting,Phase 4,Interventional,Thailand,Comparison of tele-education and conventional CPR training during COVID-19 pandemic,56,www.thaiclinicaltrials.org/show/TCTR20210602002
5571,TCTR20210524002,TCTR,2021-05-24,2021-06-15,False,Not Recruiting,Phase 4,Interventional,Thailand,SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipients,120,www.thaiclinicaltrials.org/show/TCTR20210524002
5572,TCTR20210523002,TCTR,2021-05-23,2021-01-07,True,Not Recruiting,Phase 4,Interventional,Thailand,SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipients,250,www.thaiclinicaltrials.org/show/TCTR20210523002
5573,TCTR20210517006,TCTR,2021-05-17,2021-03-31,True,Recruiting,Phase 2,Interventional,Thailand,"Immunogenicity and safety of Sputnik V, ChAdOx1, and Sinovac vaccines in Thai people.",3000,www.thaiclinicaltrials.org/show/TCTR20210517006
5574,TCTR20210514003,TCTR,2021-05-14,2021-01-06,True,Not Recruiting,Phase 3,Interventional,Thailand,Andrographolide as a medical tool for reduction of hospitalization in mild or asymptomatic COVID-19 patients: a randomized double-blind placebo controlled trial,160,www.thaiclinicaltrials.org/show/TCTR20210514003
5575,TCTR20210412005,TCTR,2021-04-12,2021-03-03,True,Recruiting,Phase 4,Interventional,Thailand,The efficacy of insulated microneedle radiofrequency in Keratosis pilaris,20,www.thaiclinicaltrials.org/show/TCTR20210412005
5576,TCTR20210310002,TCTR,2021-03-10,2021-03-05,True,Not Recruiting,Phase 3,Interventional,Thailand,Evaluating the Efficacy of Cognitive Behavior Therapy on Depression in Thai University Students: A Comparative Study of Online and Face-to-Face Methods during COVID-19 Pandemic,72,www.thaiclinicaltrials.org/show/TCTR20210310002
5577,TCTR20210308003,TCTR,2021-03-08,2021-06-03,False,Recruiting,Phase 4,Interventional,Thailand,Safety and Immunogenicity of inactivated COVID-19 vaccine and virus vector vaccine in Thai adults,370,www.thaiclinicaltrials.org/show/TCTR20210308003
5578,TCTR20210125002,TCTR,2021-01-25,2020-10-20,True,Not Recruiting,Phase 3,Interventional,Thailand,Efficacy of povidone iodine spray for SARS-CoV-2 eradication in upper respiratory tract of patients with COVID-19: A pilot study,35,www.thaiclinicaltrials.org/show/TCTR20210125002
5579,TCTR20201015003,TCTR,2020-10-15,2020-01-10,True,Recruiting,Phase 4,Interventional,No Country Given,Clinical outcomes and safety of preoperative non&#45;preserved steroid eye drop in trabeculectomy: A randomised controlled trial,162,www.thaiclinicaltrials.org/show/TCTR20201015003
5580,TCTR20200601002,TCTR,2020-06-01,2020-01-06,True,Recruiting,Not Applicable,Interventional,Malaysia,A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression&#44; Anxiety and Stress among Healthcare Workers during COVID&#45;19 Pandemic in Jerantut&#44; Pahang,110,www.thaiclinicaltrials.org/show/TCTR20200601002
5581,TCTR20200514001,TCTR,2020-05-14,2020-01-06,True,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID&#45;19 Patients without Pneumonia Ã¢Ë†â€™ An open&#45;label randomized controlled study Ã¢Ë†â€™,96,www.thaiclinicaltrials.org/show/TCTR20200514001
5582,TCTR20200409006,TCTR,2020-04-09,2020-01-05,True,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID&#45;19,206,www.thaiclinicaltrials.org/show/TCTR20200409006
5583,TCTR20200404004,TCTR,2020-04-04,2020-04-27,False,Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID&#45;19 patients,400,www.thaiclinicaltrials.org/show/TCTR20200404004
5584,KCT0006252,CRIS,2021-06-14,2021-06-14,False,Not Recruiting,Not Applicable,Interventional,South Korea,Herbal medicines for fatigue or brain fog in Coronavirus disease 2019 (COVID-19) survivors: a prospective pilot clinical study,45,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19179
5585,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8969zg
5586,RBR-658khm,REBEC,2020-04-22,2020-01-04,True,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in SÃ£o Paulo, Brazil",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-658khm
5587,RBR-6w5tbk,REBEC,2020-04-29,2020-04-30,False,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6w5tbk
5588,RBR-5s2mqg,REBEC,2020-05-05,2020-04-27,True,Recruiting,Phase 2/Phase 3,Interventional,Brazil,The effect of an inhibitor of pulmonary inflammation in patients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5s2mqg
5589,RBR-3k4wxb,REBEC,2020-05-05,2020-01-05,True,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3k4wxb
5590,RBR-4vm3yy,REBEC,2020-05-15,2020-04-19,True,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4vm3yy
5591,RBR-9d8z6m,REBEC,2020-03-27,2020-03-30,False,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9d8z6m
5592,RBR-2dxyx4,REBEC,2020-06-02,2020-04-06,True,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2dxyx4
5593,RBR-949z6v,REBEC,2020-05-06,2020-05-30,False,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-949z6v
5594,RBR-876qb5,REBEC,2020-06-08,2020-05-27,True,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-876qb5
5595,RBR-3zdynp,REBEC,2020-06-23,2020-03-16,True,Recruiting,Phase 4,Interventional,Brazil,Using Tocilizumab in critically ill patients with COVID-19.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3zdynp
5596,RBR-4wnx2q,REBEC,2020-06-26,2020-06-06,True,Recruiting,Not Applicable,Interventional,Brazil,Pulmonary rehabilitation in individuals affected by Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4wnx2q
5597,RBR-5kkpg6,REBEC,2020-06-28,2020-06-29,False,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of eating habits and exposure to light on sleep, emotion, memory and headache in college students during the COVID-19 pandemic",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5kkpg6
5598,RBR-7jqpnw,REBEC,2020-06-29,2020-01-07,True,Not Recruiting,Phase 3,Interventional,Brazil,"Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7jqpnw
5599,RBR-3rywwg,REBEC,2020-07-10,2020-01-06,True,Recruiting,Phase 2,Interventional,Brazil,"A clinical, randomized study to evaluate the efficacy and safety of Naproxen compared to placebo in combination with Azithromycin or Levofloxacin in patients with Severe Acute Respiratory Syndrome during the Covid-19 pandemic",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3rywwg
5600,RBR-7jrxqm,REBEC,2020-07-10,2020-01-06,True,Recruiting,Not Applicable,Interventional,Brazil,Effect of a special nutritional oral supplement use on inflammation in patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7jrxqm
5601,RBR-45kf9p,REBEC,2020-07-13,2020-06-29,True,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep study : Comparative study between different anti-coagulation strategies in continuous hemodialysis in COVID-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-45kf9p
5602,RBR-7drpyr,REBEC,2020-07-13,2020-06-20,True,Not Recruiting,Not Applicable,Interventional,Brazil,Effect of two covers to prevent injuries caused to professionals working in the health area due to the use of personal protective equipment,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7drpyr
5603,RBR-5ysj54,REBEC,2020-07-27,2020-07-15,True,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,BCG vaccine use to prevent COVID-19 in health care workers,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5ysj54
5604,RBR-3g5f9f,REBEC,2020-07-29,2020-08-28,False,Not Recruiting,Not Applicable,Interventional,Brazil,"Educational intervention by cell phone to increase informed choices at childbirth, in the context of the Covid-19 pandemic.",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3g5f9f
5605,RBR-8jyhxh,REBEC,2020-07-30,2020-11-04,False,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Clinical trial for the treatment of COVID-19 with Chloroquine and Colchicine,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8jyhxh
5606,RBR-35734p,REBEC,2020-08-05,2020-05-08,True,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe COVID-19 with angiotensin-(1-7),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-35734p
5607,RBR-2w7ghc,REBEC,2020-08-07,2020-07-20,True,Recruiting,Not Applicable,Interventional,Brazil,"Online meditation as an aid in reducing symptoms of Depression, Anxiety and Psychological Stress in Resident Physicians
during COVID-19 pandemic in Brazil",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2w7ghc
5608,RBR-7d7ngw,REBEC,2020-08-07,2020-07-15,True,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Early prone position in patients on spontaneous ventilation,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7d7ngw
5609,RBR-2k66ft,REBEC,2020-08-10,2020-08-20,False,Not Recruiting,Not Applicable,Interventional,Brazil,"Randomized,  study to evaluate early prone position in patients with COVID-19
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2k66ft
5610,RBR-9y32yy,REBEC,2020-05-24,2020-01-07,True,Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9y32yy
5611,RBR-4vy54v,REBEC,2020-08-11,2020-07-15,True,Not Recruiting,Not Applicable,Interventional,Brazil,On-Line Collectives in Mental Health: Transdisciplinary Action for Groups Vulnerable to COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4vy54v
5612,RBR-4pfygr,REBEC,2020-08-13,2020-07-27,True,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,"Clinical study to assess the safety and tolerability of administration, directly into a vein, of human umbilical cord and placental blood plasma (PlasmacordÂ®) in patients with Severe acute respiratory syndrome resulting from Sars-Cov-2 infection (fever, cough headache, muscle aches and difficulty breathing)",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4pfygr
5613,RBR-3rdhgm,REBEC,2020-05-14,2020-01-05,True,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3rdhgm
5614,RBR-9xs978,REBEC,2020-08-24,2020-06-17,True,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Telehealth for patients with dementia at the Hospital UniversitÃ¡rio Walter Cantidio-UFC,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9xs978
5615,RBR-2z3f7k,REBEC,2020-05-04,2020-04-29,True,Recruiting,Not Applicable,Interventional,Brazil,"Artificial ventilation setting in patients infected with COVID-19
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2z3f7k
5616,RBR-2kjm6y,REBEC,2020-08-26,2020-05-22,True,Recruiting,Phase 2,Interventional,"United States, Brazil",A phase 2 randomized double-blind placebo-controlled study to evaluate safety of BLD-2660 and its activity against COVID-19 virus in hospitalized subjects recently diagnosed with COVID-19 in comparison to standard of care treatment,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2kjm6y
5617,RBR-72bg24,REBEC,2020-08-27,2020-08-31,False,Not Recruiting,Not Applicable,Interventional,Brazil,SARS-CoV-2 quick analysis in breath device,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-72bg24
5618,RBR-5vpyh4,REBEC,2020-07-06,2020-08-28,False,Recruiting,Phase 2,Interventional,Brazil,Use of Anti-IL-17 in patients with Covid-19 associated pneumonia,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5vpyh4
5619,RBR-2fvjjm,REBEC,2020-08-11,2020-08-18,False,Recruiting,Not Applicable,Interventional,Brazil,Hyperbaric Oxygen Therapy for hospitalized patients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2fvjjm
5620,RBR-9rnkbs,REBEC,2020-09-22,2020-01-09,True,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of an equipment to reduce the dispersion of particles in emergency dental care during the Covid-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9rnkbs
5621,RBR-8nfx26,REBEC,2020-09-22,2020-10-10,False,Not Recruiting,Phase 2,Interventional,Brazil,Effect of Inhaled Nitric Oxide for the treatment of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8nfx26
5622,RBR-97nt6j,REBEC,2020-09-24,2020-09-25,False,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Multicenter Study of the Integrative and Complementary Practice of the Use of Ozone Gas in Outpatients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-97nt6j
5623,RBR-5v3k5d,REBEC,2020-10-02,2020-05-07,True,Recruiting,Phase 3,Interventional,Brazil,Study of the use of ozone therapy adjunct to the treatment of Covid-19 infections,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5v3k5d
5624,RBR-8h7q82,REBEC,2020-10-02,2020-01-05,True,Not Recruiting,Phase 2,Interventional,Brazil,"The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirus",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8h7q82
5625,RBR-2xxrrq,REBEC,2020-10-02,2020-08-13,True,Not Recruiting,Not Applicable,Interventional,Brazil,The effect of cardiac massage training in patients with cardiac arrest with COVID-19 positioned in the ventral position.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2xxrrq
5626,RBR-825p57,REBEC,2020-10-08,2020-09-20,True,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation for elderly people with Alzheimer's disease and their caregivers,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-825p57
5627,RBR-4nr86m,REBEC,2020-08-24,2020-08-06,True,Recruiting,Phase 2,Interventional,Brazil,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4nr86m
5628,RBR-58ftdj,REBEC,2020-10-28,2020-10-08,True,Recruiting,Not Applicable,Interventional,Brazil,"Evaluation of the Effectiveness of an Oral Antiseptic in Improving the Clinical Status, Decreasing Viral Load and Its Prolonged Action in Patients with COVID-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-58ftdj
5629,RBR-9b6kvp,REBEC,2020-10-29,2020-02-11,True,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of a Cloth Mask Physical Exercise session on Cardiovascular health, Feeling and Exercise Effort, Oxygen Quantity and Jumping Performance: Recommendation for Physical Mask Exercise during and after the COVID-19 global outbreak",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9b6kvp
5630,RBR-4kjqtg,REBEC,2020-08-05,2020-05-08,True,Recruiting,Phase 2,Interventional,Brazil,Testing of BCG vaccine against COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4kjqtg
5631,RBR-8x8g36,REBEC,2020-10-29,2020-01-11,True,Not Recruiting,Phase 3,Interventional,Brazil,Effectiveness of a mouthwash and toothpaste containing PHTALOX in controlling symptoms of COVID-19 and flu,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8x8g36
5632,RBR-5d7hkv,REBEC,2020-11-03,2020-11-09,False,Recruiting,Not Applicable,Interventional,Brazil,Effect of Moderate Physical Training on a bicycle associated with altitude simulation on the health status of people recovered from COVID-19 (AEROBI-COVID),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5d7hkv
5633,RBR-2fvw6v,REBEC,2020-11-16,2021-05-04,False,Not Recruiting,Not Applicable,Interventional,Brazil,"Analysis of motor response time, electromyography and muscle strength in volunteers from the group at risk for covid-19 submitted to a home exercise protocol: randomized controlled clinical trial, cross over

",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2fvw6v
5634,RBR-2z5t7z,REBEC,2020-11-16,2020-04-10,True,Recruiting,Phase 1,Interventional,Brazil,Light on COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2z5t7z
5635,ChiCTR2100043682,ChiCTR,2021-02-26,2021-03-01,False,Not Recruiting,Not Applicable,Interventional,China,A multicenter study on pulmonary rehabilitation in severe COVID-19 patients,100,http://www.chictr.org.cn/showproj.aspx?proj=122412
5636,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),120,https://clinicaltrials.gov/show/NCT04283461
5637,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,False,Not Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,101,https://clinicaltrials.gov/show/NCT04312997
5638,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,False,Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,200,https://clinicaltrials.gov/show/NCT04313023
5639,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,False,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany, Romania",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04327505
5640,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Not Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,68,https://clinicaltrials.gov/show/NCT04330586
5641,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,80,https://clinicaltrials.gov/show/NCT04332081
5642,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Not Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,1002,https://clinicaltrials.gov/show/NCT04334928
5643,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,120,https://clinicaltrials.gov/show/NCT04346615
5644,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-03-14,True,Not Recruiting,Phase 3,Interventional,"Canada, United States, Brazil",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),940,https://clinicaltrials.gov/show/NCT04348656
5645,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,False,Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19,255,https://clinicaltrials.gov/show/NCT04351581
5646,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Not Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),91,https://clinicaltrials.gov/show/NCT04355143
5647,NCT04356677,ClinicalTrials.gov,2020-04-20,2021-05-01,False,Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,0,https://clinicaltrials.gov/show/NCT04356677
5648,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Not Recruiting,Not Applicable,Interventional,France,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,50,https://clinicaltrials.gov/show/NCT04363749
5649,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,False,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,86,https://clinicaltrials.gov/show/NCT04365101
5650,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,False,Not Recruiting,Phase 3,Interventional,"South Africa, Peru, United States, Mexico, Brazil, Kenya",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,379,https://clinicaltrials.gov/show/NCT04372186
5651,NCT04377100,ClinicalTrials.gov,2020-05-05,2021-06-30,False,Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,6000,https://clinicaltrials.gov/show/NCT04377100
5652,NCT04381013,ClinicalTrials.gov,2020-05-07,2021-06-01,False,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),0,https://clinicaltrials.gov/show/NCT04381013
5653,NCT04382586,ClinicalTrials.gov,2020-05-07,2020-07-06,False,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,67,https://clinicaltrials.gov/show/NCT04382586
5654,NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,False,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,40,https://clinicaltrials.gov/show/NCT04388826
5655,NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,True,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,200,https://clinicaltrials.gov/show/NCT04390191
5656,NCT04395911,ClinicalTrials.gov,2020-05-17,2020-09-10,False,Not Recruiting,Not Applicable,Interventional,United States,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,35,https://clinicaltrials.gov/show/NCT04395911
5657,NCT04399356,ClinicalTrials.gov,2020-05-19,2020-10-01,False,Not Recruiting,Phase 2,Interventional,United States,Niclosamide for Mild to Moderate COVID-19,73,https://clinicaltrials.gov/show/NCT04399356
5658,NCT04404218,ClinicalTrials.gov,2020-05-24,2020-08-04,False,Recruiting,Phase 2,Interventional,"Canada, Brazil",The AÃ§aÃ­ Berry COVID-19 Anti-Inflammation Trial,480,https://clinicaltrials.gov/show/NCT04404218
5659,NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,True,Not Recruiting,Phase 4,Interventional,United States,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,34,https://clinicaltrials.gov/show/NCT04411667
5660,NCT04411680,ClinicalTrials.gov,2020-05-29,2020-08-18,False,Not Recruiting,Phase 2,Interventional,United States,Study of Sargramostim in Patients With COVID-19,122,https://clinicaltrials.gov/show/NCT04411680
5661,NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,50,https://clinicaltrials.gov/show/NCT04413864
5662,NCT04424797,ClinicalTrials.gov,2020-06-05,2020-07-13,False,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,100,https://clinicaltrials.gov/show/NCT04424797
5663,NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-14,False,Not Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,400,https://clinicaltrials.gov/show/NCT04425915
5664,NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-17,False,Recruiting,Phase 2/Phase 3,Interventional,"Puerto Rico, United States",A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,3160,https://clinicaltrials.gov/show/NCT04427501
5665,NCT04431453,ClinicalTrials.gov,2020-06-08,2020-07-21,False,Recruiting,Phase 2/Phase 3,Interventional,"Spain, Italy, United States, United Kingdom","Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",52,https://clinicaltrials.gov/show/NCT04431453
5666,NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,False,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,52,https://clinicaltrials.gov/show/NCT04433949
5667,NCT04435795,ClinicalTrials.gov,2020-06-16,2020-09-14,False,Not Recruiting,Phase 2/Phase 3,Interventional,Canada,Inhaled Ciclesonide for Outpatients With COVID19,215,https://clinicaltrials.gov/show/NCT04435795
5668,NCT04438850,ClinicalTrials.gov,2020-04-10,2020-07-31,False,Not Recruiting,Phase 2,Interventional,"Spain, Italy",COVidIVERmectin: Ivermectin for Treatment of Covid-19,93,https://clinicaltrials.gov/show/NCT04438850
5669,NCT04446429,ClinicalTrials.gov,2020-06-22,2020-09-15,False,Not Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,268,https://clinicaltrials.gov/show/NCT04446429
5670,NCT04448756,ClinicalTrials.gov,2020-06-25,2020-07-29,False,Recruiting,Phase 2,Interventional,"Philippines, United States, Brazil",Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE),150,https://clinicaltrials.gov/show/NCT04448756
5671,NCT04452435,ClinicalTrials.gov,2020-06-29,2020-07-21,False,Not Recruiting,Phase 2,Interventional,"India, United Kingdom",Safety and Efficacy of C21 in Subjects With COVID-19,206,https://clinicaltrials.gov/show/NCT04452435
5672,NCT04468958,ClinicalTrials.gov,2020-07-08,2020-08-05,False,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",28,https://clinicaltrials.gov/show/NCT04468958
5673,NCT04468971,ClinicalTrials.gov,2020-07-10,2020-09-29,False,Not Recruiting,Phase 1,Interventional,United States,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,45,https://clinicaltrials.gov/show/NCT04468971
5674,NCT04469179,ClinicalTrials.gov,2020-07-08,2020-08-20,False,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",21,https://clinicaltrials.gov/show/NCT04469179
5675,NCT04472559,ClinicalTrials.gov,2020-07-13,2021-06-16,False,Recruiting,Not Applicable,Interventional,United States,Acupressure for COVID-19 Related Quality of Life and Stress,200,https://clinicaltrials.gov/show/NCT04472559
5676,NCT04480112,ClinicalTrials.gov,2020-07-19,2020-06-02,True,Recruiting,Not Applicable,Interventional,United States,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,150,https://clinicaltrials.gov/show/NCT04480112
5677,NCT04480411,ClinicalTrials.gov,2020-07-17,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,50,https://clinicaltrials.gov/show/NCT04480411
5678,NCT04481685,ClinicalTrials.gov,2020-07-15,2020-07-20,False,Not Recruiting,Phase 2,Interventional,United States,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",20,https://clinicaltrials.gov/show/NCT04481685
5679,NCT04483973,ClinicalTrials.gov,2020-07-13,2021-06-14,False,Recruiting,Phase 2,Interventional,United States,SPI-1005 Treatment in Severe COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04483973
5680,NCT04484025,ClinicalTrials.gov,2020-07-13,2021-06-14,False,Recruiting,Phase 2,Interventional,United States,SPI-1005 Treatment in Moderate COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04484025
5681,NCT04488081,ClinicalTrials.gov,2020-07-14,2020-07-31,False,Recruiting,Phase 2,Interventional,United States,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,1500,https://clinicaltrials.gov/show/NCT04488081
5682,NCT04498273,ClinicalTrials.gov,2020-08-03,2020-09-07,False,Not Recruiting,Phase 3,Interventional,United States,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,657,https://clinicaltrials.gov/show/NCT04498273
5683,NCT04499391,ClinicalTrials.gov,2020-07-31,2020-12-04,False,Recruiting,Not Applicable,Interventional,United States,COVID-19 Project ECHO in Nursing Homes,136,https://clinicaltrials.gov/show/NCT04499391
5684,NCT04501978,ClinicalTrials.gov,2020-08-03,2020-08-04,False,Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom, United States, Spain, Uganda, Poland, India, Singapore, Switzerland",ACTIV-3: Therapeutics for Inpatients With COVID-19,10000,https://clinicaltrials.gov/show/NCT04501978
5685,NCT04507256,ClinicalTrials.gov,2020-08-07,2020-08-18,False,Not Recruiting,Phase 1,Interventional,United Kingdom,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04507256
5686,NCT04508023,ClinicalTrials.gov,2020-08-10,2020-08-13,False,Recruiting,Phase 3,Interventional,United States,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",4000,https://clinicaltrials.gov/show/NCT04508023
5687,NCT04511650,ClinicalTrials.gov,2020-08-07,2020-10-21,False,Not Recruiting,Phase 2,Interventional,United States,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",31,https://clinicaltrials.gov/show/NCT04511650
5688,NCT04518410,ClinicalTrials.gov,2020-08-17,2020-08-19,False,Recruiting,Phase 2/Phase 3,Interventional,"Argentina, South Africa, Canada, Puerto Rico, United States, Brazil",ACTIV-2: A Study for Outpatients With COVID-19,2000,https://clinicaltrials.gov/show/NCT04518410
5689,NCT04526912,ClinicalTrials.gov,2020-08-21,2020-08-28,False,Not Recruiting,Phase 1,Interventional,United States,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,10,https://clinicaltrials.gov/show/NCT04526912
5690,NCT04530617,ClinicalTrials.gov,2020-08-26,2020-10-05,False,Not Recruiting,Phase 2,Interventional,Mexico,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,246,https://clinicaltrials.gov/show/NCT04530617
5691,NCT04535167,ClinicalTrials.gov,2020-08-21,2020-09-09,False,Not Recruiting,Phase 1,Interventional,"Spain, Brazil, United States, Belgium","First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.",26,https://clinicaltrials.gov/show/NCT04535167
5692,NCT04535453,ClinicalTrials.gov,2020-08-27,2020-08-28,False,Not Recruiting,Phase 2,Interventional,"United Kingdom, Netherlands, Canada, United States, Brazil, Spain, Germany",A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,1210,https://clinicaltrials.gov/show/NCT04535453
5693,NCT04537949,ClinicalTrials.gov,2020-09-02,2020-09-09,False,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,96,https://clinicaltrials.gov/show/NCT04537949
5694,NCT04546581,ClinicalTrials.gov,2020-09-08,2020-10-08,False,Not Recruiting,Phase 3,Interventional,"Denmark, Argentina, Greece, United Kingdom, United States, Spain, Japan, Nigeria",Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),593,https://clinicaltrials.gov/show/NCT04546581
5695,NCT04551547,ClinicalTrials.gov,2020-09-15,2020-10-31,False,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,552,https://clinicaltrials.gov/show/NCT04551547
5696,NCT04568031,ClinicalTrials.gov,2020-08-21,2020-08-23,False,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of AZD1222 for the Prevention of COVID-19 in Japan,256,https://clinicaltrials.gov/show/NCT04568031
5697,NCT04568122,ClinicalTrials.gov,2020-09-25,2020-11-20,False,Recruiting,Not Applicable,Interventional,United States,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",3015,https://clinicaltrials.gov/show/NCT04568122
5698,NCT04572360,ClinicalTrials.gov,2020-09-27,2020-10-01,False,Recruiting,Not Applicable,Interventional,Hong Kong,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,172,https://clinicaltrials.gov/show/NCT04572360
5699,NCT04575597,ClinicalTrials.gov,2020-09-30,2020-10-19,False,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, Canada, Ukraine, United States, Brazil, Israel, Italy, Japan, Mexico, Spain, France, Germany, Philippines",Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),1850,https://clinicaltrials.gov/show/NCT04575597
5700,NCT04576728,ClinicalTrials.gov,2020-09-24,2020-10-06,False,Not Recruiting,Phase 2,Interventional,"Spain, France, Russian Federation, Brazil",Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,164,https://clinicaltrials.gov/show/NCT04576728
5701,NCT04577534,ClinicalTrials.gov,2020-09-03,2020-08-14,True,Not Recruiting,Phase 3,Interventional,Finland,COVID-19: Salvage TOcilizumab as a Rescue Measure,88,https://clinicaltrials.gov/show/NCT04577534
5702,NCT04583969,ClinicalTrials.gov,2020-10-09,2020-10-19,False,Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04583969
5703,NCT04590547,ClinicalTrials.gov,2020-10-13,2021-05-07,False,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),132,https://clinicaltrials.gov/show/NCT04590547
5704,NCT04590586,ClinicalTrials.gov,2020-10-14,2020-11-24,False,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, South Africa, Ukraine, United States, Mexico, Brazil",Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,516,https://clinicaltrials.gov/show/NCT04590586
5705,NCT04598594,ClinicalTrials.gov,2020-10-15,2020-11-06,False,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,220,https://clinicaltrials.gov/show/NCT04598594
5706,NCT04615949,ClinicalTrials.gov,2020-11-02,2021-04-30,False,Recruiting,Phase 2/Phase 3,Interventional,"Mexico, United States, Brazil",Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,422,https://clinicaltrials.gov/show/NCT04615949
5707,NCT04618042,ClinicalTrials.gov,2020-10-23,2020-11-13,False,Not Recruiting,Phase 2,Interventional,France,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04618042
5708,NCT04629703,ClinicalTrials.gov,2020-11-13,2021-02-22,False,Recruiting,Phase 3,Interventional,"Argentina, Peru, United States, Mexico, Brazil","Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",308,https://clinicaltrials.gov/show/NCT04629703
5709,NCT04631705,ClinicalTrials.gov,2020-11-10,2020-12-14,False,Recruiting,Phase 1/Phase 2,Interventional,Germany,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation,78,https://clinicaltrials.gov/show/NCT04631705
5710,NCT04632706,ClinicalTrials.gov,2020-10-26,2020-09-22,True,Not Recruiting,Phase 1,Interventional,United Kingdom,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,24,https://clinicaltrials.gov/show/NCT04632706
5711,NCT04634409,ClinicalTrials.gov,2020-11-17,2020-10-29,True,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,1556,https://clinicaltrials.gov/show/NCT04634409
5712,NCT04640194,ClinicalTrials.gov,2020-11-20,2020-12-16,False,Recruiting,Phase 2/Phase 3,Interventional,"Denmark, Russian Federation, Portugal, Belgium, Netherlands, Italy, Brazil, Spain, Austria, France, Germany",A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,270,https://clinicaltrials.gov/show/NCT04640194
5713,NCT04657484,ClinicalTrials.gov,2020-12-05,2020-12-08,False,Recruiting,Not Applicable,Interventional,India,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,100,https://clinicaltrials.gov/show/NCT04657484
5714,NCT04661839,ClinicalTrials.gov,2020-12-09,2020-12-24,False,Not Recruiting,Phase 1,Interventional,United States,A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults,28,https://clinicaltrials.gov/show/NCT04661839
5715,NCT04667780,ClinicalTrials.gov,2020-12-11,2020-12-10,True,Not Recruiting,Phase 3,Interventional,Pakistan,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,102,https://clinicaltrials.gov/show/NCT04667780
5716,NCT04669015,ClinicalTrials.gov,2020-12-14,2021-06-18,False,Recruiting,Phase 3,Interventional,"Chile, Colombia, Brazil",Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,914,https://clinicaltrials.gov/show/NCT04669015
5717,NCT04674189,ClinicalTrials.gov,2020-12-14,2020-12-23,False,Not Recruiting,Phase 3,Interventional,Germany,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,2360,https://clinicaltrials.gov/show/NCT04674189
5718,NCT04698993,ClinicalTrials.gov,2021-01-05,2021-02-12,False,Not Recruiting,Not Applicable,Interventional,Germany,DrÃ¤ger COVID-19 Antigen Test Clinical Performance Study,388,https://clinicaltrials.gov/show/NCT04698993
5719,NCT04701658,ClinicalTrials.gov,2021-01-07,2021-02-01,False,Not Recruiting,Phase 2,Interventional,United States,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),3000,https://clinicaltrials.gov/show/NCT04701658
5720,NCT04703205,ClinicalTrials.gov,2020-12-01,2020-09-16,True,Recruiting,Phase 2,Interventional,Japan,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),240,https://clinicaltrials.gov/show/NCT04703205
5721,NCT04705597,ClinicalTrials.gov,2021-01-04,2021-03-18,False,Recruiting,Phase 2,Interventional,"United States, Brazil","Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Participants = 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure",132,https://clinicaltrials.gov/show/NCT04705597
5722,NCT04707664,ClinicalTrials.gov,2021-01-11,2021-04-27,False,Recruiting,Phase 2,Interventional,United States,Sargramostim Use in COVID-19 to Recover Patient Health,400,https://clinicaltrials.gov/show/NCT04707664
5723,NCT04723394,ClinicalTrials.gov,2021-01-14,2010-06-21,True,Recruiting,Phase 3,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Ukraine, United States, Brazil, Italy, Mexico, Japan, Spain, Poland, Germany, Czech Republic, Bulgaria",Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,1700,https://clinicaltrials.gov/show/NCT04723394
5724,NCT04723537,ClinicalTrials.gov,2021-01-18,2021-02-16,False,Recruiting,Phase 2/Phase 3,Interventional,United States,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",310,https://clinicaltrials.gov/show/NCT04723537
5725,NCT04728802,ClinicalTrials.gov,2021-01-27,2021-02-01,False,Not Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for Hospitalized COVID-19 Patients,645,https://clinicaltrials.gov/show/NCT04728802
5726,NCT04734873,ClinicalTrials.gov,2021-01-29,2021-02-25,False,Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Canada, Ukraine, United States, Brazil, Italy, Mexico, Spain, Israel, France, Germany",CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,1000,https://clinicaltrials.gov/show/NCT04734873
5727,NCT04751682,ClinicalTrials.gov,2021-02-08,2021-03-01,False,Not Recruiting,Phase 1,Interventional,India,Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,175,https://clinicaltrials.gov/show/NCT04751682
5728,NCT04753619,ClinicalTrials.gov,2021-02-10,2021-01-03,True,Recruiting,Phase 2,Interventional,Iraq,Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management,150,https://clinicaltrials.gov/show/NCT04753619
5729,NCT04754594,ClinicalTrials.gov,2021-02-09,2021-02-16,False,Recruiting,Phase 3,Interventional,"South Africa, United Kingdom, United States, Brazil, Spain","Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",700,https://clinicaltrials.gov/show/NCT04754594
5730,NCT04754698,ClinicalTrials.gov,2021-02-08,2021-02-09,False,Not Recruiting,Phase 4,Interventional,Brazil,COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS,2067,https://clinicaltrials.gov/show/NCT04754698
5731,NCT04758962,ClinicalTrials.gov,2021-02-08,2021-02-15,False,Not Recruiting,Phase 1,Interventional,United States,A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,10,https://clinicaltrials.gov/show/NCT04758962
5732,NCT04761822,ClinicalTrials.gov,2021-02-17,2021-04-07,False,Recruiting,Phase 2,Interventional,United States,COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations,3400,https://clinicaltrials.gov/show/NCT04761822
5733,NCT04765540,ClinicalTrials.gov,2021-01-06,2021-01-03,True,Not Recruiting,Not Applicable,Interventional,Bangladesh,The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh,855,https://clinicaltrials.gov/show/NCT04765540
5734,NCT04776317,ClinicalTrials.gov,2021-02-25,2021-03-25,False,Recruiting,Phase 1,Interventional,United States,Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,150,https://clinicaltrials.gov/show/NCT04776317
5735,NCT04780698,ClinicalTrials.gov,2021-02-12,2021-02-12,False,Recruiting,Not Applicable,Interventional,United States,DCI COVID-19 Surveillance Project,160,https://clinicaltrials.gov/show/NCT04780698
5736,NCT04782700,ClinicalTrials.gov,2021-02-25,2021-04-01,False,Not Recruiting,Not Applicable,Interventional,United States,P-Co-Li (Pulmonary Covid-19 Study),6,https://clinicaltrials.gov/show/NCT04782700
5737,NCT04784559,ClinicalTrials.gov,2021-03-04,2021-06-04,False,Recruiting,Phase 3,Interventional,"Argentina, Peru, Greece, Colombia, Italy, Brazil, Mexico, Spain, Turkey, France, Bulgaria, Romania",Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection,609,https://clinicaltrials.gov/show/NCT04784559
5738,NCT04785144,ClinicalTrials.gov,2021-03-04,2021-03-29,False,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in NaÃ¯ve and Previously Vaccinated Adults,135,https://clinicaltrials.gov/show/NCT04785144
5739,NCT04794946,ClinicalTrials.gov,2021-03-08,2021-03-19,False,Recruiting,Not Applicable,Interventional,India,"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis",2200,https://clinicaltrials.gov/show/NCT04794946
5740,NCT04795583,ClinicalTrials.gov,2021-03-10,2021-08-01,False,Not Recruiting,Phase 3,Interventional,"Mexico, Colombia",Corticosteroids for COVID-19,1526,https://clinicaltrials.gov/show/NCT04795583
5741,NCT04796896,ClinicalTrials.gov,2021-03-11,2021-03-15,False,Recruiting,Phase 2/Phase 3,Interventional,United States,A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age,7050,https://clinicaltrials.gov/show/NCT04796896
5742,NCT04805125,ClinicalTrials.gov,2021-03-15,2021-04-19,False,Not Recruiting,Phase 3,Interventional,Switzerland,Immunocompromised Swiss Cohorts Based Trial Platform,431,https://clinicaltrials.gov/show/NCT04805125
5743,NCT04818216,ClinicalTrials.gov,2021-03-24,2021-06-11,False,Recruiting,Phase 2,Interventional,United States,Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection,100,https://clinicaltrials.gov/show/NCT04818216
5744,NCT04818320,ClinicalTrials.gov,2021-03-24,2021-02-16,True,Not Recruiting,Phase 3,Interventional,Malaysia,Favipiravir in High-risk COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04818320
5745,NCT04821531,ClinicalTrials.gov,2021-03-11,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04821531
5746,NCT04822701,ClinicalTrials.gov,2021-03-29,2021-04-21,False,Recruiting,Phase 2/Phase 3,Interventional,"Portugal, Belgium, Netherlands, United States, Spain",A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19,1500,https://clinicaltrials.gov/show/NCT04822701
5747,NCT04824443,ClinicalTrials.gov,2021-03-29,2021-03-29,False,Recruiting,Phase 1,Interventional,United States,Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19,20,https://clinicaltrials.gov/show/NCT04824443
5748,NCT04826588,ClinicalTrials.gov,2021-03-31,2021-05-21,False,Recruiting,Phase 3,Interventional,Switzerland,Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY),75,https://clinicaltrials.gov/show/NCT04826588
5749,NCT04830033,ClinicalTrials.gov,2021-03-31,2021-04-28,False,Recruiting,Not Applicable,Interventional,United Kingdom,ENO Breathe vs Usual Care in COVID-19 Recovery,120,https://clinicaltrials.gov/show/NCT04830033
5750,NCT04836806,ClinicalTrials.gov,2021-04-06,2021-08-01,False,Recruiting,Phase 4,Interventional,United States,Cetirizine and Famotidine for COVID-19,160,https://clinicaltrials.gov/show/NCT04836806
5751,NCT04843930,ClinicalTrials.gov,2021-04-10,2021-06-17,False,Recruiting,Phase 2,Interventional,United States,Improving Cognitive Health in COVID-19 Survivors,125,https://clinicaltrials.gov/show/NCT04843930
5752,NCT04844307,ClinicalTrials.gov,2021-03-23,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups,200,https://clinicaltrials.gov/show/NCT04844307
5753,NCT04844489,ClinicalTrials.gov,2021-04-02,2021-04-16,False,Recruiting,Not Applicable,Interventional,France,Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People,485,https://clinicaltrials.gov/show/NCT04844489
5754,NCT04854772,ClinicalTrials.gov,2021-04-20,2021-05-15,False,Recruiting,Not Applicable,Interventional,United States,Mind Body Intervention for COVID-19 Long Haul Syndrome,22,https://clinicaltrials.gov/show/NCT04854772
5755,NCT04858789,ClinicalTrials.gov,2021-04-22,2021-06-24,False,Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04858789
5756,NCT04859517,ClinicalTrials.gov,2021-04-21,2021-04-23,False,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of ADG20 for the Prevention of COVID-19,6412,https://clinicaltrials.gov/show/NCT04859517
5757,NCT04864548,ClinicalTrials.gov,2021-04-20,2021-05-27,False,Recruiting,Phase 1,Interventional,United Kingdom,COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study,64,https://clinicaltrials.gov/show/NCT04864548
5758,NCT04867226,ClinicalTrials.gov,2021-04-25,2021-05-08,False,Not Recruiting,Phase 2,Interventional,Iraq,Effectiveness of Colchicine Among Patients With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04867226
5759,NCT04870593,ClinicalTrials.gov,2021-04-28,2021-04-17,True,Not Recruiting,Not Applicable,Interventional,India,What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India,3006,https://clinicaltrials.gov/show/NCT04870593
5760,NCT04872075,ClinicalTrials.gov,2021-04-29,2021-05-26,False,Not Recruiting,Not Applicable,Interventional,France,Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event,7500,https://clinicaltrials.gov/show/NCT04872075
5761,NCT04878055,ClinicalTrials.gov,2021-04-30,2021-02-14,True,Recruiting,Phase 3,Interventional,"Italy, United States",Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.,312,https://clinicaltrials.gov/show/NCT04878055
5762,NCT04878809,ClinicalTrials.gov,2021-04-28,2021-04-22,True,Not Recruiting,Not Applicable,Interventional,Spain,"Rapid Screening Circuit of COVID 19 in Schools, Pilot Study",153,https://clinicaltrials.gov/show/NCT04878809
5763,NCT04881227,ClinicalTrials.gov,2021-05-10,2021-05-25,False,Recruiting,Not Applicable,Interventional,France,The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT),892,https://clinicaltrials.gov/show/NCT04881227
5764,NCT04888949,ClinicalTrials.gov,2021-05-09,2021-06-15,False,Recruiting,Phase 2,Interventional,Japan,A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),20,https://clinicaltrials.gov/show/NCT04888949
5765,NCT04889209,ClinicalTrials.gov,2021-05-13,2021-05-28,False,Recruiting,Phase 1/Phase 2,Interventional,United States,Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines,400,https://clinicaltrials.gov/show/NCT04889209
5766,NCT04902911,ClinicalTrials.gov,2021-05-21,2021-04-13,True,Recruiting,Not Applicable,Interventional,United States,Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold),120,https://clinicaltrials.gov/show/NCT04902911
5767,NCT04911777,ClinicalTrials.gov,2021-06-01,2021-06-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,"Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandirâ„¢ UPPTA for Patients With Early COVID-19",90,https://clinicaltrials.gov/show/NCT04911777
5768,NCT04915820,ClinicalTrials.gov,2021-05-28,2021-06-04,False,Recruiting,Not Applicable,Interventional,Kenya,Iron and COVID-19 Vaccine Response,112,https://clinicaltrials.gov/show/NCT04915820
5769,NCT04920942,ClinicalTrials.gov,2021-05-31,2021-06-01,False,Recruiting,Phase 4,Interventional,Malaysia,Ivermectin Treatment Efficacy in Covid-19 High Risk Patients,500,https://clinicaltrials.gov/show/NCT04920942
5770,NCT04926428,ClinicalTrials.gov,2021-06-13,2020-12-25,True,Not Recruiting,Not Applicable,Interventional,Mexico,In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection,15,https://clinicaltrials.gov/show/NCT04926428
5771,NCT04926779,ClinicalTrials.gov,2021-06-11,2021-05-24,True,Recruiting,Not Applicable,Interventional,United States,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test",150,https://clinicaltrials.gov/show/NCT04926779
5772,NCT04927065,ClinicalTrials.gov,2021-06-14,2021-05-28,True,Not Recruiting,Phase 2/Phase 3,Interventional,United States,A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants,300,https://clinicaltrials.gov/show/NCT04927065
5773,NCT04927169,ClinicalTrials.gov,2021-06-14,2021-03-01,True,Recruiting,Phase 2,Interventional,Brazil,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort),48,https://clinicaltrials.gov/show/NCT04927169
5774,NCT04927182,ClinicalTrials.gov,2021-06-14,2020-10-15,True,Recruiting,Not Applicable,Interventional,Pakistan,Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.,102,https://clinicaltrials.gov/show/NCT04927182
5775,NCT04927845,ClinicalTrials.gov,2021-06-09,2021-05-19,True,Recruiting,Not Applicable,Interventional,United States,StriveWeekly Trial Post-pandemic,1000,https://clinicaltrials.gov/show/NCT04927845
5776,NCT04927936,ClinicalTrials.gov,2021-06-06,2021-07-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,A Trial Among HealthCare Workers (HCW) Vaccinated With Janssen Vaccine: the SWITCH Trial,432,https://clinicaltrials.gov/show/NCT04927936
5777,NCT04928430,ClinicalTrials.gov,2021-05-27,2021-04-28,True,Recruiting,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19,722,https://clinicaltrials.gov/show/NCT04928430
5778,NCT04928456,ClinicalTrials.gov,2021-06-11,2021-06-11,False,Recruiting,Not Applicable,Interventional,United States,Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps,200,https://clinicaltrials.gov/show/NCT04928456
5779,NCT04928495,ClinicalTrials.gov,2021-06-14,2021-06-09,True,Not Recruiting,Phase 3,Interventional,Brazil,Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19,219,https://clinicaltrials.gov/show/NCT04928495
5780,NCT04929691,ClinicalTrials.gov,2021-06-08,2020-11-13,True,Recruiting,Not Applicable,Interventional,Nigeria,The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19,370,https://clinicaltrials.gov/show/NCT04929691
5781,NCT04930003,ClinicalTrials.gov,2021-02-22,2021-06-15,False,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine",244,https://clinicaltrials.gov/show/NCT04930003
5782,NCT04930770,ClinicalTrials.gov,2021-06-03,2021-08-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination,80,https://clinicaltrials.gov/show/NCT04930770
5783,NCT04930861,ClinicalTrials.gov,2021-06-16,2021-03-29,True,Not Recruiting,Phase 1,Interventional,Brazil,Study of Codivir in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04930861
5784,NCT04930874,ClinicalTrials.gov,2021-06-15,2021-06-22,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Cerebral Autoregulation and COVID-19,37,https://clinicaltrials.gov/show/NCT04930874
5785,NCT04930965,ClinicalTrials.gov,2021-06-16,2021-08-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate,100,https://clinicaltrials.gov/show/NCT04930965
5786,NCT04931004,ClinicalTrials.gov,2021-06-16,2021-07-01,False,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection,90,https://clinicaltrials.gov/show/NCT04931004
5787,NCT04931238,ClinicalTrials.gov,2021-06-13,2021-01-20,True,Recruiting,Phase 1,Interventional,China,"Tolerability,Safety of JS016 in SARS-CoV-2 (COVID-19)",200,https://clinicaltrials.gov/show/NCT04931238
5788,NCT04931888,ClinicalTrials.gov,2021-06-11,2021-06-21,False,Not Recruiting,Not Applicable,Interventional,United States,Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04931888
5789,NCT04932824,ClinicalTrials.gov,2021-04-13,2021-01-19,True,Recruiting,Phase 1,Interventional,Australia,Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.,150,https://clinicaltrials.gov/show/NCT04932824
5790,NCT04932850,ClinicalTrials.gov,2021-06-15,2021-03-01,True,Not Recruiting,Phase 1,Interventional,Italy,Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.,30,https://clinicaltrials.gov/show/NCT04932850
5791,NCT04932915,ClinicalTrials.gov,2021-06-18,2021-06-21,False,Not Recruiting,Phase 2,Interventional,Germany,Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19,330,https://clinicaltrials.gov/show/NCT04932915
5792,NCT04932941,ClinicalTrials.gov,2021-06-18,2021-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,MP1032 Treatment in Patients With Moderate to Severe COVID-19,120,https://clinicaltrials.gov/show/NCT04932941
5793,NCT04933474,ClinicalTrials.gov,2021-06-18,2021-10-01,False,Not Recruiting,Not Applicable,Interventional,United States,"Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain",300,https://clinicaltrials.gov/show/NCT04933474
5794,NCT04933799,ClinicalTrials.gov,2021-04-23,2021-01-06,True,Recruiting,Phase 2,Interventional,United States,IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.,68,https://clinicaltrials.gov/show/NCT04933799
5795,NCT04933864,ClinicalTrials.gov,2021-06-15,2020-04-24,True,Not Recruiting,Phase 1,Interventional,Russian Federation,COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04933864
5796,NCT04933929,ClinicalTrials.gov,2021-05-24,2021-03-05,True,Recruiting,Not Applicable,Interventional,France,Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization,135,https://clinicaltrials.gov/show/NCT04933929
5797,NCT04934111,ClinicalTrials.gov,2021-06-10,2021-09-01,False,Not Recruiting,Phase 1,Interventional,Uganda,"Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19",42,https://clinicaltrials.gov/show/NCT04934111
5798,NCT04935437,ClinicalTrials.gov,2021-06-01,2021-01-21,True,Recruiting,Not Applicable,Interventional,Greece,Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection,40,https://clinicaltrials.gov/show/NCT04935437
5799,NCT04935476,ClinicalTrials.gov,2021-06-21,2021-07-05,False,Not Recruiting,Phase 3,Interventional,"Canada, United States",Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19,3000,https://clinicaltrials.gov/show/NCT04935476
5800,NCT04935489,ClinicalTrials.gov,2021-06-11,2021-07-15,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic,24,https://clinicaltrials.gov/show/NCT04935489
5801,NCT04935502,ClinicalTrials.gov,2021-06-14,2021-03-15,True,Recruiting,Not Applicable,Interventional,Pakistan,Home Based Exercises With and Without Posture and Ergonomics Among Students During COVID-19,100,https://clinicaltrials.gov/show/NCT04935502
5802,NCT04935515,ClinicalTrials.gov,2021-06-20,2021-04-15,True,Not Recruiting,Not Applicable,Interventional,India,C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.,25,https://clinicaltrials.gov/show/NCT04935515
5803,NCT04935528,ClinicalTrials.gov,2021-06-18,2021-06-02,True,Recruiting,Not Applicable,Interventional,France,Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center,430,https://clinicaltrials.gov/show/NCT04935528
5804,NCT04936503,ClinicalTrials.gov,2021-06-02,2020-06-18,True,Not Recruiting,Not Applicable,Interventional,France,Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19,984,https://clinicaltrials.gov/show/NCT04936503
5805,NCT04936893,ClinicalTrials.gov,2021-06-07,2020-05-19,True,Not Recruiting,Not Applicable,Interventional,Singapore,Effects of Mindfulness Practice on Healthcare Workers,80,https://clinicaltrials.gov/show/NCT04936893
5806,NCT04936997,ClinicalTrials.gov,2021-06-18,2021-06-07,True,Recruiting,Phase 1,Interventional,United States,Immune Response to the COVID-19 Vaccine,1000,https://clinicaltrials.gov/show/NCT04936997
5807,NCT04937088,ClinicalTrials.gov,2021-06-16,2021-07-01,False,Not Recruiting,Phase 2,Interventional,No Country Given,Outpatient Liquid Aspirin (OLA),200,https://clinicaltrials.gov/show/NCT04937088
5808,NCT04937543,ClinicalTrials.gov,2021-06-23,2021-06-28,False,Not Recruiting,Phase 2,Interventional,Brazil,Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19,260,https://clinicaltrials.gov/show/NCT04937543
5809,NCT04937556,ClinicalTrials.gov,2021-06-14,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19.,60,https://clinicaltrials.gov/show/NCT04937556
5810,NCT04937569,ClinicalTrials.gov,2021-06-23,2021-07-01,False,Not Recruiting,Phase 3,Interventional,Egypt,Ivermectin Versus Standard Treatment in Mild COVID-19,1644,https://clinicaltrials.gov/show/NCT04937569
5811,NCT04937582,ClinicalTrials.gov,2021-05-28,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,No Country Given,Cognitive and Psychological Disorders After Severe COVID-19 Infection,250,https://clinicaltrials.gov/show/NCT04937582
5812,NCT04937595,ClinicalTrials.gov,2021-06-21,2021-01-01,True,Recruiting,Not Applicable,Interventional,United States,iCareDx PSS-1 Point-of-Care (POC) Assay for Detection of COVID-19,500,https://clinicaltrials.gov/show/NCT04937595
5813,NCT04939402,ClinicalTrials.gov,2021-04-22,2021-05-05,False,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector,200,https://clinicaltrials.gov/show/NCT04939402
5814,NCT04939415,ClinicalTrials.gov,2021-06-21,2021-07-01,False,Not Recruiting,Phase 1,Interventional,United States,Chinese Herbal Formula for COVID-19,66,https://clinicaltrials.gov/show/NCT04939415
5815,NCT04939428,ClinicalTrials.gov,2021-06-24,2021-08-16,False,Not Recruiting,Phase 3,Interventional,No Country Given,Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013),1332,https://clinicaltrials.gov/show/NCT04939428
5816,NCT04939506,ClinicalTrials.gov,2021-06-22,2022-01-01,False,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana,375,https://clinicaltrials.gov/show/NCT04939506
5817,NCT04939519,ClinicalTrials.gov,2021-04-07,2021-03-29,True,Recruiting,Not Applicable,Interventional,United States,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers,128000,https://clinicaltrials.gov/show/NCT04939519
5818,NCT04939532,ClinicalTrials.gov,2021-04-07,2021-03-29,True,Recruiting,Not Applicable,Interventional,United States,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers,128000,https://clinicaltrials.gov/show/NCT04939532
5819,NCT04939714,ClinicalTrials.gov,2021-06-17,2021-06-07,True,Recruiting,Not Applicable,Interventional,United States,Caregiving During Crisis,100,https://clinicaltrials.gov/show/NCT04939714
5820,NCT04940182,ClinicalTrials.gov,2021-06-23,2021-07-01,False,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19,274,https://clinicaltrials.gov/show/NCT04940182
5821,NCT04940195,ClinicalTrials.gov,2021-06-21,2021-07-01,False,Not Recruiting,Not Applicable,Interventional,United States,Clinical Investigation for 2019-nCoV Antigen Saliva Rapid Test Kit and V-CHEK SARS-CoV-2 Antigen Detection Kit to Detect COVID-19,500,https://clinicaltrials.gov/show/NCT04940195
5822,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-20,False,Recruiting,Not Applicable,Interventional,"New Zealand, Australia, South Africa, United Kingdom, United States, Canada, Singapore",Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,154,https://anzctr.org.au/ACTRN12620000448943.aspx
5823,ACTRN12621000637842,ANZCTR,2021-05-27,2021-02-08,True,Not Recruiting,Phase 3,Interventional,"India, Australia",Impact of Colchicine To Improve long-COVID-19 or ARDS Outcomes,1000,https://anzctr.org.au/ACTRN12621000637842.aspx
5824,ACTRN12620000816954,ANZCTR,2020-08-14,2020-08-17,False,Not Recruiting,Phase 1,Interventional,Australia,"A Double-blinded, Randomised, and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults",32,https://anzctr.org.au/ACTRN12620000816954.aspx
5825,ISRCTN16993428,ISRCTN,2021-06-25,2019-04-07,True,Recruiting,Not Applicable,Interventional,"Canada, Ireland, United Kingdom",GenOMICC study - Looking at DNA of patients with severe illness and injury to find the genes that cause some people to become very unwell and be admitted to intensive care,40000,http://isrctn.com/ISRCTN16993428
5826,ISRCTN16269648,ISRCTN,2021-06-24,2021-06-28,False,Recruiting,Not Applicable,Interventional,United Kingdom,Assessing the effectiveness of mouthwashes against SARS-CoV-2 before dental procedures,92,http://isrctn.com/ISRCTN16269648
5827,ISRCTN23403781,ISRCTN,2021-06-16,2020-01-11,True,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluating a school-based programme to prevent offending behaviour among young people,4000,http://isrctn.com/ISRCTN23403781
5828,ISRCTN15162325,ISRCTN,2021-06-15,2021-01-06,True,Not Recruiting,Not Applicable,Interventional,Norway,Social media campaign to increase COVID-19 testing in migrant groups,234112,http://isrctn.com/ISRCTN15162325
5829,ISRCTN38734433,ISRCTN,2021-06-15,2022-07-01,False,Recruiting,Not Applicable,Interventional,Italy,"Better Outcomes for Everybody: a study to evaluate whether a new service delivered by community pharmacists in collaboration with physicians to asthma and COPD patients, improves disease control and is value for money, compared with usual care, during and after COVID-19",1000,http://isrctn.com/ISRCTN38734433
5830,ISRCTN29153109,ISRCTN,2021-06-14,2021-02-17,True,Recruiting,Not Applicable,Interventional,Saudi Arabia,Acceptability of teledentistry during the COVID-19 pandemic in Saudi Arabia,102,http://isrctn.com/ISRCTN29153109
5831,ISRCTN48554326,ISRCTN,2021-06-14,2021-12-05,False,Recruiting,Phase 2,Interventional,Estonia,BioBlock nasal spray against COVID-19,372,http://isrctn.com/ISRCTN48554326
5832,ISRCTN73765130,ISRCTN,2021-05-13,2021-01-06,True,Recruiting,Phase 2,Interventional,United Kingdom,Evaluating COVID-19 Vaccination Boosters,2886,http://isrctn.com/ISRCTN73765130
5833,ISRCTN12272130,ISRCTN,2021-04-22,2021-06-13,False,Not Recruiting,Not Applicable,Interventional,"Netherlands, Nepal","The comprehensive anaemia programme and personalized therapies (CAPPT) trial testing the effect of home visits, tailored iron therapy and womenâ€™s groups to reduce anaemia in pregnant women in southern Nepal",842,http://isrctn.com/ISRCTN12272130
5834,ISRCTN27841311,ISRCTN,2021-03-26,2021-04-19,False,Recruiting,Phase 2,Interventional,United Kingdom,Comparing COVID-19 vaccine schedule combinations  â€“ stage 2,1050,http://isrctn.com/ISRCTN27841311
5835,ISRCTN15328700,ISRCTN,2021-03-12,2021-01-07,True,Recruiting,Not Applicable,Interventional,United Kingdom,Developing and evaluating a diabetes self-management intervention for people with severe mental illness,30,http://isrctn.com/ISRCTN15328700
5836,ISRCTN69254139,ISRCTN,2021-02-03,2021-08-02,False,Recruiting,Phase 2,Interventional,United Kingdom,Comparing coronavirus (COVID-19) vaccine schedule combinations,820,http://isrctn.com/ISRCTN69254139
5837,ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,False,Not Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,240,http://isrctn.com/ISRCTN54917435
5838,ISRCTN12107048,ISRCTN,2020-05-28,2020-08-06,False,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,360,http://isrctn.com/ISRCTN12107048
5839,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,False,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A clinical trial evaluating treatments for suspected and confirmed COVID-19 for recovery at home,6000,http://isrctn.com/ISRCTN86534580
5840,EUCTR2020-001250-21-FR,EU Clinical Trials Register,2020-03-24,2020-03-04,True,Not Recruiting,Phase 2,Interventional,France,COVID-19 - Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease upon Hydroxychloroquine and Azithromycin Therapy in French Cancer patients,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001250-21
5841,EUCTR2020-001320-34-NL,EU Clinical Trials Register,2020-03-30,2020-10-04,False,Not Recruiting,Phase 4,Interventional,Netherlands,A clinicial trial to investigate te effect of valsartan compared to placebo on acute respiratory failure in hospitalized SARS-CoV-2-infected patients,651,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001320-34
5842,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-03-04,True,Not Recruiting,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32
5843,EUCTR2020-001206-35-DE,EU Clinical Trials Register,2020-04-09,2020-04-14,False,Not Recruiting,Phase 4,Interventional,"Germany, Austria",Discontinuation of ACE inhibitors in patients with COVID-19 infection,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35
5844,EUCTR2020-005524-11-CZ,EU Clinical Trials Register,2020-12-01,2020-12-21,False,Not Recruiting,Phase 4,Interventional,Czech Republic,IMUNORÂ® preparation in the prevention of COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005524-11
5845,EUCTR2020-003936-25-FR,EU Clinical Trials Register,2021-01-28,2021-06-04,False,Authorised,Phase 2/Phase 3,Interventional,"France, Italy",Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25
5846,EUCTR2021-001070-38-DE,EU Clinical Trials Register,2021-03-24,2021-06-21,False,Authorised,Phase 2,Interventional,Germany,B-pVAC-SARS-CoV-2: Phase I/II multi-center safety and immungenicity trial of multi-peptide vaccination to prevent COVID-19 infection in adults with B-cell/antibody deficiency,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001070-38
5847,EUCTR2020-005759-18-FR,EU Clinical Trials Register,2021-03-24,2021-08-06,False,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18
5848,EUCTR2021-000045-41-FR,EU Clinical Trials Register,2021-04-12,2021-08-06,False,Authorised,Phase 2/Phase 3,Interventional,France,"Adaptive, Ambulatory, Randomised, Placebo-Controlled, Double-Blind, Phase 2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of TEE001DP in Patients at the Early Stage of Symptomatic COVID-19",686,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000045-41
5849,EUCTR2021-002174-52-FR,EU Clinical Trials Register,2021-05-06,2021-05-19,False,Authorised,Phase 3,Interventional,France,,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002174-52
5850,EUCTR2020-005523-37-DE,EU Clinical Trials Register,2021-04-26,2021-06-21,False,Authorised,Phase 2,Interventional,Germany,A prospective controlled proof-of-concept trial to demonstrate anti-viral effects of oral bromelaine in COVID-19 positive patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005523-37
5851,EUCTR2021-003388-90-NL,EU Clinical Trials Register,2021-06-21,,False,Not Available,Phase 4,Interventional,Netherlands,Monitoring response on COVID-19 vaccination in children with cancer,130,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-003388-90
5852,EUCTR2020-000936-23-BE,EU Clinical Trials Register,2020-03-27,2020-05-20,False,Authorised,Phase 3,Interventional,"Portugal, Belgium, Czech Republic, Norway, Turkey, Austria, France",Safety and efficacy of treatments of COVID-19 in hospitalized adults (Discovery),1240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23
5853,EUCTR2020-001335-28-NL,EU Clinical Trials Register,2020-03-27,2020-03-29,False,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, South Africa, Peru, Belgium, Netherlands, United States, Brazil, Mexico, France, Germany",A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,430,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28
5854,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 â€“ a pilot study,20,https://trialregister.nl/trial/8523
5855,NL8521,Netherlands Trial Register,2020-04-13,2020-08-05,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,13,https://trialregister.nl/trial/8521
5856,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),124,https://trialregister.nl/trial/8578
5857,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,394,https://trialregister.nl/trial/8577
5858,NL9275,Netherlands Trial Register,2021-02-16,2021-01-03,True,Not Recruiting,Not Applicable,Interventional,Netherlands,"Establishing the tolerability, safety and immunogenicity of intradermal delivery of mRNA SARS-CoV-2 vaccine in healthy adults",150,https://trialregister.nl/trial/9275
5859,NL8609,Netherlands Trial Register,2020-05-11,2020-05-25,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),100,https://trialregister.nl/trial/8609
5860,NL8547,Netherlands Trial Register,2020-04-22,2020-04-16,True,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GUÃ‰RIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",1600,https://trialregister.nl/trial/8547
5861,NL8633,Netherlands Trial Register,2020-05-13,2020-05-13,False,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",430,https://trialregister.nl/trial/8633
5862,NL9320,Netherlands Trial Register,2021-02-18,2021-02-25,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Remote Early Detection of SARS-CoV-2 infections,20000,https://trialregister.nl/trial/9320
5863,NL8726,Netherlands Trial Register,2020-06-23,2020-01-06,True,Recruiting,Not Applicable,Interventional,Netherlands,Effect of hydroxychloroquine treatment on the general immunocompetence,40,https://trialregister.nl/trial/8726
5864,NL9334,Netherlands Trial Register,2021-03-10,2021-11-03,False,Recruiting,Not Applicable,Interventional,Netherlands,Safety and tolerability of ABNCoV2,42,https://trialregister.nl/trial/9334
5865,NL8490,Netherlands Trial Register,2020-03-31,2020-12-04,False,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",950,https://trialregister.nl/trial/8490
5866,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,342,https://trialregister.nl/trial/8538
5867,NL8787,Netherlands Trial Register,2020-07-21,2020-01-06,True,Recruiting,Not Applicable,Interventional,Netherlands,COVID-VTE follow-up study,400,https://trialregister.nl/trial/8787
5868,NL9081,Netherlands Trial Register,2020-11-30,2021-11-01,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Early@home,62,https://trialregister.nl/trial/9081
5869,NL9354,Netherlands Trial Register,2021-03-23,2021-02-17,True,Recruiting,Not Applicable,Interventional,Netherlands,Intranasal Ampligen in healthy volunteers.,40,https://trialregister.nl/trial/9354
5870,NL9365,Netherlands Trial Register,2021-03-25,2021-08-02,False,Recruiting,Not Applicable,Interventional,Netherlands,Behavioural interventions to increase test uptake and self-isolation compliance during Covid-19 community test pilots in the Netherlands: four population-level randomised control trials.,25644,https://trialregister.nl/trial/9365
5871,NL8477,Netherlands Trial Register,2020-03-20,2020-03-20,False,Not Recruiting,Not Applicable,Interventional,Netherlands,BCG vaccination for healthcare workers in SARS-CoV-2 pandemic,1500,https://trialregister.nl/trial/8477
5872,NL8842,Netherlands Trial Register,2020-08-18,2020-09-04,False,Recruiting,Not Applicable,Interventional,Netherlands,Online Communities,50,https://trialregister.nl/trial/8842
5873,NL9379,Netherlands Trial Register,2021-03-29,2021-01-04,True,Recruiting,Not Applicable,Interventional,Netherlands,A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV2 immunoglobulines,104,https://trialregister.nl/trial/9379
5874,NL8903,Netherlands Trial Register,2020-09-15,2020-09-15,False,Recruiting,Not Applicable,Interventional,Netherlands,A diet for the treatment of gout,30,https://trialregister.nl/trial/8903
5875,NL8922,Netherlands Trial Register,2020-09-23,2020-01-10,True,Not Recruiting,Not Applicable,Interventional,Netherlands,"COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial",2200,https://trialregister.nl/trial/8922
5876,NL8835,Netherlands Trial Register,2020-08-14,2020-06-29,True,Not Recruiting,Not Applicable,Interventional,Netherlands,"Intensive Care Unit specific Virtual Reality (ICU-VR) to improve psychological impairments in survivors of COVID-19; a multicentre, randomised controlled trial.",80,https://trialregister.nl/trial/8835
5877,NL9419,Netherlands Trial Register,2021-04-19,2021-04-19,False,Recruiting,Not Applicable,Interventional,Netherlands,Precision Medicine for more Oxygen - COVID-19 extension,100,https://trialregister.nl/trial/9419
5878,NL8993,Netherlands Trial Register,2020-10-21,2020-01-07,True,Recruiting,Not Applicable,Interventional,Netherlands,Online cognitive behavioral therapy for distress in people who lost a loved one during the corona pandemic: A randomized waitlist-controlled trial,52,https://trialregister.nl/trial/8993
5879,NL9007,Netherlands Trial Register,2020-10-29,2020-09-06,True,Recruiting,Not Applicable,Interventional,Netherlands,"Exercise via videoconferencing for people with severe mental illness during covid-19 times, a feasibility study",70,https://trialregister.nl/trial/9007
5880,NL9019,Netherlands Trial Register,2020-10-23,2020-10-23,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,200,https://trialregister.nl/trial/9019
5881,NL8947,Netherlands Trial Register,2020-10-04,2020-05-10,True,Recruiting,Not Applicable,Interventional,Netherlands,ReCOVer: Cognitive Behavioural Therapy for post-COVID-19 fatigue,114,https://trialregister.nl/trial/8947
5882,NL9430,Netherlands Trial Register,2021-02-04,2021-01-20,True,Recruiting,Not Applicable,Interventional,Netherlands,Intranasal LMWH against COVID-19,24,https://trialregister.nl/trial/9430
5883,NL9436,Netherlands Trial Register,2021-04-22,2021-04-15,True,Recruiting,Not Applicable,Interventional,Netherlands,COVID-Compromise,86,https://trialregister.nl/trial/9436
5884,NL8954,Netherlands Trial Register,2020-10-06,2020-01-11,True,Recruiting,Not Applicable,Interventional,Netherlands,A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home,50,https://trialregister.nl/trial/8954
5885,NL9141,Netherlands Trial Register,2020-12-23,2020-12-23,False,Not Recruiting,Not Applicable,Interventional,Netherlands,Obesity and COVID-19: AdipoSe TissuE Responses to SARS-CoV-2 infection,36,https://trialregister.nl/trial/9141
5886,NL9161,Netherlands Trial Register,2021-01-08,2020-10-23,True,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,200,https://trialregister.nl/trial/9161
5887,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,17000,https://trialregister.nl/trial/8483
5888,NL9220,Netherlands Trial Register,2021-01-25,2021-01-25,False,Recruiting,Not Applicable,Interventional,Netherlands,Virtual reality for relatives of ICU patients (ICU-VR-F) to improve psychological sequelae.,160,https://trialregister.nl/trial/9220
5889,NL8491,Netherlands Trial Register,2020-03-31,2020-03-31,False,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,386,https://trialregister.nl/trial/8491
5890,NL9485,Netherlands Trial Register,2021-05-18,2021-01-03,True,Recruiting,Not Applicable,Interventional,Netherlands,Online guided vs. unguided cognitive behavioral therapy for distress in people who lost a loved one during the COVID-19 pandemic: A controlled trial,102,https://trialregister.nl/trial/9485
5891,NL8504,Netherlands Trial Register,2020-04-03,2020-06-04,False,Not Recruiting,Not Applicable,Interventional,Netherlands,"Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial",354,https://trialregister.nl/trial/8504
5892,NL9553,Netherlands Trial Register,2021-06-07,2021-01-03,True,Not Recruiting,Not Applicable,Interventional,Netherlands,"COVID-19 vaccination in patients with reduced B-cell and T-cell immunity: response after vaccination of a kaleidoscopic group hematological patients, whatâ€™s the impact?",850,https://trialregister.nl/trial/9553
5893,PER-010-20,REPEC,2020-04-16,2020-03-04,True,Recruiting,Phase 3,Interventional,"Argentina, Iran, South Africa, Peru, Bahrain, Norway, Thailand, Spain, India, Switzerland",SOLIDARITY: AN INTERNATIONAL RANDOMIZED CONTROLLED TRIAL TO EVALUATE NON-LICENSED COVID-19 TREATMENTS IN ADDITION TO STANDARD OF CARE AMONG HOSPITALIZED PATIENTS,1000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=010-20
5894,PER-013-20,REPEC,2020-06-25,2020-01-06,True,Not Recruiting,Phase 2,Interventional,Peru,CONVALESCENT PLASMA AS TREATMENT FOR COVID-19,192,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20
5895,PER-016-20,REPEC,2020-06-27,2020-01-06,True,Not Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: EVALUATING THE USE OF CONVALESCENT PLASMA AS MANAGEMENT OF COVID-19,98,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=016-20
5896,PER-018-20,REPEC,2020-06-30,2020-05-07,True,Recruiting,Phase 2,Interventional,"Chile, Sweden, Argentina, Russian Federation, South Africa, Peru, Italy, Brazil, Turkey, Spain, Japan, Mexico, India, Germany","
					A PHASE 2, OPEN LABEL, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF
					ACALABRUTINIB WITH BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE IN
					SUBJECTS HOSPITALIZED WITH COVID-19
				",30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=018-20
5897,PER-030-20,REPEC,2020-07-22,2020-03-08,True,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, Peru, Colombia, Canada, United Kindgdom, Italy, Brazil, Spain, Mexico, United States, France, Germany","PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID)",60,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=030-20
5898,PER-031-20,REPEC,2020-07-27,2020-06-07,True,Not Recruiting,Phase 2,Interventional,Peru,PHASE 2 STUDY OF EFFICACY AND SAFETY OF PLASMA FROM CONVALESCENT PATIENTS WITH COVID-19 IN PATIENTS WITH MODERATE DISEASE (AUNA 20-01),50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20
5899,PER-032-20,REPEC,2020-07-23,2020-07-22,True,Recruiting,Phase 2,Interventional,"Chile, Ireland, South Africa, Peru, United Kindgdom, Italy, United States","A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAVRILIMUMAB (KPL-301) TREATMENT IN ADULT SUBJECTS HOSPITALIZED WITH SEVERE COVID-19 PNEUMONIA AND HYPER-INFLAMMATION",115,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20
5900,PER-034-20,REPEC,2020-07-17,2020-09-07,False,Recruiting,Phase 2,Interventional,Peru,RANDOMIZED PHASE IIA CLINICAL TRIAL TO COMPARE THE EFFICACY OF IVERMECTIN VERSUS PLACEBO TO OBTAIN NEGATIVE PCR RESULTS IN PATIENTS WITH EARLY PHASE COVID-19,68,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20
5901,PER-042-20,REPEC,2020-08-21,2020-01-08,True,Not Recruiting,Phase 2,Interventional,"Chile, Sweden, Argentina, South Africa, Peru, Belgium, Colombia, Canada, United Kindgdom, United States, Brazil, Spain, Mexico, Japan, Poland, France, India, Nederland",Investigating otilimab in patients with severe pulmonary COVID-19 related disease,35,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=042-20
5902,PER-048-20,REPEC,2020-09-28,2020-04-09,True,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Canada, United States, Brazil, Mexico, Philippines","
					A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO ASSESS THE EFFICACY AND
					SAFETY OF AD26.COV2.S FOR THE PREVENTION OF SARS-COV-2-MEDIATED COVID-19 IN ADULTS
					AGED 18 YEARS AND OLDER
				",2000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=048-20
5903,PER-050-20,REPEC,2020-09-17,2020-09-28,False,Not Recruiting,Phase 2,Interventional,"Denmark, Argentina, Hungary, Russian Federation, Peru, Ukraine, Italy, Brazil, Spain, United States, France, Germany, Philippines, Romania","â€œA PHASE 1/2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF TL-895 WITH STANDARD AVAILABLE TREATMENT VERSUS STANDARD AVAILABLE TREATMENT FOR THE TREATMENT OF COVID-19 IN PATIENTS WITH CANCERâ€",30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20
5904,PER-054-20,REPEC,2020-08-20,2020-10-09,False,Not Recruiting,Phase 2,Interventional,"Panama, Peru, Brazil","COVID-19: A PHASE 2A, PARTIALLY OBSERVER-BLIND, MULTICENTER, CONTROLLED, DOSE-CONFIRMATION CLINICAL TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF THE INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS >60 YEARS OF AGE AND 18 TO 60 YEARS OF AGE",270,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20
5905,PER-055-20,REPEC,2020-08-31,2020-01-10,True,Recruiting,Phase 2,Interventional,"Denmark, Argentina, South Africa, Peru, Brazil, Spain, Mexico, Hungaria, India, Germany",STUDY OF EFFICACY AND SAFETY OF DFV890 IN PATIENTS WITH COVID-19 PNEUMONIA,20,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=055-20
5906,PER-059-20,REPEC,2020-09-17,2020-03-11,True,Recruiting,Phase 3,Interventional,"Chile, Peru, United States","
					A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY IN ADULTS TO DETERMINE THE SAFETY, EFFICACY, AND
					IMMUNOGENICITY OF AZD1222, A NON-REPLICATING CHADOX1 VECTOR VACCINE, FOR THE PREVENTION OF COVID-19
				",5000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=059-20
5907,PER-060-20,REPEC,2020-09-21,2020-07-09,True,Recruiting,Phase 2,Interventional,Peru,"
					RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF THE USE OF PLASMA FROM CONVALESCENT PATIENTS WITH THE NEW CORONAVIRUS DISEASE (COVID-19) FOR THE EXPERIMENTAL TREATMENT  OF PATIENTS HOSPITALIZED IN THE CENTRO MÃ‰DICO NAVAL ""CIRUJANO MAYOR SANTIAGO TÃVARA""
					""
				",100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20
5908,PER-064-20,REPEC,2020-09-29,2020-01-10,True,Recruiting,Phase 2,Interventional,Peru,LACTOFERRIN FOR PREVENTION OF COVID-19 IN HEALTH CARE PERSONNEL.,336,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20
5909,PER-067-20,REPEC,2020-10-29,2020-09-18,True,Not Recruiting,Phase 2,Interventional,Argentina,"A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTI CENTER STUDY OF OT 101 IN HOSPITALIZED COVID 19 SUBJECTS",48,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20
5910,PER-069-20,REPEC,2020-10-05,2020-10-15,False,Not Recruiting,Phase 2,Interventional,"Hungary, Poland, Slovakia, Belgium, Czech Republic, United Kindgdom, Italy, Spain, Austria, France, Slovenia, Germany","â€œA PHASE 2/3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND THE SAFETY OF ABX464 IN TREATING INFLAMMATION AND PREVENTING COVID-19 ASSOCIATED ACUTE RESPIRATORY FAILURE IN PATIENTS AGED &#8805; 65 AND PATIENTS AGED &#8805;18 WITH AT LEAST ONE ADDITIONAL RISK FACTOR WHO ARE INFECTED WITH SARS-COV-2. (THE MIR-AGE STUDY).â€",100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=069-20
5911,PER-090-20,REPEC,2020-12-16,2020-12-19,False,Recruiting,Phase 2,Interventional,"Argentina, Peru, United States","A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ANTROQUINONOL IN HOSPITALIZED PATIENTS WITH MILD TO MODERATE PNEUMONIA DUE TO COVID-19",50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=090-20
5912,PER-093-20,REPEC,2020-12-30,2020-11-23,True,Not Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia, United States, Mexico, Brazil",LOSVID STUDY,60,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=093-20
5913,PER-095-20,REPEC,2020-12-15,2020-01-12,True,Not Recruiting,Phase 2,Interventional,"Chile, Peru, Canada, United Kindgdom, Italy, Brazil, Spain, United States","A RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY VIR-7831 FOR THE EARLY TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) IN NON-HOSPITALIZED PATIENTS",50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=095-20
5914,PER-099-20,REPEC,2020-12-30,2020-11-30,True,Recruiting,Phase 2,Interventional,"Argentina, Peru, Colombia, United States, Mexico",Fenofibrate research for the treatment of COVID-19.,150,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=099-20
5915,PER-101-20,REPEC,2020-12-30,2021-04-01,False,Not Recruiting,Phase 3,Interventional,United States,"
					RANDOMIZED MASTER PROTOCOL FOR IMMUNE MODULATORS FOR TREATING COVID-19
				",200,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=101-20
5916,PER-106-20,REPEC,2020-12-29,2020-12-30,False,Recruiting,Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Belgium, Colombia, Mexico, Spain, Germany, Nederland",HERALD,10720,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=106-20
5917,PER-108-20,REPEC,2021-03-23,2021-01-01,True,Not Recruiting,Phase 2,Interventional,"Russian Federation, Peru, Brazil, Mexico, Israel","OPAGANIB, A SPHINGOSINE KINASE-2 (SK-2) INHIBITOR IN COVID-19 PNEUMONIA: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN HOSPITALIZED ADULT SUBJECTS WITH SEVERE SARS-COV-PNEUMONIA- 2 POSITIVE",55,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=108-20
